IL-2 G#other_name_B XX-d G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
and NE xxx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
activation G#other_name_E xxx G#other_name_E
through NE xxx NE
CD28 G#protein_molecule XXdd G#protein_molecule
requires NE xxx NE
reactive NE xxx NE
oxygen NE xxx NE
production NE xxx NE
by NE xx NE
5-lipoxygenase G#protein_molecule d-xxx G#protein_molecule
. NE . NE

Activation NE Xxxx NE
of NE xx NE
the NE xxx NE
CD28 G#protein_family_or_group_B XXdd G#protein_family_or_group_B
surface G#protein_family_or_group_M xxx G#protein_family_or_group_M
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
provides NE xxx NE
a NE x NE
major NE xxx NE
costimulatory NE xxx NE
signal NE xxx NE
for NE xxx NE
T G#other_name_B X G#other_name_B
cell G#other_name_M xxx G#other_name_M
activation G#other_name_E xxx G#other_name_E
resulting NE xxx NE
in NE xx NE
enhanced NE xxx NE
production NE xxx NE
of NE xx NE
interleukin-2 G#protein_molecule xxx-d G#protein_molecule
( NE ( NE
IL-2 G#protein_molecule XX-d G#protein_molecule
) NE ) NE
and NE xxx NE
cell G#other_name_B xxx G#other_name_B
proliferation G#other_name_E xxx G#other_name_E
. NE . NE

In NE Xx NE
primary G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
lymphocytes G#cell_type_E xxx G#cell_type_E
we NE xx NE
show NE xxx NE
that NE xxx NE
CD28 G#protein_molecule XXdd G#protein_molecule
ligation NE xxx NE
leads NE xxx NE
to NE xx NE
the NE xxx NE
rapid NE xxx NE
intracellular NE xxx NE
formation NE xxx NE
of NE xx NE
reactive G#inorganic_B xxx G#inorganic_B
oxygen G#inorganic_M xxx G#inorganic_M
intermediates G#inorganic_E xxx G#inorganic_E
( NE ( NE
ROIs G#inorganic XXXx G#inorganic
) NE ) NE
which NE xxx NE
are NE xxx NE
required NE xxx NE
for NE xxx NE
CD28 NE XXdd NE
-mediated NE -xxx NE
activation NE xxx NE
of NE xx NE
the NE xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
/ NE / NE
CD28 NE XXdd NE
-responsive NE -xxx NE
complex NE xxx NE
and NE xxx NE
IL-2 NE XX-d NE
expression NE xxx NE
. NE . NE

Delineation NE Xxxx NE
of NE xx NE
the NE xxx NE
CD28 G#other_name_B XXdd G#other_name_B
signaling G#other_name_M xxx G#other_name_M
cascade G#other_name_E xxx G#other_name_E
was NE xxx NE
found NE xxx NE
to NE xx NE
involve NE xxx NE
protein G#other_name_B xxx G#other_name_B
tyrosine G#other_name_M xxx G#other_name_M
kinase G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
, NE , NE
followed NE xxx NE
by NE xx NE
the NE xxx NE
activation NE xxx NE
of NE xx NE
phospholipase G#protein_molecule_B xxx G#protein_molecule_B
A2 G#protein_molecule_E Xd G#protein_molecule_E
and NE xxx NE
5-lipoxygenase G#protein_molecule d-xxx G#protein_molecule
. NE . NE

Our NE Xxx NE
data NE xxx NE
suggest NE xxx NE
that NE xxx NE
lipoxygenase G#protein_family_or_group_B xxx G#protein_family_or_group_B
metabolites G#protein_family_or_group_E xxx G#protein_family_or_group_E
activate NE xxx NE
ROI G#other_name_B XXX G#other_name_B
formation G#other_name_E xxx G#other_name_E
which NE xxx NE
then NE xxx NE
induce NE xxx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
expression NE xxx NE
via NE xxx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
activation G#other_name_E xxx G#other_name_E
. NE . NE

These NE Xxxx NE
findings NE xxx NE
should NE xxx NE
be NE xx NE
useful NE xxx NE
for NE xxx NE
therapeutic G#other_name_B xxx G#other_name_B
strategies G#other_name_E xxx G#other_name_E
and NE xxx NE
the NE xxx NE
development NE xxx NE
of NE xx NE
immunosuppressants G#other_name xxx G#other_name
targeting NE xxx NE
the NE xxx NE
CD28 G#other_name_B XXdd G#other_name_B
costimulatory G#other_name_M xxx G#other_name_M
pathway G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
peri-kappa G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
B G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
mediates NE xxx NE
human G#other_name_B xxx G#other_name_B
immunodeficiency G#other_name_M xxx G#other_name_M
virus G#other_name_M xxx G#other_name_M
type G#other_name_M xxx G#other_name_M
2 G#other_name_M d G#other_name_M
enhancer G#other_name_M xxx G#other_name_M
activation G#other_name_E xxx G#other_name_E
in NE xx NE
monocytes G#cell_type xxx G#cell_type
but NE xxx NE
not NE xxx NE
in NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Human G#virus_B Xxxx G#virus_B
immunodeficiency G#virus_M xxx G#virus_M
virus G#virus_M xxx G#virus_M
type G#virus_M xxx G#virus_M
2 G#virus_E d G#virus_E
( NE ( NE
HIV-2 G#virus XXX-d G#virus
) NE ) NE
, NE , NE
like NE xxx NE
HIV-1 G#virus XXX-d G#virus
, NE , NE
causes NE xxx NE
AIDS G#other_name XXXX G#other_name
and NE xxx NE
is NE xx NE
associated NE xxx NE
with NE xxx NE
AIDS G#other_name XXXX G#other_name
cases NE xxx NE
primarily NE xxx NE
in NE xx NE
West NE Xxxx NE
Africa NE Xxxx NE
. NE . NE

HIV-1 G#virus XXX-d G#virus
and NE xxx NE
HIV-2 G#virus XXX-d G#virus
display NE xxx NE
significant NE xxx NE
differences NE xxx NE
in NE xx NE
nucleic G#DNA_N/A_B xxx G#DNA_N/A_B
acid G#DNA_N/A_M xxx G#DNA_N/A_M
sequence G#DNA_N/A_E xxx G#DNA_N/A_E
and NE xxx NE
in NE xx NE
the NE xxx NE
natural NE xxx NE
history NE xxx NE
of NE xx NE
clinical NE xxx NE
disease NE xxx NE
. NE . NE

Consistent NE Xxxx NE
with NE xxx NE
these NE xxx NE
differences NE xxx NE
, NE , NE
we NE xx NE
have NE xxx NE
previously NE xxx NE
demonstrated NE xxx NE
that NE xxx NE
the NE xxx NE
enhancer/promoter G#DNA_domain_or_region_B xxx/xxx G#DNA_domain_or_region_B
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
HIV-2 G#virus XXX-d G#virus
functions NE xxx NE
quite NE xxx NE
differently NE xxx NE
from NE xxx NE
that NE xxx NE
of NE xx NE
HIV-1 G#virus XXX-d G#virus
. NE . NE

Whereas NE Xxxx NE
activation NE xxx NE
of NE xx NE
the NE xxx NE
HIV-1 G#DNA_domain_or_region_B XXX-d G#DNA_domain_or_region_B
enhancer G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
following NE xxx NE
T-cell G#other_name_B X-xxx G#other_name_B
stimulation G#other_name_E xxx G#other_name_E
is NE xx NE
mediated NE xxx NE
largely NE xxx NE
through NE xxx NE
binding NE xxx NE
of NE xx NE
the NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
to NE xx NE
two NE xxx NE
adjacent NE xxx NE
kappa G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
B G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
the NE xxx NE
HIV-1 G#DNA_domain_or_region_B XXX-d G#DNA_domain_or_region_B
long G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
terminal G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
repeat G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
activation NE xxx NE
of NE xx NE
the NE xxx NE
HIV-2 G#DNA_domain_or_region_B XXX-d G#DNA_domain_or_region_B
enhancer G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
monocytes G#cell_type xxx G#cell_type
and NE xxx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
is NE xx NE
dependent NE xxx NE
on NE xx NE
four NE xxx NE
cis-acting G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
elements G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
: NE : NE
a NE x NE
single NE xxx NE
kappa G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
B G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
two NE xxx NE
purine-rich G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
PuB1 G#DNA_domain_or_region XxXd G#DNA_domain_or_region
and NE xxx NE
PuB2 G#DNA_domain_or_region XxXd G#DNA_domain_or_region
, NE , NE
and NE xxx NE
a NE x NE
pets G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

We NE Xx NE
have NE xxx NE
now NE xxx NE
identified NE xxx NE
a NE x NE
novel NE xxx NE
cis-acting G#DNA_family_or_group_B xxx-xxx G#DNA_family_or_group_B
element G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
within NE xxx NE
the NE xxx NE
HIV-2 G#DNA_domain_or_region_B XXX-d G#DNA_domain_or_region_B
enhancer G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
immediately NE xxx NE
upstream NE xxx NE
of NE xx NE
the NE xxx NE
kappa G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
B G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
designated NE xxx NE
peri-kappa G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
B G#DNA_domain_or_region_E X G#DNA_domain_or_region_E
. NE . NE

This NE Xxxx NE
site NE xxx NE
is NE xx NE
conserved NE xxx NE
among NE xxx NE
isolates NE xxx NE
of NE xx NE
HIV-2 G#virus XXX-d G#virus
and NE xxx NE
the NE xxx NE
closely NE xxx NE
related NE xxx NE
simian G#virus_B xxx G#virus_B
immunodeficiency G#virus_M xxx G#virus_M
virus G#virus_E xxx G#virus_E
, NE , NE
and NE xxx NE
transfection G#other_name_B xxx G#other_name_B
assays G#other_name_E xxx G#other_name_E
show NE xxx NE
this NE xxx NE
site NE xxx NE
to NE xx NE
mediate NE xxx NE
HIV-2 G#other_name_B XXX-d G#other_name_B
enhancer G#other_name_M xxx G#other_name_M
activation G#other_name_E xxx G#other_name_E
following NE xxx NE
stimulation NE xxx NE
of NE xx NE
monocytic NE xxx NE
but NE xxx NE
not NE xxx NE
T-cell NE X-xxx NE
lines NE xxx NE
. NE . NE

This NE Xxxx NE
is NE xx NE
the NE xxx NE
first NE xxx NE
description NE xxx NE
of NE xx NE
an NE xx NE
HIV-2 G#DNA_domain_or_region_B XXX-d G#DNA_domain_or_region_B
enhancer G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
which NE xxx NE
displays NE xxx NE
such NE xxx NE
monocyte NE xxx NE
specificity NE xxx NE
, NE , NE
and NE xxx NE
no NE xx NE
comparable NE xxx NE
enhancer G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
has NE xxx NE
been NE xxx NE
clearly NE xxx NE
defined NE xxx NE
for NE xxx NE
HIV-1 G#virus XXX-d G#virus
. NE . NE

While NE Xxxx NE
a NE x NE
nuclear G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
(s) NE (x) NE
from NE xxx NE
both NE xxx NE
peripheral G#cell_type_B xxx G#cell_type_B
blood G#cell_type_M xxx G#cell_type_M
monocytes G#cell_type_E xxx G#cell_type_E
and NE xxx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
binds NE xxx NE
the NE xxx NE
peri-kappa G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
B G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
electrophoretic G#other_name_B xxx G#other_name_B
mobility G#other_name_M xxx G#other_name_M
shift G#other_name_M xxx G#other_name_M
assays G#other_name_E xxx G#other_name_E
suggest NE xxx NE
that NE xxx NE
either NE xxx NE
a NE x NE
different NE xxx NE
protein NE xxx NE
binds NE xxx NE
to NE xx NE
this NE xxx NE
site NE xxx NE
in NE xx NE
monocytes G#cell_type xxx G#cell_type
versus NE xxx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
or NE xx NE
that NE xxx NE
the NE xxx NE
protein NE xxx NE
recognizing NE xxx NE
this NE xxx NE
enhancer G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
undergoes NE xxx NE
differential G#other_name_B xxx G#other_name_B
modification G#other_name_E xxx G#other_name_E
in NE xx NE
monocytes G#cell_type xxx G#cell_type
and NE xxx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
, NE , NE
thus NE xxx NE
supporting NE xxx NE
the NE xxx NE
transfection NE xxx NE
data NE xxx NE
. NE . NE

Further NE Xxxx NE
, NE , NE
while NE xxx NE
specific NE xxx NE
constitutive NE xxx NE
binding NE xxx NE
to NE xx NE
the NE xxx NE
peri-kappa G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
B G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
is NE xx NE
seen NE xxx NE
in NE xx NE
monocytes G#cell_type xxx G#cell_type
, NE , NE
stimulation NE xxx NE
with NE xxx NE
phorbol G#other_organic_compound_B xxx G#other_organic_compound_B
esters G#other_organic_compound_E xxx G#other_organic_compound_E
induces NE xxx NE
additional NE xxx NE
, NE , NE
specific NE xxx NE
binding NE xxx NE
. NE . NE

Understanding NE Xxxx NE
the NE xxx NE
monocyte-specific G#other_name_B xxx-xxx G#other_name_B
function G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
peri-kappa G#protein_molecule_B xxx-xxx G#protein_molecule_B
B G#protein_molecule_M X G#protein_molecule_M
factor G#protein_molecule_E xxx G#protein_molecule_E
may NE xxx NE
ultimately NE xxx NE
provide NE xxx NE
insight NE xxx NE
into NE xxx NE
the NE xxx NE
different NE xxx NE
role NE xxx NE
monocytes G#cell_type xxx G#cell_type
and NE xxx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
play NE xxx NE
in NE xx NE
HIV G#other_name_B XXX G#other_name_B
pathogenesis G#other_name_E xxx G#other_name_E
. NE . NE

E1A G#other_name_B XdX G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
induces NE xxx NE
susceptibility NE xxx NE
to NE xx NE
killing NE xxx NE
by NE xx NE
NK G#cell_type_B XX G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
following NE xxx NE
immortalization NE xxx NE
but NE xxx NE
not NE xxx NE
adenovirus G#other_name_B xxx G#other_name_B
infection G#other_name_E xxx G#other_name_E
of NE xx NE
human G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Adenovirus G#other_name_B Xxxx G#other_name_B
(Ad) G#other_name_M (Xx) G#other_name_M
infection G#other_name_E xxx G#other_name_E
and NE xxx NE
E1A G#other_name_B XdX G#other_name_B
transfection G#other_name_E xxx G#other_name_E
were NE xxx NE
used NE xxx NE
to NE xx NE
model NE xxx NE
changes NE xxx NE
in NE xx NE
susceptibility NE xxx NE
to NE xx NE
NK G#other_name_B XX G#other_name_B
cell G#other_name_M xxx G#other_name_M
killing G#other_name_E xxx G#other_name_E
caused NE xxx NE
by NE xx NE
transient NE xxx NE
vs NE xx NE
stable NE xxx NE
E1A G#other_name_B XdX G#other_name_B
expression G#other_name_E xxx G#other_name_E
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Only NE Xxxx NE
stably NE xxx NE
transfected G#cell_line_B xxx G#cell_line_B
target G#cell_line_M xxx G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
exhibited NE xxx NE
cytolytic NE xxx NE
susceptibility NE xxx NE
, NE , NE
despite NE xxx NE
expression NE xxx NE
of NE xx NE
equivalent NE xxx NE
levels NE xxx NE
of NE xx NE
E1A G#protein_family_or_group_B XdX G#protein_family_or_group_B
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
in NE xx NE
Ad-infected G#cell_line_B Xx-xxx G#cell_line_B
targets G#cell_line_E xxx G#cell_line_E
. NE . NE

The NE Xxx NE
inability NE xxx NE
of NE xx NE
E1A G#DNA_domain_or_region_B XdX G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
products NE xxx NE
to NE xx NE
induce NE xxx NE
cytolytic G#other_name_B xxx G#other_name_B
susceptibility G#other_name_E xxx G#other_name_E
during NE xxx NE
infection NE xxx NE
was NE xxx NE
not NE xxx NE
explained NE xxx NE
by NE xx NE
an NE xx NE
inhibitory NE xxx NE
effect NE xxx NE
of NE xx NE
viral NE xxx NE
infection NE xxx NE
on NE xx NE
otherwise NE xxx NE
susceptible NE xxx NE
target G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
or NE xx NE
by NE xx NE
viral G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
effects NE xxx NE
on NE xx NE
class G#other_name_B xxx G#other_name_B
I G#other_name_M X G#other_name_M
MHC G#other_name_M XXX G#other_name_M
antigen G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
on NE xx NE
target G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

This NE Xxxx NE
differential NE xxx NE
effect NE xxx NE
of NE xx NE
E1A G#other_name_B XdX G#other_name_B
expression G#other_name_E xxx G#other_name_E
on NE xx NE
the NE xxx NE
cytolytic NE xxx NE
phenotypes NE xxx NE
of NE xx NE
infected NE xxx NE
and NE xxx NE
stably NE xxx NE
transfected NE xxx NE
human G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
suggests NE xxx NE
that NE xxx NE
human G#cell_type_B xxx G#cell_type_B
NK G#cell_type_M XX G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
provide NE xxx NE
an NE xx NE
effective NE xxx NE
immunologic NE xxx NE
barrier NE xxx NE
against NE xxx NE
the NE xxx NE
in NE xx NE
vivo NE xxx NE
survival NE xxx NE
and NE xxx NE
neoplastic G#other_name_B xxx G#other_name_B
progression G#other_name_E xxx G#other_name_E
of NE xx NE
E1A-immortalized G#cell_line_B XdX-xxx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
that NE xxx NE
may NE xxx NE
emerge NE xxx NE
from NE xxx NE
the NE xxx NE
reservoir NE xxx NE
of NE xx NE
persistently G#cell_type_B xxx G#cell_type_B
infected G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
in NE xx NE
the NE xxx NE
human G#multi_cell_B xxx G#multi_cell_B
host G#multi_cell_E xxx G#multi_cell_E
. NE . NE

Distinct NE Xxxx NE
signaling NE xxx NE
properties NE xxx NE
identify NE xxx NE
functionally NE xxx NE
different NE xxx NE
CD4 G#protein_family_or_group_B XXd G#protein_family_or_group_B
epitopes G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

The NE Xxx NE
CD4 G#protein_molecule_B XXd G#protein_molecule_B
coreceptor G#protein_molecule_E xxx G#protein_molecule_E
interacts NE xxx NE
with NE xxx NE
non-polymorphic G#protein_domain_or_region_B xxx-xxx G#protein_domain_or_region_B
regions G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
of NE xx NE
major G#protein_family_or_group_B xxx G#protein_family_or_group_B
histocompatibility G#protein_family_or_group_M xxx G#protein_family_or_group_M
complex G#protein_family_or_group_M xxx G#protein_family_or_group_M
class G#protein_family_or_group_M xxx G#protein_family_or_group_M
II G#protein_family_or_group_M XX G#protein_family_or_group_M
molecules G#protein_family_or_group_E xxx G#protein_family_or_group_E
on NE xx NE
antigen-presenting G#cell_type_B xxx-xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
and NE xxx NE
contributes NE xxx NE
to NE xx NE
T G#other_name_B X G#other_name_B
cell G#other_name_M xxx G#other_name_M
activation G#other_name_E xxx G#other_name_E
. NE . NE

We NE Xx NE
have NE xxx NE
investigated NE xxx NE
the NE xxx NE
effect NE xxx NE
of NE xx NE
CD4 G#other_name_B XXd G#other_name_B
triggering G#other_name_E xxx G#other_name_E
on NE xx NE
T G#other_name_B X G#other_name_B
cell G#other_name_M xxx G#other_name_M
activating G#other_name_M xxx G#other_name_M
signals G#other_name_E xxx G#other_name_E
in NE xx NE
a NE x NE
lymphoma G#other_name_B xxx G#other_name_B
model G#other_name_E xxx G#other_name_E
using NE xxx NE
monoclonal NE xxx NE
antibodies NE xxx NE
( NE ( NE
mAb NE xXx NE
) NE ) NE
which NE xxx NE
recognize NE xxx NE
different NE xxx NE
CD4 NE XXd NE
epitopes NE xxx NE
. NE . NE

We NE Xx NE
demonstrate NE xxx NE
that NE xxx NE
CD4 G#other_name_B XXd G#other_name_B
triggering G#other_name_E xxx G#other_name_E
delivers NE xxx NE
signals NE xxx NE
capable NE xxx NE
of NE xx NE
activating NE xxx NE
the NE xxx NE
NF-AT G#protein_molecule_B XX-XX G#protein_molecule_B
transcription G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_E xxx G#protein_molecule_E
which NE xxx NE
is NE xx NE
required NE xxx NE
for NE xxx NE
interleukin-2 G#other_name_B xxx-d G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
. NE . NE

Whereas NE Xxxx NE
different NE xxx NE
anti-CD4 G#protein_family_or_group_B xxx-XXd G#protein_family_or_group_B
mAb G#protein_family_or_group_E xXx G#protein_family_or_group_E
or NE xx NE
HIV-1 G#protein_molecule_B XXX-d G#protein_molecule_B
gp120 G#protein_molecule_E xxddd G#protein_molecule_E
could NE xxx NE
all NE xxx NE
trigger NE xxx NE
activation NE xxx NE
of NE xx NE
the NE xxx NE
protein G#protein_family_or_group_B xxx G#protein_family_or_group_B
tyrosine G#protein_family_or_group_M xxx G#protein_family_or_group_M
kinases G#protein_family_or_group_E xxx G#protein_family_or_group_E
p56lck G#protein_molecule xddxxx G#protein_molecule
and NE xxx NE
p59fyn G#protein_molecule xddxxx G#protein_molecule
and NE xxx NE
phosphorylation NE xxx NE
of NE xx NE
the NE xxx NE
Shc G#protein_molecule_B Xxx G#protein_molecule_B
adaptor G#protein_molecule_M xxx G#protein_molecule_M
protein G#protein_molecule_E xxx G#protein_molecule_E
, NE , NE
which NE xxx NE
mediates NE xxx NE
signals NE xxx NE
to NE xx NE
Ras G#protein_family_or_group Xxx G#protein_family_or_group
, NE , NE
they NE xxx NE
differed NE xxx NE
significantly NE xxx NE
in NE xx NE
their NE xxx NE
ability NE xxx NE
to NE xx NE
activate NE xxx NE
NF-AT G#protein_molecule XX-XX G#protein_molecule
. NE . NE

Lack NE Xxxx NE
of NE xx NE
full NE xxx NE
activation NE xxx NE
of NE xx NE
NF-AT G#protein_molecule XX-XX G#protein_molecule
could NE xxx NE
be NE xx NE
correlated NE xxx NE
to NE xx NE
a NE x NE
dramatically NE xxx NE
reduced NE xxx NE
capacity NE xxx NE
to NE xx NE
induce NE xxx NE
calcium G#other_name_B xxx G#other_name_B
flux G#other_name_E xxx G#other_name_E
and NE xxx NE
could NE xxx NE
be NE xx NE
complemented NE xxx NE
with NE xxx NE
a NE x NE
calcium G#other_organic_compound_B xxx G#other_organic_compound_B
ionophore G#other_organic_compound_E xxx G#other_organic_compound_E
. NE . NE

The NE Xxx NE
results NE xxx NE
identify NE xxx NE
functionally NE xxx NE
distinct NE xxx NE
epitopes G#protein_family_or_group xxx G#protein_family_or_group
on NE xx NE
the NE xxx NE
CD4 G#protein_molecule_B XXd G#protein_molecule_B
coreceptor G#protein_molecule_E xxx G#protein_molecule_E
involved NE xxx NE
in NE xx NE
activation NE xxx NE
of NE xx NE
the NE xxx NE
Ras NE Xxx NE
/protein NE /xxx NE
kinase NE xxx NE
C NE X NE
and NE xxx NE
calcium NE xxx NE
pathways NE xxx NE
. NE . NE

Ligand-dependent G#other_name_B Xxxx-xxx G#other_name_B
repression G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
erythroid G#protein_family_or_group_B xxx G#protein_family_or_group_B
transcription G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
GATA-1 G#protein_molecule XXXX-d G#protein_molecule
by NE xx NE
the NE xxx NE
estrogen G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

High-dose G#other_name_B Xxxx-xxx G#other_name_B
estrogen G#other_name_M xxx G#other_name_M
administration G#other_name_E xxx G#other_name_E
induces NE xxx NE
anemia G#other_name xxx G#other_name
in NE xx NE
mammals G#multi_cell xxx G#multi_cell
. NE . NE

In NE Xx NE
chickens NE xxx NE
, NE , NE
estrogens NE xxx NE
stimulate NE xxx NE
outgrowth NE xxx NE
of NE xx NE
bone G#cell_type_B xxx G#cell_type_B
marrow-derived G#cell_type_M xxx-xxx G#cell_type_M
erythroid G#cell_type_M xxx G#cell_type_M
progenitor G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
and NE xxx NE
delay NE xxx NE
their NE xxx NE
maturation G#other_name xxx G#other_name
. NE . NE

This NE Xxxx NE
delay NE xxx NE
is NE xx NE
associated NE xxx NE
with NE xxx NE
down-regulation G#other_name xxx-xxx G#other_name
of NE xx NE
many NE xxx NE
erythroid G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
cell-specific G#DNA_family_or_group_M xxx-xxx G#DNA_family_or_group_M
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
, NE , NE
including NE xxx NE
alpha-globin G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
beta-globin G#DNA_domain_or_region_E xxx-xxx G#DNA_domain_or_region_E
H5 NE Xd NE
. G#DNA_N/A . G#DNA_N/A

We NE Xx NE
show NE xxx NE
here NE xxx NE
that NE xxx NE
estrogens NE xxx NE
also NE xxx NE
reduce NE xxx NE
the NE xxx NE
number NE xxx NE
of NE xx NE
erythroid G#cell_type_B xxx G#cell_type_B
progenitor G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
in NE xx NE
primary G#cell_line_B xxx G#cell_line_B
human G#cell_line_M xxx G#cell_line_M
bone G#cell_line_M xxx G#cell_line_M
marrow G#cell_line_M xxx G#cell_line_M
cultures G#cell_line_E xxx G#cell_line_E
. NE . NE

To NE Xx NE
address NE xxx NE
potential NE xxx NE
mechanisms NE xxx NE
by NE xx NE
which NE xxx NE
estrogens G#lipid xxx G#lipid
suppress NE xxx NE
erythropoiesis G#other_name xxx G#other_name
, NE , NE
we NE xx NE
have NE xxx NE
examined NE xxx NE
their NE xxx NE
effects NE xxx NE
on NE xx NE
GATA-1 G#protein_molecule XXXX-d G#protein_molecule
, NE , NE
an NE xx NE
erythroid G#protein_family_or_group_B xxx G#protein_family_or_group_B
transcription G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
that NE xxx NE
participates NE xxx NE
in NE xx NE
the NE xxx NE
regulation NE xxx NE
of NE xx NE
the NE xxx NE
majority NE xxx NE
of NE xx NE
erythroid G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
cell-specific G#DNA_domain_or_region_M xxx-xxx G#DNA_domain_or_region_M
genes G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
is NE xx NE
necessary NE xxx NE
for NE xxx NE
full NE xxx NE
maturation NE xxx NE
of NE xx NE
erythrocytes G#cell_type xxx G#cell_type
. NE . NE

We NE Xx NE
demonstrate NE xxx NE
that NE xxx NE
the NE xxx NE
transcriptional G#other_name_B xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
of NE xx NE
GATA-1 G#protein_molecule XXXX-d G#protein_molecule
is NE xx NE
strongly NE xxx NE
repressed NE xxx NE
by NE xx NE
the NE xxx NE
estrogen G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
ER G#protein_family_or_group XX G#protein_family_or_group
) NE ) NE
in NE xx NE
a NE x NE
ligand-dependent NE xxx-xxx NE
manner NE xxx NE
and NE xxx NE
that NE xxx NE
this NE xxx NE
repression G#other_name xxx G#other_name
is NE xx NE
reversible NE xxx NE
in NE xx NE
the NE xxx NE
presence NE xxx NE
of NE xx NE
4-hydroxytamoxifen G#other_organic_compound d-xxx G#other_organic_compound
. NE . NE

ER NE XX NE
-mediated NE -xxx NE
repression NE xxx NE
of NE xx NE
GATA-1 NE XXXX-d NE
activity NE xxx NE
occurs NE xxx NE
on NE xx NE
an NE xx NE
artificial NE xxx NE
promoter NE xxx NE
containing NE xxx NE
a NE x NE
single NE xxx NE
GATA-binding NE XXXX-xxx NE
site NE xxx NE
, NE , NE
as NE xx NE
well NE xxx NE
as NE xx NE
in NE xx NE
the NE xxx NE
context NE xxx NE
of NE xx NE
an NE xx NE
intact NE xxx NE
promoter NE xxx NE
which NE xxx NE
is NE xx NE
normally NE xxx NE
regulated NE xxx NE
by NE xx NE
GATA-1 NE XXXX-d NE
. NE . NE

GATA-1 G#protein_molecule XXXX-d G#protein_molecule
and NE xxx NE
ER G#protein_family_or_group XX G#protein_family_or_group
bind NE xxx NE
to NE xx NE
each NE xxx NE
other NE xxx NE
in NE xx NE
vitro NE xxx NE
in NE xx NE
the NE xxx NE
absence NE xxx NE
of NE xx NE
DNA NE XXX NE
. NE . NE

In NE Xx NE
coimmunoprecipitation G#other_name_B xxx G#other_name_B
experiments G#other_name_E xxx G#other_name_E
using NE xxx NE
transfected NE xxx NE
COS G#cell_line_B XXX G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
GATA-1 G#protein_molecule XXXX-d G#protein_molecule
and NE xxx NE
ER G#protein_family_or_group XX G#protein_family_or_group
associate NE xxx NE
in NE xx NE
a NE x NE
ligand-dependent G#other_name_B xxx-xxx G#other_name_B
manner G#other_name_E xxx G#other_name_E
. NE . NE

Mapping NE Xxxx NE
experiments NE xxx NE
indicate NE xxx NE
that NE xxx NE
GATA-1 G#protein_molecule XXXX-d G#protein_molecule
and NE xxx NE
the NE xxx NE
ER G#protein_family_or_group XX G#protein_family_or_group
form NE xxx NE
at NE xx NE
least NE xxx NE
two NE xxx NE
contacts NE xxx NE
, NE , NE
which NE xxx NE
involve NE xxx NE
the NE xxx NE
finger NE xxx NE
region NE xxx NE
and NE xxx NE
the NE xxx NE
N-terminal G#protein_domain_or_region_B X-xxx G#protein_domain_or_region_B
activation G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
of NE xx NE
GATA-1 G#protein_molecule XXXX-d G#protein_molecule
. NE . NE

We NE Xx NE
speculate NE xxx NE
that NE xxx NE
estrogens G#lipid xxx G#lipid
exert NE xxx NE
effects NE xxx NE
on NE xx NE
erythropoiesis G#other_name xxx G#other_name
by NE xx NE
modulating NE xxx NE
GATA-1 G#other_name_B XXXX-d G#other_name_B
activity G#other_name_E xxx G#other_name_E
through NE xxx NE
protein-protein G#other_name_B xxx-xxx G#other_name_B
interaction G#other_name_E xxx G#other_name_E
with NE xxx NE
the NE xxx NE
ER G#protein_family_or_group XX G#protein_family_or_group
. NE . NE

(ABSTRACT NE (XXXXXXXX NE
TRUNCATED NE XXXXXXXXX NE
AT NE XX NE
250 NE ddd NE
WORDS) NE XXXXX) NE

Mouse G#other_name_B Xxxx G#other_name_B
interleukin-2 G#other_name_M xxx-d G#other_name_M
receptor G#other_name_M xxx G#other_name_M
alpha G#other_name_M xxx G#other_name_M
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
. NE . NE

Interleukin-1 G#protein_molecule Xxxx-d G#protein_molecule
and NE xxx NE
interleukin-2 G#protein_molecule xxx-d G#protein_molecule
control NE xxx NE
transcription NE xxx NE
via NE xxx NE
distinct NE xxx NE
cis-acting G#DNA_family_or_group_B xxx-xxx G#DNA_family_or_group_B
elements G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
. NE . NE

We NE Xx NE
have NE xxx NE
shown NE xxx NE
that NE xxx NE
interleukin-1 G#protein_molecule xxx-d G#protein_molecule
( NE ( NE
IL-1 G#protein_molecule XX-d G#protein_molecule
) NE ) NE
and NE xxx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
control NE xxx NE
IL-2 NE XX-d NE
receptor NE xxx NE
alpha NE xxx NE
( NE ( NE
IL-2R NE XX-dX NE
alpha NE xxx NE
) NE ) NE
gene NE xxx NE
transcription NE xxx NE
in NE xx NE
CD4-CD8- NE XXd-XXd- NE
murine NE xxx NE
T NE X NE
lymphocyte NE xxx NE
precursors NE xxx NE
. NE . NE

Here NE Xxxx NE
we NE xx NE
map NE xxx NE
the NE xxx NE
cis-acting G#DNA_family_or_group_B xxx-xxx G#DNA_family_or_group_B
elements G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
that NE xxx NE
mediate NE xxx NE
interleukin NE xxx NE
responsiveness NE xxx NE
of NE xx NE
the NE xxx NE
mouse G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
IL-2R G#DNA_domain_or_region_M XX-dX G#DNA_domain_or_region_M
alpha G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
using NE xxx NE
a NE x NE
thymic G#cell_line_B xxx G#cell_line_B
lymphoma-derived G#cell_line_M xxx-xxx G#cell_line_M
hybridoma G#cell_line_E xxx G#cell_line_E
( NE ( NE
PC60 G#cell_line XXdd G#cell_line
) NE ) NE
. NE . NE

The NE Xxx NE
transcriptional NE xxx NE
response NE xxx NE
of NE xx NE
the NE xxx NE
IL-2R G#DNA_domain_or_region_B XX-dX G#DNA_domain_or_region_B
alpha G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
to NE xx NE
stimulation NE xxx NE
by NE xx NE
IL-1 G#protein_molecule XX-d G#protein_molecule
+ NE + NE
IL-2 G#protein_molecule XX-d G#protein_molecule
is NE xx NE
biphasic NE xxx NE
. NE . NE

IL-1 G#protein_molecule XX-d G#protein_molecule
induces NE xxx NE
a NE x NE
rapid NE xxx NE
, NE , NE
protein G#other_name_B xxx G#other_name_B
synthesis-independent G#other_name_M xxx-xxx G#other_name_M
appearance G#other_name_E xxx G#other_name_E
of NE xx NE
IL-2R G#RNA_molecule_B XX-dX G#RNA_molecule_B
alpha G#RNA_molecule_M xxx G#RNA_molecule_M
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
that NE xxx NE
is NE xx NE
blocked NE xxx NE
by NE xx NE
inhibitors NE xxx NE
of NE xx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
activation G#other_name_E xxx G#other_name_E
. NE . NE

It NE Xx NE
also NE xxx NE
primes NE xxx NE
cells NE xxx NE
to NE xx NE
become NE xxx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
responsive NE xxx NE
and NE xxx NE
thereby NE xxx NE
prepares NE xxx NE
the NE xxx NE
second NE xxx NE
phase NE xxx NE
, NE , NE
in NE xx NE
which NE xxx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
induces NE xxx NE
a NE x NE
100-fold NE ddd-xxx NE
further NE xxx NE
increase NE xxx NE
in NE xx NE
IL-2R G#RNA_family_or_group_B XX-dX G#RNA_family_or_group_B
alpha G#RNA_family_or_group_M xxx G#RNA_family_or_group_M
transcripts G#RNA_family_or_group_E xxx G#RNA_family_or_group_E
. NE . NE

Transient G#other_name_B Xxxx G#other_name_B
transfection G#other_name_M xxx G#other_name_M
experiments G#other_name_E xxx G#other_name_E
show NE xxx NE
that NE xxx NE
several NE xxx NE
elements NE xxx NE
in NE xx NE
the NE xxx NE
promoter-proximal G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
the NE xxx NE
IL-2R G#DNA_domain_or_region_B XX-dX G#DNA_domain_or_region_B
alpha G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
contribute NE xxx NE
to NE xx NE
IL-1 G#protein_molecule XX-d G#protein_molecule
responsiveness NE xxx NE
, NE , NE
most NE xxx NE
importantly NE xxx NE
an NE xx NE
NF-kappa G#DNA_domain_or_region_B XX-xxx G#DNA_domain_or_region_B
B G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
conserved NE xxx NE
in NE xx NE
the NE xxx NE
human G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
gene G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
and G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
mouse G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
gene G#DNA_family_or_group_E xxx G#DNA_family_or_group_E

IL-2 G#other_name_B XX-d G#other_name_B
responsiveness G#other_name_E xxx G#other_name_E
, NE , NE
on NE xx NE
the NE xxx NE
other NE xxx NE
hand NE xxx NE
, NE , NE
depends NE xxx NE
on NE xx NE
a NE x NE
78-nucleotide G#DNA_domain_or_region_B dd-xxx G#DNA_domain_or_region_B
segment G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
1.3 NE d.d NE
kilobases NE xxx NE
upstream NE xxx NE
of NE xx NE
the NE xxx NE
major G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
transcription G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
start G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

This NE Xxxx NE
segment NE xxx NE
functions NE xxx NE
as NE xx NE
an NE xx NE
IL-2-inducible G#DNA_domain_or_region_B XX-d-xxx G#DNA_domain_or_region_B
enhancer G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
lies NE xxx NE
within NE xxx NE
a NE x NE
region NE xxx NE
that NE xxx NE
becomes NE xxx NE
DNase G#other_name_B XXxxx G#other_name_B
I G#other_name_M X G#other_name_M
hypersensitive G#other_name_E xxx G#other_name_E
in NE xx NE
normal NE xxx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
in NE xx NE
which NE xxx NE
IL-2R G#other_name_B XX-dX G#other_name_B
alpha G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
has NE xxx NE
been NE xxx NE
induced NE xxx NE
. NE . NE

IL-2 G#other_name_B XX-d G#other_name_B
responsiveness G#other_name_E xxx G#other_name_E
requires NE xxx NE
three NE xxx NE
distinct NE xxx NE
elements G#DNA_domain_or_region xxx G#DNA_domain_or_region
within NE xxx NE
the NE xxx NE
enhancer G#DNA_domain_or_region xxx G#DNA_domain_or_region
. NE . NE

Two NE Xxx NE
of NE xx NE
these NE xxx NE
are NE xxx NE
potential NE xxx NE
binding NE xxx NE
sites NE xxx NE
for NE xxx NE
STAT G#protein_family_or_group_B XXXX G#protein_family_or_group_B
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Hematopoietic G#other_name_B Xxxx G#other_name_B
lineage G#other_name_M xxx G#other_name_M
commitment G#other_name_E xxx G#other_name_E
: NE : NE
role NE xxx NE
of NE xx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

This NE Xxxx NE
review NE xxx NE
focuses NE xxx NE
on NE xx NE
the NE xxx NE
roles NE xxx NE
of NE xx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
in NE xx NE
hematopoietic G#other_name_B xxx G#other_name_B
lineage G#other_name_M xxx G#other_name_M
commitment G#other_name_E xxx G#other_name_E
. NE . NE

A NE X NE
brief NE xxx NE
introduction NE xxx NE
to NE xx NE
lineage G#other_name_B xxx G#other_name_B
commitment G#other_name_E xxx G#other_name_E
and NE xxx NE
asymmetric G#other_name_B xxx G#other_name_B
cell G#other_name_M xxx G#other_name_M
division G#other_name_E xxx G#other_name_E
is NE xx NE
followed NE xxx NE
by NE xx NE
a NE x NE
discussion NE xxx NE
of NE xx NE
several NE xxx NE
methods NE xxx NE
used NE xxx NE
to NE xx NE
identify NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
important NE xxx NE
in NE xx NE
specifying NE xxx NE
hematopoietic G#cell_type_B xxx G#cell_type_B
cell G#cell_type_M xxx G#cell_type_M
types G#cell_type_E xxx G#cell_type_E
. NE . NE

Next NE Xxxx NE
is NE xx NE
presented NE xxx NE
a NE x NE
discussion NE xxx NE
of NE xx NE
the NE xxx NE
use NE xxx NE
of NE xx NE
embryonic G#cell_type_B xxx G#cell_type_B
stem G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
in NE xx NE
the NE xxx NE
analysis NE xxx NE
of NE xx NE
hematopoietic G#other_name_B xxx G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
and NE xxx NE
the NE xxx NE
use NE xxx NE
of NE xx NE
targeted G#other_name_B xxx G#other_name_B
gene G#other_name_M xxx G#other_name_M
disruption G#other_name_E xxx G#other_name_E
to NE xx NE
analyze NE xxx NE
the NE xxx NE
role NE xxx NE
of NE xx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
in NE xx NE
hematopoiesis G#other_name xxx G#other_name
. NE . NE

Finally NE Xxxx NE
, NE , NE
the NE xxx NE
status NE xxx NE
of NE xx NE
our NE xxx NE
current NE xxx NE
knowledge NE xxx NE
concerning NE xxx NE
the NE xxx NE
roles NE xxx NE
of NE xx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
in NE xx NE
the NE xxx NE
commitment NE xxx NE
to NE xx NE
erythroid G#cell_type_B xxx G#cell_type_B
cell G#cell_type_M xxx G#cell_type_M
type G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
myeloid G#cell_type_M xxx G#cell_type_M
cell G#cell_type_M xxx G#cell_type_M
type G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
lymphoid G#cell_type_M xxx G#cell_type_M
cell G#cell_type_M xxx G#cell_type_M
type G#cell_type_E xxx G#cell_type_E

Epstein-Barr G#other_name_B Xxxx-Xxxx G#other_name_B
virus G#other_name_M xxx G#other_name_M
replicative G#other_name_M xxx G#other_name_M
gene G#other_name_M xxx G#other_name_M
transcription G#other_name_E xxx G#other_name_E
during NE xxx NE
de G#other_name_B xx G#other_name_B
novo G#other_name_M xxx G#other_name_M
infection G#other_name_E xxx G#other_name_E
of NE xx NE
human G#cell_type_B xxx G#cell_type_B
thymocytes G#cell_type_E xxx G#cell_type_E
: NE : NE
simultaneous G#other_name_B xxx G#other_name_B
early G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
of NE xx NE
BZLF-1 G#protein_molecule XXXX-d G#protein_molecule
and NE xxx NE
its NE xxx NE
repressor NE xxx NE
RAZ G#protein_molecule XXX G#protein_molecule
. NE . NE

Epstein-Barr G#virus_B Xxxx-Xxxx G#virus_B
virus G#virus_E xxx G#virus_E
( NE ( NE
EBV G#virus XXX G#virus
) NE ) NE
is NE xx NE
known NE xxx NE
to NE xx NE
infect NE xxx NE
B G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
and NE xxx NE
epithelial G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

We NE Xx NE
and NE xxx NE
others NE xxx NE
have NE xxx NE
shown NE xxx NE
that NE xxx NE
EBV G#virus XXX G#virus
can NE xxx NE
also NE xxx NE
infect NE xxx NE
a NE x NE
subset NE xxx NE
of NE xx NE
thymocytes G#cell_type xxx G#cell_type
. NE . NE

Infection NE Xxxx NE
of NE xx NE
thymocytes G#cell_type xxx G#cell_type
was NE xxx NE
accompanied NE xxx NE
by NE xx NE
the NE xxx NE
appearance NE xxx NE
of NE xx NE
linear G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
EBV G#DNA_family_or_group_M XXX G#DNA_family_or_group_M
genome G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
within NE xxx NE
8 NE d NE
hr NE xx NE
of NE xx NE
infection NE xxx NE
. NE . NE

Circularization NE Xxxx NE
of NE xx NE
the NE xxx NE
EBV G#DNA_family_or_group_B XXX G#DNA_family_or_group_B
genome G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
was NE xxx NE
not NE xxx NE
detected NE xxx NE
. NE . NE

This NE Xxxx NE
is NE xx NE
in NE xx NE
contrast NE xxx NE
to NE xx NE
the NE xxx NE
infection NE xxx NE
in NE xx NE
B G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
where NE xxx NE
the NE xxx NE
genome NE xxx NE
can NE xxx NE
circularize NE xxx NE
within NE xxx NE
24 NE dd NE
hr NE xx NE
of NE xx NE
infection NE xxx NE
. NE . NE

The NE Xxx NE
appearance NE xxx NE
of NE xx NE
the NE xxx NE
BamHI G#protein_molecule_B XxxXX G#protein_molecule_B
ZLF-1 G#protein_molecule_M XXX-d G#protein_molecule_M
gene G#protein_molecule_M xxx G#protein_molecule_M
product G#protein_molecule_E xxx G#protein_molecule_E
, NE , NE
ZEBRA G#protein_molecule XXXXX G#protein_molecule
, NE , NE
by NE xx NE
RT-PCR G#other_name XX-XXX G#other_name
, NE , NE
was NE xxx NE
observed NE xxx NE
within NE xxx NE
8 NE d NE
hr NE xx NE
of NE xx NE
infection NE xxx NE
. NE . NE

The NE Xxx NE
appearance NE xxx NE
of NE xx NE
a NE x NE
novel NE xxx NE
fusion G#protein_family_or_group_B xxx G#protein_family_or_group_B
transcript G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
RAZ G#protein_molecule XXX G#protein_molecule
) NE ) NE
, NE , NE
which NE xxx NE
comprised NE xxx NE
regions NE xxx NE
of NE xx NE
the NE xxx NE
BZLF-1 G#DNA_domain_or_region_B XXXX-d G#DNA_domain_or_region_B
locus G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
the NE xxx NE
adjacent NE xxx NE
BRLF-1 G#DNA_domain_or_region_B XXXX-d G#DNA_domain_or_region_B
locus G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
was NE xxx NE
detected NE xxx NE
by NE xx NE
RT-PCR G#other_name XX-XXX G#other_name
. NE . NE

ZEBRA G#protein_molecule_B XXXXX G#protein_molecule_B
protein G#protein_molecule_E xxx G#protein_molecule_E
was NE xxx NE
also NE xxx NE
identified NE xxx NE
in NE xx NE
infected NE xxx NE
thymocytes G#cell_type xxx G#cell_type
by NE xx NE
immunoprecipitation G#other_name xxx G#other_name
. NE . NE

In NE Xx NE
addition NE xxx NE
, NE , NE
we NE xx NE
demonstrated NE xxx NE
that NE xxx NE
the NE xxx NE
EBNA-1 G#DNA_domain_or_region_B XXXX-d G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
infected NE xxx NE
thymocytes G#cell_type xxx G#cell_type
was NE xxx NE
transcribed NE xxx NE
from NE xxx NE
the NE xxx NE
Fp G#DNA_domain_or_region_B Xx G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
rather NE xxx NE
than NE xxx NE
from NE xxx NE
the NE xxx NE
Cp/Wp G#DNA_domain_or_region_B Xx/Xx G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
which NE xxx NE
is NE xx NE
used NE xxx NE
in NE xx NE
latently G#cell_type_B xxx G#cell_type_B
infected G#cell_type_M xxx G#cell_type_M
B G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Transcripts NE Xxxx NE
encoding NE xxx NE
gp350/220 G#protein_molecule xxddd/ddd G#protein_molecule
, NE , NE
the NE xxx NE
major G#protein_family_or_group_B xxx G#protein_family_or_group_B
coat G#protein_family_or_group_M xxx G#protein_family_or_group_M
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
of NE xx NE
EBV G#virus XXX G#virus
, NE , NE
were NE xxx NE
identified NE xxx NE
, NE , NE
but NE xxx NE
we NE xx NE
did NE xxx NE
not NE xxx NE
find NE xxx NE
any NE xxx NE
evidence NE xxx NE
of NE xx NE
transcription NE xxx NE
from NE xxx NE
the NE xxx NE
LMP-2A G#DNA_domain_or_region XXX-dX G#DNA_domain_or_region
or NE xx NE
EBER-1 G#DNA_domain_or_region_B XXXX-d G#DNA_domain_or_region_B
loci G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
infected NE xxx NE
thymocytes G#cell_type xxx G#cell_type
. NE . NE

These NE Xxxx NE
observations NE xxx NE
suggest NE xxx NE
that NE xxx NE
de NE xx NE
novo NE xxx NE
EBV G#other_name_B XXX G#other_name_B
infection G#other_name_E xxx G#other_name_E
of NE xx NE
thymocytes G#cell_type xxx G#cell_type
differs NE xxx NE
from NE xxx NE
infection NE xxx NE
of NE xx NE
B G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

The NE Xxx NE
main NE xxx NE
difference NE xxx NE
is NE xx NE
that NE xxx NE
with NE xxx NE
thymocytes G#cell_type xxx G#cell_type
, NE , NE
no NE xx NE
evidence NE xxx NE
could NE xxx NE
be NE xx NE
found NE xxx NE
that NE xxx NE
the NE xxx NE
virus G#virus xxx G#virus
ever NE xxx NE
circularizes NE xxx NE
. NE . NE

Rather NE Xxxx NE
, NE , NE
EBV G#virus XXX G#virus
remains NE xxx NE
in NE xx NE
a NE x NE
linear G#other_name_B xxx G#other_name_B
configuration G#other_name_E xxx G#other_name_E
from NE xxx NE
which NE xxx NE
replicative G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
are NE xxx NE
transcribed NE xxx NE
. NE . NE

Identification NE Xxxx NE
and NE xxx NE
purification NE xxx NE
of NE xx NE
human G#protein_family_or_group_B xxx G#protein_family_or_group_B
Stat G#protein_family_or_group_M Xxxx G#protein_family_or_group_M
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
activated NE xxx NE
in NE xx NE
response NE xxx NE
to NE xx NE
interleukin-2 G#protein_molecule xxx-d G#protein_molecule
. NE . NE

A NE X NE
key NE xxx NE
cytokine G#protein_family_or_group xxx G#protein_family_or_group
induced NE xxx NE
during NE xxx NE
the NE xxx NE
immune G#other_name_B xxx G#other_name_B
response G#other_name_E xxx G#other_name_E
is NE xx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
. NE . NE

Following NE Xxxx NE
T G#other_name_B X G#other_name_B
cell G#other_name_M xxx G#other_name_M
activation G#other_name_E xxx G#other_name_E
, NE , NE
the NE xxx NE
genes NE xxx NE
encoding NE xxx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
and NE xxx NE
the NE xxx NE
various NE xxx NE
chains NE xxx NE
of NE xx NE
its NE xxx NE
receptor NE xxx NE
are NE xxx NE
transcriptionally NE xxx NE
induced NE xxx NE
. NE . NE

In NE Xx NE
turn NE xxx NE
, NE , NE
secreted NE xxx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
serves NE xxx NE
to NE xx NE
stimulate NE xxx NE
the NE xxx NE
proliferation NE xxx NE
and NE xxx NE
differentiation NE xxx NE
of NE xx NE
T G#cell_type_B X G#cell_type_B
lymphocytes G#cell_type_E xxx G#cell_type_E
. NE . NE

Several NE Xxxx NE
recent NE xxx NE
studies NE xxx NE
have NE xxx NE
implicated NE xxx NE
Jak NE Xxx NE
kinases NE xxx NE
in NE xx NE
the NE xxx NE
signaling G#other_name_B xxx G#other_name_B
pathway G#other_name_E xxx G#other_name_E
induced NE xxx NE
by NE xx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
. NE . NE

Following NE Xxxx NE
this NE xxx NE
lead NE xxx NE
, NE , NE
we NE xx NE
set NE xxx NE
out NE xxx NE
to NE xx NE
identify NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
induced NE xxx NE
in NE xx NE
response NE xxx NE
to NE xx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
. NE . NE

Human G#cell_type_B Xxxx G#cell_type_B
peripheral G#cell_type_M xxx G#cell_type_M
blood G#cell_type_M xxx G#cell_type_M
lymphocytes G#cell_type_E xxx G#cell_type_E
were NE xxx NE
observed NE xxx NE
to NE xx NE
contain NE xxx NE
several NE xxx NE
IL-2 NE XX-d NE
-inducible NE -xxx NE
DNA NE XXX NE
binding NE xxx NE
activities NE xxx NE
. NE . NE

Similar NE Xxxx NE
activities NE xxx NE
were NE xxx NE
also NE xxx NE
observed NE xxx NE
in NE xx NE
a NE x NE
transformed G#cell_line_B xxx G#cell_line_B
human G#cell_line_M xxx G#cell_line_M
lymphocyte G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
, NE , NE
termed NE xxx NE
YT G#cell_line XX G#cell_line
. NE . NE

We NE Xx NE
have NE xxx NE
purified NE xxx NE
these NE xxx NE
activities NE xxx NE
and NE xxx NE
found NE xxx NE
that NE xxx NE
the NE xxx NE
principal NE xxx NE
IL-2 NE XX-d NE
-inducible NE -xxx NE
component NE xxx NE
bears NE xxx NE
significant NE xxx NE
relatedness NE xxx NE
to NE xx NE
a NE x NE
prolactin-induced NE xxx-xxx NE
transcription NE xxx NE
factor NE xxx NE
first NE xxx NE
identified NE xxx NE
in NE xx NE
sheep NE xxx NE
mammary NE xxx NE
gland NE xxx NE
tissue NE xxx NE
. NE . NE

We NE Xx NE
hypothesize NE xxx NE
that NE xxx NE
activation NE xxx NE
of NE xx NE
this NE xxx NE
protein NE xxx NE
, NE , NE
designated NE xxx NE
hStat5 G#protein_molecule xXxxxd G#protein_molecule
, NE , NE
helps NE xxx NE
govern NE xxx NE
the NE xxx NE
biological NE xxx NE
effects NE xxx NE
of NE xx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
during NE xxx NE
the NE xxx NE
immune G#other_name_B xxx G#other_name_B
response G#other_name_E xxx G#other_name_E
. NE . NE

E2F-1 G#protein_molecule XdX-d G#protein_molecule
and NE xxx NE
a NE x NE
cyclin-like G#protein_family_or_group_B xxx-xxx G#protein_family_or_group_B
DNA G#protein_family_or_group_M XXX G#protein_family_or_group_M
repair G#protein_family_or_group_M xxx G#protein_family_or_group_M
enzyme G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
uracil-DNA G#protein_molecule_B xxx-XXX G#protein_molecule_B
glycosylase G#protein_molecule_E xxx G#protein_molecule_E
, NE , NE
provide NE xxx NE
evidence NE xxx NE
for NE xxx NE
an NE xx NE
autoregulatory G#other_name_B xxx G#other_name_B
mechanism G#other_name_M xxx G#other_name_M
for G#other_name_M xxx G#other_name_M
transcription G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
cell G#protein_family_or_group_B xxx G#protein_family_or_group_B
cycle-dependent G#protein_family_or_group_M xxx-xxx G#protein_family_or_group_M
transcription G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
E2F-1 G#protein_molecule XdX-d G#protein_molecule
, NE , NE
regulates NE xxx NE
the NE xxx NE
cyclin G#protein_family_or_group xxx G#protein_family_or_group
-like NE -xxx NE
species NE xxx NE
of NE xx NE
the NE xxx NE
DNA G#protein_family_or_group_B XXX G#protein_family_or_group_B
repair G#protein_family_or_group_M xxx G#protein_family_or_group_M
enzyme G#protein_family_or_group_E xxx G#protein_family_or_group_E
uracil-DNA NE xxx-XXX NE
glycosylase NE xxx NE
( NE ( NE
UDG NE XXX NE
) NE ) NE
gene NE xxx NE
in NE xx NE
human NE xxx NE
osteosarcoma NE xxx NE
( NE ( NE
Saos-2 NE Xxxx-d NE
) NE ) NE
cells NE xxx NE
. NE . NE

We NE Xx NE
demonstrate NE xxx NE
, NE , NE
through NE xxx NE
the NE xxx NE
deletion NE xxx NE
of NE xx NE
the NE xxx NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
UDG G#DNA_domain_or_region_M XXX G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sequences G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
that NE xxx NE
expression NE xxx NE
of NE xx NE
E2F-1 G#protein_molecule XdX-d G#protein_molecule
activates NE xxx NE
the NE xxx NE
UDG G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
through NE xxx NE
several NE xxx NE
E2F G#DNA_domain_or_region_B XdX G#DNA_domain_or_region_B
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

The NE Xxx NE
major G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
putative G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
downstream G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
for NE xxx NE
E2F G#protein_family_or_group XdX G#protein_family_or_group
, NE , NE
located NE xxx NE
in NE xx NE
the NE xxx NE
first G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
exon G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
serves NE xxx NE
as NE xx NE
a NE x NE
target NE xxx NE
for NE xxx NE
E2F-1/DP1 G#protein_complex_B XdX-d/XXd G#protein_complex_B
complex G#protein_complex_E xxx G#protein_complex_E
binding NE xxx NE
in NE xx NE
vitro NE xxx NE
. NE . NE

We NE Xx NE
also NE xxx NE
provide NE xxx NE
evidence NE xxx NE
for NE xxx NE
the NE xxx NE
functional NE xxx NE
relationship NE xxx NE
between NE xxx NE
the NE xxx NE
cyclin-like G#protein_molecule_B xxx-xxx G#protein_molecule_B
UDG G#protein_molecule_M XXX G#protein_molecule_M
gene G#protein_molecule_M xxx G#protein_molecule_M
product G#protein_molecule_E xxx G#protein_molecule_E
and NE xxx NE
E2F G#protein_family_or_group XdX G#protein_family_or_group
. NE . NE

High NE Xxxx NE
levels NE xxx NE
of NE xx NE
UDG G#other_name_B XXX G#other_name_B
expression G#other_name_E xxx G#other_name_E
in NE xx NE
a NE x NE
transient G#other_name_B xxx G#other_name_B
transfection G#other_name_M xxx G#other_name_M
assay G#other_name_E xxx G#other_name_E
result NE xxx NE
in NE xx NE
the NE xxx NE
down-regulation G#other_name xxx-xxx G#other_name
of NE xx NE
transcriptional G#other_name_B xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
through NE xxx NE
elements G#DNA_domain_or_region xxx G#DNA_domain_or_region
specific NE xxx NE
for NE xxx NE
E2F NE XdX NE
-mediated NE -xxx NE
transcription NE xxx NE
. NE . NE

Overexpression G#other_name Xxxx G#other_name
of NE xx NE
UDG G#protein_molecule XXX G#protein_molecule
in NE xx NE
Saos G#cell_line_B Xxxx G#cell_line_B
2 G#cell_line_M d G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
was NE xxx NE
observed NE xxx NE
to NE xx NE
delay NE xxx NE
growth NE xxx NE
late NE xxx NE
in NE xx NE
G1 G#other_name_B Xd G#other_name_B
phase G#other_name_E xxx G#other_name_E
and NE xxx NE
transiently NE xxx NE
arrest NE xxx NE
these NE xxx NE
cells NE xxx NE
from NE xxx NE
progressing NE xxx NE
into NE xxx NE
the NE xxx NE
S G#other_name_B X G#other_name_B
phase G#other_name_E xxx G#other_name_E
. NE . NE

This NE Xxxx NE
hypothetical NE xxx NE
model NE xxx NE
integrates NE xxx NE
one NE xxx NE
mechanism NE xxx NE
of NE xx NE
DNA G#other_name_B XXX G#other_name_B
repair G#other_name_E xxx G#other_name_E
with NE xxx NE
the NE xxx NE
cell G#other_name_B xxx G#other_name_B
cycle G#other_name_M xxx G#other_name_M
control G#other_name_E xxx G#other_name_E
of NE xx NE
gene G#other_name_B xxx G#other_name_B
transcription G#other_name_E xxx G#other_name_E
, NE , NE
likely NE xxx NE
through NE xxx NE
E2F G#protein_family_or_group XdX G#protein_family_or_group
. NE . NE

This NE Xxxx NE
implicates NE xxx NE
E2F G#protein_family_or_group XdX G#protein_family_or_group
as NE xx NE
a NE x NE
multifunctional NE xxx NE
target NE xxx NE
for NE xxx NE
proteins NE xxx NE
and NE xxx NE
enzymes NE xxx NE
, NE , NE
possibly NE xxx NE
, NE , NE
responsive NE xxx NE
to NE xx NE
DNA G#other_name_B XXX G#other_name_B
damage G#other_name_E xxx G#other_name_E
through NE xxx NE
the NE xxx NE
negative NE xxx NE
effect NE xxx NE
of NE xx NE
UDG G#protein_molecule XXX G#protein_molecule
on NE xx NE
E2F NE XdX NE
-mediated NE -xxx NE
transcriptional NE xxx NE
activity NE xxx NE
. NE . NE

Cellular G#other_name_B Xxxx G#other_name_B
mechanism G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
molecular G#other_name_M xxx G#other_name_M
mechanism G#other_name_E xxx G#other_name_E
of NE xx NE
IFN-gamma G#other_name_B XXX-xxx G#other_name_B
production G#other_name_E xxx G#other_name_E
induced NE xxx NE
by NE xx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
and NE xxx NE
IL-12 G#protein_molecule XX-dd G#protein_molecule
in NE xx NE
a NE x NE
human G#cell_line_B xxx G#cell_line_B
NK G#cell_line_M XX G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
. NE . NE

Interferon-gamma G#protein_molecule Xxxx-xxx G#protein_molecule
( NE ( NE
IFN-gamma G#protein_molecule XXX-xxx G#protein_molecule
) NE ) NE
is NE xx NE
an NE xx NE
important NE xxx NE
immunoregulatory G#protein_molecule_B xxx G#protein_molecule_B
protein G#protein_molecule_E xxx G#protein_molecule_E
produced NE xxx NE
predominantly NE xxx NE
by NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
and NE xxx NE
large G#cell_type_B xxx G#cell_type_B
granular G#cell_type_M xxx G#cell_type_M
lymphocytes G#cell_type_E xxx G#cell_type_E
( NE ( NE
LGL G#cell_type XXX G#cell_type
) NE ) NE
in NE xx NE
response NE xxx NE
to NE xx NE
different NE xxx NE
extracellular G#other_name_B xxx G#other_name_B
signals G#other_name_E xxx G#other_name_E
. NE . NE

In NE Xx NE
particular NE xxx NE
, NE , NE
two NE xxx NE
interleukins G#protein_family_or_group xxx G#protein_family_or_group
( NE ( NE
ILs G#protein_family_or_group XXx G#protein_family_or_group
) NE ) NE
, NE , NE
IL-2 G#protein_molecule XX-d G#protein_molecule
and NE xxx NE
IL-12 G#protein_molecule XX-dd G#protein_molecule
, NE , NE
have NE xxx NE
been NE xxx NE
shown NE xxx NE
to NE xx NE
be NE xx NE
potent NE xxx NE
inducers NE xxx NE
of NE xx NE
IFN-gamma G#other_name_B XXX-xxx G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
in NE xx NE
both NE xxx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
and NE xxx NE
LGL G#cell_type XXX G#cell_type
. NE . NE

Although NE Xxxx NE
it NE xx NE
has NE xxx NE
been NE xxx NE
reported NE xxx NE
that NE xxx NE
there NE xxx NE
are NE xxx NE
some NE xxx NE
T G#cell_line_B X G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
that NE xxx NE
produce NE xxx NE
IFN-gamma G#protein_molecule XXX-xxx G#protein_molecule
in NE xx NE
response NE xxx NE
to NE xx NE
IL-2 G#other_name_B XX-d G#other_name_B
stimulation G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
IL-12 G#other_name_M XX-dd G#other_name_M
stimulation G#other_name_E xxx G#other_name_E

In NE Xx NE
this NE xxx NE
report NE xxx NE
we NE xx NE
present NE xxx NE
evidence NE xxx NE
that NE xxx NE
the NE xxx NE
cell G#cell_line_B xxx G#cell_line_B
line G#cell_line_M xxx G#cell_line_M
NK3.3 G#cell_line_E XXd.d G#cell_line_E
derived NE xxx NE
from NE xxx NE
human G#cell_type_B xxx G#cell_type_B
NK G#cell_type_M XX G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
, NE , NE
responds NE xxx NE
to NE xx NE
both NE xxx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
and NE xxx NE
IL-12 G#protein_molecule XX-dd G#protein_molecule
, NE , NE
as NE xx NE
measured NE xxx NE
by NE xx NE
increases NE xxx NE
in NE xx NE
IFN-gamma G#protein_molecule XXX-xxx G#protein_molecule
and NE xxx NE
granulocyte-macrophage G#protein_molecule_B xxx-xxx G#protein_molecule_B
colony-stimulating G#protein_molecule_M xxx-xxx G#protein_molecule_M
factor G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
GM-CSF G#protein_molecule XX-XXX G#protein_molecule
) NE ) NE
cytoplasmic G#other_name_B xxx G#other_name_B
mRNA G#other_name_M xXXX G#other_name_M
expression G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
cytoplasmic G#other_name_M xxx G#other_name_M
protein G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E

In NE Xx NE
addition NE xxx NE
, NE , NE
when NE xxx NE
used NE xxx NE
together NE xxx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
and NE xxx NE
IL-12 G#protein_molecule XX-dd G#protein_molecule
synergized NE xxx NE
in NE xx NE
the NE xxx NE
induction NE xxx NE
of NE xx NE
IFN-gamma G#protein_molecule XXX-xxx G#protein_molecule
and NE xxx NE
GM-CSF G#protein_molecule XX-XXX G#protein_molecule
and NE xxx NE
this NE xxx NE
synergy NE xxx NE
was NE xxx NE
attributed NE xxx NE
to NE xx NE
an NE xx NE
increased NE xxx NE
accumulation NE xxx NE
and NE xxx NE
stability NE xxx NE
of NE xx NE
the NE xxx NE
IFN-gamma G#RNA_molecule_B XXX-xxx G#RNA_molecule_B
and G#RNA_molecule_M xxx G#RNA_molecule_M
GM-CSF G#RNA_molecule_M XX-XXX G#RNA_molecule_M
mRNAs G#RNA_molecule_E xXXXx G#RNA_molecule_E
. NE . NE

To NE Xx NE
investigate NE xxx NE
the NE xxx NE
signaling NE xxx NE
pathways NE xxx NE
involved NE xxx NE
in NE xx NE
the NE xxx NE
gene NE xxx NE
induction NE xxx NE
, NE , NE
five NE xxx NE
inhibitors NE xxx NE
, NE , NE
cyclosporin G#other_organic_compound_B xxx G#other_organic_compound_B
A G#other_organic_compound_E X G#other_organic_compound_E
( NE ( NE
CsA G#other_organic_compound XxX G#other_organic_compound
) NE ) NE
, NE , NE
transforming G#protein_molecule_B xxx G#protein_molecule_B
growth G#protein_molecule_M xxx G#protein_molecule_M
factor-beta G#protein_molecule_E xxx-xxx G#protein_molecule_E
, NE , NE
cycloheximide G#other_organic_compound xxx G#other_organic_compound
, NE , NE
genistein G#other_organic_compound xxx G#other_organic_compound
, NE , NE
and NE xxx NE
staurosporine G#other_organic_compound_B xxx G#other_organic_compound_B
A G#other_organic_compound_E X G#other_organic_compound_E
, NE , NE
were NE xxx NE
used NE xxx NE
in NE xx NE
analyzing NE xxx NE
the NE xxx NE
effects NE xxx NE
of NE xx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
and NE xxx NE
IL-12 G#protein_molecule XX-dd G#protein_molecule
on NE xx NE
NK3.3 G#cell_line_B XXd.d G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

The NE Xxx NE
results NE xxx NE
suggest NE xxx NE
that NE xxx NE
activation NE xxx NE
of NE xx NE
protein G#protein_molecule_B xxx G#protein_molecule_B
kinase G#protein_molecule_M xxx G#protein_molecule_M
C G#protein_molecule_E X G#protein_molecule_E
, NE , NE
but NE xxx NE
not NE xxx NE
new G#other_name_B xxx G#other_name_B
protein G#other_name_M xxx G#other_name_M
synthesis G#other_name_E xxx G#other_name_E
, NE , NE
is NE xx NE
required NE xxx NE
for NE xxx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
induction NE xxx NE
of NE xx NE
IFN-gamma G#RNA_molecule_B XXX-xxx G#RNA_molecule_B
cytoplasmic G#RNA_molecule_M xxx G#RNA_molecule_M
mRNA G#RNA_molecule_M xXXX G#RNA_molecule_M
and G#RNA_molecule_M xxx G#RNA_molecule_M
GM-CSF G#RNA_molecule_M XX-XXX G#RNA_molecule_M
cytoplasmic G#RNA_molecule_M xxx G#RNA_molecule_M
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E

In NE Xx NE
contrast NE xxx NE
, NE , NE
IL-12 G#other_name_B XX-dd G#other_name_B
induction G#other_name_E xxx G#other_name_E
of NE xx NE
IFN-gamma G#RNA_molecule_B XXX-xxx G#RNA_molecule_B
cytoplasmic G#RNA_molecule_M xxx G#RNA_molecule_M
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
appears NE xxx NE
to NE xx NE
only NE xxx NE
partially NE xxx NE
depend NE xxx NE
on NE xx NE
activation NE xxx NE
of NE xx NE
protein G#protein_molecule_B xxx G#protein_molecule_B
kinase G#protein_molecule_M xxx G#protein_molecule_M
C G#protein_molecule_E X G#protein_molecule_E
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
both NE xxx NE
transforming G#protein_molecule_B xxx G#protein_molecule_B
growth G#protein_molecule_M xxx G#protein_molecule_M
factor-beta G#protein_molecule_E xxx-xxx G#protein_molecule_E
and NE xxx NE
genistein G#other_organic_compound xxx G#other_organic_compound
, NE , NE
a NE x NE
tyrosine G#other_name_B xxx G#other_name_B
kinase G#other_name_M xxx G#other_name_M
inhibitor G#other_name_E xxx G#other_name_E
, NE , NE
could NE xxx NE
suppress NE xxx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
and NE xxx NE
IL-12 G#protein_molecule XX-dd G#protein_molecule
signaling NE xxx NE
but NE xxx NE
CsA G#other_organic_compound XxX G#other_organic_compound
was NE xxx NE
generally NE xxx NE
inactive NE xxx NE
. NE . NE

It NE Xx NE
also NE xxx NE
was NE xxx NE
observed NE xxx NE
that NE xxx NE
suppression NE xxx NE
of NE xx NE
cytokine G#other_name_B xxx G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
by NE xx NE
these NE xxx NE
agents NE xxx NE
was NE xxx NE
independent NE xxx NE
of NE xx NE
the NE xxx NE
inhibition G#other_name_B xxx G#other_name_B
of G#other_name_M xx G#other_name_M
proliferation G#other_name_E xxx G#other_name_E
. NE . NE

In NE Xx NE
addition NE xxx NE
, NE , NE
IL-2 G#protein_molecule XX-d G#protein_molecule
but NE xxx NE
not NE xxx NE
IL-12 G#protein_molecule XX-dd G#protein_molecule
induced NE xxx NE
nuclear G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
NF-kappa NE XX-xxx NE
B NE X NE
and NE xxx NE
AP1 G#protein_molecule XXd G#protein_molecule
, NE , NE
and NE xxx NE
regulation NE xxx NE
of NE xx NE
the NE xxx NE
nuclear G#other_name_B xxx G#other_name_B
levels G#other_name_E xxx G#other_name_E
of NE xx NE
these NE xxx NE
two NE xxx NE
DNA NE XXX NE
binding NE xxx NE
protein NE xxx NE
complexes NE xxx NE
is NE xx NE
correlated NE xxx NE
with NE xxx NE
IFN-gamma G#other_name_B XXX-xxx G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
GM-CSF G#other_name_M XX-XXX G#other_name_M
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E

These NE Xxxx NE
data NE xxx NE
indicate NE xxx NE
that NE xxx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
and NE xxx NE
IL-12 G#protein_molecule XX-dd G#protein_molecule
may NE xxx NE
have NE xxx NE
distinct NE xxx NE
signaling G#other_name_B xxx G#other_name_B
pathways G#other_name_E xxx G#other_name_E
leading NE xxx NE
to NE xx NE
the NE xxx NE
induction NE xxx NE
of NE xx NE
IFN-gamma G#protein_molecule XXX-xxx G#protein_molecule
and NE xxx NE
GM-CSF G#other_name_B XX-XXX G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
, NE , NE
and NE xxx NE
that NE xxx NE
the NE xxx NE
NK3.3 G#cell_line_B XXd.d G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
may NE xxx NE
serve NE xxx NE
as NE xx NE
a NE x NE
novel NE xxx NE
model NE xxx NE
for NE xxx NE
dissecting NE xxx NE
the NE xxx NE
biochemical G#other_name_B xxx G#other_name_B
and G#other_name_M xxx G#other_name_M
molecular G#other_name_M xxx G#other_name_M
events G#other_name_E xxx G#other_name_E
involved NE xxx NE
in NE xx NE
these NE xxx NE
pathways NE xxx NE
. NE . NE

A NE X NE
functional G#other_name_B xxx G#other_name_B
T-cell G#other_name_M X-xxx G#other_name_M
receptor G#other_name_M xxx G#other_name_M
signaling G#other_name_M xxx G#other_name_M
pathway G#other_name_E xxx G#other_name_E
is NE xx NE
required NE xxx NE
for NE xxx NE
p95vav G#other_name_B xddxxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
. NE . NE

Stimulation NE Xxxx NE
of NE xx NE
the NE xxx NE
T-cell G#protein_molecule_B X-xxx G#protein_molecule_B
antigen G#protein_molecule_M xxx G#protein_molecule_M
receptor G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
TCR G#protein_molecule XXX G#protein_molecule
) NE ) NE
induces NE xxx NE
activation NE xxx NE
of NE xx NE
multiple NE xxx NE
tyrosine G#protein_molecule_B xxx G#protein_molecule_B
kinases G#protein_molecule_E xxx G#protein_molecule_E
, NE , NE
resulting NE xxx NE
in NE xx NE
phosphorylation G#other_name xxx G#other_name
of NE xx NE
numerous NE xxx NE
intracellular G#other_organic_compound_B xxx G#other_organic_compound_B
substrates G#other_organic_compound_E xxx G#other_organic_compound_E
. NE . NE

One NE Xxx NE
substrate NE xxx NE
is NE xx NE
p95vav G#protein_molecule xddxxx G#protein_molecule
, NE , NE
which NE xxx NE
is NE xx NE
expressed NE xxx NE
exclusively NE xxx NE
in NE xx NE
hematopoietic G#cell_type_B xxx G#cell_type_B
cell G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
trophoblast G#cell_type_M xxx G#cell_type_M
cell G#cell_type_E xxx G#cell_type_E

It NE Xx NE
contains NE xxx NE
a NE x NE
number NE xxx NE
of NE xx NE
structural G#protein_substructure_B xxx G#protein_substructure_B
motifs G#protein_substructure_E xxx G#protein_substructure_E
, NE , NE
including NE xxx NE
Src NE Xxx NE
homology NE xxx NE
2 NE d NE
, NE , NE
Src NE Xxx NE
homology NE xxx NE
3 NE d NE
, NE , NE
and NE xxx NE
pleckstrin NE xxx NE
homology NE xxx NE
domains NE xxx NE
and NE xxx NE
a NE x NE
putative NE xxx NE
guanine NE xxx NE
nucleotide NE xxx NE
exchange NE xxx NE
domain NE xxx NE
. NE . NE

The NE Xxx NE
role NE xxx NE
of NE xx NE
p95vav G#protein_molecule xddxxx G#protein_molecule
in NE xx NE
TCR NE XXX NE
-mediated NE -xxx NE
signaling NE xxx NE
processes NE xxx NE
is NE xx NE
unclear NE xxx NE
. NE . NE

Here NE Xxxx NE
, NE , NE
we NE xx NE
show NE xxx NE
that NE xxx NE
overexpression NE xxx NE
of NE xx NE
p95vav G#protein_molecule xddxxx G#protein_molecule
alone NE xxx NE
in NE xx NE
Jurkat NE Xxxx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
leads NE xxx NE
to NE xx NE
activation NE xxx NE
of NE xx NE
the NE xxx NE
nuclear G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
including NE xxx NE
NFAT G#protein_family_or_group XXXX G#protein_family_or_group
, NE , NE
involved NE xxx NE
in NE xx NE
interleukin-2 G#other_name_B xxx-d G#other_name_B
expression G#other_name_E xxx G#other_name_E
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
p95vav G#protein_molecule xddxxx G#protein_molecule
synergizes NE xxx NE
with NE xxx NE
TCR G#other_name_B XXX G#other_name_B
stimulation G#other_name_E xxx G#other_name_E
in NE xx NE
inducing NE xxx NE
NFAT-dependent G#other_name_B XXXX-xxx G#other_name_B
transcription G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
interleukin-2-dependent G#other_name_M xxx-d-xxx G#other_name_M
transcription G#other_name_E xxx G#other_name_E

In NE Xx NE
contrast NE xxx NE
, NE , NE
NFAT G#other_name_B XXXX G#other_name_B
activation G#other_name_E xxx G#other_name_E
by NE xx NE
a NE x NE
G-protein-coupled G#protein_family_or_group_B X-xxx-xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
is NE xx NE
not NE xxx NE
modulated NE xxx NE
by NE xx NE
p95vav G#other_name_B xddxxx G#other_name_B
overexpression G#other_name_E xxx G#other_name_E
, NE , NE
suggesting NE xxx NE
that NE xxx NE
the NE xxx NE
effect NE xxx NE
is NE xx NE
specific NE xxx NE
to NE xx NE
the NE xxx NE
TCR G#other_name_B XXX G#other_name_B
signaling G#other_name_M xxx G#other_name_M
pathways G#other_name_E xxx G#other_name_E
. NE . NE

Although NE Xxxx NE
removal NE xxx NE
of NE xx NE
the NE xxx NE
first G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
67 G#protein_domain_or_region_M dd G#protein_domain_or_region_M
amino G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
acids G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
of NE xx NE
p95vav G#protein_molecule xddxxx G#protein_molecule
activates NE xxx NE
its NE xxx NE
transforming G#other_name_B xxx G#other_name_B
potential G#other_name_E xxx G#other_name_E
in NE xx NE
NIH G#cell_line_B XXX G#cell_line_B
3T3 G#cell_line_M dXd G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
this NE xxx NE
region NE xxx NE
appears NE xxx NE
to NE xx NE
be NE xx NE
required NE xxx NE
for NE xxx NE
its NE xxx NE
function NE xxx NE
in NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

We NE Xx NE
further NE xxx NE
demonstrate NE xxx NE
that NE xxx NE
the NE xxx NE
p95vav NE xddxxx NE
-induced NE -xxx NE
NFAT NE XXXX NE
activation NE xxx NE
is NE xx NE
not NE xxx NE
mimicked NE xxx NE
by NE xx NE
Ras NE Xxx NE
activation NE xxx NE
, NE , NE
though NE xxx NE
its NE xxx NE
function NE xxx NE
is NE xx NE
dependent NE xxx NE
upon NE xxx NE
Ras NE Xxx NE
and NE xxx NE
Raf NE Xxx NE
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
the NE xxx NE
activating G#other_name_B xxx G#other_name_B
function G#other_name_E xxx G#other_name_E
of NE xx NE
p95vav G#protein_molecule xddxxx G#protein_molecule
is NE xx NE
blocked NE xxx NE
by NE xx NE
FK506 G#other_organic_compound XXddd G#other_organic_compound
, NE , NE
suggesting NE xxx NE
that NE xxx NE
its NE xxx NE
activity NE xxx NE
also NE xxx NE
depends NE xxx NE
on NE xx NE
calcineurin G#protein_molecule xxx G#protein_molecule
. NE . NE

To NE Xx NE
further NE xxx NE
dissect NE xxx NE
p95vav G#other_name_B xddxxx G#other_name_B
involvement G#other_name_E xxx G#other_name_E
in NE xx NE
TCR G#other_name_B XXX G#other_name_B
signaling G#other_name_E xxx G#other_name_E
, NE , NE
we NE xx NE
analyzed NE xxx NE
various NE xxx NE
Jurkat G#cell_line_B Xxxx G#cell_line_B
mutants G#cell_line_E xxx G#cell_line_E
deficient NE xxx NE
in NE xx NE
TCR G#other_name_B XXX G#other_name_B
signaling G#other_name_M xxx G#other_name_M
function G#other_name_E xxx G#other_name_E
or NE xx NE
TCR G#other_name_B XXX G#other_name_B
expression G#other_name_E xxx G#other_name_E
and NE xxx NE
showed NE xxx NE
that NE xxx NE
an NE xx NE
intact NE xxx NE
TCR G#other_name_B XXX G#other_name_B
signaling G#other_name_M xxx G#other_name_M
pathway G#other_name_E xxx G#other_name_E
is NE xx NE
required NE xxx NE
for NE xxx NE
p95vav G#protein_molecule xddxxx G#protein_molecule
to NE xx NE
function NE xxx NE
. NE . NE

However NE Xxxx NE
, NE , NE
overexpression G#other_name xxx G#other_name
of NE xx NE
p95vav G#protein_molecule xddxxx G#protein_molecule
does NE xxx NE
not NE xxx NE
appear NE xxx NE
to NE xx NE
influence NE xxx NE
TCR NE XXX NE
-induced NE -xxx NE
protein NE xxx NE
tyrosine NE xxx NE
phosphorylation NE xxx NE
or NE xx NE
increases NE xxx NE
in NE xx NE
cytoplasmic NE xxx NE
free NE xxx NE
calcium NE xxx NE
. NE . NE

Taken NE Xxxx NE
together NE xxx NE
, NE , NE
our NE xxx NE
data NE xxx NE
suggest NE xxx NE
that NE xxx NE
p95vav G#protein_molecule xddxxx G#protein_molecule
plays NE xxx NE
an NE xx NE
important NE xxx NE
role NE xxx NE
at NE xx NE
an NE xx NE
yet NE xxx NE
unidentified G#other_name_B xxx G#other_name_B
proximal G#other_name_M xxx G#other_name_M
position G#other_name_E xxx G#other_name_E
in NE xx NE
the NE xxx NE
TCR G#other_name_B XXX G#other_name_B
signaling G#other_name_M xxx G#other_name_M
cascade G#other_name_E xxx G#other_name_E
. NE . NE

positive G#other_name_B xxx G#other_name_B
regulation G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
negative G#other_name_M xxx G#other_name_M
regulation G#other_name_E xxx G#other_name_E
of NE xx NE
granulocyte-macrophage G#other_name_B xxx-xxx G#other_name_B
colony-stimulating G#other_name_M xxx-xxx G#other_name_M
factor G#other_name_M xxx G#other_name_M
promoter G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
by NE xx NE
AML1-related G#protein_molecule_B XXXd-xxx G#protein_molecule_B
transcription G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_E xxx G#protein_molecule_E
, NE , NE
PEBP2 G#protein_molecule XXXXd G#protein_molecule
. NE . NE

The NE Xxx NE
granulocyte-macrophage G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
colony-stimulating G#DNA_domain_or_region_M xxx-xxx G#DNA_domain_or_region_M
factor G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
( G#DNA_domain_or_region_E ( G#DNA_domain_or_region_E
GM-CSF NE XX-XXX NE
) NE ) NE
gene NE xxx NE
promoter NE xxx NE
contains NE xxx NE
a NE x NE
consensus NE xxx NE
sequence NE xxx NE
for NE xxx NE
the NE xxx NE
polyomavirus G#protein_molecule_B xxx G#protein_molecule_B
enhancer G#protein_molecule_M xxx G#protein_molecule_M
binding-protein G#protein_molecule_M xxx-xxx G#protein_molecule_M
2 G#protein_molecule_M d G#protein_molecule_M
( G#protein_molecule_E ( G#protein_molecule_E
PEBP2 NE XXXXd NE
) NE ) NE
transcription NE xxx NE
factor NE xxx NE
, NE , NE
which NE xxx NE
consists NE xxx NE
of NE xx NE
alpha G#protein_subunit_B xxx G#protein_subunit_B
subunit G#protein_subunit_M xxx G#protein_subunit_M
and G#protein_subunit_M xxx G#protein_subunit_M
beta G#protein_subunit_M xxx G#protein_subunit_M
subunit G#protein_subunit_E xxx G#protein_subunit_E

There NE Xxxx NE
are NE xxx NE
at NE xx NE
least NE xxx NE
two NE xxx NE
genes NE xxx NE
, NE , NE
alpha G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
A G#DNA_domain_or_region_E X G#DNA_domain_or_region_E
and NE xxx NE
alpha G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
B G#DNA_domain_or_region_E X G#DNA_domain_or_region_E
, NE , NE
encoding NE xxx NE
the NE xxx NE
alpha G#protein_subunit_B xxx G#protein_subunit_B
subunit G#protein_subunit_E xxx G#protein_subunit_E
. NE . NE

alpha G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
B G#DNA_domain_or_region_E X G#DNA_domain_or_region_E
is NE xx NE
the NE xxx NE
mouse G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
homologue G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
of NE xx NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
AML1 G#DNA_domain_or_region_M XXXd G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
detected NE xxx NE
at NE xx NE
the NE xxx NE
breakpoints NE xxx NE
of NE xx NE
t(8;21) G#other_artificial_source_B x(d;dd) G#other_artificial_source_B
myeloid G#other_artificial_source_M xxx G#other_artificial_source_M
leukemia G#other_artificial_source_M xxx G#other_artificial_source_M
and G#other_artificial_source_M xxx G#other_artificial_source_M
t(3;21) G#other_artificial_source_M x(d;dd) G#other_artificial_source_M
myeloid G#other_artificial_source_M xxx G#other_artificial_source_M
leukemia G#other_artificial_source_E xxx G#other_artificial_source_E

We NE Xx NE
examined NE xxx NE
alpha G#protein_subunit_B xxx G#protein_subunit_B
A1 G#protein_subunit_E Xd G#protein_subunit_E
(an NE (xx NE
alpha NE xxx NE
A NE X NE
-gene NE -xxx NE
product NE xxx NE
) NE ) NE
and NE xxx NE
alpha NE xxx NE
B1 NE Xd NE
and NE xxx NE
alpha NE xxx NE
B2 NE Xd NE
(two NE (xxx NE
alpha NE xxx NE
B NE X NE
-encoded NE -xxx NE
isomers NE xxx NE
) NE ) NE
for NE xxx NE
their NE xxx NE
effects NE xxx NE
on NE xx NE
the NE xxx NE
GM-CSF NE XX-XXX NE
promoter NE xxx NE
. NE . NE

PEBP2 G#protein_molecule_B XXXXd G#protein_molecule_B
alpha G#protein_molecule_M xxx G#protein_molecule_M
A1 G#protein_molecule_E Xd G#protein_molecule_E
, NE , NE
alpha G#protein_subunit_B xxx G#protein_subunit_B
B1 G#protein_subunit_E Xd G#protein_subunit_E
, NE , NE
and NE xxx NE
alpha G#protein_family_or_group_B xxx G#protein_family_or_group_B
B2 G#protein_family_or_group_M Xd G#protein_family_or_group_M
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
bound NE xxx NE
the NE xxx NE
PEBP2 G#DNA_domain_or_region_B XXXXd G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
within NE xxx NE
the NE xxx NE
mouse G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
GM-CSF G#DNA_domain_or_region_M XX-XXX G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

PEBP2 G#protein_molecule_B XXXXd G#protein_molecule_B
alpha G#protein_molecule_M xxx G#protein_molecule_M
A1 G#protein_molecule_E Xd G#protein_molecule_E
and NE xxx NE
alpha G#protein_subunit_B xxx G#protein_subunit_B
B1 G#protein_subunit_E Xd G#protein_subunit_E
enhanced NE xxx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
GM-CSF G#DNA_molecule_B XX-XXX G#DNA_molecule_B
promoter-driven G#DNA_molecule_M xxx-xxx G#DNA_molecule_M
reporter G#DNA_molecule_M xxx G#DNA_molecule_M
plasmid G#DNA_molecule_E xxx G#DNA_molecule_E
in NE xx NE
unstimulated G#cell_line_B xxx G#cell_line_B
human G#cell_line_M xxx G#cell_line_M
Jurkat G#cell_line_M Xxxx G#cell_line_M
T G#cell_line_M X G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
and G#cell_line_M xxx G#cell_line_M
12-O-tetradecanoylphorbol G#cell_line_M dd-X-xxx G#cell_line_M
13-acetate/phytohemagglutinin-stimulated G#cell_line_M dd-xxx/xxx-xxx G#cell_line_M
human G#cell_line_M xxx G#cell_line_M
Jurkat G#cell_line_M Xxxx G#cell_line_M
T G#cell_line_M X G#cell_line_M
cell G#cell_line_E xxx G#cell_line_E

In NE Xx NE
contrast NE xxx NE
, NE , NE
the NE xxx NE
promoter G#other_name_B xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
was NE xxx NE
suppressed NE xxx NE
by NE xx NE
alpha G#protein_subunit_B xxx G#protein_subunit_B
B2 G#protein_subunit_E Xd G#protein_subunit_E
. NE . NE

Coexpression NE Xxxx NE
of NE xx NE
alpha G#protein_subunit_B xxx G#protein_subunit_B
B1 G#protein_subunit_E Xd G#protein_subunit_E
and NE xxx NE
alpha G#protein_subunit_B xxx G#protein_subunit_B
B2 G#protein_subunit_E Xd G#protein_subunit_E
showed NE xxx NE
that NE xxx NE
the NE xxx NE
promoter G#other_name_B xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
could NE xxx NE
be NE xx NE
determined NE xxx NE
by NE xx NE
the NE xxx NE
alpha NE xxx NE
B1 NE Xd NE
/alpha NE /xxx NE
B2 NE Xd NE
ratio NE xxx NE
. NE . NE

Jurkat G#cell_component_B Xxxx G#cell_component_B
cell G#cell_component_M xxx G#cell_component_M
extract G#cell_component_E xxx G#cell_component_E
contained NE xxx NE
PEBP2 G#protein_family_or_group_B XXXXd G#protein_family_or_group_B
site-binding G#protein_family_or_group_M xxx-xxx G#protein_family_or_group_M
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
(s) NE (x) NE
that NE xxx NE
cross-reacted NE xxx-xxx NE
with NE xxx NE
antimouse NE xxx NE
alpha NE xxx NE
A1 NE Xd NE
antibodies NE xxx NE
. NE . NE

Northern G#other_name_B Xxxx G#other_name_B
blot G#other_name_M xxx G#other_name_M
analysis G#other_name_E xxx G#other_name_E
indicated NE xxx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
human NE xxx NE
PEBP2 G#protein_molecule_B XXXXd G#protein_molecule_B
alpha G#protein_molecule_M xxx G#protein_molecule_M
A G#protein_molecule_E X G#protein_molecule_E
, NE , NE
alpha G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
B G#DNA_domain_or_region_E X G#DNA_domain_or_region_E
( NE ( NE
AML1 G#DNA_domain_or_region XXXd G#DNA_domain_or_region
) NE ) NE
, NE , NE
and NE xxx NE
beta G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
genes G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
Jurkat G#cell_line_B Xxxx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

Although NE Xxxx NE
further NE xxx NE
studies NE xxx NE
are NE xxx NE
required NE xxx NE
to NE xx NE
determine NE xxx NE
the NE xxx NE
precise NE xxx NE
role NE xxx NE
of NE xx NE
PEBP2 G#protein_molecule XXXXd G#protein_molecule
in NE xx NE
the NE xxx NE
GM-CSF G#other_name_B XX-XXX G#other_name_B
promoter G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
, NE , NE
the NE xxx NE
present NE xxx NE
findings NE xxx NE
suggested NE xxx NE
the NE xxx NE
importance NE xxx NE
of NE xx NE
the NE xxx NE
relative NE xxx NE
ratio NE xxx NE
of NE xx NE
different NE xxx NE
PEBP2 G#protein_family_or_group_B XXXXd G#protein_family_or_group_B
isoforms G#protein_family_or_group_E xxx G#protein_family_or_group_E
in NE xx NE
regulating NE xxx NE
the NE xxx NE
levels NE xxx NE
of NE xx NE
the NE xxx NE
promoter G#other_name_B xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
. NE . NE

IFN-gamma G#protein_molecule XXX-xxx G#protein_molecule
priming NE xxx NE
of NE xx NE
monocytes G#cell_type xxx G#cell_type
enhances NE xxx NE
LPS NE XXX NE
-induced NE -xxx NE
TNF NE XXX NE
production NE xxx NE
by NE xx NE
augmenting NE xxx NE
both NE xxx NE
transcription NE xxx NE
and NE xxx NE
MRNA NE XXXX NE
stability NE xxx NE
. NE . NE

The NE Xxx NE
induction NE xxx NE
of NE xx NE
cytokine G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
in NE xx NE
monocytes G#cell_type xxx G#cell_type
/ NE / NE
macrophages G#cell_type xxx G#cell_type
by NE xx NE
bacterial G#protein_family_or_group_B xxx G#protein_family_or_group_B
endotoxin G#protein_family_or_group_E xxx G#protein_family_or_group_E
or NE xx NE
lipopolysaccharide G#lipid xxx G#lipid
is NE xx NE
a NE x NE
critical NE xxx NE
, NE , NE
highly NE xxx NE
regulated NE xxx NE
host G#other_name_B xxx G#other_name_B
defence G#other_name_M xxx G#other_name_M
response G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
augmentation NE xxx NE
of NE xx NE
LPS G#lipid XXX G#lipid
responses NE xxx NE
by NE xx NE
interferon G#protein_molecule_B xxx G#protein_molecule_B
gamma G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
IFN-gamma G#protein_molecule XXX-xxx G#protein_molecule
) NE ) NE
, NE , NE
referred NE xxx NE
to NE xx NE
as NE xx NE
priming NE xxx NE
, NE , NE
is NE xx NE
well NE xxx NE
established NE xxx NE
. NE . NE

However NE Xxxx NE
, NE , NE
the NE xxx NE
mechanism(s) NE xxx(x) NE
by NE xx NE
which NE xxx NE
priming NE xxx NE
occurs NE xxx NE
is NE xx NE
poorly NE xxx NE
defined NE xxx NE
. NE . NE

Using NE Xxxx NE
tumour NE xxx NE
necrosis NE xxx NE
factor NE xxx NE
( NE ( NE
TNF NE XXX NE
) NE ) NE
induction NE xxx NE
as NE xx NE
a NE x NE
model NE xxx NE
, NE , NE
experiments NE xxx NE
were NE xxx NE
designed NE xxx NE
to NE xx NE
analyse NE xxx NE
in NE xx NE
detail NE xxx NE
the NE xxx NE
priming NE xxx NE
effect NE xxx NE
on NE xx NE
the NE xxx NE
LPS NE XXX NE
response NE xxx NE
in NE xx NE
human NE xxx NE
monocytes NE xxx NE
. NE . NE

Priming NE Xxxx NE
by NE xx NE
IFN-gamma G#protein_molecule XXX-xxx G#protein_molecule
was NE xxx NE
primarily NE xxx NE
manifested NE xxx NE
at NE xx NE
the NE xxx NE
level NE xxx NE
of NE xx NE
TNF G#other_name_B XXX G#other_name_B
mRNA G#other_name_M xXXX G#other_name_M
accumulation G#other_name_E xxx G#other_name_E
. NE . NE

IFN-gamma G#other_name_B XXX-xxx G#other_name_B
pre-treatment G#other_name_E xxx-xxx G#other_name_E
affected NE xxx NE
the NE xxx NE
magnitude NE xxx NE
rather NE xxx NE
than NE xxx NE
the NE xxx NE
sensitivity NE xxx NE
of NE xx NE
the NE xxx NE
LPS G#other_name_B XXX G#other_name_B
response G#other_name_E xxx G#other_name_E
. NE . NE

Priming NE Xxxx NE
occurred NE xxx NE
after NE xxx NE
several NE xxx NE
hours NE xxx NE
of NE xx NE
treatment G#other_name xxx G#other_name
, NE , NE
and NE xxx NE
the NE xxx NE
primed G#other_name_B xxx G#other_name_B
state G#other_name_E xxx G#other_name_E
was NE xxx NE
induced NE xxx NE
by NE xx NE
either NE xxx NE
IFN-gamma G#protein_molecule XXX-xxx G#protein_molecule
or NE xx NE
GM-CSF G#protein_molecule XX-XXX G#protein_molecule
, NE , NE
but NE xxx NE
not NE xxx NE
M-CSF G#protein_molecule X-XXX G#protein_molecule
. NE . NE

Primed NE Xxxx NE
monocytes G#cell_type xxx G#cell_type
transcribed NE xxx NE
TNF G#RNA_family_or_group_B XXX G#RNA_family_or_group_B
mRNA G#RNA_family_or_group_E xXXX G#RNA_family_or_group_E
at NE xx NE
a NE x NE
higher NE xxx NE
rate NE xxx NE
than NE xxx NE
freshly NE xxx NE
isolated NE xxx NE
monocytes G#cell_type xxx G#cell_type
upon NE xxx NE
activation NE xxx NE
with NE xxx NE
LPS G#lipid XXX G#lipid
. NE . NE

The NE Xxx NE
increased NE xxx NE
transcriptional G#other_name_B xxx G#other_name_B
rate G#other_name_E xxx G#other_name_E
correlated NE xxx NE
with NE xxx NE
a NE x NE
marked NE xxx NE
increase NE xxx NE
in NE xx NE
nuclear G#other_name_B xxx G#other_name_B
factor-kappa G#other_name_M xxx-xxx G#other_name_M
B G#other_name_M X G#other_name_M
activity G#other_name_E xxx G#other_name_E
in NE xx NE
these NE xxx NE
cells NE xxx NE
as NE xx NE
determined NE xxx NE
by NE xx NE
electrophoretic G#other_name_B xxx G#other_name_B
mobility G#other_name_M xxx G#other_name_M
shift G#other_name_M xxx G#other_name_M
assay G#other_name_E xxx G#other_name_E
using NE xxx NE
a NE x NE
consensus G#DNA_molecule_B xxx G#DNA_molecule_B
NF-kappa G#DNA_molecule_M XX-xxx G#DNA_molecule_M
B G#DNA_molecule_M X G#DNA_molecule_M
oligonucleotide G#DNA_molecule_E xxx G#DNA_molecule_E
. NE . NE

An NE Xx NE
additional NE xxx NE
significant NE xxx NE
finding NE xxx NE
was NE xxx NE
than NE xxx NE
TNF G#RNA_family_or_group_B XXX G#RNA_family_or_group_B
mRNA G#RNA_family_or_group_E xXXX G#RNA_family_or_group_E
induced NE xxx NE
in NE xx NE
primed G#cell_line_B xxx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
was NE xxx NE
much NE xxx NE
more NE xxx NE
stable NE xxx NE
than NE xxx NE
in NE xx NE
unprimed G#cell_line_B xxx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
(T1/2 NE (Xd/d NE
increased NE xxx NE
6-8-fold) NE d-d-xxx) NE
. NE . NE

Consistent NE Xxxx NE
with NE xxx NE
the NE xxx NE
increased NE xxx NE
mRNA G#other_name_B xXXX G#other_name_B
stability G#other_name_E xxx G#other_name_E
, NE , NE
the NE xxx NE
duration NE xxx NE
of NE xx NE
mRNA G#other_name_B xXXX G#other_name_B
accumulation G#other_name_E xxx G#other_name_E
was NE xxx NE
longer NE xxx NE
following NE xxx NE
LPS G#lipid XXX G#lipid
stimulation NE xxx NE
in NE xx NE
primed NE xxx NE
monocytes G#cell_type xxx G#cell_type
, NE , NE
in NE xx NE
addition NE xxx NE
to NE xx NE
being NE xxx NE
of NE xx NE
greater NE xxx NE
magnitude NE xxx NE
. NE . NE

Finally NE Xxxx NE
, NE , NE
primed NE xxx NE
and NE xxx NE
unprimed NE xxx NE
cells NE xxx NE
possessed NE xxx NE
a NE x NE
differential NE xxx NE
sensitivity NE xxx NE
to NE xx NE
the NE xxx NE
kinase G#other_organic_compound_B xxx G#other_organic_compound_B
inhibitor G#other_organic_compound_M xxx G#other_organic_compound_M
H-89 G#other_organic_compound_E X-dd G#other_organic_compound_E
. NE . NE

H-89 G#other_organic_compound X-dd G#other_organic_compound
substantially NE xxx NE
suppressed NE xxx NE
LPS NE XXX NE
-induced NE -xxx NE
TNF NE XXX NE
mRNA NE xXXX NE
accumulation NE xxx NE
in NE xx NE
unprimed NE xxx NE
cells NE xxx NE
, NE , NE
but NE xxx NE
had NE xxx NE
no NE xx NE
effect NE xxx NE
on NE xx NE
primed NE xxx NE
monocytes NE xxx NE
following NE xxx NE
LPS NE XXX NE
stimulation NE xxx NE
. NE . NE

(ABSTRACT NE (XXXXXXXX NE
TRUNCATED NE XXXXXXXXX NE
AT NE XX NE
250 NE ddd NE
WORDS) NE XXXXX) NE

A NE X NE
Myc-associated G#DNA_domain_or_region_B Xxx-xxx G#DNA_domain_or_region_B
zinc G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
finger G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
protein G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
is NE xx NE
one NE xxx NE
of NE xx NE
four NE xxx NE
important NE xxx NE
functional G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
regions G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
the NE xxx NE
CD4 G#DNA_domain_or_region_B XXd G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

The NE Xxx NE
CD4 G#DNA_domain_or_region_B XXd G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
plays NE xxx NE
an NE xx NE
important NE xxx NE
role NE xxx NE
in NE xx NE
the NE xxx NE
developmental G#other_name_B xxx G#other_name_B
control G#other_name_E xxx G#other_name_E
of NE xx NE
CD4 G#other_name_B XXd G#other_name_B
transcription G#other_name_E xxx G#other_name_E
. NE . NE

In NE Xx NE
this NE xxx NE
report NE xxx NE
, NE , NE
we NE xx NE
show NE xxx NE
that NE xxx NE
the NE xxx NE
minimal NE xxx NE
CD4 G#DNA_domain_or_region_B XXd G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
has NE xxx NE
four NE xxx NE
factor G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
each NE xxx NE
of NE xx NE
which NE xxx NE
is NE xx NE
required NE xxx NE
for NE xxx NE
full NE xxx NE
function NE xxx NE
. NE . NE

Using NE Xxxx NE
biochemical G#other_name_B xxx G#other_name_B
analysis G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
mutagenesis G#other_name_M xxx G#other_name_M
analysis G#other_name_E xxx G#other_name_E
analyses NE xxx NE
, NE , NE
we NE xx NE
determined NE xxx NE
that NE xxx NE
multiple NE xxx NE
nuclear G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
bind NE xxx NE
to NE xx NE
these NE xxx NE
independent NE xxx NE
sites NE xxx NE
. NE . NE

We NE Xx NE
determined NE xxx NE
that NE xxx NE
an NE xx NE
initiator-like G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
present NE xxx NE
at NE xx NE
the NE xxx NE
cap G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
an NE xx NE
Ets G#DNA_domain_or_region_B Xxx G#DNA_domain_or_region_B
consensus G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
are NE xxx NE
required NE xxx NE
for NE xxx NE
full NE xxx NE
promoter G#other_name_B xxx G#other_name_B
function G#other_name_E xxx G#other_name_E
. NE . NE

We NE Xx NE
also NE xxx NE
demonstrate NE xxx NE
that NE xxx NE
the NE xxx NE
Myc-associated G#protein_molecule_B Xxx-xxx G#protein_molecule_B
zinc G#protein_molecule_M xxx G#protein_molecule_M
finger G#protein_molecule_M xxx G#protein_molecule_M
protein G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
MAZ G#protein_molecule XXX G#protein_molecule
) NE ) NE
appears NE xxx NE
to NE xx NE
be NE xx NE
the NE xxx NE
predominant G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
binding NE xxx NE
to NE xx NE
one NE xxx NE
of NE xx NE
these NE xxx NE
sites NE xxx NE
. NE . NE

This NE Xxxx NE
last NE xxx NE
site NE xxx NE
closely NE xxx NE
resembles NE xxx NE
the NE xxx NE
ME1a1 G#DNA_domain_or_region_B XXdxd G#DNA_domain_or_region_B
G3AG4AG3 G#DNA_domain_or_region_M XdXXdXXd G#DNA_domain_or_region_M
motif G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
previously NE xxx NE
shown NE xxx NE
to NE xx NE
be NE xx NE
a NE x NE
critical NE xxx NE
element NE xxx NE
in NE xx NE
the NE xxx NE
P2 G#DNA_domain_or_region_B Xd G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
the NE xxx NE
c-myc G#DNA_domain_or_region_B x-xxx G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

We NE Xx NE
therefore NE xxx NE
believe NE xxx NE
that NE xxx NE
the NE xxx NE
MAZ G#protein_family_or_group_B XXX G#protein_family_or_group_B
transcription G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
is NE xx NE
also NE xxx NE
likely NE xxx NE
to NE xx NE
play NE xxx NE
an NE xx NE
important NE xxx NE
role NE xxx NE
in NE xx NE
the NE xxx NE
control NE xxx NE
of NE xx NE
developmental G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
CD4 G#DNA_domain_or_region_B XXd G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Erythropoietin G#protein_molecule Xxxx G#protein_molecule
stimulates NE xxx NE
transcription NE xxx NE
of NE xx NE
the NE xxx NE
TAL1/SCL G#DNA_domain_or_region_B XXXd/XXX G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
phosphorylation G#other_name xxx G#other_name
of NE xx NE
its NE xxx NE
protein G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
products G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
. NE . NE

Activation NE Xxxx NE
of NE xx NE
the NE xxx NE
TAL1 G#DNA_domain_or_region_B XXXd G#DNA_domain_or_region_B
(or G#DNA_domain_or_region_M (xx G#DNA_domain_or_region_M
SCL) G#DNA_domain_or_region_M XXX) G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
originally NE xxx NE
identified NE xxx NE
through NE xxx NE
its NE xxx NE
involvement NE xxx NE
by NE xx NE
a NE x NE
recurrent G#other_name_B xxx G#other_name_B
chromosomal G#other_name_M xxx G#other_name_M
translocation G#other_name_E xxx G#other_name_E
, NE , NE
is NE xx NE
the NE xxx NE
most NE xxx NE
frequent NE xxx NE
molecular G#DNA_N/A_B xxx G#DNA_N/A_B
lesion G#DNA_N/A_E xxx G#DNA_N/A_E
recognized NE xxx NE
in NE xx NE
T-cell G#other_name_B X-xxx G#other_name_B
acute G#other_name_M xxx G#other_name_M
lymphoblastic G#other_name_M xxx G#other_name_M
leukemia G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
protein G#protein_family_or_group_B xxx G#protein_family_or_group_B
products G#protein_family_or_group_E xxx G#protein_family_or_group_E
of NE xx NE
this NE xxx NE
gene NE xxx NE
contain NE xxx NE
the NE xxx NE
basic-helix-loop-helix G#protein_family_or_group_B xxx-xxx-xxx-xxx G#protein_family_or_group_B
motif G#protein_family_or_group_E xxx G#protein_family_or_group_E
characteristic NE xxx NE
of NE xx NE
a NE x NE
large NE xxx NE
family NE xxx NE
of NE xx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
that NE xxx NE
bind NE xxx NE
to NE xx NE
the NE xxx NE
canonical G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
DNA G#DNA_domain_or_region_M XXX G#DNA_domain_or_region_M
sequence G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
CANNTG G#DNA_domain_or_region_E XXXXXX G#DNA_domain_or_region_E
as NE xx NE
protein G#protein_family_or_group_B xxx G#protein_family_or_group_B
heterodimers G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

TAL1 G#other_name_B XXXd G#other_name_B
expression G#other_name_E xxx G#other_name_E
by NE xx NE
erythroid G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
in NE xx NE
vivo NE xxx NE
and NE xxx NE
in NE xx NE
chemical-induced G#cell_line_B xxx-xxx G#cell_line_B
erythroleukemia G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
in NE xx NE
vivo NE xxx NE
suggested NE xxx NE
the NE xxx NE
gene NE xxx NE
might NE xxx NE
regulate NE xxx NE
aspects NE xxx NE
of NE xx NE
erythroid G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
. NE . NE

Since NE Xxxx NE
the NE xxx NE
terminal NE xxx NE
events NE xxx NE
of NE xx NE
erythropoiesis G#other_name xxx G#other_name
are NE xxx NE
controlled NE xxx NE
by NE xx NE
the NE xxx NE
glycoprotein G#protein_molecule_B xxx G#protein_molecule_B
hormone G#protein_molecule_M xxx G#protein_molecule_M
erythropoietin G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
Epo G#protein_molecule Xxx G#protein_molecule
) NE ) NE
, NE , NE
we NE xx NE
investigated NE xxx NE
whether NE xxx NE
the NE xxx NE
expression NE xxx NE
or NE xx NE
activity NE xxx NE
of NE xx NE
the NE xxx NE
TAL1 G#DNA_domain_or_region_B XXXd G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
its NE xxx NE
protein G#protein_family_or_group_B xxx G#protein_family_or_group_B
products G#protein_family_or_group_E xxx G#protein_family_or_group_E
were NE xxx NE
affected NE xxx NE
by NE xx NE
Epo G#protein_molecule Xxx G#protein_molecule
in NE xx NE
splenic G#cell_type_B xxx G#cell_type_B
erythroblasts G#cell_type_E xxx G#cell_type_E
from NE xxx NE
mice G#multi_cell xxx G#multi_cell
infected NE xxx NE
with NE xxx NE
an NE xx NE
anemia-inducing NE xxx-xxx NE
strain NE xxx NE
of NE xx NE
Friend NE Xxxx NE
virus NE xxx NE
(FVA NE (XXX NE
cells) NE xxx) NE
. NE . NE

Epo G#protein_molecule Xxx G#protein_molecule
elicited NE xxx NE
a NE x NE
rapid NE xxx NE
, NE , NE
dose-related NE xxx-xxx NE
increase NE xxx NE
in NE xx NE
TAL1 G#RNA_family_or_group_B XXXd G#RNA_family_or_group_B
mRNA G#RNA_family_or_group_E xXXX G#RNA_family_or_group_E
by NE xx NE
increasing NE xxx NE
transcription G#other_name xxx G#other_name
of NE xx NE
the NE xxx NE
gene NE xxx NE
and NE xxx NE
stabilizing NE xxx NE
one NE xxx NE
of NE xx NE
its NE xxx NE
mRNAs G#RNA_family_or_group xXXXx G#RNA_family_or_group
. NE . NE

An NE Xx NE
Epo NE Xxx NE
-inducible NE -xxx NE
TAL1 NE XXXd NE
DNA NE XXX NE
binding NE xxx NE
activity NE xxx NE
was NE xxx NE
identified NE xxx NE
in NE xx NE
FVA NE XXX NE
cell NE xxx NE
nuclear NE xxx NE
extracts NE xxx NE
that NE xxx NE
subsequently NE xxx NE
decayed NE xxx NE
despite NE xxx NE
accumulating NE xxx NE
mRNA NE xXXX NE
and NE xxx NE
protein NE xxx NE
. NE . NE

Induction NE Xxxx NE
of NE xx NE
DNA G#other_name_B XXX G#other_name_B
binding G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
was NE xxx NE
associated NE xxx NE
temporally NE xxx NE
with NE xxx NE
Epo NE Xxx NE
-induced NE -xxx NE
phosphorylation NE xxx NE
of NE xx NE
nuclear NE xxx NE
TAL1 NE XXXd NE
protein NE xxx NE
. NE . NE

These NE Xxxx NE
results NE xxx NE
indicate NE xxx NE
that NE xxx NE
Epo G#protein_molecule Xxx G#protein_molecule
acts NE xxx NE
at NE xx NE
both NE xxx NE
transcriptional G#other_name_B xxx G#other_name_B
level G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
posttranscriptional G#other_name_M xxx G#other_name_M
level G#other_name_E xxx G#other_name_E
on NE xx NE
the NE xxx NE
TAL1 G#protein_molecule XXXd G#protein_molecule
locus NE xxx NE
in NE xx NE
Friend G#cell_line_B Xxxx G#cell_line_B
virus G#cell_line_E xxx G#cell_line_E
-induced NE -xxx NE
erythroblasts NE xxx NE
and NE xxx NE
establish NE xxx NE
a NE x NE
link NE xxx NE
between NE xxx NE
Epo G#other_name_B Xxx G#other_name_B
signaling G#other_name_M xxx G#other_name_M
mechanisms G#other_name_E xxx G#other_name_E
and NE xxx NE
a NE x NE
member NE xxx NE
of NE xx NE
a NE x NE
family NE xxx NE
of NE xx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
involved NE xxx NE
in NE xx NE
the NE xxx NE
differentiation NE xxx NE
of NE xx NE
diverse G#cell_type_B xxx G#cell_type_B
cell G#cell_type_M xxx G#cell_type_M
lineages G#cell_type_E xxx G#cell_type_E
. NE . NE

Nonradioactive G#other_name_B Xxxx G#other_name_B
quantification G#other_name_E xxx G#other_name_E
of NE xx NE
glucocorticoid G#other_name_B xxx G#other_name_B
receptor G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
during NE xxx NE
differentiation NE xxx NE
of NE xx NE
human NE xxx NE
monocytic G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
( NE ( NE
U937 G#cell_line Xddd G#cell_line
) NE ) NE
. NE . NE

We NE Xx NE
describe NE xxx NE
a NE x NE
method NE xxx NE
for NE xxx NE
relative NE xxx NE
quantification NE xxx NE
of NE xx NE
specific NE xxx NE
mRNA G#RNA_family_or_group xXXX G#RNA_family_or_group
using NE xxx NE
a NE x NE
nonradioactive G#other_name_B xxx G#other_name_B
assay G#other_name_E xxx G#other_name_E
based NE xxx NE
on NE xx NE
DNA G#other_name_B XXX G#other_name_B
strand G#other_name_M xxx G#other_name_M
competition G#other_name_E xxx G#other_name_E
between NE xxx NE
identical NE xxx NE
sequences NE xxx NE
of NE xx NE
biotin- G#other_organic_compound_B xxx- G#other_organic_compound_B
and G#other_organic_compound_M xxx G#other_organic_compound_M
fluorescein-labeled G#other_organic_compound_M xxx-xxx G#other_organic_compound_M
amplicon G#other_organic_compound_E xxx G#other_organic_compound_E
(probe) NE (xxx) NE
and NE xxx NE
unlabeled G#other_organic_compound_B xxx G#other_organic_compound_B
amplicon G#other_organic_compound_E xxx G#other_organic_compound_E
(target) NE (xxx) NE
during NE xxx NE
hybridization G#other_name xxx G#other_name
. NE . NE

As NE Xx NE
the NE xxx NE
target NE xxx NE
quantity NE xxx NE
increased NE xxx NE
, NE , NE
that NE xxx NE
of NE xx NE
the NE xxx NE
double-labeled G#other_organic_compound_B xxx-xxx G#other_organic_compound_B
probe G#other_organic_compound_E xxx G#other_organic_compound_E
decreased NE xxx NE
in NE xx NE
accordance NE xxx NE
with NE xxx NE
the NE xxx NE
mass NE xxx NE
action NE xxx NE
law NE xxx NE
. NE . NE

This NE Xxxx NE
technique NE xxx NE
was NE xxx NE
successfully NE xxx NE
applied NE xxx NE
to NE xx NE
evaluate NE xxx NE
differences NE xxx NE
in NE xx NE
glucocorticoid G#other_name_B xxx G#other_name_B
receptor G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
in NE xx NE
U937 G#cell_line_B Xddd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
before NE xxx NE
and NE xxx NE
after NE xxx NE
the NE xxx NE
addition NE xxx NE
of NE xx NE
potent NE xxx NE
differentiation G#other_name_B xxx G#other_name_B
inducers G#other_name_E xxx G#other_name_E
: NE : NE
12-O-tetradecanoylphorbol G#other_organic_compound_B dd-X-xxx G#other_organic_compound_B
13-acetate G#other_organic_compound_E dd-xxx G#other_organic_compound_E
( NE ( NE
TPA G#other_organic_compound XXX G#other_organic_compound
) NE ) NE
and NE xxx NE
a NE x NE
combination NE xxx NE
of NE xx NE
all-trans G#other_organic_compound_B xxx-xxx G#other_organic_compound_B
retinoic G#other_organic_compound_M xxx G#other_organic_compound_M
acid G#other_organic_compound_E xxx G#other_organic_compound_E
( NE ( NE
RA G#other_organic_compound XX G#other_organic_compound
) NE ) NE
and NE xxx NE
1,25-dihydroxyvitamin G#other_organic_compound_B d,dd-xxx G#other_organic_compound_B
D2 G#other_organic_compound_E Xd G#other_organic_compound_E
( NE ( NE
VD G#other_organic_compound XX G#other_organic_compound
) NE ) NE
. NE . NE

We NE Xx NE
observed NE xxx NE
that NE xxx NE
TPA G#other_organic_compound XXX G#other_organic_compound
treatment NE xxx NE
was NE xxx NE
associated NE xxx NE
with NE xxx NE
an NE xx NE
increase NE xxx NE
in NE xx NE
specific NE xxx NE
binding NE xxx NE
of NE xx NE
[3H]dexamethasone G#lipid [dX]xxx G#lipid
and NE xxx NE
up-regulation NE xx-xxx NE
of NE xx NE
GR G#RNA_family_or_group_B XX G#RNA_family_or_group_B
mRNA G#RNA_family_or_group_E xXXX G#RNA_family_or_group_E
while NE xxx NE
no NE xx NE
enhanced NE xxx NE
GR G#other_name_B XX G#other_name_B
expression G#other_name_E xxx G#other_name_E
was NE xxx NE
perceived NE xxx NE
with NE xxx NE
RA/VD G#other_name_B XX/XX G#other_name_B
treatment G#other_name_E xxx G#other_name_E
. NE . NE

Induction NE Xxxx NE
of NE xx NE
Sp1 G#other_name_B Xxd G#other_name_B
phosphorylation G#other_name_E xxx G#other_name_E
and NE xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
-independent NE -xxx NE
HIV NE XXX NE
promoter NE xxx NE
domain NE xxx NE
activity NE xxx NE
in NE xx NE
T NE X NE
lymphocytes NE xxx NE
stimulated NE xxx NE
by NE xx NE
okadaic NE xxx NE
acid NE xxx NE
. NE . NE

In NE Xx NE
contrast NE xxx NE
to NE xx NE
the NE xxx NE
purely NE xxx NE
enhancer-dependent G#other_name_B xxx-xxx G#other_name_B
effect G#other_name_E xxx G#other_name_E
of NE xx NE
cytokines G#protein_family_or_group xxx G#protein_family_or_group
such NE xxx NE
as NE xx NE
TNF G#protein_family_or_group XXX G#protein_family_or_group
on NE xx NE
the NE xxx NE
activity NE xxx NE
of NE xx NE
the NE xxx NE
HIV G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
regulatory G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
LTR G#DNA_domain_or_region XXX G#DNA_domain_or_region
) NE ) NE
, NE , NE
we NE xx NE
observed NE xxx NE
that NE xxx NE
okadaic G#other_organic_compound_B xxx G#other_organic_compound_B
acid G#other_organic_compound_E xxx G#other_organic_compound_E
( NE ( NE
OKA G#other_organic_compound XXX G#other_organic_compound
) NE ) NE
activates NE xxx NE
HIV G#other_name_B XXX G#other_name_B
transcription G#other_name_E xxx G#other_name_E
through NE xxx NE
both NE xxx NE
the NE xxx NE
enhancer NE xxx NE
, NE , NE
responding NE xxx NE
to NE xx NE
the NE xxx NE
factor NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
, NE , NE
and NE xxx NE
the NE xxx NE
promoter G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
domain G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
the NE xxx NE
LTR G#DNA_domain_or_region XXX G#DNA_domain_or_region
. NE . NE

The NE Xxx NE
inducibility NE xxx NE
of NE xx NE
HIV NE XXX NE
LTR NE XXX NE
-driven NE -xxx NE
luciferase NE xxx NE
expression NE xxx NE
constructs NE xxx NE
in NE xx NE
lymphoblastoid NE xxx NE
cells NE xxx NE
stimulated NE xxx NE
by NE xx NE
OKA NE XXX NE
depended NE xxx NE
on NE xx NE
both NE xxx NE
functional NE xxx NE
Sp1 NE Xxd NE
binding NE xxx NE
elements NE xxx NE
and NE xxx NE
the NE xxx NE
ability NE xxx NE
of NE xx NE
the NE xxx NE
TATA NE XXXX NE
box NE xxx NE
to NE xx NE
bind NE xxx NE
the NE xxx NE
protein NE xxx NE
TBP NE XXX NE
. NE . NE

In NE Xx NE
both NE xxx NE
transformed G#cell_type_B xxx G#cell_type_B
lymphocyte G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
normal G#cell_type_M xxx G#cell_type_M
lymphocyte G#cell_type_E xxx G#cell_type_E
OKA NE XXX NE
stimulation G#other_name xxx G#other_name
induced NE xxx NE
intense NE xxx NE
phosphorylation G#other_name xxx G#other_name
of NE xx NE
the NE xxx NE
constitutively NE xxx NE
expressed NE xxx NE
Sp1 G#protein_molecule_B Xxd G#protein_molecule_B
protein G#protein_molecule_E xxx G#protein_molecule_E
in NE xx NE
the NE xxx NE
nucleus G#cell_component xxx G#cell_component
, NE , NE
a NE x NE
property NE xxx NE
of NE xx NE
OKA G#other_organic_compound XXX G#other_organic_compound
not NE xxx NE
shared NE xxx NE
by NE xx NE
TNF G#protein_family_or_group XXX G#protein_family_or_group
, NE , NE
phorbol G#other_organic_compound_B xxx G#other_organic_compound_B
ester G#other_organic_compound_E xxx G#other_organic_compound_E
, NE , NE
or NE xx NE
PHA G#protein_molecule XXX G#protein_molecule
and NE xxx NE
interleukin G#protein_molecule_B xxx G#protein_molecule_B
2 G#protein_molecule_E d G#protein_molecule_E
. NE . NE

Responsiveness NE Xxxx NE
of NE xx NE
LTR G#DNA_family_or_group_B XXX G#DNA_family_or_group_B
constructs G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
deleted NE xxx NE
of NE xx NE
kappa G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
B G#DNA_family_or_group_M X G#DNA_family_or_group_M
elements G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
to NE xx NE
HIV G#other_name_B XXX G#other_name_B
Tat G#other_name_M Xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
was NE xxx NE
increased NE xxx NE
upon NE xxx NE
OKA G#other_name_B XXX G#other_name_B
stimulation G#other_name_M xxx G#other_name_M
but G#other_name_M xxx G#other_name_M
not G#other_name_M xxx G#other_name_M
TNF G#other_name_M XXX G#other_name_M
stimulation G#other_name_E xxx G#other_name_E
but NE xxx NE
not NE xxx NE
TNF NE XXX NE
stimulation NE xxx NE
. NE . NE

Our NE Xxx NE
results NE xxx NE
suggest NE xxx NE
that NE xxx NE
SP1 G#protein_molecule XXd G#protein_molecule
phosphorylation G#other_name xxx G#other_name
induced NE xxx NE
by NE xx NE
OKA G#other_organic_compound XXX G#other_organic_compound
, NE , NE
a NE x NE
selective NE xxx NE
inhibitor NE xxx NE
of NE xx NE
the NE xxx NE
serine-threonine G#protein_family_or_group_B xxx-xxx G#protein_family_or_group_B
phosphatase G#protein_family_or_group_E xxx G#protein_family_or_group_E
PP2A G#protein_molecule XXdX G#protein_molecule
, NE , NE
facilitates NE xxx NE
the NE xxx NE
formation NE xxx NE
of NE xx NE
a NE x NE
transcription G#protein_complex_B xxx G#protein_complex_B
complex G#protein_complex_E xxx G#protein_complex_E
involving NE xxx NE
general NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
HIV G#protein_molecule_B XXX G#protein_molecule_B
Tat G#protein_molecule_E Xxx G#protein_molecule_E
, NE , NE
and NE xxx NE
Sp1 G#protein_family_or_group_B Xxd G#protein_family_or_group_B
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

The NE Xxx NE
formation NE xxx NE
of NE xx NE
this NE xxx NE
complex NE xxx NE
would NE xxx NE
increase NE xxx NE
, NE , NE
independently NE xxx NE
of NE xx NE
an NE xx NE
in NE xx NE
synergy NE xxx NE
with NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
, NE , NE
the NE xxx NE
low NE xxx NE
basal G#other_name_B xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
HIV G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
LTR G#DNA_domain_or_region_E XXX G#DNA_domain_or_region_E
observed NE xxx NE
in NE xx NE
normal G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
lymphocytes G#cell_type_E xxx G#cell_type_E
. NE . NE

The NE Xxx NE
role NE xxx NE
of NE xx NE
shared G#protein_substructure_B xxx G#protein_substructure_B
receptor G#protein_substructure_M xxx G#protein_substructure_M
motifs G#protein_substructure_E xxx G#protein_substructure_E
and NE xxx NE
common G#protein_family_or_group_B xxx G#protein_family_or_group_B
Stat G#protein_family_or_group_M Xxxx G#protein_family_or_group_M
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
in NE xx NE
the NE xxx NE
generation NE xxx NE
of NE xx NE
cytokine G#other_name_B xxx G#other_name_B
pleiotropy G#other_name_E xxx G#other_name_E
and NE xxx NE
redundancy NE xxx NE
by NE xx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
, NE , NE
IL-4 G#protein_molecule XX-d G#protein_molecule
, NE , NE
IL-7 G#protein_molecule XX-d G#protein_molecule
, NE , NE
IL-13 G#protein_molecule XX-dd G#protein_molecule
, NE , NE
and NE xxx NE
IL-15 G#protein_molecule XX-dd G#protein_molecule
. NE . NE

To NE Xx NE
understand NE xxx NE
the NE xxx NE
molecular NE xxx NE
bases NE xxx NE
for NE xxx NE
cytokine G#other_name_B xxx G#other_name_B
redundancy G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
cytokine G#other_name_M xxx G#other_name_M
pleiotropy G#other_name_E xxx G#other_name_E
cytokine G#protein_family_or_group xxx G#protein_family_or_group
Stat NE Xxxx NE
proteins NE xxx NE
activated NE xxx NE
in NE xx NE
peripheral G#cell_type_B xxx G#cell_type_B
blood G#cell_type_M xxx G#cell_type_M
lymphocytes G#cell_type_E xxx G#cell_type_E
( NE ( NE
PBLs G#cell_type XXXx G#cell_type
) NE ) NE
by NE xx NE
cytokines NE xxx NE
with NE xxx NE
shared NE xxx NE
and NE xxx NE
distinct NE xxx NE
actions NE xxx NE
. NE . NE

Interleukin-2 G#protein_molecule Xxxx-d G#protein_molecule
( NE ( NE
IL-2 G#protein_molecule XX-d G#protein_molecule
) NE ) NE
rapidly NE xxx NE
activated NE xxx NE
Stat5 G#protein_molecule Xxxxd G#protein_molecule
in NE xx NE
fresh NE xxx NE
PBL G#cell_type XXX G#cell_type
, NE , NE
and NE xxx NE
Stat3 G#protein_molecule Xxxxd G#protein_molecule
and NE xxx NE
Stat5 G#protein_molecule Xxxxd G#protein_molecule
in NE xx NE
preactivated G#cell_type_B xxx G#cell_type_B
PBL G#cell_type_E XXX G#cell_type_E
. NE . NE

IL-7 G#protein_molecule XX-d G#protein_molecule
and NE xxx NE
IL-15 G#protein_molecule XX-dd G#protein_molecule
induced NE xxx NE
the NE xxx NE
same NE xxx NE
complexes NE xxx NE
as NE xx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
, NE , NE
a NE x NE
feature NE xxx NE
explained NE xxx NE
by NE xx NE
the NE xxx NE
existence NE xxx NE
of NE xx NE
similar NE xxx NE
tyrosine NE xxx NE
-phosphorylated NE -xxx NE
motifs NE xxx NE
in NE xx NE
the NE xxx NE
cytoplasmic NE xxx NE
domains NE xxx NE
of NE xx NE
IL-2R NE XX-dX NE
beta NE xxx NE
and NE xxx NE
IL-7R NE XX-dX NE
that NE xxx NE
can NE xxx NE
serve NE xxx NE
as NE xx NE
docking NE xxx NE
sites NE xxx NE
for NE xxx NE
Stat NE Xxxx NE
proteins NE xxx NE
. NE . NE

IL-13 G#protein_molecule XX-dd G#protein_molecule
Induced NE Xxxx NE
the NE xxx NE
same NE xxx NE
complexes NE xxx NE
as NE xx NE
IL-4 G#protein_molecule XX-d G#protein_molecule
, NE , NE
a NE x NE
finding NE xxx NE
explained NE xxx NE
by NE xx NE
our NE xxx NE
studies NE xxx NE
implicating NE xxx NE
IL-4R G#protein_molecule XX-dX G#protein_molecule
as NE xx NE
a NE x NE
shared NE xxx NE
component NE xxx NE
of NE xx NE
the NE xxx NE
receptors G#protein_family_or_group xxx G#protein_family_or_group
. NE . NE

These NE Xxxx NE
studies NE xxx NE
demonstrate NE xxx NE
that NE xxx NE
a NE x NE
single NE xxx NE
cytokine G#protein_family_or_group xxx G#protein_family_or_group
can NE xxx NE
activate NE xxx NE
different NE xxx NE
combinations NE xxx NE
of NE xx NE
Stat G#protein_family_or_group_B Xxxx G#protein_family_or_group_B
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
under NE xxx NE
different NE xxx NE
physiological G#other_name_B xxx G#other_name_B
conditions G#other_name_E xxx G#other_name_E
, NE , NE
and NE xxx NE
also NE xxx NE
indicate NE xxx NE
two NE xxx NE
mechanisms NE xxx NE
by NE xx NE
which NE xxx NE
distinct NE xxx NE
cytokines G#protein_family_or_group xxx G#protein_family_or_group
can NE xxx NE
activate NE xxx NE
the NE xxx NE
same NE xxx NE
Stat G#protein_family_or_group_B Xxxx G#protein_family_or_group_B
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Control NE Xxxx NE
of NE xx NE
I G#other_name_B X G#other_name_B
kappa G#other_name_M xxx G#other_name_M
B-alpha G#other_name_M X-xxx G#other_name_M
proteolysis G#other_name_E xxx G#other_name_E
by NE xx NE
site-specific NE xxx-xxx NE
, NE , NE
signal-induced NE xxx-xxx NE
phosphorylation G#other_name xxx G#other_name
. NE . NE

I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B-alpha G#protein_molecule_E X-xxx G#protein_molecule_E
inhibits NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
by NE xx NE
retaining NE xxx NE
it NE xx NE
in NE xx NE
the NE xxx NE
cytoplasm G#cell_component xxx G#cell_component
. NE . NE

Various NE Xxxx NE
stimuli NE xxx NE
, NE , NE
typically NE xxx NE
those NE xxx NE
associated NE xxx NE
with NE xxx NE
stress NE xxx NE
or NE xx NE
pathogens NE xxx NE
, NE , NE
rapidly NE xxx NE
inactivate NE xxx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B-alpha G#protein_molecule_E X-xxx G#protein_molecule_E
. NE . NE

This NE Xxxx NE
liberates NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
to NE xx NE
translocate NE xxx NE
to NE xx NE
the NE xxx NE
nucleus G#cell_component xxx G#cell_component
and NE xxx NE
initiate NE xxx NE
transcription G#other_name xxx G#other_name
of NE xx NE
genes G#DNA_family_or_group xxx G#DNA_family_or_group
important NE xxx NE
for NE xxx NE
the NE xxx NE
defense NE xxx NE
of NE xx NE
the NE xxx NE
organism NE xxx NE
. NE . NE

Activation NE Xxxx NE
of NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
correlates NE xxx NE
with NE xxx NE
phosphorylation G#other_name xxx G#other_name
of NE xx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B-alpha G#protein_molecule_E X-xxx G#protein_molecule_E
and NE xxx NE
requires NE xxx NE
the NE xxx NE
proteolysis G#other_name xxx G#other_name
of NE xx NE
this NE xxx NE
inhibitor NE xxx NE
. NE . NE

When NE Xxxx NE
either NE xxx NE
serine-32 G#amino_acid_monomer xxx-dd G#amino_acid_monomer
or NE xx NE
serine-36 G#amino_acid_monomer xxx-dd G#amino_acid_monomer
of NE xx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B-alpha G#protein_molecule_E X-xxx G#protein_molecule_E
was NE xxx NE
mutated NE xxx NE
, NE , NE
the NE xxx NE
protein NE xxx NE
did NE xxx NE
not NE xxx NE
undergo NE xxx NE
signal-induced G#other_name_B xxx-xxx G#other_name_B
phosphorylation G#other_name_E xxx G#other_name_E
or NE xx NE
degradation G#other_name xxx G#other_name
, NE , NE
and NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
could NE xxx NE
not NE xxx NE
be NE xx NE
activated NE xxx NE
. NE . NE

These NE Xxxx NE
results NE xxx NE
suggest NE xxx NE
that NE xxx NE
phosphorylation G#other_name xxx G#other_name
at NE xx NE
one NE xxx NE
or NE xx NE
both NE xxx NE
of NE xx NE
these NE xxx NE
residues G#amino_acid_monomer xxx G#amino_acid_monomer
is NE xx NE
critical NE xxx NE
for NE xxx NE
activation NE xxx NE
of NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
. NE . NE

Regulation NE Xxxx NE
of NE xx NE
transcription G#other_name xxx G#other_name
of NE xx NE
the NE xxx NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
erythropoietin G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
receptor G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
by NE xx NE
proteins NE xxx NE
binding NE xxx NE
to NE xx NE
GATA-1 G#DNA_domain_or_region_B XXXX-d G#DNA_domain_or_region_B
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
Sp1 G#DNA_domain_or_region_M Xxd G#DNA_domain_or_region_M
motifs G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Erythropoietin G#protein_molecule Xxxx G#protein_molecule
( NE ( NE
Epo G#protein_molecule Xxx G#protein_molecule
) NE ) NE
, NE , NE
the NE xxx NE
primary NE xxx NE
regulator NE xxx NE
of NE xx NE
the NE xxx NE
production NE xxx NE
of NE xx NE
erythroid G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
, NE , NE
acts NE xxx NE
by NE xx NE
binding NE xxx NE
to NE xx NE
a NE x NE
cell G#protein_family_or_group_B xxx G#protein_family_or_group_B
surface G#protein_family_or_group_M xxx G#protein_family_or_group_M
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
EpoR G#protein_molecule XxxX G#protein_molecule
) NE ) NE
on NE xx NE
erythroid G#cell_type_B xxx G#cell_type_B
progenitors G#cell_type_E xxx G#cell_type_E
. NE . NE

We NE Xx NE
used NE xxx NE
deletion G#other_name_B xxx G#other_name_B
analysis G#other_name_E xxx G#other_name_E
and NE xxx NE
transfection G#other_name_B xxx G#other_name_B
assays G#other_name_E xxx G#other_name_E
with NE xxx NE
reporter G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
gene G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
constructs G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
to NE xx NE
examine NE xxx NE
the NE xxx NE
transcription G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
control G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
elements G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
the NE xxx NE
5' G#DNA_domain_or_region_B d' G#DNA_domain_or_region_B
flanking G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
the NE xxx NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
EpoR G#DNA_domain_or_region_M XxxX G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

In NE Xx NE
erythroid G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
most NE xxx NE
of NE xx NE
the NE xxx NE
transcription G#other_name_B xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
was NE xxx NE
contained NE xxx NE
in NE xx NE
a NE x NE
150 G#DNA_domain_or_region_B ddd G#DNA_domain_or_region_B
bp G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
fragment NE xxx NE
with NE xxx NE
binding G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
for NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
AP2 G#protein_molecule XXd G#protein_molecule
, NE , NE
Sp1 G#protein_molecule Xxd G#protein_molecule
and NE xxx NE
the NE xxx NE
erythroid-specific G#protein_molecule_B xxx-xxx G#protein_molecule_B
GATA-1 G#protein_molecule_E XXXX-d G#protein_molecule_E
. NE . NE

The NE Xxx NE
150 G#DNA_domain_or_region_B ddd G#DNA_domain_or_region_B
bp G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
hEpoR G#DNA_domain_or_region_M xXxxX G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
exhibited NE xxx NE
high NE xxx NE
and NE xxx NE
low NE xxx NE
activity NE xxx NE
in NE xx NE
erythroid NE xxx NE
OCIM1 G#cell_line XXXXd G#cell_line
and NE xxx NE
K562 G#cell_line_B Xddd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
respectively NE xxx NE
, NE , NE
reflecting NE xxx NE
the NE xxx NE
high NE xxx NE
and NE xxx NE
low NE xxx NE
levels NE xxx NE
of NE xx NE
constitutive NE xxx NE
hEpoR G#other_name_B xXxxX G#other_name_B
expression G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
GATA-1 G#DNA_domain_or_region_B XXXX-d G#DNA_domain_or_region_B
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
Sp1 G#DNA_domain_or_region_M Xxd G#DNA_domain_or_region_M
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
this NE xxx NE
promoter NE xxx NE
lacking NE xxx NE
a NE x NE
TATA G#DNA_domain_or_region_B XXXX G#DNA_domain_or_region_B
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
were NE xxx NE
necessary NE xxx NE
for NE xxx NE
a NE x NE
high NE xxx NE
level NE xxx NE
of NE xx NE
transcription G#other_name_B xxx G#other_name_B
activation G#other_name_E xxx G#other_name_E
. NE . NE

Protein-DNA NE Xxxx-XXX NE
binding NE xxx NE
studies NE xxx NE
suggested NE xxx NE
that NE xxx NE
Sp1 G#protein_molecule Xxd G#protein_molecule
and NE xxx NE
two NE xxx NE
other NE xxx NE
CCGCCC G#protein_family_or_group_B XXXXXX G#protein_family_or_group_B
binding G#protein_family_or_group_M xxx G#protein_family_or_group_M
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
from NE xxx NE
erythroid G#cell_type_B xxx G#cell_type_B
cell G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
non-erythroid G#cell_type_M xxx-xxx G#cell_type_M
cell G#cell_type_E xxx G#cell_type_E
could NE xxx NE
bind NE xxx NE
to NE xx NE
the NE xxx NE
Sp1 G#DNA_domain_or_region_B Xxd G#DNA_domain_or_region_B
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
motif G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

By NE Xx NE
increasing NE xxx NE
GATA-1 G#other_name_B XXXX-d G#other_name_B
levels G#other_name_E xxx G#other_name_E
via NE xxx NE
co-transfection G#other_name xx-xxx G#other_name
, NE , NE
we NE xx NE
were NE xxx NE
able NE xxx NE
to NE xx NE
transactivate NE xxx NE
the NE xxx NE
hEpoR G#DNA_domain_or_region_B xXxxX G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
K562 G#cell_line_B Xddd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
and NE xxx NE
non-erythroid G#cell_type_B xxx-xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
, NE , NE
but NE xxx NE
not NE xxx NE
in NE xx NE
the NE xxx NE
highly NE xxx NE
active NE xxx NE
OCIM1 G#cell_type_B XXXXd G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
, NE , NE
although NE xxx NE
GATA-1 G#other_name_B XXXX-d G#other_name_B
mRNA G#other_name_M xXXX G#other_name_M
levels G#other_name_E xxx G#other_name_E
were NE xxx NE
comparable NE xxx NE
in NE xx NE
OCIM1 G#cell_line XXXXd G#cell_line
and NE xxx NE
K562 G#cell_line Xddd G#cell_line
. NE . NE

Interestingly NE Xxxx NE
, NE , NE
when NE xxx NE
we NE xx NE
mutated NE xxx NE
the NE xxx NE
Sp1 G#DNA_domain_or_region_B Xxd G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
resulting NE xxx NE
in NE xx NE
a NE x NE
marked NE xxx NE
decrease NE xxx NE
in NE xx NE
hEpoR G#other_name_B xXxxX G#other_name_B
promoter G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
, NE , NE
we NE xx NE
could NE xxx NE
restore NE xxx NE
transactivation G#other_name xxx G#other_name
by NE xx NE
increasing NE xxx NE
GATA-1 G#other_name_B XXXX-d G#other_name_B
levels G#other_name_E xxx G#other_name_E
in NE xx NE
OCIM1 G#cell_type_B XXXXd G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

These NE Xxxx NE
data NE xxx NE
suggest NE xxx NE
that NE xxx NE
while NE xxx NE
GATA-1 G#protein_molecule XXXX-d G#protein_molecule
can NE xxx NE
transactivate NE xxx NE
the NE xxx NE
EpoR G#DNA_domain_or_region_B XxxX G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
the NE xxx NE
level NE xxx NE
of NE xx NE
hEpoR G#other_name_B xXxxX G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
does NE xxx NE
not NE xxx NE
depend NE xxx NE
on NE xx NE
GATA-1 G#protein_molecule XXXX-d G#protein_molecule
alone NE xxx NE
. NE . NE

Rather NE Xxxx NE
, NE , NE
hEpoR G#other_name_B xXxxX G#other_name_B
transcription G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
depends NE xxx NE
on NE xx NE
coordination NE xxx NE
between NE xxx NE
Sp1 G#protein_molecule Xxd G#protein_molecule
and NE xxx NE
GATA-1 G#protein_molecule XXXX-d G#protein_molecule
with NE xxx NE
other NE xxx NE
cell-specific G#protein_family_or_group_B xxx-xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
including NE xxx NE
possibly NE xxx NE
other NE xxx NE
Sp1 NE Xxd NE
-like NE -xxx NE
binding NE xxx NE
proteins NE xxx NE
, NE , NE
to NE xx NE
provide NE xxx NE
high NE xxx NE
level NE xxx NE
, NE , NE
tissue-specific NE xxx-xxx NE
expression NE xxx NE
. NE . NE

Overexpression NE Xxxx NE
of NE xx NE
DR-nm23 G#protein_molecule XX-xxdd G#protein_molecule
, NE , NE
a NE x NE
protein NE xxx NE
encoded NE xxx NE
by NE xx NE
a NE x NE
member NE xxx NE
of NE xx NE
the NE xxx NE
nm23 G#DNA_family_or_group_B xxdd G#DNA_family_or_group_B
gene G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
family G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
, NE , NE
inhibits NE xxx NE
granulocyte G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
and NE xxx NE
induces NE xxx NE
apoptosis G#other_name xxx G#other_name
in NE xx NE
32Dc13 G#cell_line_B ddXxdd G#cell_line_B
myeloid G#cell_line_M xxx G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

Chronic G#other_name_B Xxxx G#other_name_B
myelogenous G#other_name_M xxx G#other_name_M
leukemia G#other_name_E xxx G#other_name_E
evolves NE xxx NE
in NE xx NE
two NE xxx NE
clinically NE xxx NE
distinct NE xxx NE
stages NE xxx NE
: NE : NE
a NE x NE
chronic NE xxx NE
and NE xxx NE
a NE x NE
blast NE xxx NE
crisis NE xxx NE
phase NE xxx NE
. NE . NE

The NE Xxx NE
molecular NE xxx NE
changes NE xxx NE
associated NE xxx NE
with NE xxx NE
chronic G#other_name_B xxx G#other_name_B
phase G#other_name_E xxx G#other_name_E
to NE xx NE
blast G#other_name_B xxx G#other_name_B
crisis G#other_name_E xxx G#other_name_E
transition NE xxx NE
are NE xxx NE
largely NE xxx NE
unknown NE xxx NE
. NE . NE

We NE Xx NE
have NE xxx NE
identified NE xxx NE
a NE x NE
cDNA G#DNA_family_or_group_B xXXX G#DNA_family_or_group_B
clone G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
, NE , NE
DR-nm23 G#protein_molecule XX-xxdd G#protein_molecule
, NE , NE
differentially NE xxx NE
expressed NE xxx NE
in NE xx NE
a NE x NE
blast-crisis NE xxx-xxx NE
cDNA NE xXXX NE
library NE xxx NE
, NE , NE
which NE xxx NE
has NE xxx NE
approximately NE xxx NE
70% NE dd% NE
sequence NE xxx NE
similarity NE xxx NE
to NE xx NE
the NE xxx NE
putative NE xxx NE
metastatic NE xxx NE
suppressor NE xxx NE
genes NE xxx NE
, NE , NE
nm23-H1 NE xxdd-Xd NE
and NE xxx NE
nm23-H2 NE xxdd-Xd NE
. NE . NE

The NE Xxx NE
deduced NE xxx NE
amino G#other_name_B xxx G#other_name_B
acid G#other_name_M xxx G#other_name_M
sequence G#other_name_M xxx G#other_name_M
similarity G#other_name_E xxx G#other_name_E
to NE xx NE
the NE xxx NE
proteins NE xxx NE
encoded NE xxx NE
by NE xx NE
these NE xxx NE
two NE xxx NE
latter NE xxx NE
genes NE xxx NE
is NE xx NE
approximately NE xxx NE
65% NE dd% NE
and NE xxx NE
includes NE xxx NE
domains NE xxx NE
and NE xxx NE
amino G#amino_acid_monomer_B xxx G#amino_acid_monomer_B
acid G#amino_acid_monomer_M xxx G#amino_acid_monomer_M
residues G#amino_acid_monomer_E xxx G#amino_acid_monomer_E
(the NE (xxx NE
leucine NE xxx NE
zipper-like NE xxx-xxx NE
and NE xxx NE
the NE xxx NE
RGD NE XXX NE
domain NE xxx NE
, NE , NE
a NE x NE
serine NE xxx NE
and NE xxx NE
a NE x NE
histidine NE xxx NE
residue NE xxx NE
in NE xx NE
the NE xxx NE
NH2- NE XXd- NE
and NE xxx NE
in NE xx NE
the NE xxx NE
COOH-terminal NE XXXX-xxx NE
portion NE xxx NE
of NE xx NE
the NE xxx NE
protein NE xxx NE
, NE , NE
respectively) NE xxx) NE
postulated NE xxx NE
to NE xx NE
be NE xx NE
important NE xxx NE
for NE xxx NE
nm23 NE xxdd NE
function NE xxx NE
. NE . NE

DR-nm23 G#RNA_molecule_B XX-xxdd G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
is NE xx NE
preferentially NE xxx NE
expressed NE xxx NE
at NE xx NE
early NE xxx NE
stages NE xxx NE
of NE xx NE
myeloid G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
of NE xx NE
highly G#cell_line_B xxx G#cell_line_B
purified G#cell_line_M xxx G#cell_line_M
CD34+ G#cell_line_M XXdd+ G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

Its NE Xxx NE
constitutive NE xxx NE
expression NE xxx NE
in NE xx NE
the NE xxx NE
myeloid G#cell_line_B xxx G#cell_line_B
precursor G#cell_line_M xxx G#cell_line_M
32Dc13 G#cell_line_M ddXxdd G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
, NE , NE
which NE xxx NE
is NE xx NE
growth-factor G#other_name_B xxx-xxx G#other_name_B
dependent G#other_name_E xxx G#other_name_E
for NE xxx NE
both NE xxx NE
proliferation G#other_name xxx G#other_name
and NE xxx NE
differentiation G#other_name xxx G#other_name
, NE , NE
results NE xxx NE
in NE xx NE
inhibition NE xxx NE
of NE xx NE
granulocytic G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
induced NE xxx NE
by NE xx NE
granulocyte G#protein_molecule_B xxx G#protein_molecule_B
colony-stimulating G#protein_molecule_M xxx-xxx G#protein_molecule_M
factor G#protein_molecule_E xxx G#protein_molecule_E
and NE xxx NE
causes NE xxx NE
apoptotic G#other_name_B xxx G#other_name_B
cell G#other_name_M xxx G#other_name_M
death G#other_name_E xxx G#other_name_E
. NE . NE

These NE Xxxx NE
results NE xxx NE
are NE xxx NE
consistent NE xxx NE
with NE xxx NE
a NE x NE
role NE xxx NE
for NE xxx NE
DR-nm23 G#protein_molecule XX-xxdd G#protein_molecule
in NE xx NE
normal G#other_name_B xxx G#other_name_B
hematopoiesis G#other_name_E xxx G#other_name_E
and NE xxx NE
raise NE xxx NE
the NE xxx NE
possibility NE xxx NE
that NE xxx NE
its NE xxx NE
overexpression G#other_name xxx G#other_name
contributes NE xxx NE
to NE xx NE
differentiation G#other_name_B xxx G#other_name_B
arrest G#other_name_E xxx G#other_name_E
, NE , NE
a NE x NE
feature NE xxx NE
of NE xx NE
blastic G#other_name_B xxx G#other_name_B
transformation G#other_name_E xxx G#other_name_E
in NE xx NE
chronic G#other_name_B xxx G#other_name_B
myelogenous G#other_name_M xxx G#other_name_M
leukemia G#other_name_E xxx G#other_name_E
. NE . NE

An NE Xx NE
interferon-gamma G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
activation G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
mediates NE xxx NE
the NE xxx NE
transcriptional G#other_name_B xxx G#other_name_B
regulation G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
IgG G#DNA_domain_or_region_B XxX G#DNA_domain_or_region_B
Fc G#DNA_domain_or_region_M Xx G#DNA_domain_or_region_M
receptor G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
type G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
IC G#DNA_domain_or_region_M XX G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
by NE xx NE
interferon-gamma G#protein_molecule xxx-xxx G#protein_molecule
. NE . NE

Expression NE Xxxx NE
of NE xx NE
the NE xxx NE
IgG G#protein_molecule_B XxX G#protein_molecule_B
Fc G#protein_molecule_M Xx G#protein_molecule_M
receptor G#protein_molecule_M xxx G#protein_molecule_M
type G#protein_molecule_M xxx G#protein_molecule_M
I G#protein_molecule_E X G#protein_molecule_E
( NE ( NE
Fc G#protein_molecule_B Xx G#protein_molecule_B
gamma G#protein_molecule_M xxx G#protein_molecule_M
RI G#protein_molecule_E XX G#protein_molecule_E
) NE ) NE
on NE xx NE
myeloid G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
is NE xx NE
dramatically NE xxx NE
increased NE xxx NE
by NE xx NE
treatment NE xxx NE
with NE xxx NE
interferon-gamma G#protein_molecule xxx-xxx G#protein_molecule
( NE ( NE
IFN-gamma G#protein_molecule XXX-xxx G#protein_molecule
) NE ) NE
. NE . NE

We NE Xx NE
observed NE xxx NE
that NE xxx NE
Fc G#other_name_B Xx G#other_name_B
gamma G#other_name_M xxx G#other_name_M
RI G#other_name_M XX G#other_name_M
transcript G#other_name_M xxx G#other_name_M
levels G#other_name_E xxx G#other_name_E
in NE xx NE
monoblast-like G#cell_line_B xxx-xxx G#cell_line_B
U937 G#cell_line_M Xddd G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
were NE xxx NE
elevated NE xxx NE
within NE xxx NE
3 NE d NE
hr NE xx NE
and NE xxx NE
peaked NE xxx NE
12 NE dd NE
hr NE xx NE
after NE xxx NE
exposure NE xxx NE
to NE xx NE
IFN-gamma G#protein_molecule XXX-xxx G#protein_molecule
. NE . NE

Treatment NE Xxxx NE
of NE xx NE
U937 G#cell_line Xddd G#cell_line
with NE xxx NE
IFN-gamma G#protein_molecule XXX-xxx G#protein_molecule
for NE xxx NE
9 NE d NE
hr NE xx NE
in NE xx NE
the NE xxx NE
presence NE xxx NE
of NE xx NE
cycloheximide NE xxx NE
led NE xxx NE
to NE xx NE
super-induction NE xxx-xxx NE
of NE xx NE
Fc G#protein_molecule_B Xx G#protein_molecule_B
gamma G#protein_molecule_M xxx G#protein_molecule_M
RI G#protein_molecule_E XX G#protein_molecule_E
expression NE xxx NE
. NE . NE

Nuclear NE Xxxx NE
run-on NE xxx-xx NE
analysis NE xxx NE
revealed NE xxx NE
that NE xxx NE
the NE xxx NE
rate NE xxx NE
of NE xx NE
Fc G#protein_molecule_B Xx G#protein_molecule_B
gamma G#protein_molecule_M xxx G#protein_molecule_M
RI G#protein_molecule_E XX G#protein_molecule_E
transcription NE xxx NE
was NE xxx NE
increased NE xxx NE
by NE xx NE
IFN-gamma G#protein_molecule XXX-xxx G#protein_molecule
. NE . NE

Genomic NE Xxxx NE
sequence NE xxx NE
upstream NE xxx NE
of NE xx NE
the NE xxx NE
Fc G#DNA_domain_or_region_B Xx G#DNA_domain_or_region_B
gamma G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
RIC G#DNA_domain_or_region_M XXX G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
was NE xxx NE
cloned NE xxx NE
and NE xxx NE
subjected NE xxx NE
to NE xx NE
primer G#other_name_B xxx G#other_name_B
extension G#other_name_M xxx G#other_name_M
analysis G#other_name_E xxx G#other_name_E
, NE , NE
which NE xxx NE
demonstrated NE xxx NE
a NE x NE
single NE xxx NE
transcription G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
initiation G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
without NE xxx NE
a NE x NE
TATA G#DNA_domain_or_region_B XXXX G#DNA_domain_or_region_B
box G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Transient NE Xxxx NE
transfections NE xxx NE
of NE xx NE
CAT G#DNA_family_or_group_B XXX G#DNA_family_or_group_B
reporter G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
gene G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
constructs G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
containing NE xxx NE
various NE xxx NE
Fc G#DNA_domain_or_region_B Xx G#DNA_domain_or_region_B
gamma G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
RIC G#DNA_domain_or_region_M XXX G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sequences G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
into NE xxx NE
U937 G#cell_line_B Xddd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
revealed NE xxx NE
that NE xxx NE
a NE x NE
20-bp G#DNA_domain_or_region_B dd-xx G#DNA_domain_or_region_B
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
surrounding NE xxx NE
the NE xxx NE
transcription G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
start G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
(-7 NE (-d NE
to NE xx NE
+13) NE +dd) NE
was NE xxx NE
capable NE xxx NE
of NE xx NE
mediating NE xxx NE
transcription G#other_name_B xxx G#other_name_B
initiation G#other_name_E xxx G#other_name_E
and NE xxx NE
that NE xxx NE
an NE xx NE
IFN-gamma G#DNA_domain_or_region_B XXX-xxx G#DNA_domain_or_region_B
responsive G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
GIRE G#DNA_domain_or_region XXXX G#DNA_domain_or_region
) NE ) NE
was NE xxx NE
present NE xxx NE
within NE xxx NE
74 G#DNA_domain_or_region_B dd G#DNA_domain_or_region_B
bp G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
upstream G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
the NE xxx NE
transcription G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
initiation G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

A NE X NE
17-bp G#DNA_domain_or_region_B dd-xx G#DNA_domain_or_region_B
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
between NE xxx NE
positions NE xxx NE
-51 NE -dd NE
and NE xxx NE
-35 NE -dd NE
conferred NE xxx NE
IFN-gamma G#other_name_B XXX-xxx G#other_name_B
responsiveness G#other_name_E xxx G#other_name_E
on NE xx NE
a NE x NE
heterologous G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Double-stranded G#DNA_domain_or_region_B Xxxx-xxx G#DNA_domain_or_region_B
GIRE G#DNA_domain_or_region_M XXXX G#DNA_domain_or_region_M
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
but NE xxx NE
not NE xxx NE
a NE x NE
scrambled G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
sequence G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
, NE , NE
was NE xxx NE
specifically NE xxx NE
bound NE xxx NE
by NE xx NE
nuclear G#protein_family_or_group_B xxx G#protein_family_or_group_B
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
from NE xxx NE
IFN-gamma G#cell_line_B XXX-xxx G#cell_line_B
treated G#cell_line_M xxx G#cell_line_M
U937 G#cell_line_M Xddd G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

Gel NE Xxx NE
shift NE xxx NE
experiments NE xxx NE
further NE xxx NE
showed NE xxx NE
that NE xxx NE
the NE xxx NE
STAT1 G#protein_molecule_B XXXXd G#protein_molecule_B
alpha G#protein_molecule_M xxx G#protein_molecule_M
protein G#protein_molecule_E xxx G#protein_molecule_E
bound NE xxx NE
to NE xx NE
the NE xxx NE
Fc G#DNA_domain_or_region_B Xx G#DNA_domain_or_region_B
gamma G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
RIC G#DNA_domain_or_region_M XXX G#DNA_domain_or_region_M
GIRE G#DNA_domain_or_region_E XXXX G#DNA_domain_or_region_E
in NE xx NE
response NE xxx NE
to NE xx NE
IFN-gamma G#other_name_B XXX-xxx G#other_name_B
treatment G#other_name_E xxx G#other_name_E
of NE xx NE
U937 G#cell_line_B Xddd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

The NE Xxx NE
Fc G#DNA_domain_or_region_B Xx G#DNA_domain_or_region_B
gamma G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
RIC G#DNA_domain_or_region_M XXX G#DNA_domain_or_region_M
GIRE G#DNA_domain_or_region_E XXXX G#DNA_domain_or_region_E
is NE xx NE
homologous NE xxx NE
to NE xx NE
the NE xxx NE
IFN-gamma G#DNA_domain_or_region_B XXX-xxx G#DNA_domain_or_region_B
activation G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
GAS G#DNA_domain_or_region XXX G#DNA_domain_or_region
) NE ) NE
of NE xx NE
the NE xxx NE
guanylate G#protein_molecule_B xxx G#protein_molecule_B
binding G#protein_molecule_M xxx G#protein_molecule_M
protein G#protein_molecule_E xxx G#protein_molecule_E
and NE xxx NE
to NE xx NE
X G#DNA_family_or_group_B X G#DNA_family_or_group_B
box G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
elements G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
of NE xx NE
class G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
II G#DNA_family_or_group_M XX G#DNA_family_or_group_M
MHC G#DNA_family_or_group_M XXX G#DNA_family_or_group_M
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
. NE . NE

Our NE Xxx NE
results NE xxx NE
demonstrate NE xxx NE
that NE xxx NE
transcriptional G#other_name_B xxx G#other_name_B
regulation G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
Fc G#DNA_domain_or_region_B Xx G#DNA_domain_or_region_B
gamma G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
RIC G#DNA_domain_or_region_M XXX G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
by NE xx NE
IFN-gamma G#protein_molecule XXX-xxx G#protein_molecule
involves NE xxx NE
the NE xxx NE
binding NE xxx NE
of NE xx NE
STAT1 G#protein_molecule_B XXXXd G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
to NE xx NE
a NE x NE
17-bp G#DNA_domain_or_region_B dd-xx G#DNA_domain_or_region_B
GAS G#DNA_domain_or_region_M XXX G#DNA_domain_or_region_M
homology G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
the NE xxx NE
proximal G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Constitutively NE Xxxx NE
activated NE xxx NE
Jak NE Xxx NE
-STAT NE -XXXX NE
pathway NE xxx NE
in NE xx NE
T NE X NE
cells NE xxx NE
transformed NE xxx NE
with NE xxx NE
HTLV-I NE XXXX-X NE
. NE . NE

Human G#virus_B Xxxx G#virus_B
T G#virus_M X G#virus_M
cell G#virus_M xxx G#virus_M
lymphotropic G#virus_M xxx G#virus_M
virus G#virus_M xxx G#virus_M
I G#virus_E X G#virus_E
( NE ( NE
HTLV-I G#virus XXXX-X G#virus
) NE ) NE
is NE xx NE
the NE xxx NE
etiological G#other_name_B xxx G#other_name_B
agent G#other_name_E xxx G#other_name_E
for NE xxx NE
adult G#other_name_B xxx G#other_name_B
T G#other_name_M X G#other_name_M
cell G#other_name_M xxx G#other_name_M
leukemia G#other_name_E xxx G#other_name_E
and NE xxx NE
tropical G#other_name_B xxx G#other_name_B
spastic G#other_name_M xxx G#other_name_M
paraparesis G#other_name_E xxx G#other_name_E
(also NE (xxx NE
termed NE xxx NE
HTLV-I NE XXXX-X NE
-associated NE -xxx NE
myelopathy NE xxx NE
) NE ) NE
. NE . NE

HTLV-I NE XXXX-X NE
-infected NE -xxx NE
peripheral NE xxx NE
blood NE xxx NE
T NE X NE
cells NE xxx NE
exhibit NE xxx NE
an NE xx NE
initial NE xxx NE
phase NE xxx NE
of NE xx NE
interleukin-2 NE xxx-d NE
( NE ( NE
IL-2 NE XX-d NE
)-dependent NE )-xxx NE
growth NE xxx NE
; NE ; NE
over NE xxx NE
time NE xxx NE
, NE , NE
by NE xx NE
an NE xx NE
unknown NE xxx NE
mechanism NE xxx NE
, NE , NE
the NE xxx NE
cells NE xxx NE
become NE xxx NE
IL-2 NE XX-d NE
-independent NE -xxx NE
. NE . NE

Whereas NE Xxxx NE
the NE xxx NE
Jak G#protein_family_or_group_B Xxx G#protein_family_or_group_B
kinases G#protein_family_or_group_E xxx G#protein_family_or_group_E
Jak1 G#protein_molecule Xxxd G#protein_molecule
and NE xxx NE
Jak3 G#protein_molecule Xxxd G#protein_molecule
and NE xxx NE
the NE xxx NE
signal NE xxx NE
transducer NE xxx NE
and NE xxx NE
activator NE xxx NE
of NE xx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
Stat3 G#protein_molecule Xxxxd G#protein_molecule
and NE xxx NE
Stat5 G#protein_molecule Xxxxd G#protein_molecule
are NE xxx NE
activated NE xxx NE
in NE xx NE
normal G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
in NE xx NE
response NE xxx NE
to NE xx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
, NE , NE
this NE xxx NE
signaling NE xxx NE
pathway NE xxx NE
was NE xxx NE
constitutively NE xxx NE
activated NE xxx NE
in NE xx NE
HTLV-I NE XXXX-X NE
-transformed NE -xxx NE
cells NE xxx NE
. NE . NE

In NE Xx NE
HTLV-I NE XXXX-X NE
-infected NE -xxx NE
cord NE xxx NE
blood NE xxx NE
lymphocytes NE xxx NE
, NE , NE
the NE xxx NE
transition NE xxx NE
from NE xxx NE
IL-2 NE XX-d NE
-dependent NE -xxx NE
to NE xx NE
IL-2 NE XX-d NE
-independent NE -xxx NE
growth NE xxx NE
correlated NE xxx NE
with NE xxx NE
the NE xxx NE
acquisition NE xxx NE
of NE xx NE
a NE x NE
constitutively NE xxx NE
activated NE xxx NE
Jak NE Xxx NE
-STAT NE -XXXX NE
pathway NE xxx NE
, NE , NE
which NE xxx NE
suggests NE xxx NE
that NE xxx NE
this NE xxx NE
pathway NE xxx NE
participates NE xxx NE
in NE xx NE
HTLV-I NE XXXX-X NE
-mediated NE -xxx NE
T NE X NE
cell NE xxx NE
transformation NE xxx NE
. NE . NE

Nitric G#inorganic_B Xxxx G#inorganic_B
oxide G#inorganic_E xxx G#inorganic_E
decreases NE xxx NE
cytokine NE xxx NE
-induced NE -xxx NE
endothelial NE xxx NE
activation NE xxx NE
. NE . NE

Nitric G#inorganic_B Xxxx G#inorganic_B
oxide G#inorganic_E xxx G#inorganic_E
selectively NE xxx NE
reduces NE xxx NE
endothelial G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
of NE xx NE
adhesion G#protein_family_or_group_B xxx G#protein_family_or_group_B
molecules G#protein_family_or_group_E xxx G#protein_family_or_group_E
and NE xxx NE
proinflammatory G#protein_family_or_group_B xxx G#protein_family_or_group_B
cytokines G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

To NE Xx NE
test NE xxx NE
the NE xxx NE
hypothesis NE xxx NE
that NE xxx NE
nitric G#inorganic_B xxx G#inorganic_B
oxide G#inorganic_E xxx G#inorganic_E
( NE ( NE
NO G#inorganic XX G#inorganic
) NE ) NE
limits NE xxx NE
endothelial G#other_name_B xxx G#other_name_B
activation G#other_name_E xxx G#other_name_E
, NE , NE
we NE xx NE
treated NE xxx NE
cytokine-stimulated G#cell_line_B xxx-xxx G#cell_line_B
human G#cell_line_M xxx G#cell_line_M
saphenous G#cell_line_M xxx G#cell_line_M
vein G#cell_line_M xxx G#cell_line_M
endothelial G#cell_line_M xxx G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
with NE xxx NE
several NE xxx NE
NO G#inorganic_B XX G#inorganic_B
donors G#inorganic_E xxx G#inorganic_E
and NE xxx NE
assessed NE xxx NE
their NE xxx NE
effects NE xxx NE
on NE xx NE
the NE xxx NE
inducible NE xxx NE
expression NE xxx NE
of NE xx NE
vascular G#protein_molecule_B xxx G#protein_molecule_B
cell G#protein_molecule_M xxx G#protein_molecule_M
adhesion G#protein_molecule_M xxx G#protein_molecule_M
molecule-1 G#protein_molecule_E xxx-d G#protein_molecule_E
( NE ( NE
VCAM-1 G#protein_molecule XXXX-d G#protein_molecule
) NE ) NE
. NE . NE

In NE Xx NE
a NE x NE
concentration-dependent G#other_name_B xxx-xxx G#other_name_B
manner G#other_name_E xxx G#other_name_E
, NE , NE
NO G#inorganic XX G#inorganic
inhibited NE xxx NE
interleukin G#other_name_B xxx G#other_name_B
(IL)-1 G#other_name_M (XX)-d G#other_name_M
alpha-stimulated G#other_name_M xxx-xxx G#other_name_M
VCAM-1 G#other_name_M XXXX-d G#other_name_M
expression G#other_name_E xxx G#other_name_E
by NE xx NE
35-55% NE dd-dd% NE
as NE xx NE
determined NE xxx NE
by NE xx NE
cell G#other_name_B xxx G#other_name_B
surface G#other_name_M xxx G#other_name_M
enzyme G#other_name_M xxx G#other_name_M
immunoassays G#other_name_E xxx G#other_name_E
and NE xxx NE
flow G#other_name_B xxx G#other_name_B
cytometry G#other_name_E xxx G#other_name_E
. NE . NE

This NE Xxxx NE
inhibition NE xxx NE
was NE xxx NE
paralleled NE xxx NE
by NE xx NE
reduced NE xxx NE
monocyte G#other_name_B xxx G#other_name_B
adhesion G#other_name_E xxx G#other_name_E
to NE xx NE
endothelial G#other_name_B xxx G#other_name_B
monolayers G#other_name_E xxx G#other_name_E
in NE xx NE
nonstatic G#other_name_B xxx G#other_name_B
assays G#other_name_E xxx G#other_name_E
, NE , NE
was NE xxx NE
unaffected NE xxx NE
by NE xx NE
cGMP G#other_organic_compound_B xXXX G#other_organic_compound_B
analogues G#other_organic_compound_E xxx G#other_organic_compound_E
, NE , NE
and NE xxx NE
was NE xxx NE
quantitatively NE xxx NE
similar NE xxx NE
after NE xxx NE
stimulation NE xxx NE
by NE xx NE
either NE xxx NE
IL-1 G#protein_family_or_group_B XX-d G#protein_family_or_group_B
alpha G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
IL-1 G#protein_molecule_B XX-d G#protein_molecule_B
beta G#protein_molecule_E xxx G#protein_molecule_E
, NE , NE
IL-4 G#protein_molecule XX-d G#protein_molecule
, NE , NE
tumor G#protein_family_or_group_B xxx G#protein_family_or_group_B
necrosis G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
TNF G#protein_molecule_B XXX G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
) NE ) NE
, NE , NE
or NE xx NE
bacterial G#lipid_B xxx G#lipid_B
lipopolysaccharide G#lipid_E xxx G#lipid_E
. NE . NE

NO G#inorganic XX G#inorganic
also NE xxx NE
decreased NE xxx NE
the NE xxx NE
endothelial G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
of NE xx NE
other NE xxx NE
leukocyte G#protein_family_or_group_B xxx G#protein_family_or_group_B
adhesion G#protein_family_or_group_M xxx G#protein_family_or_group_M
molecules G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
E-selectin G#protein_molecule X-xxx G#protein_molecule
and NE xxx NE
to NE xx NE
a NE x NE
lesser NE xxx NE
extent NE xxx NE
, NE , NE
intercellular G#protein_molecule_B xxx G#protein_molecule_B
adhesion G#protein_molecule_M xxx G#protein_molecule_M
molecule-1 G#protein_molecule_E xxx-d G#protein_molecule_E
) NE ) NE
and NE xxx NE
secretable NE xxx NE
cytokines G#protein_family_or_group xxx G#protein_family_or_group
( NE ( NE
IL-6 G#protein_molecule XX-d G#protein_molecule
and NE xxx NE
IL-8 G#protein_molecule XX-d G#protein_molecule
) NE ) NE
. NE . NE

Inhibition NE Xxxx NE
of NE xx NE
endogenous NE xxx NE
NO G#inorganic XX G#inorganic
production NE xxx NE
by NE xx NE
L-N-monomethyl-arginine G#amino_acid_monomer X-X-xxx-xxx G#amino_acid_monomer
also NE xxx NE
induced NE xxx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
VCAM-1 G#protein_molecule XXXX-d G#protein_molecule
, NE , NE
but NE xxx NE
did NE xxx NE
not NE xxx NE
augment NE xxx NE
cytokine-induced G#other_name_B xxx-xxx G#other_name_B
VCAM-1 G#other_name_M XXXX-d G#other_name_M
expression G#other_name_E xxx G#other_name_E
. NE . NE

Nuclear G#other_name_B Xxxx G#other_name_B
run-on G#other_name_M xxx-xx G#other_name_M
assays G#other_name_E xxx G#other_name_E
, NE , NE
transfection NE xxx NE
studies NE xxx NE
using NE xxx NE
various NE xxx NE
VCAM-1 NE XXXX-d NE
promoter NE xxx NE
reporter NE xxx NE
gene NE xxx NE
constructs NE xxx NE
, NE , NE
and NE xxx NE
electrophoretic NE xxx NE
mobility NE xxx NE
shift NE xxx NE
assays NE xxx NE
indicated NE xxx NE
that NE xxx NE
NO NE XX NE
represses NE xxx NE
VCAM-1 NE XXXX-d NE
gene NE xxx NE
transcription NE xxx NE
, NE , NE
in NE xx NE
part NE xxx NE
, NE , NE
by NE xx NE
inhibiting NE xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
. NE . NE

We NE Xx NE
propose NE xxx NE
that NE xxx NE
NO G#inorganic XX G#inorganic
's NE 'x NE
ability NE xxx NE
to NE xx NE
limit NE xxx NE
endothelial G#other_name_B xxx G#other_name_B
activation G#other_name_E xxx G#other_name_E
and NE xxx NE
inhibit NE xxx NE
monocyte G#other_name_B xxx G#other_name_B
adhesion G#other_name_E xxx G#other_name_E
may NE xxx NE
contribute NE xxx NE
to NE xx NE
some NE xxx NE
of NE xx NE
its NE xxx NE
antiatherogenic G#other_name_B xxx G#other_name_B
property G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
antiinflammatory G#other_name_M xxx G#other_name_M
property G#other_name_E xxx G#other_name_E
properties NE xxx NE
within NE xxx NE
the NE xxx NE
vessel G#tissue_B xxx G#tissue_B
wall G#tissue_E xxx G#tissue_E
. NE . NE

MIP1 G#protein_molecule_B XXXd G#protein_molecule_B
alpha G#protein_molecule_M xxx G#protein_molecule_M
nuclear G#protein_molecule_M xxx G#protein_molecule_M
protein G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
MNP G#protein_molecule XXX G#protein_molecule
) NE ) NE
, NE , NE
a NE x NE
novel NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
expressed NE xxx NE
in NE xx NE
hematopoietic NE xxx NE
cells NE xxx NE
that NE xxx NE
is NE xx NE
crucial NE xxx NE
for NE xxx NE
transcription G#other_name xxx G#other_name
of NE xx NE
the NE xxx NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
MIP-1 G#DNA_domain_or_region_M XXX-d G#DNA_domain_or_region_M
alpha G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Murine G#protein_molecule_B Xxxx G#protein_molecule_B
macrophage G#protein_molecule_M xxx G#protein_molecule_M
inflammatory G#protein_molecule_M xxx G#protein_molecule_M
protein G#protein_molecule_M xxx G#protein_molecule_M
1 G#protein_molecule_M d G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
MIP-1 G#protein_molecule_B XXX-d G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
) NE ) NE
and NE xxx NE
its NE xxx NE
human G#protein_family_or_group_B xxx G#protein_family_or_group_B
equivalent G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
GOS19 G#protein_molecule XXXdd G#protein_molecule
, NE , NE
LD78 G#protein_molecule XXdd G#protein_molecule
, NE , NE
or NE xx NE
AT464 G#protein_molecule XXddd G#protein_molecule
) NE ) NE
are NE xxx NE
members NE xxx NE
of NE xx NE
the NE xxx NE
-C-C G#protein_family_or_group_B -X-X G#protein_family_or_group_B
family G#protein_family_or_group_E xxx G#protein_family_or_group_E
of NE xx NE
low-molecular-weight G#protein_domain_or_region_B xxx-xxx-xxx G#protein_domain_or_region_B
chemokines G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
. NE . NE

Secreted NE Xxxx NE
from NE xxx NE
activated G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
and NE xxx NE
macrophages G#cell_type xxx G#cell_type
, NE , NE
bone NE xxx NE
marrow-derived NE xxx-xxx NE
MIP-1 NE XXX-d NE
alpha NE xxx NE
/GOS19 NE /XXXdd NE
inhibits NE xxx NE
primitive NE xxx NE
hematopoietic NE xxx NE
stem NE xxx NE
cells NE xxx NE
and NE xxx NE
appears NE xxx NE
to NE xx NE
be NE xx NE
involved NE xxx NE
in NE xx NE
the NE xxx NE
homeostatic NE xxx NE
control NE xxx NE
of NE xx NE
stem NE xxx NE
cell NE xxx NE
proliferation NE xxx NE
. NE . NE

It NE Xx NE
also NE xxx NE
induces NE xxx NE
chemotaxis G#other_name xxx G#other_name
and NE xxx NE
inflammatory G#other_name_B xxx G#other_name_B
responses G#other_name_E xxx G#other_name_E
in NE xx NE
mature G#cell_type_B xxx G#cell_type_B
cell G#cell_type_M xxx G#cell_type_M
types G#cell_type_E xxx G#cell_type_E
. NE . NE

Therefore NE Xxxx NE
, NE , NE
it NE xx NE
is NE xx NE
important NE xxx NE
to NE xx NE
understand NE xxx NE
the NE xxx NE
mechanisms NE xxx NE
which NE xxx NE
control NE xxx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
MIP-1 G#protein_molecule_B XXX-d G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
/GOS19 NE /XXXdd NE
. NE . NE

Previous NE Xxxx NE
work NE xxx NE
has NE xxx NE
shown NE xxx NE
that NE xxx NE
in NE xx NE
Jurkat G#cell_line_B Xxxx G#cell_line_B
T G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
a NE x NE
set NE xxx NE
of NE xx NE
widely NE xxx NE
expressed NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
(the NE (xxx NE
ICK-1 G#protein_domain_or_region_B XXX-d G#protein_domain_or_region_B
family G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
) NE ) NE
affect NE xxx NE
the NE xxx NE
GOS19 G#DNA_domain_or_region_B XXXdd G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

One NE Xxx NE
member NE xxx NE
, NE , NE
ICK-1A G#protein_molecule XXX-dX G#protein_molecule
, NE , NE
behaves NE xxx NE
as NE xx NE
a NE x NE
strong G#protein_family_or_group_B xxx G#protein_family_or_group_B
negative G#protein_family_or_group_M xxx G#protein_family_or_group_M
regulator G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

In NE Xx NE
this NE xxx NE
communication NE xxx NE
, NE , NE
we NE xx NE
provide NE xxx NE
evidence NE xxx NE
that NE xxx NE
the NE xxx NE
pathway NE xxx NE
of NE xx NE
induction NE xxx NE
in NE xx NE
the NE xxx NE
macrophage G#cell_line_B xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
U937 G#cell_line Xddd G#cell_line
is NE xx NE
different NE xxx NE
from NE xxx NE
that NE xxx NE
in NE xx NE
Jurkat G#cell_line_B Xxxx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
we NE xx NE
show NE xxx NE
that NE xxx NE
the NE xxx NE
ICK-1 G#DNA_domain_or_region_B XXX-d G#DNA_domain_or_region_B
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
does NE xxx NE
not NE xxx NE
confer NE xxx NE
negative G#other_name_B xxx G#other_name_B
regulation G#other_name_E xxx G#other_name_E
in NE xx NE
U937 G#cell_line_B Xddd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

We NE Xx NE
provide NE xxx NE
evidence NE xxx NE
for NE xxx NE
an NE xx NE
additional NE xxx NE
binding G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
the NE xxx NE
MIP-1 G#DNA_domain_or_region_B XXX-d G#DNA_domain_or_region_B
alpha G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
nuclear G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
protein G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
(MNP) G#DNA_domain_or_region_M (XXX) G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
which NE xxx NE
overlaps NE xxx NE
the NE xxx NE
ICK-1 G#DNA_domain_or_region_B XXX-d G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Interaction NE Xxxx NE
of NE xx NE
nuclear G#cell_component_B xxx G#cell_component_B
extracts G#cell_component_E xxx G#cell_component_E
from NE xxx NE
various G#cell_line_B xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
and NE xxx NE
tissue G#tissue xxx G#tissue
with NE xxx NE
the NE xxx NE
MNP G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
leads NE xxx NE
to NE xx NE
the NE xxx NE
formation NE xxx NE
of NE xx NE
fast-migrating NE xxx-xxx NE
protein-DNA NE xxx-XXX NE
complexes NE xxx NE
with NE xxx NE
similar NE xxx NE
but NE xxx NE
distinct NE xxx NE
electrophoretic NE xxx NE
mobilities NE xxx NE
. NE . NE

A NE X NE
mutation NE xxx NE
of NE xx NE
the NE xxx NE
MNP G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
which NE xxx NE
does NE xxx NE
not NE xxx NE
abrogate NE xxx NE
ICK-1 G#other_name_B XXX-d G#other_name_B
binding G#other_name_E xxx G#other_name_E
inactivates NE xxx NE
the NE xxx NE
GOS19.1 G#DNA_domain_or_region_B XXXdd.d G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
U937 G#cell_line_B Xddd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
and NE xxx NE
reduces NE xxx NE
its NE xxx NE
activity NE xxx NE
by NE xx NE
fourfold NE xxx NE
in NE xx NE
Jurkat G#cell_line_B Xxxx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

We NE Xx NE
propose NE xxx NE
that NE xxx NE
the NE xxx NE
MNP G#protein_family_or_group_B XXX G#protein_family_or_group_B
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
(s) NE (x) NE
binding NE xxx NE
at NE xx NE
the NE xxx NE
MNP G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
constitutes NE xxx NE
a NE x NE
novel NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
(s) NE (x) NE
expressed NE xxx NE
in NE xx NE
hematopoietic G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

The NE Xxx NE
effect NE xxx NE
of NE xx NE
Toremifene G#other_organic_compound Xxxx G#other_organic_compound
on NE xx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
some NE xxx NE
genes NE xxx NE
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
mononuclear G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Toremifene G#other_organic_compound Xxxx G#other_organic_compound
exerts NE xxx NE
multiple NE xxx NE
and NE xxx NE
varied NE xxx NE
effects NE xxx NE
on NE xx NE
the NE xxx NE
gene G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
of NE xx NE
human G#cell_type_B xxx G#cell_type_B
peripheral G#cell_type_M xxx G#cell_type_M
mononuclear G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

After NE Xxxx NE
short-term NE xxx-xxx NE
, NE , NE
in NE xx NE
vitro G#other_name_B xxx G#other_name_B
exposure G#other_name_E xxx G#other_name_E
to NE xx NE
therapeutical G#other_name_B xxx G#other_name_B
levels G#other_name_E xxx G#other_name_E
, NE , NE
distinct NE xxx NE
changes NE xxx NE
in NE xx NE
P-glycoprotein G#other_name_B X-xxx G#other_name_B
expression G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
steroid G#other_name_M xxx G#other_name_M
receptors G#other_name_M xxx G#other_name_M
expression G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
p53 G#other_name_M xdd G#other_name_M
expression G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
Bcl-2 G#other_name_M Xxx-d G#other_name_M
expression G#other_name_E xxx G#other_name_E

In NE Xx NE
view NE xxx NE
of NE xx NE
the NE xxx NE
increasing NE xxx NE
use NE xxx NE
of NE xx NE
antiestrogens G#lipid xxx G#lipid
in NE xx NE
cancer G#other_name_B xxx G#other_name_B
therapy G#other_name_E xxx G#other_name_E
and NE xxx NE
prevention NE xxx NE
, NE , NE
there NE xxx NE
is NE xx NE
obvious NE xxx NE
merit NE xxx NE
in NE xx NE
long-term NE xxx-xxx NE
in NE xx NE
vivo NE xxx NE
studies NE xxx NE
to NE xx NE
be NE xx NE
conducted NE xxx NE
. NE . NE

The NE Xxx NE
interleukin-5 G#other_name xxx-d G#other_name
/receptor NE /xxx NE
interaction NE xxx NE
activates NE xxx NE
Lyn G#protein_family_or_group_B Xxx G#protein_family_or_group_B
tyrosine G#protein_family_or_group_M xxx G#protein_family_or_group_M
kinase G#protein_family_or_group_M xxx G#protein_family_or_group_M
and G#protein_family_or_group_M xxx G#protein_family_or_group_M
Jak2 G#protein_family_or_group_M Xxxd G#protein_family_or_group_M
tyrosine G#protein_family_or_group_M xxx G#protein_family_or_group_M
kinase G#protein_family_or_group_E xxx G#protein_family_or_group_E
pathways NE xxx NE
in G#protein_molecule xx G#protein_molecule
eosinophils NE xxx NE
. NE . NE

We NE Xx NE
have NE xxx NE
shown NE xxx NE
that NE xxx NE
the NE xxx NE
interaction NE xxx NE
of NE xx NE
interleukin G#protein_molecule_B xxx G#protein_molecule_B
(IL)-5 G#protein_molecule_E (XX)-d G#protein_molecule_E
with NE xxx NE
the NE xxx NE
receptor NE xxx NE
activates NE xxx NE
Lyn G#protein_molecule_B Xxx G#protein_molecule_B
tyrosine G#protein_molecule_M xxx G#protein_molecule_M
kinase G#protein_molecule_E xxx G#protein_molecule_E
within NE xxx NE
1 NE d NE
min NE xxx NE
and NE xxx NE
Jak2 G#protein_molecule_B Xxxd G#protein_molecule_B
tyrosine G#protein_molecule_M xxx G#protein_molecule_M
kinase G#protein_molecule_E xxx G#protein_molecule_E
within NE xxx NE
1-3 NE d-d NE
min NE xxx NE
. NE . NE

IL-5 G#protein_molecule XX-d G#protein_molecule
also NE xxx NE
stimulates NE xxx NE
GTP G#other_name_B XXX G#other_name_B
binding G#other_name_E xxx G#other_name_E
to NE xx NE
p21ras G#protein_molecule xddxxx G#protein_molecule
. NE . NE

The NE Xxx NE
signal NE xxx NE
is NE xx NE
subsequently NE xxx NE
propagated NE xxx NE
through NE xxx NE
the NE xxx NE
activation NE xxx NE
of NE xx NE
Raf-1 G#protein_molecule Xxx-d G#protein_molecule
, NE , NE
MEK G#protein_family_or_group XXX G#protein_family_or_group
, NE , NE
and NE xxx NE
MAP G#protein_family_or_group_B XXX G#protein_family_or_group_B
kinases G#protein_family_or_group_E xxx G#protein_family_or_group_E
as NE xx NE
shown NE xxx NE
by NE xx NE
their NE xxx NE
increased NE xxx NE
autophosphorylation G#other_name xxx G#other_name
in NE xx NE
vitro NE xxx NE
and NE xxx NE
phosphorylation G#other_name xxx G#other_name
in NE xx NE
situ NE xxx NE
. NE . NE

Jak2 G#protein_molecule_B Xxxd G#protein_molecule_B
kinase G#protein_molecule_E xxx G#protein_molecule_E
has NE xxx NE
been NE xxx NE
shown NE xxx NE
to NE xx NE
phosphorylate NE xxx NE
STAT G#protein_family_or_group_B XXXX G#protein_family_or_group_B
nuclear G#protein_family_or_group_M xxx G#protein_family_or_group_M
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

The NE Xxx NE
activation NE xxx NE
of NE xx NE
STAT G#protein_family_or_group_B XXXX G#protein_family_or_group_B
nuclear G#protein_family_or_group_M xxx G#protein_family_or_group_M
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
was NE xxx NE
studied NE xxx NE
by NE xx NE
electrophoretic G#other_name_B xxx G#other_name_B
mobility G#other_name_M xxx G#other_name_M
shift G#other_name_M xxx G#other_name_M
assay G#other_name_E xxx G#other_name_E
using NE xxx NE
a NE x NE
gamma NE xxx NE
activation NE xxx NE
site NE xxx NE
( NE ( NE
GAS NE XXX NE
) NE ) NE
probe NE xxx NE
. NE . NE

We NE Xx NE
found NE xxx NE
that NE xxx NE
IL-5 G#protein_molecule XX-d G#protein_molecule
induces NE xxx NE
two NE xxx NE
GAS-binding G#protein_family_or_group_B XXX-xxx G#protein_family_or_group_B
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
in NE xx NE
eosinophils G#cell_type xxx G#cell_type
, NE , NE
one NE xxx NE
of NE xx NE
which NE xxx NE
is NE xx NE
STAT1 G#protein_molecule XXXXd G#protein_molecule
. NE . NE

We NE Xx NE
conclude NE xxx NE
that NE xxx NE
IL-5 G#other_name_B XX-d G#other_name_B
induced G#other_name_M xxx G#other_name_M
signals G#other_name_E xxx G#other_name_E
are NE xxx NE
propagated NE xxx NE
through NE xxx NE
two NE xxx NE
distinct NE xxx NE
pathways NE xxx NE
: NE : NE
(1) NE (d) NE
Lyn G#protein_family_or_group Xxx G#protein_family_or_group
--> NE --> NE
Ras G#protein_family_or_group Xxx G#protein_family_or_group
--> NE --> NE
Raf-1 G#protein_molecule Xxx-d G#protein_molecule
--> NE --> NE
MEK G#protein_family_or_group XXX G#protein_family_or_group
--> NE --> NE
MAP G#protein_family_or_group_B XXX G#protein_family_or_group_B
kinase G#protein_family_or_group_E xxx G#protein_family_or_group_E
and NE xxx NE
(2) NE (d) NE
Jak2 G#protein_molecule Xxxd G#protein_molecule
--> NE --> NE
STAT1 G#protein_molecule XXXXd G#protein_molecule
. NE . NE

The NE Xxx NE
retinoblastoma G#protein_molecule_B xxx G#protein_molecule_B
gene G#protein_molecule_M xxx G#protein_molecule_M
product G#protein_molecule_E xxx G#protein_molecule_E
negatively NE xxx NE
regulates NE xxx NE
transcriptional G#protein_N/A_B xxx G#protein_N/A_B
activation G#protein_N/A_E xxx G#protein_N/A_E
mediated NE xxx NE
by NE xx NE
the NE xxx NE
human G#protein_molecule_B xxx G#protein_molecule_B
cytomegalovirus G#protein_molecule_M xxx G#protein_molecule_M
IE2 G#protein_molecule_M XXd G#protein_molecule_M
protein G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

The NE Xxx NE
IE2 G#protein_molecule_B XXd G#protein_molecule_B
gene G#protein_molecule_M xxx G#protein_molecule_M
product G#protein_molecule_E xxx G#protein_molecule_E
of NE xx NE
human G#virus_B xxx G#virus_B
cytomegalovirus G#virus_E xxx G#virus_E
( NE ( NE
HCMV G#virus XXXX G#virus
) NE ) NE
is NE xx NE
one NE xxx NE
of NE xx NE
a NE x NE
few NE xxx NE
viral G#protein_family_or_group_B xxx G#protein_family_or_group_B
regulatory G#protein_family_or_group_M xxx G#protein_family_or_group_M
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
expressed NE xxx NE
immediately NE xxx NE
upon NE xxx NE
infection G#other_name xxx G#other_name
of NE xx NE
the NE xxx NE
host G#cell_type_B xxx G#cell_type_B
cell G#cell_type_E xxx G#cell_type_E
. NE . NE

It NE Xx NE
is NE xx NE
a NE x NE
potent NE xxx NE
transcriptional G#protein_family_or_group_B xxx G#protein_family_or_group_B
activator G#protein_family_or_group_E xxx G#protein_family_or_group_E
of NE xx NE
many NE xxx NE
viral G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
promoter G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
and G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
cellular G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
promoter G#DNA_family_or_group_E xxx G#DNA_family_or_group_E

We NE Xx NE
found NE xxx NE
that NE xxx NE
the NE xxx NE
retinoblastoma G#protein_molecule_B xxx G#protein_molecule_B
susceptibility G#protein_molecule_M xxx G#protein_molecule_M
gene G#protein_molecule_M xxx G#protein_molecule_M
product G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
Rb G#protein_molecule Xx G#protein_molecule
) NE ) NE
dramatically NE xxx NE
suppressed NE xxx NE
this NE xxx NE
IE2 G#other_name_B XXd G#other_name_B
transactivation G#other_name_E xxx G#other_name_E
of NE xx NE
various G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
promoters G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
. NE . NE

However NE Xxxx NE
, NE , NE
unlike NE xxx NE
another NE xxx NE
tumor G#protein_family_or_group_B xxx G#protein_family_or_group_B
suppressor G#protein_family_or_group_M xxx G#protein_family_or_group_M
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
p53 G#protein_molecule xdd G#protein_molecule
, NE , NE
Rb G#protein_molecule Xx G#protein_molecule
did NE xxx NE
not NE xxx NE
have NE xxx NE
any NE xxx NE
significant NE xxx NE
effect NE xxx NE
on NE xx NE
basal G#other_name_B xxx G#other_name_B
levels G#other_name_E xxx G#other_name_E
of NE xx NE
transcription G#other_name xxx G#other_name
, NE , NE
suggesting NE xxx NE
that NE xxx NE
Rb G#protein_molecule Xx G#protein_molecule
specifically NE xxx NE
interacts NE xxx NE
with NE xxx NE
IE2 G#protein_molecule XXd G#protein_molecule
rather NE xxx NE
than NE xxx NE
other NE xxx NE
cellular G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
involved NE xxx NE
in NE xx NE
the NE xxx NE
general NE xxx NE
transcription G#other_name_B xxx G#other_name_B
machinery G#other_name_E xxx G#other_name_E
. NE . NE

We NE Xx NE
found NE xxx NE
by NE xx NE
protein-affinity G#other_name_B xxx-xxx G#other_name_B
chromatography G#other_name_E xxx G#other_name_E
that NE xxx NE
Rb G#protein_molecule Xx G#protein_molecule
in NE xx NE
nuclear G#cell_component_B xxx G#cell_component_B
extracts G#cell_component_E xxx G#cell_component_E
or NE xx NE
produced NE xxx NE
by NE xx NE
in NE xx NE
vitro NE xxx NE
translation NE xxx NE
directly NE xxx NE
bound NE xxx NE
to NE xx NE
IE2 G#protein_molecule XXd G#protein_molecule
. NE . NE

Our NE Xxx NE
results NE xxx NE
suggest NE xxx NE
that NE xxx NE
Rb G#protein_molecule Xx G#protein_molecule
may NE xxx NE
regulate NE xxx NE
the NE xxx NE
life NE xxx NE
cycle NE xxx NE
of NE xx NE
HCMV G#virus XXXX G#virus
, NE , NE
which NE xxx NE
is NE xx NE
endemic NE xxx NE
in NE xx NE
the NE xxx NE
human G#multi_cell_B xxx G#multi_cell_B
population G#multi_cell_E xxx G#multi_cell_E
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
these NE xxx NE
data NE xxx NE
may NE xxx NE
provide NE xxx NE
new NE xxx NE
insights NE xxx NE
into NE xxx NE
the NE xxx NE
slow NE xxx NE
rate NE xxx NE
of NE xx NE
HCMV G#other_name_B XXXX G#other_name_B
DNA G#other_name_M XXX G#other_name_M
replication G#other_name_E xxx G#other_name_E
in NE xx NE
cells NE xxx NE
and NE xxx NE
the NE xxx NE
possible NE xxx NE
involvement NE xxx NE
of NE xx NE
HCMV G#virus XXXX G#virus
in NE xx NE
tumorigenesis G#other_name xxx G#other_name
. NE . NE

Expression NE Xxxx NE
of NE xx NE
the NE xxx NE
nucleoside G#protein_molecule_B xxx G#protein_molecule_B
diphosphate G#protein_molecule_M xxx G#protein_molecule_M
kinase G#protein_molecule_E xxx G#protein_molecule_E
in NE xx NE
human G#other_name_B xxx G#other_name_B
skin G#other_name_M xxx G#other_name_M
cancers G#other_name_E xxx G#other_name_E
: NE : NE
an NE xx NE
immunohistochemical G#other_name_B xxx G#other_name_B
study G#other_name_E xxx G#other_name_E
. NE . NE

Expression NE Xxxx NE
of NE xx NE
nucleoside G#protein_molecule_B xxx G#protein_molecule_B
diphosphate(NDP) G#protein_molecule_M xxx(XXX) G#protein_molecule_M
kinase G#protein_molecule_E xxx G#protein_molecule_E
, NE , NE
which NE xxx NE
is NE xx NE
homologous NE xxx NE
to NE xx NE
the NE xxx NE
nm23 G#protein_molecule_B xxdd G#protein_molecule_B
gene G#protein_molecule_M xxx G#protein_molecule_M
product G#protein_molecule_E xxx G#protein_molecule_E
in NE xx NE
a NE x NE
variety NE xxx NE
of NE xx NE
species NE xxx NE
, NE , NE
has NE xxx NE
been NE xxx NE
found NE xxx NE
to NE xx NE
be NE xx NE
inversely NE xxx NE
associated NE xxx NE
with NE xxx NE
metastatic G#other_name_B xxx G#other_name_B
potential G#other_name_E xxx G#other_name_E
. NE . NE

However NE Xxxx NE
, NE , NE
the NE xxx NE
relationship NE xxx NE
remains NE xxx NE
controversial NE xxx NE
according NE xxx NE
to NE xx NE
the NE xxx NE
tumor G#cell_type_B xxx G#cell_type_B
cell G#cell_type_M xxx G#cell_type_M
types G#cell_type_E xxx G#cell_type_E
and NE xxx NE
experimental G#other_name_B xxx G#other_name_B
system G#other_name_E xxx G#other_name_E
, NE , NE
with NE xxx NE
conflicting NE xxx NE
results NE xxx NE
from NE xxx NE
different NE xxx NE
research NE xxx NE
groups NE xxx NE
. NE . NE

In NE Xx NE
order NE xxx NE
to NE xx NE
determine NE xxx NE
whether NE xxx NE
NDP G#other_name_B XXX G#other_name_B
kinase G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
serves NE xxx NE
as NE xx NE
a NE x NE
marker NE xxx NE
for NE xxx NE
metastatic G#other_name_B xxx G#other_name_B
potential G#other_name_E xxx G#other_name_E
in NE xx NE
human G#other_name_B xxx G#other_name_B
skin G#other_name_M xxx G#other_name_M
cancer G#other_name_E xxx G#other_name_E
, NE , NE
we NE xx NE
assessed NE xxx NE
the NE xxx NE
levels NE xxx NE
of NE xx NE
NDP G#other_name_B XXX G#other_name_B
kinase G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
in NE xx NE
9 NE d NE
keratoacanthomas G#other_name xxx G#other_name
( NE ( NE
KAs G#other_name XXx G#other_name
) NE ) NE
, NE , NE
26 NE dd NE
squamous G#other_name_B xxx G#other_name_B
cell G#other_name_M xxx G#other_name_M
carcinomas G#other_name_E xxx G#other_name_E
( NE ( NE
SCCs G#other_name XXXx G#other_name
) NE ) NE
, NE , NE
and NE xxx NE
25 NE dd NE
basal G#other_name_B xxx G#other_name_B
cell G#other_name_M xxx G#other_name_M
carcinomas G#other_name_E xxx G#other_name_E
( NE ( NE
BCCs G#other_name XXXx G#other_name
) NE ) NE
using NE xxx NE
immunohistochemistry G#other_name xxx G#other_name
. NE . NE

The NE Xxx NE
expression NE xxx NE
of NE xx NE
NDP G#protein_molecule_B XXX G#protein_molecule_B
kinase G#protein_molecule_E xxx G#protein_molecule_E
was NE xxx NE
intense NE xxx NE
in NE xx NE
KA G#other_name XX G#other_name
and NE xxx NE
SCC G#other_name XXX G#other_name
compared NE xxx NE
with NE xxx NE
BCC G#other_name XXX G#other_name
. NE . NE

However NE Xxxx NE
, NE , NE
the NE xxx NE
difference NE xxx NE
of NE xx NE
NDP G#other_name_B XXX G#other_name_B
kinase G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
between NE xxx NE
KA G#other_name XX G#other_name
and NE xxx NE
SCC G#other_name XXX G#other_name
was NE xxx NE
not NE xxx NE
statistically NE xxx NE
significant NE xxx NE
. NE . NE

And NE Xxx NE
there NE xxx NE
was NE xxx NE
no NE xx NE
statistically NE xxx NE
significant NE xxx NE
difference NE xxx NE
in NE xx NE
NDP G#other_name_B XXX G#other_name_B
kinase G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
between NE xxx NE
SCC G#other_name XXX G#other_name
with NE xxx NE
metastasis G#other_name xxx G#other_name
and NE xxx NE
SCC G#other_name XXX G#other_name
without NE xxx NE
metastasis G#other_name xxx G#other_name
. NE . NE

Our NE Xxx NE
results NE xxx NE
contradict NE xxx NE
the NE xxx NE
hypothesis NE xxx NE
concerning NE xxx NE
the NE xxx NE
possible NE xxx NE
role NE xxx NE
of NE xx NE
nm23 G#DNA_domain_or_region_B xxdd G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
as NE xx NE
a NE x NE
metastatic NE xxx NE
suppressor NE xxx NE
gene NE xxx NE
in NE xx NE
human G#other_name_B xxx G#other_name_B
skin G#other_name_M xxx G#other_name_M
cancer G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
mechanism NE xxx NE
of NE xx NE
overexpression G#other_name xxx G#other_name
in NE xx NE
various NE xxx NE
tumor G#cell_type_B xxx G#cell_type_B
cell G#cell_type_M xxx G#cell_type_M
types G#cell_type_E xxx G#cell_type_E
and NE xxx NE
its NE xxx NE
biological G#other_name_B xxx G#other_name_B
significance G#other_name_E xxx G#other_name_E
in NE xx NE
cutaneous G#other_name_B xxx G#other_name_B
carcinogenesis G#other_name_E xxx G#other_name_E
remain NE xxx NE
to NE xx NE
be NE xx NE
determined NE xxx NE
. NE . NE

RB G#protein_molecule XX G#protein_molecule
and NE xxx NE
a NE x NE
novel NE xxx NE
E2F-1 G#protein_family_or_group_B XdX-d G#protein_family_or_group_B
binding G#protein_family_or_group_M xxx G#protein_family_or_group_M
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
in NE xx NE
MHC G#cell_line_B XXX G#cell_line_B
class G#cell_line_M xxx G#cell_line_M
II G#cell_line_M XX G#cell_line_M
deficient G#cell_line_M xxx G#cell_line_M
B-cell G#cell_line_M X-xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
and NE xxx NE
normal NE xxx NE
IFN-gamma G#other_name_B XXX-xxx G#other_name_B
induction G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
class G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
IL G#DNA_domain_or_region_M XX G#DNA_domain_or_region_M
transactivator G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
CIITA G#DNA_domain_or_region XXXXX G#DNA_domain_or_region
in NE xx NE
class NE xxx NE
II NE XX NE
non-inducible NE xxx-xxx NE
RB NE XX NE
-defective NE -xxx NE
tumor NE xxx NE
lines NE xxx NE
. NE . NE

The NE Xxx NE
major G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
histocompatibility G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
(MHC) G#DNA_family_or_group_M (XXX) G#DNA_family_or_group_M
class G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
II G#DNA_family_or_group_M XX G#DNA_family_or_group_M
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
encode NE xxx NE
cell G#protein_family_or_group_B xxx G#protein_family_or_group_B
surface G#protein_family_or_group_M xxx G#protein_family_or_group_M
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
that NE xxx NE
bind NE xxx NE
antigenic G#peptide_B xxx G#peptide_B
peptide G#peptide_E xxx G#peptide_E
for NE xxx NE
presentation NE xxx NE
to NE xx NE
T-cells G#cell_type X-xxx G#cell_type
. NE . NE

The NE Xxx NE
class G#protein_family_or_group_B xxx G#protein_family_or_group_B
II G#protein_family_or_group_M XX G#protein_family_or_group_M
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
are NE xxx NE
expressed NE xxx NE
constitutively NE xxx NE
on NE xx NE
B-cells G#cell_type X-xxx G#cell_type
and NE xxx NE
EBV-transformed G#cell_line_B XXX-xxx G#cell_line_B
B-cells G#cell_line_E X-xxx G#cell_line_E
, NE , NE
and NE xxx NE
are NE xxx NE
inducible NE xxx NE
by NE xx NE
IFN-gamma G#protein_molecule XXX-xxx G#protein_molecule
on NE xx NE
a NE x NE
wide NE xxx NE
variety NE xxx NE
of NE xx NE
cell G#cell_type_B xxx G#cell_type_B
types G#cell_type_E xxx G#cell_type_E
. NE . NE

Retinoblastoma G#protein_family_or_group_B Xxxx G#protein_family_or_group_B
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
RB G#protein_molecule XX G#protein_molecule
) NE ) NE
is NE xx NE
a NE x NE
tumor G#other_name_B xxx G#other_name_B
suppressor G#other_name_E xxx G#other_name_E
and NE xxx NE
functions NE xxx NE
as NE xx NE
a NE x NE
transcriptional G#protein_family_or_group_B xxx G#protein_family_or_group_B
repressor G#protein_family_or_group_E xxx G#protein_family_or_group_E
by NE xx NE
binding NE xxx NE
and NE xxx NE
inactivating NE xxx NE
the NE xxx NE
transactivator G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
E2F-I G#DNA_domain_or_region_E XdX-X G#DNA_domain_or_region_E
. NE . NE

RB NE XX NE
-defective NE -xxx NE
tumor NE xxx NE
lines NE xxx NE
are NE xxx NE
non-inducible NE xxx-xxx NE
for NE xxx NE
MHC NE XXX NE
class NE xxx NE
II NE XX NE
by NE xx NE
IFN-gamma NE XXX-xxx NE
, NE , NE
or NE xx NE
very NE xxx NE
weakly NE xxx NE
inducible NE xxx NE
, NE , NE
but NE xxx NE
transfection NE xxx NE
of NE xx NE
2 NE d NE
different NE xxx NE
lines NE xxx NE
with NE xxx NE
RB NE XX NE
expression NE xxx NE
vectors NE xxx NE
re-establishes NE xx-xxx NE
or NE xx NE
substantially NE xxx NE
enhances NE xxx NE
class NE xxx NE
II NE XX NE
inducibility NE xxx NE
. NE . NE

Therefore NE Xxxx NE
, NE , NE
we NE xx NE
examined NE xxx NE
the NE xxx NE
RB G#protein_molecule XX G#protein_molecule
status NE xxx NE
of NE xx NE
a NE x NE
series NE xxx NE
of NE xx NE
B-cell NE X-xxx NE
mutants NE xxx NE
that NE xxx NE
are NE xxx NE
defective NE xxx NE
in NE xx NE
class NE xxx NE
II NE XX NE
expression NE xxx NE
, NE , NE
generated NE xxx NE
either NE xxx NE
in NE xx NE
vitro NE xxx NE
or NE xx NE
derived NE xxx NE
from NE xxx NE
Bare NE Xxxx NE
Lymphocyte NE Xxxx NE
Syndrome NE Xxxx NE
(BLS) NE (XXX) NE
patients NE xxx NE
. NE . NE

Nuclear NE Xxxx NE
matrix-bound NE xxx-xxx NE
RB G#protein_molecule XX G#protein_molecule
was NE xxx NE
detectable NE xxx NE
in NE xx NE
all NE xxx NE
cases NE xxx NE
, NE , NE
indicating NE xxx NE
that NE xxx NE
loss NE xxx NE
of NE xx NE
RB G#protein_molecule XX G#protein_molecule
is NE xx NE
not NE xxx NE
responsible NE xxx NE
for NE xxx NE
decreased NE xxx NE
class NE xxx NE
II NE XX NE
expression NE xxx NE
in NE xx NE
these NE xxx NE
lines NE xxx NE
. NE . NE

A NE X NE
second NE xxx NE
E2F-I NE XdX-X NE
binding NE xxx NE
protein NE xxx NE
, NE , NE
most NE xxx NE
likely NE xxx NE
DP-I NE XX-X NE
, NE , NE
was NE xxx NE
also NE xxx NE
apparently NE xxx NE
normal NE xxx NE
in NE xx NE
both NE xxx NE
class NE xxx NE
II-positive NE XX-xxx NE
and NE xxx NE
-negative NE -xxx NE
B-cell NE X-xxx NE
lines NE xxx NE
. NE . NE

We NE Xx NE
also NE xxx NE
examined NE xxx NE
the NE xxx NE
IFN-gamma G#other_name_B XXX-xxx G#other_name_B
induction G#other_name_E xxx G#other_name_E
of NE xx NE
CIITA G#DNA_domain_or_region XXXXX G#DNA_domain_or_region
in NE xx NE
RB G#protein_molecule XX G#protein_molecule
-defective NE -xxx NE
lines NE xxx NE
. NE . NE

CIITA G#DNA_domain_or_region XXXXX G#DNA_domain_or_region
is NE xx NE
a NE x NE
class G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
II G#DNA_family_or_group_M XX G#DNA_family_or_group_M
gene G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
transactivator G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
known NE xxx NE
to NE xx NE
be NE xx NE
defective NE xxx NE
in NE xx NE
one NE xxx NE
form NE xxx NE
of NE xx NE
BLS G#other_name XXX G#other_name
and NE xxx NE
to NE xx NE
be NE xx NE
required NE xxx NE
for NE xxx NE
the NE xxx NE
induction NE xxx NE
of NE xx NE
MHC G#protein_family_or_group_B XXX G#protein_family_or_group_B
class G#protein_family_or_group_M xxx G#protein_family_or_group_M
II G#protein_family_or_group_E XX G#protein_family_or_group_E
by NE xx NE
IFN-gamma G#protein_molecule XXX-xxx G#protein_molecule
. NE . NE

CIITA G#RNA_family_or_group_B XXXXX G#RNA_family_or_group_B
mRNA G#RNA_family_or_group_E xXXX G#RNA_family_or_group_E
is NE xx NE
normally NE xxx NE
inducible NE xxx NE
by NE xx NE
IFN-gamma G#protein_molecule XXX-xxx G#protein_molecule
in NE xx NE
class NE xxx NE
II NE XX NE
non-inducible NE xxx-xxx NE
, NE , NE
RB NE XX NE
-defective NE -xxx NE
lines NE xxx NE
, NE , NE
and NE xxx NE
in NE xx NE
one NE xxx NE
line NE xxx NE
, NE , NE
re-expression NE xx-xxx NE
of NE xx NE
RB NE XX NE
has NE xxx NE
no NE xx NE
effect NE xxx NE
on NE xx NE
CIITA NE XXXXX NE
mRNA NE xXXX NE
induction NE xxx NE
levels NE xxx NE
. NE . NE

Thus NE Xxxx NE
, NE , NE
the NE xxx NE
block NE xxx NE
in NE xx NE
MHC G#other_name_B XXX G#other_name_B
class G#other_name_M xxx G#other_name_M
II G#other_name_M XX G#other_name_M
inducibility G#other_name_E xxx G#other_name_E
in NE xx NE
RB NE XX NE
-defective NE -xxx NE
cells NE xxx NE
is NE xx NE
not NE xxx NE
due NE xxx NE
to NE xx NE
a NE x NE
block NE xxx NE
in NE xx NE
CIITA NE XXXXX NE
inducibility NE xxx NE
. NE . NE

Interleukin G#protein_molecule_B Xxxx G#protein_molecule_B
12 G#protein_molecule_E dd G#protein_molecule_E
induces NE xxx NE
tyrosine G#other_name_B xxx G#other_name_B
phosphorylation G#other_name_E xxx G#other_name_E
and NE xxx NE
activation NE xxx NE
of NE xx NE
STAT4 G#protein_molecule XXXXd G#protein_molecule
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
lymphocytes G#cell_type_E xxx G#cell_type_E
. NE . NE

Interleukin G#protein_molecule_B Xxxx G#protein_molecule_B
12 G#protein_molecule_E dd G#protein_molecule_E
( NE ( NE
IL-12 G#protein_molecule XX-dd G#protein_molecule
) NE ) NE
is NE xx NE
an NE xx NE
important NE xxx NE
immunoregulatory G#protein_family_or_group_B xxx G#protein_family_or_group_B
cytokine G#protein_family_or_group_E xxx G#protein_family_or_group_E
whose NE xxx NE
receptor NE xxx NE
is NE xx NE
a NE x NE
member NE xxx NE
of NE xx NE
the NE xxx NE
hematopoietin G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_M xxx G#protein_family_or_group_M
superfamily G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

We NE Xx NE
have NE xxx NE
recently NE xxx NE
demonstrated NE xxx NE
that NE xxx NE
stimulation NE xxx NE
of NE xx NE
human G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
cell G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
human G#cell_type_M xxx G#cell_type_M
natural G#cell_type_M xxx G#cell_type_M
killer G#cell_type_M xxx G#cell_type_M
cell G#cell_type_E xxx G#cell_type_E
with NE xxx NE
IL-12 G#protein_molecule XX-dd G#protein_molecule
induces NE xxx NE
tyrosine G#other_name_B xxx G#other_name_B
phosphorylation G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
Janus G#protein_family_or_group_B Xxxx G#protein_family_or_group_B
family G#protein_family_or_group_M xxx G#protein_family_or_group_M
tyrosine G#protein_family_or_group_M xxx G#protein_family_or_group_M
kinase G#protein_family_or_group_E xxx G#protein_family_or_group_E
JAK2 NE XXXd NE
and NE xxx NE
Tyk2 G#protein_molecule Xxxd G#protein_molecule
, NE , NE
implicating NE xxx NE
these NE xxx NE
kinases G#protein_family_or_group xxx G#protein_family_or_group
in NE xx NE
the NE xxx NE
immediate NE xxx NE
biochemical NE xxx NE
response NE xxx NE
to NE xx NE
IL-12 G#protein_molecule XX-dd G#protein_molecule
. NE . NE

Recently NE Xxxx NE
, NE , NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
known NE xxx NE
as NE xx NE
STATs G#protein_family_or_group XXXXx G#protein_family_or_group
( NE ( NE
signal G#protein_family_or_group_B xxx G#protein_family_or_group_B
transducers G#protein_family_or_group_M xxx G#protein_family_or_group_M
and G#protein_family_or_group_M xxx G#protein_family_or_group_M
activators G#protein_family_or_group_M xxx G#protein_family_or_group_M
of G#protein_family_or_group_M xx G#protein_family_or_group_M
transcription G#protein_family_or_group_E xxx G#protein_family_or_group_E
) NE ) NE
have NE xxx NE
been NE xxx NE
shown NE xxx NE
to NE xx NE
be NE xx NE
tyrosine G#other_name_B xxx G#other_name_B
phosphorylated G#other_name_E xxx G#other_name_E
and NE xxx NE
activated NE xxx NE
in NE xx NE
response NE xxx NE
to NE xx NE
a NE x NE
number NE xxx NE
of NE xx NE
cytokines G#protein_family_or_group xxx G#protein_family_or_group
that NE xxx NE
bind NE xxx NE
hematopoietin G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
and NE xxx NE
activate NE xxx NE
JAK G#protein_family_or_group_B XXX G#protein_family_or_group_B
kinases G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

In NE Xx NE
this NE xxx NE
report NE xxx NE
we NE xx NE
demonstrate NE xxx NE
that NE xxx NE
IL-12 G#protein_molecule XX-dd G#protein_molecule
induces NE xxx NE
tyrosine G#other_name_B xxx G#other_name_B
phosphorylation G#other_name_E xxx G#other_name_E
of NE xx NE
a NE x NE
recently NE xxx NE
identified NE xxx NE
STAT G#protein_family_or_group_B XXXX G#protein_family_or_group_B
family G#protein_family_or_group_M xxx G#protein_family_or_group_M
member G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
STAT4 G#protein_molecule XXXXd G#protein_molecule
, NE , NE
and NE xxx NE
show NE xxx NE
that NE xxx NE
STAT4 G#other_name_B XXXXd G#other_name_B
expression G#other_name_E xxx G#other_name_E
is NE xx NE
regulated NE xxx NE
by NE xx NE
T-cell G#other_name_B X-xxx G#other_name_B
activation G#other_name_E xxx G#other_name_E
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
we NE xx NE
show NE xxx NE
that NE xxx NE
IL-12 G#protein_molecule XX-dd G#protein_molecule
stimulates NE xxx NE
formation NE xxx NE
of NE xx NE
a NE x NE
DNA-binding G#protein_complex_B XXX-xxx G#protein_complex_B
complex G#protein_complex_E xxx G#protein_complex_E
that NE xxx NE
recognizes NE xxx NE
a NE x NE
DNA NE XXX NE
sequence NE xxx NE
previously NE xxx NE
shown NE xxx NE
to NE xx NE
bind NE xxx NE
STAT G#protein_family_or_group_B XXXX G#protein_family_or_group_B
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
and NE xxx NE
that NE xxx NE
this NE xxx NE
complex NE xxx NE
contains NE xxx NE
STAT4 G#protein_molecule XXXXd G#protein_molecule
. NE . NE

These NE Xxxx NE
data NE xxx NE
, NE , NE
and NE xxx NE
the NE xxx NE
recent NE xxx NE
demonstration NE xxx NE
of NE xx NE
JAK G#other_name_B XXX G#other_name_B
phosphorylation G#other_name_E xxx G#other_name_E
by NE xx NE
IL-12 G#protein_molecule XX-dd G#protein_molecule
, NE , NE
identify NE xxx NE
a NE x NE
rapid NE xxx NE
signal-transduction G#other_name_B xxx-xxx G#other_name_B
pathway G#other_name_E xxx G#other_name_E
likely NE xxx NE
to NE xx NE
mediate NE xxx NE
IL-12 NE XX-dd NE
-induced NE -xxx NE
gene NE xxx NE
expression NE xxx NE
. NE . NE

Temperature-induced NE Xxxx-xxx NE
down-regulation NE xxx-xxx NE
of NE xx NE
the NE xxx NE
glucocorticoid G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
in NE xx NE
peripheral G#cell_type_B xxx G#cell_type_B
blood G#cell_type_M xxx G#cell_type_M
mononuclear G#cell_type_M xxx G#cell_type_M
leucocyte G#cell_type_E xxx G#cell_type_E
in NE xx NE
patients G#multi_cell xxx G#multi_cell
with NE xxx NE
sepsis G#other_name xxx G#other_name
or NE xx NE
septic G#other_name_B xxx G#other_name_B
shock G#other_name_E xxx G#other_name_E
. NE . NE

OBJECTIVE NE XXXXXXXXX NE
: NE : NE
Activation NE Xxxx NE
of NE xx NE
the NE xxx NE
hypothalamic-pituitary-adrenal G#body_part_B xxx-xxx-xxx G#body_part_B
axis G#body_part_E xxx G#body_part_E
is NE xx NE
of NE xx NE
vital NE xxx NE
importance NE xxx NE
during NE xxx NE
critical NE xxx NE
illness NE xxx NE
. NE . NE

We NE Xx NE
have NE xxx NE
studied NE xxx NE
the NE xxx NE
adaptive NE xxx NE
mechanisms NE xxx NE
which NE xxx NE
occur NE xxx NE
at NE xx NE
the NE xxx NE
level NE xxx NE
of NE xx NE
the NE xxx NE
glucocorticoid G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
in NE xx NE
glucocorticoid G#tissue_B xxx G#tissue_B
target G#tissue_M xxx G#tissue_M
tissues G#tissue_E xxx G#tissue_E
in NE xx NE
patients G#multi_cell xxx G#multi_cell
with NE xxx NE
sepsis G#other_name xxx G#other_name
or NE xx NE
septic G#other_name_B xxx G#other_name_B
shock G#other_name_E xxx G#other_name_E
. NE . NE

DESIGN NE XXXXXX NE
: NE : NE
The NE Xxx NE
effects NE xxx NE
of NE xx NE
hypercortisolaemia G#other_name xxx G#other_name
, NE , NE
hyperthermia G#other_name xxx G#other_name
and NE xxx NE
cellular G#other_name_B xxx G#other_name_B
composition G#other_name_E xxx G#other_name_E
on NE xx NE
number NE xxx NE
of NE xx NE
glucocorticoid G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
per NE xxx NE
cell NE xxx NE
and NE xxx NE
their NE xxx NE
affinity NE xxx NE
were NE xxx NE
evaluated NE xxx NE
, NE , NE
both NE xxx NE
in NE xx NE
vitro NE xxx NE
and NE xxx NE
in NE xx NE
vivo NE xxx NE
, NE , NE
in NE xx NE
peripheral G#cell_type_B xxx G#cell_type_B
blood G#cell_type_M xxx G#cell_type_M
mononuclear G#cell_type_M xxx G#cell_type_M
leucocytes G#cell_type_E xxx G#cell_type_E
of NE xx NE
control NE xxx NE
subjects NE xxx NE
and NE xxx NE
in NE xx NE
patients G#multi_cell xxx G#multi_cell
with NE xxx NE
sepsis G#other_name xxx G#other_name
or NE xx NE
septic G#other_name_B xxx G#other_name_B
shock G#other_name_E xxx G#other_name_E
. NE . NE

SUBJECTS NE XXXXXXXX NE
: NE : NE
Fifteen NE Xxxx NE
patients G#multi_cell xxx G#multi_cell
(age NE (xxx NE
25-79) NE dd-dd) NE
with NE xxx NE
sepsis G#other_name xxx G#other_name
or NE xx NE
septic G#other_name_B xxx G#other_name_B
shock G#other_name_E xxx G#other_name_E
who NE xxx NE
were NE xxx NE
admitted NE xxx NE
to NE xx NE
an NE xx NE
intensive NE xxx NE
care NE xxx NE
unit NE xxx NE
were NE xxx NE
studied NE xxx NE
. NE . NE

The NE Xxx NE
control NE xxx NE
group NE xxx NE
consisted NE xxx NE
of NE xx NE
24 NE dd NE
healthy NE xxx NE
laboratory NE xxx NE
employees NE xxx NE
. NE . NE

MEASUREMENTS NE XXXXXXXXXXXX NE
: NE : NE
The NE Xxx NE
binding NE xxx NE
capacity NE xxx NE
and NE xxx NE
affinity NE xxx NE
of NE xx NE
the NE xxx NE
glucocorticoid G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
were NE xxx NE
measured NE xxx NE
and NE xxx NE
compared NE xxx NE
to NE xx NE
clinical NE xxx NE
data NE xxx NE
and NE xxx NE
the NE xxx NE
plasma NE xxx NE
cortisol NE xxx NE
concentrations NE xxx NE
. NE . NE

RESULTS NE XXXXXXX NE
: NE : NE
Hypercortisolaemia NE Xxxx NE
, NE , NE
in NE xx NE
vitro NE xxx NE
, NE , NE
resulted NE xxx NE
in NE xx NE
a NE x NE
decreased NE xxx NE
affinity NE xxx NE
and NE xxx NE
a NE x NE
decreased NE xxx NE
binding NE xxx NE
capacity NE xxx NE
of NE xx NE
the NE xxx NE
glucocorticoid G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

In NE Xx NE
vitro NE xxx NE
, NE , NE
hyperthermia NE xxx NE
as NE xx NE
well NE xxx NE
as NE xx NE
variations NE xxx NE
in NE xx NE
the NE xxx NE
cellular NE xxx NE
composition NE xxx NE
did NE xxx NE
not NE xxx NE
influence NE xxx NE
the NE xxx NE
glucocorticoid NE xxx NE
receptor NE xxx NE
. NE . NE

In NE Xx NE
vivo NE xxx NE
, NE , NE
there NE xxx NE
was NE xxx NE
no NE xx NE
change NE xxx NE
in NE xx NE
the NE xxx NE
number NE xxx NE
of NE xx NE
receptors NE xxx NE
per NE xxx NE
cell NE xxx NE
in NE xx NE
patients G#multi_cell xxx G#multi_cell
with NE xxx NE
sepsis G#other_name xxx G#other_name
or NE xx NE
septic G#other_name_B xxx G#other_name_B
shock G#other_name_E xxx G#other_name_E
as NE xx NE
compared NE xxx NE
to NE xx NE
healthy G#multi_cell_B xxx G#multi_cell_B
controls G#multi_cell_E xxx G#multi_cell_E
. NE . NE

However NE Xxxx NE
, NE , NE
a NE x NE
decreased NE xxx NE
affinity NE xxx NE
of NE xx NE
the NE xxx NE
glucocorticoid G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
was NE xxx NE
observed NE xxx NE
. NE . NE

There NE Xxxx NE
was NE xxx NE
a NE x NE
weak NE xxx NE
but NE xxx NE
significant NE xxx NE
negative NE xxx NE
correlation NE xxx NE
between NE xxx NE
body G#other_name_B xxx G#other_name_B
temperature G#other_name_E xxx G#other_name_E
and NE xxx NE
the NE xxx NE
number NE xxx NE
of NE xx NE
glucocorticoid G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
in NE xx NE
the NE xxx NE
patient NE xxx NE
group NE xxx NE
. NE . NE

There NE Xxxx NE
was NE xxx NE
no NE xx NE
relation NE xxx NE
between NE xxx NE
circulating G#other_name_B xxx G#other_name_B
cortisol G#other_name_M xxx G#other_name_M
concentrations G#other_name_E xxx G#other_name_E
and NE xxx NE
glucocorticoid NE xxx NE
receptor NE xxx NE
affinity NE xxx NE
and NE xxx NE
number NE xxx NE
. NE . NE

CONCLUSIONS NE XXXXXXXXXXX NE
: NE : NE
There NE Xxxx NE
is NE xx NE
no NE xx NE
obvious NE xxx NE
regulation NE xxx NE
of NE xx NE
the NE xxx NE
number NE xxx NE
of NE xx NE
glucocorticoid G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
by NE xx NE
plasma G#other_name_B xxx G#other_name_B
cortisol G#other_name_M xxx G#other_name_M
concentrations G#other_name_E xxx G#other_name_E
in NE xx NE
vivo NE xxx NE
. NE . NE

The NE Xxx NE
decreased NE xxx NE
affinity NE xxx NE
of NE xx NE
the NE xxx NE
glucocorticoid G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
together NE xxx NE
with NE xxx NE
the NE xxx NE
negative NE xxx NE
correlation NE xxx NE
between NE xxx NE
hyperthermia G#other_name xxx G#other_name
and NE xxx NE
the NE xxx NE
number NE xxx NE
of NE xx NE
glucocorticoid G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
in NE xx NE
patients G#multi_cell xxx G#multi_cell
with NE xxx NE
sepsis G#other_name xxx G#other_name
or NE xx NE
septic G#other_name_B xxx G#other_name_B
shock G#other_name_E xxx G#other_name_E
suggest NE xxx NE
that NE xxx NE
hypothalamic-pituitary-adrenal G#body_part_B xxx-xxx-xxx G#body_part_B
axis G#body_part_E xxx G#body_part_E
activation NE xxx NE
during NE xxx NE
critical NE xxx NE
illness NE xxx NE
is NE xx NE
accompanied NE xxx NE
by NE xx NE
peripheral G#other_name_B xxx G#other_name_B
adaptation G#other_name_E xxx G#other_name_E
in NE xx NE
glucocorticoid G#other_name_B xxx G#other_name_B
receptor G#other_name_M xxx G#other_name_M
number G#other_name_E xxx G#other_name_E
and NE xxx NE
affinity NE xxx NE
. NE . NE

Integrin-mediated NE Xxxx-xxx NE
tyrosine G#other_name_B xxx G#other_name_B
phosphorylation G#other_name_E xxx G#other_name_E
and NE xxx NE
cytokine G#other_name_B xxx G#other_name_B
message G#other_name_M xxx G#other_name_M
induction G#other_name_E xxx G#other_name_E
in NE xx NE
monocytic G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

A NE X NE
possible NE xxx NE
signaling NE xxx NE
role NE xxx NE
for NE xxx NE
the NE xxx NE
Syk G#protein_family_or_group_B Xxx G#protein_family_or_group_B
tyrosine G#protein_family_or_group_M xxx G#protein_family_or_group_M
kinase G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Activation NE Xxxx NE
of NE xx NE
cytoplasmic G#protein_family_or_group_B xxx G#protein_family_or_group_B
tyrosine G#protein_family_or_group_M xxx G#protein_family_or_group_M
kinases G#protein_family_or_group_E xxx G#protein_family_or_group_E
is NE xx NE
an NE xx NE
important NE xxx NE
aspect NE xxx NE
of NE xx NE
signal G#other_name_B xxx G#other_name_B
transduction G#other_name_E xxx G#other_name_E
mediated NE xxx NE
by NE xx NE
integrins G#protein_family_or_group xxx G#protein_family_or_group
. NE . NE

In NE Xx NE
the NE xxx NE
human G#cell_line_B xxx G#cell_line_B
monocytic G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_M xxx G#cell_line_M
THP-1 G#cell_line_E XXX-d G#cell_line_E
, NE , NE
either NE xxx NE
integrin G#other_name xxx G#other_name
-dependent NE -xxx NE
cell NE xxx NE
adhesion NE xxx NE
to NE xx NE
fibronectin G#protein_family_or_group xxx G#protein_family_or_group
or NE xx NE
ligation NE xxx NE
of NE xx NE
beta G#protein_N/A_B xxx G#protein_N/A_B
1 G#protein_N/A_M d G#protein_N/A_M
integrins G#protein_N/A_E xxx G#protein_N/A_E
with NE xxx NE
antibodies G#protein_family_or_group xxx G#protein_family_or_group
causes NE xxx NE
a NE x NE
rapid NE xxx NE
and NE xxx NE
intense NE xxx NE
tyrosine G#other_name_B xxx G#other_name_B
phosphorylation G#other_name_E xxx G#other_name_E
of NE xx NE
two NE xxx NE
sets NE xxx NE
of NE xx NE
proteins G#protein_N/A xxx G#protein_N/A
of NE xx NE
about NE xxx NE
65-75 G#protein_family_or_group_B dd-dd G#protein_family_or_group_B
kDa G#protein_family_or_group_M xXx G#protein_family_or_group_M
and G#protein_family_or_group_M xxx G#protein_family_or_group_M
120-125 G#protein_family_or_group_M ddd-ddd G#protein_family_or_group_M
kDa G#protein_family_or_group_E xXx G#protein_family_or_group_E

In NE Xx NE
addition NE xxx NE
, NE , NE
integrin G#other_name_B xxx G#other_name_B
ligation G#other_name_E xxx G#other_name_E
leads NE xxx NE
to NE xx NE
nuclear G#other_name_B xxx G#other_name_B
translocation G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
p50 G#protein_subunit xdd G#protein_subunit
and NE xxx NE
p65 G#protein_subunit_B xdd G#protein_subunit_B
subunits G#protein_subunit_E xxx G#protein_subunit_E
of NE xx NE
the NE xxx NE
NF-kappa G#protein_complex_B XX-xxx G#protein_complex_B
B G#protein_complex_M X G#protein_complex_M
transcription G#protein_complex_M xxx G#protein_complex_M
factor G#protein_complex_E xxx G#protein_complex_E
, NE , NE
to NE xx NE
activation NE xxx NE
of NE xx NE
a NE x NE
reporter G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
gene G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
driven NE xxx NE
by NE xx NE
a NE x NE
promoter G#DNA_domain_or_region xxx G#DNA_domain_or_region
containing NE xxx NE
NF-kappa G#DNA_domain_or_region_B XX-xxx G#DNA_domain_or_region_B
B G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
and NE xxx NE
to NE xx NE
increased NE xxx NE
levels NE xxx NE
of NE xx NE
mRNAs G#RNA_family_or_group xXXXx G#RNA_family_or_group
for NE xxx NE
immediate-early G#DNA_family_or_group_B xxx-xxx G#DNA_family_or_group_B
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
, NE , NE
including NE xxx NE
the NE xxx NE
cytokine G#protein_molecule_B xxx G#protein_molecule_B
interleukin G#protein_molecule_M xxx G#protein_molecule_M
(IL)-1 G#protein_molecule_M (XX)-d G#protein_molecule_M
beta G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

The NE Xxx NE
tyrosine G#other_organic_compound_B xxx G#other_organic_compound_B
kinase G#other_organic_compound_M xxx G#other_organic_compound_M
inhibitors G#other_organic_compound_E xxx G#other_organic_compound_E
genistein G#other_organic_compound xxx G#other_organic_compound
and NE xxx NE
herbimycin G#other_organic_compound_B xxx G#other_organic_compound_B
A G#other_organic_compound_E X G#other_organic_compound_E
block NE xxx NE
both NE xxx NE
integrin NE xxx NE
-mediated NE -xxx NE
tyrosine NE xxx NE
phosphorylation NE xxx NE
and NE xxx NE
increases NE xxx NE
in NE xx NE
IL-1 NE XX-d NE
beta NE xxx NE
message NE xxx NE
levels NE xxx NE
, NE , NE
indicating NE xxx NE
a NE x NE
causal NE xxx NE
relationship NE xxx NE
between NE xxx NE
the NE xxx NE
two NE xxx NE
events NE xxx NE
. NE . NE

The NE Xxx NE
components NE xxx NE
tyrosine G#amino_acid_monomer xxx G#amino_acid_monomer
phosphorylated NE xxx NE
subsequent NE xxx NE
to NE xx NE
cell G#other_name_B xxx G#other_name_B
adhesion G#other_name_E xxx G#other_name_E
include NE xxx NE
paxillin G#protein_molecule xxx G#protein_molecule
, NE , NE
pp125FAK G#protein_molecule xxdddXXX G#protein_molecule
, NE , NE
and NE xxx NE
the NE xxx NE
SH2 G#protein_molecule_B XXd G#protein_molecule_B
domain G#protein_molecule_M xxx G#protein_molecule_M
containing G#protein_molecule_M xxx G#protein_molecule_M
tyrosine G#protein_molecule_M xxx G#protein_molecule_M
kinase G#protein_molecule_M xxx G#protein_molecule_M
Syk G#protein_molecule_E Xxx G#protein_molecule_E
. NE . NE

In NE Xx NE
contrast NE xxx NE
, NE , NE
integrin G#other_name_B xxx G#other_name_B
ligation G#other_name_E xxx G#other_name_E
with NE xxx NE
antibodies NE xxx NE
induces NE xxx NE
tyrosine NE xxx NE
phosphorylation NE xxx NE
of NE xx NE
Syk NE Xxx NE
but NE xxx NE
not NE xxx NE
of NE xx NE
FAK NE XXX NE
or NE xx NE
paxillin NE xxx NE
. NE . NE

In NE Xx NE
adhering G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
, NE , NE
pre-treatment NE xxx-xxx NE
with NE xxx NE
cytochalasin G#other_organic_compound_B xxx G#other_organic_compound_B
D G#other_organic_compound_E X G#other_organic_compound_E
suppresses NE xxx NE
tyrosine G#other_name_B xxx G#other_name_B
phosphorylation G#other_name_E xxx G#other_name_E
of NE xx NE
FAK G#protein_molecule XXX G#protein_molecule
and NE xxx NE
paxillin G#protein_molecule xxx G#protein_molecule
but NE xxx NE
not NE xxx NE
of NE xx NE
Syk G#protein_molecule Xxx G#protein_molecule
, NE , NE
while NE xxx NE
IL-1 G#protein_molecule_B XX-d G#protein_molecule_B
beta G#protein_molecule_E xxx G#protein_molecule_E
message NE xxx NE
induction NE xxx NE
is NE xx NE
unaffected NE xxx NE
. NE . NE

These NE Xxxx NE
observations NE xxx NE
indicate NE xxx NE
that NE xxx NE
the NE xxx NE
Syk G#protein_molecule Xxx G#protein_molecule
tyrosine G#amino_acid_monomer xxx G#amino_acid_monomer
kinase NE xxx NE
may NE xxx NE
be NE xx NE
an NE xx NE
important NE xxx NE
component NE xxx NE
of NE xx NE
an NE xx NE
integrin G#other_name_B xxx G#other_name_B
signaling G#other_name_M xxx G#other_name_M
pathway G#other_name_E xxx G#other_name_E
in NE xx NE
monocytic G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
, NE , NE
leading NE xxx NE
to NE xx NE
activation NE xxx NE
of NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
and NE xxx NE
to NE xx NE
increased NE xxx NE
levels NE xxx NE
of NE xx NE
cytokine G#other_name_B xxx G#other_name_B
messages G#other_name_E xxx G#other_name_E
. NE . NE

Inhibition NE Xxxx NE
of NE xx NE
dexamethasone G#lipid xxx G#lipid
binding NE xxx NE
to NE xx NE
human G#protein_family_or_group_B xxx G#protein_family_or_group_B
glucocorticoid G#protein_family_or_group_M xxx G#protein_family_or_group_M
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
by NE xx NE
New G#cell_component_B Xxx G#cell_component_B
World G#cell_component_M Xxxx G#cell_component_M
primate G#cell_component_M xxx G#cell_component_M
cell G#cell_component_M xxx G#cell_component_M
extracts G#cell_component_E xxx G#cell_component_E
. NE . NE

To NE Xx NE
determine NE xxx NE
if NE xx NE
New G#multi_cell_B Xxx G#multi_cell_B
World G#multi_cell_M Xxxx G#multi_cell_M
primates G#multi_cell_E xxx G#multi_cell_E
express NE xxx NE
an NE xx NE
inhibitor NE xxx NE
that NE xxx NE
influences NE xxx NE
glucocorticoid NE xxx NE
receptor NE xxx NE
( NE ( NE
GR NE XX NE
) NE ) NE
binding NE xxx NE
characteristics NE xxx NE
, NE , NE
we NE xx NE
examined NE xxx NE
[3H]dexamethasone NE [dX]xxx NE
binding NE xxx NE
in NE xx NE
cytosol NE xxx NE
prepared NE xxx NE
from NE xxx NE
B95-8 NE Xdd-d NE
lymphoid NE xxx NE
cells NE xxx NE
, NE , NE
derived NE xxx NE
from NE xxx NE
the NE xxx NE
cotton NE xxx NE
top NE xxx NE
tamarin NE xxx NE
( NE ( NE
Saguinus NE Xxxx NE
oedipus NE xxx NE
) NE ) NE
, NE , NE
in NE xx NE
combination NE xxx NE
with NE xxx NE
cytosol NE xxx NE
prepared NE xxx NE
from NE xxx NE
human NE xxx NE
or NE xx NE
rat NE xxx NE
tissues NE xxx NE
. NE . NE

B95-8 G#cell_component_B Xdd-d G#cell_component_B
cytosol G#cell_component_E xxx G#cell_component_E
inhibited NE xxx NE
specific NE xxx NE
binding NE xxx NE
of NE xx NE
[3H]dexamethasone G#lipid [dX]xxx G#lipid
(P NE (X NE
< NE < NE
0.01) NE d.dd) NE
when NE xxx NE
mixed NE xxx NE
with NE xxx NE
cytosol G#cell_component xxx G#cell_component
prepared NE xxx NE
from NE xxx NE
either NE xxx NE
a NE x NE
human G#cell_line_B xxx G#cell_line_B
lymphoid G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
( NE ( NE
HL G#cell_line XX G#cell_line
) NE ) NE
or NE xx NE
rat G#body_part_B xxx G#body_part_B
thymus G#body_part_E xxx G#body_part_E
. NE . NE

The NE Xxx NE
inhibitory G#other_name_B xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
was NE xxx NE
heat G#other_name_B xxx G#other_name_B
labile G#other_name_E xxx G#other_name_E
and NE xxx NE
trypsin G#other_name_B xxx G#other_name_B
sensitive G#other_name_E xxx G#other_name_E
. NE . NE

Peak NE Xxxx NE
inhibitory G#other_name_B xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
was NE xxx NE
found NE xxx NE
in NE xx NE
the NE xxx NE
150-200 NE ddd-ddd NE
kd NE xx NE
fractions NE xxx NE
after NE xxx NE
Sephacryl G#other_name_B Xxxx G#other_name_B
G-200 G#other_name_M X-ddd G#other_name_M
ultrafiltration G#other_name_E xxx G#other_name_E
. NE . NE

Scatchard G#other_name_B Xxxx G#other_name_B
analysis G#other_name_E xxx G#other_name_E
of NE xx NE
[3H]dexamethasone G#lipid [dX]xxx G#lipid
binding NE xxx NE
using NE xxx NE
mixed NE xxx NE
cytosol G#cell_component xxx G#cell_component
showed NE xxx NE
a NE x NE
diminished NE xxx NE
GR G#protein_domain_or_region XX G#protein_domain_or_region
apparent NE xxx NE
binding G#other_name_B xxx G#other_name_B
affinity G#other_name_E xxx G#other_name_E
when NE xxx NE
compared NE xxx NE
to NE xx NE
HL G#cell_component_B XX G#cell_component_B
cytosol G#cell_component_E xxx G#cell_component_E
. NE . NE

Kinetic NE Xxxx NE
studies NE xxx NE
using NE xxx NE
mixed NE xxx NE
cytosol NE xxx NE
indicated NE xxx NE
that NE xxx NE
B95-8 NE Xdd-d NE
cytosol NE xxx NE
did NE xxx NE
not NE xxx NE
affect NE xxx NE
the NE xxx NE
apparent NE xxx NE
dissociation NE xxx NE
rate NE xxx NE
of NE xx NE
[3H]dexamethasone NE [dX]xxx NE
. NE . NE

These NE Xxxx NE
data NE xxx NE
demonstrate NE xxx NE
that NE xxx NE
B95-8 G#cell_type_B Xdd-d G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
contain NE xxx NE
a NE x NE
competitive NE xxx NE
inhibitor NE xxx NE
that NE xxx NE
prevents NE xxx NE
binding NE xxx NE
of NE xx NE
dexamethasone G#lipid xxx G#lipid
to NE xx NE
its NE xxx NE
cognate G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Disruption NE Xxxx NE
of NE xx NE
a NE x NE
GATA G#DNA_domain_or_region_B XXXX G#DNA_domain_or_region_B
motif G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
the NE xxx NE
Duffy G#DNA_domain_or_region_B Xxxx G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
abolishes NE xxx NE
erythroid G#other_name_B xxx G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
in NE xx NE
Duffy-negative G#multi_cell_B Xxxx-xxx G#multi_cell_B
individuals G#multi_cell_E xxx G#multi_cell_E
. NE . NE

The NE Xxx NE
mRNA G#RNA_family_or_group xXXX G#RNA_family_or_group
for NE xxx NE
the NE xxx NE
Duffy G#protein_molecule_B Xxxx G#protein_molecule_B
blood G#protein_molecule_M xxx G#protein_molecule_M
group G#protein_molecule_M xxx G#protein_molecule_M
antigen G#protein_molecule_E xxx G#protein_molecule_E
, NE , NE
the NE xxx NE
erythrocyte G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
for NE xxx NE
the NE xxx NE
Plasmodium G#multi_cell_B Xxxx G#multi_cell_B
vivax G#multi_cell_M xxx G#multi_cell_M
malaria G#multi_cell_M xxx G#multi_cell_M
parasite G#multi_cell_E xxx G#multi_cell_E
, NE , NE
has NE xxx NE
recently NE xxx NE
been NE xxx NE
cloned NE xxx NE
and NE xxx NE
shown NE xxx NE
to NE xx NE
encode NE xxx NE
a NE x NE
widely NE xxx NE
expressed NE xxx NE
chemokine G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Here NE Xxxx NE
, NE , NE
we NE xx NE
show NE xxx NE
that NE xxx NE
the NE xxx NE
Duffy G#DNA_domain_or_region_B Xxxx G#DNA_domain_or_region_B
antigen/chemokine G#DNA_domain_or_region_M xxx/xxx G#DNA_domain_or_region_M
receptor G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
DARC G#DNA_domain_or_region XXXX G#DNA_domain_or_region
) NE ) NE
is NE xx NE
composed NE xxx NE
of NE xx NE
a NE x NE
single NE xxx NE
exon G#DNA_family_or_group xxx G#DNA_family_or_group
and NE xxx NE
that NE xxx NE
most NE xxx NE
Duffy-negative G#multi_cell_B Xxxx-xxx G#multi_cell_B
blacks G#multi_cell_E xxx G#multi_cell_E
carry NE xxx NE
a NE x NE
silent G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
FY*B G#DNA_domain_or_region_M XX*X G#DNA_domain_or_region_M
allele G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
with NE xxx NE
a NE x NE
single NE xxx NE
T G#other_name_B X G#other_name_B
to G#other_name_M xx G#other_name_M
C G#other_name_M X G#other_name_M
substitution G#other_name_E xxx G#other_name_E
at NE xx NE
nucleotide G#nucleotide_B xxx G#nucleotide_B
-46 G#nucleotide_E -dd G#nucleotide_E
. NE . NE

This NE Xxxx NE
mutation NE xxx NE
impairs NE xxx NE
the NE xxx NE
promoter G#other_name_B xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
in NE xx NE
erythroid G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
by NE xx NE
disrupting NE xxx NE
a NE x NE
binding G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
for NE xxx NE
the NE xxx NE
GATA1 G#protein_domain_or_region_B XXXXd G#protein_domain_or_region_B
erythroid G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
transcription G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
factor G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
. NE . NE

With NE Xxxx NE
the NE xxx NE
recent NE xxx NE
characterization NE xxx NE
of NE xx NE
the NE xxx NE
FY*A G#DNA_domain_or_region_B XX*X G#DNA_domain_or_region_B
allele G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
FY*B G#DNA_domain_or_region_M XX*X G#DNA_domain_or_region_M
allele G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
Duffy NE Xxxx NE
blood NE xxx NE
group NE xxx NE
system NE xxx NE
and NE xxx NE
an NE xx NE
explanation NE xxx NE
for NE xxx NE
the NE xxx NE
erythroid-specific G#other_name_B xxx-xxx G#other_name_B
repression G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
DARC G#DNA_domain_or_region_B XXXX G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
Duffy-negative G#multi_cell_B Xxxx-xxx G#multi_cell_B
individuals G#multi_cell_E xxx G#multi_cell_E
. NE . NE

Activation NE Xxxx NE
of NE xx NE
pp90rsk G#protein_molecule xxddxxx G#protein_molecule
and NE xxx NE
early G#other_name_B xxx G#other_name_B
growth G#other_name_M xxx G#other_name_M
response-1 G#other_name_M xxx-d G#other_name_M
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
by NE xx NE
pokeweed G#protein_molecule_B xxx G#protein_molecule_B
mitogen G#protein_molecule_E xxx G#protein_molecule_E
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
B G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

The NE Xxx NE
present NE xxx NE
studies NE xxx NE
have NE xxx NE
examined NE xxx NE
the NE xxx NE
effects NE xxx NE
of NE xx NE
pokeweed G#protein_molecule_B xxx G#protein_molecule_B
mitogen G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
PWM G#protein_molecule XXX G#protein_molecule
) NE ) NE
on NE xx NE
the NE xxx NE
induction NE xxx NE
of NE xx NE
early G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
growth G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
response-1 G#DNA_domain_or_region_M xxx-d G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
EGR-1 G#DNA_domain_or_region XXX-d G#DNA_domain_or_region
) NE ) NE
in NE xx NE
normal G#cell_type_B xxx G#cell_type_B
human G#cell_type_M xxx G#cell_type_M
B G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

PWM G#protein_molecule XXX G#protein_molecule
regulates NE xxx NE
EGR-1 G#other_name_B XXX-d G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
by NE xx NE
both NE xxx NE
transcriptional G#other_name_B xxx G#other_name_B
mechanism G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
post-transcriptional G#other_name_M xxx-xxx G#other_name_M
mechanism G#other_name_E xxx G#other_name_E

Transient G#other_name_B Xxxx G#other_name_B
transfection G#other_name_M xxx G#other_name_M
assays G#other_name_E xxx G#other_name_E
with NE xxx NE
EGR-1 G#DNA_molecule_B XXX-d G#DNA_molecule_B
promoter G#DNA_molecule_M xxx G#DNA_molecule_M
fragments G#DNA_molecule_E xxx G#DNA_molecule_E
linked NE xxx NE
to NE xx NE
the NE xxx NE
chloramphenicol NE xxx NE
acetyltransferase NE xxx NE
( NE ( NE
CAT NE XXX NE
) NE ) NE
gene NE xxx NE
demonstrated NE xxx NE
that NE xxx NE
PWM NE XXX NE
induced NE xxx NE
EGR-1 NE XXX-d NE
transcription NE xxx NE
is NE xx NE
conferred NE xxx NE
by NE xx NE
the NE xxx NE
CArG NE XXxX NE
motif NE xxx NE
( NE ( NE
C NE X NE
C[AT]6GG NE X[XX]dXX NE
) NE ) NE
in NE xx NE
the NE xxx NE
EGR-1 NE XXX-d NE
promoter NE xxx NE
. NE . NE

The NE Xxx NE
results NE xxx NE
further NE xxx NE
demonstrated NE xxx NE
the NE xxx NE
activation NE xxx NE
of NE xx NE
S6 G#protein_molecule_B Xd G#protein_molecule_B
kinase G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
pp90rsk G#protein_molecule xxddxxx G#protein_molecule
) NE ) NE
, NE , NE
evidenced NE xxx NE
by NE xx NE
phosphorylation G#other_name xxx G#other_name
of NE xx NE
S6 G#protein_molecule Xd G#protein_molecule
and NE xxx NE
serum G#peptide_B xxx G#peptide_B
response G#peptide_M xxx G#peptide_M
factor G#peptide_M xxx G#peptide_M
(SRF) G#peptide_M (XXX) G#peptide_M
peptides G#peptide_E xxx G#peptide_E
, NE , NE
in NE xx NE
PWM G#cell_line_B XXX G#cell_line_B
treated G#cell_line_M xxx G#cell_line_M
B G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

Taken NE Xxxx NE
together NE xxx NE
, NE , NE
these NE xxx NE
findings NE xxx NE
suggest NE xxx NE
that NE xxx NE
PWM G#protein_molecule XXX G#protein_molecule
is NE xx NE
able NE xxx NE
to NE xx NE
initiate NE xxx NE
an NE xx NE
intracytoplasmic G#other_name_B xxx G#other_name_B
signalling G#other_name_M xxx G#other_name_M
cascade G#other_name_E xxx G#other_name_E
and NE xxx NE
EGR-1 G#other_name_B XXX-d G#other_name_B
induction G#other_name_E xxx G#other_name_E
in NE xx NE
normal G#cell_type_B xxx G#cell_type_B
human G#cell_type_M xxx G#cell_type_M
B G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

A NE X NE
conserved G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
motif G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
the NE xxx NE
promoters G#DNA_family_or_group xxx G#DNA_family_or_group
of NE xx NE
several NE xxx NE
cytokines G#protein_family_or_group xxx G#protein_family_or_group
expressed NE xxx NE
by NE xx NE
human G#cell_line_B xxx G#cell_line_B
Th2-type G#cell_line_M Xxd-xxx G#cell_line_M
lymphocytes G#cell_line_E xxx G#cell_line_E
. NE . NE

We NE Xx NE
have NE xxx NE
recently NE xxx NE
found NE xxx NE
a NE x NE
novel NE xxx NE
conserved G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
motif G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
the NE xxx NE
promoters G#DNA_domain_or_region xxx G#DNA_domain_or_region
of NE xx NE
several NE xxx NE
T-cell-expressed G#protein_family_or_group_B X-xxx-xxx G#protein_family_or_group_B
cytokines G#protein_family_or_group_E xxx G#protein_family_or_group_E
[ NE [ NE
human G#protein_molecule_B xxx G#protein_molecule_B
interleukin-2 G#protein_molecule_M xxx-d G#protein_molecule_M
and G#protein_molecule_M xxx G#protein_molecule_M
human G#protein_molecule_M xxx G#protein_molecule_M
interleukin-4 G#protein_molecule_M xxx-d G#protein_molecule_M
and G#protein_molecule_M xxx G#protein_molecule_M
human G#protein_molecule_M xxx G#protein_molecule_M
interleukin-5 G#protein_molecule_M xxx-d G#protein_molecule_M
and G#protein_molecule_M xxx G#protein_molecule_M
human G#protein_molecule_M xxx G#protein_molecule_M
interleukin-13 G#protein_molecule_E xxx-dd G#protein_molecule_E
mouse NE xxx NE
human G#protein_molecule_B xxx G#protein_molecule_B
granulocyte/macrophage-colony G#protein_molecule_M xxx/xxx-xxx G#protein_molecule_M
stimulating G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_M xxx G#protein_molecule_M
and G#protein_molecule_M xxx G#protein_molecule_M
mouse G#protein_molecule_M xxx G#protein_molecule_M
granulocyte/macrophage-colony G#protein_molecule_M xxx/xxx-xxx G#protein_molecule_M
stimulating G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_E xxx G#protein_molecule_E

It NE Xx NE
contains NE xxx NE
a NE x NE
core G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
CTTGG NE XXXXX NE
.. NE .. NE
. NE . NE
CCAAG NE XXXXX NE
which NE xxx NE
is NE xx NE
present NE xxx NE
as NE xx NE
part NE xxx NE
of NE xx NE
larger NE xxx NE
palindromic NE xxx NE
sequences NE xxx NE
in NE xx NE
each NE xxx NE
gene NE xxx NE
. NE . NE

This NE Xxxx NE
suggest NE xxx NE
that NE xxx NE
they NE xxx NE
may NE xxx NE
interact NE xxx NE
with NE xxx NE
a NE x NE
new NE xxx NE
family NE xxx NE
of NE xx NE
trans-acting G#protein_family_or_group_B xxx-xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

In NE Xx NE
transfection G#other_name_B xxx G#other_name_B
assays G#other_name_E xxx G#other_name_E
, NE , NE
the NE xxx NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
GM-CSF G#DNA_domain_or_region_M XX-XXX G#DNA_domain_or_region_M
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
has NE xxx NE
a NE x NE
strong NE xxx NE
positive NE xxx NE
effect NE xxx NE
on NE xx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
a NE x NE
reporter G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
gene G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
by NE xx NE
the NE xxx NE
human G#cell_line_B xxx G#cell_line_B
T G#cell_line_M X G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
Jurkat G#cell_line_B Xxxx G#cell_line_B
J6 G#cell_line_E Xd G#cell_line_E
upon NE xxx NE
stimulation G#other_name xxx G#other_name
. NE . NE

In NE Xx NE
DNA G#other_name_B XXX G#other_name_B
mobility G#other_name_M xxx G#other_name_M
shift G#other_name_M xxx G#other_name_M
assays G#other_name_E xxx G#other_name_E
, NE , NE
this NE xxx NE
sequence NE xxx NE
can NE xxx NE
give NE xxx NE
either NE xxx NE
six NE xxx NE
different NE xxx NE
specific G#other_name_B xxx G#other_name_B
bands G#other_name_E xxx G#other_name_E
which NE xxx NE
are NE xxx NE
competed NE xxx NE
out NE xxx NE
by NE xx NE
different NE xxx NE
parts NE xxx NE
of NE xx NE
the NE xxx NE
sequence NE xxx NE
or NE xx NE
one NE xxx NE
specific G#other_name_B xxx G#other_name_B
band G#other_name_E xxx G#other_name_E
which NE xxx NE
is NE xx NE
competed NE xxx NE
out NE xxx NE
by NE xx NE
each NE xxx NE
of NE xx NE
the NE xxx NE
inverted NE xxx NE
repeats NE xxx NE
, NE , NE
depending NE xxx NE
on NE xx NE
the NE xxx NE
reconstitution G#other_name_B xxx G#other_name_B
conditions G#other_name_E xxx G#other_name_E
. NE . NE

In NE Xx NE
different NE xxx NE
genes G#DNA_family_or_group xxx G#DNA_family_or_group
, NE , NE
the NE xxx NE
core G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
sequences G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
are NE xxx NE
separated NE xxx NE
by NE xx NE
integer NE xxx NE
numbers NE xxx NE
of NE xx NE
helical G#DNA_substructure_B xxx G#DNA_substructure_B
turns G#DNA_substructure_E xxx G#DNA_substructure_E
. NE . NE

Considering NE Xxxx NE
the NE xxx NE
strong G#other_name_B xxx G#other_name_B
positive G#other_name_M xxx G#other_name_M
regulatory G#other_name_M xxx G#other_name_M
effect G#other_name_E xxx G#other_name_E
of NE xx NE
this NE xxx NE
element G#DNA_family_or_group xxx G#DNA_family_or_group
and NE xxx NE
its NE xxx NE
presence NE xxx NE
in NE xx NE
several NE xxx NE
T-cell-expressed G#DNA_family_or_group_B X-xxx-xxx G#DNA_family_or_group_B
cytokine G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
, NE , NE
it NE xx NE
may NE xxx NE
be NE xx NE
crucial NE xxx NE
to NE xx NE
the NE xxx NE
coordinated NE xxx NE
expression NE xxx NE
of NE xx NE
these NE xxx NE
cytokines G#protein_family_or_group xxx G#protein_family_or_group
in NE xx NE
T G#cell_type_B X G#cell_type_B
helper G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

cDNA G#other_name_B xXXX G#other_name_B
cloning G#other_name_E xxx G#other_name_E
of NE xx NE
a NE x NE
NGFI-B/nur77-related G#protein_family_or_group_B XXXX-X/xxxdd-xxx G#protein_family_or_group_B
transcription G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
from NE xxx NE
an NE xx NE
apoptotic G#cell_line_B xxx G#cell_line_B
human G#cell_line_M xxx G#cell_line_M
T G#cell_line_M X G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
. NE . NE

A NE X NE
human G#cell_line_B xxx G#cell_line_B
T G#cell_line_M X G#cell_line_M
lymphoid G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
, NE , NE
PEER G#cell_line XXXX G#cell_line
, NE , NE
dies NE xxx NE
by NE xx NE
apoptosis G#other_name xxx G#other_name
in NE xx NE
the NE xxx NE
presence NE xxx NE
of NE xx NE
PMA G#other_organic_compound XXX G#other_organic_compound
and NE xxx NE
calcium G#other_organic_compound_B xxx G#other_organic_compound_B
ionophore G#other_organic_compound_E xxx G#other_organic_compound_E
. NE . NE

A NE X NE
new NE xxx NE
gene G#DNA_domain_or_region xxx G#DNA_domain_or_region
, NE , NE
TINUR G#DNA_domain_or_region XXXXX G#DNA_domain_or_region
, NE , NE
was NE xxx NE
cloned NE xxx NE
from NE xxx NE
apoptotic G#cell_line_B xxx G#cell_line_B
PEER G#cell_line_M XXXX G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

The NE Xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
TINUR G#DNA_domain_or_region_B XXXXX G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
is NE xx NE
induced NE xxx NE
within NE xxx NE
1 NE d NE
h NE x NE
after NE xxx NE
the NE xxx NE
cross-linking NE xxx-xxx NE
of NE xx NE
the NE xxx NE
T G#protein_subunit_B X G#protein_subunit_B
cell G#protein_subunit_M xxx G#protein_subunit_M
Ag G#protein_subunit_M Xx G#protein_subunit_M
receptor G#protein_subunit_M xxx G#protein_subunit_M
complex G#protein_subunit_E xxx G#protein_subunit_E
. NE . NE

TINUR G#DNA_domain_or_region XXXXX G#DNA_domain_or_region
belongs NE xxx NE
to NE xx NE
the NE xxx NE
NGFI-B/nur77 G#protein_family_or_group_B XXXX-X/xxxdd G#protein_family_or_group_B
family G#protein_family_or_group_E xxx G#protein_family_or_group_E
of NE xx NE
the NE xxx NE
steroid G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_M xxx G#protein_family_or_group_M
superfamily G#protein_family_or_group_E xxx G#protein_family_or_group_E
and NE xxx NE
is NE xx NE
an NE xx NE
orphan G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

TINUR G#DNA_domain_or_region XXXXX G#DNA_domain_or_region
binds NE xxx NE
to NE xx NE
the NE xxx NE
same NE xxx NE
DNA G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
as NE xx NE
NGFI-B/nur77 G#protein_molecule XXXX-X/xxxdd G#protein_molecule
. NE . NE

We NE Xx NE
also NE xxx NE
propose NE xxx NE
that NE xxx NE
the NE xxx NE
NGFI-B/nur77 G#protein_family_or_group_B XXXX-X/xxxdd G#protein_family_or_group_B
family G#protein_family_or_group_E xxx G#protein_family_or_group_E
can NE xxx NE
be NE xx NE
classified NE xxx NE
into NE xxx NE
two NE xxx NE
subtypes NE xxx NE
. NE . NE

Aspirin G#other_organic_compound Xxxx G#other_organic_compound
inhibits NE xxx NE
nuclear G#other_name_B xxx G#other_name_B
factor-kappa G#other_name_M xxx-xxx G#other_name_M
B G#other_name_M X G#other_name_M
mobilization G#other_name_E xxx G#other_name_E
and NE xxx NE
monocyte G#other_name_B xxx G#other_name_B
adhesion G#other_name_E xxx G#other_name_E
in NE xx NE
stimulated G#cell_line_B xxx G#cell_line_B
human G#cell_line_M xxx G#cell_line_M
endothelial G#cell_line_M xxx G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

BACKGROUND NE XXXXXXXXXX NE
: NE : NE
The NE Xxx NE
induction NE xxx NE
of NE xx NE
vascular G#protein_molecule_B xxx G#protein_molecule_B
cell G#protein_molecule_M xxx G#protein_molecule_M
adhesion G#protein_molecule_M xxx G#protein_molecule_M
molecule-1 G#protein_molecule_E xxx-d G#protein_molecule_E
( NE ( NE
VCAM-1 G#protein_molecule XXXX-d G#protein_molecule
) NE ) NE
and NE xxx NE
E-selectin G#protein_molecule X-xxx G#protein_molecule
by NE xx NE
tumor G#protein_molecule_B xxx G#protein_molecule_B
necrosis G#protein_molecule_M xxx G#protein_molecule_M
factor-alpha G#protein_molecule_E xxx-xxx G#protein_molecule_E
( NE ( NE
TNF G#protein_molecule XXX G#protein_molecule
) NE ) NE
is NE xx NE
mediated NE xxx NE
by NE xx NE
mobilization NE xxx NE
of NE xx NE
the NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
nuclear G#protein_molecule_B xxx G#protein_molecule_B
factor-kappa G#protein_molecule_M xxx-xxx G#protein_molecule_M
B G#protein_molecule_E X G#protein_molecule_E
( NE ( NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
) NE ) NE
. NE . NE

Since NE Xxxx NE
salicylates G#other_organic_compound xxx G#other_organic_compound
have NE xxx NE
been NE xxx NE
reported NE xxx NE
to NE xx NE
inhibit NE xxx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
activation G#other_name_E xxx G#other_name_E
by NE xx NE
preventing NE xxx NE
the NE xxx NE
degradation NE xxx NE
of NE xx NE
its NE xxx NE
inhibitor NE xxx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_E X G#protein_molecule_E
, NE , NE
we NE xx NE
studied NE xxx NE
a NE x NE
potential NE xxx NE
inhibition NE xxx NE
of NE xx NE
this NE xxx NE
pathway NE xxx NE
by NE xx NE
acetylsalicylate G#other_organic_compound xxx G#other_organic_compound
( NE ( NE
aspirin G#other_organic_compound xxx G#other_organic_compound
) NE ) NE
in NE xx NE
human G#cell_line_B xxx G#cell_line_B
umbilical G#cell_line_M xxx G#cell_line_M
vein G#cell_line_M xxx G#cell_line_M
endothelial G#cell_line_M xxx G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
( NE ( NE
HUVECs G#cell_line XXXXXx G#cell_line
) NE ) NE
. NE . NE

METHODS NE XXXXXXX NE
AND NE XXX NE
RESULTS NE XXXXXXX NE
: NE : NE
Gel-shift NE Xxx-xxx NE
analyses NE xxx NE
demonstrated NE xxx NE
dose-dependent NE xxx-xxx NE
inhibition NE xxx NE
of NE xx NE
TNF NE XXX NE
-induced NE -xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
mobilization NE xxx NE
by NE xx NE
aspirin NE xxx NE
at NE xx NE
concentrations NE xxx NE
ranging NE xxx NE
from NE xxx NE
1 NE d NE
to NE xx NE
10 NE dd NE
mmol/L NE xxx/X NE
. NE . NE

Induction NE Xxxx NE
of NE xx NE
VCAM-1 G#protein_molecule XXXX-d G#protein_molecule
and NE xxx NE
E-selectin G#other_name_B X-xxx G#other_name_B
surface G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
by NE xx NE
TNF G#protein_molecule XXX G#protein_molecule
was NE xxx NE
dose-dependently NE xxx-xxx NE
reduced NE xxx NE
by NE xx NE
aspirin G#other_organic_compound xxx G#other_organic_compound
over NE xxx NE
the NE xxx NE
same NE xxx NE
range NE xxx NE
, NE , NE
while NE xxx NE
induction NE xxx NE
of NE xx NE
intercellular G#protein_molecule_B xxx G#protein_molecule_B
adhesion G#protein_molecule_M xxx G#protein_molecule_M
molecule-1 G#protein_molecule_E xxx-d G#protein_molecule_E
( NE ( NE
ICAM-1 G#protein_molecule XXXX-d G#protein_molecule
) NE ) NE
was NE xxx NE
hardly NE xxx NE
affected NE xxx NE
. NE . NE

Aspirin G#other_organic_compound Xxxx G#other_organic_compound
appeared NE xxx NE
to NE xx NE
prevent NE xxx NE
VCAM-1 G#other_name_B XXXX-d G#other_name_B
transcription G#other_name_E xxx G#other_name_E
, NE , NE
since NE xxx NE
it NE xx NE
dose-dependently NE xxx-xxx NE
inhibited NE xxx NE
induction NE xxx NE
of NE xx NE
VCAM-1 G#RNA_molecule_B XXXX-d G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
by NE xx NE
TNF G#protein_molecule XXX G#protein_molecule
. NE . NE

As NE Xx NE
a NE x NE
functional NE xxx NE
consequence NE xxx NE
, NE , NE
adhesion NE xxx NE
of NE xx NE
U937 G#cell_line_B Xddd G#cell_line_B
monocytes G#cell_line_E xxx G#cell_line_E
to NE xx NE
TNF NE XXX NE
-stimulated NE -xxx NE
HUVECs NE XXXXXx NE
was NE xxx NE
markedly NE xxx NE
reduced NE xxx NE
by NE xx NE
aspirin NE xxx NE
due NE xxx NE
to NE xx NE
suppression NE xxx NE
of NE xx NE
VCAM-1 NE XXXX-d NE
and NE xxx NE
E-selectin NE X-xxx NE
upregulation NE xxx NE
. NE . NE

These NE Xxxx NE
effects NE xxx NE
of NE xx NE
aspirin G#other_organic_compound xxx G#other_organic_compound
were NE xxx NE
not NE xxx NE
related NE xxx NE
to NE xx NE
the NE xxx NE
inhibition NE xxx NE
of NE xx NE
cyclooxygenase G#other_name_B xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
, NE , NE
since NE xxx NE
indomethacin G#other_organic_compound xxx G#other_organic_compound
was NE xxx NE
ineffective NE xxx NE
. NE . NE

CONCLUSIONS NE XXXXXXXXXXX NE
: NE : NE
Our NE Xxx NE
data NE xxx NE
suggest NE xxx NE
that NE xxx NE
aspirin G#other_organic_compound xxx G#other_organic_compound
inhibits NE xxx NE
NF-kappa G#other_organic_compound_B XX-xxx G#other_organic_compound_B
B G#other_organic_compound_M X G#other_organic_compound_M
mobilization G#other_organic_compound_E xxx G#other_organic_compound_E
, NE , NE
induction NE xxx NE
of NE xx NE
VCAM-1 G#protein_molecule XXXX-d G#protein_molecule
and NE xxx NE
E-selectin G#protein_molecule X-xxx G#protein_molecule
, NE , NE
and NE xxx NE
subsequent NE xxx NE
monocyte G#other_name_B xxx G#other_name_B
adhesion G#other_name_E xxx G#other_name_E
in NE xx NE
endothelial G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
stimulated NE xxx NE
by NE xx NE
TNF G#protein_molecule XXX G#protein_molecule
, NE , NE
thereby NE xxx NE
providing NE xxx NE
an NE xx NE
additional NE xxx NE
mechanism NE xxx NE
for NE xxx NE
therapeutic G#other_name_B xxx G#other_name_B
effects G#other_name_E xxx G#other_name_E
of NE xx NE
aspirin G#other_organic_compound xxx G#other_organic_compound
. NE . NE

Activation NE Xxxx NE
of NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
by NE xx NE
phosphatase G#other_name_B xxx G#other_name_B
inhibitors G#other_name_E xxx G#other_name_E
involves NE xxx NE
the NE xxx NE
phosphorylation G#other_name xxx G#other_name
of NE xx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
at NE xx NE
phosphatase G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
2A-sensitive G#protein_domain_or_region_M dX-xxx G#protein_domain_or_region_M
sites G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
. NE . NE

Activation NE Xxxx NE
of NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
by NE xx NE
various NE xxx NE
cellular G#other_name_B xxx G#other_name_B
stimuli G#other_name_E xxx G#other_name_E
involves NE xxx NE
the NE xxx NE
phosphorylation G#other_name xxx G#other_name
and NE xxx NE
subsequent NE xxx NE
degradation NE xxx NE
of NE xx NE
its NE xxx NE
inhibitor NE xxx NE
, NE , NE
I NE X NE
kappa NE xxx NE
B NE X NE
alpha NE xxx NE
, NE , NE
although NE xxx NE
the NE xxx NE
underlying NE xxx NE
mechanism NE xxx NE
remains NE xxx NE
unclear NE xxx NE
. NE . NE

In NE Xx NE
the NE xxx NE
present NE xxx NE
study NE xxx NE
, NE , NE
the NE xxx NE
role NE xxx NE
of NE xx NE
serine/threonine G#protein_molecule_B xxx/xxx G#protein_molecule_B
phosphatases G#protein_molecule_E xxx G#protein_molecule_E
in NE xx NE
the NE xxx NE
regulation NE xxx NE
of NE xx NE
I G#other_name_B X G#other_name_B
kappa G#other_name_M xxx G#other_name_M
B G#other_name_M X G#other_name_M
alpha G#other_name_M xxx G#other_name_M
phosphorylation G#other_name_E xxx G#other_name_E
was NE xxx NE
investigated NE xxx NE
. NE . NE

Our NE Xxx NE
studies NE xxx NE
demonstrate NE xxx NE
that NE xxx NE
incubation NE xxx NE
of NE xx NE
human G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
with NE xxx NE
low NE xxx NE
concentrations NE xxx NE
(approximately NE (xxx NE
1-5 NE d-d NE
nM) NE xX) NE
of NE xx NE
calyculin G#other_organic_compound_B xxx G#other_organic_compound_B
A G#other_organic_compound_E X G#other_organic_compound_E
or NE xx NE
okadaic G#other_organic_compound_B xxx G#other_organic_compound_B
acid G#other_organic_compound_E xxx G#other_organic_compound_E
, NE , NE
potent NE xxx NE
inhibitors NE xxx NE
of NE xx NE
protein G#protein_family_or_group_B xxx G#protein_family_or_group_B
phosphatase G#protein_family_or_group_M xxx G#protein_family_or_group_M
type G#protein_family_or_group_M xxx G#protein_family_or_group_M
1 G#protein_family_or_group_M d G#protein_family_or_group_M
(PP-1) G#protein_family_or_group_M (XX-d) G#protein_family_or_group_M
and G#protein_family_or_group_M xxx G#protein_family_or_group_M
protein G#protein_family_or_group_M xxx G#protein_family_or_group_M
phosphatase G#protein_family_or_group_M xxx G#protein_family_or_group_M
type G#protein_family_or_group_M xxx G#protein_family_or_group_M
2A G#protein_family_or_group_E dX G#protein_family_or_group_E
phosphorylation NE xxx NE
of NE xx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
even NE xxx NE
in NE xx NE
the NE xxx NE
absence NE xxx NE
of NE xx NE
any NE xxx NE
cellular NE xxx NE
stimulus NE xxx NE
. NE . NE

This NE Xxxx NE
action NE xxx NE
of NE xx NE
the NE xxx NE
phosphatase G#other_organic_compound_B xxx G#other_organic_compound_B
inhibitors G#other_organic_compound_E xxx G#other_organic_compound_E
, NE , NE
which NE xxx NE
is NE xx NE
associated NE xxx NE
with NE xxx NE
the NE xxx NE
activation NE xxx NE
of NE xx NE
the NE xxx NE
RelA.p50 G#protein_complex_B XxxX.xdd G#protein_complex_B
NF-kappa G#protein_complex_M XX-xxx G#protein_complex_M
B G#protein_complex_M X G#protein_complex_M
heterodimer G#protein_complex_E xxx G#protein_complex_E
, NE , NE
is NE xx NE
not NE xxx NE
affected NE xxx NE
by NE xx NE
agents NE xxx NE
that NE xxx NE
block NE xxx NE
the NE xxx NE
induction NE xxx NE
of NE xx NE
I G#other_name_B X G#other_name_B
kappa G#other_name_M xxx G#other_name_M
B G#other_name_M X G#other_name_M
alpha G#other_name_M xxx G#other_name_M
phosphorylation G#other_name_E xxx G#other_name_E
by NE xx NE
tumor G#protein_molecule_B xxx G#protein_molecule_B
necrosis G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_M xxx G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
TNF-alpha G#protein_molecule XXX-xxx G#protein_molecule
) NE ) NE
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
the NE xxx NE
phosphorylated G#protein_molecule_B xxx G#protein_molecule_B
I G#protein_molecule_M X G#protein_molecule_M
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
from NE xxx NE
calyculin NE xxx NE
A NE X NE
-treated NE -xxx NE
cells NE xxx NE
, NE , NE
but NE xxx NE
not NE xxx NE
that NE xxx NE
from NE xxx NE
TNF-alpha NE XXX-xxx NE
-stimulated NE -xxx NE
cells NE xxx NE
, NE , NE
is NE xx NE
sensitive NE xxx NE
to NE xx NE
PP-2A NE XX-dX NE
in NE xx NE
vitro NE xxx NE
, NE , NE
suggesting NE xxx NE
the NE xxx NE
existence NE xxx NE
of NE xx NE
fundamental NE xxx NE
differences NE xxx NE
in NE xx NE
the NE xxx NE
phosphorylation NE xxx NE
of NE xx NE
I NE X NE
kappa NE xxx NE
B NE X NE
alpha NE xxx NE
induced NE xxx NE
by NE xx NE
the NE xxx NE
two NE xxx NE
different NE xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
inducers NE xxx NE
. NE . NE

However NE Xxxx NE
, NE , NE
induction NE xxx NE
of NE xx NE
I G#other_name_B X G#other_name_B
kappa G#other_name_M xxx G#other_name_M
B G#other_name_M X G#other_name_M
alpha G#other_name_M xxx G#other_name_M
phosphorylation G#other_name_E xxx G#other_name_E
by NE xx NE
both NE xxx NE
TNF-alpha G#protein_molecule XXX-xxx G#protein_molecule
and NE xxx NE
the NE xxx NE
phosphatase G#other_organic_compound_B xxx G#other_organic_compound_B
inhibitors G#other_organic_compound_E xxx G#other_organic_compound_E
is NE xx NE
associated NE xxx NE
with NE xxx NE
the NE xxx NE
subsequent NE xxx NE
degradation NE xxx NE
of NE xx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

We NE Xx NE
further NE xxx NE
demonstrate NE xxx NE
that NE xxx NE
TNF-alpha-degradation G#other_name_B XXX-xxx-xxx G#other_name_B
and G#other_name_M xxx G#other_name_M
calyculin G#other_name_M xxx G#other_name_M
A-induced G#other_name_M X-xxx G#other_name_M
I G#other_name_M X G#other_name_M
kappa G#other_name_M xxx G#other_name_M
B G#other_name_M X G#other_name_M
alpha G#other_name_M xxx G#other_name_M
degradation G#other_name_E xxx G#other_name_E
exhibits NE xxx NE
similar NE xxx NE
but NE xxx NE
not NE xxx NE
identical NE xxx NE
sensitivities NE xxx NE
to NE xx NE
a NE x NE
proteasome G#other_organic_compound_B xxx G#other_organic_compound_B
inhibitor G#other_organic_compound_E xxx G#other_organic_compound_E
. NE . NE

Together NE Xxxx NE
, NE , NE
these NE xxx NE
results NE xxx NE
suggest NE xxx NE
that NE xxx NE
phosphorylation G#other_name xxx G#other_name
of NE xx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
, NE , NE
mediated NE xxx NE
through NE xxx NE
both NE xxx NE
the NE xxx NE
TNF-alpha G#protein_molecule XXX-xxx G#protein_molecule
-inducible NE -xxx NE
and NE xxx NE
the NE xxx NE
PP-2A NE XX-dX NE
-opposing NE -xxx NE
kinases NE xxx NE
, NE , NE
may NE xxx NE
serve NE xxx NE
to NE xx NE
target NE xxx NE
I NE X NE
kappa NE xxx NE
B NE X NE
alpha NE xxx NE
for NE xxx NE
proteasome NE xxx NE
-mediated NE -xxx NE
degradation NE xxx NE
. NE . NE

Sp1 G#other_name_B Xxd G#other_name_B
functions G#other_name_E xxx G#other_name_E
in NE xx NE
a NE x NE
chromatin NE xxx NE
-dependent NE -xxx NE
manner NE xxx NE
to NE xx NE
augment NE xxx NE
human NE xxx NE
alpha-globin NE xxx-xxx NE
promoter NE xxx NE
activity NE xxx NE
. NE . NE

The NE Xxx NE
5' G#DNA_domain_or_region_B d' G#DNA_domain_or_region_B
flanking G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
the NE xxx NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
alpha-globin G#DNA_domain_or_region_M xxx-xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
is NE xx NE
highly NE xxx NE
G G#DNA_N/A_B X G#DNA_N/A_B
+ G#DNA_N/A_M + G#DNA_N/A_M
C G#DNA_N/A_M X G#DNA_N/A_M
rich G#DNA_N/A_E xxx G#DNA_N/A_E
and NE xxx NE
contains NE xxx NE
multiple NE xxx NE
copies NE xxx NE
of NE xx NE
the NE xxx NE
consensus G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
for NE xxx NE
the NE xxx NE
Sp1 G#DNA_domain_or_region_B Xxd G#DNA_domain_or_region_B
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

We NE Xx NE
investigated NE xxx NE
the NE xxx NE
role NE xxx NE
of NE xx NE
this NE xxx NE
G G#DNA_domain_or_region_B X G#DNA_domain_or_region_B
+ G#DNA_domain_or_region_M + G#DNA_domain_or_region_M
C-rich G#DNA_domain_or_region_M X-xxx G#DNA_domain_or_region_M
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
augmenting NE xxx NE
alpha-globin G#other_name_B xxx-xxx G#other_name_B
promoter G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
in NE xx NE
the NE xxx NE
presence NE xxx NE
of NE xx NE
the NE xxx NE
far-upstream G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
alpha-globin G#DNA_domain_or_region_M xxx-xxx G#DNA_domain_or_region_M
enhancer G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
HS-40 G#DNA_domain_or_region XX-dd G#DNA_domain_or_region
. NE . NE

We NE Xx NE
show NE xxx NE
that NE xxx NE
in NE xx NE
transiently G#cell_line_B xxx G#cell_line_B
transfected G#cell_line_M xxx G#cell_line_M
erythroid G#cell_line_M xxx G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
deletion NE xxx NE
of NE xx NE
the NE xxx NE
alpha-globin G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
G G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
+ G#DNA_domain_or_region_M + G#DNA_domain_or_region_M
C-rich G#DNA_domain_or_region_M X-xxx G#DNA_domain_or_region_M
5' G#DNA_domain_or_region_M d' G#DNA_domain_or_region_M
flanking G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
has NE xxx NE
no NE xx NE
effect NE xxx NE
on NE xx NE
alpha-globin G#other_name_B xxx-xxx G#other_name_B
promoter G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
. NE . NE

However NE Xxxx NE
, NE , NE
upon NE xxx NE
stable NE xxx NE
integration NE xxx NE
into NE xxx NE
chromatin G#DNA_family_or_group xxx G#DNA_family_or_group
, NE , NE
deletion NE xxx NE
of NE xx NE
this NE xxx NE
region NE xxx NE
causes NE xxx NE
a NE x NE
nearly NE xxx NE
90% NE dd% NE
decrease NE xxx NE
in NE xx NE
promoter G#other_name_B xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
compared NE xxx NE
with NE xxx NE
expression NE xxx NE
from NE xxx NE
an NE xx NE
alpha-globin G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
retaining NE xxx NE
this NE xxx NE
region NE xxx NE
. NE . NE

These NE Xxxx NE
results NE xxx NE
suggest NE xxx NE
that NE xxx NE
the NE xxx NE
alpha-globin G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
G G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
+ G#DNA_domain_or_region_M + G#DNA_domain_or_region_M
C-rich G#DNA_domain_or_region_M X-xxx G#DNA_domain_or_region_M
5' G#DNA_domain_or_region_M d' G#DNA_domain_or_region_M
flanking G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
augments NE xxx NE
alpha-globin G#other_name_B xxx-xxx G#other_name_B
promoter G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
in NE xx NE
a NE x NE
chromatin NE xxx NE
-dependent NE -xxx NE
manner NE xxx NE
. NE . NE

We NE Xx NE
further NE xxx NE
show NE xxx NE
that NE xxx NE
this NE xxx NE
G G#DNA_domain_or_region_B X G#DNA_domain_or_region_B
+ G#DNA_domain_or_region_M + G#DNA_domain_or_region_M
C-rich G#DNA_domain_or_region_M X-xxx G#DNA_domain_or_region_M
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
is NE xx NE
required NE xxx NE
for NE xxx NE
the NE xxx NE
activation NE xxx NE
of NE xx NE
alpha-globin G#other_name_B xxx-xxx G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
during NE xxx NE
erythroid G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
. NE . NE

Finally NE Xxxx NE
, NE , NE
we NE xx NE
show NE xxx NE
by NE xx NE
both NE xxx NE
footprint G#other_name_B xxx G#other_name_B
analysis G#other_name_E xxx G#other_name_E
and NE xxx NE
functional G#other_name_B xxx G#other_name_B
assays G#other_name_E xxx G#other_name_E
that NE xxx NE
the NE xxx NE
ability NE xxx NE
of NE xx NE
the NE xxx NE
G G#DNA_domain_or_region_B X G#DNA_domain_or_region_B
+ G#DNA_domain_or_region_M + G#DNA_domain_or_region_M
C-rich G#DNA_domain_or_region_M X-xxx G#DNA_domain_or_region_M
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
to NE xx NE
increase NE xxx NE
alpha-globin G#other_name_B xxx-xxx G#other_name_B
promoter G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
from NE xxx NE
a NE x NE
stably NE xxx NE
integrated NE xxx NE
alpha-globin G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
is NE xx NE
mediated NE xxx NE
by NE xx NE
its NE xxx NE
multiple G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
for NE xxx NE
the NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
Sp1 G#protein_molecule Xxd G#protein_molecule
. NE . NE

Costimulation NE Xxxx NE
of NE xx NE
human G#cell_line_B xxx G#cell_line_B
CD4+ G#cell_line_M XXd+ G#cell_line_M
T G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
with NE xxx NE
LFA-3 G#protein_molecule XXX-d G#protein_molecule
and NE xxx NE
B7 G#protein_molecule Xd G#protein_molecule
induce NE xxx NE
distinct NE xxx NE
effects NE xxx NE
on NE xx NE
AP-1 G#protein_N/A XX-d G#protein_N/A
and NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

We NE Xx NE
have NE xxx NE
earlier NE xxx NE
shown NE xxx NE
that NE xxx NE
stimulation NE xxx NE
of NE xx NE
human G#cell_line_B xxx G#cell_line_B
CD4+ G#cell_line_M XXd+ G#cell_line_M
T G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
with NE xxx NE
SEA NE XXX NE
presented NE xxx NE
on NE xx NE
Chinese G#cell_line_B Xxxx G#cell_line_B
hamster G#cell_line_M xxx G#cell_line_M
ovary G#cell_line_M xxx G#cell_line_M
(CHO)-DR G#cell_line_M (XXX)-XX G#cell_line_M
transfectants G#cell_line_E xxx G#cell_line_E
coexpressing NE xxx NE
either NE xxx NE
B7 G#protein_molecule Xd G#protein_molecule
or NE xx NE
LFA-3 G#protein_molecule XXX-d G#protein_molecule
resulted NE xxx NE
in NE xx NE
distinct NE xxx NE
cytokine G#other_name_B xxx G#other_name_B
profiles G#other_name_E xxx G#other_name_E
. NE . NE

We NE Xx NE
now NE xxx NE
demonstrate NE xxx NE
that NE xxx NE
B7 G#protein_molecule Xd G#protein_molecule
, NE , NE
but NE xxx NE
not NE xxx NE
LFA-3 G#protein_molecule XXX-d G#protein_molecule
, NE , NE
strongly NE xxx NE
costimulated NE xxx NE
IL-2 G#other_name_B XX-d G#other_name_B
transcription G#other_name_E xxx G#other_name_E
and NE xxx NE
mRNA G#other_name_B xXXX G#other_name_B
expression G#other_name_E xxx G#other_name_E
in NE xx NE
CD4+ G#cell_line_B XXd+ G#cell_line_B
T G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

Maximal NE Xxxx NE
increase NE xxx NE
in NE xx NE
IL-2 G#other_name_B XX-d G#other_name_B
transcription G#other_name_E xxx G#other_name_E
was NE xxx NE
recorded NE xxx NE
with NE xxx NE
CHO-DR NE XXX-XX NE
/ NE / NE
B7 NE Xd NE
/ NE / NE
LFA-3 NE XXX-d NE
, NE , NE
suggesting NE xxx NE
a NE x NE
cooperative NE xxx NE
effect NE xxx NE
of NE xx NE
B7 NE Xd NE
and NE xxx NE
LFA-3 NE XXX-d NE
at NE xx NE
the NE xxx NE
transcriptional NE xxx NE
level NE xxx NE
. NE . NE

Gel-shift NE Xxx-xxx NE
analysis NE xxx NE
demonstrated NE xxx NE
that NE xxx NE
stimulation NE xxx NE
of NE xx NE
CD4+ G#cell_line_B XXd+ G#cell_line_B
T G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
with NE xxx NE
CHO-DR G#protein_molecule XXX-XX G#protein_molecule
and NE xxx NE
staphylococcal G#other_organic_compound_B xxx G#other_organic_compound_B
enterotoxin G#other_organic_compound_M xxx G#other_organic_compound_M
A G#other_organic_compound_E X G#other_organic_compound_E
was NE xxx NE
sufficient NE xxx NE
to NE xx NE
induce NE xxx NE
significant NE xxx NE
amounts NE xxx NE
of NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
binding NE xxx NE
proteins NE xxx NE
, NE , NE
whereas NE xxx NE
induction NE xxx NE
of NE xx NE
AP-1 G#protein_family_or_group_B XX-d G#protein_family_or_group_B
binding G#protein_family_or_group_M xxx G#protein_family_or_group_M
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
required NE xxx NE
costimulation NE xxx NE
. NE . NE

LFA-3 G#protein_molecule XXX-d G#protein_molecule
induced NE xxx NE
moderate NE xxx NE
levels NE xxx NE
of NE xx NE
AP-1 G#protein_molecule XX-d G#protein_molecule
, NE , NE
but NE xxx NE
did NE xxx NE
not NE xxx NE
influence NE xxx NE
the NE xxx NE
levels NE xxx NE
of NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
, NE , NE
while NE xxx NE
B7 G#other_name_B Xd G#other_name_B
costimulation G#other_name_E xxx G#other_name_E
strongly NE xxx NE
induced NE xxx NE
both NE xxx NE
AP-1 G#protein_molecule XX-d G#protein_molecule
and NE xxx NE
substantially NE xxx NE
enhanced NE xxx NE
NF-kappa G#protein_family_or_group_B XX-xxx G#protein_family_or_group_B
B G#protein_family_or_group_M X G#protein_family_or_group_M
binding G#protein_family_or_group_M xxx G#protein_family_or_group_M
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

The NE Xxx NE
CHO-DR NE XXX-XX NE
/ NE / NE
B7 NE Xd NE
/ NE / NE
LFA-3 NE XXX-d NE
triple NE xxx NE
transfectant NE xxx NE
induced NE xxx NE
a NE x NE
further NE xxx NE
increase NE xxx NE
in NE xx NE
AP-1 NE XX-d NE
and NE xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
binding NE xxx NE
proteins NE xxx NE
compared NE xxx NE
with NE xxx NE
the NE xxx NE
double NE xxx NE
transfectants NE xxx NE
. NE . NE

The NE Xxx NE
level NE xxx NE
of NE xx NE
Oct-1 G#protein_family_or_group_B Xxx-d G#protein_family_or_group_B
binding G#protein_family_or_group_M xxx G#protein_family_or_group_M
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
remained NE xxx NE
similar NE xxx NE
in NE xx NE
all NE xxx NE
samples NE xxx NE
. NE . NE

Super-shift G#other_name_B Xxxx-xxx G#other_name_B
analysis G#other_name_E xxx G#other_name_E
revealed NE xxx NE
that NE xxx NE
the NE xxx NE
NF-kappa G#protein_complex_B XX-xxx G#protein_complex_B
B G#protein_complex_M X G#protein_complex_M
complex G#protein_complex_E xxx G#protein_complex_E
of NE xx NE
costimulated G#cell_line_B xxx G#cell_line_B
CD4+ G#cell_line_M XXd+ G#cell_line_M
T G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
contained NE xxx NE
large NE xxx NE
amounts NE xxx NE
of NE xx NE
p50 G#protein_subunit xdd G#protein_subunit
, NE , NE
substantial NE xxx NE
amounts NE xxx NE
of NE xx NE
p65 G#protein_subunit xdd G#protein_subunit
, NE , NE
and NE xxx NE
marginal NE xxx NE
levels NE xxx NE
of NE xx NE
c-Rel G#protein_family_or_group_B x-Xxx G#protein_family_or_group_B
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

The NE Xxx NE
AP-1 G#protein_family_or_group_B XX-d G#protein_family_or_group_B
binding G#protein_family_or_group_M xxx G#protein_family_or_group_M
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
contained NE xxx NE
c-Jun G#protein_molecule x-Xxx G#protein_molecule
, NE , NE
Jun-D G#protein_molecule Xxx-X G#protein_molecule
, NE , NE
and NE xxx NE
Fra-1 G#protein_molecule Xxx-d G#protein_molecule
, NE , NE
but NE xxx NE
marginal NE xxx NE
amounts NE xxx NE
of NE xx NE
Jun-B G#protein_molecule Xxx-X G#protein_molecule
and NE xxx NE
c-Fos G#protein_molecule x-Xxx G#protein_molecule
. NE . NE

Our NE Xxx NE
results NE xxx NE
indicate NE xxx NE
distinct NE xxx NE
effects NE xxx NE
of NE xx NE
B7 G#other_name_B Xd G#other_name_B
and G#other_name_M xxx G#other_name_M
LFA-3 G#other_name_M XXX-d G#other_name_M
costimulation G#other_name_E xxx G#other_name_E
on NE xx NE
the NE xxx NE
activity NE xxx NE
of NE xx NE
AP-1 G#protein_molecule XX-d G#protein_molecule
and NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
. NE . NE

These NE Xxxx NE
may NE xxx NE
partly NE xxx NE
account NE xxx NE
for NE xxx NE
the NE xxx NE
differential G#other_name_B xxx G#other_name_B
effects G#other_name_E xxx G#other_name_E
of NE xx NE
B7 G#other_name_B Xd G#other_name_B
and G#other_name_M xxx G#other_name_M
LFA-3 G#other_name_M XXX-d G#other_name_M
costimulation G#other_name_E xxx G#other_name_E
on NE xx NE
IL-2 G#other_name_B XX-d G#other_name_B
expression G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
Ah G#protein_molecule_B Xx G#protein_molecule_B
receptor G#protein_molecule_E xxx G#protein_molecule_E
recognizes NE xxx NE
DNA G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
for NE xxx NE
the NE xxx NE
B G#protein_family_or_group_B X G#protein_family_or_group_B
cell G#protein_family_or_group_M xxx G#protein_family_or_group_M
transcription G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
BSAP G#protein_molecule XXXX G#protein_molecule
: NE : NE
a NE x NE
possible NE xxx NE
mechanism NE xxx NE
for NE xxx NE
dioxin-mediated G#other_name_B xxx-xxx G#other_name_B
alteration G#other_name_E xxx G#other_name_E
of NE xx NE
CD19 G#other_name_B XXdd G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
B G#cell_type_M X G#cell_type_M
lymphocytes G#cell_type_E xxx G#cell_type_E
. NE . NE

2,3,7,8-tetrachlorodibenzo-p-dioxin G#other_organic_compound d,d,d,d-xxx-x-xxx G#other_organic_compound
( NE ( NE
TCDD G#other_organic_compound XXXX G#other_organic_compound
) NE ) NE
inhibits NE xxx NE
murine G#other_name_B xxx G#other_name_B
B G#other_name_M X G#other_name_M
lymphocyte G#other_name_M xxx G#other_name_M
immunoglobulin G#other_name_M xxx G#other_name_M
production G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
human G#other_name_M xxx G#other_name_M
B G#other_name_M X G#other_name_M
lymphocyte G#other_name_M xxx G#other_name_M
immunoglobulin G#other_name_M xxx G#other_name_M
production G#other_name_E xxx G#other_name_E

This NE Xxxx NE
study NE xxx NE
investigated NE xxx NE
the NE xxx NE
effect NE xxx NE
of NE xx NE
TCDD G#other_organic_compound XXXX G#other_organic_compound
on NE xx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
CD19 G#DNA_domain_or_region_B XXdd G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
a NE x NE
human G#cell_line_B xxx G#cell_line_B
B G#cell_line_M X G#cell_line_M
lymphocyte G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
. NE . NE

Northern G#other_name_B Xxxx G#other_name_B
blot G#other_name_M xxx G#other_name_M
analysis G#other_name_E xxx G#other_name_E
showed NE xxx NE
that NE xxx NE
TCDD G#other_organic_compound XXXX G#other_organic_compound
treatment NE xxx NE
decreased NE xxx NE
steady NE xxx NE
state NE xxx NE
levels NE xxx NE
of NE xx NE
CD19 G#RNA_molecule_B XXdd G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
by NE xx NE
67% NE dd% NE
in NE xx NE
the NE xxx NE
IM-9 G#cell_line_B XX-d G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
. NE . NE

Using NE Xxxx NE
a NE x NE
gel G#other_name_B xxx G#other_name_B
mobility G#other_name_M xxx G#other_name_M
shift G#other_name_M xxx G#other_name_M
assay G#other_name_E xxx G#other_name_E
, NE , NE
we NE xx NE
identified NE xxx NE
a NE x NE
DNA-binding G#protein_complex_B XXX-xxx G#protein_complex_B
complex G#protein_complex_E xxx G#protein_complex_E
in NE xx NE
IM-9 G#cell_component_B XX-d G#cell_component_B
nuclear G#cell_component_M xxx G#cell_component_M
extracts G#cell_component_E xxx G#cell_component_E
that NE xxx NE
by NE xx NE
several NE xxx NE
criteria NE xxx NE
appears NE xxx NE
to NE xx NE
be NE xx NE
the NE xxx NE
Ah G#protein_molecule_B Xx G#protein_molecule_B
receptor G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

In NE Xx NE
addition NE xxx NE
, NE , NE
the NE xxx NE
Ah G#protein_complex_B Xx G#protein_complex_B
receptor G#protein_complex_M xxx G#protein_complex_M
complex G#protein_complex_E xxx G#protein_complex_E
recognized NE xxx NE
a NE x NE
DNA G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
for NE xxx NE
B G#protein_family_or_group_B X G#protein_family_or_group_B
cell G#protein_family_or_group_M xxx G#protein_family_or_group_M
lineage-specific G#protein_family_or_group_M xxx-xxx G#protein_family_or_group_M
activator G#protein_family_or_group_M xxx G#protein_family_or_group_M
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
BSAP G#protein_molecule XXXX G#protein_molecule
) NE ) NE
in NE xx NE
the NE xxx NE
promoter G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
the NE xxx NE
human NE xxx NE
CD19 G#DNA_domain_or_region_B XXdd G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
which NE xxx NE
is NE xx NE
similar NE xxx NE
to NE xx NE
the NE xxx NE
consensus G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
Ah G#DNA_domain_or_region_M Xx G#DNA_domain_or_region_M
receptor G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
DNA G#DNA_domain_or_region_M XXX G#DNA_domain_or_region_M
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

These NE Xxxx NE
results NE xxx NE
suggest NE xxx NE
that NE xxx NE
the NE xxx NE
AhR G#protein_molecule XxX G#protein_molecule
could NE xxx NE
interfere NE xxx NE
with NE xxx NE
BSAP NE XXXX NE
-stimulated NE -xxx NE
CD19 NE XXdd NE
gene NE xxx NE
transcription NE xxx NE
by NE xx NE
competition NE xxx NE
for NE xxx NE
a NE x NE
common NE xxx NE
DNA NE XXX NE
binding NE xxx NE
site NE xxx NE
. NE . NE

Inhibitory G#other_name_B Xxxx G#other_name_B
action G#other_name_E xxx G#other_name_E
of NE xx NE
nm23 G#protein_family_or_group_B xxdd G#protein_family_or_group_B
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
on NE xx NE
induction NE xxx NE
of NE xx NE
erythroid G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
of NE xx NE
human G#cell_type_B xxx G#cell_type_B
leukemia G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

We NE Xx NE
recently NE xxx NE
identified NE xxx NE
a NE x NE
differentiation G#protein_family_or_group_B xxx G#protein_family_or_group_B
inhibitory G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
I-factor G#protein_family_or_group X-xxx G#protein_family_or_group
) NE ) NE
in NE xx NE
mouse G#cell_line_B xxx G#cell_line_B
myeloid G#cell_line_M xxx G#cell_line_M
leukemia G#cell_line_M xxx G#cell_line_M
M1 G#cell_line_M Xd G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
as NE xx NE
a NE x NE
murine G#protein_family_or_group_B xxx G#protein_family_or_group_B
homolog G#protein_family_or_group_E xxx G#protein_family_or_group_E
of NE xx NE
the NE xxx NE
human G#protein_molecule_B xxx G#protein_molecule_B
nm23-H2 G#protein_molecule_M xxdd-Xd G#protein_molecule_M
gene G#protein_molecule_M xxx G#protein_molecule_M
product G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

nm23 G#DNA_family_or_group_B xxdd G#DNA_family_or_group_B
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
encode NE xxx NE
proteins NE xxx NE
that NE xxx NE
participate NE xxx NE
in NE xx NE
tumor G#other_name_B xxx G#other_name_B
metastasis G#other_name_M xxx G#other_name_M
regulation G#other_name_E xxx G#other_name_E
and NE xxx NE
in NE xx NE
various NE xxx NE
fundamental NE xxx NE
cellular NE xxx NE
processes NE xxx NE
, NE , NE
although NE xxx NE
their NE xxx NE
mechanisms NE xxx NE
of NE xx NE
action NE xxx NE
are NE xxx NE
still NE xxx NE
unknown NE xxx NE
. NE . NE

Although NE Xxxx NE
all NE xxx NE
nm23 G#protein_family_or_group_B xxdd G#protein_family_or_group_B
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
contain NE xxx NE
nucleoside G#other_name_B xxx G#other_name_B
diphosphate G#other_name_M xxx G#other_name_M
(NDP) G#other_name_M (XXX) G#other_name_M
kinase G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
, NE , NE
it NE xx NE
has NE xxx NE
not NE xxx NE
been NE xxx NE
established NE xxx NE
that NE xxx NE
the NE xxx NE
enzyme G#other_name_B xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
mediated NE xxx NE
the NE xxx NE
various NE xxx NE
functions NE xxx NE
of NE xx NE
nm23 G#protein_family_or_group_B xxdd G#protein_family_or_group_B
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

In NE Xx NE
the NE xxx NE
present NE xxx NE
experiment NE xxx NE
, NE , NE
we NE xx NE
examined NE xxx NE
the NE xxx NE
effect NE xxx NE
of NE xx NE
nm23 G#protein_family_or_group_B xxdd G#protein_family_or_group_B
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
on NE xx NE
various NE xxx NE
differentiation NE xxx NE
induction NE xxx NE
systems NE xxx NE
of NE xx NE
human G#cell_type_B xxx G#cell_type_B
leukemic G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
including NE xxx NE
HL-60 G#cell_line_B XX-dd G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
and G#cell_line_M xxx G#cell_line_M
U937 G#cell_line_M Xddd G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
and G#cell_line_M xxx G#cell_line_M
HEL/S G#cell_line_M XXX/X G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
and G#cell_line_M xxx G#cell_line_M
KU812F G#cell_line_M XXdddX G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
and G#cell_line_M xxx G#cell_line_M
K562 G#cell_line_M Xddd G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
and G#cell_line_M xxx G#cell_line_M
HEL G#cell_line_M XXX G#cell_line_M
cell G#cell_line_E xxx G#cell_line_E

Native G#protein_family_or_group_B Xxxx G#protein_family_or_group_B
human G#protein_family_or_group_M xxx G#protein_family_or_group_M
erythrocyte G#protein_family_or_group_M xxx G#protein_family_or_group_M
NDP G#protein_family_or_group_M XXX G#protein_family_or_group_M
kinase G#protein_family_or_group_M xxx G#protein_family_or_group_M
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
inhibited NE xxx NE
the NE xxx NE
induction NE xxx NE
of NE xx NE
erythroid G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
of NE xx NE
HEL G#cell_line_B XXX G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
and G#cell_line_M xxx G#cell_line_M
KU812 G#cell_line_M XXddd G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
and G#cell_line_M xxx G#cell_line_M
K562 G#cell_line_M Xddd G#cell_line_M
cell G#cell_line_E xxx G#cell_line_E
HL-60 G#cell_line_B XX-dd G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
and G#cell_line_M xxx G#cell_line_M
U937 G#cell_line_M Xddd G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
and G#cell_line_M xxx G#cell_line_M
HEL/S G#cell_line_M XXX/X G#cell_line_M
cell G#cell_line_E xxx G#cell_line_E
monocytic NE xxx NE
or NE xx NE
monocytic G#other_name_B xxx G#other_name_B
differentiation G#other_name_M xxx G#other_name_M
or G#other_name_M xx G#other_name_M
granulocytic G#other_name_M xxx G#other_name_M
differentiation G#other_name_E xxx G#other_name_E
of NE xx NE
HL-60 NE XX-dd NE
, NE , NE
U937 NE Xddd NE
and NE xxx NE
HEL/S NE XXX/X NE
cells NE xxx NE
. NE . NE

The NE Xxx NE
erythroid G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
of NE xx NE
HEL G#cell_line_B XXX G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
was NE xxx NE
inhibited NE xxx NE
by NE xx NE
recombinant G#protein_molecule_B xxx G#protein_molecule_B
human G#protein_molecule_M xxx G#protein_molecule_M
nm23-H1 G#protein_molecule_M xxdd-Xd G#protein_molecule_M
protein G#protein_molecule_M xxx G#protein_molecule_M
and G#protein_molecule_M xxx G#protein_molecule_M
recombinant G#protein_molecule_M xxx G#protein_molecule_M
human-H2 G#protein_molecule_M xxx-Xd G#protein_molecule_M
protein G#protein_molecule_M xxx G#protein_molecule_M
and G#protein_molecule_M xxx G#protein_molecule_M
recombinant G#protein_molecule_M xxx G#protein_molecule_M
mouse G#protein_molecule_M xxx G#protein_molecule_M
nm23-M1 G#protein_molecule_M xxdd-Xd G#protein_molecule_M
protein G#protein_molecule_M xxx G#protein_molecule_M
and G#protein_molecule_M xxx G#protein_molecule_M
recombinant G#protein_molecule_M xxx G#protein_molecule_M
mouse G#protein_molecule_M xxx G#protein_molecule_M
nm23-M2 G#protein_molecule_M xxdd-Xd G#protein_molecule_M
protein G#protein_molecule_E xxx G#protein_molecule_E

Moreover NE Xxxx NE
, NE , NE
both NE xxx NE
the NE xxx NE
mutant G#protein_molecule_B xxx G#protein_molecule_B
nm23-H2His G#protein_molecule_M xxdd-XdXxx G#protein_molecule_M
protein G#protein_molecule_E xxx G#protein_molecule_E
and NE xxx NE
truncated G#protein_molecule_B xxx G#protein_molecule_B
nm23-H2 G#protein_molecule_M xxdd-Xd G#protein_molecule_M
protein G#protein_molecule_E xxx G#protein_molecule_E
containing NE xxx NE
N-terminal G#protein_domain_or_region_B X-xxx G#protein_domain_or_region_B
(1-60) G#protein_domain_or_region_M (d-dd) G#protein_domain_or_region_M
peptide G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
, NE , NE
which NE xxx NE
do NE xx NE
not NE xxx NE
have NE xxx NE
NDP G#other_name_B XXX G#other_name_B
kinase G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
, NE , NE
also NE xxx NE
inhibited NE xxx NE
erythroid G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
of NE xx NE
HEL G#cell_line_B XXX G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

These NE Xxxx NE
results NE xxx NE
suggest NE xxx NE
that NE xxx NE
(1) NE (d) NE
the NE xxx NE
differentiation G#other_name_B xxx G#other_name_B
inhibitory G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
of NE xx NE
I-factor NE X-xxx NE
/nm23 NE /xxdd NE
protein NE xxx NE
is NE xx NE
not NE xxx NE
restricted NE xxx NE
to NE xx NE
monocytic NE xxx NE
differentiation NE xxx NE
of NE xx NE
M1 NE Xd NE
cells NE xxx NE
, NE , NE
(2) NE (d) NE
the NE xxx NE
inhibitory NE xxx NE
activity NE xxx NE
is NE xx NE
exhibited NE xxx NE
without NE xxx NE
species NE xxx NE
specificity NE xxx NE
, NE , NE
and NE xxx NE
(3) NE (d) NE
the NE xxx NE
differentiation NE xxx NE
inhibitory NE xxx NE
activity NE xxx NE
of NE xx NE
the NE xxx NE
nm23/NDP NE xxdd/XXX NE
kinase NE xxx NE
protein NE xxx NE
is NE xx NE
independent NE xxx NE
of NE xx NE
its NE xxx NE
enzyme NE xxx NE
activity NE xxx NE
and NE xxx NE
requires NE xxx NE
the NE xxx NE
presence NE xxx NE
of NE xx NE
N-terminal NE X-xxx NE
peptides NE xxx NE
. NE . NE

Lipopolysaccharide NE Xxxx NE
-induced NE -xxx NE
E-selectin NE X-xxx NE
expression NE xxx NE
requires NE xxx NE
continuous NE xxx NE
presence NE xxx NE
of NE xx NE
LPS NE XXX NE
and NE xxx NE
is NE xx NE
inhibited NE xxx NE
by NE xx NE
bactericidal/permeability-increasing NE xxx/xxx-xxx NE
protein NE xxx NE
. NE . NE

Endothelial G#cell_type_B Xxxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
stimulated NE xxx NE
by NE xx NE
LPS G#lipid XXX G#lipid
express NE xxx NE
E-selectin G#protein_molecule X-xxx G#protein_molecule
, NE , NE
which NE xxx NE
plays NE xxx NE
an NE xx NE
important NE xxx NE
role NE xxx NE
in NE xx NE
mediating NE xxx NE
neutrophil G#other_name_B xxx G#other_name_B
adhesion G#other_name_E xxx G#other_name_E
during NE xxx NE
inflammation G#other_name xxx G#other_name
. NE . NE

E-selectin G#protein_molecule X-xxx G#protein_molecule
is NE xx NE
induced NE xxx NE
within NE xxx NE
1-2 NE d-d NE
h NE x NE
, NE , NE
peaks NE xxx NE
at NE xx NE
4-6 NE d-d NE
h NE x NE
, NE , NE
and NE xxx NE
gradually NE xxx NE
returns NE xxx NE
to NE xx NE
basal NE xxx NE
level NE xxx NE
by NE xx NE
24 NE dd NE
h NE x NE
. NE . NE

rBPI21 G#protein_molecule xXXXdd G#protein_molecule
, NE , NE
a NE x NE
recombinant G#protein_family_or_group_B xxx G#protein_family_or_group_B
N-terminal G#protein_family_or_group_M X-xxx G#protein_family_or_group_M
fragment G#protein_family_or_group_E xxx G#protein_family_or_group_E
of NE xx NE
human G#protein_molecule_B xxx G#protein_molecule_B
bactericidal/permeability-increasing G#protein_molecule_M xxx/xxx-xxx G#protein_molecule_M
protein G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
BPI G#protein_molecule XXX G#protein_molecule
) NE ) NE
, NE , NE
inhibited NE xxx NE
LPS NE XXX NE
-induced NE -xxx NE
E-selectin NE X-xxx NE
expression NE xxx NE
when NE xxx NE
added NE xxx NE
at NE xx NE
the NE xxx NE
same NE xxx NE
time NE xxx NE
as NE xx NE
, NE , NE
and NE xxx NE
up NE xx NE
to NE xx NE
6 NE d NE
h NE x NE
after NE xxx NE
, NE , NE
LPS NE XXX NE
. NE . NE

Delayed NE Xxxx NE
administration NE xxx NE
of NE xx NE
rBPI21 G#protein_molecule xXXXdd G#protein_molecule
also NE xxx NE
affected NE xxx NE
LPS NE XXX NE
-mediated NE -xxx NE
activation NE xxx NE
of NE xx NE
the NE xxx NE
nuclear NE xxx NE
factor NE xxx NE
, NE , NE
NF-kappa NE XX-xxx NE
B NE X NE
. NE . NE

Two NE Xxx NE
to NE xx NE
4 NE d NE
h NE x NE
following NE xxx NE
LPS G#lipid XXX G#lipid
addition NE xxx NE
to NE xx NE
endothelial G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
, NE , NE
when NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
was NE xxx NE
already NE xxx NE
activated NE xxx NE
, NE , NE
addition NE xxx NE
of NE xx NE
rBPI21 G#protein_molecule xXXXdd G#protein_molecule
resulted NE xxx NE
in NE xx NE
marked NE xxx NE
reduction NE xxx NE
of NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
detectable NE xxx NE
at NE xx NE
4 NE d NE
or NE xx NE
6 NE d NE
h NE x NE
. NE . NE

These NE Xxxx NE
results NE xxx NE
indicate NE xxx NE
that NE xxx NE
endothelial G#other_name_B xxx G#other_name_B
activation G#other_name_E xxx G#other_name_E
requires NE xxx NE
continuous NE xxx NE
presence NE xxx NE
of NE xx NE
LPS G#lipid XXX G#lipid
, NE , NE
and NE xxx NE
rBPI21 G#protein_molecule xXXXdd G#protein_molecule
acts NE xxx NE
to NE xx NE
reverse NE xxx NE
LPS NE XXX NE
-mediated NE -xxx NE
endothelial NE xxx NE
activation NE xxx NE
by NE xx NE
interrupting NE xxx NE
the NE xxx NE
on-going NE xx-xxx NE
LPS NE XXX NE
signal NE xxx NE
. NE . NE

GM-CSF G#protein_molecule XX-XXX G#protein_molecule
and NE xxx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
share NE xxx NE
common NE xxx NE
control G#other_name_B xxx G#other_name_B
mechanisms G#other_name_E xxx G#other_name_E
in NE xx NE
response NE xxx NE
to NE xx NE
costimulatory G#other_name_B xxx G#other_name_B
signals G#other_name_E xxx G#other_name_E
in NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Antigen NE Xxxx NE
complexed NE xxx NE
with NE xxx NE
major G#protein_family_or_group_B xxx G#protein_family_or_group_B
histocompatibility G#protein_family_or_group_M xxx G#protein_family_or_group_M
complex G#protein_family_or_group_M xxx G#protein_family_or_group_M
class G#protein_family_or_group_M xxx G#protein_family_or_group_M
I G#protein_family_or_group_M X G#protein_family_or_group_M
molecule G#protein_family_or_group_M xxx G#protein_family_or_group_M
or G#protein_family_or_group_M xx G#protein_family_or_group_M
major G#protein_family_or_group_M xxx G#protein_family_or_group_M
histocompatibility G#protein_family_or_group_M xxx G#protein_family_or_group_M
complex G#protein_family_or_group_M xxx G#protein_family_or_group_M
class G#protein_family_or_group_M xxx G#protein_family_or_group_M
II G#protein_family_or_group_M XX G#protein_family_or_group_M
molecule G#protein_family_or_group_E xxx G#protein_family_or_group_E
on NE xx NE
the NE xxx NE
surface NE xxx NE
of NE xx NE
antigen G#cell_type_B xxx G#cell_type_B
presenting G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
interacts NE xxx NE
with NE xxx NE
the NE xxx NE
T G#protein_family_or_group_B X G#protein_family_or_group_B
cell G#protein_family_or_group_M xxx G#protein_family_or_group_M
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
TCR G#protein_family_or_group XXX G#protein_family_or_group
) NE ) NE
on NE xx NE
the NE xxx NE
surface NE xxx NE
of NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
and NE xxx NE
initiates NE xxx NE
an NE xx NE
activation NE xxx NE
cascade NE xxx NE
. NE . NE

So NE Xx NE
called NE xxx NE
costimulatory G#other_name_B xxx G#other_name_B
signals G#other_name_E xxx G#other_name_E
, NE , NE
mediated NE xxx NE
by NE xx NE
other NE xxx NE
cell NE xxx NE
surface NE xxx NE
interactions NE xxx NE
or NE xx NE
soluble G#protein_family_or_group_B xxx G#protein_family_or_group_B
cytokines G#protein_family_or_group_E xxx G#protein_family_or_group_E
produced NE xxx NE
by NE xx NE
antigen G#cell_type_B xxx G#cell_type_B
presenting G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
, NE , NE
are NE xxx NE
also NE xxx NE
required NE xxx NE
for NE xxx NE
complete NE xxx NE
T G#other_name_B X G#other_name_B
cell G#other_name_M xxx G#other_name_M
activation G#other_name_E xxx G#other_name_E
. NE . NE

High NE Xxxx NE
levels NE xxx NE
of NE xx NE
cytokine G#other_name_B xxx G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
in NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
also NE xxx NE
required NE xxx NE
both NE xxx NE
TCR G#protein_family_or_group XXX G#protein_family_or_group
and NE xxx NE
costimulatory G#other_name_B xxx G#other_name_B
signals G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
granulocyte-macrophage G#protein_molecule_B xxx-xxx G#protein_molecule_B
colony-stimulating G#protein_molecule_M xxx-xxx G#protein_molecule_M
factor G#protein_molecule_E xxx G#protein_molecule_E
requires NE xxx NE
sequences NE xxx NE
in NE xx NE
the NE xxx NE
promoter G#DNA_domain_or_region xxx G#DNA_domain_or_region
as NE xx NE
well NE xxx NE
as NE xx NE
a NE x NE
powerful NE xxx NE
enhancer G#DNA_domain_or_region xxx G#DNA_domain_or_region
located NE xxx NE
3kb NE dxx NE
upstream NE xxx NE
to NE xx NE
respond NE xxx NE
to NE xx NE
TCR NE XXX NE
-like NE -xxx NE
signals NE xxx NE
. NE . NE

These NE Xxxx NE
promoter G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
enhancer G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
regions G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
are NE xxx NE
mainly NE xxx NE
activated NE xxx NE
by NE xx NE
the NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_M xxx G#protein_family_or_group_M
nuclear G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_M xxx G#protein_family_or_group_M
of G#protein_family_or_group_M xx G#protein_family_or_group_M
activated G#protein_family_or_group_M xxx G#protein_family_or_group_M
T G#protein_family_or_group_M X G#protein_family_or_group_M
cells G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
NFAT G#protein_family_or_group XXXX G#protein_family_or_group
) NE ) NE
. NE . NE

The NE Xxx NE
activation NE xxx NE
of NE xx NE
NFAT G#protein_family_or_group XXXX G#protein_family_or_group
by NE xx NE
TCR G#protein_family_or_group XXX G#protein_family_or_group
signals NE xxx NE
has NE xxx NE
been NE xxx NE
well NE xxx NE
described NE xxx NE
for NE xxx NE
interleukin-2 G#other_name_B xxx-d G#other_name_B
(IL-2) G#other_name_M (XX-d) G#other_name_M
gene G#other_name_M xxx G#other_name_M
transcription G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
IL-4 G#other_name_M XX-d G#other_name_M
gene G#other_name_M xxx G#other_name_M
transcription G#other_name_E xxx G#other_name_E
T NE X NE
cells NE xxx NE
. NE . NE

Costimulatory NE Xxxx NE
signals NE xxx NE
, NE , NE
such NE xxx NE
as NE xx NE
activation NE xxx NE
of NE xx NE
the NE xxx NE
CD28 G#protein_molecule_B XXdd G#protein_molecule_B
cell G#protein_molecule_M xxx G#protein_molecule_M
surface G#protein_molecule_M xxx G#protein_molecule_M
molecule G#protein_molecule_E xxx G#protein_molecule_E
on NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
, NE , NE
lead NE xxx NE
to NE xx NE
activation NE xxx NE
through NE xxx NE
a NE x NE
distinct NE xxx NE
region NE xxx NE
of NE xx NE
the NE xxx NE
granulocyte-macrophage NE xxx-xxx NE
colony-stimulating NE xxx-xxx NE
factor NE xxx NE
( NE ( NE
GM-CSF NE XX-XXX NE
) NE ) NE
promoter NE xxx NE
. NE . NE

This NE Xxxx NE
region NE xxx NE
is NE xx NE
termed NE xxx NE
the NE xxx NE
CK-1 G#DNA_domain_or_region XX-d G#DNA_domain_or_region
or NE xx NE
CD28RE G#DNA_domain_or_region XXddXX G#DNA_domain_or_region
and NE xxx NE
appears NE xxx NE
to NE xx NE
bind NE xxx NE
specific NE xxx NE
members NE xxx NE
of NE xx NE
the NE xxx NE
NF-kappa G#protein_family_or_group_B XX-xxx G#protein_family_or_group_B
B G#protein_family_or_group_M X G#protein_family_or_group_M
family G#protein_family_or_group_E xxx G#protein_family_or_group_E
of NE xx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Human G#virus_B Xxxx G#virus_B
T G#virus_M X G#virus_M
leukemia G#virus_M xxx G#virus_M
virus G#virus_M xxx G#virus_M
type G#virus_M xxx G#virus_M
1 G#virus_E d G#virus_E
( NE ( NE
HTLV-1 G#virus XXXX-d G#virus
) NE ) NE
infects NE xxx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
and NE xxx NE
can NE xxx NE
lead NE xxx NE
to NE xx NE
increase NE xxx NE
GM-CSF G#other_name_B XX-XXX G#other_name_B
expression G#other_name_E xxx G#other_name_E
. NE . NE

We NE Xx NE
have NE xxx NE
found NE xxx NE
that NE xxx NE
the NE xxx NE
HTLV-1 G#protein_family_or_group_B XXXX-d G#protein_family_or_group_B
transactivator G#protein_family_or_group_M xxx G#protein_family_or_group_M
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
tax G#protein_molecule xxx G#protein_molecule
, NE , NE
acts NE xxx NE
as NE xx NE
a NE x NE
costimulatory NE xxx NE
signal NE xxx NE
for NE xxx NE
GM-CSF G#other_name_B XX-XXX G#other_name_B
gene G#other_name_M xxx G#other_name_M
transcription G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
IL-2 G#other_name_M XX-d G#other_name_M
gene G#other_name_M xxx G#other_name_M
transcription G#other_name_E xxx G#other_name_E
TCR NE XXX NE
signals NE xxx NE
to NE xx NE
mediate NE xxx NE
high NE xxx NE
level NE xxx NE
gene G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
. NE . NE

Tax NE Xxx NE
activates NE xxx NE
the NE xxx NE
GM-CSF G#DNA_domain_or_region_B XX-XXX G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
through NE xxx NE
the NE xxx NE
CK-1 G#DNA_domain_or_region XX-d G#DNA_domain_or_region
/CD28RE NE /XXddXX NE
region NE xxx NE
and NE xxx NE
also NE xxx NE
activates NE xxx NE
nuclear NE xxx NE
factor-kappa NE xxx-xxx NE
B NE X NE
binding NE xxx NE
to NE xx NE
this NE xxx NE
region NE xxx NE
. NE . NE

However NE Xxxx NE
, NE , NE
other NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
or NE xx NE
coactivators NE xxx NE
of NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
are NE xxx NE
required NE xxx NE
for NE xxx NE
tax G#other_name_B xxx G#other_name_B
activation G#other_name_E xxx G#other_name_E
but NE xxx NE
these NE xxx NE
remain NE xxx NE
to NE xx NE
be NE xx NE
identified NE xxx NE
. NE . NE

The NE Xxx NE
CK-1 G#DNA_domain_or_region XX-d G#DNA_domain_or_region
/CD28RE NE /XXddXX NE
of NE xx NE
GM-CSF NE XX-XXX NE
shows NE xxx NE
a NE x NE
high NE xxx NE
degree NE xxx NE
of NE xx NE
similarity NE xxx NE
to NE xx NE
the NE xxx NE
IL-2 NE XX-d NE
CD28RE G#DNA_domain_or_region XXddXX G#DNA_domain_or_region
and NE xxx NE
the NE xxx NE
IL-3 NE XX-d NE
gene NE xxx NE
also NE xxx NE
contains NE xxx NE
a NE x NE
related NE xxx NE
region NE xxx NE
. NE . NE

This NE Xxxx NE
observation NE xxx NE
, NE , NE
together NE xxx NE
with NE xxx NE
the NE xxx NE
fact NE xxx NE
that NE xxx NE
both NE xxx NE
GM-CSF G#protein_molecule XX-XXX G#protein_molecule
and NE xxx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
respond NE xxx NE
to NE xx NE
TCR G#protein_family_or_group XXX G#protein_family_or_group
signals NE xxx NE
via NE xxx NE
NFAT G#protein_family_or_group XXXX G#protein_family_or_group
, NE , NE
implies NE xxx NE
a NE x NE
high NE xxx NE
degree NE xxx NE
of NE xx NE
conservation NE xxx NE
in NE xx NE
the NE xxx NE
regulation NE xxx NE
of NE xx NE
cytokine G#other_name_B xxx G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
in NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Danazol G#other_organic_compound Xxxx G#other_organic_compound
decreases NE xxx NE
transcription NE xxx NE
of NE xx NE
estrogen G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
receptor G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
monocytes G#cell_type_E xxx G#cell_type_E
. NE . NE

1 NE d NE
. NE . NE
Administration NE Xxxx NE
of NE xx NE
danazol G#other_organic_compound xxx G#other_organic_compound
for NE xxx NE
over NE xxx NE
one NE xxx NE
month NE xxx NE
reduced NE xxx NE
the NE xxx NE
levels NE xxx NE
of NE xx NE
estrogen G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
ER G#protein_family_or_group XX G#protein_family_or_group
) NE ) NE
and NE xxx NE
its NE xxx NE
mRNA G#RNA_family_or_group xXXX G#RNA_family_or_group
to NE xx NE
approximately NE xxx NE
50 NE dd NE
and NE xxx NE
20% NE dd% NE
, NE , NE
respectively NE xxx NE
in NE xx NE
monocytes G#cell_type xxx G#cell_type
. NE . NE

2 NE d NE
. NE . NE
Danazol G#other_organic_compound Xxxx G#other_organic_compound
did NE xxx NE
not NE xxx NE
alter NE xxx NE
the NE xxx NE
degradation NE xxx NE
rate NE xxx NE
of NE xx NE
ER G#RNA_family_or_group_B XX G#RNA_family_or_group_B
mRNA G#RNA_family_or_group_E xXXX G#RNA_family_or_group_E
in NE xx NE
monocytes G#cell_type xxx G#cell_type
. NE . NE

3 NE d NE
. NE . NE
Danazol G#other_organic_compound Xxxx G#other_organic_compound
decreased NE xxx NE
the NE xxx NE
transcription G#other_name_B xxx G#other_name_B
rate G#other_name_E xxx G#other_name_E
of NE xx NE
ER G#DNA_domain_or_region_B XX G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
to NE xx NE
approximately NE xxx NE
50% NE dd% NE
in NE xx NE
monocytes G#cell_type xxx G#cell_type
in NE xx NE
a NE x NE
run-on G#other_name_B xxx-xx G#other_name_B
assay G#other_name_E xxx G#other_name_E
. NE . NE

4 NE d NE
. NE . NE
Danazol G#other_organic_compound Xxxx G#other_organic_compound
may NE xxx NE
release NE xxx NE
estrogen G#lipid xxx G#lipid
predominance NE xxx NE
via NE xxx NE
the NE xxx NE
reduction NE xxx NE
of NE xx NE
transcription NE xxx NE
for NE xxx NE
ER G#DNA_domain_or_region_B XX G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
which NE xxx NE
leads NE xxx NE
to NE xx NE
the NE xxx NE
reduction NE xxx NE
of NE xx NE
ER G#RNA_molecule_B XX G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
and NE xxx NE
ER G#other_name_B XX G#other_name_B
expressions G#other_name_E xxx G#other_name_E
in NE xx NE
monocytes G#cell_type xxx G#cell_type
. NE . NE

Functional NE Xxxx NE
characterization NE xxx NE
of NE xx NE
novel NE xxx NE
IL-2 G#other_name_B XX-d G#other_name_B
transcriptional G#other_name_M xxx G#other_name_M
inhibitors G#other_name_E xxx G#other_name_E
. NE . NE

IL-2 NE XX-d NE
-mediated NE -xxx NE
T NE X NE
cell NE xxx NE
proliferation NE xxx NE
is NE xx NE
a NE x NE
critical NE xxx NE
early NE xxx NE
event NE xxx NE
in NE xx NE
the NE xxx NE
inflammatory NE xxx NE
process NE xxx NE
. NE . NE

Formation NE Xxxx NE
of NE xx NE
the NE xxx NE
NFAT NE XXXX NE
-1 NE -d NE
transcriptional NE xxx NE
complex NE xxx NE
on NE xx NE
the NE xxx NE
IL-2 NE XX-d NE
promoter NE xxx NE
is NE xx NE
essential NE xxx NE
for NE xxx NE
IL-2 NE XX-d NE
transcription NE xxx NE
. NE . NE

Using NE Xxxx NE
a NE x NE
cell NE xxx NE
line NE xxx NE
that NE xxx NE
is NE xx NE
stably NE xxx NE
transfected NE xxx NE
with NE xxx NE
a NE x NE
trimer NE xxx NE
of NE xx NE
the NE xxx NE
NFAT NE XXXX NE
-1 NE -d NE
regulatory NE xxx NE
element NE xxx NE
linked NE xxx NE
to NE xx NE
a NE x NE
lac-Z NE xxx-X NE
reporter NE xxx NE
gene NE xxx NE
, NE , NE
we NE xx NE
screened NE xxx NE
for NE xxx NE
inhibitors NE xxx NE
of NE xx NE
NFAT NE XXXX NE
-1-mediated NE -d-xxx NE
beta-galactosidase NE xxx-xxx NE
activity NE xxx NE
. NE . NE

WIN G#other_organic_compound_B XXX G#other_organic_compound_B
61058 G#other_organic_compound_E ddddd G#other_organic_compound_E
and NE xxx NE
WIN G#other_organic_compound_B XXX G#other_organic_compound_B
53071 G#other_organic_compound_E ddddd G#other_organic_compound_E
were NE xxx NE
identified NE xxx NE
as NE xx NE
microM G#other_name_B xxxX G#other_name_B
inhibitors G#other_name_E xxx G#other_name_E
. NE . NE

These NE Xxxx NE
compounds NE xxx NE
also NE xxx NE
inhibited NE xxx NE
beta-galactosidase G#other_name_B xxx-xxx G#other_name_B
mRNA G#other_name_M xXXX G#other_name_M
levels G#other_name_E xxx G#other_name_E
. NE . NE

Similar NE Xxxx NE
inhibition NE xxx NE
of NE xx NE
NFAT NE XXXX NE
-1-mediated NE -d-xxx NE
gene NE xxx NE
expression NE xxx NE
was NE xxx NE
observed NE xxx NE
in NE xx NE
a NE x NE
second NE xxx NE
cell NE xxx NE
line NE xxx NE
, NE , NE
which NE xxx NE
is NE xx NE
stably NE xxx NE
transfected NE xxx NE
with NE xxx NE
NFAT NE XXXX NE
-1 NE -d NE
regulatory NE xxx NE
elements NE xxx NE
linked NE xxx NE
to NE xx NE
the NE xxx NE
reporter NE xxx NE
gene NE xxx NE
for NE xxx NE
sCD8 NE xXXd NE
. NE . NE

At NE Xx NE
10 NE dd NE
microM NE xxxX NE
, NE , NE
both NE xxx NE
compounds NE xxx NE
inhibited NE xxx NE
IL-2 G#other_name_B XX-d G#other_name_B
mRNA G#other_name_M xXXX G#other_name_M
level G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
IL-2 G#other_name_M XX-d G#other_name_M
protein G#other_name_M xxx G#other_name_M
level G#other_name_E xxx G#other_name_E
in NE xx NE
the NE xxx NE
NFAT G#cell_line XXXX G#cell_line
-1-linked NE -d-xxx NE
lac-Z NE xxx-X NE
transfectants NE xxx NE
, NE , NE
and NE xxx NE
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
lymphocytes G#cell_type_E xxx G#cell_type_E
. NE . NE

Both NE Xxxx NE
compounds NE xxx NE
inhibited NE xxx NE
the NE xxx NE
mixed G#other_name_B xxx G#other_name_B
lymphocyte G#other_name_M xxx G#other_name_M
reaction G#other_name_E xxx G#other_name_E
, NE , NE
and NE xxx NE
this NE xxx NE
inhibition NE xxx NE
was NE xxx NE
reversed NE xxx NE
by NE xx NE
exogenous NE xxx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
. NE . NE

WIN G#other_organic_compound_B XXX G#other_organic_compound_B
53071 G#other_organic_compound_E ddddd G#other_organic_compound_E
inhibited NE xxx NE
IL-2 G#other_name_B XX-d G#other_name_B
production G#other_name_E xxx G#other_name_E
induced NE xxx NE
in NE xx NE
the NE xxx NE
calcium-dependent G#other_name_B xxx-xxx G#other_name_B
PMA G#other_name_M XXX G#other_name_M
and G#other_name_M xxx G#other_name_M
ionomycin G#other_name_M xxx G#other_name_M
pathway G#other_name_E xxx G#other_name_E
. NE . NE

Conversely NE Xxxx NE
, NE , NE
calcium-independent G#protein_molecule_B xxx-xxx G#protein_molecule_B
anti-CD28 G#protein_molecule_M xxx-XXdd G#protein_molecule_M
Ab G#protein_molecule_E Xx G#protein_molecule_E
and NE xxx NE
PMA-induced G#other_name_B XXX-xxx G#other_name_B
IL-2 G#other_name_M XX-d G#other_name_M
production G#other_name_E xxx G#other_name_E
was NE xxx NE
resistant NE xxx NE
. NE . NE

Both NE Xxxx NE
compounds NE xxx NE
altered NE xxx NE
the NE xxx NE
NFAT NE XXXX NE
-1 NE -d NE
transcriptional NE xxx NE
complex NE xxx NE
, NE , NE
causing NE xxx NE
its NE xxx NE
retarded NE xxx NE
mobility NE xxx NE
on NE xx NE
gels NE xxx NE
. NE . NE

By NE Xx NE
these NE xxx NE
functional NE xxx NE
criteria NE xxx NE
, NE , NE
we NE xx NE
believe NE xxx NE
we NE xx NE
have NE xxx NE
identified NE xxx NE
two NE xxx NE
structurally NE xxx NE
distinct NE xxx NE
, NE , NE
novel G#other_name_B xxx G#other_name_B
inhibitors G#other_name_E xxx G#other_name_E
of NE xx NE
NFAT NE XXXX NE
-1-mediated NE -d-xxx NE
transcription NE xxx NE
. NE . NE

Transcriptional G#other_name_B Xxxx G#other_name_B
regulation G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
vacuolar G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
H(+)-ATPase G#DNA_domain_or_region_M X(+)-XXXxxx G#DNA_domain_or_region_M
B2 G#DNA_domain_or_region_M Xd G#DNA_domain_or_region_M
subunit G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
differentiating G#cell_line_B xxx G#cell_line_B
THP-1 G#cell_line_M XXX-d G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

Monocyte-macrophage G#other_name_B Xxxx-xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
was NE xxx NE
used NE xxx NE
as NE xx NE
a NE x NE
model NE xxx NE
system NE xxx NE
for NE xxx NE
studying NE xxx NE
gene G#other_name_B xxx G#other_name_B
regulation G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
human G#protein_molecule_B xxx G#protein_molecule_B
vacuolar G#protein_molecule_M xxx G#protein_molecule_M
H(+)-ATPase G#protein_molecule_E X(+)-XXXxxx G#protein_molecule_E
( NE ( NE
V-ATPase G#protein_molecule X-XXXxxx G#protein_molecule
) NE ) NE
. NE . NE

We NE Xx NE
examined NE xxx NE
mRNA G#other_name_B xXXX G#other_name_B
levels G#other_name_E xxx G#other_name_E
of NE xx NE
various NE xxx NE
V-ATPase G#protein_molecule X-XXXxxx G#protein_molecule
subunits NE xxx NE
during NE xxx NE
differentiation NE xxx NE
of NE xx NE
both NE xxx NE
native G#cell_type_B xxx G#cell_type_B
monocytes G#cell_type_E xxx G#cell_type_E
and NE xxx NE
the NE xxx NE
cell G#cell_line_B xxx G#cell_line_B
line G#cell_line_E xxx G#cell_line_E
THP-1 NE XXX-d NE
, NE , NE
and NE xxx NE
found NE xxx NE
that NE xxx NE
transcriptional G#other_name_B xxx G#other_name_B
mechanism G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
post-transcriptional G#other_name_M xxx-xxx G#other_name_M
mechanism G#other_name_E xxx G#other_name_E
could NE xxx NE
account NE xxx NE
for NE xxx NE
increases NE xxx NE
in NE xx NE
cell G#other_name_B xxx G#other_name_B
V-ATPase G#other_name_M X-XXXxxx G#other_name_M
content G#other_name_E xxx G#other_name_E
. NE . NE

From NE Xxxx NE
nuclear NE xxx NE
runoff NE xxx NE
experiments NE xxx NE
, NE , NE
we NE xx NE
found NE xxx NE
that NE xxx NE
one NE xxx NE
subunit NE xxx NE
in NE xx NE
particular NE xxx NE
, NE , NE
the NE xxx NE
B2 G#protein_subunit_B Xd G#protein_subunit_B
isoform G#protein_subunit_E xxx G#protein_subunit_E
(Mr NE (Xx NE
= NE = NE
56,000) NE dd,ddd) NE
, NE , NE
was NE xxx NE
amplified NE xxx NE
primarily NE xxx NE
by NE xx NE
transcriptional G#other_name_B xxx G#other_name_B
means G#other_name_E xxx G#other_name_E
. NE . NE

We NE Xx NE
have NE xxx NE
begun NE xxx NE
to NE xx NE
examine NE xxx NE
the NE xxx NE
structure NE xxx NE
of NE xx NE
the NE xxx NE
B2 G#DNA_domain_or_region_B Xd G#DNA_domain_or_region_B
subunit G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Isolation NE Xxxx NE
and NE xxx NE
sequencing NE xxx NE
of NE xx NE
the NE xxx NE
first G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
exon G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
5'-flanking G#DNA_domain_or_region_B d'-xxx G#DNA_domain_or_region_B
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
this NE xxx NE
gene NE xxx NE
reveal NE xxx NE
a NE x NE
TATA-less G#DNA_domain_or_region_B XXXX-xxx G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
with NE xxx NE
a NE x NE
high NE xxx NE
G G#other_name_B X G#other_name_B
+ G#other_name_M + G#other_name_M
C G#other_name_M X G#other_name_M
content G#other_name_E xxx G#other_name_E
. NE . NE

Primer G#other_name_B Xxxx G#other_name_B
extension G#other_name_E xxx G#other_name_E
and NE xxx NE
ribonuclease NE xxx NE
protection NE xxx NE
analyses NE xxx NE
indicate NE xxx NE
a NE x NE
single NE xxx NE
major NE xxx NE
transcriptional NE xxx NE
start NE xxx NE
site NE xxx NE
. NE . NE

We NE Xx NE
transfected NE xxx NE
promoter-luciferase G#DNA_molecule_B xxx-xxx G#DNA_molecule_B
reporter G#DNA_molecule_M xxx G#DNA_molecule_M
plasmids G#DNA_molecule_E xxx G#DNA_molecule_E
into NE xxx NE
THP-1 G#cell_line_B XXX-d G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
to NE xx NE
define NE xxx NE
sequences NE xxx NE
that NE xxx NE
mediate NE xxx NE
transcriptional G#other_name_B xxx G#other_name_B
control G#other_name_E xxx G#other_name_E
during NE xxx NE
monocyte G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
. NE . NE

We NE Xx NE
found NE xxx NE
that NE xxx NE
sequences NE xxx NE
downstream NE xxx NE
from NE xxx NE
the NE xxx NE
transcriptional NE xxx NE
start NE xxx NE
site NE xxx NE
were NE xxx NE
sufficient NE xxx NE
to NE xx NE
confer NE xxx NE
increased NE xxx NE
expression NE xxx NE
during NE xxx NE
THP-1 G#other_name_B XXX-d G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
. NE . NE

DNase G#other_name_B XXxxx G#other_name_B
I G#other_name_M X G#other_name_M
footprinting G#other_name_E xxx G#other_name_E
and NE xxx NE
sequence G#other_name_B xxx G#other_name_B
analysis G#other_name_E xxx G#other_name_E
revealed NE xxx NE
the NE xxx NE
existence NE xxx NE
of NE xx NE
multiple NE xxx NE
AP2 G#DNA_domain_or_region_B XXd G#DNA_domain_or_region_B
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
Sp1 G#DNA_domain_or_region_M Xxd G#DNA_domain_or_region_M
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
the NE xxx NE
5'-untranslated G#DNA_domain_or_region_B d'-xxx G#DNA_domain_or_region_B
region G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
proximal G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
coding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E

Synergy NE Xxxx NE
between NE xxx NE
signal G#other_name_B xxx G#other_name_B
transduction G#other_name_M xxx G#other_name_M
pathways G#other_name_E xxx G#other_name_E
is NE xx NE
obligatory NE xxx NE
for NE xxx NE
expression NE xxx NE
of NE xx NE
c-fos G#DNA_domain_or_region x-xxx G#DNA_domain_or_region
in NE xx NE
B G#cell_line_B X G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_M xxx G#cell_line_M
and G#cell_line_M xxx G#cell_line_M
T G#cell_line_M X G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
B G#protein_family_or_group X G#protein_family_or_group
control NE xxx NE
via NE xxx NE
surface NE xxx NE
immunoglobulin NE xxx NE
and NE xxx NE
T G#protein_family_or_group_B X G#protein_family_or_group_B
cell G#protein_family_or_group_M xxx G#protein_family_or_group_M
antigen G#protein_family_or_group_M xxx G#protein_family_or_group_M
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Expression NE Xxxx NE
of NE xx NE
the NE xxx NE
protooncogene G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
c-fos G#DNA_family_or_group_E x-xxx G#DNA_family_or_group_E
is NE xx NE
controlled NE xxx NE
by NE xx NE
three NE xxx NE
main NE xxx NE
regulatory G#other_name_B xxx G#other_name_B
pathways G#other_name_E xxx G#other_name_E
involving NE xxx NE
kinase G#protein_molecule_B xxx G#protein_molecule_B
C G#protein_molecule_E X G#protein_molecule_E
, NE , NE
cAMP G#nucleotide xXXX G#nucleotide
, NE , NE
and NE xxx NE
calcium G#atom xxx G#atom
. NE . NE

Kinase G#protein_family_or_group_B Xxxx G#protein_family_or_group_B
C G#protein_family_or_group_E X G#protein_family_or_group_E
mediates NE xxx NE
its NE xxx NE
effects NE xxx NE
via NE xxx NE
phosphorylation G#other_name xxx G#other_name
of NE xx NE
serum G#protein_molecule_B xxx G#protein_molecule_B
response G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
SRF G#protein_molecule XXX G#protein_molecule
) NE ) NE
which NE xxx NE
interacts NE xxx NE
with NE xxx NE
the NE xxx NE
serum G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
response G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
SRE G#DNA_domain_or_region XXX G#DNA_domain_or_region
) NE ) NE
; NE ; NE
cAMP G#nucleotide xXXX G#nucleotide
and NE xxx NE
calcium G#atom xxx G#atom
mediate NE xxx NE
their NE xxx NE
effects NE xxx NE
via NE xxx NE
phosphorylation G#other_name xxx G#other_name
of NE xx NE
CREB G#protein_molecule XXXX G#protein_molecule
( NE ( NE
cAMP G#protein_molecule_B xXXX G#protein_molecule_B
regulatory G#protein_molecule_M xxx G#protein_molecule_M
element G#protein_molecule_M xxx G#protein_molecule_M
binding G#protein_molecule_M xxx G#protein_molecule_M
protein G#protein_molecule_E xxx G#protein_molecule_E
) NE ) NE
presumably NE xxx NE
by NE xx NE
activation NE xxx NE
of NE xx NE
a NE x NE
protein G#protein_molecule_B xxx G#protein_molecule_B
kinase G#protein_molecule_M xxx G#protein_molecule_M
A G#protein_molecule_E X G#protein_molecule_E
or NE xx NE
calmodulin-regulated G#protein_family_or_group_B xxx-xxx G#protein_family_or_group_B
kinase G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

We NE Xx NE
have NE xxx NE
examined NE xxx NE
the NE xxx NE
function NE xxx NE
of NE xx NE
these NE xxx NE
elements NE xxx NE
in NE xx NE
Burkitt's G#cell_line_B Xxxx'x G#cell_line_B
lymphoma G#cell_line_M xxx G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
( NE ( NE
Ramos G#cell_line Xxxx G#cell_line
and NE xxx NE
Daudi G#cell_line Xxxx G#cell_line
) NE ) NE
as NE xx NE
well NE xxx NE
as NE xx NE
a NE x NE
T G#cell_line_B X G#cell_line_B
lymphocytic G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
( NE ( NE
Jurkat G#cell_line Xxxx G#cell_line
) NE ) NE
. NE . NE

We NE Xx NE
have NE xxx NE
found NE xxx NE
that NE xxx NE
stimulation NE xxx NE
of NE xx NE
any NE xxx NE
one NE xxx NE
of NE xx NE
these NE xxx NE
pathways NE xxx NE
alone NE xxx NE
has NE xxx NE
little NE xxx NE
or NE xx NE
no NE xx NE
effect NE xxx NE
on NE xx NE
c-fos G#other_name_B x-xxx G#other_name_B
induction G#other_name_E xxx G#other_name_E
. NE . NE

However NE Xxxx NE
, NE , NE
kinase G#other_name_B xxx G#other_name_B
C G#other_name_M X G#other_name_M
activation G#other_name_E xxx G#other_name_E
( NE ( NE
PMA G#other_name_B XXX G#other_name_B
stimulation G#other_name_E xxx G#other_name_E
) NE ) NE
combined NE xxx NE
with NE xxx NE
either NE xxx NE
cAMP G#nucleotide xXXX G#nucleotide
( NE ( NE
forskolin G#other_organic_compound_B xxx G#other_organic_compound_B
plus G#other_organic_compound_M xxx G#other_organic_compound_M
MIX G#other_organic_compound_E XXX G#other_organic_compound_E
) NE ) NE
or NE xx NE
calcium G#other_name_B xxx G#other_name_B
stimulation G#other_name_E xxx G#other_name_E
( NE ( NE
ionophore G#other_name xxx G#other_name
) NE ) NE
leads NE xxx NE
to NE xx NE
greatly NE xxx NE
enhanced NE xxx NE
c-fos G#other_name_B x-xxx G#other_name_B
induction G#other_name_E xxx G#other_name_E
. NE . NE

By NE Xx NE
contrast NE xxx NE
, NE , NE
cAMP G#nucleotide xXXX G#nucleotide
in NE xx NE
the NE xxx NE
presence NE xxx NE
of NE xx NE
calcium G#atom xxx G#atom
shows NE xxx NE
no NE xx NE
synergy NE xxx NE
in NE xx NE
c-fos G#other_name_B x-xxx G#other_name_B
induction G#other_name_E xxx G#other_name_E
. NE . NE

Okadaic G#other_organic_compound_B Xxxx G#other_organic_compound_B
acid G#other_organic_compound_E xxx G#other_organic_compound_E
augments NE xxx NE
PMA-mediated G#other_name_B XXX-xxx G#other_name_B
activation G#other_name_M xxx G#other_name_M
as G#other_name_M xx G#other_name_M
well G#other_name_M xxx G#other_name_M
as G#other_name_M xx G#other_name_M
calcium-mediated G#other_name_M xxx-xxx G#other_name_M
activation G#other_name_E xxx G#other_name_E
as NE xx NE
well NE xxx NE
as NE xx NE
calcium- NE xxx- NE
mediated NE xxx NE
activation NE xxx NE
of NE xx NE
c-fos G#DNA_domain_or_region x-xxx G#DNA_domain_or_region
, NE , NE
and NE xxx NE
has NE xxx NE
little NE xxx NE
or NE xx NE
no NE xx NE
effect NE xxx NE
when NE xxx NE
combined NE xxx NE
with NE xxx NE
cAMP G#nucleotide xXXX G#nucleotide
. NE . NE

The NE Xxx NE
main NE xxx NE
difference NE xxx NE
between NE xxx NE
Ramos G#cell_line Xxxx G#cell_line
( NE ( NE
B G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
) NE ) NE
and NE xxx NE
Jurkat G#cell_line Xxxx G#cell_line
( NE ( NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
) NE ) NE
in NE xx NE
the NE xxx NE
regulation NE xxx NE
of NE xx NE
c-fos G#DNA_domain_or_region x-xxx G#DNA_domain_or_region
is NE xx NE
that NE xxx NE
cAMP G#nucleotide xXXX G#nucleotide
plus NE xxx NE
calcium G#atom xxx G#atom
is NE xx NE
strongly NE xxx NE
synergistic NE xxx NE
in NE xx NE
Jurkat G#cell_line Xxxx G#cell_line
and NE xxx NE
is NE xx NE
without NE xxx NE
effect NE xxx NE
in NE xx NE
Ramos G#cell_line Xxxx G#cell_line
. NE . NE

Analysis NE Xxxx NE
of NE xx NE
AP-1 G#other_name_B XX-d G#other_name_B
activity G#other_name_E xxx G#other_name_E
using NE xxx NE
gel G#other_name_B xxx G#other_name_B
mobility G#other_name_M xxx G#other_name_M
shift G#other_name_M xxx G#other_name_M
assays G#other_name_E xxx G#other_name_E
confirms NE xxx NE
that NE xxx NE
the NE xxx NE
requirements NE xxx NE
for NE xxx NE
synergy NE xxx NE
in NE xx NE
c-fos G#other_name_B x-xxx G#other_name_B
mRNA G#other_name_M xXXX G#other_name_M
induction G#other_name_E xxx G#other_name_E
are NE xxx NE
paralleled NE xxx NE
by NE xx NE
requirements NE xxx NE
for NE xxx NE
synergy NE xxx NE
in NE xx NE
induction NE xxx NE
of NE xx NE
AP-1 G#other_name_B XX-d G#other_name_B
activity G#other_name_E xxx G#other_name_E
. NE . NE

Signaling NE Xxxx NE
in NE xx NE
B G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
due NE xxx NE
to NE xx NE
anti-Ig G#other_name_B xxx-Xx G#other_name_B
stimulation G#other_name_E xxx G#other_name_E
involves NE xxx NE
both NE xxx NE
kinase G#protein_molecule_B xxx G#protein_molecule_B
C G#protein_molecule_E X G#protein_molecule_E
activation NE xxx NE
and NE xxx NE
release NE xxx NE
of NE xx NE
intracellular NE xxx NE
calcium G#atom xxx G#atom
, NE , NE
and NE xxx NE
results NE xxx NE
in NE xx NE
c-fos G#other_name_B x-xxx G#other_name_B
mRNA G#other_name_M xXXX G#other_name_M
induction G#other_name_E xxx G#other_name_E
. NE . NE

Our NE Xxx NE
results NE xxx NE
indicate NE xxx NE
that NE xxx NE
synergy NE xxx NE
between NE xxx NE
the NE xxx NE
kinase G#other_name_B xxx G#other_name_B
C G#other_name_M X G#other_name_M
activation G#other_name_E xxx G#other_name_E
and NE xxx NE
calcium G#atom xxx G#atom
is NE xx NE
needed NE xxx NE
for NE xxx NE
efficient NE xxx NE
c-fos G#other_name_B x-xxx G#other_name_B
induction G#other_name_E xxx G#other_name_E
since NE xxx NE
neither NE xxx NE
of NE xx NE
these NE xxx NE
two NE xxx NE
alone NE xxx NE
induces NE xxx NE
c-fos G#DNA_domain_or_region x-xxx G#DNA_domain_or_region
well NE xxx NE
. NE . NE

That NE Xxxx NE
synergy NE xxx NE
of NE xx NE
signaling NE xxx NE
pathways NE xxx NE
is NE xx NE
relevant NE xxx NE
for NE xxx NE
the NE xxx NE
anti-Ig G#other_name_B xxx-Xx G#other_name_B
induction G#other_name_E xxx G#other_name_E
of NE xx NE
c-fos G#DNA_domain_or_region x-xxx G#DNA_domain_or_region
is NE xx NE
supported NE xxx NE
by NE xx NE
the NE xxx NE
fact NE xxx NE
that NE xxx NE
cAMP NE xXXX NE
-inducing NE -xxx NE
agents NE xxx NE
and NE xxx NE
okadaic NE xxx NE
acid NE xxx NE
further NE xxx NE
enhance NE xxx NE
anti-Ig NE xxx-Xx NE
induction NE xxx NE
of NE xx NE
c-fos NE x-xxx NE
. NE . NE

These NE Xxxx NE
results NE xxx NE
suggest NE xxx NE
that NE xxx NE
cell-specific NE xxx-xxx NE
patterns NE xxx NE
of NE xx NE
synergy NE xxx NE
are NE xxx NE
an NE xx NE
essential NE xxx NE
feature NE xxx NE
for NE xxx NE
c-fos G#other_name_B x-xxx G#other_name_B
induction G#other_name_E xxx G#other_name_E
and NE xxx NE
may NE xxx NE
be NE xx NE
relevant NE xxx NE
for NE xxx NE
c-fos G#other_name_B x-xxx G#other_name_B
control G#other_name_E xxx G#other_name_E
through NE xxx NE
B G#protein_family_or_group_B X G#protein_family_or_group_B
cell G#protein_family_or_group_M xxx G#protein_family_or_group_M
antigen G#protein_family_or_group_M xxx G#protein_family_or_group_M
receptor G#protein_family_or_group_M xxx G#protein_family_or_group_M
and G#protein_family_or_group_M xxx G#protein_family_or_group_M
T G#protein_family_or_group_M X G#protein_family_or_group_M
cell G#protein_family_or_group_M xxx G#protein_family_or_group_M
antigen G#protein_family_or_group_M xxx G#protein_family_or_group_M
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E

Multiple NE Xxxx NE
signals NE xxx NE
are NE xxx NE
required NE xxx NE
for NE xxx NE
function NE xxx NE
of NE xx NE
the NE xxx NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
granulocyte-macrophage G#DNA_domain_or_region_M xxx-xxx G#DNA_domain_or_region_M
colony-stimulating G#DNA_domain_or_region_M xxx-xxx G#DNA_domain_or_region_M
factor G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

The NE Xxx NE
human NE xxx NE
granulocyte-macrophage NE xxx-xxx NE
CSF NE XXX NE
( NE ( NE
GM-CSF NE XX-XXX NE
) NE ) NE
gene NE xxx NE
is NE xx NE
expressed NE xxx NE
in NE xx NE
T NE X NE
cells NE xxx NE
in NE xx NE
response NE xxx NE
to NE xx NE
TCR NE XXX NE
activation NE xxx NE
that NE xxx NE
can NE xxx NE
be NE xx NE
mimicked NE xxx NE
by NE xx NE
treatment NE xxx NE
of NE xx NE
the NE xxx NE
cells NE xxx NE
with NE xxx NE
PMA NE XXX NE
and NE xxx NE
Ca2+ NE Xxd+ NE
ionophore NE xxx NE
. NE . NE

The NE Xxx NE
gene NE xxx NE
contains NE xxx NE
a NE x NE
proximal G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
functional G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
-620 G#DNA_domain_or_region_B -ddd G#DNA_domain_or_region_B
to G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
+34 G#DNA_domain_or_region_E +dd G#DNA_domain_or_region_E
) NE ) NE
, NE , NE
as NE xx NE
well NE xxx NE
as NE xx NE
a NE x NE
powerful NE xxx NE
enhancer G#DNA_domain_or_region xxx G#DNA_domain_or_region
located NE xxx NE
3 NE d NE
kb NE xx NE
upstream NE xxx NE
, NE , NE
both NE xxx NE
of NE xx NE
which NE xxx NE
are NE xxx NE
involved NE xxx NE
in NE xx NE
the NE xxx NE
response NE xxx NE
of NE xx NE
the NE xxx NE
gene NE xxx NE
to NE xx NE
TCR G#other_name_B XXX G#other_name_B
activation G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
proximal G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
contains NE xxx NE
a NE x NE
region NE xxx NE
termed NE xxx NE
CLEO G#DNA_domain_or_region XXXX G#DNA_domain_or_region
( NE ( NE
-54 G#DNA_domain_or_region_B -dd G#DNA_domain_or_region_B
to G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
-31 G#DNA_domain_or_region_E -dd G#DNA_domain_or_region_E
) NE ) NE
that NE xxx NE
consists NE xxx NE
of NE xx NE
a NE x NE
purine NE xxx NE
-rich NE -xxx NE
element NE xxx NE
abutting NE xxx NE
an NE xx NE
activator NE xxx NE
protein-1 NE xxx-d NE
( NE ( NE
AP-1 NE XX-d NE
)-like NE )-xxx NE
site NE xxx NE
, NE , NE
as NE xx NE
well NE xxx NE
as NE xx NE
an NE xx NE
upstream NE xxx NE
nuclear NE xxx NE
factor-kappa NE xxx-xxx NE
B NE X NE
( NE ( NE
NF-kappa NE XX-xxx NE
B NE X NE
) NE ) NE
site NE xxx NE
( NE ( NE
-85 NE -dd NE
to NE xx NE
-76 NE -dd NE
) NE ) NE
and NE xxx NE
a NE x NE
CK-1 NE XX-d NE
element NE xxx NE
( NE ( NE
-101 NE -ddd NE
to NE xx NE
-92 NE -dd NE
) NE ) NE
. NE . NE

We NE Xx NE
show NE xxx NE
in NE xx NE
this NE xxx NE
work NE xxx NE
that NE xxx NE
mutations NE xxx NE
in NE xx NE
either NE xxx NE
the NE xxx NE
purine NE xxx NE
-rich NE -xxx NE
region NE xxx NE
of NE xx NE
the NE xxx NE
CLEO NE XXXX NE
element NE xxx NE
or NE xx NE
the NE xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
site NE xxx NE
result NE xxx NE
in NE xx NE
reduced NE xxx NE
PMA NE XXX NE
/ NE / NE
Ca2+ NE Xxd+ NE
activation NE xxx NE
of NE xx NE
a NE x NE
620-bp NE ddd-xx NE
human NE xxx NE
GM-CSF NE XX-XXX NE
promoter- NE xxx- NE
luciferase NE xxx NE
reporter NE xxx NE
construct NE xxx NE
in NE xx NE
Jurkat NE Xxxx NE
T NE X NE
cells NE xxx NE
by NE xx NE
65% NE dd% NE
and NE xxx NE
50% NE dd% NE
, NE , NE
respectively NE xxx NE
. NE . NE

The NE Xxx NE
major NE xxx NE
inducible G#protein_complex_B xxx G#protein_complex_B
protein G#protein_complex_M xxx G#protein_complex_M
complex G#protein_complex_E xxx G#protein_complex_E
that NE xxx NE
binds NE xxx NE
to NE xx NE
the NE xxx NE
human NE xxx NE
CLEO NE XXXX NE
( NE ( NE
hCLEO NE xXXXX NE
) NE ) NE
element NE xxx NE
is NE xx NE
an NE xx NE
AP-1 NE XX-d NE
-like NE -xxx NE
complex NE xxx NE
that NE xxx NE
is NE xx NE
inducible NE xxx NE
by NE xx NE
PMA NE XXX NE
alone NE xxx NE
, NE , NE
but NE xxx NE
shows NE xxx NE
increased NE xxx NE
binding NE xxx NE
in NE xx NE
response NE xxx NE
to NE xx NE
PMA NE XXX NE
together NE xxx NE
with NE xxx NE
Ca2+ NE Xxd+ NE
ionophore NE xxx NE
. NE . NE

Although NE Xxxx NE
the NE xxx NE
binding NE xxx NE
of NE xx NE
this NE xxx NE
complex NE xxx NE
is NE xx NE
not NE xxx NE
cyclosporin NE xxx NE
-sensitive NE -xxx NE
, NE , NE
promoter NE xxx NE
induction NE xxx NE
is NE xx NE
inhibited NE xxx NE
by NE xx NE
cyclosporin NE xxx NE
treatment NE xxx NE
. NE . NE

A NE X NE
second NE xxx NE
weak NE xxx NE
inducible NE xxx NE
complex NE xxx NE
resembling NE xxx NE
nuclear G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_M xxx G#protein_family_or_group_M
of G#protein_family_or_group_M xx G#protein_family_or_group_M
activated G#protein_family_or_group_M xxx G#protein_family_or_group_M
T G#protein_family_or_group_M X G#protein_family_or_group_M
cells G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
NF-AT G#protein_family_or_group XX-XX G#protein_family_or_group
) NE ) NE
was NE xxx NE
also NE xxx NE
observed NE xxx NE
binding NE xxx NE
to NE xx NE
the NE xxx NE
hCLEO G#DNA_domain_or_region_B xXXXX G#DNA_domain_or_region_B
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

By NE Xx NE
using NE xxx NE
recombinant G#protein_family_or_group_B xxx G#protein_family_or_group_B
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
we NE xx NE
confirmed NE xxx NE
that NE xxx NE
AP-1 G#protein_molecule XX-d G#protein_molecule
, NE , NE
NF-ATp G#protein_molecule XX-XXx G#protein_molecule
, NE , NE
and NE xxx NE
a NE x NE
higher NE xxx NE
order NE xxx NE
NF-ATp NE XX-XXx NE
/ NE / NE
AP-1 NE XX-d NE
complex NE xxx NE
could NE xxx NE
all NE xxx NE
form NE xxx NE
with NE xxx NE
the NE xxx NE
hCLEO NE xXXXX NE
element NE xxx NE
, NE , NE
and NE xxx NE
we NE xx NE
have NE xxx NE
also NE xxx NE
defined NE xxx NE
the NE xxx NE
sequence NE xxx NE
requirements NE xxx NE
for NE xxx NE
binding NE xxx NE
of NE xx NE
each NE xxx NE
of NE xx NE
these NE xxx NE
complexes NE xxx NE
. NE . NE

We NE Xx NE
found NE xxx NE
that NE xxx NE
expression NE xxx NE
of NE xx NE
a NE x NE
constitutively NE xxx NE
active NE xxx NE
form NE xxx NE
of NE xx NE
calcineurin G#protein_molecule xxx G#protein_molecule
could NE xxx NE
substitute NE xxx NE
for NE xxx NE
Ca2+ G#other_organic_compound_B Xxd+ G#other_organic_compound_B
ionophore G#other_organic_compound_E xxx G#other_organic_compound_E
and NE xxx NE
synergize NE xxx NE
with NE xxx NE
PMA G#other_organic_compound XXX G#other_organic_compound
to NE xx NE
activate NE xxx NE
the NE xxx NE
GM-CSF G#DNA_domain_or_region_B XX-XXX G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
and NE xxx NE
conversely NE xxx NE
that NE xxx NE
mutant-activated G#protein_molecule_B xxx-xxx G#protein_molecule_B
Ras G#protein_molecule_E Xxx G#protein_molecule_E
could NE xxx NE
substitute NE xxx NE
for NE xxx NE
PMA G#other_organic_compound XXX G#other_organic_compound
and NE xxx NE
cooperate NE xxx NE
with NE xxx NE
Ca2+ G#other_organic_compound_B Xxd+ G#other_organic_compound_B
ionophore G#other_organic_compound_E xxx G#other_organic_compound_E
. NE . NE

Co-expression NE Xx-xxx NE
of NE xx NE
Ras G#protein_molecule Xxx G#protein_molecule
and NE xxx NE
calcineurin G#protein_molecule xxx G#protein_molecule
, NE , NE
however NE xxx NE
, NE , NE
did NE xxx NE
not NE xxx NE
activate NE xxx NE
the NE xxx NE
GM-CSF G#DNA_domain_or_region_B XX-XXX G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
but NE xxx NE
required NE xxx NE
the NE xxx NE
additional NE xxx NE
expression NE xxx NE
of NE xx NE
NF-kappa G#protein_subunit_B XX-xxx G#protein_subunit_B
B G#protein_subunit_M X G#protein_subunit_M
p65 G#protein_subunit_E xdd G#protein_subunit_E
. NE . NE

These NE Xxxx NE
results NE xxx NE
imply NE xxx NE
that NE xxx NE
at NE xx NE
least NE xxx NE
three NE xxx NE
signals NE xxx NE
are NE xxx NE
required NE xxx NE
to NE xx NE
activate NE xxx NE
the NE xxx NE
GM-CSF G#DNA_domain_or_region_B XX-XXX G#DNA_domain_or_region_B
proximal G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
and NE xxx NE
that NE xxx NE
the NE xxx NE
signals NE xxx NE
impinge NE xxx NE
on NE xx NE
distinct NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
that NE xxx NE
bind NE xxx NE
to NE xx NE
the NE xxx NE
hCLEO G#DNA_domain_or_region_B xXXXX G#DNA_domain_or_region_B
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
NF-kappa G#DNA_domain_or_region_M XX-xxx G#DNA_domain_or_region_M
B G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
regions G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
the NE xxx NE
promoter G#DNA_domain_or_region xxx G#DNA_domain_or_region
. NE . NE

IL-10 NE XX-dd NE
induces NE xxx NE
the NE xxx NE
tyrosine G#other_name_B xxx G#other_name_B
phosphorylation G#other_name_E xxx G#other_name_E
of NE xx NE
tyk2 G#protein_molecule xxxd G#protein_molecule
and NE xxx NE
Jak1 G#protein_molecule Xxxd G#protein_molecule
and NE xxx NE
the NE xxx NE
differential NE xxx NE
assembly NE xxx NE
of NE xx NE
STAT1 G#protein_molecule_B XXXXd G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
and NE xxx NE
STAT3 NE XXXXd NE
complexes NE xxx NE
in NE xx NE
human NE xxx NE
T NE X NE
cells NE xxx NE
and NE xxx NE
monocytes NE xxx NE
. NE . NE

IL-10 G#protein_molecule XX-dd G#protein_molecule
affects NE xxx NE
monocytes G#cell_type xxx G#cell_type
and NE xxx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
by NE xx NE
driving NE xxx NE
the NE xxx NE
progression NE xxx NE
of NE xx NE
immune G#other_name_B xxx G#other_name_B
responsiveness G#other_name_E xxx G#other_name_E
such NE xxx NE
that NE xxx NE
Th2 G#other_name_B Xxd G#other_name_B
lymphocyte-mediated G#other_name_M xxx-xxx G#other_name_M
effects G#other_name_E xxx G#other_name_E
predominate NE xxx NE
. NE . NE

In NE Xx NE
this NE xxx NE
report NE xxx NE
, NE , NE
we NE xx NE
show NE xxx NE
that NE xxx NE
in NE xx NE
monocytes G#cell_type xxx G#cell_type
and NE xxx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
IL-10 NE XX-dd NE
stimulates NE xxx NE
tyrosine G#other_name_B xxx G#other_name_B
phosphorylation G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
signal G#protein_family_or_group_B xxx G#protein_family_or_group_B
transducers G#protein_family_or_group_E xxx G#protein_family_or_group_E
and NE xxx NE
activators NE xxx NE
of NE xx NE
transcription NE xxx NE
, NE , NE
STAT1 G#protein_molecule_B XXXXd G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
and NE xxx NE
STAT3 G#protein_molecule XXXXd G#protein_molecule
, NE , NE
in NE xx NE
a NE x NE
differential NE xxx NE
manner NE xxx NE
such NE xxx NE
that NE xxx NE
the NE xxx NE
relative NE xxx NE
formation NE xxx NE
of NE xx NE
homo- NE xxx- NE
and NE xxx NE
homodimer G#protein_family_or_group_B xxx G#protein_family_or_group_B
and G#protein_family_or_group_M xxx G#protein_family_or_group_M
heterodimer G#protein_family_or_group_E xxx G#protein_family_or_group_E

Moreover NE Xxxx NE
, NE , NE
monocytes G#cell_type xxx G#cell_type
express NE xxx NE
a NE x NE
novel NE xxx NE
IL-10 NE XX-dd NE
-stimulated NE -xxx NE
STAT NE XXXX NE
protein NE xxx NE
with NE xxx NE
an NE xx NE
M(r) NE X(x) NE
of NE xx NE
70 NE dd NE
kDa NE xXx NE
that NE xxx NE
is NE xx NE
recognized NE xxx NE
by NE xx NE
the NE xxx NE
anti- NE xxx- NE
STAT3 NE XXXXd NE
Ab NE Xx NE
but NE xxx NE
is NE xx NE
not NE xxx NE
observed NE xxx NE
in NE xx NE
T NE X NE
cells NE xxx NE
. NE . NE

IL-10 G#protein_molecule XX-dd G#protein_molecule
treatment NE xxx NE
of NE xx NE
both NE xxx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
and NE xxx NE
monocytes G#cell_type xxx G#cell_type
results NE xxx NE
in NE xx NE
the NE xxx NE
ligand-induced G#other_name_B xxx-xxx G#other_name_B
tyrosine G#other_name_M xxx G#other_name_M
phosphorylation G#other_name_E xxx G#other_name_E
of NE xx NE
tyk2 G#protein_molecule xxxd G#protein_molecule
and NE xxx NE
Jak1 G#protein_molecule Xxxd G#protein_molecule
, NE , NE
but NE xxx NE
not NE xxx NE
Jak2 G#protein_molecule Xxxd G#protein_molecule
or NE xx NE
Jak3 G#protein_molecule Xxxd G#protein_molecule
. NE . NE

Selective NE Xxxx NE
modulation NE xxx NE
of NE xx NE
immune G#other_name_B xxx G#other_name_B
responsiveness G#other_name_E xxx G#other_name_E
by NE xx NE
IL-10 G#protein_molecule XX-dd G#protein_molecule
in NE xx NE
cells NE xxx NE
such NE xxx NE
as NE xx NE
monocytes G#cell_type xxx G#cell_type
and NE xxx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
may NE xxx NE
result NE xxx NE
in NE xx NE
part NE xxx NE
from NE xxx NE
the NE xxx NE
differential G#other_name_B xxx G#other_name_B
activation G#other_name_E xxx G#other_name_E
of NE xx NE
STAT G#protein_family_or_group_B XXXX G#protein_family_or_group_B
protein G#protein_family_or_group_M xxx G#protein_family_or_group_M
pairs G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Use NE Xxx NE
of NE xx NE
new NE xxx NE
biologic G#other_name_B xxx G#other_name_B
markers G#other_name_E xxx G#other_name_E
in NE xx NE
the NE xxx NE
ovulation G#other_name_B xxx G#other_name_B
induction G#other_name_E xxx G#other_name_E
. NE . NE

Biological G#other_name_B Xxxx G#other_name_B
markers G#other_name_M xxx G#other_name_M
of G#other_name_M xx G#other_name_M
ovulation G#other_name_E xxx G#other_name_E
, NE , NE
after NE xxx NE
a NE x NE
great NE xxx NE
in NE xx NE
the NE xxx NE
past NE xxx NE
, NE , NE
have NE xxx NE
been NE xxx NE
fallen NE xxx NE
into NE xxx NE
disuse NE xxx NE
for NE xxx NE
the NE xxx NE
large NE xxx NE
diffusion NE xxx NE
of NE xx NE
biochemical NE xxx NE
and NE xxx NE
biophysical NE xxx NE
ones NE xxx NE
. NE . NE

However NE Xxxx NE
, NE , NE
the NE xxx NE
real NE xxx NE
effect NE xxx NE
of NE xx NE
hormones G#other_organic_compound xxx G#other_organic_compound
involved NE xxx NE
in NE xx NE
ovulation G#other_name xxx G#other_name
is NE xx NE
expressed NE xxx NE
by NE xx NE
biological G#other_name_B xxx G#other_name_B
modifications G#other_name_E xxx G#other_name_E
on NE xx NE
target G#cell_type_B xxx G#cell_type_B
tissues G#cell_type_E xxx G#cell_type_E
. NE . NE

To NE Xx NE
explore NE xxx NE
the NE xxx NE
modifications NE xxx NE
of NE xx NE
not NE xxx NE
reproductive NE xxx NE
target NE xxx NE
tissues NE xxx NE
as NE xx NE
ovulation NE xxx NE
markers NE xxx NE
we NE xx NE
studied NE xxx NE
the NE xxx NE
behaviour NE xxx NE
of NE xx NE
Albuminemia G#other_name Xxxx G#other_name
, NE , NE
Platelet G#protein_molecule_B Xxxx G#protein_molecule_B
Factor G#protein_molecule_M Xxxx G#protein_molecule_M
IV G#protein_molecule_E XX G#protein_molecule_E
(as NE (xx NE
indicator NE xxx NE
of NE xx NE
Platelet G#other_name_B Xxxx G#other_name_B
Aggregation G#other_name_E Xxxx G#other_name_E
) NE ) NE
, NE , NE
Type G#protein_family_or_group_B Xxxx G#protein_family_or_group_B
II G#protein_family_or_group_M XX G#protein_family_or_group_M
estrogenic G#protein_family_or_group_M xxx G#protein_family_or_group_M
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
in NE xx NE
42 NE dd NE
ovulation G#multi_cell_B xxx G#multi_cell_B
induced G#multi_cell_M xxx G#multi_cell_M
women G#multi_cell_E xxx G#multi_cell_E
, NE , NE
undergoing NE xxx NE
our NE xxx NE
observation NE xxx NE
. NE . NE

33 NE dd NE
of NE xx NE
them NE xxx NE
had NE xxx NE
ovulation G#other_name xxx G#other_name
and NE xxx NE
9 NE d NE
developed NE xxx NE
a NE x NE
LUF G#other_name_B XXX G#other_name_B
syndrome G#other_name_E xxx G#other_name_E
, NE , NE
constituting NE xxx NE
two NE xxx NE
biological NE xxx NE
models NE xxx NE
of NE xx NE
an NE xx NE
opposite NE xxx NE
situation NE xxx NE
for NE xxx NE
the NE xxx NE
three NE xxx NE
markers NE xxx NE
observed NE xxx NE
. NE . NE

All NE Xxx NE
the NE xxx NE
markers NE xxx NE
considered NE xxx NE
were NE xxx NE
sufficiently NE xxx NE
sensitive NE xxx NE
, NE , NE
but NE xxx NE
among NE xxx NE
them NE xxx NE
, NE , NE
Platelet G#protein_molecule_B Xxxx G#protein_molecule_B
Factor G#protein_molecule_M Xxxx G#protein_molecule_M
IV G#protein_molecule_E XX G#protein_molecule_E
was NE xxx NE
the NE xxx NE
most NE xxx NE
reliable NE xxx NE
to NE xx NE
the NE xxx NE
hormonal G#other_name_B xxx G#other_name_B
ovulatory G#other_name_M xxx G#other_name_M
situation G#other_name_E xxx G#other_name_E
. NE . NE

Abnormal NE Xxxx NE
regulation NE xxx NE
of NE xx NE
the NE xxx NE
IL-2 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
lpr NE xxx NE
CD4-CD8- G#cell_line_B XXd-XXd- G#cell_line_B
T G#cell_line_M X G#cell_line_M
lymphocytes G#cell_line_E xxx G#cell_line_E
results NE xxx NE
in NE xx NE
constitutive G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
of NE xx NE
a NE x NE
novel NE xxx NE
nuclear NE xxx NE
factor NE xxx NE
of NE xx NE
activated NE xxx NE
T NE X NE
cells NE xxx NE
-binding NE -xxx NE
factor NE xxx NE
. NE . NE

The NE Xxx NE
inert NE xxx NE
quality NE xxx NE
of NE xx NE
MRL-Ipr/Ipr G#cell_line_B XXX-Xxx/Xxx G#cell_line_B
(Ipr) G#cell_line_M (Xxx) G#cell_line_M
peripheral G#cell_line_M xxx G#cell_line_M
CD4-CD8- G#cell_line_M XXd-XXd- G#cell_line_M
(CD4-8-) G#cell_line_M (XXd-d-) G#cell_line_M
T G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
manifests NE xxx NE
primarily NE xxx NE
as NE xx NE
an NE xx NE
inability NE xxx NE
to NE xx NE
proliferate NE xxx NE
or NE xx NE
produce NE xxx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
in NE xx NE
response NE xxx NE
to NE xx NE
TCR G#protein_family_or_group XXX G#protein_family_or_group
or NE xx NE
mitogenic G#other_name_B xxx G#other_name_B
stimulation G#other_name_E xxx G#other_name_E
. NE . NE

Yet NE Xxx NE
these NE xxx NE
same NE xxx NE
cells NE xxx NE
do NE xx NE
initiate NE xxx NE
early NE xxx NE
TCR NE XXX NE
-mediated NE -xxx NE
signaling NE xxx NE
events NE xxx NE
, NE , NE
such NE xxx NE
as NE xx NE
generation NE xxx NE
of NE xx NE
inositol NE xxx NE
phosphates NE xxx NE
and NE xxx NE
increased NE xxx NE
intracellular NE xxx NE
calcium NE xxx NE
. NE . NE

They NE Xxxx NE
also NE xxx NE
display NE xxx NE
constitutively NE xxx NE
high NE xxx NE
levels NE xxx NE
of NE xx NE
p59fyn G#protein_molecule xddxxx G#protein_molecule
and NE xxx NE
CD3 G#protein_molecule_B XXd G#protein_molecule_B
zeta G#protein_molecule_E xxx G#protein_molecule_E
tyrosine G#other_name_B xxx G#other_name_B
phosphorylation G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
generation NE xxx NE
of NE xx NE
second G#other_organic_compound_B xxx G#other_organic_compound_B
messengers G#other_organic_compound_E xxx G#other_organic_compound_E
in NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
normally NE xxx NE
leads NE xxx NE
to NE xx NE
downstream G#other_name_B xxx G#other_name_B
signaling G#other_name_E xxx G#other_name_E
that NE xxx NE
results NE xxx NE
in NE xx NE
transcriptional G#other_name_B xxx G#other_name_B
activation G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
IL-2 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

We NE Xx NE
, NE , NE
therefore NE xxx NE
, NE , NE
compared NE xxx NE
the NE xxx NE
activation NE xxx NE
state NE xxx NE
of NE xx NE
the NE xxx NE
IL-2 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
freshly NE xxx NE
isolated NE xxx NE
and NE xxx NE
stimulated NE xxx NE
Ipr G#cell_line_B Xxx G#cell_line_B
CD4-8- G#cell_line_M XXd-d- G#cell_line_M
T G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
with NE xxx NE
that NE xxx NE
of NE xx NE
normal G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
lymphocytes G#cell_type_E xxx G#cell_type_E
. NE . NE

Levels NE Xxxx NE
of NE xx NE
the NE xxx NE
octamer G#polynucleotide xxx G#polynucleotide
, NE , NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
( NE ( NE
p50-p65 G#protein_molecule_B xdd-xdd G#protein_molecule_B
heterodimer G#protein_molecule_E xxx G#protein_molecule_E
) NE ) NE
, NE , NE
and NE xxx NE
AP-1 G#protein_family_or_group_B XX-d G#protein_family_or_group_B
transcriptional G#protein_family_or_group_M xxx G#protein_family_or_group_M
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
are NE xxx NE
constitutively NE xxx NE
elevated NE xxx NE
in NE xx NE
freshly NE xxx NE
isolated NE xxx NE
Ipr G#cell_line_B Xxx G#cell_line_B
CD4-8- G#cell_line_M XXd-d- G#cell_line_M
T G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
consistent NE xxx NE
with NE xxx NE
the NE xxx NE
activated NE xxx NE
phenotype NE xxx NE
of NE xx NE
these NE xxx NE
cells NE xxx NE
. NE . NE

Upon NE Xxxx NE
stimulation NE xxx NE
with NE xxx NE
mitogens G#other_organic_compound xxx G#other_organic_compound
, NE , NE
formation NE xxx NE
of NE xx NE
the NE xxx NE
transactivating NE xxx NE
complex NE xxx NE
, NE , NE
nuclear G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_M xxx G#protein_family_or_group_M
of G#protein_family_or_group_M xx G#protein_family_or_group_M
activated G#protein_family_or_group_M xxx G#protein_family_or_group_M
T G#protein_family_or_group_M X G#protein_family_or_group_M
cells G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
NF-AT G#protein_family_or_group XX-XX G#protein_family_or_group
) NE ) NE
, NE , NE
occurs NE xxx NE
with NE xxx NE
normal NE xxx NE
kinetics NE xxx NE
in NE xx NE
Ipr G#cell_line_B Xxx G#cell_line_B
CD4-8- G#cell_line_M XXd-d- G#cell_line_M
T G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

Yet NE Xxx NE
, NE , NE
the NE xxx NE
levels NE xxx NE
of NE xx NE
the NE xxx NE
activating NE xxx NE
NF-AT G#protein_complex_B XX-XX G#protein_complex_B
complex G#protein_complex_E xxx G#protein_complex_E
never NE xxx NE
reach NE xxx NE
those NE xxx NE
observed NE xxx NE
in NE xx NE
similarly NE xxx NE
stimulated NE xxx NE
normal NE xxx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
nuclear G#cell_component_B xxx G#cell_component_B
extracts G#cell_component_E xxx G#cell_component_E
from NE xxx NE
Ipr G#cell_line_B Xxx G#cell_line_B
CD4-8- G#cell_line_M XXd-d- G#cell_line_M
T G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
display NE xxx NE
high NE xxx NE
levels NE xxx NE
of NE xx NE
a NE x NE
novel G#other_name_B xxx G#other_name_B
specific G#other_name_M xxx G#other_name_M
binding G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
at NE xx NE
the NE xxx NE
NF-AT G#DNA_domain_or_region_B XX-XX G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
which NE xxx NE
is NE xx NE
present NE xxx NE
at NE xx NE
much NE xxx NE
lower NE xxx NE
levels NE xxx NE
in NE xx NE
freshly NE xxx NE
isolated NE xxx NE
normal G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
lymphocytes G#cell_type_E xxx G#cell_type_E
. NE . NE

Upon NE Xxxx NE
mitogenic G#other_name_B xxx G#other_name_B
stimulation G#other_name_E xxx G#other_name_E
, NE , NE
the NE xxx NE
binding NE xxx NE
activity NE xxx NE
of NE xx NE
the NE xxx NE
novel NE xxx NE
NF-AT NE XX-XX NE
-binding NE -xxx NE
factor NE xxx NE
is NE xx NE
rapidly NE xxx NE
down-regulated NE xxx-xxx NE
in NE xx NE
normal NE xxx NE
T NE X NE
cells NE xxx NE
, NE , NE
but NE xxx NE
persists NE xxx NE
at NE xx NE
high NE xxx NE
levels NE xxx NE
in NE xx NE
Ipr NE Xxx NE
CD4-8- NE XXd-d- NE
T NE X NE
cells NE xxx NE
. NE . NE

These NE Xxxx NE
two NE xxx NE
abnormalities NE xxx NE
at NE xx NE
the NE xxx NE
NF-AT G#DNA_domain_or_region_B XX-XX G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
provide NE xxx NE
a NE x NE
potential NE xxx NE
mechanism NE xxx NE
to NE xx NE
account NE xxx NE
for NE xxx NE
the NE xxx NE
defect NE xxx NE
in NE xx NE
IL-2 G#other_name_B XX-d G#other_name_B
production G#other_name_E xxx G#other_name_E
from NE xxx NE
Ipr G#cell_line_B Xxx G#cell_line_B
CD4-8- G#cell_line_M XXd-d- G#cell_line_M
T G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

Cross-linking NE Xxxx-xxx NE
of NE xx NE
CD30 G#protein_molecule XXdd G#protein_molecule
induces NE xxx NE
HIV G#other_name_B XXX G#other_name_B
expression G#other_name_E xxx G#other_name_E
in NE xx NE
chronically NE xxx NE
infected NE xxx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

CD30 G#protein_molecule XXdd G#protein_molecule
, NE , NE
a NE x NE
member NE xxx NE
of NE xx NE
the NE xxx NE
tumor NE xxx NE
necrosis NE xxx NE
factor NE xxx NE
(TNF) NE (XXX) NE
receptor NE xxx NE
family NE xxx NE
, NE , NE
is NE xx NE
expressed NE xxx NE
constitutively NE xxx NE
on NE xx NE
the NE xxx NE
surface NE xxx NE
of NE xx NE
the NE xxx NE
human NE xxx NE
T NE X NE
cell NE xxx NE
line NE xxx NE
ACH-2 NE XXX-d NE
, NE , NE
which NE xxx NE
is NE xx NE
chronically NE xxx NE
infected NE xxx NE
with NE xxx NE
human NE xxx NE
immunodeficiency NE xxx NE
virus NE xxx NE
type-1 NE xxx-d NE
( NE ( NE
HIV G#virus XXX G#virus
)-1 NE )-d NE
. NE . NE

We NE Xx NE
demonstrate NE xxx NE
that NE xxx NE
cross-linking NE xxx-xxx NE
CD30 G#protein_molecule XXdd G#protein_molecule
with NE xxx NE
an NE xx NE
anti- NE xxx- NE
CD30 G#protein_molecule XXdd G#protein_molecule
-specific NE -xxx NE
monoclonal NE xxx NE
antibody NE xxx NE
, NE , NE
which NE xxx NE
mimics NE xxx NE
the NE xxx NE
described NE xxx NE
biological NE xxx NE
activities NE xxx NE
of NE xx NE
the NE xxx NE
CD30 NE XXdd NE
ligand NE xxx NE
( NE ( NE
CD30L NE XXddX NE
) NE ) NE
, NE , NE
results NE xxx NE
in NE xx NE
HIV NE XXX NE
expression NE xxx NE
. NE . NE

CD30 G#protein_molecule XXdd G#protein_molecule
cross-linking NE xxx-xxx NE
does NE xxx NE
not NE xxx NE
alter NE xxx NE
proliferation NE xxx NE
of NE xx NE
ACH-2 G#cell_line_B XXX-d G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
and NE xxx NE
the NE xxx NE
induction NE xxx NE
of NE xx NE
HIV G#other_name_B XXX G#other_name_B
expression G#other_name_E xxx G#other_name_E
is NE xx NE
not NE xxx NE
mediated NE xxx NE
by NE xx NE
endogenous NE xxx NE
TNF G#protein_molecule_B XXX G#protein_molecule_B
alpha/beta G#protein_molecule_E xxx/xxx G#protein_molecule_E
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
cross-linking NE xxx-xxx NE
of NE xx NE
CD30 G#protein_molecule XXdd G#protein_molecule
leads NE xxx NE
to NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
activation NE xxx NE
and NE xxx NE
enhanced NE xxx NE
HIV G#other_name_B XXX G#other_name_B
transcription G#other_name_E xxx G#other_name_E
. NE . NE

Thus NE Xxxx NE
, NE , NE
CD30 NE XXdd NE
-CD30L NE -XXddX NE
interactions NE xxx NE
mediate NE xxx NE
the NE xxx NE
induction NE xxx NE
of NE xx NE
HIV NE XXX NE
expression NE xxx NE
by NE xx NE
a NE x NE
kappa NE xxx NE
B-dependent NE X-xxx NE
pathway NE xxx NE
that NE xxx NE
is NE xx NE
independent NE xxx NE
of NE xx NE
TNF NE XXX NE
. NE . NE

This NE Xxxx NE
mechanism NE xxx NE
may NE xxx NE
be NE xx NE
important NE xxx NE
in NE xx NE
the NE xxx NE
activation NE xxx NE
of NE xx NE
HIV G#other_name_B XXX G#other_name_B
expression G#other_name_E xxx G#other_name_E
from NE xxx NE
latently NE xxx NE
infected NE xxx NE
CD4+ G#cell_line_B XXd+ G#cell_line_B
T G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
especially NE xxx NE
in NE xx NE
lymphoid G#body_part_B xxx G#body_part_B
organs G#body_part_E xxx G#body_part_E
where NE xxx NE
cell G#other_name_B xxx G#other_name_B
to G#other_name_M xx G#other_name_M
cell G#other_name_M xxx G#other_name_M
contact G#other_name_E xxx G#other_name_E
is NE xx NE
conducive NE xxx NE
to NE xx NE
receptor-ligand G#other_name_B xxx-xxx G#other_name_B
interactions G#other_name_E xxx G#other_name_E
. NE . NE

Human G#other_name_B Xxxx G#other_name_B
MHC G#other_name_M XXX G#other_name_M
class G#other_name_M xxx G#other_name_M
II G#other_name_M XX G#other_name_M
gene G#other_name_M xxx G#other_name_M
transcription G#other_name_E xxx G#other_name_E
directed NE xxx NE
by NE xx NE
the NE xxx NE
carboxyl G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
terminus G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
of NE xx NE
CIITA G#DNA_domain_or_region XXXXX G#DNA_domain_or_region
, NE , NE
one NE xxx NE
of NE xx NE
the NE xxx NE
defective G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
in NE xx NE
type NE xxx NE
II G#other_name_B XX G#other_name_B
MHC G#other_name_M XXX G#other_name_M
combined G#other_name_M xxx G#other_name_M
immune G#other_name_M xxx G#other_name_M
deficiency G#other_name_E xxx G#other_name_E
. NE . NE

Type G#other_name_B Xxxx G#other_name_B
II G#other_name_M XX G#other_name_M
major G#other_name_M xxx G#other_name_M
histocompatibility G#other_name_M xxx G#other_name_M
complex G#other_name_M xxx G#other_name_M
combined G#other_name_M xxx G#other_name_M
immune G#other_name_M xxx G#other_name_M
deficiency G#other_name_E xxx G#other_name_E
( NE ( NE
type G#other_name_B xxx G#other_name_B
II G#other_name_M XX G#other_name_M
MHC G#other_name_M XXX G#other_name_M
CID G#other_name_E XXX G#other_name_E
or NE xx NE
bare G#other_name_B xxx G#other_name_B
lymphocyte G#other_name_M xxx G#other_name_M
syndrome G#other_name_E xxx G#other_name_E
) NE ) NE
is NE xx NE
a NE x NE
congenital NE xxx NE
immunodeficiency NE xxx NE
disease NE xxx NE
characterized NE xxx NE
by NE xx NE
absent NE xxx NE
MHC G#other_name_B XXX G#other_name_B
class G#other_name_M xxx G#other_name_M
II G#other_name_M XX G#other_name_M
expression G#other_name_E xxx G#other_name_E
. NE . NE

Four NE Xxxx NE
distinct NE xxx NE
complementation NE xxx NE
groups NE xxx NE
have NE xxx NE
been NE xxx NE
identified NE xxx NE
. NE . NE

Recently NE Xxxx NE
, NE , NE
the NE xxx NE
defective G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
gene G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
in NE xx NE
group G#other_name_B xxx G#other_name_B
II G#other_name_M XX G#other_name_M
type G#other_name_M xxx G#other_name_M
II G#other_name_M XX G#other_name_M
MHC G#other_name_M XXX G#other_name_M
CID G#other_name_E XXX G#other_name_E
has NE xxx NE
been NE xxx NE
isolated NE xxx NE
and NE xxx NE
termed NE xxx NE
CIITA G#DNA_domain_or_region XXXXX G#DNA_domain_or_region
. NE . NE

Here NE Xxxx NE
, NE , NE
we NE xx NE
demonstrate NE xxx NE
that NE xxx NE
CIITA G#DNA_domain_or_region XXXXX G#DNA_domain_or_region
is NE xx NE
an NE xx NE
MHC G#DNA_family_or_group_B XXX G#DNA_family_or_group_B
class G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
II G#DNA_family_or_group_M XX G#DNA_family_or_group_M
gene-specific G#DNA_family_or_group_M xxx-xxx G#DNA_family_or_group_M
transcription G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
activator G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
. NE . NE

The NE Xxx NE
transcription G#other_name_B xxx G#other_name_B
activation G#other_name_M xxx G#other_name_M
function G#other_name_E xxx G#other_name_E
is NE xx NE
provided NE xxx NE
by NE xx NE
the NE xxx NE
N-terminal G#protein_domain_or_region_B X-xxx G#protein_domain_or_region_B
acidic G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
( NE ( NE
amino G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
acids G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
26-137 G#protein_domain_or_region_E dd-ddd G#protein_domain_or_region_E
) NE ) NE
, NE , NE
which NE xxx NE
is NE xx NE
experimentally NE xxx NE
exchangeable NE xxx NE
with NE xxx NE
a NE x NE
heterologous G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
viral G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
transcription-activating G#protein_domain_or_region_M xxx-xxx G#protein_domain_or_region_M
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
. NE . NE

The NE Xxx NE
specificity NE xxx NE
of NE xx NE
CIITA G#protein_molecule XXXXX G#protein_molecule
for NE xxx NE
three NE xxx NE
major NE xxx NE
MHC G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
class G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
II G#DNA_domain_or_region_M XX G#DNA_domain_or_region_M
genes G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
DR G#DNA_domain_or_region XX G#DNA_domain_or_region
, NE , NE
DQ G#DNA_domain_or_region XX G#DNA_domain_or_region
and NE xxx NE
DP G#DNA_domain_or_region XX G#DNA_domain_or_region
, NE , NE
is NE xx NE
mediated NE xxx NE
by NE xx NE
its NE xxx NE
remaining NE xxx NE
C-terminal G#protein_domain_or_region_B X-xxx G#protein_domain_or_region_B
residues G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
( NE ( NE
amino G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
acids G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
317-1130 G#protein_domain_or_region_E ddd-dddd G#protein_domain_or_region_E
) NE ) NE
. NE . NE

The NE Xxx NE
transactivation NE xxx NE
of NE xx NE
multiple G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
cis G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
elements G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
especially NE xxx NE
S G#DNA_domain_or_region X G#DNA_domain_or_region
and NE xxx NE
X2 G#DNA_domain_or_region Xd G#DNA_domain_or_region
, NE , NE
of NE xx NE
the NE xxx NE
DR G#DNA_domain_or_region_B XX G#DNA_domain_or_region_B
alpha G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
proximal G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
group G#cell_line_B xxx G#cell_line_B
II G#cell_line_M XX G#cell_line_M
CID G#cell_line_M XXX G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
is NE xx NE
CIITA G#protein_molecule XXXXX G#protein_molecule
dependent NE xxx NE
. NE . NE

Since NE Xxxx NE
CIITA G#other_name_B XXXXX G#other_name_B
overexpression G#other_name_E xxx G#other_name_E
in NE xx NE
normal G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
did NE xxx NE
not NE xxx NE
increase NE xxx NE
class G#other_name_B xxx G#other_name_B
II G#other_name_M XX G#other_name_M
expression G#other_name_E xxx G#other_name_E
, NE , NE
we NE xx NE
propose NE xxx NE
that NE xxx NE
initiation NE xxx NE
of NE xx NE
CIITA G#other_name_B XXXXX G#other_name_B
expression G#other_name_E xxx G#other_name_E
serves NE xxx NE
as NE xx NE
the NE xxx NE
on-off NE xx-xxx NE
switch NE xxx NE
, NE , NE
while NE xxx NE
availability NE xxx NE
of NE xx NE
downstream G#other_name_B xxx G#other_name_B
interactor G#other_name_E xxx G#other_name_E
(s) NE (x) NE
limits NE xxx NE
transcription G#other_name xxx G#other_name
. NE . NE

Monocyte NE Xxxx NE
tethering NE xxx NE
by NE xx NE
P-selectin G#protein_molecule X-xxx G#protein_molecule
regulates NE xxx NE
monocyte G#protein_molecule_B xxx G#protein_molecule_B
chemotactic G#protein_molecule_M xxx G#protein_molecule_M
protein-1 G#protein_molecule_E xxx-d G#protein_molecule_E
and NE xxx NE
tumor G#other_name_B xxx G#other_name_B
necrosis G#other_name_M xxx G#other_name_M
factor-alpha G#other_name_M xxx-xxx G#other_name_M
secretion G#other_name_E xxx G#other_name_E
. NE . NE

Signal G#other_name_B Xxxx G#other_name_B
integration G#other_name_E xxx G#other_name_E
and NE xxx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
translocation G#other_name_E xxx G#other_name_E
[see NE [xxx NE
comments] NE xxx] NE

Adhesion G#protein_family_or_group_B Xxxx G#protein_family_or_group_B
molecules G#protein_family_or_group_E xxx G#protein_family_or_group_E
that NE xxx NE
tether NE xxx NE
circulating G#cell_type_B xxx G#cell_type_B
leukocytes G#cell_type_E xxx G#cell_type_E
to NE xx NE
endothelial G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
may NE xxx NE
also NE xxx NE
transduce NE xxx NE
or NE xx NE
modulate NE xxx NE
outside-in NE xxx-xx NE
signals NE xxx NE
for NE xxx NE
cellular G#other_name_B xxx G#other_name_B
activation G#other_name_E xxx G#other_name_E
, NE , NE
providing NE xxx NE
an NE xx NE
initial NE xxx NE
regulatory NE xxx NE
point NE xxx NE
in NE xx NE
the NE xxx NE
inflammatory G#other_name_B xxx G#other_name_B
response G#other_name_E xxx G#other_name_E
. NE . NE

Adhesion NE Xxxx NE
of NE xx NE
human G#cell_type_B xxx G#cell_type_B
monocytes G#cell_type_E xxx G#cell_type_E
to NE xx NE
P-selectin G#protein_molecule X-xxx G#protein_molecule
, NE , NE
the NE xxx NE
most NE xxx NE
rapidly NE xxx NE
expressed NE xxx NE
endothelial G#protein_molecule_B xxx G#protein_molecule_B
tethering G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_E xxx G#protein_molecule_E
, NE , NE
increased NE xxx NE
the NE xxx NE
secretion NE xxx NE
of NE xx NE
monocyte G#protein_molecule_B xxx G#protein_molecule_B
chemotactic G#protein_molecule_M xxx G#protein_molecule_M
protein-1 G#protein_molecule_E xxx-d G#protein_molecule_E
( NE ( NE
MCP-1 G#protein_molecule XXX-d G#protein_molecule
) NE ) NE
and NE xxx NE
tumor G#protein_molecule_B xxx G#protein_molecule_B
necrosis G#protein_molecule_M xxx G#protein_molecule_M
factor-alpha G#protein_molecule_E xxx-xxx G#protein_molecule_E
( NE ( NE
TNF-alpha G#protein_molecule XXX-xxx G#protein_molecule
) NE ) NE
by NE xx NE
the NE xxx NE
leukocytes G#cell_type xxx G#cell_type
when NE xxx NE
they NE xxx NE
were NE xxx NE
stimulated NE xxx NE
with NE xxx NE
platelet-activating G#protein_molecule_B xxx-xxx G#protein_molecule_B
factor G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

Increased NE Xxxx NE
cytokine NE xxx NE
secretion NE xxx NE
was NE xxx NE
specifically NE xxx NE
inhibited NE xxx NE
by NE xx NE
G1 G#protein_molecule Xd G#protein_molecule
, NE , NE
an NE xx NE
anti- NE xxx- NE
P-selectin NE X-xxx NE
mAb NE xXx NE
that NE xxx NE
prevents NE xxx NE
P-selectin NE X-xxx NE
from NE xxx NE
binding NE xxx NE
to NE xx NE
its NE xxx NE
ligand NE xxx NE
( NE ( NE
P-selectin NE X-xxx NE
glycoprotein NE xxx NE
ligand-1 NE xxx-d NE
) NE ) NE
on NE xx NE
myeloid NE xxx NE
cells NE xxx NE
. NE . NE

Moreover NE Xxxx NE
, NE , NE
tethering NE xxx NE
by NE xx NE
P-selectin G#protein_molecule X-xxx G#protein_molecule
specifically NE xxx NE
enhanced NE xxx NE
nuclear G#other_name_B xxx G#other_name_B
translocation G#other_name_E xxx G#other_name_E
of NE xx NE
nuclear G#protein_molecule_B xxx G#protein_molecule_B
factor-kappa G#protein_molecule_M xxx-xxx G#protein_molecule_M
B G#protein_molecule_E X G#protein_molecule_E
( NE ( NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
) NE ) NE
, NE , NE
a NE x NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
required NE xxx NE
for NE xxx NE
expression NE xxx NE
of NE xx NE
MCP-1 G#protein_molecule XXX-d G#protein_molecule
, NE , NE
TNF-alpha G#protein_molecule XXX-xxx G#protein_molecule
, NE , NE
and NE xxx NE
other NE xxx NE
immediate-early G#DNA_family_or_group_B xxx-xxx G#DNA_family_or_group_B
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
. NE . NE

These NE Xxxx NE
results NE xxx NE
demonstrate NE xxx NE
that NE xxx NE
P-selectin G#protein_molecule X-xxx G#protein_molecule
, NE , NE
through NE xxx NE
its NE xxx NE
ligands NE xxx NE
on NE xx NE
monocytes G#cell_type xxx G#cell_type
, NE , NE
may NE xxx NE
locally NE xxx NE
regulate NE xxx NE
cytokine G#other_name_B xxx G#other_name_B
secretion G#other_name_E xxx G#other_name_E
in NE xx NE
inflamed G#tissue_B xxx G#tissue_B
tissues G#tissue_E xxx G#tissue_E
. NE . NE

Functional NE Xxxx NE
roles NE xxx NE
of NE xx NE
in G#DNA_family_or_group_B xx G#DNA_family_or_group_B
vivo G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
footprinted G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
DNA G#DNA_family_or_group_M XXX G#DNA_family_or_group_M
motifs G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
within NE xxx NE
an NE xx NE
alpha-globin G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
enhancer G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Erythroid G#other_name_B Xxxx G#other_name_B
lineage G#other_name_E xxx G#other_name_E
and NE xxx NE
developmental NE xxx NE
stage NE xxx NE
specificities NE xxx NE
. NE . NE

Transcriptional G#other_name_B Xxxx G#other_name_B
regulation G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
human G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
alpha-like G#DNA_family_or_group_M xxx-xxx G#DNA_family_or_group_M
globin G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
, NE , NE
embryonic G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
zeta G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
2 G#DNA_domain_or_region_E d G#DNA_domain_or_region_E
and NE xxx NE
adult G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
alpha G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
during NE xxx NE
erythroid G#other_name_B xxx G#other_name_B
development G#other_name_E xxx G#other_name_E
is NE xx NE
mediated NE xxx NE
by NE xx NE
a NE x NE
distal G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
enhancer G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
HS-40 G#DNA_domain_or_region XX-dd G#DNA_domain_or_region
. NE . NE

Previous NE Xxxx NE
protein-DNA NE xxx-XXX NE
binding NE xxx NE
studies NE xxx NE
have NE xxx NE
shown NE xxx NE
that NE xxx NE
HS-40 G#DNA_domain_or_region XX-dd G#DNA_domain_or_region
consists NE xxx NE
of NE xx NE
multiple NE xxx NE
nuclear G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
factor G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
binding G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
motifs G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
that NE xxx NE
are NE xxx NE
occupied NE xxx NE
in NE xx NE
vivo NE xxx NE
in NE xx NE
an NE xx NE
erythroid G#other_name_B xxx G#other_name_B
lineage-specific G#other_name_M xxx-xxx G#other_name_M
manner G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
developmental G#other_name_M xxx G#other_name_M
stage-specific G#other_name_M xxx-xxx G#other_name_M
manner G#other_name_E xxx G#other_name_E

We NE Xx NE
have NE xxx NE
systematically NE xxx NE
analyzed NE xxx NE
the NE xxx NE
functional NE xxx NE
roles NE xxx NE
of NE xx NE
these NE xxx NE
factor G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
motifs G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
HS-40 G#DNA_domain_or_region XX-dd G#DNA_domain_or_region
by NE xx NE
site-directed G#other_name_B xxx-xxx G#other_name_B
mutagenesis G#other_name_E xxx G#other_name_E
and NE xxx NE
transient G#other_name_B xxx G#other_name_B
expression G#other_name_M xxx G#other_name_M
assay G#other_name_E xxx G#other_name_E
in NE xx NE
erythroid G#cell_line_B xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
cultures G#cell_line_E xxx G#cell_line_E
. NE . NE

Three NE Xxxx NE
of NE xx NE
these NE xxx NE
HS-40 G#DNA_domain_or_region_B XX-dd G#DNA_domain_or_region_B
enhancer G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
motifs G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
5'NF-E2/AP1 G#DNA_domain_or_region d'XX-Xd/XXd G#DNA_domain_or_region
, NE , NE
GT G#DNA_domain_or_region_B XX G#DNA_domain_or_region_B
II G#DNA_domain_or_region_E XX G#DNA_domain_or_region_E
, NE , NE
and NE xxx NE
GATA-1(c) G#DNA_domain_or_region XXXX-d(x) G#DNA_domain_or_region
, NE , NE
positively NE xxx NE
regulate NE xxx NE
the NE xxx NE
zeta G#other_name_B xxx G#other_name_B
2-globin G#other_name_M d-xxx G#other_name_M
promoter G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
in NE xx NE
embryonic/fetal G#cell_line_B xxx/xxx G#cell_line_B
erythroid G#cell_line_M xxx G#cell_line_M
K562 G#cell_line_M Xddd G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
and NE xxx NE
the NE xxx NE
adult NE xxx NE
alpha NE xxx NE
-globin NE -xxx NE
promoter NE xxx NE
activity NE xxx NE
in NE xx NE
adult NE xxx NE
erythroid NE xxx NE
MEL NE XXX NE
cells NE xxx NE
. NE . NE

On NE Xx NE
the NE xxx NE
other NE xxx NE
hand NE xxx NE
, NE , NE
the NE xxx NE
3'NF-E2/AP1 G#DNA_domain_or_region_B d'XX-Xd/XXd G#DNA_domain_or_region_B
motif G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
is NE xx NE
able NE xxx NE
to NE xx NE
exert NE xxx NE
both NE xxx NE
positive NE xxx NE
and NE xxx NE
negative NE xxx NE
regulatory G#other_name_B xxx G#other_name_B
effects G#other_name_E xxx G#other_name_E
on NE xx NE
the NE xxx NE
zeta G#other_name_B xxx G#other_name_B
2-globin G#other_name_M d-xxx G#other_name_M
promoter G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
in NE xx NE
K562 G#cell_line_B Xddd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
and NE xxx NE
this NE xxx NE
dual NE xxx NE
function NE xxx NE
appears NE xxx NE
to NE xx NE
be NE xx NE
modulated NE xxx NE
through NE xxx NE
differential NE xxx NE
binding NE xxx NE
of NE xx NE
the NE xxx NE
ubiquitous G#protein_family_or_group_B xxx G#protein_family_or_group_B
AP1 G#protein_family_or_group_M XXd G#protein_family_or_group_M
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
and NE xxx NE
the NE xxx NE
erythroid-enriched G#protein_molecule_B xxx-xxx G#protein_molecule_B
NF-E2 G#protein_molecule_M XX-Xd G#protein_molecule_M
factor G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

Mutation NE Xxxx NE
in NE xx NE
the NE xxx NE
GATA-1(d) G#DNA_domain_or_region_B XXXX-d(x) G#DNA_domain_or_region_B
motif G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
which NE xxx NE
exhibits NE xxx NE
an NE xx NE
adult G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
erythroid-specific G#DNA_domain_or_region_M xxx-xxx G#DNA_domain_or_region_M
genomic G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
footprint G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
decreases NE xxx NE
the NE xxx NE
HS-40 G#DNA_domain_or_region_B XX-dd G#DNA_domain_or_region_B
enhancer G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
function NE xxx NE
in NE xx NE
dimethyl G#cell_line_B xxx G#cell_line_B
sulfoxide-induced G#cell_line_M xxx-xxx G#cell_line_M
MEL G#cell_line_M XXX G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
but NE xxx NE
not NE xxx NE
in NE xx NE
K562 G#cell_line_B Xddd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

These NE Xxxx NE
studies NE xxx NE
have NE xxx NE
defined NE xxx NE
the NE xxx NE
regulatory NE xxx NE
roles NE xxx NE
of NE xx NE
the NE xxx NE
different NE xxx NE
HS-40 G#DNA_domain_or_region_B XX-dd G#DNA_domain_or_region_B
motifs G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

The NE Xxx NE
remarkable NE xxx NE
correlation NE xxx NE
between NE xxx NE
genomic G#other_name_B xxx G#other_name_B
footprinting G#other_name_M xxx G#other_name_M
data G#other_name_E xxx G#other_name_E
and NE xxx NE
the NE xxx NE
mutagenesis G#other_name_B xxx G#other_name_B
results G#other_name_E xxx G#other_name_E
also NE xxx NE
suggests NE xxx NE
that NE xxx NE
the NE xxx NE
erythroid G#other_name_B xxx G#other_name_B
lineage-specific G#other_name_M xxx-xxx G#other_name_M
regulation G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
developmental G#other_name_M xxx G#other_name_M
stage-specific G#other_name_M xxx-xxx G#other_name_M
regulation G#other_name_E xxx G#other_name_E
of NE xx NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
alpha-like G#DNA_domain_or_region_M xxx-xxx G#DNA_domain_or_region_M
globin G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
promoters G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
is NE xx NE
indeed NE xxx NE
modulated NE xxx NE
by NE xx NE
stable NE xxx NE
binding NE xxx NE
of NE xx NE
specific G#protein_family_or_group_B xxx G#protein_family_or_group_B
nuclear G#protein_family_or_group_M xxx G#protein_family_or_group_M
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
in NE xx NE
vivo NE xxx NE
. NE . NE

Nitric NE Xxxx NE
oxide NE xxx NE
-stimulated NE -xxx NE
guanine NE xxx NE
nucleotide NE xxx NE
exchange NE xxx NE
on NE xx NE
p21ras NE xddxxx NE
. NE . NE

The NE Xxx NE
protooncogene G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
p21ras G#DNA_domain_or_region_E xddxxx G#DNA_domain_or_region_E
, NE , NE
a NE x NE
monomeric G#protein_family_or_group_B xxx G#protein_family_or_group_B
G G#protein_family_or_group_M X G#protein_family_or_group_M
protein G#protein_family_or_group_M xxx G#protein_family_or_group_M
family G#protein_family_or_group_M xxx G#protein_family_or_group_M
member G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
plays NE xxx NE
a NE x NE
critical NE xxx NE
role NE xxx NE
in NE xx NE
converting G#other_name_B xxx G#other_name_B
extracellular G#other_name_M xxx G#other_name_M
signals G#other_name_E xxx G#other_name_E
into NE xxx NE
intracellular G#other_name_B xxx G#other_name_B
biochemical G#other_name_M xxx G#other_name_M
events G#other_name_E xxx G#other_name_E
. NE . NE

Here NE Xxxx NE
, NE , NE
we NE xx NE
report NE xxx NE
that NE xxx NE
nitric G#inorganic_B xxx G#inorganic_B
oxide G#inorganic_E xxx G#inorganic_E
( NE ( NE
NO G#inorganic XX G#inorganic
) NE ) NE
activates NE xxx NE
p21ras G#DNA_domain_or_region xddxxx G#DNA_domain_or_region
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
as NE xx NE
evidenced NE xxx NE
by NE xx NE
an NE xx NE
increase NE xxx NE
in NE xx NE
GTP NE XXX NE
-bound NE -xxx NE
p21ras NE xddxxx NE
. NE . NE

In NE Xx NE
vitro NE xxx NE
studies NE xxx NE
using NE xxx NE
pure G#protein_molecule_B xxx G#protein_molecule_B
recombinant G#protein_molecule_M xxx G#protein_molecule_M
p21ras G#protein_molecule_E xddxxx G#protein_molecule_E
demonstrate NE xxx NE
that NE xxx NE
the NE xxx NE
activation NE xxx NE
is NE xx NE
direct NE xxx NE
and NE xxx NE
reversible NE xxx NE
. NE . NE

Circular NE Xxxx NE
dichroism NE xxx NE
analysis NE xxx NE
reveals NE xxx NE
that NE xxx NE
NO G#inorganic XX G#inorganic
induces NE xxx NE
a NE x NE
profound G#other_name_B xxx G#other_name_B
conformational G#other_name_M xxx G#other_name_M
change G#other_name_E xxx G#other_name_E
in NE xx NE
p21ras G#DNA_domain_or_region xddxxx G#DNA_domain_or_region
in NE xx NE
association NE xxx NE
with NE xxx NE
GDP NE XXX NE
/GTP NE /XXX NE
exchange NE xxx NE
. NE . NE

The NE Xxx NE
mechanism G#other_name_B xxx G#other_name_B
of G#other_name_M xx G#other_name_M
activation G#other_name_E xxx G#other_name_E
is NE xx NE
due NE xxx NE
to NE xx NE
S-nitrosylation G#other_name X-xxx G#other_name
of NE xx NE
a NE x NE
critical NE xxx NE
cysteine G#amino_acid_monomer_B xxx G#amino_acid_monomer_B
residue G#amino_acid_monomer_E xxx G#amino_acid_monomer_E
which NE xxx NE
stimulates NE xxx NE
guanine NE xxx NE
nucleotide NE xxx NE
exchange NE xxx NE
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
we NE xx NE
demonstrate NE xxx NE
that NE xxx NE
p21ras G#protein_molecule xddxxx G#protein_molecule
is NE xx NE
essential NE xxx NE
for NE xxx NE
NO NE XX NE
-induced NE -xxx NE
downstream NE xxx NE
signaling NE xxx NE
, NE , NE
such NE xxx NE
as NE xx NE
NF-kappa NE XX-xxx NE
B NE X NE
activation NE xxx NE
, NE , NE
and NE xxx NE
that NE xxx NE
endogenous NE xxx NE
NO NE XX NE
can NE xxx NE
activate NE xxx NE
p21ras NE xddxxx NE
in NE xx NE
the NE xxx NE
same NE xxx NE
cell NE xxx NE
. NE . NE

These NE Xxxx NE
studies NE xxx NE
identify NE xxx NE
p21ras G#DNA_domain_or_region xddxxx G#DNA_domain_or_region
as NE xx NE
a NE x NE
target NE xxx NE
of NE xx NE
the NE xxx NE
same NE xxx NE
cell NE xxx NE
. NE . NE

These NE Xxxx NE
studies NE xxx NE
identify NE xxx NE
p21ras G#DNA_domain_or_region xddxxx G#DNA_domain_or_region
as NE xx NE
a NE x NE
target NE xxx NE
of NE xx NE
NO G#inorganic XX G#inorganic
in NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
and NE xxx NE
suggest NE xxx NE
that NE xxx NE
NO G#inorganic XX G#inorganic
activates NE xxx NE
p21ras G#DNA_domain_or_region xddxxx G#DNA_domain_or_region
by NE xx NE
an NE xx NE
action NE xxx NE
which NE xxx NE
mimics NE xxx NE
that NE xxx NE
of NE xx NE
guanine G#protein_family_or_group_B xxx G#protein_family_or_group_B
nucleotide G#protein_family_or_group_M xxx G#protein_family_or_group_M
exchange G#protein_family_or_group_M xxx G#protein_family_or_group_M
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Interleukin-2 G#other_name_B Xxxx-d G#other_name_B
promoter G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
in NE xx NE
Epstein-Barr NE Xxxx-Xxxx NE
virus NE xxx NE
-transformed NE -xxx NE
B NE X NE
lymphocytes NE xxx NE
is NE xx NE
controlled NE xxx NE
by NE xx NE
nuclear NE xxx NE
factor-chi NE xxx-xxx NE
B NE X NE
. NE . NE

The NE Xxx NE
regulation NE xxx NE
of NE xx NE
interleukin G#other_name_B xxx G#other_name_B
(IL)-2 G#other_name_M (XX)-d G#other_name_M
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
has NE xxx NE
been NE xxx NE
investigated NE xxx NE
mainly NE xxx NE
in NE xx NE
T G#cell_type_B X G#cell_type_B
lymphocytes G#cell_type_E xxx G#cell_type_E
, NE , NE
the NE xxx NE
predominant NE xxx NE
producers NE xxx NE
of NE xx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
. NE . NE

However NE Xxxx NE
, NE , NE
B G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
can NE xxx NE
also NE xxx NE
synthesize NE xxx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
. NE . NE

In NE Xx NE
the NE xxx NE
present NE xxx NE
study NE xxx NE
we NE xx NE
analyzed NE xxx NE
the NE xxx NE
control NE xxx NE
of NE xx NE
IL-2 G#other_name_B XX-d G#other_name_B
promoter G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
in NE xx NE
Epstein-Barr NE Xxxx-Xxxx NE
virus NE xxx NE
( NE ( NE
EBV NE XXX NE
)-transformed NE )-xxx NE
B NE X NE
cell NE xxx NE
clones NE xxx NE
which NE xxx NE
are NE xxx NE
capable NE xxx NE
of NE xx NE
secreting NE xxx NE
IL-2 NE XX-d NE
at NE xx NE
a NE x NE
low NE xxx NE
level NE xxx NE
after NE xxx NE
stimulation NE xxx NE
with NE xxx NE
phorbol NE xxx NE
12-myristate NE dd-xxx NE
13-acetate NE dd-xxx NE
and NE xxx NE
the NE xxx NE
Ca2+ NE Xxd+ NE
ionophore NE xxx NE
ionomycin NE xxx NE
. NE . NE

Transient G#other_name_B Xxxx G#other_name_B
transfections G#other_name_E xxx G#other_name_E
using NE xxx NE
reporter G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
constructs G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
with NE xxx NE
multiples NE xxx NE
of NE xx NE
transcription G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
factor G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
from NE xxx NE
the NE xxx NE
IL-2 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
[ NE [ NE
distal G#protein_molecule_B xxx G#protein_molecule_B
nuclear G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_M xxx G#protein_molecule_M
(NF)-AT G#protein_molecule_E (XX)-XX G#protein_molecule_E
, NE , NE
proximal G#protein_molecule_B xxx G#protein_molecule_B
NF-AT G#protein_molecule_E XX-XX G#protein_molecule_E
, NE , NE
AP-1/Octamer G#protein_molecule XX-d/Xxxx G#protein_molecule
( NE ( NE
UPS G#protein_molecule XXX G#protein_molecule
) NE ) NE
or NE xx NE
NF-chi G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
( NE ( NE
TCEd G#protein_molecule XXXx G#protein_molecule
) NE ) NE
sites] NE xxx] NE
were NE xxx NE
performed NE xxx NE
. NE . NE

In NE Xx NE
EBV-transformed G#cell_line_B XXX-xxx G#cell_line_B
B G#cell_line_M X G#cell_line_M
clones G#cell_line_E xxx G#cell_line_E
, NE , NE
the NE xxx NE
chi G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
B G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
exerted NE xxx NE
the NE xxx NE
strongest G#other_name_B xxx G#other_name_B
inducible G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
; NE ; NE
the NE xxx NE
NF-AT G#DNA_domain_or_region_B XX-XX G#DNA_domain_or_region_B
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
showed NE xxx NE
either NE xxx NE
no NE xx NE
or NE xx NE
only NE xxx NE
weak NE xxx NE
activity NE xxx NE
compared NE xxx NE
to NE xx NE
Jurkat G#cell_line_B Xxxx G#cell_line_B
T G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

An NE Xx NE
IL-2 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
bearing NE xxx NE
a NE x NE
defective NE xxx NE
NF- NE XX- NE
chi NE xxx NE
B NE X NE
site NE xxx NE
was NE xxx NE
completely NE xxx NE
inactive NE xxx NE
in NE xx NE
EBV-transformed NE XXX-xxx NE
B NE X NE
cells NE xxx NE
, NE , NE
while NE xxx NE
it NE xx NE
still NE xxx NE
had NE xxx NE
activity NE xxx NE
in NE xx NE
Jurkat NE Xxxx NE
T NE X NE
cells NE xxx NE
. NE . NE

In NE Xx NE
seven NE xxx NE
EBV-B G#cell_line_B XXX-X G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
clones G#cell_line_E xxx G#cell_line_E
or NE xx NE
lines NE xxx NE
differing NE xxx NE
in NE xx NE
their NE xxx NE
capacity NE xxx NE
to NE xx NE
secrete NE xxx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
, NE , NE
the NE xxx NE
activity NE xxx NE
of NE xx NE
the NE xxx NE
IL-2 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
correlated NE xxx NE
well NE xxx NE
with NE xxx NE
the NE xxx NE
status NE xxx NE
of NE xx NE
IL-2 G#other_name_B XX-d G#other_name_B
secretion G#other_name_E xxx G#other_name_E
. NE . NE

Similarly NE Xxxx NE
, NE , NE
a NE x NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
immunodeficiency G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
virus G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
whose NE xxx NE
activity NE xxx NE
is NE xx NE
controlled NE xxx NE
through NE xxx NE
chi G#protein_family_or_group_B xxx G#protein_family_or_group_B
B G#protein_family_or_group_M X G#protein_family_or_group_M
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
was NE xxx NE
found NE xxx NE
to NE xx NE
be NE xx NE
active NE xxx NE
in NE xx NE
the NE xxx NE
IL-2 NE XX-d NE
producing NE xxx NE
EBV- NE XXX- NE
B NE X NE
cells NE xxx NE
, NE , NE
but NE xxx NE
inactive NE xxx NE
in NE xx NE
the NE xxx NE
non- NE xxx- NE
IL-2 NE XX-d NE
-producing NE -xxx NE
cells NE xxx NE
. NE . NE

Electrophoretic G#other_name_B Xxxx G#other_name_B
mobility G#other_name_M xxx G#other_name_M
shift G#other_name_M xxx G#other_name_M
assays G#other_name_E xxx G#other_name_E
using NE xxx NE
protein G#protein_N/A_B xxx G#protein_N/A_B
extracts G#protein_N/A_E xxx G#protein_N/A_E
from NE xxx NE
EBV- NE XXX- NE
B NE X NE
cells NE xxx NE
and NE xxx NE
the NE xxx NE
IL-2 NE XX-d NE
NF-chi NE XX-xxx NE
B NE X NE
probe NE xxx NE
revealed NE xxx NE
the NE xxx NE
constitutive NE xxx NE
generation NE xxx NE
of NE xx NE
chi NE xxx NE
B NE X NE
complexes NE xxx NE
in NE xx NE
IL-2 NE XX-d NE
-secreting NE -xxx NE
cells NE xxx NE
consisting NE xxx NE
mainly NE xxx NE
of NE xx NE
heterodimeric NE xxx NE
p50/p65 NE xdd/xdd NE
complexes NE xxx NE
. NE . NE

A NE X NE
weaker NE xxx NE
chi G#other_name_B xxx G#other_name_B
B G#other_name_M X G#other_name_M
complex G#other_name_M xxx G#other_name_M
formation G#other_name_E xxx G#other_name_E
and NE xxx NE
faster-migrating NE xxx-xxx NE
complexes NE xxx NE
were NE xxx NE
detected NE xxx NE
in NE xx NE
non- NE xxx- NE
IL-2 NE XX-d NE
-secreting NE -xxx NE
cells NE xxx NE
. NE . NE

These NE Xxxx NE
results NE xxx NE
demonstrate NE xxx NE
that NE xxx NE
the NE xxx NE
IL-2 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
NF-chi G#DNA_domain_or_region_M XX-xxx G#DNA_domain_or_region_M
B G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
is NE xx NE
indispensable NE xxx NE
for NE xxx NE
the NE xxx NE
activity NE xxx NE
of NE xx NE
the NE xxx NE
IL-2 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
EBV-transformed G#cell_line_B XXX-xxx G#cell_line_B
B G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
whereas NE xxx NE
other NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
appear NE xxx NE
to NE xx NE
be NE xx NE
less NE xxx NE
important NE xxx NE
for NE xxx NE
IL-2 G#other_name_B XX-d G#other_name_B
expression G#other_name_E xxx G#other_name_E
in NE xx NE
these NE xxx NE
cells NE xxx NE
. NE . NE

Latent G#protein_molecule_B Xxxx G#protein_molecule_B
membrane G#protein_molecule_M xxx G#protein_molecule_M
protein-1 G#protein_molecule_E xxx-d G#protein_molecule_E
induces NE xxx NE
cyclin G#other_name_B xxx G#other_name_B
D2 G#other_name_M Xd G#other_name_M
expression G#other_name_E xxx G#other_name_E
, NE , NE
pRb G#other_name_B xXx G#other_name_B
hyperphosphorylation G#other_name_E xxx G#other_name_E
, NE , NE
and NE xxx NE
loss NE xxx NE
of NE xx NE
TGF-beta NE XXX-xxx NE
1 NE d NE
-mediated NE -xxx NE
growth NE xxx NE
inhibition NE xxx NE
in NE xx NE
EBV-positive NE XXX-xxx NE
B NE X NE
cells NE xxx NE
. NE . NE

The NE Xxx NE
normal NE xxx NE
cell NE xxx NE
cycle NE xxx NE
is NE xx NE
regulated NE xxx NE
by NE xx NE
several NE xxx NE
molecules NE xxx NE
, NE , NE
such NE xxx NE
as NE xx NE
the NE xxx NE
tumor-suppressor G#protein_molecule_B xxx-xxx G#protein_molecule_B
protein G#protein_molecule_M xxx G#protein_molecule_M
pRb G#protein_molecule_E xXx G#protein_molecule_E
, NE , NE
the NE xxx NE
G1 G#protein_family_or_group_B Xd G#protein_family_or_group_B
cyclins G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
the NE xxx NE
cyclin-dependent G#protein_family_or_group_B xxx-xxx G#protein_family_or_group_B
kinases G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
and NE xxx NE
their NE xxx NE
inhibitors G#other_name xxx G#other_name
. NE . NE

These NE Xxxx NE
regulators NE xxx NE
are NE xxx NE
targeted NE xxx NE
by NE xx NE
negative NE xxx NE
growth NE xxx NE
regulatory G#other_name_B xxx G#other_name_B
signals G#other_name_E xxx G#other_name_E
, NE , NE
such NE xxx NE
as NE xx NE
that NE xxx NE
provided NE xxx NE
by NE xx NE
TGF-beta G#protein_molecule XXX-xxx G#protein_molecule
. NE . NE

Here NE Xxxx NE
, NE , NE
we NE xx NE
show NE xxx NE
that NE xxx NE
the NE xxx NE
presence NE xxx NE
of NE xx NE
either NE xxx NE
wild-type G#virus_B xxx-xxx G#virus_B
EBV G#virus_E XXX G#virus_E
or NE xx NE
its NE xxx NE
transforming G#protein_molecule_B xxx G#protein_molecule_B
latent G#protein_molecule_M xxx G#protein_molecule_M
membrane G#protein_molecule_M xxx G#protein_molecule_M
protein-1 G#protein_molecule_E xxx-d G#protein_molecule_E
( NE ( NE
LMP-1 G#protein_molecule XXX-d G#protein_molecule
) NE ) NE
results NE xxx NE
in NE xx NE
the NE xxx NE
loss NE xxx NE
of NE xx NE
TGF-beta NE XXX-xxx NE
1 NE d NE
-mediated NE -xxx NE
growth NE xxx NE
inhibition NE xxx NE
in NE xx NE
human NE xxx NE
B NE X NE
cells NE xxx NE
. NE . NE

Chemical NE Xxxx NE
cross-linking NE xxx-xxx NE
with NE xxx NE
125I-labeled G#protein_molecule_B dddX-xxx G#protein_molecule_B
TGF-beta G#protein_molecule_M XXX-xxx G#protein_molecule_M
1 G#protein_molecule_E d G#protein_molecule_E
showed NE xxx NE
an NE xx NE
essentially NE xxx NE
normal NE xxx NE
TGF-beta G#other_name_B XXX-xxx G#other_name_B
receptor G#other_name_M xxx G#other_name_M
profile G#other_name_E xxx G#other_name_E
in NE xx NE
EBV-positive G#cell_line_B XXX-xxx G#cell_line_B
Burkitt's G#cell_line_M Xxxx'x G#cell_line_M
lymphoma G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_M xxx G#cell_line_M
and G#cell_line_M xxx G#cell_line_M
EBV-negative G#cell_line_M XXX-xxx G#cell_line_M
Burkitt's G#cell_line_M Xxxx'x G#cell_line_M
lymphoma G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
transducing NE xxx NE
signals NE xxx NE
, NE , NE
as NE xx NE
evidenced NE xxx NE
by NE xx NE
the NE xxx NE
TGF-beta G#other_name_B XXX-xxx G#other_name_B
1 G#other_name_E d G#other_name_E
-mediated NE -xxx NE
modulation NE xxx NE
of NE xx NE
junB G#other_name_B xxxX G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
. NE . NE

However NE Xxxx NE
, NE , NE
TGF-beta G#protein_molecule_B XXX-xxx G#protein_molecule_B
1 G#protein_molecule_E d G#protein_molecule_E
did NE xxx NE
not NE xxx NE
induce NE xxx NE
dephosphorylation NE xxx NE
of NE xx NE
pRb G#protein_molecule xXx G#protein_molecule
in NE xx NE
EBV NE XXX NE
(or NE (xx NE
LMP-1 NE XXX-d NE
)-positive NE )-xxx NE
cells NE xxx NE
as NE xx NE
opposed NE xxx NE
to NE xx NE
EBV NE XXX NE
-negative NE -xxx NE
cells NE xxx NE
, NE , NE
suggesting NE xxx NE
a NE x NE
dichotomy NE xxx NE
in NE xx NE
the NE xxx NE
TGF-beta NE XXX-xxx NE
1 NE d NE
signaling NE xxx NE
pathway NE xxx NE
leading NE xxx NE
to NE xx NE
separable NE xxx NE
gene NE xxx NE
regulatory NE xxx NE
and NE xxx NE
growth NE xxx NE
inhibitory NE xxx NE
responses NE xxx NE
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
LMP-1 G#protein_molecule XXX-d G#protein_molecule
was NE xxx NE
found NE xxx NE
to NE xx NE
induce NE xxx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
cyclin G#protein_molecule_B xxx G#protein_molecule_B
D2 G#protein_molecule_E Xd G#protein_molecule_E
; NE ; NE
normal NE xxx NE
B G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
or NE xx NE
EBV NE XXX NE
-negative NE -xxx NE
Burkitt's NE Xxxx'x NE
lymphoma NE xxx NE
cells NE xxx NE
do NE xx NE
not NE xxx NE
express NE xxx NE
D-type NE X-xxx NE
cyclins NE xxx NE
. NE . NE

Taken NE Xxxx NE
together NE xxx NE
, NE , NE
these NE xxx NE
data NE xxx NE
point NE xxx NE
to NE xx NE
a NE x NE
potential NE xxx NE
mechanism NE xxx NE
underlying NE xxx NE
EBV NE XXX NE
-mediated NE -xxx NE
B NE X NE
cell NE xxx NE
transformation NE xxx NE
whereby NE xxx NE
constitutive NE xxx NE
induction NE xxx NE
of NE xx NE
key NE xxx NE
cell NE xxx NE
cycle NE xxx NE
regulators NE xxx NE
by NE xx NE
LMP-1 NE XXX-d NE
can NE xxx NE
lead NE xxx NE
to NE xx NE
pRb NE xXx NE
hyperphosphorylation NE xxx NE
and NE xxx NE
uncontrolled NE xxx NE
cell NE xxx NE
proliferation NE xxx NE
. NE . NE

Does NE Xxxx NE
thyroidectomy G#other_name xxx G#other_name
, NE , NE
radioactive G#other_name_B xxx G#other_name_B
iodine G#other_name_M xxx G#other_name_M
therapy G#other_name_E xxx G#other_name_E
, NE , NE
or NE xx NE
antithyroid G#other_name_B xxx G#other_name_B
drug G#other_name_M xxx G#other_name_M
treatment G#other_name_E xxx G#other_name_E
alter NE xxx NE
reactivity NE xxx NE
of NE xx NE
patients' NE xxx' NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
to NE xx NE
epitopes G#other_name xxx G#other_name
of NE xx NE
thyrotropin G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
in NE xx NE
autoimmune G#other_name_B xxx G#other_name_B
thyroid G#other_name_M xxx G#other_name_M
diseases G#other_name_E xxx G#other_name_E
? NE ? NE

The NE Xxx NE
effect NE xxx NE
of NE xx NE
treatment NE xxx NE
on NE xx NE
thyroid G#other_name_B xxx G#other_name_B
antibody G#other_name_M xxx G#other_name_M
production G#other_name_E xxx G#other_name_E
and NE xxx NE
T G#other_name_B X G#other_name_B
cell G#other_name_M xxx G#other_name_M
reactivity G#other_name_E xxx G#other_name_E
to NE xx NE
thyroid G#other_name_B xxx G#other_name_B
antigens G#other_name_E xxx G#other_name_E
was NE xxx NE
studied NE xxx NE
in NE xx NE
15 NE dd NE
patients G#multi_cell xxx G#multi_cell
with NE xxx NE
Graves' G#other_name_B Xxxx' G#other_name_B
disease G#other_name_E xxx G#other_name_E
( NE ( NE
GD G#other_name XX G#other_name
) NE ) NE
before NE xxx NE
and NE xxx NE
after NE xxx NE
thyroidectomy G#other_name xxx G#other_name
, NE , NE
19 NE dd NE
patients G#multi_cell xxx G#multi_cell
with NE xxx NE
GD G#other_name XX G#other_name
before NE xxx NE
and NE xxx NE
after NE xxx NE
radioactive NE xxx NE
iodine G#atom xxx G#atom
(RAI) NE (XXX) NE
therapy NE xxx NE
, NE , NE
and NE xxx NE
9 NE d NE
patients G#multi_cell xxx G#multi_cell
maintained NE xxx NE
euthyroid NE xxx NE
on NE xx NE
antithyroid G#other_organic_compound_B xxx G#other_organic_compound_B
drugs G#other_organic_compound_E xxx G#other_organic_compound_E
( NE ( NE
ATD G#other_organic_compound XXX G#other_organic_compound
) NE ) NE
. NE . NE

Twenty NE Xxxx NE
subjects NE xxx NE
matched NE xxx NE
for NE xxx NE
age NE xxx NE
and NE xxx NE
sex NE xxx NE
without NE xxx NE
known NE xxx NE
thyroid G#other_name_B xxx G#other_name_B
disease G#other_name_E xxx G#other_name_E
served NE xxx NE
as NE xx NE
controls NE xxx NE
. NE . NE

In NE Xx NE
GD G#other_name XX G#other_name
patients G#multi_cell xxx G#multi_cell
, NE , NE
the NE xxx NE
responses NE xxx NE
of NE xx NE
peripheral G#cell_type_B xxx G#cell_type_B
blood G#cell_type_M xxx G#cell_type_M
mononuclear G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
( NE ( NE
PBMC G#cell_type XXXX G#cell_type
) NE ) NE
and NE xxx NE
TSH NE XXX NE
receptor NE xxx NE
( NE ( NE
TSHR NE XXXX NE
)-specific NE )-xxx NE
T NE X NE
cell NE xxx NE
lines NE xxx NE
to NE xx NE
recombinant NE xxx NE
human NE xxx NE
TSHR NE XXXX NE
extracellular NE xxx NE
domain NE xxx NE
, NE , NE
thyroglobulin NE xxx NE
, NE , NE
and NE xxx NE
TSHR NE XXXX NE
peptides NE xxx NE
were NE xxx NE
examined NE xxx NE
on NE xx NE
the NE xxx NE
day NE xxx NE
of NE xx NE
surgery NE xxx NE
or NE xx NE
RAI NE XXX NE
therapy NE xxx NE
(day NE (xxx NE
0) NE d) NE
and NE xxx NE
also NE xxx NE
6-8 NE d-d NE
weeks NE xxx NE
and NE xxx NE
3-6 NE d-d NE
months NE xxx NE
thereafter NE xxx NE
. NE . NE

Reactivity NE Xxxx NE
to NE xx NE
TSHR G#peptide_B XXXX G#peptide_B
peptides G#peptide_E xxx G#peptide_E
before NE xxx NE
surgery G#other_name xxx G#other_name
was NE xxx NE
heterogeneous NE xxx NE
and NE xxx NE
spanned NE xxx NE
the NE xxx NE
entire NE xxx NE
extracellular G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
. NE . NE

Six NE Xxx NE
to NE xx NE
8 NE d NE
weeks NE xxx NE
after NE xxx NE
subtotal NE xxx NE
thyroidectomy G#other_name xxx G#other_name
, NE , NE
the NE xxx NE
number NE xxx NE
of NE xx NE
patients G#multi_cell xxx G#multi_cell
' NE ' NE
PBMC G#cell_type XXXX G#cell_type
responding NE xxx NE
to NE xx NE
any NE xxx NE
peptide G#peptide xxx G#peptide
and NE xxx NE
the NE xxx NE
average NE xxx NE
number NE xxx NE
of NE xx NE
recognized G#peptide_B xxx G#peptide_B
peptides G#peptide_E xxx G#peptide_E
decreased NE xxx NE
. NE . NE

A NE X NE
further NE xxx NE
decrease NE xxx NE
in NE xx NE
the NE xxx NE
T G#other_name_B X G#other_name_B
cell G#other_name_M xxx G#other_name_M
reactivity G#other_name_E xxx G#other_name_E
to NE xx NE
TSHR G#protein_family_or_group XXXX G#protein_family_or_group
peptides NE xxx NE
was NE xxx NE
observed NE xxx NE
3-6 NE d-d NE
months NE xxx NE
after NE xxx NE
surgery G#other_name xxx G#other_name
. NE . NE

The NE Xxx NE
responses NE xxx NE
of NE xx NE
PBMC G#cell_type XXXX G#cell_type
from NE xxx NE
Graves' NE Xxxx' NE
patients G#multi_cell xxx G#multi_cell
before NE xxx NE
RAI G#other_name_B XXX G#other_name_B
therapy G#other_name_E xxx G#other_name_E
were NE xxx NE
less NE xxx NE
than NE xxx NE
those NE xxx NE
in NE xx NE
the NE xxx NE
presurgical NE xxx NE
group NE xxx NE
. NE . NE

Six NE Xxx NE
to NE xx NE
8 NE d NE
weeks NE xxx NE
after NE xxx NE
RAI G#other_name_B XXX G#other_name_B
therapy G#other_name_E xxx G#other_name_E
, NE , NE
the NE xxx NE
number NE xxx NE
of NE xx NE
patients G#multi_cell xxx G#multi_cell
responding NE xxx NE
to NE xx NE
any NE xxx NE
peptide G#peptide xxx G#peptide
and NE xxx NE
the NE xxx NE
average NE xxx NE
number NE xxx NE
of NE xx NE
recognized NE xxx NE
peptides NE xxx NE
increased NE xxx NE
. NE . NE

Three NE Xxxx NE
to NE xx NE
6 NE d NE
months NE xxx NE
after NE xxx NE
RAI G#other_name XXX G#other_name
, NE , NE
T G#other_name_B X G#other_name_B
cell G#other_name_M xxx G#other_name_M
responses G#other_name_E xxx G#other_name_E
to NE xx NE
TSHR G#peptide_B XXXX G#peptide_B
peptides G#peptide_E xxx G#peptide_E
were NE xxx NE
less NE xxx NE
than NE xxx NE
those NE xxx NE
6-8 NE d-d NE
weeks NE xxx NE
after NE xxx NE
RAI G#other_name_B XXX G#other_name_B
therapy G#other_name_E xxx G#other_name_E
, NE , NE
but NE xxx NE
still NE xxx NE
higher NE xxx NE
than NE xxx NE
the NE xxx NE
values NE xxx NE
on NE xx NE
day NE xxx NE
0 NE d NE
. NE . NE

Responses NE Xxxx NE
of NE xx NE
PBMC G#cell_type XXXX G#cell_type
from NE xxx NE
patients G#multi_cell xxx G#multi_cell
with NE xxx NE
GD G#other_name XX G#other_name
, NE , NE
maintained NE xxx NE
euthyroid NE xxx NE
on NE xx NE
ATD G#other_organic_compound XXX G#other_organic_compound
, NE , NE
were NE xxx NE
lower NE xxx NE
than NE xxx NE
those NE xxx NE
before NE xxx NE
surgery G#other_name xxx G#other_name
or NE xx NE
RAI G#other_name_B XXX G#other_name_B
therapy G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
reactivity NE xxx NE
of NE xx NE
T G#cell_line_B X G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
in NE xx NE
different NE xxx NE
groups NE xxx NE
reflected NE xxx NE
a NE x NE
pattern NE xxx NE
similar NE xxx NE
to NE xx NE
PBMC G#cell_type XXXX G#cell_type
after NE xxx NE
treatment NE xxx NE
. NE . NE

TSHR G#protein_family_or_group_B XXXX G#protein_family_or_group_B
antibody G#protein_family_or_group_E xxx G#protein_family_or_group_E
and NE xxx NE
microsomal G#protein_family_or_group_B xxx G#protein_family_or_group_B
antibody G#protein_family_or_group_E xxx G#protein_family_or_group_E
levels NE xxx NE
decreased NE xxx NE
after NE xxx NE
surgery G#other_name xxx G#other_name
, NE , NE
but NE xxx NE
increased NE xxx NE
after NE xxx NE
RAI G#other_name_B XXX G#other_name_B
therapy G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
difference NE xxx NE
in NE xx NE
the NE xxx NE
number NE xxx NE
of NE xx NE
recognized G#peptide_B xxx G#peptide_B
peptides G#peptide_E xxx G#peptide_E
by NE xx NE
patients G#multi_cell xxx G#multi_cell
' NE ' NE
PBMC G#cell_type XXXX G#cell_type
before NE xxx NE
RAI G#other_name XXX G#other_name
and NE xxx NE
surgery G#other_name xxx G#other_name
may NE xxx NE
reflect NE xxx NE
the NE xxx NE
effect NE xxx NE
of NE xx NE
long NE xxx NE
term NE xxx NE
therapy NE xxx NE
with NE xxx NE
ATD G#other_organic_compound XXX G#other_organic_compound
in NE xx NE
the NE xxx NE
patients G#multi_cell xxx G#multi_cell
before NE xxx NE
RAI G#other_name XXX G#other_name
vs NE xx NE
. NE . NE
the NE xxx NE
shorter NE xxx NE
period NE xxx NE
in NE xx NE
patients G#multi_cell xxx G#multi_cell
before NE xxx NE
surgery G#other_name xxx G#other_name
. NE . NE

The NE Xxx NE
decreased NE xxx NE
T G#other_name_B X G#other_name_B
cell G#other_name_M xxx G#other_name_M
reactivity G#other_name_E xxx G#other_name_E
to NE xx NE
thyroid G#protein_family_or_group_B xxx G#protein_family_or_group_B
antigens G#protein_family_or_group_E xxx G#protein_family_or_group_E
after NE xxx NE
thyroidectomy G#other_name xxx G#other_name
could NE xxx NE
be NE xx NE
the NE xxx NE
result NE xxx NE
of NE xx NE
removal NE xxx NE
of NE xx NE
a NE x NE
major NE xxx NE
part NE xxx NE
of NE xx NE
the NE xxx NE
thyroid G#body_part_B xxx G#body_part_B
gland G#body_part_E xxx G#body_part_E
or NE xx NE
redistribution NE xxx NE
of NE xx NE
suppressor-inducer NE xxx-xxx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

The NE Xxx NE
increased NE xxx NE
T G#other_name_B X G#other_name_B
cell G#other_name_M xxx G#other_name_M
response G#other_name_E xxx G#other_name_E
after NE xxx NE
RAI G#other_name_B XXX G#other_name_B
therapy G#other_name_E xxx G#other_name_E
is NE xx NE
probably NE xxx NE
epitope G#other_name_B xxx G#other_name_B
specific G#other_name_E xxx G#other_name_E
, NE , NE
rather NE xxx NE
than NE xxx NE
a NE x NE
response NE xxx NE
to NE xx NE
the NE xxx NE
whole NE xxx NE
TSHR G#protein_family_or_group XXXX G#protein_family_or_group
molecule NE xxx NE
. NE . NE

Synchronous G#other_name_B Xxxx G#other_name_B
recognition G#other_name_E xxx G#other_name_E
of NE xx NE
peptides NE xxx NE
158-176 NE ddd-ddd NE
and NE xxx NE
248-263 NE ddd-ddd NE
is NE xx NE
important NE xxx NE
for NE xxx NE
the NE xxx NE
development NE xxx NE
of NE xx NE
GD NE XX NE
, NE , NE
and NE xxx NE
the NE xxx NE
loss NE xxx NE
of NE xx NE
recognition NE xxx NE
of NE xx NE
one NE xxx NE
of NE xx NE
these NE xxx NE
epitopes NE xxx NE
may NE xxx NE
be NE xx NE
an NE xx NE
early NE xxx NE
sign NE xxx NE
of NE xx NE
immune NE xxx NE
remission NE xxx NE
and NE xxx NE
a NE x NE
predictor NE xxx NE
of NE xx NE
euthyroidism NE xxx NE
. NE . NE

Circumvention NE Xxxx NE
of NE xx NE
tolerance NE xxx NE
for NE xxx NE
the NE xxx NE
nuclear G#protein_family_or_group_B xxx G#protein_family_or_group_B
T G#protein_family_or_group_M X G#protein_family_or_group_M
cell G#protein_family_or_group_M xxx G#protein_family_or_group_M
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
TCF-1 G#protein_molecule XXX-d G#protein_molecule
by NE xx NE
immunization NE xxx NE
of NE xx NE
TCF-1 G#other_artificial_source_B XXX-d G#other_artificial_source_B
knock-out G#other_artificial_source_M xxx-xxx G#other_artificial_source_M
mice G#other_artificial_source_E xxx G#other_artificial_source_E
. NE . NE

Molecular NE Xxxx NE
events NE xxx NE
that NE xxx NE
underlie NE xxx NE
the NE xxx NE
well-defined NE xxx-xxx NE
phenotypic NE xxx NE
changes NE xxx NE
of NE xx NE
the NE xxx NE
differentiating G#cell_type_B xxx G#cell_type_B
thymocyte G#cell_type_E xxx G#cell_type_E
are NE xxx NE
poorly NE xxx NE
understood NE xxx NE
. NE . NE

A NE X NE
candidate NE xxx NE
gene NE xxx NE
to NE xx NE
control NE xxx NE
thymocyte G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
, NE , NE
T G#protein_molecule_B X G#protein_molecule_B
cell G#protein_molecule_M xxx G#protein_molecule_M
factor-1 G#protein_molecule_E xxx-d G#protein_molecule_E
( NE ( NE
TCF-1 G#protein_molecule XXX-d G#protein_molecule
) NE ) NE
* NE * NE
encodes NE xxx NE
a NE x NE
DNA-binding G#protein_family_or_group_B XXX-xxx G#protein_family_or_group_B
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Its NE Xxx NE
mRNA G#other_name_B xXXX G#other_name_B
expression G#other_name_M xxx G#other_name_M
pattern G#other_name_E xxx G#other_name_E
is NE xx NE
complex NE xxx NE
during NE xxx NE
embryogenesis G#other_name xxx G#other_name
, NE , NE
yet NE xxx NE
restricted NE xxx NE
to NE xx NE
lymphocytes G#cell_type xxx G#cell_type
postnatally NE xxx NE
. NE . NE

Expression NE Xxxx NE
studies NE xxx NE
on NE xx NE
TCF-1 G#protein_molecule_B XXX-d G#protein_molecule_B
protein G#protein_molecule_E xxx G#protein_molecule_E
have NE xxx NE
been NE xxx NE
hampered NE xxx NE
by NE xx NE
the NE xxx NE
difficulty NE xxx NE
to NE xx NE
raise NE xxx NE
antibodies NE xxx NE
due NE xxx NE
to NE xx NE
extreme NE xxx NE
evolutionary NE xxx NE
conservation NE xxx NE
. NE . NE

TCF-1 G#other_artificial_source_B XXX-d G#other_artificial_source_B
knock-out G#other_artificial_source_M xxx-xxx G#other_artificial_source_M
mice G#other_artificial_source_E xxx G#other_artificial_source_E
, NE , NE
generated NE xxx NE
recently NE xxx NE
in NE xx NE
our NE xxx NE
laboratory NE xxx NE
, NE , NE
have NE xxx NE
strongly NE xxx NE
decreased NE xxx NE
numbers NE xxx NE
of NE xx NE
thymocytes G#cell_type xxx G#cell_type
, NE , NE
but NE xxx NE
are NE xxx NE
otherwise NE xxx NE
normal NE xxx NE
. NE . NE

We NE Xx NE
have NE xxx NE
used NE xxx NE
these NE xxx NE
mice NE xxx NE
to NE xx NE
generate NE xxx NE
anti- NE xxx- NE
TCF-1 NE XXX-d NE
antibodies NE xxx NE
. NE . NE

By NE Xx NE
immunization NE xxx NE
with NE xxx NE
a NE x NE
recombinant G#protein_family_or_group_B xxx G#protein_family_or_group_B
fusion G#protein_family_or_group_M xxx G#protein_family_or_group_M
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
we NE xx NE
show NE xxx NE
that NE xxx NE
TCF-1 G#other_artificial_source_B XXX-d G#other_artificial_source_B
knock-out G#other_artificial_source_M xxx-xxx G#other_artificial_source_M
mice G#other_artificial_source_E xxx G#other_artificial_source_E
readily NE xxx NE
yield NE xxx NE
antiserum NE xxx NE
titers NE xxx NE
against NE xxx NE
human G#protein_N/A_B xxx G#protein_N/A_B
TCF-1 G#protein_N/A_M XXX-d G#protein_N/A_M
protein G#protein_N/A_M xxx G#protein_N/A_M
and G#protein_N/A_M xxx G#protein_N/A_M
mouse G#protein_N/A_M xxx G#protein_N/A_M
TCF-1 G#protein_N/A_M XXX-d G#protein_N/A_M
protein G#protein_N/A_E xxx G#protein_N/A_E

Wild-type NE Xxxx-xxx NE
littermates NE xxx NE
remain NE xxx NE
unresponsive NE xxx NE
to NE xx NE
TCF-1 G#protein_molecule XXX-d G#protein_molecule
while NE xxx NE
they NE xxx NE
mount NE xxx NE
a NE x NE
high-titer G#other_name_B xxx-xxx G#other_name_B
antibody G#other_name_M xxx G#other_name_M
response G#other_name_E xxx G#other_name_E
to NE xx NE
the NE xxx NE
fusion G#protein_family_or_group_B xxx G#protein_family_or_group_B
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
Maltose G#protein_molecule_B Xxxx G#protein_molecule_B
Binding G#protein_molecule_M Xxxx G#protein_molecule_M
Protein G#protein_molecule_E Xxxx G#protein_molecule_E
( NE ( NE
MBP G#protein_molecule XXX G#protein_molecule
) NE ) NE
. NE . NE

Subsequently NE Xxxx NE
, NE , NE
TCF-1 NE XXX-d NE
-specific NE -xxx NE
hybridomas NE xxx NE
could NE xxx NE
be NE xx NE
prepared NE xxx NE
from NE xxx NE
the NE xxx NE
spleens NE xxx NE
of NE xx NE
immunized NE xxx NE
knock-out NE xxx-xxx NE
mice NE xxx NE
. NE . NE

This NE Xxxx NE
study NE xxx NE
illustrates NE xxx NE
the NE xxx NE
almost NE xxx NE
complete NE xxx NE
tolerance NE xxx NE
of NE xx NE
mice G#multi_cell xxx G#multi_cell
for NE xxx NE
human G#protein_molecule_B xxx G#protein_molecule_B
TCF-1 G#protein_molecule_E XXX-d G#protein_molecule_E
and NE xxx NE
demonstrates NE xxx NE
that NE xxx NE
this NE xxx NE
tolerance NE xxx NE
is NE xx NE
readily NE xxx NE
broken NE xxx NE
by NE xx NE
gene G#other_name_B xxx G#other_name_B
knock-out G#other_name_E xxx-xxx G#other_name_E
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
the NE xxx NE
usefulness NE xxx NE
of NE xx NE
knock-out G#other_artificial_source_B xxx-xxx G#other_artificial_source_B
mice G#other_artificial_source_E xxx G#other_artificial_source_E
for NE xxx NE
the NE xxx NE
generation NE xxx NE
of NE xx NE
monoclonal NE xxx NE
antibodies NE xxx NE
against NE xxx NE
the NE xxx NE
gene NE xxx NE
product NE xxx NE
of NE xx NE
interest NE xxx NE
is NE xx NE
underscored NE xxx NE
. NE . NE

The NE Xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
Nm23H2 G#protein_molecule XxddXd G#protein_molecule
, NE , NE
binds NE xxx NE
to NE xx NE
and NE xxx NE
activates NE xxx NE
the NE xxx NE
translocated NE xxx NE
c-myc G#DNA_domain_or_region_B x-xxx G#DNA_domain_or_region_B
allele G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
Burkitt's G#other_name_B Xxxx'x G#other_name_B
lymphoma G#other_name_E xxx G#other_name_E
. NE . NE

We NE Xx NE
have NE xxx NE
identified NE xxx NE
an NE xx NE
in G#other_name_B xx G#other_name_B
vivo G#other_name_M xxx G#other_name_M
footprint G#other_name_E xxx G#other_name_E
over NE xxx NE
the NE xxx NE
PuF G#DNA_domain_or_region_B XxX G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
on NE xx NE
the NE xxx NE
translocated NE xxx NE
c-myc G#DNA_domain_or_region_B x-xxx G#DNA_domain_or_region_B
allele G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
Burkitt's G#other_name_B Xxxx'x G#other_name_B
lymphoma G#other_name_E xxx G#other_name_E
cells NE xxx NE
. NE . NE

The NE Xxx NE
PuF G#DNA_domain_or_region_B XxX G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
on NE xx NE
the NE xxx NE
silent G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
normal G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
c-myc G#DNA_domain_or_region_M x-xxx G#DNA_domain_or_region_M
allele G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
was NE xxx NE
unoccupied NE xxx NE
. NE . NE

We NE Xx NE
demonstrated NE xxx NE
by NE xx NE
electrophoretic G#other_name_B xxx G#other_name_B
mobility G#other_name_M xxx G#other_name_M
shift G#other_name_M xxx G#other_name_M
assay G#other_name_E xxx G#other_name_E
, NE , NE
electrophoretic G#other_name_B xxx G#other_name_B
mobility G#other_name_M xxx G#other_name_M
shift G#other_name_M xxx G#other_name_M
assay G#other_name_E xxx G#other_name_E
with NE xxx NE
antibody NE xxx NE
, NE , NE
UV G#other_name_B XX G#other_name_B
cross-linking G#other_name_E xxx-xxx G#other_name_E
followed NE xxx NE
by NE xx NE
SDS-gel G#other_name_B XXX-xxx G#other_name_B
electrophoresis G#other_name_E xxx G#other_name_E
, NE , NE
and NE xxx NE
Western G#other_name_B Xxxx G#other_name_B
analysis G#other_name_E xxx G#other_name_E
that NE xxx NE
Nm23H2 G#protein_molecule XxddXd G#protein_molecule
in NE xx NE
B G#cell_component_B X G#cell_component_B
cell G#cell_component_M xxx G#cell_component_M
nuclear G#cell_component_M xxx G#cell_component_M
extracts G#cell_component_E xxx G#cell_component_E
bound NE xxx NE
to NE xx NE
the NE xxx NE
c-myc NE x-xxx NE
PuF G#DNA_domain_or_region_B XxX G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Transfection NE Xxxx NE
experiments NE xxx NE
with NE xxx NE
c-myc G#DNA_family_or_group_B x-xxx G#DNA_family_or_group_B
promoter G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
constructs G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
in NE xx NE
both NE xxx NE
DHL-9 G#cell_line XXX-d G#cell_line
and NE xxx NE
Raji G#cell_line_B Xxxx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
revealed NE xxx NE
that NE xxx NE
the NE xxx NE
PuF G#DNA_domain_or_region_B XxX G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
functioned NE xxx NE
as NE xx NE
a NE x NE
positive G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
regulatory G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
element G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
in NE xx NE
B G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
with NE xxx NE
a NE x NE
drop NE xxx NE
in NE xx NE
activity NE xxx NE
with NE xxx NE
mutation NE xxx NE
of NE xx NE
this NE xxx NE
site NE xxx NE
. NE . NE

Access NE Xxxx NE
to NE xx NE
this NE xxx NE
site NE xxx NE
is NE xx NE
blocked NE xxx NE
in NE xx NE
the NE xxx NE
normal G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
silent G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
c-myc G#DNA_domain_or_region_M x-xxx G#DNA_domain_or_region_M
allele G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
; NE ; NE
these NE xxx NE
data NE xxx NE
suggest NE xxx NE
that NE xxx NE
the NE xxx NE
Nm23H2 G#protein_molecule XxddXd G#protein_molecule
protein NE xxx NE
is NE xx NE
involved NE xxx NE
in NE xx NE
deregulation NE xxx NE
of NE xx NE
the NE xxx NE
translocated NE xxx NE
c-myc G#DNA_domain_or_region_B x-xxx G#DNA_domain_or_region_B
allele G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
Burkitt's G#cell_line_B Xxxx'x G#cell_line_B
lymphoma G#cell_line_M xxx G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

Identification NE Xxxx NE
of NE xx NE
two NE xxx NE
novel NE xxx NE
regulatory G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
elements G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
within NE xxx NE
the NE xxx NE
5'-untranslated G#DNA_domain_or_region_B d'-xxx G#DNA_domain_or_region_B
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
the NE xxx NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
A G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
gamma-globin G#DNA_domain_or_region_M xxx-xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Interaction NE Xxxx NE
between NE xxx NE
the NE xxx NE
stage G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
selector G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
SSE G#DNA_substructure XXX G#DNA_substructure
) NE ) NE
in NE xx NE
the NE xxx NE
proximal G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
gamma-globin G#DNA_domain_or_region_M xxx-xxx G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
hypersensitivity G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
site G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
2 G#DNA_domain_or_region_E d G#DNA_domain_or_region_E
in NE xx NE
the NE xxx NE
locus G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
control G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
partly NE xxx NE
mediates NE xxx NE
the NE xxx NE
competitive NE xxx NE
silencing NE xxx NE
of NE xx NE
the NE xxx NE
beta-globin G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
the NE xxx NE
fetal NE xxx NE
developmental NE xxx NE
stage NE xxx NE
. NE . NE

We NE Xx NE
have NE xxx NE
now NE xxx NE
demonstrated NE xxx NE
that NE xxx NE
a NE x NE
second NE xxx NE
SSE-like G#DNA_domain_or_region_B XXX-xxx G#DNA_domain_or_region_B
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
the NE xxx NE
5'-untranslated G#DNA_domain_or_region_B d'-xxx G#DNA_domain_or_region_B
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
the NE xxx NE
gamma-gene G#DNA_domain_or_region xxx-xxx G#DNA_domain_or_region
also NE xxx NE
contributes NE xxx NE
to NE xx NE
this NE xxx NE
competitive NE xxx NE
silencing NE xxx NE
of NE xx NE
the NE xxx NE
beta-gene G#DNA_domain_or_region xxx-xxx G#DNA_domain_or_region
. NE . NE

Utilizing NE Xxxx NE
transient G#other_name_B xxx G#other_name_B
transfection G#other_name_M xxx G#other_name_M
assays G#other_name_E xxx G#other_name_E
in NE xx NE
the NE xxx NE
fetal G#cell_line_B xxx G#cell_line_B
erythroid G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
, NE , NE
K562 G#cell_line Xddd G#cell_line
, NE , NE
we NE xx NE
have NE xxx NE
shown NE xxx NE
that NE xxx NE
the NE xxx NE
core G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
enhancer G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
hypersensitivity G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
site G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
2 G#DNA_domain_or_region_E d G#DNA_domain_or_region_E
can NE xxx NE
preferentially NE xxx NE
interact NE xxx NE
with NE xxx NE
the NE xxx NE
proximal G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
gamma-promoter G#DNA_domain_or_region_E xxx-xxx G#DNA_domain_or_region_E
in NE xx NE
the NE xxx NE
absence NE xxx NE
of NE xx NE
the NE xxx NE
SSE G#DNA_domain_or_region XXX G#DNA_domain_or_region
, NE , NE
completely NE xxx NE
silencing NE xxx NE
a NE x NE
linked G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
beta-promoter G#DNA_domain_or_region_E xxx-xxx G#DNA_domain_or_region_E
. NE . NE

Mutation NE Xxxx NE
of NE xx NE
a NE x NE
20-base NE dd-xxx NE
pair NE xxx NE
sequence NE xxx NE
of NE xx NE
the NE xxx NE
gamma-gene G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
5'-untranslated G#DNA_domain_or_region_M d'-xxx G#DNA_domain_or_region_M
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
UTR G#DNA_domain_or_region XXX G#DNA_domain_or_region
) NE ) NE
led NE xxx NE
to NE xx NE
derepression NE xxx NE
of NE xx NE
beta-promoter G#other_name_B xxx-xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
. NE . NE

A NE X NE
marked NE xxx NE
activation NE xxx NE
of NE xx NE
gamma-promoter G#other_name_B xxx-xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
was NE xxx NE
also NE xxx NE
observed NE xxx NE
with NE xxx NE
this NE xxx NE
mutation G#other_name xxx G#other_name
, NE , NE
suggesting NE xxx NE
the NE xxx NE
presence NE xxx NE
of NE xx NE
a NE x NE
repressor NE xxx NE
. NE . NE

Fine NE Xxxx NE
mutagenesis G#other_name xxx G#other_name
dissected NE xxx NE
these NE xxx NE
activities NE xxx NE
to NE xx NE
different NE xxx NE
regions NE xxx NE
of NE xx NE
the NE xxx NE
5'-UTR G#DNA_domain_or_region d'-XXX G#DNA_domain_or_region
. NE . NE

The NE Xxx NE
stage G#other_name_B xxx G#other_name_B
selector G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
was NE xxx NE
localized NE xxx NE
to NE xx NE
a NE x NE
region NE xxx NE
centered NE xxx NE
on NE xx NE
nucleotides G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
+13 G#DNA_domain_or_region_M +dd G#DNA_domain_or_region_M
to G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
+15 G#DNA_domain_or_region_E +dd G#DNA_domain_or_region_E
. NE . NE

Electromobility G#other_name_B Xxxx G#other_name_B
shift G#other_name_M xxx G#other_name_M
assays G#other_name_E xxx G#other_name_E
utilizing NE xxx NE
this NE xxx NE
sequence NE xxx NE
demonstrated NE xxx NE
binding NE xxx NE
of NE xx NE
a NE x NE
fetal-specific G#protein_family_or_group_B xxx-xxx G#protein_family_or_group_B
protein G#protein_family_or_group_M xxx G#protein_family_or_group_M
and G#protein_family_or_group_M xxx G#protein_family_or_group_M
erythroid-specific G#protein_family_or_group_M xxx-xxx G#protein_family_or_group_M
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E

The NE Xxx NE
repressor G#other_name_B xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
5'-UTR G#DNA_domain_or_region d'-XXX G#DNA_domain_or_region
was NE xxx NE
localized NE xxx NE
to NE xx NE
tandem NE xxx NE
GATA-like G#DNA_family_or_group_B XXXX-xxx G#DNA_family_or_group_B
sites G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
, NE , NE
which NE xxx NE
appear NE xxx NE
to NE xx NE
bind NE xxx NE
a NE x NE
complex NE xxx NE
of NE xx NE
two NE xxx NE
proteins NE xxx NE
, NE , NE
one NE xxx NE
of NE xx NE
which NE xxx NE
is NE xx NE
the NE xxx NE
erythroid G#protein_family_or_group_B xxx G#protein_family_or_group_B
transcription G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
GATA-1 G#protein_molecule XXXX-d G#protein_molecule
. NE . NE

These NE Xxxx NE
results NE xxx NE
indicate NE xxx NE
that NE xxx NE
the NE xxx NE
5'-UTR G#DNA_domain_or_region d'-XXX G#DNA_domain_or_region
of NE xx NE
the NE xxx NE
gamma-gene G#DNA_domain_or_region xxx-xxx G#DNA_domain_or_region
contains NE xxx NE
sequences NE xxx NE
that NE xxx NE
may NE xxx NE
be NE xx NE
important NE xxx NE
for NE xxx NE
its NE xxx NE
transcriptional G#other_name_B xxx G#other_name_B
and G#other_name_M xxx G#other_name_M
developmental G#other_name_M xxx G#other_name_M
regulation G#other_name_E xxx G#other_name_E
. NE . NE

Coupling NE Xxxx NE
of NE xx NE
a NE x NE
signal G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
response G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
in NE xx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
to NE xx NE
multiple G#other_name_B xxx G#other_name_B
pathways G#other_name_E xxx G#other_name_E
for NE xxx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
activation G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
eukaryotic G#protein_family_or_group_B xxx G#protein_family_or_group_B
transcription G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
plays NE xxx NE
a NE x NE
central NE xxx NE
role NE xxx NE
in NE xx NE
the NE xxx NE
induced NE xxx NE
expression NE xxx NE
of NE xx NE
human G#virus_B xxx G#virus_B
immunodeficiency G#virus_M xxx G#virus_M
virus G#virus_M xxx G#virus_M
type G#virus_M xxx G#virus_M
1 G#virus_E d G#virus_E
and NE xxx NE
in NE xx NE
many NE xxx NE
aspects NE xxx NE
of NE xx NE
the NE xxx NE
genetic NE xxx NE
program NE xxx NE
mediating NE xxx NE
normal G#other_name_B xxx G#other_name_B
T-cell G#other_name_M X-xxx G#other_name_M
activation G#other_name_E xxx G#other_name_E
and NE xxx NE
growth NE xxx NE
. NE . NE

The NE Xxx NE
nuclear G#other_name_B xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
of NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
is NE xx NE
tightly NE xxx NE
regulated NE xxx NE
from NE xxx NE
the NE xxx NE
cytoplasmic G#cell_component_B xxx G#cell_component_B
compartment G#cell_component_E xxx G#cell_component_E
by NE xx NE
an NE xx NE
inhibitory G#protein_subunit_B xxx G#protein_subunit_B
subunit G#protein_subunit_E xxx G#protein_subunit_E
called NE xxx NE
I G#protein_subunit_B X G#protein_subunit_B
kappa G#protein_subunit_M xxx G#protein_subunit_M
B G#protein_subunit_M X G#protein_subunit_M
alpha G#protein_subunit_E xxx G#protein_subunit_E
. NE . NE

This NE Xxxx NE
cytoplasmic NE xxx NE
inhibitor NE xxx NE
is NE xx NE
rapidly NE xxx NE
phosphorylated NE xxx NE
and NE xxx NE
degraded NE xxx NE
in NE xx NE
response NE xxx NE
to NE xx NE
a NE x NE
diverse NE xxx NE
set NE xxx NE
of NE xx NE
NF-kappa NE XX-xxx NE
B NE X NE
-inducing NE -xxx NE
agents NE xxx NE
, NE , NE
including NE xxx NE
T-cell NE X-xxx NE
mitogens NE xxx NE
, NE , NE
proinflammatory NE xxx NE
cytokines NE xxx NE
, NE , NE
and NE xxx NE
viral NE xxx NE
transactivators NE xxx NE
such NE xxx NE
as NE xx NE
the NE xxx NE
Tax NE Xxx NE
protein NE xxx NE
of NE xx NE
human NE xxx NE
T-cell NE X-xxx NE
leukemia NE xxx NE
virus NE xxx NE
type NE xxx NE
1 NE d NE
. NE . NE

To NE Xx NE
explore NE xxx NE
these NE xxx NE
I NE X NE
kappa NE xxx NE
B NE X NE
alpha NE xxx NE
-dependent NE -xxx NE
mechanisms NE xxx NE
for NE xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
induction NE xxx NE
, NE , NE
we NE xx NE
identified NE xxx NE
novel NE xxx NE
mutants NE xxx NE
of NE xx NE
I NE X NE
kappa NE xxx NE
B NE X NE
alpha NE xxx NE
that NE xxx NE
uncouple NE xxx NE
its NE xxx NE
inhibitory NE xxx NE
and NE xxx NE
signal-transducing NE xxx-xxx NE
functions NE xxx NE
in NE xx NE
human NE xxx NE
T NE X NE
lymphocytes NE xxx NE
. NE . NE

Specifically NE Xxxx NE
, NE , NE
removal NE xxx NE
of NE xx NE
the NE xxx NE
N-terminal G#protein_domain_or_region_B X-xxx G#protein_domain_or_region_B
36 G#protein_domain_or_region_M dd G#protein_domain_or_region_M
amino G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
acids G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
of NE xx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
failed NE xxx NE
to NE xx NE
disrupt NE xxx NE
its NE xxx NE
ability NE xxx NE
to NE xx NE
form NE xxx NE
latent NE xxx NE
complexes NE xxx NE
with NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
in NE xx NE
the NE xxx NE
cytoplasm G#cell_component xxx G#cell_component
. NE . NE

However NE Xxxx NE
, NE , NE
this NE xxx NE
deletion NE xxx NE
mutation G#other_name xxx G#other_name
prevented NE xxx NE
the NE xxx NE
induced NE xxx NE
phosphorylation G#other_name xxx G#other_name
, NE , NE
degradative G#other_name_B xxx G#other_name_B
loss G#other_name_E xxx G#other_name_E
, NE , NE
and NE xxx NE
functional NE xxx NE
release NE xxx NE
of NE xx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
from NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
in NE xx NE
Tax NE Xxx NE
-expressing NE -xxx NE
cells NE xxx NE
. NE . NE

Alanine NE Xxxx NE
substitutions NE xxx NE
introduced NE xxx NE
at NE xx NE
two NE xxx NE
serine G#amino_acid_monomer_B xxx G#amino_acid_monomer_B
residues G#amino_acid_monomer_E xxx G#amino_acid_monomer_E
positioned NE xxx NE
within NE xxx NE
this NE xxx NE
N-terminal G#protein_domain_or_region_B X-xxx G#protein_domain_or_region_B
regulatory G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
region G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
of NE xx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
also NE xxx NE
yielded NE xxx NE
constitutive NE xxx NE
repressors NE xxx NE
that NE xxx NE
escaped NE xxx NE
from NE xxx NE
Tax G#other_name Xxx G#other_name
-induced NE -xxx NE
turnover NE xxx NE
and NE xxx NE
that NE xxx NE
potently NE xxx NE
inhibited NE xxx NE
immune G#other_name_B xxx G#other_name_B
activation G#other_name_M xxx G#other_name_M
pathways G#other_name_E xxx G#other_name_E
for NE xxx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
induction G#other_name_E xxx G#other_name_E
, NE , NE
including NE xxx NE
those NE xxx NE
initiated NE xxx NE
from NE xxx NE
antigen G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_M xxx G#protein_family_or_group_M
and G#protein_family_or_group_M xxx G#protein_family_or_group_M
cytokine G#protein_family_or_group_M xxx G#protein_family_or_group_M
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E

In NE Xx NE
contrast NE xxx NE
, NE , NE
introduction NE xxx NE
of NE xx NE
a NE x NE
phosphoserine G#amino_acid_monomer_B xxx G#amino_acid_monomer_B
mimetic G#amino_acid_monomer_E xxx G#amino_acid_monomer_E
at NE xx NE
these NE xxx NE
sites NE xxx NE
rectified NE xxx NE
this NE xxx NE
functional NE xxx NE
defect NE xxx NE
, NE , NE
a NE x NE
finding NE xxx NE
consistent NE xxx NE
with NE xxx NE
a NE x NE
causal NE xxx NE
linkage NE xxx NE
between NE xxx NE
the NE xxx NE
phosphorylation G#other_name_B xxx G#other_name_B
status G#other_name_E xxx G#other_name_E
and NE xxx NE
proteolytic G#other_name_B xxx G#other_name_B
stability G#other_name_E xxx G#other_name_E
of NE xx NE
this NE xxx NE
cytoplasmic G#protein_family_or_group_B xxx G#protein_family_or_group_B
inhibitor G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Together NE Xxxx NE
, NE , NE
these NE xxx NE
in NE xx NE
vivo NE xxx NE
studies NE xxx NE
define NE xxx NE
a NE x NE
critical NE xxx NE
signal NE xxx NE
response NE xxx NE
domain NE xxx NE
in NE xx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
that NE xxx NE
coordinately NE xxx NE
controls NE xxx NE
the NE xxx NE
biologic NE xxx NE
activities NE xxx NE
of NE xx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
and NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
in NE xx NE
response NE xxx NE
to NE xx NE
viral G#other_name_B xxx G#other_name_B
stimulus G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
immune G#other_name_M xxx G#other_name_M
stimulus G#other_name_E xxx G#other_name_E
stimuli NE xxx NE
. NE . NE

Growth G#other_name_B Xxxx G#other_name_B
regulation G#other_name_E xxx G#other_name_E
and NE xxx NE
cellular G#other_name_B xxx G#other_name_B
changes G#other_name_E xxx G#other_name_E
during NE xxx NE
differentiation NE xxx NE
of NE xx NE
human G#cell_line_B xxx G#cell_line_B
prostatic G#cell_line_M xxx G#cell_line_M
cancer G#cell_line_M xxx G#cell_line_M
LNCaP G#cell_line_M XXXxX G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
as NE xx NE
induced NE xxx NE
by NE xx NE
T G#other_organic_compound_B X G#other_organic_compound_B
lymphocyte-conditioned G#other_organic_compound_M xxx-xxx G#other_organic_compound_M
medium G#other_organic_compound_E xxx G#other_organic_compound_E
. NE . NE

Human G#cell_line_B Xxxx G#cell_line_B
prostatic G#cell_line_M xxx G#cell_line_M
epithelial G#cell_line_M xxx G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
from NE xxx NE
an NE xx NE
androgen-dependent G#cell_line_B xxx-xxx G#cell_line_B
LNCaP G#cell_line_M XXXxX G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
were NE xxx NE
examined NE xxx NE
in NE xx NE
response NE xxx NE
to NE xx NE
conditioned G#other_organic_compound_B xxx G#other_organic_compound_B
medium G#other_organic_compound_E xxx G#other_organic_compound_E
( NE ( NE
CM G#other_organic_compound XX G#other_organic_compound
) NE ) NE
derived NE xxx NE
from NE xxx NE
phytohemagglutinin NE xxx NE
( NE ( NE
PHA NE XXX NE
)-stimulated NE )-xxx NE
lymphocytes NE xxx NE
. NE . NE

Addition NE Xxxx NE
of NE xx NE
CM G#other_organic_compound XX G#other_organic_compound
caused NE xxx NE
a NE x NE
greater NE xxx NE
than NE xxx NE
70% NE dd% NE
reduction NE xxx NE
of NE xx NE
cell G#other_name_B xxx G#other_name_B
proliferation G#other_name_E xxx G#other_name_E
by NE xx NE
cell G#other_name_B xxx G#other_name_B
counting G#other_name_E xxx G#other_name_E
and NE xxx NE
cell G#other_name_B xxx G#other_name_B
cycle G#other_name_E xxx G#other_name_E
. NE . NE

These NE Xxxx NE
cells NE xxx NE
showed NE xxx NE
G1 G#other_name_B Xd G#other_name_B
phase G#other_name_M xxx G#other_name_M
arrest G#other_name_E xxx G#other_name_E
and NE xxx NE
the NE xxx NE
clonogenicity G#other_name xxx G#other_name
was NE xxx NE
reduced NE xxx NE
. NE . NE

The NE Xxx NE
growth-modulating NE xxx-xxx NE
effect NE xxx NE
was NE xxx NE
dose-dependent G#other_name xxx-xxx G#other_name
and NE xxx NE
not NE xxx NE
due NE xxx NE
to NE xx NE
cell G#other_name_B xxx G#other_name_B
lysis G#other_name_E xxx G#other_name_E
or NE xx NE
apoptosis G#other_name xxx G#other_name
. NE . NE

The NE Xxx NE
binding NE xxx NE
of NE xx NE
androgen G#lipid xxx G#lipid
to NE xx NE
androgen G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
on NE xx NE
these NE xxx NE
cells NE xxx NE
showed NE xxx NE
approximately NE xxx NE
50% NE dd% NE
reduction NE xxx NE
, NE , NE
underlining NE xxx NE
a NE x NE
proliferation G#other_name_B xxx G#other_name_B
reduction G#other_name_M xxx G#other_name_M
mechanism G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
prostate-specific G#protein_molecule_B xxx-xxx G#protein_molecule_B
antigen G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
PSA G#protein_molecule XXX G#protein_molecule
) NE ) NE
was NE xxx NE
downregulated NE xxx NE
to NE xx NE
approximately NE xxx NE
75% NE dd% NE
during NE xxx NE
the NE xxx NE
process NE xxx NE
. NE . NE

Cell G#other_name_B Xxxx G#other_name_B
morphology G#other_name_E xxx G#other_name_E
showed NE xxx NE
dendritic NE xxx NE
processes NE xxx NE
extending NE xxx NE
from NE xxx NE
cytoplasm G#cell_component xxx G#cell_component
and NE xxx NE
other NE xxx NE
neuroendocrine G#other_name_B xxx G#other_name_B
cell G#other_name_M xxx G#other_name_M
characteristics G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
expression NE xxx NE
of NE xx NE
several NE xxx NE
cytoskeleton G#protein_family_or_group_B xxx G#protein_family_or_group_B
protein G#protein_family_or_group_M xxx G#protein_family_or_group_M
and G#protein_family_or_group_M xxx G#protein_family_or_group_M
intracellular G#protein_family_or_group_M xxx G#protein_family_or_group_M
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
increased NE xxx NE
as NE xx NE
determined NE xxx NE
by NE xx NE
immunostaining G#other_name xxx G#other_name
on NE xx NE
slides NE xxx NE
and NE xxx NE
by NE xx NE
ELISA G#other_name_B XXXXX G#other_name_B
procedures G#other_name_E xxx G#other_name_E
. NE . NE

These NE Xxxx NE
included NE xxx NE
vimentin G#protein_molecule xxx G#protein_molecule
, NE , NE
correlating NE xxx NE
to NE xx NE
cell G#other_name_B xxx G#other_name_B
shape G#other_name_M xxx G#other_name_M
changes G#other_name_E xxx G#other_name_E
, NE , NE
cytokeratins NE xxx NE
cytokeratin G#protein_molecule_B xxx G#protein_molecule_B
8 G#protein_molecule_M d G#protein_molecule_M
and G#protein_molecule_M xxx G#protein_molecule_M
cytokeratin G#protein_molecule_M xxx G#protein_molecule_M
18 G#protein_molecule_E dd G#protein_molecule_E
differentiated NE xxx NE
cell NE xxx NE
types NE xxx NE
of NE xx NE
prostate G#tissue_B xxx G#tissue_B
epithelia G#tissue_E xxx G#tissue_E
, NE , NE
and NE xxx NE
neuron-specific G#protein_molecule_B xxx-xxx G#protein_molecule_B
enolase G#protein_molecule_E xxx G#protein_molecule_E
and NE xxx NE
serotonin G#other_organic_compound xxx G#other_organic_compound
, NE , NE
associated NE xxx NE
with NE xxx NE
neuroendocrine G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

From NE Xxxx NE
these NE xxx NE
cellular G#other_name_B xxx G#other_name_B
changes G#other_name_E xxx G#other_name_E
, NE , NE
we NE xx NE
can NE xxx NE
infer NE xxx NE
that NE xxx NE
the NE xxx NE
cell G#other_name_B xxx G#other_name_B
growth G#other_name_E xxx G#other_name_E
was NE xxx NE
modulated NE xxx NE
along NE xxx NE
with NE xxx NE
induction NE xxx NE
of NE xx NE
terminal G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
. NE . NE

Activated NE Xxxx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
were NE xxx NE
demonstrated NE xxx NE
to NE xx NE
be NE xx NE
important NE xxx NE
in NE xx NE
providing NE xxx NE
the NE xxx NE
modulating NE xxx NE
activity NE xxx NE
. NE . NE

This NE Xxxx NE
growth G#protein_family_or_group_B xxx G#protein_family_or_group_B
modulator G#protein_family_or_group_E xxx G#protein_family_or_group_E
was NE xxx NE
semipurified NE xxx NE
and NE xxx NE
had NE xxx NE
an NE xx NE
estimated NE xxx NE
molecular NE xxx NE
weight NE xxx NE
13,000 NE dd,ddd NE
to NE xx NE
24,000 NE dd,ddd NE
Da NE Xx NE
. NE . NE

The NE Xxx NE
activity NE xxx NE
was NE xxx NE
determined NE xxx NE
to NE xx NE
be NE xx NE
distinct NE xxx NE
from NE xxx NE
TGF G#protein_family_or_group XXX G#protein_family_or_group
, NE , NE
TNF G#protein_family_or_group XXX G#protein_family_or_group
, NE , NE
and NE xxx NE
some NE xxx NE
commonly NE xxx NE
known NE xxx NE
lymphokines G#protein_family_or_group xxx G#protein_family_or_group
. NE . NE

The NE Xxx NE
interaction NE xxx NE
between NE xxx NE
lymphoid G#cell_type_B xxx G#cell_type_B
cell G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
prostatic G#cell_type_M xxx G#cell_type_M
cell G#cell_type_E xxx G#cell_type_E

Platelet-activating G#protein_family_or_group_B Xxxx-xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
stimulates NE xxx NE
transcription NE xxx NE
of NE xx NE
the NE xxx NE
heparin-binding G#protein_molecule_B xxx-xxx G#protein_molecule_B
epidermal G#protein_molecule_M xxx G#protein_molecule_M
growth G#protein_molecule_M xxx G#protein_molecule_M
factor-like G#protein_molecule_M xxx-xxx G#protein_molecule_M
growth G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_E xxx G#protein_molecule_E
in NE xx NE
monocytes G#cell_type xxx G#cell_type
. NE . NE

Correlation NE Xxxx NE
with NE xxx NE
an NE xx NE
increased NE xxx NE
kappa G#other_name_B xxx G#other_name_B
B G#other_name_M X G#other_name_M
binding G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
. NE . NE

Human NE Xxxx NE
peripheral NE xxx NE
blood NE xxx NE
monocytes G#cell_type xxx G#cell_type
responded NE xxx NE
to NE xx NE
stimulation NE xxx NE
of NE xx NE
platelet-activating G#protein_molecule_B xxx-xxx G#protein_molecule_B
factor G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
PAF G#protein_molecule XXX G#protein_molecule
) NE ) NE
with NE xxx NE
up-regulation NE xx-xxx NE
of NE xx NE
the NE xxx NE
transcript NE xxx NE
for NE xxx NE
heparin-binding G#protein_molecule_B xxx-xxx G#protein_molecule_B
epidermal G#protein_molecule_M xxx G#protein_molecule_M
growth G#protein_molecule_M xxx G#protein_molecule_M
factor-like G#protein_molecule_M xxx-xxx G#protein_molecule_M
growth G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
HB-EGF G#protein_molecule XX-XXX G#protein_molecule
) NE ) NE
, NE , NE
a NE x NE
potent G#protein_family_or_group_B xxx G#protein_family_or_group_B
mitogen G#protein_family_or_group_E xxx G#protein_family_or_group_E
for NE xxx NE
vascular G#cell_type_B xxx G#cell_type_B
smooth G#cell_type_M xxx G#cell_type_M
muscle G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

This NE Xxxx NE
function NE xxx NE
of NE xx NE
PAF G#protein_molecule XXX G#protein_molecule
was NE xxx NE
observed NE xxx NE
at NE xx NE
nanomolar NE xxx NE
concentrations NE xxx NE
of NE xx NE
the NE xxx NE
ligand NE xxx NE
, NE , NE
starting NE xxx NE
at NE xx NE
30 NE dd NE
min NE xxx NE
after NE xxx NE
stimulation NE xxx NE
. NE . NE

The NE Xxx NE
PAF G#protein_molecule XXX G#protein_molecule
-induced NE -xxx NE
up-regulation NE xx-xxx NE
of NE xx NE
HB-EGF G#RNA_molecule_B XX-XXX G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
was NE xxx NE
accompanied NE xxx NE
by NE xx NE
an NE xx NE
increase NE xxx NE
in NE xx NE
kappa G#other_name_B xxx G#other_name_B
B G#other_name_M X G#other_name_M
binding G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
. NE . NE

These NE Xxxx NE
functions NE xxx NE
of NE xx NE
PAF G#protein_molecule XXX G#protein_molecule
appeared NE xxx NE
to NE xx NE
be NE xx NE
mediated NE xxx NE
through NE xxx NE
the NE xxx NE
cell G#protein_family_or_group_B xxx G#protein_family_or_group_B
surface G#protein_family_or_group_M xxx G#protein_family_or_group_M
PAF G#protein_family_or_group_M XXX G#protein_family_or_group_M
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
as NE xx NE
two NE xxx NE
PAF G#other_name_B XXX G#other_name_B
receptor G#other_name_M xxx G#other_name_M
antagonists G#other_name_E xxx G#other_name_E
, NE , NE
WEB G#other_organic_compound_B XXX G#other_organic_compound_B
2086 G#other_organic_compound_E dddd G#other_organic_compound_E
and NE xxx NE
L-659,989 G#other_organic_compound X-ddd,ddd G#other_organic_compound
, NE , NE
blocked NE xxx NE
both NE xxx NE
the NE xxx NE
up-regulation NE xx-xxx NE
of NE xx NE
HB-EGF G#RNA_molecule_B XX-XXX G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
and NE xxx NE
kappa G#other_name_B xxx G#other_name_B
B G#other_name_M X G#other_name_M
binding G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
induced NE xxx NE
by NE xx NE
PAF G#protein_molecule XXX G#protein_molecule
. NE . NE

The NE Xxx NE
antagonists NE xxx NE
, NE , NE
however NE xxx NE
, NE , NE
had NE xxx NE
no NE xx NE
effect NE xxx NE
on NE xx NE
phorbol NE xxx NE
ester NE xxx NE
-induced NE -xxx NE
up-regulation NE xx-xxx NE
of NE xx NE
HB-EGF NE XX-XXX NE
mRNA NE xXXX NE
and NE xxx NE
kappa NE xxx NE
B NE X NE
binding NE xxx NE
activity NE xxx NE
. NE . NE

Pretreatment NE Xxxx NE
of NE xx NE
monocytes G#cell_type xxx G#cell_type
with NE xxx NE
pertussis NE xxx NE
toxin NE xxx NE
inhibited NE xxx NE
these NE xxx NE
functions NE xxx NE
of NE xx NE
PAF G#protein_molecule XXX G#protein_molecule
, NE , NE
whereas NE xxx NE
cholera G#other_organic_compound_B xxx G#other_organic_compound_B
toxin G#other_organic_compound_E xxx G#other_organic_compound_E
had NE xxx NE
no NE xx NE
inhibitory NE xxx NE
effect NE xxx NE
. NE . NE

Pyrrolidine G#other_organic_compound_B Xxxx G#other_organic_compound_B
dithiocarbamate G#other_organic_compound_E xxx G#other_organic_compound_E
, NE , NE
an NE xx NE
inhibitor NE xxx NE
for NE xxx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
activation G#other_name_E xxx G#other_name_E
, NE , NE
markedly NE xxx NE
reduced NE xxx NE
PAF NE XXX NE
-stimulated NE -xxx NE
kappa NE xxx NE
B NE X NE
binding NE xxx NE
activity NE xxx NE
as NE xx NE
well NE xxx NE
as NE xx NE
up-regulation NE xx-xxx NE
of NE xx NE
HB-EGF NE XX-XXX NE
mRNA NE xXXX NE
. NE . NE

These NE Xxxx NE
results NE xxx NE
suggest NE xxx NE
a NE x NE
potential NE xxx NE
role NE xxx NE
of NE xx NE
PAF G#protein_molecule XXX G#protein_molecule
in NE xx NE
HB-EGF G#other_name_B XX-XXX G#other_name_B
expression G#other_name_E xxx G#other_name_E
and NE xxx NE
provide NE xxx NE
evidence NE xxx NE
that NE xxx NE
this NE xxx NE
stimulation NE xxx NE
may NE xxx NE
occur NE xxx NE
through NE xxx NE
increased NE xxx NE
kappa G#other_name_B xxx G#other_name_B
B G#other_name_M X G#other_name_M
binding G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
. NE . NE

Mapping NE Xxxx NE
of NE xx NE
the NE xxx NE
interaction G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
site G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
of NE xx NE
the NE xxx NE
defective G#protein_family_or_group_B xxx G#protein_family_or_group_B
transcription G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
in NE xx NE
the NE xxx NE
class G#cell_line_B xxx G#cell_line_B
II G#cell_line_M XX G#cell_line_M
major G#cell_line_M xxx G#cell_line_M
histocompatibility G#cell_line_M xxx G#cell_line_M
complex G#cell_line_M xxx G#cell_line_M
mutant G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_M xxx G#cell_line_M
clone-13 G#cell_line_E xxx-dd G#cell_line_E
to NE xx NE
the NE xxx NE
divergent G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
X2-box G#DNA_domain_or_region_E Xd-xxx G#DNA_domain_or_region_E
. NE . NE

We NE Xx NE
have NE xxx NE
previously NE xxx NE
described NE xxx NE
a NE x NE
mutant G#cell_line_B xxx G#cell_line_B
B G#cell_line_M X G#cell_line_M
lymphoblastoid G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
, NE , NE
Clone-13 NE Xxxx-dd NE
, NE , NE
that NE xxx NE
expresses NE xxx NE
HLA-DQ G#protein_molecule XXX-XX G#protein_molecule
in NE xx NE
the NE xxx NE
absence NE xxx NE
of NE xx NE
HLA-DR G#protein_molecule_B XXX-XX G#protein_molecule_B
and G#protein_molecule_M xxx G#protein_molecule_M
HLA-DP G#protein_molecule_E XXX-XX G#protein_molecule_E

Several NE Xxxx NE
criteria NE xxx NE
indicated NE xxx NE
that NE xxx NE
the NE xxx NE
defect NE xxx NE
in NE xx NE
this NE xxx NE
cell NE xxx NE
line NE xxx NE
influences NE xxx NE
the NE xxx NE
activity NE xxx NE
of NE xx NE
an NE xx NE
isotype-specific G#protein_family_or_group_B xxx-xxx G#protein_family_or_group_B
transcription G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Indeed NE Xxxx NE
, NE , NE
transient NE xxx NE
transfection NE xxx NE
of NE xx NE
HLA-DRA G#DNA_molecule_B XXX-XXX G#DNA_molecule_B
reporter G#DNA_molecule_M xxx G#DNA_molecule_M
construct G#DNA_molecule_M xxx G#DNA_molecule_M
and G#DNA_molecule_M xxx G#DNA_molecule_M
DQB G#DNA_molecule_M XXX G#DNA_molecule_M
reporter G#DNA_molecule_M xxx G#DNA_molecule_M
construct G#DNA_molecule_E xxx G#DNA_molecule_E
indicated NE xxx NE
that NE xxx NE
the NE xxx NE
affected NE xxx NE
factor NE xxx NE
operates NE xxx NE
via NE xxx NE
cis-elements G#DNA_family_or_group xxx-xxx G#DNA_family_or_group
located NE xxx NE
between NE xxx NE
-141 G#DNA_domain_or_region_B -ddd G#DNA_domain_or_region_B
base G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
pairs G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
the NE xxx NE
transcription G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
initiation G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

A NE X NE
series NE xxx NE
of NE xx NE
hybrid G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
DRA/DQB G#DNA_family_or_group_M XXX/XXX G#DNA_family_or_group_M
reporter G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
constructs G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
was NE xxx NE
generated NE xxx NE
to NE xx NE
further NE xxx NE
map NE xxx NE
the NE xxx NE
relevant NE xxx NE
cis-elements G#DNA_family_or_group xxx-xxx G#DNA_family_or_group
in NE xx NE
this NE xxx NE
system NE xxx NE
. NE . NE

Insertion NE Xxxx NE
of NE xx NE
oligonucleotides G#polynucleotide xxx G#polynucleotide
spanning NE xxx NE
the NE xxx NE
DQB G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
X-box G#DNA_domain_or_region_E X-xxx G#DNA_domain_or_region_E
(but NE (xxx NE
not NE xxx NE
the NE xxx NE
DQB-W G#DNA_domain_or_region_B XXX-X G#DNA_domain_or_region_B
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
or NE xx NE
the NE xxx NE
DQB G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
Y-box G#DNA_domain_or_region_E X-xxx G#DNA_domain_or_region_E
) NE ) NE
upstream G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
of G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
-141 G#DNA_domain_or_region_E -ddd G#DNA_domain_or_region_E
in NE xx NE
a NE x NE
DRA G#DNA_molecule_B XXX G#DNA_molecule_B
reporter G#DNA_molecule_M xxx G#DNA_molecule_M
plasmid G#DNA_molecule_E xxx G#DNA_molecule_E
rescued NE xxx NE
expression NE xxx NE
to NE xx NE
nearly NE xxx NE
wild-type G#other_name_B xxx-xxx G#other_name_B
levels G#other_name_E xxx G#other_name_E
. NE . NE

Substitution NE Xxxx NE
promoters NE xxx NE
were NE xxx NE
then NE xxx NE
generated NE xxx NE
where NE xxx NE
the NE xxx NE
entire NE xxx NE
X-box G#DNA_domain_or_region X-xxx G#DNA_domain_or_region
, NE , NE
or NE xx NE
only NE xxx NE
the NE xxx NE
X1-box G#DNA_domain_or_region_B Xd-xxx G#DNA_domain_or_region_B
or G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
X2-box G#DNA_domain_or_region_E Xd-xxx G#DNA_domain_or_region_E
boxes NE xxx NE
of NE xx NE
HLA-DRA G#DNA_domain_or_region XXX-XXX G#DNA_domain_or_region
were NE xxx NE
replaced NE xxx NE
with NE xxx NE
the NE xxx NE
analogous NE xxx NE
regions NE xxx NE
of NE xx NE
HLA-DQB G#DNA_domain_or_region XXX-XXX G#DNA_domain_or_region
. NE . NE

The NE Xxx NE
DQB G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
X2-box G#DNA_domain_or_region_E Xd-xxx G#DNA_domain_or_region_E
was NE xxx NE
able NE xxx NE
to NE xx NE
restore NE xxx NE
expression NE xxx NE
to NE xx NE
the NE xxx NE
silent G#DNA_molecule_B xxx G#DNA_molecule_B
DRA G#DNA_molecule_M XXX G#DNA_molecule_M
reporter G#DNA_molecule_M xxx G#DNA_molecule_M
construct G#DNA_molecule_E xxx G#DNA_molecule_E
. NE . NE

Moreover NE Xxxx NE
, NE , NE
replacement NE xxx NE
of NE xx NE
the NE xxx NE
DQB G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
X2-box G#DNA_domain_or_region_E Xd-xxx G#DNA_domain_or_region_E
with NE xxx NE
the NE xxx NE
DRA G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
X2-box G#DNA_domain_or_region_E Xd-xxx G#DNA_domain_or_region_E
markedly NE xxx NE
diminished NE xxx NE
the NE xxx NE
activity NE xxx NE
of NE xx NE
the NE xxx NE
DQB G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
the NE xxx NE
mutant G#cell_line_B xxx G#cell_line_B
cell G#cell_line_E xxx G#cell_line_E
. NE . NE

None NE Xxxx NE
of NE xx NE
the NE xxx NE
hybrid G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
reporter G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
constructs G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
were NE xxx NE
defective NE xxx NE
when NE xxx NE
transfected NE xxx NE
into NE xxx NE
the NE xxx NE
wild-type G#protein_family_or_group xxx-xxx G#protein_family_or_group
, NE , NE
HLA-DR/-DQ G#cell_line_B XXX-XX/-XX G#cell_line_B
positive G#cell_line_M xxx G#cell_line_M
parental G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
, NE , NE
Jijoye G#cell_line Xxxx G#cell_line
. NE . NE

These NE Xxxx NE
studies NE xxx NE
suggest NE xxx NE
that NE xxx NE
the NE xxx NE
divergent G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
X2-box G#DNA_domain_or_region_E Xd-xxx G#DNA_domain_or_region_E
of NE xx NE
the NE xxx NE
class G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
II G#DNA_family_or_group_M XX G#DNA_family_or_group_M
major G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
histocompatibility G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
complex G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
promoters G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
plays NE xxx NE
an NE xx NE
important NE xxx NE
role NE xxx NE
in NE xx NE
influencing NE xxx NE
differential G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
human G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
class G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
II G#DNA_family_or_group_M XX G#DNA_family_or_group_M
isotypes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
. NE . NE

Restoration NE Xxxx NE
of NE xx NE
the NE xxx NE
Epstein-Barr G#protein_molecule_B Xxxx-Xxxx G#protein_molecule_B
virus G#protein_molecule_M xxx G#protein_molecule_M
ZEBRA G#protein_molecule_M XXXXX G#protein_molecule_M
protein G#protein_molecule_E xxx G#protein_molecule_E
's NE 'x NE
capacity NE xxx NE
to NE xx NE
disrupt NE xxx NE
latency NE xxx NE
by NE xx NE
the NE xxx NE
addition NE xxx NE
of NE xx NE
heterologous G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
activation G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
regions G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
. NE . NE

The NE Xxx NE
ZEBRA G#protein_molecule_B XXXXX G#protein_molecule_B
protein G#protein_molecule_E xxx G#protein_molecule_E
has NE xxx NE
a NE x NE
unique NE xxx NE
biological NE xxx NE
function NE xxx NE
among NE xxx NE
herpesviral G#protein_family_or_group_B xxx G#protein_family_or_group_B
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

It NE Xx NE
is NE xx NE
responsible NE xxx NE
for NE xxx NE
the NE xxx NE
disruption NE xxx NE
of NE xx NE
Epstein-Barr NE Xxxx-Xxxx NE
virus NE xxx NE
( NE ( NE
EBV NE XXX NE
) NE ) NE
latency NE xxx NE
and NE xxx NE
the NE xxx NE
induction NE xxx NE
of NE xx NE
the NE xxx NE
lytic NE xxx NE
cycle NE xxx NE
. NE . NE

ZEBRA G#protein_molecule XXXXX G#protein_molecule
is NE xx NE
a NE x NE
bZIP G#protein_family_or_group_B xXXX G#protein_family_or_group_B
transcriptional G#protein_family_or_group_M xxx G#protein_family_or_group_M
activator G#protein_family_or_group_E xxx G#protein_family_or_group_E
which NE xxx NE
binds NE xxx NE
as NE xx NE
a NE x NE
dimer NE xxx NE
to NE xx NE
7-bp G#DNA_family_or_group_B d-xx G#DNA_family_or_group_B
response G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
elements G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
within NE xxx NE
EBV G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
promoters G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
is NE xx NE
directly NE xxx NE
involved NE xxx NE
in NE xx NE
the NE xxx NE
stimulation NE xxx NE
of NE xx NE
virus G#other_name_B xxx G#other_name_B
replication G#other_name_E xxx G#other_name_E
at NE xx NE
the NE xxx NE
EBV G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
lytic G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
origin G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

We NE Xx NE
have NE xxx NE
employed NE xxx NE
the NE xxx NE
ZEBRA NE XXXXX NE
/EBV NE /XXX NE
biological NE xxx NE
system NE xxx NE
to NE xx NE
test NE xxx NE
whether NE xxx NE
a NE x NE
heterologous NE xxx NE
activation NE xxx NE
domain NE xxx NE
can NE xxx NE
substitute NE xxx NE
for NE xxx NE
another NE xxx NE
activation NE xxx NE
domain NE xxx NE
(the NE (xxx NE
ZEBRA NE XXXXX NE
domain NE xxx NE
) NE ) NE
. NE . NE

The NE Xxx NE
ZEBRA G#protein_domain_or_region_B XXXXX G#protein_domain_or_region_B
activation G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
region G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
was NE xxx NE
replaced NE xxx NE
with NE xxx NE
the NE xxx NE
potent NE xxx NE
acid G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
activation G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
region G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
from NE xxx NE
the NE xxx NE
herpes G#protein_molecule_B xxx G#protein_molecule_B
simplex G#protein_molecule_M xxx G#protein_molecule_M
virus G#protein_molecule_M xxx G#protein_molecule_M
VP16 G#protein_molecule_M XXdd G#protein_molecule_M
protein G#protein_molecule_E xxx G#protein_molecule_E
or NE xx NE
with NE xxx NE
the NE xxx NE
activation G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
region G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
of NE xx NE
the NE xxx NE
EBV G#protein_molecule_B XXX G#protein_molecule_B
R G#protein_molecule_M X G#protein_molecule_M
protein G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

Both NE Xxxx NE
chimeras NE xxx NE
were NE xxx NE
found NE xxx NE
to NE xx NE
transactivate NE xxx NE
model NE xxx NE
and NE xxx NE
native NE xxx NE
promoters NE xxx NE
at NE xx NE
equivalent NE xxx NE
or NE xx NE
better NE xxx NE
levels NE xxx NE
than NE xxx NE
ZEBRA G#protein_molecule XXXXX G#protein_molecule
itself NE xxx NE
. NE . NE

Activation NE Xxxx NE
was NE xxx NE
not NE xxx NE
target- NE xxx- NE
or NE xx NE
cell-type NE xxx-xxx NE
dependent NE xxx NE
, NE , NE
nor NE xxx NE
was NE xxx NE
it NE xx NE
dependent NE xxx NE
on NE xx NE
the NE xxx NE
presence NE xxx NE
of NE xx NE
virus G#virus xxx G#virus
. NE . NE

These NE Xxxx NE
activation NE xxx NE
domains NE xxx NE
restored NE xxx NE
ZEBRA G#protein_molecule XXXXX G#protein_molecule
's NE 'x NE
ability NE xxx NE
to NE xx NE
induce NE xxx NE
early G#protein_family_or_group_B xxx G#protein_family_or_group_B
antigen G#protein_family_or_group_E xxx G#protein_family_or_group_E
and NE xxx NE
to NE xx NE
stimulate NE xxx NE
origin G#other_name_B xxx G#other_name_B
replication G#other_name_E xxx G#other_name_E
to NE xx NE
levels NE xxx NE
that NE xxx NE
were NE xxx NE
equal NE xxx NE
to NE xx NE
or NE xx NE
greater NE xxx NE
than NE xxx NE
those NE xxx NE
of NE xx NE
wild NE xxx NE
type NE xxx NE
. NE . NE

These NE Xxxx NE
studies NE xxx NE
suggest NE xxx NE
that NE xxx NE
the NE xxx NE
specificities NE xxx NE
of NE xx NE
some NE xxx NE
of NE xx NE
the NE xxx NE
known NE xxx NE
biological NE xxx NE
functions NE xxx NE
of NE xx NE
ZEBRA G#protein_molecule XXXXX G#protein_molecule
are NE xxx NE
not NE xxx NE
dependent NE xxx NE
upon NE xxx NE
the NE xxx NE
nature NE xxx NE
of NE xx NE
the NE xxx NE
activation G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
domain G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
present G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
within NE xxx NE
ZEBRA G#protein_molecule XXXXX G#protein_molecule
. NE . NE

Interleukin G#protein_molecule_B Xxxx G#protein_molecule_B
4 G#protein_molecule_E d G#protein_molecule_E
activates NE xxx NE
a NE x NE
signal G#other_name_B xxx G#other_name_B
transducer G#other_name_E xxx G#other_name_E
and NE xxx NE
activator G#other_name xxx G#other_name
of NE xx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
(Stat) G#protein_family_or_group_M (Xxxx) G#protein_family_or_group_M
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
which NE xxx NE
interacts NE xxx NE
with NE xxx NE
an NE xx NE
interferon-gamma G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
activation G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site-like G#DNA_domain_or_region_M xxx-xxx G#DNA_domain_or_region_M
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
upstream NE xxx NE
of NE xx NE
the NE xxx NE
I G#DNA_domain_or_region_B X G#DNA_domain_or_region_B
epsilon G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
exon G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
a NE x NE
human G#cell_line_B xxx G#cell_line_B
B G#cell_line_M X G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
. NE . NE

Evidence NE Xxxx NE
for NE xxx NE
the NE xxx NE
involvement NE xxx NE
of NE xx NE
Janus G#protein_molecule_B Xxxx G#protein_molecule_B
kinase G#protein_molecule_M xxx G#protein_molecule_M
3 G#protein_molecule_E d G#protein_molecule_E
and NE xxx NE
interleukin-4 G#protein_molecule_B xxx-d G#protein_molecule_B
Stat G#protein_molecule_E Xxxx G#protein_molecule_E
. NE . NE

Germ G#RNA_family_or_group_B Xxxx G#RNA_family_or_group_B
line G#RNA_family_or_group_M xxx G#RNA_family_or_group_M
C G#RNA_family_or_group_M X G#RNA_family_or_group_M
transcripts G#RNA_family_or_group_E xxx G#RNA_family_or_group_E
can NE xxx NE
be NE xx NE
induced NE xxx NE
by NE xx NE
IL-4 G#protein_molecule XX-d G#protein_molecule
in NE xx NE
the NE xxx NE
human G#cell_line_B xxx G#cell_line_B
B G#cell_line_M X G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
, NE , NE
BL-2 G#cell_line XX-d G#cell_line
. NE . NE

Utilizing NE Xxxx NE
a NE x NE
IFN-gamma G#DNA_domain_or_region_B XXX-xxx G#DNA_domain_or_region_B
activation G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site-like G#DNA_domain_or_region_M xxx-xxx G#DNA_domain_or_region_M
DNA G#DNA_domain_or_region_M XXX G#DNA_domain_or_region_M
sequence G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
located NE xxx NE
upstream NE xxx NE
of NE xx NE
the NE xxx NE
I G#DNA_domain_or_region_B X G#DNA_domain_or_region_B
epsilon G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
exon G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
we NE xx NE
demonstrated NE xxx NE
by NE xx NE
gel G#other_name_B xxx G#other_name_B
mobility G#other_name_M xxx G#other_name_M
shift G#other_name_M xxx G#other_name_M
assays G#other_name_E xxx G#other_name_E
that NE xxx NE
IL-4 G#protein_molecule XX-d G#protein_molecule
induced NE xxx NE
a NE x NE
binding NE xxx NE
activity NE xxx NE
in NE xx NE
the NE xxx NE
cytosol G#cell_component xxx G#cell_component
and NE xxx NE
nucleus G#cell_component xxx G#cell_component
of NE xx NE
BL-2 G#cell_line_B XX-d G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

This NE Xxxx NE
factor NE xxx NE
was NE xxx NE
designated NE xxx NE
IL-4 G#protein_molecule_B XX-d G#protein_molecule_B
NAF G#protein_molecule_E XXX G#protein_molecule_E
( NE ( NE
IL-4 NE XX-d NE
-induced NE -xxx NE
nuclear-activating NE xxx-xxx NE
factors NE xxx NE
) NE ) NE
and NE xxx NE
was NE xxx NE
identified NE xxx NE
as NE xx NE
a NE x NE
tyrosine NE xxx NE
phosphoprotein NE xxx NE
, NE , NE
which NE xxx NE
translocates NE xxx NE
from NE xxx NE
the NE xxx NE
cytosol NE xxx NE
to NE xx NE
the NE xxx NE
nucleus NE xxx NE
upon NE xxx NE
IL-4 NE XX-d NE
treatment NE xxx NE
. NE . NE

Because NE Xxxx NE
these NE xxx NE
are NE xxx NE
the NE xxx NE
characteristics NE xxx NE
of NE xx NE
a NE x NE
signal G#protein_family_or_group_B xxx G#protein_family_or_group_B
transducer G#protein_family_or_group_M xxx G#protein_family_or_group_M
and G#protein_family_or_group_M xxx G#protein_family_or_group_M
activator G#protein_family_or_group_M xxx G#protein_family_or_group_M
of G#protein_family_or_group_M xx G#protein_family_or_group_M
transcription G#protein_family_or_group_M xxx G#protein_family_or_group_M
(Stat) G#protein_family_or_group_M (Xxxx) G#protein_family_or_group_M
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
we NE xx NE
determined NE xxx NE
whether NE xxx NE
antibodies G#protein_family_or_group_B xxx G#protein_family_or_group_B
to G#protein_family_or_group_M xx G#protein_family_or_group_M
Stat G#protein_family_or_group_M Xxxx G#protein_family_or_group_M
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
will NE xxx NE
interfere NE xxx NE
with NE xxx NE
gel G#other_name_B xxx G#other_name_B
mobility G#other_name_M xxx G#other_name_M
shift G#other_name_E xxx G#other_name_E
and NE xxx NE
found NE xxx NE
that NE xxx NE
antibodies G#protein_family_or_group_B xxx G#protein_family_or_group_B
to G#protein_family_or_group_M xx G#protein_family_or_group_M
IL-4 G#protein_family_or_group_M XX-d G#protein_family_or_group_M
Stat G#protein_family_or_group_E Xxxx G#protein_family_or_group_E
, NE , NE
also NE xxx NE
known NE xxx NE
as NE xx NE
Stat6 G#protein_molecule Xxxxd G#protein_molecule
, NE , NE
but NE xxx NE
not NE xxx NE
antibodies NE xxx NE
to NE xx NE
other NE xxx NE
Stat NE Xxxx NE
proteins NE xxx NE
, NE , NE
interfere NE xxx NE
with NE xxx NE
the NE xxx NE
formation NE xxx NE
of NE xx NE
the NE xxx NE
IL-4 NE XX-d NE
NAF NE XXX NE
complex NE xxx NE
. NE . NE

Congruous NE Xxxx NE
with NE xxx NE
the NE xxx NE
involvement NE xxx NE
of NE xx NE
a NE x NE
Stat G#protein_family_or_group_B Xxxx G#protein_family_or_group_B
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
IL-4 G#protein_molecule XX-d G#protein_molecule
induced NE xxx NE
robust NE xxx NE
Janus NE Xxxx NE
kinase NE xxx NE
3 NE d NE
( NE ( NE
JAK3 NE XXXd NE
) NE ) NE
activity NE xxx NE
in NE xx NE
BL-2 NE XX-d NE
cells NE xxx NE
. NE . NE

Cotransfection NE Xxxx NE
of NE xx NE
JAK3 G#protein_molecule XXXd G#protein_molecule
with NE xxx NE
IL-4 G#protein_molecule_B XX-d G#protein_molecule_B
Stat G#protein_molecule_E Xxxx G#protein_molecule_E
into NE xxx NE
COS-7 G#cell_line_B XXX-d G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
produced NE xxx NE
an NE xx NE
intracellular NE xxx NE
activity NE xxx NE
which NE xxx NE
bound NE xxx NE
the NE xxx NE
same NE xxx NE
IFN-gamma G#DNA_domain_or_region_B XXX-xxx G#DNA_domain_or_region_B
activation G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site-like G#DNA_domain_or_region_M xxx-xxx G#DNA_domain_or_region_M
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
comigrated NE xxx NE
with NE xxx NE
IL-4 G#protein_complex_B XX-d G#protein_complex_B
NAF G#protein_complex_E XXX G#protein_complex_E
in NE xx NE
electrophoretic G#other_name_B xxx G#other_name_B
mobility G#other_name_M xxx G#other_name_M
shift G#other_name_M xxx G#other_name_M
assay G#other_name_E xxx G#other_name_E
. NE . NE

These NE Xxxx NE
results NE xxx NE
show NE xxx NE
that NE xxx NE
IL-4 G#protein_complex_B XX-d G#protein_complex_B
NAF G#protein_complex_E XXX G#protein_complex_E
is NE xx NE
IL-4 G#protein_molecule_B XX-d G#protein_molecule_B
Stat G#protein_molecule_E Xxxx G#protein_molecule_E
, NE , NE
which NE xxx NE
is NE xx NE
activated NE xxx NE
by NE xx NE
JAK3 G#protein_molecule XXXd G#protein_molecule
in NE xx NE
response NE xxx NE
to NE xx NE
IL-4 G#other_name_B XX-d G#other_name_B
receptor G#other_name_M xxx G#other_name_M
engagement G#other_name_E xxx G#other_name_E
. NE . NE

Does NE Xxxx NE
activation NE xxx NE
of NE xx NE
the NE xxx NE
TAL1 G#DNA_domain_or_region_B XXXd G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
occur NE xxx NE
in NE xx NE
a NE x NE
majority NE xxx NE
of NE xx NE
patients G#multi_cell xxx G#multi_cell
with NE xxx NE
T-cell G#other_name_B X-xxx G#other_name_B
acute G#other_name_M xxx G#other_name_M
lymphoblastic G#other_name_M xxx G#other_name_M
leukemia G#other_name_E xxx G#other_name_E
? NE ? NE
A NE X NE
pediatric G#other_name_B xxx G#other_name_B
oncology G#other_name_M xxx G#other_name_M
group G#other_name_M xxx G#other_name_M
study G#other_name_E xxx G#other_name_E
. NE . NE

Almost NE Xxxx NE
25% NE dd% NE
of NE xx NE
patients G#multi_cell xxx G#multi_cell
with NE xxx NE
T-cell G#other_name_B X-xxx G#other_name_B
acute G#other_name_M xxx G#other_name_M
lymphoblastic G#other_name_M xxx G#other_name_M
leukemia G#other_name_E xxx G#other_name_E
( NE ( NE
T-ALL G#other_name X-XXX G#other_name
) NE ) NE
have NE xxx NE
tumor-specific G#other_name_B xxx-xxx G#other_name_B
rearrangements G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
TAL1 G#DNA_domain_or_region_B XXXd G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Although NE Xxxx NE
TAL1 G#other_name_B XXXd G#other_name_B
expression G#other_name_E xxx G#other_name_E
has NE xxx NE
not NE xxx NE
been NE xxx NE
observed NE xxx NE
in NE xx NE
normal G#cell_type_B xxx G#cell_type_B
lymphocytes G#cell_type_E xxx G#cell_type_E
, NE , NE
TAL1 G#protein_family_or_group_B XXXd G#protein_family_or_group_B
gene G#protein_family_or_group_M xxx G#protein_family_or_group_M
products G#protein_family_or_group_E xxx G#protein_family_or_group_E
are NE xxx NE
readily NE xxx NE
detected NE xxx NE
in NE xx NE
leukemic G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
that NE xxx NE
harbor NE xxx NE
a NE x NE
rearranged G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
TAL1 G#DNA_family_or_group_M XXXd G#DNA_family_or_group_M
allele G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
. NE . NE

Hence NE Xxxx NE
, NE , NE
it NE xx NE
has NE xxx NE
been NE xxx NE
proposed NE xxx NE
that NE xxx NE
ectopic G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
of NE xx NE
TAL1 G#protein_molecule XXXd G#protein_molecule
promotes NE xxx NE
the NE xxx NE
development NE xxx NE
of NE xx NE
T-ALL G#other_name X-XXX G#other_name
. NE . NE

In NE Xx NE
this NE xxx NE
report NE xxx NE
, NE , NE
we NE xx NE
show NE xxx NE
that NE xxx NE
TAL1 G#protein_molecule XXXd G#protein_molecule
is NE xx NE
expressed NE xxx NE
in NE xx NE
the NE xxx NE
leukemic G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
of NE xx NE
most NE xxx NE
patients G#multi_cell xxx G#multi_cell
with NE xxx NE
T-ALL G#other_name X-XXX G#other_name
, NE , NE
including NE xxx NE
many NE xxx NE
that NE xxx NE
do NE xx NE
not NE xxx NE
display NE xxx NE
an NE xx NE
apparent NE xxx NE
TAL1 G#DNA_domain_or_region_B XXXd G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
alteration NE xxx NE
. NE . NE

A NE X NE
polymorphic NE xxx NE
dinucleotide NE xxx NE
repeat NE xxx NE
in NE xx NE
the NE xxx NE
transcribed NE xxx NE
sequences NE xxx NE
of NE xx NE
TAL1 G#protein_molecule XXXd G#protein_molecule
was NE xxx NE
used NE xxx NE
to NE xx NE
determine NE xxx NE
the NE xxx NE
allele G#other_name_B xxx G#other_name_B
specificity G#other_name_E xxx G#other_name_E
of NE xx NE
TAL1 G#protein_molecule XXXd G#protein_molecule
transcription NE xxx NE
in NE xx NE
primary G#cell_type_B xxx G#cell_type_B
T-ALL G#cell_type_M X-XXX G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Monoallelic G#other_name_B Xxxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
of NE xx NE
TAL1 G#protein_molecule XXXd G#protein_molecule
was NE xxx NE
observed NE xxx NE
in NE xx NE
the NE xxx NE
leukemic G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
of NE xx NE
all NE xxx NE
patients G#multi_cell xxx G#multi_cell
(8 NE (d NE
of NE xx NE
8) NE d) NE
bearing NE xxx NE
a NE x NE
TAL1 G#other_name_B XXXd G#other_name_B
gene G#other_name_M xxx G#other_name_M
rearrangement G#other_name_E xxx G#other_name_E
. NE . NE

In NE Xx NE
the NE xxx NE
leukemic G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
of NE xx NE
patients G#multi_cell xxx G#multi_cell
without NE xxx NE
detectable NE xxx NE
TAL1 G#other_name_B XXXd G#other_name_B
rearrangements G#other_name_E xxx G#other_name_E
, NE , NE
TAL1 G#other_name_B XXXd G#other_name_B
transcription G#other_name_E xxx G#other_name_E
occurred NE xxx NE
in NE xx NE
either NE xxx NE
a NE x NE
monoallelic NE xxx NE
(3 NE (d NE
of NE xx NE
7 NE d NE
patients G#multi_cell xxx G#multi_cell
) NE ) NE
or NE xx NE
a NE x NE
biallelic NE xxx NE
(4 NE (d NE
of NE xx NE
7 NE d NE
patients G#multi_cell xxx G#multi_cell
) NE ) NE
fashion NE xxx NE
. NE . NE

Thus NE Xxxx NE
, NE , NE
TAL1 G#protein_molecule XXXd G#protein_molecule
activation NE xxx NE
in NE xx NE
these NE xxx NE
patients G#multi_cell xxx G#multi_cell
may NE xxx NE
result NE xxx NE
from NE xxx NE
subtle NE xxx NE
alterations NE xxx NE
in NE xx NE
cis-acting G#DNA_family_or_group_B xxx-xxx G#DNA_family_or_group_B
regulatory G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
sequences G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
(affecting NE (xxx NE
expression NE xxx NE
of NE xx NE
a NE x NE
single G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
TAL1 G#DNA_domain_or_region_M XXXd G#DNA_domain_or_region_M
allele G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
) NE ) NE
or NE xx NE
changes NE xxx NE
in NE xx NE
trans-acting NE xxx-xxx NE
factors NE xxx NE
that NE xxx NE
control NE xxx NE
TAL1 G#other_name_B XXXd G#other_name_B
transcription G#other_name_E xxx G#other_name_E
(affecting NE (xxx NE
expression NE xxx NE
of NE xx NE
both NE xxx NE
TAL1 G#DNA_family_or_group_B XXXd G#DNA_family_or_group_B
alleles G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
) NE ) NE
. NE . NE

Expression NE Xxxx NE
of NE xx NE
erythroid-specific G#DNA_family_or_group_B xxx-xxx G#DNA_family_or_group_B
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
in NE xx NE
acute G#other_name_B xxx G#other_name_B
megakaryoblastic G#other_name_M xxx G#other_name_M
leukaemia G#other_name_E xxx G#other_name_E
and NE xxx NE
transient G#other_name_B xxx G#other_name_B
myeloproliferative G#other_name_M xxx G#other_name_M
disorder G#other_name_E xxx G#other_name_E
in NE xx NE
Down's G#other_name_B Xxxx'x G#other_name_B
syndrome G#other_name_E xxx G#other_name_E
. NE . NE

Acute G#other_name_B Xxxx G#other_name_B
megakaryoblastic G#other_name_M xxx G#other_name_M
leukaemia G#other_name_E xxx G#other_name_E
( NE ( NE
M7 G#other_name Xd G#other_name
) NE ) NE
and NE xxx NE
transient G#other_name_B xxx G#other_name_B
myeloproliferative G#other_name_M xxx G#other_name_M
disorder G#other_name_E xxx G#other_name_E
in NE xx NE
Down's G#other_name_B Xxxx'x G#other_name_B
syndrome G#other_name_E xxx G#other_name_E
( NE ( NE
TMD G#other_name XXX G#other_name
) NE ) NE
are NE xxx NE
characterized NE xxx NE
by NE xx NE
rapid NE xxx NE
growth NE xxx NE
of NE xx NE
abnormal G#cell_type_B xxx G#cell_type_B
blast G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
which NE xxx NE
express NE xxx NE
megakaryocytic G#protein_family_or_group_B xxx G#protein_family_or_group_B
markers G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

To NE Xx NE
clarify NE xxx NE
properties NE xxx NE
of NE xx NE
the NE xxx NE
blast G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
in NE xx NE
M7 G#other_name Xd G#other_name
and NE xxx NE
TMD G#other_name XXX G#other_name
cases NE xxx NE
, NE , NE
we NE xx NE
examined NE xxx NE
erythroid G#other_name_B xxx G#other_name_B
markers G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
in NE xx NE
blasts G#cell_type xxx G#cell_type
from NE xxx NE
six NE xxx NE
cases NE xxx NE
with NE xxx NE
M7 G#other_name Xd G#other_name
and NE xxx NE
seven NE xxx NE
cases NE xxx NE
with NE xxx NE
TMD G#other_name XXX G#other_name
in NE xx NE
this NE xxx NE
study NE xxx NE
. NE . NE

Erythroid-specific G#RNA_family_or_group_B Xxxx-xxx G#RNA_family_or_group_B
mRNAs G#RNA_family_or_group_E xXXXx G#RNA_family_or_group_E
encoding NE xxx NE
gamma-globin G#protein_family_or_group xxx-xxx G#protein_family_or_group
and NE xxx NE
erythroid G#protein_molecule_B xxx G#protein_molecule_B
delta-aminolevulinate G#protein_molecule_M xxx-xxx G#protein_molecule_M
synthase G#protein_molecule_E xxx G#protein_molecule_E
were NE xxx NE
found NE xxx NE
to NE xx NE
be NE xx NE
expressed NE xxx NE
in NE xx NE
blasts G#cell_type xxx G#cell_type
from NE xxx NE
most NE xxx NE
of NE xx NE
these NE xxx NE
cases NE xxx NE
, NE , NE
indicating NE xxx NE
that NE xxx NE
majorities NE xxx NE
of NE xx NE
the NE xxx NE
blasts G#cell_type xxx G#cell_type
in NE xx NE
M7 G#other_name Xd G#other_name
and NE xxx NE
TMD G#other_name XXX G#other_name
cases NE xxx NE
have NE xxx NE
erythroid G#other_name_B xxx G#other_name_B
phenotype G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
megakaryocytic G#other_name_M xxx G#other_name_M
phenotype G#other_name_E xxx G#other_name_E

We NE Xx NE
also NE xxx NE
found NE xxx NE
that NE xxx NE
mRNAs G#RNA_family_or_group xXXXx G#RNA_family_or_group
encoding NE xxx NE
GATA-1 G#protein_molecule XXXX-d G#protein_molecule
and NE xxx NE
GATA-2 G#protein_molecule XXXX-d G#protein_molecule
are NE xxx NE
expressed NE xxx NE
in NE xx NE
all NE xxx NE
these NE xxx NE
cases NE xxx NE
. NE . NE

These NE Xxxx NE
results NE xxx NE
suggest NE xxx NE
that NE xxx NE
M7 G#cell_type_B Xd G#cell_type_B
blasts G#cell_type_E xxx G#cell_type_E
and NE xxx NE
TMD G#cell_type_B XXX G#cell_type_B
blasts G#cell_type_E xxx G#cell_type_E
correspond NE xxx NE
to NE xx NE
the NE xxx NE
erythroid/megakaryocytic G#cell_type_B xxx/xxx G#cell_type_B
bipotential G#cell_type_M xxx G#cell_type_M
progenitor G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Expression NE Xxxx NE
of NE xx NE
Ah G#protein_molecule_B Xx G#protein_molecule_B
receptor G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
TCDD G#protein_molecule_B XXXX G#protein_molecule_B
receptor G#protein_molecule_E xxx G#protein_molecule_E
) NE ) NE
during NE xxx NE
human G#other_name_B xxx G#other_name_B
monocytic G#other_name_M xxx G#other_name_M
differentiation G#other_name_E xxx G#other_name_E
. NE . NE

We NE Xx NE
have NE xxx NE
previously NE xxx NE
found NE xxx NE
a NE x NE
high NE xxx NE
expression NE xxx NE
of NE xx NE
human NE xxx NE
Ah NE Xx NE
receptor NE xxx NE
( NE ( NE
TCDD NE XXXX NE
receptor NE xxx NE
) NE ) NE
mRNA NE xXXX NE
in NE xx NE
peripheral NE xxx NE
blood NE xxx NE
cells NE xxx NE
of NE xx NE
individuals NE xxx NE
. NE . NE

In NE Xx NE
this NE xxx NE
paper NE xxx NE
, NE , NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
this NE xxx NE
gene NE xxx NE
in NE xx NE
blood G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
was NE xxx NE
first NE xxx NE
investigated NE xxx NE
in NE xx NE
fractions NE xxx NE
of NE xx NE
nucleated G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
, NE , NE
revealing NE xxx NE
predominant NE xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
Ah G#DNA_domain_or_region_B Xx G#DNA_domain_or_region_B
receptor G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
the NE xxx NE
monocyte G#cell_type_B xxx G#cell_type_B
fraction G#cell_type_E xxx G#cell_type_E
. NE . NE

Then NE Xxxx NE
the NE xxx NE
expression G#other_name_B xxx G#other_name_B
levels G#other_name_E xxx G#other_name_E
of NE xx NE
AhR G#RNA_molecule_B XxX G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
in NE xx NE
various NE xxx NE
hematopoietic G#cell_line_B xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
were NE xxx NE
examined NE xxx NE
together NE xxx NE
with NE xxx NE
those NE xxx NE
of NE xx NE
Arnt G#protein_molecule Xxxx G#protein_molecule
and NE xxx NE
P450IA1 G#protein_molecule XdddXXd G#protein_molecule
. NE . NE

AhR G#protein_molecule XxX G#protein_molecule
was NE xxx NE
expressed NE xxx NE
at NE xx NE
high NE xxx NE
levels NE xxx NE
in NE xx NE
monocytoid G#cell_line_B xxx G#cell_line_B
U937 G#cell_line_E Xddd G#cell_line_E
, NE , NE
THP1 G#cell_line XXXd G#cell_line
, NE , NE
and NE xxx NE
HEL/S G#cell_line_B XXX/X G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
and NE xxx NE
at NE xx NE
moderate NE xxx NE
levels NE xxx NE
in NE xx NE
promyelocytic G#cell_line_B xxx G#cell_line_B
HL60 G#cell_line_M XXdd G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
and NE xxx NE
erythroblastic G#cell_line_B xxx G#cell_line_B
HEL G#cell_line_M XXX G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

However NE Xxxx NE
, NE , NE
it NE xx NE
was NE xxx NE
not NE xxx NE
detected NE xxx NE
in NE xx NE
lymphoid G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
MOLT4 G#cell_line XXXXd G#cell_line
( NE ( NE
T G#cell_type_B X G#cell_type_B
cell G#cell_type_E xxx G#cell_type_E
) NE ) NE
and NE xxx NE
BALL1 G#cell_line XXXXd G#cell_line
( NE ( NE
B G#cell_type_B X G#cell_type_B
cell G#cell_type_E xxx G#cell_type_E
) NE ) NE
, NE , NE
nor NE xxx NE
in NE xx NE
K562 G#cell_line_B Xddd G#cell_line_B
erythroblasts G#cell_line_E xxx G#cell_line_E
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
a NE x NE
specific NE xxx NE
induction NE xxx NE
of NE xx NE
AhR G#protein_molecule XxX G#protein_molecule
during NE xxx NE
monocytic NE xxx NE
differentiation NE xxx NE
was NE xxx NE
investigated NE xxx NE
in NE xx NE
HL60 G#cell_line XXdd G#cell_line
and NE xxx NE
HEL G#cell_line_B XXX G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

HL60 G#cell_line_B XXdd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
were NE xxx NE
induced NE xxx NE
to NE xx NE
differentiate NE xxx NE
toward NE xxx NE
monocytes-macrophages G#cell_type xxx-xxx G#cell_type
by NE xx NE
incubation NE xxx NE
with NE xxx NE
phorbol NE xxx NE
ester NE xxx NE
, NE , NE
showing NE xxx NE
a NE x NE
5- NE d- NE
to NE xx NE
2-fold NE d-xxx NE
increase NE xxx NE
of NE xx NE
AhR G#RNA_molecule_B XxX G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
. NE . NE

The NE Xxx NE
incubation NE xxx NE
with NE xxx NE
transforming G#protein_molecule_B xxx G#protein_molecule_B
growth G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_M xxx G#protein_molecule_M
beta G#protein_molecule_M xxx G#protein_molecule_M
1 G#protein_molecule_E d G#protein_molecule_E
and NE xxx NE
1 G#lipid_B d G#lipid_B
alpha,25-dihydroxyvitamin G#lipid_M xxx,dd-xxx G#lipid_M
D3 G#lipid_E Xd G#lipid_E
resulted NE xxx NE
in NE xx NE
a NE x NE
5- NE d- NE
to NE xx NE
7-fold NE d-xxx NE
increase NE xxx NE
of NE xx NE
AhR G#RNA_molecule_B XxX G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
. NE . NE

The NE Xxx NE
HEL G#cell_line_B XXX G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
also NE xxx NE
exhibited NE xxx NE
a NE x NE
similar NE xxx NE
elevation NE xxx NE
of NE xx NE
AhR G#other_name_B XxX G#other_name_B
mRNA G#other_name_M xXXX G#other_name_M
level G#other_name_E xxx G#other_name_E
, NE , NE
when NE xxx NE
they NE xxx NE
had NE xxx NE
differentiated NE xxx NE
toward NE xxx NE
monocyte-macrophage G#cell_type_B xxx-xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
by NE xx NE
these NE xxx NE
combined NE xxx NE
inducers NE xxx NE
, NE , NE
but NE xxx NE
little NE xxx NE
change NE xxx NE
in NE xx NE
the NE xxx NE
mRNA G#other_name_B xXXX G#other_name_B
level G#other_name_E xxx G#other_name_E
was NE xxx NE
observed NE xxx NE
when NE xxx NE
the NE xxx NE
cells NE xxx NE
were NE xxx NE
induced NE xxx NE
to NE xx NE
differentiate NE xxx NE
into NE xxx NE
other NE xxx NE
cell NE xxx NE
types NE xxx NE
. NE . NE

Treatment NE Xxxx NE
of NE xx NE
the NE xxx NE
differentiated G#cell_line_B xxx G#cell_line_B
HL60 G#cell_line_M XXdd G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
with NE xxx NE
3-methylcholanthrene G#other_organic_compound d-xxx G#other_organic_compound
, NE , NE
a NE x NE
ligand NE xxx NE
of NE xx NE
AhR G#protein_molecule XxX G#protein_molecule
, NE , NE
induced NE xxx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
P450IA1 G#protein_molecule XdddXXd G#protein_molecule
gene NE xxx NE
. NE . NE

These NE Xxxx NE
results NE xxx NE
indicated NE xxx NE
that NE xxx NE
expression NE xxx NE
of NE xx NE
AhR G#RNA_molecule_B XxX G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
was NE xxx NE
significantly NE xxx NE
induced NE xxx NE
during NE xxx NE
monocytic G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
and NE xxx NE
that NE xxx NE
the NE xxx NE
differentiated G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
were NE xxx NE
responsive NE xxx NE
to NE xx NE
xenobiotics G#other_organic_compound xxx G#other_organic_compound
. NE . NE

Our NE Xxx NE
results NE xxx NE
suggest NE xxx NE
that NE xxx NE
AhR G#protein_molecule XxX G#protein_molecule
may NE xxx NE
play NE xxx NE
an NE xx NE
important NE xxx NE
role NE xxx NE
in NE xx NE
the NE xxx NE
function NE xxx NE
of NE xx NE
monocytes G#cell_type xxx G#cell_type
and NE xxx NE
also NE xxx NE
in NE xx NE
the NE xxx NE
eventual NE xxx NE
activation NE xxx NE
of NE xx NE
environmental G#other_organic_compound_B xxx G#other_organic_compound_B
carcinogens G#other_organic_compound_E xxx G#other_organic_compound_E
. NE . NE

Neutrophils G#cell_type Xxxx G#cell_type
and NE xxx NE
monocytes G#cell_type xxx G#cell_type
express NE xxx NE
high NE xxx NE
levels NE xxx NE
of NE xx NE
PU.1 G#protein_molecule XX.d G#protein_molecule
( NE ( NE
Spi-1 G#protein_molecule Xxx-d G#protein_molecule
) NE ) NE
but NE xxx NE
not NE xxx NE
Spi-B G#protein_molecule Xxx-X G#protein_molecule
. NE . NE

PU.1 G#protein_molecule XX.d G#protein_molecule
(the NE (xxx NE
Spi-1 G#DNA_domain_or_region_B Xxx-d G#DNA_domain_or_region_B
oncogene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
) NE ) NE
and NE xxx NE
Spi-B G#protein_molecule Xxx-X G#protein_molecule
are NE xxx NE
closely NE xxx NE
related NE xxx NE
members NE xxx NE
of NE xx NE
the NE xxx NE
ets G#protein_family_or_group_B xxx G#protein_family_or_group_B
transcription G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_M xxx G#protein_family_or_group_M
family G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
sharing NE xxx NE
similar NE xxx NE
DNA NE XXX NE
binding NE xxx NE
specificities NE xxx NE
mediated NE xxx NE
by NE xx NE
similar NE xxx NE
DNA NE XXX NE
binding NE xxx NE
domains NE xxx NE
. NE . NE

PU.1 G#protein_molecule XX.d G#protein_molecule
and NE xxx NE
Spi-B G#protein_molecule Xxx-X G#protein_molecule
have NE xxx NE
been NE xxx NE
previously NE xxx NE
described NE xxx NE
as NE xx NE
being NE xxx NE
predominantly NE xxx NE
expressed NE xxx NE
coordinately NE xxx NE
in NE xx NE
macrophages G#cell_type xxx G#cell_type
and NE xxx NE
B G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
, NE , NE
but NE xxx NE
their NE xxx NE
expression NE xxx NE
in NE xx NE
early G#other_name_B xxx G#other_name_B
hematopoietic G#other_name_M xxx G#other_name_M
stages G#other_name_E xxx G#other_name_E
and NE xxx NE
during NE xxx NE
the NE xxx NE
course NE xxx NE
of NE xx NE
myeloid G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
to NE xx NE
monocytes G#cell_type xxx G#cell_type
and NE xxx NE
macrophages G#cell_type xxx G#cell_type
or NE xx NE
to NE xx NE
neutrophils G#cell_type xxx G#cell_type
has NE xxx NE
not NE xxx NE
been NE xxx NE
extensively NE xxx NE
investigated NE xxx NE
. NE . NE

Here NE Xxxx NE
, NE , NE
we NE xx NE
report NE xxx NE
that NE xxx NE
PU.1 G#RNA_molecule_B XX.d G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
is NE xx NE
upregulated NE xxx NE
during NE xxx NE
myeloid G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
of NE xx NE
human G#cell_line_B xxx G#cell_line_B
purified G#cell_line_M xxx G#cell_line_M
CD34+ G#cell_line_M XXdd+ G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
and NE xxx NE
murine G#cell_line_B xxx G#cell_line_B
multipotential G#cell_line_M xxx G#cell_line_M
FDCP-mix G#cell_line_M XXXX-xxx G#cell_line_M
A4 G#cell_line_M Xd G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
suggesting NE xxx NE
that NE xxx NE
PU.1 G#protein_molecule XX.d G#protein_molecule
is NE xx NE
upregulated NE xxx NE
as NE xx NE
an NE xx NE
early NE xxx NE
event NE xxx NE
during NE xxx NE
differentiation G#other_name xxx G#other_name
of NE xx NE
multipotential G#cell_type_B xxx G#cell_type_B
progenitor G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

PU.1 G#protein_molecule XX.d G#protein_molecule
expression NE xxx NE
is NE xx NE
maintained NE xxx NE
at NE xx NE
stable NE xxx NE
levels NE xxx NE
during NE xxx NE
differentiation NE xxx NE
of NE xx NE
myeloid G#cell_line_B xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
U937 NE Xddd NE
and NE xxx NE
HL-60 G#cell_line XX-dd G#cell_line
to NE xx NE
monocytic G#cell_type_B xxx G#cell_type_B
cell G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
neutrophilic G#cell_type_M xxx G#cell_type_M
cell G#cell_type_E xxx G#cell_type_E

PU.1 G#protein_molecule XX.d G#protein_molecule
is NE xx NE
expressed NE xxx NE
at NE xx NE
highest NE xxx NE
levels NE xxx NE
in NE xx NE
mature G#cell_type_B xxx G#cell_type_B
human G#cell_type_M xxx G#cell_type_M
monocytes G#cell_type_E xxx G#cell_type_E
and NE xxx NE
human G#cell_type_B xxx G#cell_type_B
peripheral G#cell_type_M xxx G#cell_type_M
blood G#cell_type_M xxx G#cell_type_M
neutrophils G#cell_type_E xxx G#cell_type_E
. NE . NE

In NE Xx NE
contrast NE xxx NE
to NE xx NE
PU.1 G#protein_molecule XX.d G#protein_molecule
, NE , NE
significant NE xxx NE
levels NE xxx NE
of NE xx NE
Spi-B G#RNA_molecule_B Xxx-X G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
and NE xxx NE
protein NE xxx NE
are NE xxx NE
found NE xxx NE
only NE xxx NE
in NE xx NE
some NE xxx NE
B-cell G#cell_line_B X-xxx G#cell_line_B
lines G#cell_line_E xxx G#cell_line_E
and NE xxx NE
spleen G#body_part xxx G#body_part
but NE xxx NE
are NE xxx NE
not NE xxx NE
found NE xxx NE
in NE xx NE
myeloid G#cell_line_B xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
, NE , NE
neutrophils G#cell_type xxx G#cell_type
, NE , NE
or NE xx NE
macrophages G#cell_type xxx G#cell_type
. NE . NE

In NE Xx NE
vitro NE xxx NE
translated NE xxx NE
Spi-B G#protein_molecule_B Xxx-X G#protein_molecule_B
protein G#protein_molecule_E xxx G#protein_molecule_E
can NE xxx NE
bind NE xxx NE
to NE xx NE
PU.1 G#DNA_domain_or_region_B XX.d G#DNA_domain_or_region_B
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
myeloid G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
promoters G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
transactivate NE xxx NE
these NE xxx NE
promoters G#DNA_family_or_group xxx G#DNA_family_or_group
in NE xx NE
nonmyeloid G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Therefore NE Xxxx NE
, NE , NE
although NE xxx NE
PU.1 G#protein_molecule XX.d G#protein_molecule
and NE xxx NE
Spi-B G#protein_molecule Xxx-X G#protein_molecule
may NE xxx NE
bind NE xxx NE
to NE xx NE
similar NE xxx NE
DNA NE XXX NE
control NE xxx NE
elements NE xxx NE
and NE xxx NE
have NE xxx NE
redundancy NE xxx NE
of NE xx NE
transactivation G#other_name_B xxx G#other_name_B
function G#other_name_E xxx G#other_name_E
in NE xx NE
vitro NE xxx NE
, NE , NE
the NE xxx NE
lack NE xxx NE
of NE xx NE
significant NE xxx NE
levels NE xxx NE
of NE xx NE
Spi-B G#protein_molecule Xxx-X G#protein_molecule
in NE xx NE
myeloid G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
makes NE xxx NE
it NE xx NE
unlikely NE xxx NE
that NE xxx NE
Spi-B G#protein_molecule Xxx-X G#protein_molecule
plays NE xxx NE
a NE x NE
significant NE xxx NE
role NE xxx NE
in NE xx NE
myeloid G#other_name_B xxx G#other_name_B
lineage G#other_name_M xxx G#other_name_M
development G#other_name_E xxx G#other_name_E
and NE xxx NE
gene G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
. NE . NE

In NE Xx NE
contrast NE xxx NE
, NE , NE
PU.1 G#protein_molecule XX.d G#protein_molecule
is NE xx NE
expressed NE xxx NE
at NE xx NE
high NE xxx NE
levels NE xxx NE
not NE xxx NE
only NE xxx NE
in NE xx NE
monocytes G#cell_type xxx G#cell_type
and NE xxx NE
macrophages G#cell_type xxx G#cell_type
but NE xxx NE
also NE xxx NE
in NE xx NE
neutrophils G#cell_type xxx G#cell_type
, NE , NE
indicating NE xxx NE
that NE xxx NE
PU.1 G#protein_molecule XX.d G#protein_molecule
can NE xxx NE
activate NE xxx NE
gene G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
in NE xx NE
both NE xxx NE
major G#cell_type_B xxx G#cell_type_B
myeloid G#cell_type_M xxx G#cell_type_M
lineages G#cell_type_E xxx G#cell_type_E
. NE . NE

Identification NE Xxxx NE
of NE xx NE
a NE x NE
major NE xxx NE
positive G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
regulatory G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
element G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
located NE xxx NE
5' NE d' NE
to NE xx NE
the NE xxx NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
zeta-globin G#DNA_domain_or_region_M xxx-xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

The NE Xxx NE
function NE xxx NE
of NE xx NE
the NE xxx NE
zeta-globin G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
was NE xxx NE
studied NE xxx NE
using NE xxx NE
a NE x NE
series NE xxx NE
of NE xx NE
zeta-globin G#DNA_molecule_B xxx-xxx G#DNA_molecule_B
promoter G#DNA_molecule_M xxx G#DNA_molecule_M
deletion G#DNA_molecule_M xxx G#DNA_molecule_M
constructs G#DNA_molecule_E xxx G#DNA_molecule_E
to NE xx NE
drive NE xxx NE
luciferase G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
in NE xx NE
transiently G#cell_line_B xxx G#cell_line_B
transfected G#cell_line_M xxx G#cell_line_M
human G#cell_line_M xxx G#cell_line_M
erythroleukemia G#cell_line_M xxx G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

The NE Xxx NE
promoters G#DNA_family_or_group xxx G#DNA_family_or_group
were NE xxx NE
used NE xxx NE
without NE xxx NE
enhancers G#DNA_family_or_group xxx G#DNA_family_or_group
, NE , NE
or NE xx NE
with NE xxx NE
enhancers G#DNA_family_or_group xxx G#DNA_family_or_group
derived NE xxx NE
from NE xxx NE
the NE xxx NE
beta-globin G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
locus G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
control G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
the NE xxx NE
alpha-globin G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
HS-40 G#DNA_domain_or_region_M XX-dd G#DNA_domain_or_region_M
enhancer G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

When NE Xxxx NE
transfected NE xxx NE
into NE xxx NE
K562 G#cell_line_B Xddd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
which NE xxx NE
express NE xxx NE
zeta-globin G#protein_family_or_group xxx-xxx G#protein_family_or_group
, NE , NE
comparable NE xxx NE
amounts NE xxx NE
of NE xx NE
activity NE xxx NE
were NE xxx NE
obtained NE xxx NE
from NE xxx NE
the NE xxx NE
-557 G#DNA_molecule_B -ddd G#DNA_molecule_B
and G#DNA_molecule_M xxx G#DNA_molecule_M
-417 G#DNA_molecule_M -ddd G#DNA_molecule_M
zeta- G#DNA_molecule_M xxx- G#DNA_molecule_M
luciferase G#DNA_molecule_M xxx G#DNA_molecule_M
constructs G#DNA_molecule_E xxx G#DNA_molecule_E
and NE xxx NE
the NE xxx NE
alpha- NE xxx- NE
luciferase NE xxx NE
constructs NE xxx NE
when NE xxx NE
no NE xx NE
enhancers NE xxx NE
or NE xx NE
the NE xxx NE
alpha-globin NE xxx-xxx NE
locus NE xxx NE
enhancers NE xxx NE
were NE xxx NE
used NE xxx NE
. NE . NE

When NE Xxxx NE
the NE xxx NE
constructs NE xxx NE
were NE xxx NE
transfected NE xxx NE
into NE xxx NE
OCIM1 G#cell_line_B XXXXd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
which NE xxx NE
do NE xx NE
not NE xxx NE
express NE xxx NE
zeta-globin G#protein_family_or_group xxx-xxx G#protein_family_or_group
, NE , NE
the NE xxx NE
zeta-globin G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
promoters G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
were NE xxx NE
at NE xx NE
best NE xxx NE
20% NE dd% NE
as NE xx NE
active NE xxx NE
as NE xx NE
the NE xxx NE
alpha-globin G#DNA_family_or_group_B xxx-xxx G#DNA_family_or_group_B
promoters G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
. NE . NE

When NE Xxxx NE
sequences G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
from G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
-417 G#DNA_domain_or_region_M -ddd G#DNA_domain_or_region_M
to G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
-207 G#DNA_domain_or_region_M -ddd G#DNA_domain_or_region_M
5' G#DNA_domain_or_region_E d' G#DNA_domain_or_region_E
to NE xx NE
the NE xxx NE
zeta-globin G#RNA_domain_or_region_B xxx-xxx G#RNA_domain_or_region_B
mRNA G#RNA_domain_or_region_M xXXX G#RNA_domain_or_region_M
cap G#RNA_domain_or_region_M xxx G#RNA_domain_or_region_M
site G#RNA_domain_or_region_E xxx G#RNA_domain_or_region_E
were NE xxx NE
deleted NE xxx NE
, NE , NE
up NE xx NE
to NE xx NE
95% NE dd% NE
of NE xx NE
the NE xxx NE
zeta-globin G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
activity NE xxx NE
was NE xxx NE
lost NE xxx NE
in NE xx NE
K562 G#cell_line_B Xddd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

Reinsertion NE Xxxx NE
of NE xx NE
these NE xxx NE
sequences NE xxx NE
into NE xxx NE
zeta- NE xxx- NE
luciferase NE xxx NE
constructs NE xxx NE
missing NE xxx NE
the NE xxx NE
-417 NE -ddd NE
to NE xx NE
-207 NE -ddd NE
region NE xxx NE
showed NE xxx NE
that NE xxx NE
the NE xxx NE
sequences NE xxx NE
lack NE xxx NE
classical NE xxx NE
enhancer NE xxx NE
activity NE xxx NE
. NE . NE

Point G#other_name_B Xxxx G#other_name_B
mutation G#other_name_E xxx G#other_name_E
of NE xx NE
a NE x NE
GATA-1 G#DNA_domain_or_region_B XXXX-d G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
at NE xx NE
-230 NE -ddd NE
reduced NE xxx NE
promoter G#other_name_B xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
by NE xx NE
37% NE dd% NE
. NE . NE

Point G#other_name_B Xxxx G#other_name_B
mutation G#other_name_E xxx G#other_name_E
of NE xx NE
a NE x NE
CCACC G#DNA_domain_or_region_B XXXXX G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
at NE xx NE
-240 NE -ddd NE
had NE xxx NE
no NE xx NE
effect NE xxx NE
. NE . NE

Electrophoretic G#other_name_B Xxxx G#other_name_B
mobility G#other_name_M xxx G#other_name_M
shift G#other_name_M xxx G#other_name_M
assays G#other_name_E xxx G#other_name_E
indicated NE xxx NE
that NE xxx NE
the NE xxx NE
-230 G#DNA_domain_or_region_B -ddd G#DNA_domain_or_region_B
GATA-1 G#DNA_domain_or_region_M XXXX-d G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
has NE xxx NE
a NE x NE
relatively NE xxx NE
low NE xxx NE
affinity NE xxx NE
for NE xxx NE
GATA-1 G#protein_molecule XXXX-d G#protein_molecule
. NE . NE

These NE Xxxx NE
experiments NE xxx NE
show NE xxx NE
the NE xxx NE
presence NE xxx NE
of NE xx NE
a NE x NE
strong NE xxx NE
positive-acting G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
located NE xxx NE
between NE xxx NE
-417 G#DNA_domain_or_region_B -ddd G#DNA_domain_or_region_B
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
-207 G#DNA_domain_or_region_M -ddd G#DNA_domain_or_region_M
bp G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
5' G#DNA_domain_or_region_E d' G#DNA_domain_or_region_E
to NE xx NE
the NE xxx NE
zeta-globin G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
mRNA G#DNA_domain_or_region_M xXXX G#DNA_domain_or_region_M
cap G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
is NE xx NE
necessary NE xxx NE
for NE xxx NE
high-level G#other_name_B xxx-xxx G#other_name_B
promoter G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
in NE xx NE
K562 G#cell_line_B Xddd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

This NE Xxxx NE
element NE xxx NE
requires NE xxx NE
GATA-1 G#protein_molecule XXXX-d G#protein_molecule
and NE xxx NE
additional G#protein_family_or_group_B xxx G#protein_family_or_group_B
unknown G#protein_family_or_group_M xxx G#protein_family_or_group_M
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
for NE xxx NE
maximal G#other_name_B xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
. NE . NE

Analysis NE Xxxx NE
of NE xx NE
the NE xxx NE
role NE xxx NE
of NE xx NE
protein G#protein_molecule_B xxx G#protein_molecule_B
kinase G#protein_molecule_M xxx G#protein_molecule_M
C-alpha G#protein_molecule_M X-xxx G#protein_molecule_M
and G#protein_molecule_M xxx G#protein_molecule_M
protein G#protein_molecule_M xxx G#protein_molecule_M
kinase G#protein_molecule_M xxx G#protein_molecule_M
C-epsilon G#protein_molecule_M X-xxx G#protein_molecule_M
and G#protein_molecule_M xxx G#protein_molecule_M
protein G#protein_molecule_M xxx G#protein_molecule_M
kinase G#protein_molecule_M xxx G#protein_molecule_M
C-zeta G#protein_molecule_E X-xxx G#protein_molecule_E
T NE X NE
cell NE xxx NE
activation NE xxx NE
. NE . NE

T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
express NE xxx NE
multiple NE xxx NE
isotypes NE xxx NE
of NE xx NE
protein G#protein_molecule_B xxx G#protein_molecule_B
kinase G#protein_molecule_M xxx G#protein_molecule_M
C G#protein_molecule_E X G#protein_molecule_E
( NE ( NE
PKC G#protein_molecule XXX G#protein_molecule
) NE ) NE
and NE xxx NE
although NE xxx NE
it NE xx NE
is NE xx NE
well NE xxx NE
accepted NE xxx NE
that NE xxx NE
PKCs G#protein_molecule XXXx G#protein_molecule
have NE xxx NE
an NE xx NE
important NE xxx NE
role NE xxx NE
in NE xx NE
T G#other_name_B X G#other_name_B
cell G#other_name_M xxx G#other_name_M
activation G#other_name_E xxx G#other_name_E
, NE , NE
little NE xxx NE
is NE xx NE
known NE xxx NE
about NE xxx NE
the NE xxx NE
function NE xxx NE
of NE xx NE
individual NE xxx NE
PKC G#protein_family_or_group_B XXX G#protein_family_or_group_B
isotypes G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

To NE Xx NE
address NE xxx NE
this NE xxx NE
issue NE xxx NE
, NE , NE
mutationally NE xxx NE
active NE xxx NE
PKC-alpha G#protein_molecule_B XXX-xxx G#protein_molecule_B
or G#protein_molecule_M xx G#protein_molecule_M
PKC-epsilon G#protein_molecule_M XXX-xxx G#protein_molecule_M
or G#protein_molecule_M xx G#protein_molecule_M
PKC-zeta G#protein_molecule_E XXX-xxx G#protein_molecule_E
have NE xxx NE
been NE xxx NE
transfected NE xxx NE
into NE xxx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
and NE xxx NE
the NE xxx NE
consequences NE xxx NE
for NE xxx NE
T G#other_name_B X G#other_name_B
cell G#other_name_M xxx G#other_name_M
activation G#other_name_E xxx G#other_name_E
determined NE xxx NE
. NE . NE

p21ras G#protein_molecule xddxxx G#protein_molecule
plays NE xxx NE
an NE xx NE
essential NE xxx NE
role NE xxx NE
in NE xx NE
T G#other_name_B X G#other_name_B
cell G#other_name_M xxx G#other_name_M
activation G#other_name_E xxx G#other_name_E
. NE . NE

Accordingly NE Xxxx NE
, NE , NE
the NE xxx NE
effects NE xxx NE
of NE xx NE
the NE xxx NE
constitutively G#protein_family_or_group_B xxx G#protein_family_or_group_B
active G#protein_family_or_group_M xxx G#protein_family_or_group_M
PKCs G#protein_family_or_group_E XXXx G#protein_family_or_group_E
were NE xxx NE
compared NE xxx NE
to NE xx NE
the NE xxx NE
effects NE xxx NE
of NE xx NE
mutationally NE xxx NE
activated NE xxx NE
p21ras G#protein_molecule xddxxx G#protein_molecule
. NE . NE

The NE Xxx NE
data NE xxx NE
indicate NE xxx NE
that NE xxx NE
PKC-epsilon G#protein_molecule XXX-xxx G#protein_molecule
and NE xxx NE
, NE , NE
to NE xx NE
a NE x NE
lesser NE xxx NE
extent NE xxx NE
PKC-alpha G#protein_molecule XXX-xxx G#protein_molecule
but NE xxx NE
not NE xxx NE
-zeta NE -xxx NE
, NE , NE
can NE xxx NE
regulate NE xxx NE
the NE xxx NE
transcription NE xxx NE
factors NE xxx NE
AP-1 NE XX-d NE
and NE xxx NE
nuclear NE xxx NE
factor NE xxx NE
of NE xx NE
activated NE xxx NE
T NE X NE
cells NE xxx NE
( NE ( NE
NF-AT-1 NE XX-XX-d NE
) NE ) NE
. NE . NE

The NE Xxx NE
ability NE xxx NE
of NE xx NE
PKC-epsilon G#protein_molecule XXX-xxx G#protein_molecule
to NE xx NE
induce NE xxx NE
transactivation NE xxx NE
of NE xx NE
NF-AT-1 G#protein_molecule XX-XX-d G#protein_molecule
and NE xxx NE
AP-1 G#protein_molecule XX-d G#protein_molecule
was NE xxx NE
similar NE xxx NE
to NE xx NE
the NE xxx NE
stimulatory NE xxx NE
effect NE xxx NE
of NE xx NE
a NE x NE
constitutively G#protein_molecule_B xxx G#protein_molecule_B
activated G#protein_molecule_M xxx G#protein_molecule_M
p21ras G#protein_molecule_E xddxxx G#protein_molecule_E
. NE . NE

PKC-epsilon G#protein_molecule XXX-xxx G#protein_molecule
, NE , NE
but NE xxx NE
not NE xxx NE
PKC-alpha G#protein_molecule XXX-xxx G#protein_molecule
nor NE xxx NE
activated NE xxx NE
p21ras G#protein_molecule xddxxx G#protein_molecule
, NE , NE
was NE xxx NE
able NE xxx NE
to NE xx NE
induce NE xxx NE
NF-KB G#other_name_B XX-XX G#other_name_B
activity G#other_name_E xxx G#other_name_E
. NE . NE

Phorbol G#other_organic_compound_B Xxxx G#other_organic_compound_B
esters G#other_organic_compound_E xxx G#other_organic_compound_E
induce NE xxx NE
expression NE xxx NE
of NE xx NE
CD69 G#protein_molecule XXdd G#protein_molecule
whereas NE xxx NE
none NE xxx NE
of NE xx NE
the NE xxx NE
activated G#protein_family_or_group_B xxx G#protein_family_or_group_B
PKC G#protein_family_or_group_M XXX G#protein_family_or_group_M
isotypes G#protein_family_or_group_E xxx G#protein_family_or_group_E
tested NE xxx NE
were NE xxx NE
able NE xxx NE
to NE xx NE
have NE xxx NE
this NE xxx NE
effect NE xxx NE
. NE . NE

Activated NE Xxxx NE
Src G#protein_family_or_group Xxx G#protein_family_or_group
and NE xxx NE
p21ras G#protein_molecule xddxxx G#protein_molecule
were NE xxx NE
able NE xxx NE
to NE xx NE
induce NE xxx NE
CD69 G#other_name_B XXdd G#other_name_B
expression G#other_name_E xxx G#other_name_E
. NE . NE

These NE Xxxx NE
results NE xxx NE
indicate NE xxx NE
selective NE xxx NE
functions NE xxx NE
for NE xxx NE
different NE xxx NE
PKC G#protein_family_or_group_B XXX G#protein_family_or_group_B
isotypes G#protein_family_or_group_E xxx G#protein_family_or_group_E
in NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Moreover NE Xxxx NE
, NE , NE
the NE xxx NE
data NE xxx NE
comparing NE xxx NE
the NE xxx NE
effects NE xxx NE
of NE xx NE
activated G#protein_family_or_group_B xxx G#protein_family_or_group_B
Ras G#protein_family_or_group_E Xxx G#protein_family_or_group_E
and NE xxx NE
PKC G#protein_family_or_group_B XXX G#protein_family_or_group_B
mutants G#protein_family_or_group_E xxx G#protein_family_or_group_E
suggest NE xxx NE
that NE xxx NE
PKC-alpha G#protein_molecule XXX-xxx G#protein_molecule
, NE , NE
p21ras G#protein_molecule xddxxx G#protein_molecule
, NE , NE
and NE xxx NE
PKC-epsilon G#protein_molecule XXX-xxx G#protein_molecule
are NE xxx NE
not NE xxx NE
positioned NE xxx NE
linearly NE xxx NE
on NE xx NE
a NE x NE
single G#other_name_B xxx G#other_name_B
signal G#other_name_M xxx G#other_name_M
transduction G#other_name_M xxx G#other_name_M
pathway G#other_name_E xxx G#other_name_E
. NE . NE

Differences NE Xxxx NE
in NE xx NE
binding NE xxx NE
of NE xx NE
glucocorticoid G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
to NE xx NE
DNA NE XXX NE
in NE xx NE
steroid-resistant G#other_name_B xxx-xxx G#other_name_B
asthma G#other_name_E xxx G#other_name_E
. NE . NE

Although NE Xxxx NE
glucocorticosteroids G#lipid xxx G#lipid
are NE xxx NE
a NE x NE
very NE xxx NE
effective NE xxx NE
treatment NE xxx NE
for NE xxx NE
asthma G#other_name xxx G#other_name
and NE xxx NE
other NE xxx NE
chronic G#other_name_B xxx G#other_name_B
inflammatory G#other_name_M xxx G#other_name_M
diseases G#other_name_E xxx G#other_name_E
, NE , NE
a NE x NE
small NE xxx NE
proportion NE xxx NE
of NE xx NE
patients G#multi_cell xxx G#multi_cell
are NE xxx NE
resistant NE xxx NE
to NE xx NE
their NE xxx NE
therapeutic G#other_name_B xxx G#other_name_B
effects G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
molecular NE xxx NE
mechanism NE xxx NE
for NE xxx NE
this NE xxx NE
steroid G#other_name_B xxx G#other_name_B
resistance G#other_name_E xxx G#other_name_E
is NE xx NE
unclear NE xxx NE
. NE . NE

Steroid G#other_name_B Xxxx G#other_name_B
resistance G#other_name_E xxx G#other_name_E
cannot NE xxx NE
be NE xx NE
explained NE xxx NE
by NE xx NE
pharmacokinetic G#other_name_B xxx G#other_name_B
mechanisms G#other_name_E xxx G#other_name_E
, NE , NE
by NE xx NE
a NE x NE
defect NE xxx NE
in NE xx NE
the NE xxx NE
binding NE xxx NE
of NE xx NE
steroids G#lipid xxx G#lipid
to NE xx NE
glucocorticoid G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
nor NE xxx NE
by NE xx NE
defective G#other_name_B xxx G#other_name_B
nuclear G#other_name_M xxx G#other_name_M
translocation G#other_name_E xxx G#other_name_E
of NE xx NE
this NE xxx NE
receptor NE xxx NE
, NE , NE
thereby NE xxx NE
suggesting NE xxx NE
that NE xxx NE
the NE xxx NE
molecular NE xxx NE
abnormality NE xxx NE
lies NE xxx NE
distal NE xxx NE
to NE xx NE
nuclear G#other_name_B xxx G#other_name_B
translocation G#other_name_E xxx G#other_name_E
. NE . NE

We NE Xx NE
examined NE xxx NE
the NE xxx NE
ability NE xxx NE
of NE xx NE
nuclear NE xxx NE
translocated NE xxx NE
glucocorticoid G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
to NE xx NE
bind NE xxx NE
to NE xx NE
their NE xxx NE
DNA G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
GRE G#DNA_domain_or_region XXX G#DNA_domain_or_region
) NE ) NE
using NE xxx NE
electrophoretic G#other_name_B xxx G#other_name_B
mobility G#other_name_M xxx G#other_name_M
shift G#other_name_M xxx G#other_name_M
assays G#other_name_E xxx G#other_name_E
in NE xx NE
PBMC G#cell_type XXXX G#cell_type
from NE xxx NE
patients G#multi_cell xxx G#multi_cell
with NE xxx NE
steroid-sensitive NE xxx-xxx NE
and NE xxx NE
steroid-resistant G#other_name_B xxx-xxx G#other_name_B
asthma G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
binding NE xxx NE
of NE xx NE
the NE xxx NE
glucocorticoid G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
to NE xx NE
DNA NE XXX NE
in NE xx NE
these NE xxx NE
patients G#multi_cell xxx G#multi_cell
was NE xxx NE
also NE xxx NE
studied NE xxx NE
using NE xxx NE
Scatchard G#other_name_B Xxxx G#other_name_B
analysis G#other_name_E xxx G#other_name_E
. NE . NE

Dexamethasone G#lipid Xxxx G#lipid
induced NE xxx NE
a NE x NE
significant NE xxx NE
rapid NE xxx NE
and NE xxx NE
sustained NE xxx NE
twofold NE xxx NE
increase NE xxx NE
in NE xx NE
GRE G#other_name_B XXX G#other_name_B
binding G#other_name_E xxx G#other_name_E
in NE xx NE
PBMCs G#cell_type XXXXx G#cell_type
from NE xxx NE
steroid-sensitive NE xxx-xxx NE
asthmatic G#multi_cell_B xxx G#multi_cell_B
patients G#multi_cell_E xxx G#multi_cell_E
and NE xxx NE
nonasthmatic G#multi_cell_B xxx G#multi_cell_B
individuals G#multi_cell_E xxx G#multi_cell_E
, NE , NE
but NE xxx NE
this NE xxx NE
was NE xxx NE
markedly NE xxx NE
reduced NE xxx NE
in NE xx NE
steroid-resistant G#multi_cell_B xxx-xxx G#multi_cell_B
asthmatic G#multi_cell_M xxx G#multi_cell_M
patients G#multi_cell_E xxx G#multi_cell_E
. NE . NE

Scatchard G#other_name_B Xxxx G#other_name_B
analysis G#other_name_E xxx G#other_name_E
of NE xx NE
glucocorticoid G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
- NE - NE
GRE G#other_name_B XXX G#other_name_B
binding G#other_name_E xxx G#other_name_E
showed NE xxx NE
no NE xx NE
change NE xxx NE
in NE xx NE
binding NE xxx NE
affinity NE xxx NE
but NE xxx NE
did NE xxx NE
show NE xxx NE
a NE x NE
reduced NE xxx NE
number NE xxx NE
of NE xx NE
receptors G#protein_family_or_group xxx G#protein_family_or_group
available NE xxx NE
for NE xxx NE
DNA NE XXX NE
binding NE xxx NE
in NE xx NE
the NE xxx NE
steroid-resistant NE xxx-xxx NE
patients G#multi_cell xxx G#multi_cell
. NE . NE

These NE Xxxx NE
results NE xxx NE
suggest NE xxx NE
that NE xxx NE
the NE xxx NE
ability NE xxx NE
of NE xx NE
the NE xxx NE
glucocorticoid G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
to NE xx NE
bind NE xxx NE
to NE xx NE
GRE G#DNA_domain_or_region XXX G#DNA_domain_or_region
is NE xx NE
impaired NE xxx NE
in NE xx NE
steroid-resistant G#multi_cell_B xxx-xxx G#multi_cell_B
patients G#multi_cell_E xxx G#multi_cell_E
because NE xxx NE
of NE xx NE
a NE x NE
reduced NE xxx NE
number NE xxx NE
of NE xx NE
receptors G#protein_family_or_group xxx G#protein_family_or_group
available NE xxx NE
for NE xxx NE
binding NE xxx NE
to NE xx NE
DNA NE XXX NE
. NE . NE

Interleukin-5 G#other_name_B Xxxx-d G#other_name_B
signaling G#other_name_E xxx G#other_name_E
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
eosinophils G#cell_type_E xxx G#cell_type_E
involves NE xxx NE
JAK2 G#protein_molecule_B XXXd G#protein_molecule_B
tyrosine G#protein_molecule_M xxx G#protein_molecule_M
kinase G#protein_molecule_E xxx G#protein_molecule_E
and NE xxx NE
Stat1 G#protein_molecule_B Xxxxd G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

Signaling NE Xxxx NE
by NE xx NE
a NE x NE
wide NE xxx NE
variety NE xxx NE
of NE xx NE
cytokines G#protein_family_or_group xxx G#protein_family_or_group
, NE , NE
including NE xxx NE
interferons G#protein_family_or_group xxx G#protein_family_or_group
, NE , NE
interleukins G#protein_family_or_group xxx G#protein_family_or_group
, NE , NE
and NE xxx NE
growth G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
involves NE xxx NE
activation NE xxx NE
of NE xx NE
JAK G#protein_family_or_group_B XXX G#protein_family_or_group_B
kinases G#protein_family_or_group_E xxx G#protein_family_or_group_E
and NE xxx NE
Stat NE Xxxx NE
( NE ( NE
Signal NE Xxxx NE
transducers NE xxx NE
and NE xxx NE
activators NE xxx NE
of NE xx NE
transcription NE xxx NE
) NE ) NE
proteins NE xxx NE
. NE . NE

At NE Xx NE
present NE xxx NE
, NE , NE
not NE xxx NE
much NE xxx NE
is NE xx NE
known NE xxx NE
about NE xxx NE
the NE xxx NE
molecular NE xxx NE
mechanisms NE xxx NE
by NE xx NE
which NE xxx NE
interleukin-5 G#protein_molecule xxx-d G#protein_molecule
( NE ( NE
IL-5 G#protein_molecule XX-d G#protein_molecule
) NE ) NE
exerts NE xxx NE
its NE xxx NE
diverse G#other_name_B xxx G#other_name_B
biologic G#other_name_M xxx G#other_name_M
effects G#other_name_E xxx G#other_name_E
. NE . NE

Human G#cell_type_B Xxxx G#cell_type_B
eosinophils G#cell_type_E xxx G#cell_type_E
are NE xxx NE
one NE xxx NE
of NE xx NE
the NE xxx NE
most NE xxx NE
important NE xxx NE
target G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
for NE xxx NE
IL-5 G#protein_molecule XX-d G#protein_molecule
and NE xxx NE
were NE xxx NE
used NE xxx NE
here NE xxx NE
to NE xx NE
study NE xxx NE
IL-5 G#other_name_B XX-d G#other_name_B
signaling G#other_name_E xxx G#other_name_E
in NE xx NE
a NE x NE
primary G#cell_type_B xxx G#cell_type_B
human G#cell_type_M xxx G#cell_type_M
cell G#cell_type_E xxx G#cell_type_E
. NE . NE

IL-5 G#protein_molecule XX-d G#protein_molecule
induced NE xxx NE
rapid NE xxx NE
and NE xxx NE
transient NE xxx NE
tyrosine G#other_name_B xxx G#other_name_B
phosphorylation G#other_name_E xxx G#other_name_E
of NE xx NE
JAK2 G#protein_molecule XXXd G#protein_molecule
. NE . NE

Moreover NE Xxxx NE
, NE , NE
IL-5 G#protein_molecule XX-d G#protein_molecule
induced NE xxx NE
at NE xx NE
least NE xxx NE
two NE xxx NE
DNA-binding NE XXX-xxx NE
complexes NE xxx NE
, NE , NE
using NE xxx NE
nuclear NE xxx NE
extracts NE xxx NE
from NE xxx NE
normal NE xxx NE
human NE xxx NE
eosinophils NE xxx NE
and NE xxx NE
the NE xxx NE
IL-6/interferon-gamma NE XX-d/xxx-xxx NE
response NE xxx NE
element NE xxx NE
of NE xx NE
the NE xxx NE
ICAM-1 NE XXXX-d NE
promoter NE xxx NE
( NE ( NE
ICAM-1 NE XXXX-d NE
pIRE NE xXXX NE
) NE ) NE
in NE xx NE
an NE xx NE
electromobility NE xxx NE
shift NE xxx NE
assay NE xxx NE
. NE . NE

From NE Xxxx NE
supershift G#other_name_B xxx G#other_name_B
experiments G#other_name_E xxx G#other_name_E
it NE xx NE
was NE xxx NE
concluded NE xxx NE
that NE xxx NE
one NE xxx NE
DNA-binding G#protein_complex_B XXX-xxx G#protein_complex_B
complex G#protein_complex_E xxx G#protein_complex_E
contained NE xxx NE
Stat1 G#protein_molecule_B Xxxxd G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
, NE , NE
probably NE xxx NE
as NE xx NE
a NE x NE
homodimer NE xxx NE
. NE . NE

Both NE Xxxx NE
DNA-binding NE XXX-xxx NE
complexes NE xxx NE
were NE xxx NE
inhibited NE xxx NE
by NE xx NE
a NE x NE
phosphotyrosine NE xxx NE
antibody NE xxx NE
( NE ( NE
4G10 NE dXdd NE
) NE ) NE
, NE , NE
suggesting NE xxx NE
that NE xxx NE
tyrosine NE xxx NE
phosphorylation NE xxx NE
is NE xx NE
required NE xxx NE
for NE xxx NE
complex NE xxx NE
formation NE xxx NE
. NE . NE

IL-3 G#protein_family_or_group XX-d G#protein_family_or_group
and NE xxx NE
granulocyte-macrophage G#protein_molecule_B xxx-xxx G#protein_molecule_B
colony-stimulating G#protein_molecule_M xxx-xxx G#protein_molecule_M
factor G#protein_molecule_E xxx G#protein_molecule_E
induced NE xxx NE
, NE , NE
similar NE xxx NE
to NE xx NE
IL-5 G#protein_molecule XX-d G#protein_molecule
, NE , NE
two NE xxx NE
DNA-binding NE XXX-xxx NE
complexes NE xxx NE
in NE xx NE
human NE xxx NE
eosinophils NE xxx NE
, NE , NE
including NE xxx NE
Stat1 NE Xxxxd NE
alpha NE xxx NE
. NE . NE

These NE Xxxx NE
data NE xxx NE
show NE xxx NE
for NE xxx NE
the NE xxx NE
first NE xxx NE
time NE xxx NE
that NE xxx NE
molecular NE xxx NE
mechanisms NE xxx NE
of NE xx NE
IL-5 G#other_name_B XX-d G#other_name_B
signaling G#other_name_E xxx G#other_name_E
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
eosinophils G#cell_type_E xxx G#cell_type_E
involve NE xxx NE
members NE xxx NE
of NE xx NE
the NE xxx NE
JAK G#protein_family_or_group_B XXX G#protein_family_or_group_B
kinase G#protein_family_or_group_M xxx G#protein_family_or_group_M
family G#protein_family_or_group_E xxx G#protein_family_or_group_E
as NE xx NE
well NE xxx NE
as NE xx NE
members NE xxx NE
of NE xx NE
the NE xxx NE
Stat G#protein_family_or_group_B Xxxx G#protein_family_or_group_B
family G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Infection NE Xxxx NE
and NE xxx NE
replication NE xxx NE
of NE xx NE
Tat- NE Xxx- NE
human NE xxx NE
immunodeficiency NE xxx NE
viruses NE xxx NE
: NE : NE
genetic NE xxx NE
analyses NE xxx NE
of NE xx NE
LTR G#DNA_domain_or_region XXX G#DNA_domain_or_region
and NE xxx NE
tat G#protein_family_or_group_B xxx G#protein_family_or_group_B
mutations G#protein_family_or_group_E xxx G#protein_family_or_group_E
in NE xx NE
primary G#cell_type_B xxx G#cell_type_B
human G#cell_type_M xxx G#cell_type_M
lymphoid G#cell_type_M xxx G#cell_type_M
cell G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
long-term G#cell_type_M xxx-xxx G#cell_type_M
human G#cell_type_M xxx G#cell_type_M
lymphoid G#cell_type_M xxx G#cell_type_M
cell G#cell_type_E xxx G#cell_type_E

Tat G#protein_molecule Xxx G#protein_molecule
is NE xx NE
an NE xx NE
essential NE xxx NE
regulatory G#protein_family_or_group_B xxx G#protein_family_or_group_B
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
for NE xxx NE
the NE xxx NE
replication NE xxx NE
of NE xx NE
human G#virus_B xxx G#virus_B
immunodeficiency G#virus_M xxx G#virus_M
virus G#virus_E xxx G#virus_E
( NE ( NE
HIV G#virus XXX G#virus
) NE ) NE
. NE . NE

Mutations NE Xxxx NE
in NE xx NE
the NE xxx NE
tat G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
have NE xxx NE
been NE xxx NE
shown NE xxx NE
to NE xx NE
block NE xxx NE
HIV G#other_name_B XXX G#other_name_B
replication G#other_name_E xxx G#other_name_E
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Several NE Xxxx NE
studies NE xxx NE
have NE xxx NE
established NE xxx NE
that NE xxx NE
Tat G#protein_molecule Xxx G#protein_molecule
releases NE xxx NE
an NE xx NE
elongation G#protein_complex_B xxx G#protein_complex_B
block G#protein_complex_E xxx G#protein_complex_E
to NE xx NE
the NE xxx NE
transcription G#other_name xxx G#other_name
of NE xx NE
HIV G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
long G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
terminal G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
repeat G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
LTR G#DNA_domain_or_region XXX G#DNA_domain_or_region
) NE ) NE
; NE ; NE
however NE xxx NE
, NE , NE
it NE xx NE
is NE xx NE
not NE xxx NE
known NE xxx NE
whether NE xxx NE
this NE xxx NE
mechanism NE xxx NE
alone NE xxx NE
is NE xx NE
sufficient NE xxx NE
to NE xx NE
explain NE xxx NE
the NE xxx NE
block NE xxx NE
to NE xx NE
HIV G#other_name_B XXX G#other_name_B
replication G#other_name_E xxx G#other_name_E
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
when NE xxx NE
Tat G#protein_molecule Xxx G#protein_molecule
is NE xx NE
absent NE xxx NE
. NE . NE

It NE Xx NE
is NE xx NE
possible NE xxx NE
that NE xxx NE
Tat G#protein_molecule Xxx G#protein_molecule
is NE xx NE
also NE xxx NE
needed NE xxx NE
for NE xxx NE
other NE xxx NE
functions NE xxx NE
during NE xxx NE
HIV G#other_name_B XXX G#other_name_B
replication G#other_name_E xxx G#other_name_E
. NE . NE

To NE Xx NE
test NE xxx NE
these NE xxx NE
hypotheses NE xxx NE
, NE , NE
we NE xx NE
studied NE xxx NE
several NE xxx NE
tat G#protein_family_or_group_B xxx G#protein_family_or_group_B
mutants G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
including NE xxx NE
two NE xxx NE
stop G#protein_family_or_group_B xxx G#protein_family_or_group_B
codon G#protein_family_or_group_M xxx G#protein_family_or_group_M
mutants G#protein_family_or_group_E xxx G#protein_family_or_group_E
and NE xxx NE
one NE xxx NE
deletion G#protein_family_or_group_B xxx G#protein_family_or_group_B
mutant G#protein_family_or_group_E xxx G#protein_family_or_group_E
using NE xxx NE
replication-competent G#DNA_family_or_group_B xxx-xxx G#DNA_family_or_group_B
HIV-1 G#DNA_family_or_group_M XXX-d G#DNA_family_or_group_M
constructs G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
carrying NE xxx NE
wild-type G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
LTR G#DNA_domain_or_region_M XXX G#DNA_domain_or_region_M
or G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
mutant G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
LTR G#DNA_domain_or_region_E XXX G#DNA_domain_or_region_E
with NE xxx NE
modifications NE xxx NE
in NE xx NE
the NE xxx NE
NF-kappa G#DNA_domain_or_region_B XX-xxx G#DNA_domain_or_region_B
B G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and/or G#DNA_domain_or_region_M xxx/xx G#DNA_domain_or_region_M
Sp1 G#DNA_domain_or_region_M Xxd G#DNA_domain_or_region_M
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E

In NE Xx NE
this NE xxx NE
study NE xxx NE
, NE , NE
we NE xx NE
show NE xxx NE
that NE xxx NE
Tat- G#virus_B Xxx- G#virus_B
HIV-1 G#virus_E XXX-d G#virus_E
with NE xxx NE
wild-type G#DNA_family_or_group_B xxx-xxx G#DNA_family_or_group_B
LTRs G#DNA_family_or_group_E XXXx G#DNA_family_or_group_E
can NE xxx NE
replicate NE xxx NE
in NE xx NE
HeLa G#cell_line_B XxXx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
and NE xxx NE
the NE xxx NE
virus G#virus xxx G#virus
produced NE xxx NE
from NE xxx NE
HeLa G#cell_line_B XxXx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
can NE xxx NE
infect NE xxx NE
primary NE xxx NE
peripheral G#cell_type_B xxx G#cell_type_B
blood G#cell_type_M xxx G#cell_type_M
lymphocytes G#cell_type_E xxx G#cell_type_E
and NE xxx NE
macrophages G#cell_type xxx G#cell_type
. NE . NE

It NE Xx NE
was NE xxx NE
found NE xxx NE
that NE xxx NE
the NE xxx NE
propagation NE xxx NE
of NE xx NE
the NE xxx NE
Tat G#protein_family_or_group_B Xxx G#protein_family_or_group_B
mutants G#protein_family_or_group_E xxx G#protein_family_or_group_E
containing NE xxx NE
wild-type G#DNA_family_or_group_B xxx-xxx G#DNA_family_or_group_B
LTRs G#DNA_family_or_group_E XXXx G#DNA_family_or_group_E
was NE xxx NE
less NE xxx NE
efficient NE xxx NE
than NE xxx NE
that NE xxx NE
of NE xx NE
the NE xxx NE
LTR-modified G#protein_family_or_group_B XXX-xxx G#protein_family_or_group_B
Tat G#protein_family_or_group_M Xxx G#protein_family_or_group_M
mutants G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Large NE Xxxx NE
amounts NE xxx NE
of NE xx NE
viral G#RNA_family_or_group_B xxx G#RNA_family_or_group_B
RNA G#RNA_family_or_group_E XXX G#RNA_family_or_group_E
and NE xxx NE
particles NE xxx NE
were NE xxx NE
synthesized NE xxx NE
in NE xx NE
infections G#other_name xxx G#other_name
established NE xxx NE
using NE xxx NE
the NE xxx NE
tat G#protein_family_or_group_B xxx G#protein_family_or_group_B
mutants G#protein_family_or_group_E xxx G#protein_family_or_group_E
that NE xxx NE
contain NE xxx NE
modified G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
LTRs G#DNA_family_or_group_E XXXx G#DNA_family_or_group_E
. NE . NE

However NE Xxxx NE
, NE , NE
this NE xxx NE
efficient NE xxx NE
propagation NE xxx NE
of NE xx NE
the NE xxx NE
LTR-modified G#protein_family_or_group_B XXX-xxx G#protein_family_or_group_B
tat G#protein_family_or_group_M xxx G#protein_family_or_group_M
mutants G#protein_family_or_group_E xxx G#protein_family_or_group_E
was NE xxx NE
restricted NE xxx NE
to NE xx NE
some NE xxx NE
lymphoid G#cell_line_B xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
that NE xxx NE
have NE xxx NE
been NE xxx NE
transformed NE xxx NE
with NE xxx NE
other NE xxx NE
viruses NE xxx NE
. NE . NE

Thus NE Xxxx NE
, NE , NE
despite NE xxx NE
its NE xxx NE
essential NE xxx NE
role NE xxx NE
for NE xxx NE
releasing NE xxx NE
an NE xx NE
elongation G#protein_complex_B xxx G#protein_complex_B
block G#protein_complex_E xxx G#protein_complex_E
, NE , NE
Tat G#protein_molecule Xxx G#protein_molecule
is NE xx NE
not NE xxx NE
otherwise NE xxx NE
absolutely NE xxx NE
required NE xxx NE
for NE xxx NE
synthesis NE xxx NE
of NE xx NE
full-length G#RNA_family_or_group_B xxx-xxx G#RNA_family_or_group_B
HIV G#RNA_family_or_group_M XXX G#RNA_family_or_group_M
transcripts G#RNA_family_or_group_E xxx G#RNA_family_or_group_E
and NE xxx NE
assembly NE xxx NE
of NE xx NE
virus G#virus_B xxx G#virus_B
particles G#virus_E xxx G#virus_E
. NE . NE

Direct NE Xxxx NE
sequencing NE xxx NE
of NE xx NE
the NE xxx NE
viral G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
genomes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
and NE xxx NE
reinfection NE xxx NE
kinetics NE xxx NE
showed NE xxx NE
no NE xx NE
evidence NE xxx NE
of NE xx NE
wild-type G#other_name_B xxx-xxx G#other_name_B
reversion G#other_name_E xxx G#other_name_E
even NE xxx NE
after NE xxx NE
prolonged NE xxx NE
infection NE xxx NE
with NE xxx NE
the NE xxx NE
Tat NE Xxx NE
-virus NE -xxx NE
. NE . NE

The NE Xxx NE
implications NE xxx NE
for NE xxx NE
in G#other_name_B xx G#other_name_B
vivo G#other_name_M xxx G#other_name_M
HIV-1 G#other_name_M XXX-d G#other_name_M
replication G#other_name_E xxx G#other_name_E
and NE xxx NE
potential NE xxx NE
application NE xxx NE
of NE xx NE
this NE xxx NE
system NE xxx NE
to NE xx NE
the NE xxx NE
study NE xxx NE
of NE xx NE
alternative NE xxx NE
Tat G#other_name_B Xxx G#other_name_B
function G#other_name_E xxx G#other_name_E
are NE xxx NE
discussed NE xxx NE
. NE . NE

Functional NE Xxxx NE
roles NE xxx NE
of NE xx NE
the NE xxx NE
transcription G#protein_molecule_B xxx G#protein_molecule_B
factor G#protein_molecule_M xxx G#protein_molecule_M
Oct-2A G#protein_molecule_E Xxx-dX G#protein_molecule_E
and NE xxx NE
the NE xxx NE
high G#protein_family_or_group_B xxx G#protein_family_or_group_B
mobility G#protein_family_or_group_M xxx G#protein_family_or_group_M
group G#protein_family_or_group_M xxx G#protein_family_or_group_M
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
I/Y G#protein_molecule X/X G#protein_molecule
in NE xx NE
HLA-DRA G#other_name_B XXX-XXX G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
class G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
II G#DNA_domain_or_region_M XX G#DNA_domain_or_region_M
major G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
histocompatibility G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
complex G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
HLA-DRA G#DNA_domain_or_region XXX-XXX G#DNA_domain_or_region
is NE xx NE
expressed NE xxx NE
in NE xx NE
B G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
, NE , NE
activated NE xxx NE
T G#cell_type_B X G#cell_type_B
lymphocytes G#cell_type_E xxx G#cell_type_E
, NE , NE
and NE xxx NE
in NE xx NE
antigen-presenting G#cell_type_B xxx-xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

In NE Xx NE
addition NE xxx NE
, NE , NE
HLA-DRA G#other_name_B XXX-XXX G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
is NE xx NE
inducible NE xxx NE
in NE xx NE
a NE x NE
variety NE xxx NE
of NE xx NE
cell NE xxx NE
types NE xxx NE
by NE xx NE
interferon-gamma G#protein_molecule xxx-xxx G#protein_molecule
( NE ( NE
IFN-gamma G#protein_molecule XXX-xxx G#protein_molecule
) NE ) NE
. NE . NE

Here NE Xxxx NE
we NE xx NE
show NE xxx NE
that NE xxx NE
the NE xxx NE
lymphoid-specific G#protein_molecule_B xxx-xxx G#protein_molecule_B
transcription G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_M xxx G#protein_molecule_M
Oct-2A G#protein_molecule_E Xxx-dX G#protein_molecule_E
plays NE xxx NE
a NE x NE
critical NE xxx NE
role NE xxx NE
in NE xx NE
HLA-DRA G#other_name_B XXX-XXX G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
in NE xx NE
class G#cell_line_B xxx G#cell_line_B
II-positive G#cell_line_M XX-xxx G#cell_line_M
B G#cell_line_M X G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
, NE , NE
and NE xxx NE
that NE xxx NE
the NE xxx NE
high G#protein_family_or_group_B xxx G#protein_family_or_group_B
mobility G#protein_family_or_group_M xxx G#protein_family_or_group_M
group G#protein_family_or_group_M xxx G#protein_family_or_group_M
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
HMG G#protein_family_or_group XXX G#protein_family_or_group
) NE ) NE
I/Y G#protein_molecule X/X G#protein_molecule
binds NE xxx NE
to NE xx NE
multiple NE xxx NE
sites NE xxx NE
within NE xxx NE
the NE xxx NE
DRA G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
including NE xxx NE
the NE xxx NE
Oct-2A G#DNA_domain_or_region_B Xxx-dX G#DNA_domain_or_region_B
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Coexpression NE Xxxx NE
of NE xx NE
HMG G#protein_molecule_B XXX G#protein_molecule_B
I/Y G#protein_molecule_E X/X G#protein_molecule_E
and NE xxx NE
Oct-2 G#protein_family_or_group Xxx-d G#protein_family_or_group
in NE xx NE
cell G#cell_line_B xxx G#cell_line_B
lines G#cell_line_E xxx G#cell_line_E
lacking NE xxx NE
Oct-2 G#protein_family_or_group Xxx-d G#protein_family_or_group
results NE xxx NE
in NE xx NE
high NE xxx NE
levels NE xxx NE
of NE xx NE
HLA-DRA G#other_name_B XXX-XXX G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
, NE , NE
and NE xxx NE
in NE xx NE
vitro NE xxx NE
DNA-binding NE XXX-xxx NE
studies NE xxx NE
reveal NE xxx NE
that NE xxx NE
HMG NE XXX NE
I/Y G#protein_molecule X/X G#protein_molecule
stimulates NE xxx NE
Oct-2A G#other_name_B Xxx-dX G#other_name_B
binding G#other_name_E xxx G#other_name_E
to NE xx NE
the NE xxx NE
HLA-DRA G#DNA_domain_or_region_B XXX-XXX G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Thus NE Xxxx NE
, NE , NE
Oct-2A G#protein_molecule Xxx-dX G#protein_molecule
and NE xxx NE
HMG G#protein_molecule_B XXX G#protein_molecule_B
I/Y G#protein_molecule_E X/X G#protein_molecule_E
may NE xxx NE
synergize NE xxx NE
to NE xx NE
activate NE xxx NE
HLA-DRA G#other_name_B XXX-XXX G#other_name_B
expression G#other_name_E xxx G#other_name_E
in NE xx NE
B G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

By NE Xx NE
contrast NE xxx NE
, NE , NE
Oct-2A G#protein_molecule Xxx-dX G#protein_molecule
is NE xx NE
not NE xxx NE
involved NE xxx NE
in NE xx NE
the NE xxx NE
IFN-gamma G#other_name_B XXX-xxx G#other_name_B
induction G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
HLA-DRA G#DNA_domain_or_region_B XXX-XXX G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
HeLa G#cell_line_B XxXx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
but NE xxx NE
antisense G#DNA_molecule_B xxx G#DNA_molecule_B
HMG G#DNA_molecule_M XXX G#DNA_molecule_M
I/Y G#DNA_molecule_E X/X G#DNA_molecule_E
dramatically NE xxx NE
decreases NE xxx NE
the NE xxx NE
level NE xxx NE
of NE xx NE
induction NE xxx NE
. NE . NE

We NE Xx NE
conclude NE xxx NE
that NE xxx NE
distinct NE xxx NE
sets NE xxx NE
of NE xx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
are NE xxx NE
involved NE xxx NE
in NE xx NE
the NE xxx NE
two NE xxx NE
modes NE xxx NE
of NE xx NE
HLA-DRA G#other_name_B XXX-XXX G#other_name_B
expression G#other_name_E xxx G#other_name_E
, NE , NE
and NE xxx NE
that NE xxx NE
HMG G#protein_molecule_B XXX G#protein_molecule_B
I/Y G#protein_molecule_E X/X G#protein_molecule_E
may NE xxx NE
be NE xx NE
important NE xxx NE
for NE xxx NE
B G#other_name_B X G#other_name_B
cell-specific G#other_name_M xxx-xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
, NE , NE
and NE xxx NE
is NE xx NE
essential NE xxx NE
for NE xxx NE
IFN-gamma G#other_name_B XXX-xxx G#other_name_B
induction G#other_name_E xxx G#other_name_E
. NE . NE

Heterogeneous G#other_name_B Xxxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
of NE xx NE
Epstein-Barr G#protein_family_or_group_B Xxxx-Xxxx G#protein_family_or_group_B
virus G#protein_family_or_group_M xxx G#protein_family_or_group_M
latent G#protein_family_or_group_M xxx G#protein_family_or_group_M
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
in NE xx NE
endemic NE xxx NE
Burkitt's G#other_name_B Xxxx'x G#other_name_B
lymphoma G#other_name_E xxx G#other_name_E
. NE . NE

Epstein-Barr G#cell_type_B Xxxx-Xxxx G#cell_type_B
virus G#cell_type_M xxx G#cell_type_M
(EBV)-infected G#cell_type_M (XXX)-xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
may NE xxx NE
sustain NE xxx NE
three NE xxx NE
distinct NE xxx NE
forms NE xxx NE
of NE xx NE
virus G#other_name_B xxx G#other_name_B
latency G#other_name_E xxx G#other_name_E
. NE . NE

In G#cell_line Xx G#cell_line
lymphoblastoid NE xxx NE
cell NE xxx NE
lines NE xxx NE
, NE , NE
six NE xxx NE
EBV-encoded G#protein_molecule_B XXX-xxx G#protein_molecule_B
nuclear G#protein_molecule_M xxx G#protein_molecule_M
antigens G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
EBNA1 G#protein_molecule_B XXXXd G#protein_molecule_B
and G#protein_molecule_M xxx G#protein_molecule_M
EBNA2 G#protein_molecule_M XXXXd G#protein_molecule_M
and G#protein_molecule_M xxx G#protein_molecule_M
EBNA3A G#protein_molecule_M XXXXdX G#protein_molecule_M
and G#protein_molecule_M xxx G#protein_molecule_M
EBNA3B G#protein_molecule_M XXXXdX G#protein_molecule_M
and G#protein_molecule_M xxx G#protein_molecule_M
EBNA3C G#protein_molecule_M XXXXdX G#protein_molecule_M
and G#protein_molecule_M xxx G#protein_molecule_M
EBNA-LP G#protein_molecule_E XXXX-XX G#protein_molecule_E
latent NE xxx NE
membrane NE xxx NE
proteins NE xxx NE
( NE ( NE
LMP1 G#protein_molecule XXXd G#protein_molecule
, NE , NE
2A G#protein_molecule dX G#protein_molecule
, NE , NE
2B G#protein_molecule dX G#protein_molecule
) NE ) NE
, NE , NE
and NE xxx NE
two NE xxx NE
nuclear G#RNA_family_or_group_B xxx G#RNA_family_or_group_B
RNAs G#RNA_family_or_group_E XXXx G#RNA_family_or_group_E
( NE ( NE
EBERs G#RNA_family_or_group XXXXx G#RNA_family_or_group
) NE ) NE
are NE xxx NE
expressed NE xxx NE
. NE . NE

This NE Xxxx NE
form NE xxx NE
of NE xx NE
latency G#other_name xxx G#other_name
, NE , NE
termed NE xxx NE
latency G#other_name_B xxx G#other_name_B
III G#other_name_E XXX G#other_name_E
, NE , NE
is NE xx NE
also NE xxx NE
encountered NE xxx NE
in NE xx NE
some NE xxx NE
posttransplant G#other_name_B xxx G#other_name_B
lymphoproliferative G#other_name_M xxx G#other_name_M
disorders G#other_name_E xxx G#other_name_E
. NE . NE

In NE Xx NE
EBV-positive G#multi_cell_B XXX-xxx G#multi_cell_B
cases G#multi_cell_E xxx G#multi_cell_E
of NE xx NE
Hodgkin's G#other_name_B Xxxx'x G#other_name_B
disease G#other_name_E xxx G#other_name_E
, NE , NE
the NE xxx NE
EBERs G#RNA_family_or_group XXXXx G#RNA_family_or_group
, NE , NE
EBNA1 G#protein_molecule XXXXd G#protein_molecule
, NE , NE
and NE xxx NE
the NE xxx NE
LMPs G#protein_family_or_group XXXx G#protein_family_or_group
are NE xxx NE
expressed NE xxx NE
( NE ( NE
latency G#other_name_B xxx G#other_name_B
II G#other_name_E XX G#other_name_E
) NE ) NE
, NE , NE
whereas NE xxx NE
in NE xx NE
Burkitt's G#other_name_B Xxxx'x G#other_name_B
lymphoma G#other_name_E xxx G#other_name_E
(BL) NE (XX) NE
only NE xxx NE
the NE xxx NE
EBERs G#RNA_family_or_group XXXXx G#RNA_family_or_group
and NE xxx NE
EBNA1 G#protein_molecule XXXXd G#protein_molecule
have NE xxx NE
been NE xxx NE
detected NE xxx NE
( NE ( NE
latency G#other_name_B xxx G#other_name_B
I G#other_name_E X G#other_name_E
) NE ) NE
. NE . NE

We NE Xx NE
have NE xxx NE
studied NE xxx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
EBV G#protein_family_or_group_B XXX G#protein_family_or_group_B
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
in NE xx NE
17 NE dd NE
cases NE xxx NE
of NE xx NE
EBV-positive G#other_name_B XXX-xxx G#other_name_B
endemic G#other_name_M xxx G#other_name_M
BL G#other_name_E XX G#other_name_E
by NE xx NE
immunohistology G#other_name xxx G#other_name
. NE . NE

Expression NE Xxxx NE
of NE xx NE
LMP1 G#protein_molecule XXXd G#protein_molecule
was NE xxx NE
seen NE xxx NE
in NE xx NE
variable NE xxx NE
proportions NE xxx NE
of NE xx NE
tumor G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
in NE xx NE
two NE xxx NE
cases NE xxx NE
and NE xxx NE
EBNA2 G#protein_molecule XXXXd G#protein_molecule
was NE xxx NE
detected NE xxx NE
in NE xx NE
some NE xxx NE
tumor G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
in NE xx NE
three NE xxx NE
other NE xxx NE
cases NE xxx NE
. NE . NE

Also NE Xxxx NE
, NE , NE
the NE xxx NE
BZLF1 G#protein_molecule_B XXXXd G#protein_molecule_B
trans-activator G#protein_molecule_M xxx-xxx G#protein_molecule_M
protein G#protein_molecule_E xxx G#protein_molecule_E
was NE xxx NE
expressed NE xxx NE
in NE xx NE
a NE x NE
few NE xxx NE
tumor G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
in NE xx NE
6 NE d NE
cases NE xxx NE
, NE , NE
indicating NE xxx NE
entry NE xxx NE
into NE xxx NE
the NE xxx NE
lytic G#other_name_B xxx G#other_name_B
cycle G#other_name_E xxx G#other_name_E
. NE . NE

A NE X NE
phenotypic NE xxx NE
drift NE xxx NE
from NE xxx NE
latency G#other_name_B xxx G#other_name_B
I G#other_name_E X G#other_name_E
to NE xx NE
latency G#other_name_B xxx G#other_name_B
III G#other_name_E XXX G#other_name_E
has NE xxx NE
been NE xxx NE
observed NE xxx NE
previously NE xxx NE
in NE xx NE
some NE xxx NE
BL G#cell_line_B XX G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
. NE . NE

Our NE Xxx NE
results NE xxx NE
suggest NE xxx NE
that NE xxx NE
a NE x NE
similar NE xxx NE
phenomenon NE xxx NE
may NE xxx NE
occur NE xxx NE
in NE xx NE
BL G#other_name XX G#other_name
in NE xx NE
vivo NE xxx NE
and NE xxx NE
indicate NE xxx NE
that NE xxx NE
the NE xxx NE
operational NE xxx NE
definition NE xxx NE
of NE xx NE
EBV NE XXX NE
latencies NE xxx NE
is NE xx NE
not NE xxx NE
easily NE xxx NE
applied NE xxx NE
to NE xx NE
human NE xxx NE
tumors NE xxx NE
. NE . NE

The NE Xxx NE
activation NE xxx NE
of NE xx NE
the NE xxx NE
Jak NE Xxx NE
-STAT NE -XXXX NE
1 NE d NE
signaling NE xxx NE
pathway NE xxx NE
by NE xx NE
IL-5 NE XX-d NE
in NE xx NE
eosinophils NE xxx NE
. NE . NE

The NE Xxx NE
intracellular NE xxx NE
signal NE xxx NE
transduction NE xxx NE
of NE xx NE
IL-5 G#protein_molecule XX-d G#protein_molecule
in NE xx NE
eosinophils G#cell_type xxx G#cell_type
is NE xx NE
unknown NE xxx NE
. NE . NE

The NE Xxx NE
objective NE xxx NE
of NE xx NE
this NE xxx NE
study NE xxx NE
was NE xxx NE
to NE xx NE
investigate NE xxx NE
the NE xxx NE
involvement NE xxx NE
of NE xx NE
the NE xxx NE
newly NE xxx NE
discovered NE xxx NE
Jak NE Xxx NE
-STAT NE -XXXX NE
pathway NE xxx NE
in NE xx NE
the NE xxx NE
IL-5 NE XX-d NE
signal NE xxx NE
transduction NE xxx NE
mechanism NE xxx NE
. NE . NE

Eosinophils G#cell_type Xxxx G#cell_type
were NE xxx NE
purified NE xxx NE
from NE xxx NE
peripheral G#tissue_B xxx G#tissue_B
blood G#tissue_E xxx G#tissue_E
by NE xx NE
discontinuous NE xxx NE
Percoll G#other_name_B Xxxx G#other_name_B
gradients G#other_name_E xxx G#other_name_E
and NE xxx NE
stimulated NE xxx NE
with NE xxx NE
IL-5 G#protein_molecule XX-d G#protein_molecule
. NE . NE

The NE Xxx NE
involvement NE xxx NE
of NE xx NE
Jak NE Xxx NE
2 NE d NE
was NE xxx NE
investigated NE xxx NE
by NE xx NE
immunoprecipitation NE xxx NE
followed NE xxx NE
by NE xx NE
immunoblotting NE xxx NE
for NE xxx NE
tyrosine NE xxx NE
phosphorylation NE xxx NE
. NE . NE

The NE Xxx NE
activation NE xxx NE
of NE xx NE
Jak NE Xxx NE
2 NE d NE
was NE xxx NE
studied NE xxx NE
by NE xx NE
autophosphorylation NE xxx NE
of NE xx NE
the NE xxx NE
immunoprecipitated NE xxx NE
kinase NE xxx NE
. NE . NE

Jak NE Xxx NE
2 NE d NE
was NE xxx NE
tyrosine NE xxx NE
phosphorylated NE xxx NE
within NE xxx NE
1 NE d NE
to NE xx NE
3 NE d NE
min NE xxx NE
after NE xxx NE
stimulation NE xxx NE
of NE xx NE
eosinophils NE xxx NE
with NE xxx NE
IL-5 NE XX-d NE
. NE . NE

Further NE Xxxx NE
, NE , NE
the NE xxx NE
immunoprecipitated G#protein_molecule_B xxx G#protein_molecule_B
Jak G#protein_molecule_M Xxx G#protein_molecule_M
2 G#protein_molecule_E d G#protein_molecule_E
obtained NE xxx NE
from NE xxx NE
IL-5 NE XX-d NE
-stimulated NE -xxx NE
cells NE xxx NE
underwent NE xxx NE
autophosphorylation NE xxx NE
. NE . NE

Jak NE Xxx NE
2 NE d NE
coprecipitated NE xxx NE
with NE xxx NE
the NE xxx NE
beta-subunit NE xxx-xxx NE
of NE xx NE
the NE xxx NE
IL-5 NE XX-d NE
receptor NE xxx NE
, NE , NE
suggesting NE xxx NE
a NE x NE
physical NE xxx NE
association NE xxx NE
of NE xx NE
the NE xxx NE
kinase NE xxx NE
with NE xxx NE
the NE xxx NE
receptor NE xxx NE
. NE . NE

The NE Xxx NE
nuclear G#protein_molecule_B xxx G#protein_molecule_B
factor G#protein_molecule_M xxx G#protein_molecule_M
STAT-1 G#protein_molecule_E XXXX-d G#protein_molecule_E
( NE ( NE
p91 G#protein_molecule xdd G#protein_molecule
) NE ) NE
was NE xxx NE
investigated NE xxx NE
by NE xx NE
immunoprecipitation G#other_name xxx G#other_name
followed NE xxx NE
by NE xx NE
immunoblotting G#other_name xxx G#other_name
for NE xxx NE
tyrosine G#other_name_B xxx G#other_name_B
phosphorylation G#other_name_E xxx G#other_name_E
. NE . NE

STAT-1 G#protein_molecule XXXX-d G#protein_molecule
was NE xxx NE
tyrosine G#other_name_B xxx G#other_name_B
phosphorylated G#other_name_E xxx G#other_name_E
within NE xxx NE
15 NE dd NE
min NE xxx NE
of NE xx NE
IL-5 G#other_name_B XX-d G#other_name_B
stimulation G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
presence NE xxx NE
of NE xx NE
STAT-1 G#protein_molecule XXXX-d G#protein_molecule
in NE xx NE
the NE xxx NE
nuclear G#cell_component_B xxx G#cell_component_B
extract G#cell_component_E xxx G#cell_component_E
was NE xxx NE
studied NE xxx NE
by NE xx NE
electrophoretic G#other_name_B xxx G#other_name_B
mobility G#other_name_M xxx G#other_name_M
shift G#other_name_M xxx G#other_name_M
assay G#other_name_E xxx G#other_name_E
. NE . NE

IL-5 G#protein_molecule XX-d G#protein_molecule
induced NE xxx NE
two NE xxx NE
proteins NE xxx NE
that NE xxx NE
bound NE xxx NE
to NE xx NE
the NE xxx NE
gamma-activating G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

In NE Xx NE
the NE xxx NE
presence NE xxx NE
of NE xx NE
an NE xx NE
anti- NE xxx- NE
STAT-1 NE XXXX-d NE
Ab NE Xx NE
, NE , NE
the NE xxx NE
band NE xxx NE
was NE xxx NE
supershifted NE xxx NE
. NE . NE

Thus NE Xxxx NE
, NE , NE
we NE xx NE
demonstrated NE xxx NE
that NE xxx NE
IL-5 G#protein_molecule XX-d G#protein_molecule
activated NE xxx NE
the NE xxx NE
Jak NE Xxx NE
2 NE d NE
-STAT NE -XXXX NE
1 NE d NE
signaling NE xxx NE
pathway NE xxx NE
in NE xx NE
eosinophils NE xxx NE
. NE . NE

We NE Xx NE
speculate NE xxx NE
that NE xxx NE
the NE xxx NE
Jak NE Xxx NE
2 NE d NE
-STAT NE -XXXX NE
1 NE d NE
pathway NE xxx NE
may NE xxx NE
be NE xx NE
involved NE xxx NE
in NE xx NE
the NE xxx NE
activation NE xxx NE
of NE xx NE
IL-5 NE XX-d NE
-inducible NE -xxx NE
genes NE xxx NE
in NE xx NE
eosinophils NE xxx NE
. NE . NE

Reduced NE Xxxx NE
mitogenic G#other_name_B xxx G#other_name_B
stimulation G#other_name_E xxx G#other_name_E
of NE xx NE
peripheral G#cell_type_B xxx G#cell_type_B
blood G#cell_type_M xxx G#cell_type_M
mononuclear G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
as NE xx NE
a NE x NE
prognostic NE xxx NE
parameter NE xxx NE
for NE xxx NE
the NE xxx NE
course NE xxx NE
of NE xx NE
breast G#other_name_B xxx G#other_name_B
cancer G#other_name_E xxx G#other_name_E
: NE : NE
a NE x NE
prospective G#other_name_B xxx G#other_name_B
longitudinal G#other_name_M xxx G#other_name_M
study G#other_name_E xxx G#other_name_E
. NE . NE

Immunosuppression G#other_name Xxxx G#other_name
has NE xxx NE
been NE xxx NE
often NE xxx NE
associated NE xxx NE
with NE xxx NE
the NE xxx NE
course NE xxx NE
of NE xx NE
malignant G#other_name_B xxx G#other_name_B
diseases G#other_name_E xxx G#other_name_E
. NE . NE

In NE Xx NE
the NE xxx NE
present NE xxx NE
study NE xxx NE
, NE , NE
the NE xxx NE
proliferation NE xxx NE
of NE xx NE
peripheral G#cell_type_B xxx G#cell_type_B
blood G#cell_type_M xxx G#cell_type_M
mononuclear G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
( NE ( NE
PBMCs G#cell_type XXXXx G#cell_type
) NE ) NE
in NE xx NE
response NE xxx NE
to NE xx NE
mitogenic G#other_name_B xxx G#other_name_B
stimulation G#other_name_E xxx G#other_name_E
with NE xxx NE
phytohaemagglutinin G#protein_molecule xxx G#protein_molecule
( NE ( NE
PHA G#protein_molecule XXX G#protein_molecule
) NE ) NE
was NE xxx NE
assessed NE xxx NE
prospectively NE xxx NE
in NE xx NE
90 NE dd NE
patients G#multi_cell xxx G#multi_cell
with NE xxx NE
stage NE xxx NE
I-III NE X-XXX NE
breast G#other_name_B xxx G#other_name_B
cancer G#other_name_E xxx G#other_name_E
. NE . NE

Whereas NE Xxxx NE
PHA NE XXX NE
-induced NE -xxx NE
proliferation NE xxx NE
of NE xx NE
PBMCs NE XXXXx NE
derived NE xxx NE
from NE xxx NE
patients NE xxx NE
with NE xxx NE
breast NE xxx NE
cancer NE xxx NE
preoperatively NE xxx NE
was NE xxx NE
significantly NE xxx NE
decreased NE xxx NE
when NE xxx NE
compared NE xxx NE
with NE xxx NE
data NE xxx NE
obtained NE xxx NE
in NE xx NE
healthy NE xxx NE
control NE xxx NE
individuals NE xxx NE
(P NE (X NE
< NE < NE
0.001) NE d.ddd) NE
, NE , NE
the NE xxx NE
degree NE xxx NE
of NE xx NE
the NE xxx NE
defect NE xxx NE
in NE xx NE
PHA NE XXX NE
-induced NE -xxx NE
proliferation NE xxx NE
of NE xx NE
PBMCs NE XXXXx NE
depended NE xxx NE
upon NE xxx NE
the NE xxx NE
tumour NE xxx NE
burden NE xxx NE
as NE xx NE
manifested NE xxx NE
by NE xx NE
tumour NE xxx NE
size NE xxx NE
and NE xxx NE
axillary NE xxx NE
lymph NE xxx NE
node NE xxx NE
involvement NE xxx NE
(P NE (X NE
< NE < NE
0.003 NE d.ddd NE
in NE xx NE
each NE xxx NE
case) NE xxx) NE
. NE . NE

PHA NE XXX NE
-induced NE -xxx NE
proliferation NE xxx NE
of NE xx NE
PBMCs NE XXXXx NE
dropped NE xxx NE
significantly NE xxx NE
in NE xx NE
patients NE xxx NE
who NE xxx NE
received NE xxx NE
adjuvant NE xxx NE
chemotherapy NE xxx NE
consisting NE xxx NE
of NE xx NE
cyclophosphamide NE xxx NE
, NE , NE
methotrexate NE xxx NE
and NE xxx NE
fluorouracil NE xxx NE
( NE ( NE
CMF NE XXX NE
) NE ) NE
after NE xxx NE
an NE xx NE
observation NE xxx NE
period NE xxx NE
of NE xx NE
6 NE d NE
months NE xxx NE
(P NE (X NE
< NE < NE
0.01) NE d.dd) NE
, NE , NE
but NE xxx NE
not NE xxx NE
in NE xx NE
patients NE xxx NE
under NE xxx NE
adjuvant NE xxx NE
treatment NE xxx NE
with NE xxx NE
tamoxifen NE xxx NE
only NE xxx NE
. NE . NE

After NE Xxxx NE
an NE xx NE
additional NE xxx NE
6 NE d NE
months NE xxx NE
(i.e NE (x.x NE
. NE . NE
12 NE dd NE
months NE xxx NE
after NE xxx NE
surgery) NE xxx) NE
, NE , NE
PHA NE XXX NE
-induced NE -xxx NE
proliferation NE xxx NE
of NE xx NE
PBMCs NE XXXXx NE
was NE xxx NE
similar NE xxx NE
in NE xx NE
patients NE xxx NE
after NE xxx NE
adjuvant NE xxx NE
chemotherapy NE xxx NE
with NE xxx NE
CMF NE XXX NE
and NE xxx NE
in NE xx NE
those NE xxx NE
receiving NE xxx NE
continued NE xxx NE
adjuvant NE xxx NE
tamoxifen NE xxx NE
treatment NE xxx NE
(P NE (X NE
> NE > NE
0.1) NE d.d) NE
, NE , NE
but NE xxx NE
in NE xx NE
all NE xxx NE
patients NE xxx NE
still NE xxx NE
significantly NE xxx NE
decreased NE xxx NE
as NE xx NE
compared NE xxx NE
with NE xxx NE
healthy NE xxx NE
controls NE xxx NE
(P NE (X NE
< NE < NE
0.001) NE d.ddd) NE
. NE . NE

When NE Xxxx NE
data NE xxx NE
obtained NE xxx NE
preoperatively NE xxx NE
and NE xxx NE
after NE xxx NE
12 NE dd NE
months NE xxx NE
were NE xxx NE
compared NE xxx NE
, NE , NE
it NE xx NE
was NE xxx NE
found NE xxx NE
that NE xxx NE
out NE xxx NE
of NE xx NE
23 NE dd NE
patients G#multi_cell xxx G#multi_cell
whose NE xxx NE
PBMCs G#cell_type XXXXx G#cell_type
had NE xxx NE
experienced NE xxx NE
a NE x NE
drop NE xxx NE
in NE xx NE
their NE xxx NE
PHA NE XXX NE
-induced NE -xxx NE
proliferation NE xxx NE
, NE , NE
14 NE dd NE
(61%) NE (dd%) NE
had NE xxx NE
developed NE xxx NE
metastatic NE xxx NE
disease NE xxx NE
within NE xxx NE
the NE xxx NE
subsequent NE xxx NE
24 NE dd NE
months NE xxx NE
(i.e NE (x.x NE
. NE . NE
36 NE dd NE
months NE xxx NE
after NE xxx NE
surgery) NE xxx) NE
. NE . NE

In NE Xx NE
contrast NE xxx NE
, NE , NE
out NE xxx NE
of NE xx NE
59 NE dd NE
patients G#multi_cell xxx G#multi_cell
whose NE xxx NE
PBMCs G#cell_type XXXXx G#cell_type
showed NE xxx NE
an NE xx NE
increase NE xxx NE
in NE xx NE
their NE xxx NE
PHA NE XXX NE
-induced NE -xxx NE
proliferation NE xxx NE
within NE xxx NE
the NE xxx NE
first NE xxx NE
12 NE dd NE
months NE xxx NE
after NE xxx NE
surgery NE xxx NE
, NE , NE
only NE xxx NE
one NE xxx NE
(2%) NE (d%) NE
presented NE xxx NE
with NE xxx NE
disease NE xxx NE
progression NE xxx NE
. NE . NE

We NE Xx NE
thus NE xxx NE
conclude NE xxx NE
that NE xxx NE
PHA NE XXX NE
-induced NE -xxx NE
proliferation NE xxx NE
of NE xx NE
PBMCs NE XXXXx NE
derived NE xxx NE
from NE xxx NE
patients NE xxx NE
with NE xxx NE
breast NE xxx NE
cancer NE xxx NE
depends NE xxx NE
upon NE xxx NE
the NE xxx NE
tumour NE xxx NE
load NE xxx NE
and NE xxx NE
is NE xx NE
a NE x NE
good NE xxx NE
clinical NE xxx NE
predictor NE xxx NE
for NE xxx NE
the NE xxx NE
further NE xxx NE
course NE xxx NE
of NE xx NE
the NE xxx NE
disease NE xxx NE
. NE . NE

Activation G#other_name_B Xxxx G#other_name_B
of G#other_name_M xx G#other_name_M
transcription G#other_name_E xxx G#other_name_E
by NE xx NE
binding NE xxx NE
of NE xx NE
NF-E1 G#protein_molecule XX-Xd G#protein_molecule
( NE ( NE
YY1 G#protein_molecule XXd G#protein_molecule
) NE ) NE
to NE xx NE
a NE x NE
newly NE xxx NE
identified NE xxx NE
element NE xxx NE
in NE xx NE
the NE xxx NE
first NE xxx NE
exon NE xxx NE
of NE xx NE
the NE xxx NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
DR G#DNA_domain_or_region_M XX G#DNA_domain_or_region_M
alpha G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

A NE X NE
previously NE xxx NE
unrecognized NE xxx NE
element NE xxx NE
, NE , NE
located NE xxx NE
downstream NE xxx NE
of NE xx NE
the NE xxx NE
start G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
site G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
of G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
transcription G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
the NE xxx NE
first NE xxx NE
exon G#DNA_domain_or_region xxx G#DNA_domain_or_region
of NE xx NE
the NE xxx NE
DR G#DNA_domain_or_region_B XX G#DNA_domain_or_region_B
alpha G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
has NE xxx NE
been NE xxx NE
defined NE xxx NE
that NE xxx NE
enhances NE xxx NE
promoter G#other_name_B xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
up NE xx NE
to NE xx NE
eightfold NE xxx NE
in NE xx NE
a NE x NE
position-dependent G#other_name_B xxx-xxx G#other_name_B
manner G#other_name_E xxx G#other_name_E
. NE . NE

Mutations NE Xxxx NE
in NE xx NE
this NE xxx NE
DNA-binding G#DNA_domain_or_region_B XXX-xxx G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
abolished NE xxx NE
binding NE xxx NE
of NE xx NE
a NE x NE
nuclear G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
in NE xx NE
human G#cell_component_B xxx G#cell_component_B
B G#cell_component_M X G#cell_component_M
cell G#cell_component_M xxx G#cell_component_M
nuclear G#cell_component_M xxx G#cell_component_M
extract G#cell_component_E xxx G#cell_component_E
and NE xxx NE
decreased NE xxx NE
the NE xxx NE
activity NE xxx NE
of NE xx NE
the NE xxx NE
DR G#DNA_domain_or_region_B XX G#DNA_domain_or_region_B
alpha G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
to NE xx NE
a NE x NE
basal G#other_name_B xxx G#other_name_B
level G#other_name_E xxx G#other_name_E
. NE . NE

Significant NE Xxxx NE
sequence NE xxx NE
homology NE xxx NE
of NE xx NE
this NE xxx NE
element G#DNA_domain_or_region xxx G#DNA_domain_or_region
was NE xxx NE
found NE xxx NE
in NE xx NE
the NE xxx NE
DNA NE XXX NE
of NE xx NE
the NE xxx NE
DR G#DNA_domain_or_region_B XX G#DNA_domain_or_region_B
beta G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
DP G#DNA_domain_or_region_M XX G#DNA_domain_or_region_M
alpha G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
DP-beta G#DNA_domain_or_region_M XX-xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
DQ G#DNA_domain_or_region_M XX G#DNA_domain_or_region_M
alpha G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
transcriptional NE xxx NE
start NE xxx NE
site NE xxx NE
. NE . NE

The NE Xxx NE
nuclear NE xxx NE
factor NE xxx NE
binds NE xxx NE
to NE xx NE
the NE xxx NE
DR G#DNA_domain_or_region_B XX G#DNA_domain_or_region_B
alpha G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
element G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
DP G#DNA_domain_or_region_M XX G#DNA_domain_or_region_M
alpha G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
but NE xxx NE
not NE xxx NE
to NE xx NE
the NE xxx NE
element NE xxx NE
in NE xx NE
the NE xxx NE
DQ G#DNA_domain_or_region_B XX G#DNA_domain_or_region_B
alpha G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

It NE Xx NE
was NE xxx NE
identified NE xxx NE
as NE xx NE
NF-E1 G#protein_molecule XX-Xd G#protein_molecule
( NE ( NE
YY1 G#protein_molecule XXd G#protein_molecule
) NE ) NE
. NE . NE

This NE Xxxx NE
protein NE xxx NE
, NE , NE
previously NE xxx NE
identified NE xxx NE
by NE xx NE
its NE xxx NE
binding NE xxx NE
to NE xx NE
the NE xxx NE
Ig G#DNA_domain_or_region_B Xx G#DNA_domain_or_region_B
kappa G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
3' G#DNA_domain_or_region_M d' G#DNA_domain_or_region_M
enhancer G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
the NE xxx NE
Ig G#DNA_domain_or_region_B Xx G#DNA_domain_or_region_B
heavy G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
chain G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
mu G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
E1 G#DNA_domain_or_region_M Xd G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
thus NE xxx NE
also NE xxx NE
appears NE xxx NE
to NE xx NE
be NE xx NE
quite NE xxx NE
important NE xxx NE
in NE xx NE
the NE xxx NE
regulation NE xxx NE
of NE xx NE
MHC G#other_name_B XXX G#other_name_B
class G#other_name_M xxx G#other_name_M
II G#other_name_M XX G#other_name_M
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
. NE . NE

Transcriptional G#other_name_B Xxxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
of NE xx NE
core G#protein_subunit_B xxx G#protein_subunit_B
binding G#protein_subunit_M xxx G#protein_subunit_M
factor-alpha G#protein_subunit_M xxx-xxx G#protein_subunit_M
(AML1) G#protein_subunit_M (XXXd) G#protein_subunit_M
and G#protein_subunit_M xxx G#protein_subunit_M
core G#protein_subunit_M xxx G#protein_subunit_M
binding G#protein_subunit_M xxx G#protein_subunit_M
factor-beta G#protein_subunit_E xxx-xxx G#protein_subunit_E
subunits NE xxx NE
on NE xx NE
murine G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
leukemia G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
virus G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
enhancer G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
cores G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Core G#protein_family_or_group_B Xxxx G#protein_family_or_group_B
binding G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
CBF G#protein_molecule XXX G#protein_molecule
) NE ) NE
, NE , NE
also NE xxx NE
known NE xxx NE
as NE xx NE
polyomavirus G#protein_family_or_group_B xxx G#protein_family_or_group_B
enhancer-binding G#protein_family_or_group_M xxx-xxx G#protein_family_or_group_M
protein G#protein_family_or_group_M xxx G#protein_family_or_group_M
2 G#protein_family_or_group_E d G#protein_family_or_group_E
and NE xxx NE
SL3 G#protein_molecule_B XXd G#protein_molecule_B
enhancer G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_M xxx G#protein_molecule_M
1 G#protein_molecule_E d G#protein_molecule_E
, NE , NE
is NE xx NE
a NE x NE
mammalian G#protein_family_or_group_B xxx G#protein_family_or_group_B
transcription G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
that NE xxx NE
binds NE xxx NE
to NE xx NE
an NE xx NE
element NE xxx NE
termed NE xxx NE
the NE xxx NE
core NE xxx NE
within NE xxx NE
the NE xxx NE
enhancers G#DNA_domain_or_region xxx G#DNA_domain_or_region
of NE xx NE
the NE xxx NE
murine G#virus_B xxx G#virus_B
leukemia G#virus_M xxx G#virus_M
virus G#virus_M xxx G#virus_M
family G#virus_E xxx G#virus_E
of NE xx NE
retroviruses NE xxx NE
. NE . NE

The NE Xxx NE
core G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
elements G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
the NE xxx NE
SL3 G#virus_B XXd G#virus_B
virus G#virus_E xxx G#virus_E
are NE xxx NE
important NE xxx NE
genetic NE xxx NE
determinants NE xxx NE
of NE xx NE
the NE xxx NE
ability NE xxx NE
of NE xx NE
this NE xxx NE
virus NE xxx NE
to NE xx NE
induce NE xxx NE
T-cell G#other_name_B X-xxx G#other_name_B
lymphomas G#other_name_E xxx G#other_name_E
and NE xxx NE
the NE xxx NE
transcriptional G#other_name_B xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
viral G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
long G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
terminal G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
repeat G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
T G#cell_type_B X G#cell_type_B
lymphocytes G#cell_type_E xxx G#cell_type_E
. NE . NE

CBF G#protein_molecule XXX G#protein_molecule
consists NE xxx NE
of NE xx NE
two NE xxx NE
subunits NE xxx NE
, NE , NE
a NE x NE
DNA G#protein_subunit_B XXX G#protein_subunit_B
binding G#protein_subunit_M xxx G#protein_subunit_M
subunit G#protein_subunit_E xxx G#protein_subunit_E
, NE , NE
CBF G#protein_subunit_B XXX G#protein_subunit_B
alpha G#protein_subunit_E xxx G#protein_subunit_E
, NE , NE
and NE xxx NE
a NE x NE
second NE xxx NE
subunit NE xxx NE
, NE , NE
CBF G#protein_subunit_B XXX G#protein_subunit_B
beta G#protein_subunit_E xxx G#protein_subunit_E
, NE , NE
that NE xxx NE
stimulates NE xxx NE
the NE xxx NE
DNA G#other_name_B XXX G#other_name_B
binding G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
of NE xx NE
CBF G#protein_subunit_B XXX G#protein_subunit_B
alpha G#protein_subunit_E xxx G#protein_subunit_E
. NE . NE

One NE Xxx NE
of NE xx NE
the NE xxx NE
genes NE xxx NE
that NE xxx NE
encodes NE xxx NE
a NE x NE
CBF G#protein_subunit_B XXX G#protein_subunit_B
alpha G#protein_subunit_M xxx G#protein_subunit_M
subunit G#protein_subunit_E xxx G#protein_subunit_E
is NE xx NE
AML1 G#protein_subunit XXXd G#protein_subunit
, NE , NE
also NE xxx NE
called NE xxx NE
Cbf G#protein_molecule_B Xxx G#protein_molecule_B
alpha G#protein_molecule_M xxx G#protein_molecule_M
2 G#protein_molecule_E d G#protein_molecule_E
. NE . NE

This NE Xxxx NE
locus NE xxx NE
is NE xx NE
rearranged NE xxx NE
by NE xx NE
chromosomal G#other_name_B xxx G#other_name_B
translocations G#other_name_E xxx G#other_name_E
in NE xx NE
human G#other_name_B xxx G#other_name_B
myeloproliferative G#other_name_M xxx G#other_name_M
disorders G#other_name_E xxx G#other_name_E
and NE xxx NE
leukemias G#other_name xxx G#other_name
. NE . NE

An NE Xx NE
exogenously NE xxx NE
expressed NE xxx NE
Cbf NE Xxx NE
alpha NE xxx NE
2 NE d NE
-encoded NE -xxx NE
subunit NE xxx NE
( NE ( NE
CBF NE XXX NE
alpha NE xxx NE
2-451 NE d-ddd NE
) NE ) NE
stimulated NE xxx NE
transcription NE xxx NE
from NE xxx NE
the NE xxx NE
SL3 NE XXd NE
enhancer NE xxx NE
in NE xx NE
P19 NE Xdd NE
and NE xxx NE
HeLa NE XxXx NE
cells NE xxx NE
. NE . NE

Activity NE Xxxx NE
was NE xxx NE
mediated NE xxx NE
through NE xxx NE
the NE xxx NE
core G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
elements G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Three NE Xxxx NE
different NE xxx NE
isoforms NE xxx NE
of NE xx NE
CBF G#protein_subunit_B XXX G#protein_subunit_B
beta G#protein_subunit_E xxx G#protein_subunit_E
were NE xxx NE
also NE xxx NE
tested NE xxx NE
for NE xxx NE
transcriptional G#other_name_B xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
on NE xx NE
the NE xxx NE
SL3 G#DNA_domain_or_region_B XXd G#DNA_domain_or_region_B
enhancer G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

The NE Xxx NE
longest NE xxx NE
form NE xxx NE
, NE , NE
CBF NE XXX NE
beta NE xxx NE
-187 NE -ddd NE
, NE , NE
increased NE xxx NE
the NE xxx NE
transcriptional NE xxx NE
stimulation NE xxx NE
by NE xx NE
CBF NE XXX NE
alpha NE xxx NE
2-451 NE d-ddd NE
twofold NE xxx NE
in NE xx NE
HeLa NE XxXx NE
cells NE xxx NE
, NE , NE
although NE xxx NE
it NE xx NE
had NE xxx NE
no NE xx NE
effect NE xxx NE
in NE xx NE
P19 NE Xdd NE
cells NE xxx NE
. NE . NE

Transcriptional NE Xxxx NE
activation NE xxx NE
by NE xx NE
CBF G#protein_subunit_B XXX G#protein_subunit_B
beta G#protein_subunit_E xxx G#protein_subunit_E
required NE xxx NE
binding NE xxx NE
to NE xx NE
the NE xxx NE
CBF G#protein_subunit_B XXX G#protein_subunit_B
alpha G#protein_subunit_M xxx G#protein_subunit_M
subunit G#protein_subunit_E xxx G#protein_subunit_E
, NE , NE
as NE xx NE
a NE x NE
form NE xxx NE
of NE xx NE
CBF G#protein_subunit_B XXX G#protein_subunit_B
beta G#protein_subunit_E xxx G#protein_subunit_E
that NE xxx NE
lacked NE xxx NE
binding G#other_name_B xxx G#other_name_B
ability, G#other_name_E xxx, G#other_name_E
CBF NE XXX NE
beta NE xxx NE
-148 NE -ddd NE
, NE , NE
failed NE xxx NE
to NE xx NE
increase NE xxx NE
activity NE xxx NE
. NE . NE

These NE Xxxx NE
results NE xxx NE
indicated NE xxx NE
that NE xxx NE
at NE xx NE
least NE xxx NE
in NE xx NE
certain NE xxx NE
cell NE xxx NE
types NE xxx NE
, NE , NE
the NE xxx NE
maximum NE xxx NE
activity NE xxx NE
of NE xx NE
CBF G#protein_molecule XXX G#protein_molecule
required NE xxx NE
both NE xxx NE
subunits NE xxx NE
. NE . NE

They NE Xxxx NE
also NE xxx NE
provided NE xxx NE
support NE xxx NE
for NE xxx NE
the NE xxx NE
hypothesis NE xxx NE
that NE xxx NE
CBF G#protein_molecule XXX G#protein_molecule
is NE xx NE
a NE x NE
factor NE xxx NE
in NE xx NE
T G#cell_type_B X G#cell_type_B
lymphocytes G#cell_type_E xxx G#cell_type_E
that NE xxx NE
is NE xx NE
responsible NE xxx NE
for NE xxx NE
recognition NE xxx NE
of NE xx NE
the NE xxx NE
SL3 G#DNA_domain_or_region_B XXd G#DNA_domain_or_region_B
cores G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

We NE Xx NE
also NE xxx NE
examined NE xxx NE
whether NE xxx NE
CBF G#protein_molecule XXX G#protein_molecule
could NE xxx NE
distinguish NE xxx NE
a NE x NE
1-bp G#other_name_B d-xx G#other_name_B
difference G#other_name_E xxx G#other_name_E
between NE xxx NE
the NE xxx NE
enhancer G#DNA_substructure_B xxx G#DNA_substructure_B
core G#DNA_substructure_M xxx G#DNA_substructure_M
of G#DNA_substructure_M xx G#DNA_substructure_M
SL3 G#DNA_substructure_E XXd G#DNA_substructure_E
and NE xxx NE
the NE xxx NE
core NE xxx NE
of NE xx NE
the NE xxx NE
nonleukemogenic G#virus_B xxx G#virus_B
virus G#virus_E xxx G#virus_E
, NE , NE
Akv G#virus Xxx G#virus
. NE . NE

This NE Xxxx NE
difference NE xxx NE
strongly NE xxx NE
affects NE xxx NE
transcription NE xxx NE
in NE xx NE
T NE X NE
cells NE xxx NE
and NE xxx NE
leukemogenicity G#other_name xxx G#other_name
of NE xx NE
SL3 G#DNA_domain_or_region XXd G#DNA_domain_or_region
. NE . NE

However NE Xxxx NE
, NE , NE
no NE xx NE
combination NE xxx NE
of NE xx NE
CBF G#protein_subunit_B XXX G#protein_subunit_B
alpha G#protein_subunit_E xxx G#protein_subunit_E
and NE xxx NE
CBF G#protein_subunit_B XXX G#protein_subunit_B
beta G#protein_subunit_E xxx G#protein_subunit_E
subunits NE xxx NE
that NE xxx NE
we NE xx NE
tested NE xxx NE
was NE xxx NE
able NE xxx NE
to NE xx NE
distinguish NE xxx NE
the NE xxx NE
1-bp G#other_name_B d-xx G#other_name_B
difference G#other_name_E xxx G#other_name_E
in NE xx NE
transcription G#other_name_B xxx G#other_name_B
assays G#other_name_E xxx G#other_name_E
. NE . NE

Thus NE Xxxx NE
, NE , NE
a NE x NE
complete NE xxx NE
understanding NE xxx NE
of NE xx NE
how NE xxx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
recognize NE xxx NE
the NE xxx NE
SL3 G#DNA_domain_or_region_B XXd G#DNA_domain_or_region_B
core G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
remains NE xxx NE
to NE xx NE
be NE xx NE
elucidated NE xxx NE
. NE . NE

Interleukin G#protein_molecule_B Xxxx G#protein_molecule_B
(IL)-10 G#protein_molecule_E (XX)-dd G#protein_molecule_E
inhibits NE xxx NE
nuclear NE xxx NE
factor NE xxx NE
kappa NE xxx NE
B NE X NE
( NE ( NE
NF NE XX NE
kappa NE xxx NE
B NE X NE
) NE ) NE
activation NE xxx NE
in NE xx NE
human NE xxx NE
monocytes NE xxx NE
. NE . NE

IL-10 G#protein_molecule XX-dd G#protein_molecule
and NE xxx NE
IL-4 G#protein_molecule XX-d G#protein_molecule
suppress NE xxx NE
cytokine G#other_name_B xxx G#other_name_B
synthesis G#other_name_E xxx G#other_name_E
by NE xx NE
different NE xxx NE
mechanisms NE xxx NE
. NE . NE

Our NE Xxx NE
previous NE xxx NE
studies NE xxx NE
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
monocytes G#cell_type_E xxx G#cell_type_E
have NE xxx NE
demonstrated NE xxx NE
that NE xxx NE
interleukin G#protein_molecule_B xxx G#protein_molecule_B
(IL)-10 G#protein_molecule_E (XX)-dd G#protein_molecule_E
inhibits NE xxx NE
lipopolysaccharide G#other_name_B xxx G#other_name_B
(LPS)-stimulated G#other_name_M (XXX)-xxx G#other_name_M
production G#other_name_E xxx G#other_name_E
of NE xx NE
inflammatory G#protein_family_or_group_B xxx G#protein_family_or_group_B
cytokines G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
IL-1 G#protein_molecule_B XX-d G#protein_molecule_B
beta G#protein_molecule_E xxx G#protein_molecule_E
, NE , NE
IL-6 G#protein_molecule XX-d G#protein_molecule
, NE , NE
IL-8 G#protein_molecule XX-d G#protein_molecule
, NE , NE
and NE xxx NE
tumor G#protein_molecule_B xxx G#protein_molecule_B
necrosis G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_M xxx G#protein_molecule_M
(TNF)-alpha G#protein_molecule_E (XXX)-xxx G#protein_molecule_E
by NE xx NE
blocking NE xxx NE
gene G#other_name_B xxx G#other_name_B
transcription G#other_name_E xxx G#other_name_E
. NE . NE

Using NE Xxxx NE
electrophoretic G#other_name_B xxx G#other_name_B
mobility G#other_name_M xxx G#other_name_M
shift G#other_name_M xxx G#other_name_M
assays G#other_name_E xxx G#other_name_E
( NE ( NE
EMSA G#other_name XXXX G#other_name
) NE ) NE
, NE , NE
we NE xx NE
now NE xxx NE
show NE xxx NE
that NE xxx NE
, NE , NE
in NE xx NE
monocytes NE xxx NE
stimulated NE xxx NE
with NE xxx NE
LPS G#lipid XXX G#lipid
or NE xx NE
TNF G#protein_molecule_B XXX G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
, NE , NE
IL-10 G#protein_molecule XX-dd G#protein_molecule
inhibits NE xxx NE
nuclear NE xxx NE
stimulation NE xxx NE
of NE xx NE
nuclear G#protein_molecule_B xxx G#protein_molecule_B
factor G#protein_molecule_M xxx G#protein_molecule_M
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_E X G#protein_molecule_E
( NE ( NE
NF G#protein_molecule_B XX G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_E X G#protein_molecule_E
) NE ) NE
, NE , NE
a NE x NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
involved NE xxx NE
in NE xx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
inflammatory G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
cytokine G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
. NE . NE
Several NE Xxxx NE
other NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
including NE xxx NE
NF- NE XX- NE
IL-6 G#protein_molecule XX-d G#protein_molecule
, NE , NE
AP-1 G#protein_molecule XX-d G#protein_molecule
, NE , NE
AP-2 G#protein_molecule XX-d G#protein_molecule
, NE , NE
GR G#protein_family_or_group XX G#protein_family_or_group
, NE , NE
CREB G#protein_family_or_group XXXX G#protein_family_or_group
, NE , NE
Oct-1 G#protein_molecule Xxx-d G#protein_molecule
, NE , NE
and NE xxx NE
Sp-1 G#protein_molecule Xx-d G#protein_molecule
are NE xxx NE
not NE xxx NE
affected NE xxx NE
by NE xx NE
IL-10 G#protein_molecule XX-dd G#protein_molecule
. NE . NE

This NE Xxxx NE
selective NE xxx NE
inhibition NE xxx NE
by NE xx NE
IL-10 G#protein_molecule XX-dd G#protein_molecule
of NE xx NE
NF G#other_name_B XX G#other_name_B
kappa G#other_name_M xxx G#other_name_M
B G#other_name_M X G#other_name_M
activation G#other_name_E xxx G#other_name_E
occurs NE xxx NE
rapidly NE xxx NE
and NE xxx NE
in NE xx NE
a NE x NE
dose-dependent NE xxx-xxx NE
manner NE xxx NE
and NE xxx NE
correlates NE xxx NE
well NE xxx NE
with NE xxx NE
IL-10 NE XX-dd NE
's NE 'x NE
cytokine NE xxx NE
synthesis NE xxx NE
inhibitory NE xxx NE
activity NE xxx NE
in NE xx NE
terms NE xxx NE
of NE xx NE
both NE xxx NE
kinetics NE xxx NE
and NE xxx NE
dose NE xxx NE
responsiveness NE xxx NE
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
compounds NE xxx NE
such NE xxx NE
as NE xx NE
tosylphenylalanyl G#other_organic_compound_B xxx G#other_organic_compound_B
chloromethyl G#other_organic_compound_M xxx G#other_organic_compound_M
ketone G#other_organic_compound_E xxx G#other_organic_compound_E
and NE xxx NE
pyrrolidinedithiocarbamate G#other_organic_compound xxx G#other_organic_compound
that NE xxx NE
are NE xxx NE
known NE xxx NE
to NE xx NE
selectively NE xxx NE
inhibit NE xxx NE
NF G#other_name_B XX G#other_name_B
kappa G#other_name_M xxx G#other_name_M
B G#other_name_M X G#other_name_M
activation G#other_name_E xxx G#other_name_E
block NE xxx NE
cytokine G#other_name_B xxx G#other_name_B
gene G#other_name_M xxx G#other_name_M
transcription G#other_name_E xxx G#other_name_E
in NE xx NE
LPS NE XXX NE
-stimulated NE -xxx NE
monocytes NE xxx NE
. NE . NE

Taken NE Xxxx NE
together NE xxx NE
, NE , NE
these NE xxx NE
results NE xxx NE
suggest NE xxx NE
that NE xxx NE
inhibition NE xxx NE
of NE xx NE
NF G#protein_molecule_B XX G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_E X G#protein_molecule_E
activation NE xxx NE
may NE xxx NE
be NE xx NE
an NE xx NE
important NE xxx NE
mechanism NE xxx NE
for NE xxx NE
IL-10 G#protein_molecule XX-dd G#protein_molecule
suppression NE xxx NE
of NE xx NE
cytokine G#other_name_B xxx G#other_name_B
gene G#other_name_M xxx G#other_name_M
transcription G#other_name_E xxx G#other_name_E
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
monocytes G#cell_type_E xxx G#cell_type_E
. NE . NE

IL-4 G#protein_molecule XX-d G#protein_molecule
, NE , NE
another NE xxx NE
cytokine G#protein_family_or_group xxx G#protein_family_or_group
that NE xxx NE
inhibits NE xxx NE
cytokine G#other_name_B xxx G#other_name_B
mRNA G#other_name_M xXXX G#other_name_M
accumulation G#other_name_E xxx G#other_name_E
in NE xx NE
monocytes G#cell_type xxx G#cell_type
, NE , NE
shows NE xxx NE
little NE xxx NE
inhibitory NE xxx NE
effect NE xxx NE
on NE xx NE
LPS NE XXX NE
-induced NE -xxx NE
NF NE XX NE
kappa NE xxx NE
B NE X NE
activation NE xxx NE
. NE . NE

Further NE Xxxx NE
examination NE xxx NE
reveals NE xxx NE
that NE xxx NE
, NE , NE
unlike NE xxx NE
IL-10 G#protein_molecule XX-dd G#protein_molecule
, NE , NE
IL-4 G#protein_molecule XX-d G#protein_molecule
enhances NE xxx NE
mRNA G#other_name_B xXXX G#other_name_B
degradation G#other_name_E xxx G#other_name_E
and NE xxx NE
does NE xxx NE
not NE xxx NE
suppress NE xxx NE
cytokine NE xxx NE
gene G#other_name_B xxx G#other_name_B
transcription G#other_name_E xxx G#other_name_E
. NE . NE

These NE Xxxx NE
data NE xxx NE
indicate NE xxx NE
that NE xxx NE
IL-10 G#protein_molecule XX-dd G#protein_molecule
and NE xxx NE
IL-4 G#protein_molecule XX-d G#protein_molecule
inhibit NE xxx NE
cytokine G#other_name_B xxx G#other_name_B
production G#other_name_E xxx G#other_name_E
by NE xx NE
different NE xxx NE
mechanisms NE xxx NE
. NE . NE

LMP-1 G#protein_molecule XXX-d G#protein_molecule
activates NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
by NE xx NE
targeting NE xxx NE
the NE xxx NE
inhibitory G#protein_molecule_B xxx G#protein_molecule_B
molecule G#protein_molecule_M xxx G#protein_molecule_M
I G#protein_molecule_M X G#protein_molecule_M
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

LMP-1 G#protein_molecule XXX-d G#protein_molecule
, NE , NE
an NE xx NE
Epstein-Barr G#protein_family_or_group_B Xxxx-Xxxx G#protein_family_or_group_B
virus G#protein_family_or_group_M xxx G#protein_family_or_group_M
membrane G#protein_family_or_group_M xxx G#protein_family_or_group_M
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
expressed NE xxx NE
during NE xxx NE
latent G#other_name_B xxx G#other_name_B
infection G#other_name_E xxx G#other_name_E
, NE , NE
has NE xxx NE
oncogenic NE xxx NE
properties NE xxx NE
, NE , NE
as NE xx NE
judged NE xxx NE
from NE xxx NE
its NE xxx NE
ability NE xxx NE
to NE xx NE
transform NE xxx NE
B NE X NE
lymphocytes NE xxx NE
and NE xxx NE
rodent NE xxx NE
fibroblasts NE xxx NE
. NE . NE

LMP-1 G#protein_molecule XXX-d G#protein_molecule
induces NE xxx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
bcl2 G#DNA_domain_or_region xxxd G#DNA_domain_or_region
, NE , NE
an NE xx NE
oncogene G#DNA_family_or_group xxx G#DNA_family_or_group
which NE xxx NE
protects NE xxx NE
cells NE xxx NE
from NE xxx NE
apoptosis G#other_name xxx G#other_name
, NE , NE
as NE xx NE
well NE xxx NE
as NE xx NE
of NE xx NE
genes NE xxx NE
encoding NE xxx NE
other NE xxx NE
proteins NE xxx NE
involved NE xxx NE
in NE xx NE
cell G#other_name_B xxx G#other_name_B
regulation G#other_name_E xxx G#other_name_E
and NE xxx NE
growth G#other_name_B xxx G#other_name_B
control G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
mechanisms NE xxx NE
by NE xx NE
which NE xxx NE
LMP-1 G#protein_molecule XXX-d G#protein_molecule
upregulates NE xxx NE
these NE xxx NE
proteins NE xxx NE
is NE xx NE
unknown NE xxx NE
, NE , NE
but NE xxx NE
it NE xx NE
is NE xx NE
plausible NE xxx NE
that NE xxx NE
LMP-1 G#protein_molecule XXX-d G#protein_molecule
modifies NE xxx NE
signal G#other_name_B xxx G#other_name_B
transduction G#other_name_M xxx G#other_name_M
pathways G#other_name_E xxx G#other_name_E
that NE xxx NE
result NE xxx NE
in NE xx NE
the NE xxx NE
activation NE xxx NE
of NE xx NE
one NE xxx NE
or NE xx NE
more NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
that NE xxx NE
ultimately NE xxx NE
regulate NE xxx NE
transcription NE xxx NE
of NE xx NE
oncogenic G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
. NE . NE

NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
, NE , NE
a NE x NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
controlling NE xxx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
genes G#DNA_family_or_group xxx G#DNA_family_or_group
involved NE xxx NE
in NE xx NE
cell NE xxx NE
activation NE xxx NE
and NE xxx NE
growth G#other_name_B xxx G#other_name_B
control G#other_name_E xxx G#other_name_E
, NE , NE
has NE xxx NE
been NE xxx NE
shown NE xxx NE
to NE xx NE
be NE xx NE
activated NE xxx NE
by NE xx NE
LMP-1 G#protein_molecule XXX-d G#protein_molecule
. NE . NE

The NE Xxx NE
mechanism(s) NE xxx(x) NE
regulating NE xxx NE
this NE xxx NE
activation NE xxx NE
remains NE xxx NE
unknown NE xxx NE
. NE . NE

Our NE Xxx NE
data NE xxx NE
indicate NE xxx NE
that NE xxx NE
increased NE xxx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
DNA G#other_name_M XXX G#other_name_M
binding G#other_name_E xxx G#other_name_E
and NE xxx NE
functional NE xxx NE
activity NE xxx NE
are NE xxx NE
present NE xxx NE
in NE xx NE
B-lymphoid G#cell_type_B X-xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
stably NE xxx NE
or NE xx NE
transiently NE xxx NE
expressing NE xxx NE
LMP-1 G#protein_molecule XXX-d G#protein_molecule
. NE . NE

I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
is NE xx NE
selectively NE xxx NE
modified NE xxx NE
in NE xx NE
LMP-1 NE XXX-d NE
-expressing NE -xxx NE
B NE X NE
cells NE xxx NE
. NE . NE

A NE X NE
phosphorylated NE xxx NE
form NE xxx NE
of NE xx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
and NE xxx NE
increased NE xxx NE
protein G#other_name_B xxx G#other_name_B
turnover-degradation G#other_name_E xxx-xxx G#other_name_E
correlate NE xxx NE
with NE xxx NE
increased NE xxx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
nuclear G#other_name_M xxx G#other_name_M
translocation G#other_name_E xxx G#other_name_E
. NE . NE

This NE Xxxx NE
results NE xxx NE
in NE xx NE
increased NE xxx NE
transcription NE xxx NE
of NE xx NE
NF-kappa NE XX-xxx NE
B NE X NE
-dependent-genes NE -xxx-xxx NE
, NE , NE
including NE xxx NE
those NE xxx NE
encoding NE xxx NE
p105 NE xddd NE
and NE xxx NE
I NE X NE
kappa NE xxx NE
B NE X NE
alpha NE xxx NE
( NE ( NE
MAD3 NE XXXd NE
) NE ) NE
. NE . NE

These NE Xxxx NE
results NE xxx NE
indicate NE xxx NE
that NE xxx NE
LMP-1 G#protein_molecule XXX-d G#protein_molecule
activates NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
in NE xx NE
B-cell G#cell_line_B X-xxx G#cell_line_B
lines G#cell_line_E xxx G#cell_line_E
by NE xx NE
targeting NE xxx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

Identification NE Xxxx NE
of NE xx NE
the NE xxx NE
pathways NE xxx NE
activated NE xxx NE
by NE xx NE
LMP-1 G#protein_molecule XXX-d G#protein_molecule
to NE xx NE
result NE xxx NE
in NE xx NE
posttranslational G#other_name_B xxx G#other_name_B
modifications G#other_name_E xxx G#other_name_E
of NE xx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
will NE xxx NE
aid NE xxx NE
in NE xx NE
determining NE xxx NE
the NE xxx NE
role NE xxx NE
of NE xx NE
this NE xxx NE
virus-host G#other_name_B xxx-xxx G#other_name_B
cell G#other_name_M xxx G#other_name_M
protein G#other_name_M xxx G#other_name_M
interaction G#other_name_E xxx G#other_name_E
in NE xx NE
Epstein-Barr NE Xxxx-Xxxx NE
virus NE xxx NE
-mediated NE -xxx NE
oncogenesis NE xxx NE
. NE . NE

Identification NE Xxxx NE
of NE xx NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
TR2 G#DNA_domain_or_region_M XXd G#DNA_domain_or_region_M
orphan G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
receptor G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
response G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
the NE xxx NE
transcriptional G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
initiation G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
the NE xxx NE
simian G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
virus G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
40 G#DNA_domain_or_region_M dd G#DNA_domain_or_region_M
major G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
late G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
[published NE [xxx NE
erratum NE xxx NE
appears NE xxx NE
in NE xx NE
J NE X NE
Biol NE Xxxx NE
Chem NE Xxxx NE
1995 NE dddd NE
Nov NE Xxx NE
3;270(44):26721] NE d;ddd(dd):ddddd] NE

A NE X NE
DNA G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
response G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
TR2RE-SV40 G#DNA_domain_or_region XXdXX-XXdd G#DNA_domain_or_region
) NE ) NE
for NE xxx NE
the NE xxx NE
TR2 G#protein_molecule_B XXd G#protein_molecule_B
orphan G#protein_molecule_M xxx G#protein_molecule_M
receptor G#protein_molecule_E xxx G#protein_molecule_E
, NE , NE
a NE x NE
member NE xxx NE
of NE xx NE
the NE xxx NE
steroid-thyroid G#protein_family_or_group_B xxx-xxx G#protein_family_or_group_B
hormone G#protein_family_or_group_M xxx G#protein_family_or_group_M
receptor G#protein_family_or_group_M xxx G#protein_family_or_group_M
superfamily G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
has NE xxx NE
been NE xxx NE
identified NE xxx NE
in NE xx NE
the NE xxx NE
simian NE xxx NE
virus NE xxx NE
40 NE dd NE
( NE ( NE
SV40 NE XXdd NE
) NE ) NE
+55 NE +dd NE
region NE xxx NE
( NE ( NE
nucleotide NE xxx NE
numbers NE xxx NE
368-389 NE ddd-ddd NE
, NE , NE
5'-GTTAAGGTTCGTAGGTCATGGA-3' NE d'-XXXXXXXXXXXXXXXXXXXXXX-d' NE
) NE ) NE
. NE . NE

Electrophoretic G#other_name_B Xxxx G#other_name_B
mobility G#other_name_M xxx G#other_name_M
shift G#other_name_M xxx G#other_name_M
assay G#other_name_E xxx G#other_name_E
, NE , NE
using NE xxx NE
in NE xx NE
vitro NE xxx NE
translated NE xxx NE
TR2 G#protein_molecule_B XXd G#protein_molecule_B
orphan G#protein_molecule_M xxx G#protein_molecule_M
receptor G#protein_molecule_E xxx G#protein_molecule_E
with NE xxx NE
a NE x NE
molecular NE xxx NE
mass NE xxx NE
of NE xx NE
67 G#protein_molecule_B dd G#protein_molecule_B
kilodaltons G#protein_molecule_E xxx G#protein_molecule_E
, NE , NE
showed NE xxx NE
a NE x NE
specific NE xxx NE
binding NE xxx NE
with NE xxx NE
high NE xxx NE
affinity NE xxx NE
(dissociation NE (xxx NE
constant NE xxx NE
= NE = NE
9 NE d NE
nM) NE xX) NE
for NE xxx NE
this NE xxx NE
DNA G#DNA_N/A_B XXX G#DNA_N/A_B
sequence G#DNA_N/A_E xxx G#DNA_N/A_E
. NE . NE

DNA-swap G#other_name_B XXX-xxx G#other_name_B
experiments G#other_name_E xxx G#other_name_E
using NE xxx NE
chloramphenicol G#other_name_B xxx G#other_name_B
acetyl-transferase G#other_name_M xxx-xxx G#other_name_M
assay G#other_name_E xxx G#other_name_E
demonstrated NE xxx NE
that NE xxx NE
androgen G#lipid xxx G#lipid
can NE xxx NE
suppress NE xxx NE
the NE xxx NE
transcriptional NE xxx NE
activities NE xxx NE
of NE xx NE
SV40 G#DNA_domain_or_region_B XXdd G#DNA_domain_or_region_B
early G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
via NE xxx NE
the NE xxx NE
interaction NE xxx NE
between NE xxx NE
this NE xxx NE
TR2RE- G#DNA_domain_or_region XXdXX- G#DNA_domain_or_region
SV40 NE XXdd NE
and NE xxx NE
the NE xxx NE
chimeric G#protein_molecule_B xxx G#protein_molecule_B
receptor G#protein_molecule_M xxx G#protein_molecule_M
AR/TR2/AR G#protein_molecule_E XX/XXd/XX G#protein_molecule_E
with NE xxx NE
the NE xxx NE
DNA-binding G#protein_domain_or_region_B XXX-xxx G#protein_domain_or_region_B
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
of NE xx NE
the NE xxx NE
TR2 G#protein_molecule_B XXd G#protein_molecule_B
orphan G#protein_molecule_M xxx G#protein_molecule_M
receptor G#protein_molecule_E xxx G#protein_molecule_E
flanked NE xxx NE
by NE xx NE
the NE xxx NE
N-terminal G#protein_domain_or_region_B X-xxx G#protein_domain_or_region_B
domain G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
and G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
androgen-binding G#protein_domain_or_region_M xxx-xxx G#protein_domain_or_region_M
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
of NE xx NE
the NE xxx NE
androgen G#protein_molecule_B xxx G#protein_molecule_B
receptor G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

In NE Xx NE
addition NE xxx NE
, NE , NE
this NE xxx NE
TR2RE- G#DNA_domain_or_region XXdXX- G#DNA_domain_or_region
SV40 NE XXdd NE
can NE xxx NE
function NE xxx NE
as NE xx NE
a NE x NE
repressor NE xxx NE
to NE xx NE
suppress NE xxx NE
the NE xxx NE
transcriptional NE xxx NE
activities NE xxx NE
of NE xx NE
both NE xxx NE
SV40 G#DNA_domain_or_region_B XXdd G#DNA_domain_or_region_B
early G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
SV40 G#DNA_domain_or_region_M XXdd G#DNA_domain_or_region_M
late G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E

Together NE Xxxx NE
, NE , NE
these NE xxx NE
data NE xxx NE
suggest NE xxx NE
the NE xxx NE
TR2RE- NE XXdXX- NE
SV40 NE XXdd NE
may NE xxx NE
represent NE xxx NE
the NE xxx NE
first NE xxx NE
identified NE xxx NE
natural NE xxx NE
DNA NE XXX NE
response NE xxx NE
element NE xxx NE
for NE xxx NE
the NE xxx NE
TR2 NE XXd NE
orphan NE xxx NE
receptor NE xxx NE
that NE xxx NE
may NE xxx NE
function NE xxx NE
as NE xx NE
a NE x NE
repressor NE xxx NE
for NE xxx NE
the NE xxx NE
SV40 NE XXdd NE
gene NE xxx NE
expression NE xxx NE
. NE . NE

Detection NE Xxxx NE
of NE xx NE
the NE xxx NE
chromosome G#RNA_molecule_B xxx G#RNA_molecule_B
16 G#RNA_molecule_M dd G#RNA_molecule_M
CBF G#RNA_molecule_M XXX G#RNA_molecule_M
beta-MYH11 G#RNA_molecule_M xxx-XXXdd G#RNA_molecule_M
fusion G#RNA_molecule_M xxx G#RNA_molecule_M
transcript G#RNA_molecule_E xxx G#RNA_molecule_E
in NE xx NE
myelomonocytic G#other_name_B xxx G#other_name_B
leukemias G#other_name_E xxx G#other_name_E
. NE . NE

Karyotypic NE Xxxx NE
detection NE xxx NE
of NE xx NE
chromosomal NE xxx NE
16 NE dd NE
abnormalities NE xxx NE
classically NE xxx NE
associated NE xxx NE
with NE xxx NE
AML NE XXX NE
M4Eo NE XdXx NE
can NE xxx NE
be NE xx NE
difficult NE xxx NE
. NE . NE

Characterization NE Xxxx NE
of NE xx NE
the NE xxx NE
two NE xxx NE
genes NE xxx NE
involved NE xxx NE
in NE xx NE
the NE xxx NE
inv(16)(p13q22) G#other_name xxx(dd)(xddxdd) G#other_name
, NE , NE
CBF G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
beta G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
MYH11 G#DNA_domain_or_region XXXdd G#DNA_domain_or_region
, NE , NE
has NE xxx NE
allowed NE xxx NE
the NE xxx NE
detection NE xxx NE
of NE xx NE
fusion G#RNA_family_or_group_B xxx G#RNA_family_or_group_B
transcripts G#RNA_family_or_group_E xxx G#RNA_family_or_group_E
by NE xx NE
reverse-transcriptase G#other_name_B xxx-xxx G#other_name_B
polymerase G#other_name_M xxx G#other_name_M
chain G#other_name_M xxx G#other_name_M
reaction G#other_name_E xxx G#other_name_E
( NE ( NE
RT-PCR G#other_name XX-XXX G#other_name
) NE ) NE
. NE . NE

We NE Xx NE
have NE xxx NE
analyzed NE xxx NE
CBF NE XXX NE
beta NE xxx NE
-MYH11 NE -XXXdd NE
fusion NE xxx NE
transcripts NE xxx NE
by NE xx NE
RT-PCR NE XX-XXX NE
in NE xx NE
myelomonocytic NE xxx NE
leukemias NE xxx NE
, NE , NE
with NE xxx NE
or NE xx NE
without NE xxx NE
eosinophilia NE xxx NE
, NE , NE
to NE xx NE
determine NE xxx NE
whether NE xxx NE
their NE xxx NE
presence NE xxx NE
correlates NE xxx NE
with NE xxx NE
morphology NE xxx NE
. NE . NE

Fifty-three NE Xxxx-xxx NE
cases NE xxx NE
(11 NE (dd NE
AML G#other_name_B XXX G#other_name_B
M4Eo G#other_name_E XdXx G#other_name_E
; NE ; NE
1 NE d NE
AML G#other_name_B XXX G#other_name_B
M4 G#other_name_E Xd G#other_name_E
with NE xxx NE
atypical G#cell_type_B xxx G#cell_type_B
abnormal G#cell_type_M xxx G#cell_type_M
eosinophils G#cell_type_E xxx G#cell_type_E
(AML NE (XXX NE
M4 NE Xd NE
"Eo") NE "Xx") NE
; NE ; NE
29 NE dd NE
AML G#other_name_B XXX G#other_name_B
M4 G#other_name_E Xd G#other_name_E
; NE ; NE
8 NE d NE
AML G#other_name_B XXX G#other_name_B
M5 G#other_name_E Xd G#other_name_E
; NE ; NE
3 NE d NE
CMML G#other_name XXXX G#other_name
; NE ; NE
and NE xxx NE
1 NE d NE
AML G#other_name_B XXX G#other_name_B
M2 G#other_name_E Xd G#other_name_E
with NE xxx NE
eosinophilia G#other_name xxx G#other_name
) NE ) NE
were NE xxx NE
analyzed NE xxx NE
. NE . NE

All NE Xxx NE
11 NE dd NE
typical NE xxx NE
AML G#other_name_B XXX G#other_name_B
M4Eo G#other_name_E XdXx G#other_name_E
were NE xxx NE
CBF G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
beta G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
-MYH11 NE -XXXdd NE
positive NE xxx NE
. NE . NE

The NE Xxx NE
single NE xxx NE
case NE xxx NE
of NE xx NE
AML G#other_name_B XXX G#other_name_B
M4 G#other_name_E Xd G#other_name_E
with NE xxx NE
distinctive NE xxx NE
eosinophil NE xxx NE
abnormalities NE xxx NE
was NE xxx NE
negative NE xxx NE
by NE xx NE
karyotype NE xxx NE
, NE , NE
RT-PCR NE XX-XXX NE
and NE xxx NE
fluorescent NE xxx NE
in NE xx NE
situ NE xxx NE
hybridization NE xxx NE
( NE ( NE
FISH NE XXXX NE
) NE ) NE
. NE . NE

Three NE Xxxx NE
of NE xx NE
29 NE dd NE
(10%) NE (dd%) NE
AML G#other_name_B XXX G#other_name_B
M4 G#other_name_E Xd G#other_name_E
without NE xxx NE
abnormal G#cell_type_B xxx G#cell_type_B
eosinophils G#cell_type_E xxx G#cell_type_E
were NE xxx NE
CBF G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
beta G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
-MYH11 NE -XXXdd NE
positive NE xxx NE
, NE , NE
1 NE d NE
of NE xx NE
which NE xxx NE
did NE xxx NE
not NE xxx NE
show NE xxx NE
any NE xxx NE
apparent NE xxx NE
chromosome NE xxx NE
16 NE dd NE
abnormalities NE xxx NE
by NE xx NE
classical NE xxx NE
metaphase NE xxx NE
analysis NE xxx NE
(2 NE (d NE
not NE xxx NE
tested) NE xxx) NE
. NE . NE

Both NE Xxxx NE
cases NE xxx NE
tested NE xxx NE
also NE xxx NE
showed NE xxx NE
MYH11 G#other_name_B XXXdd G#other_name_B
genomic G#other_name_M xxx G#other_name_M
rearrangement G#other_name_E xxx G#other_name_E
. NE . NE

None NE Xxxx NE
of NE xx NE
the NE xxx NE
other NE xxx NE
leukemias G#other_name xxx G#other_name
were NE xxx NE
RT-PCR G#other_name XX-XXX G#other_name
positive NE xxx NE
. NE . NE

Follow-up NE Xxxx-xx NE
of NE xx NE
three NE xxx NE
patient NE xxx NE
showed NE xxx NE
residual NE xxx NE
positivity NE xxx NE
in NE xx NE
apparent NE xxx NE
complete NE xxx NE
remission NE xxx NE
. NE . NE

These NE Xxxx NE
data NE xxx NE
show NE xxx NE
that NE xxx NE
CBF NE XXX NE
beta NE xxx NE
-MYH11 NE -XXXdd NE
fusion NE xxx NE
transcripts NE xxx NE
occur NE xxx NE
not NE xxx NE
only NE xxx NE
in NE xx NE
the NE xxx NE
vast NE xxx NE
majority NE xxx NE
of NE xx NE
typical NE xxx NE
AML NE XXX NE
M4Eo NE XdXx NE
, NE , NE
but NE xxx NE
also NE xxx NE
in NE xx NE
approximately NE xxx NE
10% NE dd% NE
of NE xx NE
AML NE XXX NE
M4 NE Xd NE
without NE xxx NE
eosinophilic NE xxx NE
abnormalities NE xxx NE
, NE , NE
a NE x NE
much NE xxx NE
higher NE xxx NE
incidence NE xxx NE
than NE xxx NE
the NE xxx NE
sporadic NE xxx NE
reports NE xxx NE
of NE xx NE
chromosome NE xxx NE
16 NE dd NE
abnormalities NE xxx NE
in NE xx NE
AML NE XXX NE
M4 NE Xd NE
would NE xxx NE
suggest NE xxx NE
. NE . NE

Taken NE Xxxx NE
together NE xxx NE
with NE xxx NE
the NE xxx NE
detection NE xxx NE
of NE xx NE
CBF G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
beta G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
- NE - NE
MYH11 G#RNA_family_or_group_B XXXdd G#RNA_family_or_group_B
transcripts G#RNA_family_or_group_E xxx G#RNA_family_or_group_E
in NE xx NE
the NE xxx NE
absence NE xxx NE
of NE xx NE
apparent NE xxx NE
chromosome NE xxx NE
16 NE dd NE
abnormalities NE xxx NE
by NE xx NE
classical NE xxx NE
banding NE xxx NE
techniques NE xxx NE
, NE , NE
these NE xxx NE
data NE xxx NE
show NE xxx NE
that NE xxx NE
additional NE xxx NE
screening NE xxx NE
by NE xx NE
either NE xxx NE
RT-PCR NE XX-XXX NE
or NE xx NE
FISH NE XXXX NE
should NE xxx NE
be NE xx NE
performed NE xxx NE
in NE xx NE
all NE xxx NE
AML NE XXX NE
M4 NE Xd NE
, NE , NE
regardless NE xxx NE
of NE xx NE
morphologic NE xxx NE
features NE xxx NE
, NE , NE
to NE xx NE
allow NE xxx NE
accurate NE xxx NE
evaluation NE xxx NE
of NE xx NE
the NE xxx NE
prognostic NE xxx NE
importance NE xxx NE
of NE xx NE
this NE xxx NE
fusion NE xxx NE
transcript NE xxx NE
. NE . NE

HIV-1 G#protein_molecule_B XXX-d G#protein_molecule_B
Tat G#protein_molecule_E Xxx G#protein_molecule_E
potentiates NE xxx NE
TNF NE XXX NE
-induced NE -xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
activation NE xxx NE
and NE xxx NE
cytotoxicity NE xxx NE
by NE xx NE
altering NE xxx NE
the NE xxx NE
cellular NE xxx NE
redox NE xxx NE
state NE xxx NE
. NE . NE

This NE Xxxx NE
study NE xxx NE
demonstrates NE xxx NE
that NE xxx NE
human NE xxx NE
immunodeficiency NE xxx NE
virus NE xxx NE
type NE xxx NE
1 NE d NE
( NE ( NE
HIV-1 NE XXX-d NE
) NE ) NE
Tat NE Xxx NE
protein NE xxx NE
amplifies NE xxx NE
the NE xxx NE
activity NE xxx NE
of NE xx NE
tumor NE xxx NE
necrosis NE xxx NE
factor NE xxx NE
( NE ( NE
TNF NE XXX NE
) NE ) NE
, NE , NE
a NE x NE
cytokine NE xxx NE
that NE xxx NE
stimulates NE xxx NE
HIV-1 NE XXX-d NE
replication NE xxx NE
through NE xxx NE
activation NE xxx NE
of NE xx NE
NF-kappa NE XX-xxx NE
B NE X NE
. NE . NE

In NE Xx NE
HeLa G#cell_line_B XxXx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
stably NE xxx NE
transfected NE xxx NE
with NE xxx NE
the NE xxx NE
HIV-1 G#DNA_domain_or_region_B XXX-d G#DNA_domain_or_region_B
tat G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
HeLa-tat G#cell_line_B XxXx-xxx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
) NE ) NE
, NE , NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
Tat G#protein_molecule_B Xxx G#protein_molecule_B
protein G#protein_molecule_E xxx G#protein_molecule_E
enhanced NE xxx NE
both NE xxx NE
TNF NE XXX NE
-induced NE -xxx NE
activation NE xxx NE
of NE xx NE
NF-kappa NE XX-xxx NE
B NE X NE
and NE xxx NE
TNF NE XXX NE
-mediated NE -xxx NE
cytotoxicity NE xxx NE
. NE . NE

A NE X NE
similar NE xxx NE
potentiation NE xxx NE
of NE xx NE
TNF G#protein_molecule XXX G#protein_molecule
effects NE xxx NE
was NE xxx NE
observed NE xxx NE
in NE xx NE
Jurkat NE Xxxx NE
T NE X NE
cells NE xxx NE
and NE xxx NE
HeLa G#cell_line_B XxXx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
treated NE xxx NE
with NE xxx NE
soluble NE xxx NE
Tat G#protein_molecule_B Xxx G#protein_molecule_B
protein G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

TNF G#protein_molecule XXX G#protein_molecule
-mediated NE -xxx NE
activation NE xxx NE
of NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
and NE xxx NE
cytotoxicity NE xxx NE
involves NE xxx NE
the NE xxx NE
intracellular NE xxx NE
formation NE xxx NE
of NE xx NE
reactive G#inorganic_B xxx G#inorganic_B
oxygen G#inorganic_M xxx G#inorganic_M
intermediates G#inorganic_E xxx G#inorganic_E
. NE . NE

Therefore NE Xxxx NE
, NE , NE
Tat NE Xxx NE
-mediated NE -xxx NE
effects NE xxx NE
on NE xx NE
the NE xxx NE
cellular NE xxx NE
redox NE xxx NE
state NE xxx NE
were NE xxx NE
analyzed NE xxx NE
. NE . NE

In NE Xx NE
both NE xxx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
and NE xxx NE
HeLa G#cell_line_B XxXx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
HIV-1 G#protein_molecule_B XXX-d G#protein_molecule_B
Tat G#protein_molecule_E Xxx G#protein_molecule_E
suppressed NE xxx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
Mn-dependent G#protein_molecule_B Xx-xxx G#protein_molecule_B
superoxide G#protein_molecule_M xxx G#protein_molecule_M
dismutase G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
Mn-SOD G#protein_molecule Xx-XXX G#protein_molecule
) NE ) NE
, NE , NE
a NE x NE
mitochondrial G#protein_molecule_B xxx G#protein_molecule_B
enzyme G#protein_molecule_E xxx G#protein_molecule_E
that NE xxx NE
is NE xx NE
part NE xxx NE
of NE xx NE
the NE xxx NE
cellular NE xxx NE
defense NE xxx NE
system NE xxx NE
against NE xxx NE
oxidative G#other_name_B xxx G#other_name_B
stress G#other_name_E xxx G#other_name_E
. NE . NE

Thus NE Xxxx NE
, NE , NE
Mn-SOD G#other_name_B Xx-XXX G#other_name_B
RNA G#other_name_M XXX G#other_name_M
protein G#other_name_M xxx G#other_name_M
levels G#other_name_E xxx G#other_name_E
and NE xxx NE
activity NE xxx NE
were NE xxx NE
markedly NE xxx NE
reduced NE xxx NE
in NE xx NE
the NE xxx NE
presence NE xxx NE
of NE xx NE
Tat G#protein_molecule Xxx G#protein_molecule
. NE . NE

Decreased NE Xxxx NE
Mn-SOD G#other_name_B Xx-XXX G#other_name_B
expression G#other_name_E xxx G#other_name_E
was NE xxx NE
associated NE xxx NE
with NE xxx NE
decreased NE xxx NE
levels NE xxx NE
of NE xx NE
glutathione G#peptide xxx G#peptide
and NE xxx NE
a NE x NE
lower NE xxx NE
ratio NE xxx NE
of NE xx NE
reduced:oxidized NE xxx:xxx NE
glutathione G#peptide xxx G#peptide
. NE . NE

A NE X NE
truncated NE xxx NE
Tat G#protein_molecule_B Xxx G#protein_molecule_B
protein G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
Tat1-72 G#protein_molecule Xxxd-dd G#protein_molecule
) NE ) NE
, NE , NE
known NE xxx NE
to NE xx NE
transactivate NE xxx NE
the NE xxx NE
HIV-1 G#DNA_domain_or_region_B XXX-d G#DNA_domain_or_region_B
long G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
terminal G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
repeat G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
LTR G#DNA_domain_or_region XXX G#DNA_domain_or_region
) NE ) NE
, NE , NE
no NE xx NE
longer NE xxx NE
affected NE xxx NE
Mn-SOD G#other_name_B Xx-XXX G#other_name_B
expression G#other_name_E xxx G#other_name_E
, NE , NE
the NE xxx NE
cellular G#other_name_B xxx G#other_name_B
redox G#other_name_M xxx G#other_name_M
state G#other_name_E xxx G#other_name_E
or NE xx NE
TNF NE XXX NE
-mediated NE -xxx NE
cytotoxicity NE xxx NE
. NE . NE

Thus NE Xxxx NE
, NE , NE
our NE xxx NE
experiments NE xxx NE
demonstrate NE xxx NE
that NE xxx NE
the NE xxx NE
C-terminal G#protein_domain_or_region_B X-xxx G#protein_domain_or_region_B
region G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
of NE xx NE
HIV-1 G#protein_molecule_B XXX-d G#protein_molecule_B
Tat G#protein_molecule_E Xxx G#protein_molecule_E
is NE xx NE
required NE xxx NE
to NE xx NE
suppress NE xxx NE
Mn-SOD G#other_name_B Xx-XXX G#other_name_B
expression G#other_name_E xxx G#other_name_E
and NE xxx NE
to NE xx NE
induce NE xxx NE
pro-oxidative NE xxx-xxx NE
conditions NE xxx NE
reflected NE xxx NE
by NE xx NE
a NE x NE
drop NE xxx NE
in NE xx NE
reduced NE xxx NE
glutathione G#peptide xxx G#peptide
( NE ( NE
GSH G#protein_molecule XXX G#protein_molecule
) NE ) NE
and NE xxx NE
the NE xxx NE
GSH:oxidized NE XXX:xxx NE
GSH NE XXX NE
( NE ( NE
GSSG NE XXXX NE
) NE ) NE
ratio NE xxx NE
. NE . NE

(ABSTRACT NE (XXXXXXXX NE
TRUNCATED NE XXXXXXXXX NE
AT NE XX NE
250 NE ddd NE
WORDS) NE XXXXX) NE

The NE Xxx NE
use NE xxx NE
of NE xx NE
glucocorticoids G#lipid xxx G#lipid
in NE xx NE
acute G#other_name_B xxx G#other_name_B
lymphoblastic G#other_name_M xxx G#other_name_M
leukemia G#other_name_E xxx G#other_name_E
of NE xx NE
childhood NE xxx NE
. NE . NE

Molecular NE Xxxx NE
, NE , NE
cellular NE xxx NE
, NE , NE
and NE xxx NE
clinical NE xxx NE
considerations NE xxx NE
. NE . NE

Glucocorticoids G#lipid Xxxx G#lipid
have NE xxx NE
been NE xxx NE
included NE xxx NE
in NE xx NE
almost NE xxx NE
all NE xxx NE
treatment NE xxx NE
regimens NE xxx NE
for NE xxx NE
childhood G#other_name_B xxx G#other_name_B
acute G#other_name_M xxx G#other_name_M
lymphoblastic G#other_name_M xxx G#other_name_M
leukemia G#other_name_E xxx G#other_name_E
for NE xxx NE
decades NE xxx NE
. NE . NE

However NE Xxxx NE
, NE , NE
optimal NE xxx NE
agents NE xxx NE
, NE , NE
doses NE xxx NE
, NE , NE
and/or NE xxx/xx NE
schedules NE xxx NE
have NE xxx NE
yet NE xxx NE
to NE xx NE
be NE xx NE
defined NE xxx NE
despite NE xxx NE
extensive NE xxx NE
clinical NE xxx NE
application NE xxx NE
. NE . NE

New NE Xxx NE
data NE xxx NE
on NE xx NE
the NE xxx NE
pharmacokinetics G#other_name xxx G#other_name
, NE , NE
pharmacodynamics G#other_name xxx G#other_name
, NE , NE
and NE xxx NE
molecular NE xxx NE
mechanisms NE xxx NE
of NE xx NE
action NE xxx NE
of NE xx NE
glucocorticoids G#lipid xxx G#lipid
have NE xxx NE
suggested NE xxx NE
alternative NE xxx NE
approaches NE xxx NE
in NE xx NE
ALL G#other_name XXX G#other_name
. NE . NE

These NE Xxxx NE
suggest NE xxx NE
that NE xxx NE
prolonged NE xxx NE
, NE , NE
i.e NE x.x NE
. NE . NE
28 NE dd NE
day NE xxx NE
, NE , NE
glucocorticoid G#other_name_B xxx G#other_name_B
therapy G#other_name_E xxx G#other_name_E
may NE xxx NE
be NE xx NE
unnecessary NE xxx NE
as NE xx NE
exposure NE xxx NE
to NE xx NE
glucocorticoid G#lipid xxx G#lipid
induces NE xxx NE
down-regulation NE xxx-xxx NE
of NE xx NE
glucocorticoid G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Dexamethasone G#lipid Xxxx G#lipid
may NE xxx NE
be NE xx NE
superior NE xxx NE
to NE xx NE
prednisone NE xxx NE
in NE xx NE
conventional NE xxx NE
equi-effective NE xxx-xxx NE
doses NE xxx NE
. NE . NE

Blast NE Xxxx NE
sensitivity NE xxx NE
to NE xx NE
glucocorticoids G#lipid xxx G#lipid
correlates NE xxx NE
closely NE xxx NE
with NE xxx NE
sensitivity NE xxx NE
to NE xx NE
other NE xxx NE
, NE , NE
putatively NE xxx NE
non-cross-resisting NE xxx-xxx-xxx NE
agents NE xxx NE
and NE xxx NE
with NE xxx NE
outcome NE xxx NE
after NE xxx NE
multi-agent G#other_name_B xxx-xxx G#other_name_B
therapy G#other_name_E xxx G#other_name_E
, NE , NE
suggesting NE xxx NE
overlapping NE xxx NE
mechanisms NE xxx NE
of NE xx NE
action NE xxx NE
, NE , NE
and NE xxx NE
focusing NE xxx NE
attention NE xxx NE
on NE xx NE
the NE xxx NE
determinants NE xxx NE
of NE xx NE
the NE xxx NE
threshold NE xxx NE
for NE xxx NE
apoptosis G#other_name xxx G#other_name
. NE . NE

Increasing NE Xxxx NE
success NE xxx NE
in NE xx NE
the NE xxx NE
treatment NE xxx NE
of NE xx NE
childhood G#other_name_B xxx G#other_name_B
acute G#other_name_M xxx G#other_name_M
lymphoblastic G#other_name_M xxx G#other_name_M
leukemia G#other_name_E xxx G#other_name_E
has NE xxx NE
led NE xxx NE
to NE xx NE
increasing NE xxx NE
awareness NE xxx NE
of NE xx NE
avascular G#other_name_B xxx G#other_name_B
necrosis G#other_name_E xxx G#other_name_E
of NE xx NE
bone G#tissue xxx G#tissue
as NE xx NE
a NE x NE
potentially NE xxx NE
disabling NE xxx NE
sequela NE xxx NE
of NE xx NE
glucocorticoid G#other_name_B xxx G#other_name_B
therapy G#other_name_E xxx G#other_name_E
, NE , NE
especially NE xxx NE
in NE xx NE
adolescent G#multi_cell_B xxx G#multi_cell_B
patient G#multi_cell_M xxx G#multi_cell_M
and G#multi_cell_M xxx G#multi_cell_M
young G#multi_cell_M xxx G#multi_cell_M
adult G#multi_cell_M xxx G#multi_cell_M
patient G#multi_cell_E xxx G#multi_cell_E

Epstein-Barr G#other_name_B Xxxx-Xxxx G#other_name_B
virus G#other_name_M xxx G#other_name_M
nuclear G#other_name_M xxx G#other_name_M
protein G#other_name_M xxx G#other_name_M
2 G#other_name_M d G#other_name_M
transactivation G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
latent G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
membrane G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
protein G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
1 G#DNA_domain_or_region_M d G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
is NE xx NE
mediated NE xxx NE
by NE xx NE
J G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_E xxx G#protein_molecule_E
and NE xxx NE
PU.1 G#protein_molecule XX.d G#protein_molecule
. NE . NE

Expression NE Xxxx NE
of NE xx NE
the NE xxx NE
Epstein-Barr NE Xxxx-Xxxx NE
virus NE xxx NE
( NE ( NE
EBV NE XXX NE
) NE ) NE
latent NE xxx NE
membrane NE xxx NE
protein NE xxx NE
1 NE d NE
( NE ( NE
LMP-1 NE XXX-d NE
) NE ) NE
oncogene NE xxx NE
is NE xx NE
regulated NE xxx NE
by NE xx NE
the NE xxx NE
EBV NE XXX NE
nuclear NE xxx NE
protein NE xxx NE
2 NE d NE
( NE ( NE
EBNA-2 NE XXXX-d NE
) NE ) NE
transactivator NE xxx NE
. NE . NE

EBNA-2 G#protein_molecule XXXX-d G#protein_molecule
is NE xx NE
known NE xxx NE
to NE xx NE
interact NE xxx NE
with NE xxx NE
the NE xxx NE
cellular G#protein_family_or_group_B xxx G#protein_family_or_group_B
DNA-binding G#protein_family_or_group_M XXX-xxx G#protein_family_or_group_M
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
J G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_E xxx G#protein_molecule_E
and NE xxx NE
is NE xx NE
recruited NE xxx NE
to NE xx NE
promoters G#DNA_family_or_group xxx G#DNA_family_or_group
containing NE xxx NE
the NE xxx NE
GTGGGAA G#polynucleotide XXXXXXX G#polynucleotide
J G#DNA_domain_or_region_B X G#DNA_domain_or_region_B
kappa G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
recognition G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

The NE Xxx NE
minimal NE xxx NE
EBNA-2 NE XXXX-d NE
-responsive NE -xxx NE
LMP-1 NE XXX-d NE
promoter NE xxx NE
includes NE xxx NE
one NE xxx NE
J NE X NE
kappa NE xxx NE
-binding NE -xxx NE
site NE xxx NE
, NE , NE
and NE xxx NE
we NE xx NE
now NE xxx NE
show NE xxx NE
that NE xxx NE
mutation NE xxx NE
of NE xx NE
that NE xxx NE
site NE xxx NE
, NE , NE
such NE xxx NE
that NE xxx NE
J NE X NE
kappa NE xxx NE
cannot NE xxx NE
bind NE xxx NE
, NE , NE
reduces NE xxx NE
EBNA-2 NE XXXX-d NE
responsiveness NE xxx NE
by NE xx NE
60% NE dd% NE
. NE . NE

To NE Xx NE
identify NE xxx NE
other NE xxx NE
factors NE xxx NE
which NE xxx NE
interact NE xxx NE
with NE xxx NE
the NE xxx NE
LMP-1 G#DNA_domain_or_region_B XXX-d G#DNA_domain_or_region_B
EBNA-2 G#DNA_domain_or_region_M XXXX-d G#DNA_domain_or_region_M
response G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
E2RE G#DNA_domain_or_region XdXX G#DNA_domain_or_region
) NE ) NE
, NE , NE
a NE x NE
-236/-145 G#DNA_molecule_B -ddd/-ddd G#DNA_molecule_B
minimal G#DNA_molecule_M xxx G#DNA_molecule_M
E2RE G#DNA_molecule_E XdXX G#DNA_molecule_E
was NE xxx NE
used NE xxx NE
as NE xx NE
a NE x NE
probe NE xxx NE
in NE xx NE
an NE xx NE
electrophoretic G#other_name_B xxx G#other_name_B
mobility G#other_name_M xxx G#other_name_M
shift G#other_name_M xxx G#other_name_M
assay G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
previously NE xxx NE
characterized NE xxx NE
factors NE xxx NE
J G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_E xxx G#protein_molecule_E
, NE , NE
PU.1 G#protein_molecule XX.d G#protein_molecule
, NE , NE
and NE xxx NE
AML1 G#protein_molecule XXXd G#protein_molecule
bind NE xxx NE
to NE xx NE
the NE xxx NE
LMP-1 G#DNA_domain_or_region_B XXX-d G#DNA_domain_or_region_B
E2RE G#DNA_domain_or_region_E XdXX G#DNA_domain_or_region_E
, NE , NE
along NE xxx NE
with NE xxx NE
six NE xxx NE
other NE xxx NE
unidentified NE xxx NE
factors NE xxx NE
( NE ( NE
LBF2 G#protein_molecule XXXd G#protein_molecule
to NE xx NE
LBF7 G#protein_molecule XXXd G#protein_molecule
) NE ) NE
. NE . NE

Binding NE Xxxx NE
sites NE xxx NE
were NE xxx NE
mapped NE xxx NE
for NE xxx NE
each NE xxx NE
factor NE xxx NE
. NE . NE

LBF4 G#protein_molecule XXXd G#protein_molecule
is NE xx NE
B- NE X- NE
and NE xxx NE
T-cell NE X-xxx NE
specific NE xxx NE
and NE xxx NE
recognizes NE xxx NE
the NE xxx NE
PU.1 G#DNA_domain_or_region_B XX.d G#DNA_domain_or_region_B
GGAA G#DNA_domain_or_region_M XXXX G#DNA_domain_or_region_M
core G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
as NE xx NE
shown NE xxx NE
by NE xx NE
methylation G#other_name_B xxx G#other_name_B
interference G#other_name_E xxx G#other_name_E
. NE . NE

LBF4 G#protein_molecule XXXd G#protein_molecule
has NE xxx NE
a NE x NE
molecular NE xxx NE
mass NE xxx NE
of NE xx NE
105 NE ddd NE
kDa NE xXx NE
and NE xxx NE
is NE xx NE
probably NE xxx NE
unrelated NE xxx NE
to NE xx NE
PU.1 G#protein_molecule XX.d G#protein_molecule
. NE . NE

LBF2 G#protein_molecule XXXd G#protein_molecule
was NE xxx NE
found NE xxx NE
only NE xxx NE
in NE xx NE
epithelial G#cell_line_B xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
, NE , NE
whereas NE xxx NE
LBF3 G#protein_molecule XXXd G#protein_molecule
, NE , NE
LBF5 G#protein_molecule XXXd G#protein_molecule
, NE , NE
LBF6 G#protein_molecule XXXd G#protein_molecule
, NE , NE
and NE xxx NE
LBF7 G#protein_molecule XXXd G#protein_molecule
were NE xxx NE
not NE xxx NE
cell NE xxx NE
type NE xxx NE
specific NE xxx NE
. NE . NE

Mutations NE Xxxx NE
of NE xx NE
the NE xxx NE
AML1-binding G#DNA_domain_or_region_B XXXd-xxx G#DNA_domain_or_region_B
site G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
or G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
LBF4-binding G#DNA_domain_or_region_M XXXd-xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
had NE xxx NE
no NE xx NE
effect NE xxx NE
on NE xx NE
EBNA-2 G#other_name_B XXXX-d G#other_name_B
transactivation G#other_name_E xxx G#other_name_E
, NE , NE
whereas NE xxx NE
mutation NE xxx NE
of NE xx NE
the NE xxx NE
PU.1 G#DNA_domain_or_region XX.d G#DNA_domain_or_region
-binding NE -xxx NE
site NE xxx NE
completely NE xxx NE
eliminated NE xxx NE
EBNA-2 G#other_name_B XXXX-d G#other_name_B
responses G#other_name_E xxx G#other_name_E
. NE . NE

A NE X NE
gst- NE xxx- NE
EBNA-2 NE XXXX-d NE
fusion NE xxx NE
protein NE xxx NE
specifically NE xxx NE
depleted NE xxx NE
PU.1 NE XX.d NE
from NE xxx NE
nuclear NE xxx NE
extracts NE xxx NE
and NE xxx NE
bound NE xxx NE
in NE xx NE
vitro NE xxx NE
translated NE xxx NE
PU.1 NE XX.d NE
, NE , NE
providing NE xxx NE
biochemical NE xxx NE
evidence NE xxx NE
for NE xxx NE
a NE x NE
direct NE xxx NE
EBNA-2 NE XXXX-d NE
-PU.1 NE -XX.d NE
interaction NE xxx NE
. NE . NE

Thus NE Xxxx NE
, NE , NE
EBNA-2 G#protein_molecule XXXX-d G#protein_molecule
transactivation NE xxx NE
of NE xx NE
the NE xxx NE
LMP-1 G#DNA_domain_or_region_B XXX-d G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
is NE xx NE
dependent NE xxx NE
on NE xx NE
interaction NE xxx NE
with NE xxx NE
at NE xx NE
least NE xxx NE
two NE xxx NE
distinct NE xxx NE
sequence-specific NE xxx-xxx NE
DNA-binding G#protein_family_or_group_B XXX-xxx G#protein_family_or_group_B
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
J G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_E xxx G#protein_molecule_E
and NE xxx NE
PU.1 G#protein_molecule XX.d G#protein_molecule
. NE . NE

LBF3 G#protein_molecule XXXd G#protein_molecule
, NE , NE
LBF5 G#protein_molecule XXXd G#protein_molecule
, NE , NE
LBF6 G#protein_molecule XXXd G#protein_molecule
, NE , NE
or NE xx NE
LBF7 G#protein_molecule XXXd G#protein_molecule
may NE xxx NE
also NE xxx NE
be NE xx NE
involved NE xxx NE
, NE , NE
since NE xxx NE
their NE xxx NE
binding NE xxx NE
sites NE xxx NE
also NE xxx NE
contribute NE xxx NE
to NE xx NE
EBNA-2 G#other_name_B XXXX-d G#other_name_B
responsiveness G#other_name_E xxx G#other_name_E
. NE . NE

Lymphocyte G#protein_family_or_group_B Xxxx G#protein_family_or_group_B
glucocorticoid G#protein_family_or_group_M xxx G#protein_family_or_group_M
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
: NE : NE
predictor NE xxx NE
of NE xx NE
sertraline G#other_name_B xxx G#other_name_B
response G#other_name_E xxx G#other_name_E
in NE xx NE
adolescent G#other_name_B xxx G#other_name_B
major G#other_name_M xxx G#other_name_M
depressive G#other_name_M xxx G#other_name_M
disorder G#other_name_E xxx G#other_name_E
( NE ( NE
MDD G#other_name XXX G#other_name
) NE ) NE
. NE . NE

Major G#other_name_B Xxxx G#other_name_B
depressive G#other_name_M xxx G#other_name_M
disorder G#other_name_E xxx G#other_name_E
( NE ( NE
MDD G#other_name XXX G#other_name
) NE ) NE
in NE xx NE
adolescents G#multi_cell xxx G#multi_cell
demonstrates NE xxx NE
resistance NE xxx NE
to NE xx NE
tricyclic G#other_organic_compound_B xxx G#other_organic_compound_B
antidepressants G#other_organic_compound_E xxx G#other_organic_compound_E
and NE xxx NE
absence NE xxx NE
of NE xx NE
hypercortisolemia G#other_name xxx G#other_name
. NE . NE

The NE Xxx NE
efficacy NE xxx NE
of NE xx NE
serotonin G#other_organic_compound_B xxx G#other_organic_compound_B
reuptake G#other_organic_compound_M xxx G#other_organic_compound_M
inhibitors G#other_organic_compound_E xxx G#other_organic_compound_E
( NE ( NE
SRIs G#other_organic_compound XXXx G#other_organic_compound
) NE ) NE
is NE xx NE
uncertain NE xxx NE
, NE , NE
and NE xxx NE
response NE xxx NE
predictors NE xxx NE
are NE xxx NE
unavailable NE xxx NE
. NE . NE

Abnormal NE Xxxx NE
fast NE xxx NE
feedback NE xxx NE
and NE xxx NE
negative NE xxx NE
feedback NE xxx NE
of NE xx NE
the NE xxx NE
hypothalamic-pituitary-adrenal G#body_part_B xxx-xxx-xxx G#body_part_B
axis G#body_part_E xxx G#body_part_E
implicates NE xxx NE
a NE x NE
dampened NE xxx NE
limbic-hippocampal G#protein_molecule_B xxx-xxx G#protein_molecule_B
glucocorticoid G#protein_molecule_M xxx G#protein_molecule_M
type G#protein_molecule_M xxx G#protein_molecule_M
II G#protein_molecule_M XX G#protein_molecule_M
receptor G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
GCII G#protein_molecule XXXX G#protein_molecule
) NE ) NE
. NE . NE

We NE Xx NE
hypothesized NE xxx NE
that NE xxx NE
lymphocyte G#protein_molecule_B xxx G#protein_molecule_B
GCII G#protein_molecule_E XXXX G#protein_molecule_E
is NE xx NE
altered NE xxx NE
in NE xx NE
adolescent NE xxx NE
MDD G#other_name XXX G#other_name
and NE xxx NE
could NE xxx NE
serve NE xxx NE
as NE xx NE
a NE x NE
marker NE xxx NE
for NE xxx NE
response NE xxx NE
to NE xx NE
SRIs G#other_organic_compound XXXx G#other_organic_compound
. NE . NE

In NE Xx NE
an NE xx NE
open-label NE xxx-xxx NE
study NE xxx NE
, NE , NE
adolescents G#multi_cell xxx G#multi_cell
(n NE (x NE
= NE = NE
20) NE dd) NE
meeting NE xxx NE
DSM-III-R G#other_name_B XXX-XXX-X G#other_name_B
criteria G#other_name_E xxx G#other_name_E
for NE xxx NE
MDD G#other_name XXX G#other_name
showed NE xxx NE
baseline NE xxx NE
lymphocyte G#protein_family_or_group_B xxx G#protein_family_or_group_B
GCII G#protein_family_or_group_M XXXX G#protein_family_or_group_M
sites G#protein_family_or_group_E xxx G#protein_family_or_group_E
per NE xxx NE
cell NE xxx NE
(sites/cell) NE (xxx/xxx) NE
values NE xxx NE
of NE xx NE
793 NE ddd NE
+/- NE +/- NE
106 NE ddd NE
versus NE xxx NE
2,563 NE d,ddd NE
+/- NE +/- NE
499 NE ddd NE
(+/- NE (+/- NE
SEM) NE XXX) NE
for NE xxx NE
matched NE xxx NE
controls NE xxx NE
(n NE (x NE
= NE = NE
18) NE dd) NE
(t NE (x NE
= NE = NE
3.5 NE d.d NE
; NE ; NE
df NE xx NE
= NE = NE
36 NE dd NE
; NE ; NE
p NE x NE
< NE < NE
.001) NE .ddd) NE
. NE . NE

GCII G#protein_molecule XXXX G#protein_molecule
was NE xxx NE
bimodally NE xxx NE
distributed NE xxx NE
, NE , NE
with NE xxx NE
SRI G#other_organic_compound XXX G#other_organic_compound
responders NE xxx NE
differing NE xxx NE
from NE xxx NE
nonresponders NE xxx NE
(t NE (x NE
= NE = NE
3.9 NE d.d NE
; NE ; NE
df NE xx NE
= NE = NE
14 NE dd NE
; NE ; NE
p NE x NE
< NE < NE
.001) NE .ddd) NE
. NE . NE

GCII G#protein_molecule XXXX G#protein_molecule
accurately NE xxx NE
classified NE xxx NE
90 NE dd NE
percent NE xxx NE
of NE xx NE
sertraline G#other_organic_compound xxx G#other_organic_compound
responders NE xxx NE
and NE xxx NE
80 NE dd NE
percent NE xxx NE
of NE xx NE
nonresponders NE xxx NE
. NE . NE

Only NE Xxxx NE
SRI G#other_organic_compound XXX G#other_organic_compound
responders NE xxx NE
showed NE xxx NE
GCII G#protein_molecule XXXX G#protein_molecule
sites/cell NE xxx/xxx NE
upregulated NE xxx NE
after NE xxx NE
6 NE d NE
weeks NE xxx NE
of NE xx NE
treatment NE xxx NE
(t NE (x NE
= NE = NE
2.1 NE d.d NE
, NE , NE
df NE xx NE
= NE = NE
10 NE dd NE
; NE ; NE
p NE x NE
< NE < NE
.05) NE .dd) NE
. NE . NE

The NE Xxx NE
role NE xxx NE
of NE xx NE
NFATp G#protein_molecule XXXXx G#protein_molecule
in NE xx NE
cyclosporin NE xxx NE
A-sensitive NE X-xxx NE
tumor NE xxx NE
necrosis NE xxx NE
factor NE xxx NE
-alpha NE -xxx NE
gene NE xxx NE
transcription NE xxx NE
. NE . NE

The NE Xxx NE
tumor NE xxx NE
necrosis NE xxx NE
factor-alpha NE xxx-xxx NE
( NE ( NE
TNF NE XXX NE
alpha) NE xxx) NE
gene NE xxx NE
is NE xx NE
an NE xx NE
immediate NE xxx NE
early NE xxx NE
gene NE xxx NE
in NE xx NE
activated NE xxx NE
T NE X NE
cells NE xxx NE
, NE , NE
in NE xx NE
that NE xxx NE
it NE xx NE
is NE xx NE
rapidly NE xxx NE
induced NE xxx NE
without NE xxx NE
a NE x NE
requirement NE xxx NE
for NE xxx NE
protein NE xxx NE
synthesis NE xxx NE
. NE . NE

Maximal NE Xxxx NE
induction NE xxx NE
of NE xx NE
TNF G#RNA_molecule_B XXX G#RNA_molecule_B
alpha G#RNA_molecule_M xxx G#RNA_molecule_M
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
can NE xxx NE
be NE xx NE
induced NE xxx NE
by NE xx NE
treatment NE xxx NE
of NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
with NE xxx NE
calcium G#other_organic_compound_B xxx G#other_organic_compound_B
ionophores G#other_organic_compound_E xxx G#other_organic_compound_E
alone NE xxx NE
, NE , NE
via NE xxx NE
a NE x NE
calcineurin NE xxx NE
-dependent NE -xxx NE
process NE xxx NE
that NE xxx NE
is NE xx NE
blocked NE xxx NE
by NE xx NE
cyclosporin NE xxx NE
A NE X NE
. NE . NE

We NE Xx NE
have NE xxx NE
previously NE xxx NE
identified NE xxx NE
a NE x NE
promoter G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
kappa G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
3 G#DNA_domain_or_region_E d G#DNA_domain_or_region_E
, NE , NE
that NE xxx NE
is NE xx NE
required NE xxx NE
for NE xxx NE
calcium-stimulated NE xxx-xxx NE
, NE , NE
cyclosporin NE xxx NE
A NE X NE
-sensitive NE -xxx NE
induction NE xxx NE
of NE xx NE
the NE xxx NE
TNF NE XXX NE
alpha NE xxx NE
gene NE xxx NE
in NE xx NE
activated NE xxx NE
T NE X NE
cells NE xxx NE
. NE . NE

Here NE Xxxx NE
, NE , NE
we NE xx NE
demonstrate NE xxx NE
that NE xxx NE
the NE xxx NE
kappa G#protein_molecule_B xxx G#protein_molecule_B
3 G#protein_molecule_M d G#protein_molecule_M
binding G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_E xxx G#protein_molecule_E
contains NE xxx NE
NFATp G#protein_molecule XXXXx G#protein_molecule
, NE , NE
a NE x NE
cyclosporin-sensitive G#protein_family_or_group_B xxx-xxx G#protein_family_or_group_B
DNA-binding G#protein_family_or_group_M XXX-xxx G#protein_family_or_group_M
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
required NE xxx NE
for NE xxx NE
interleukin-2 G#other_name_B xxx-d G#other_name_B
gene G#other_name_M xxx G#other_name_M
transcription G#other_name_E xxx G#other_name_E
. NE . NE

NFATp G#protein_molecule XXXXx G#protein_molecule
binds NE xxx NE
to NE xx NE
two NE xxx NE
sites NE xxx NE
within NE xxx NE
the NE xxx NE
kappa G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
3 G#DNA_domain_or_region_M d G#DNA_domain_or_region_M
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
and NE xxx NE
occupancy NE xxx NE
of NE xx NE
both NE xxx NE
sites NE xxx NE
is NE xx NE
required NE xxx NE
for NE xxx NE
TNF G#other_name_B XXX G#other_name_B
alpha G#other_name_M xxx G#other_name_M
gene G#other_name_M xxx G#other_name_M
induction G#other_name_E xxx G#other_name_E
. NE . NE

Thus NE Xxxx NE
, NE , NE
although NE xxx NE
the NE xxx NE
kappa G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
3 G#DNA_domain_or_region_M d G#DNA_domain_or_region_M
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
has NE xxx NE
little NE xxx NE
sequence NE xxx NE
similarity NE xxx NE
to NE xx NE
other NE xxx NE
NFATp NE XXXXx NE
-binding NE -xxx NE
sites NE xxx NE
, NE , NE
it NE xx NE
appears NE xxx NE
to NE xx NE
function NE xxx NE
as NE xx NE
a NE x NE
cyclosporin-sensitive NE xxx-xxx NE
promoter NE xxx NE
element NE xxx NE
in NE xx NE
T NE X NE
cells NE xxx NE
by NE xx NE
virtue NE xxx NE
of NE xx NE
its NE xxx NE
ability NE xxx NE
to NE xx NE
bind NE xxx NE
NFATp NE XXXXx NE
. NE . NE

The NE Xxx NE
involvement NE xxx NE
of NE xx NE
NFATp G#protein_molecule XXXXx G#protein_molecule
in NE xx NE
transcriptional G#other_name_B xxx G#other_name_B
activation G#other_name_E xxx G#other_name_E
of NE xx NE
both NE xxx NE
the NE xxx NE
interleukin-2 G#protein_molecule xxx-d G#protein_molecule
and NE xxx NE
TNF G#DNA_family_or_group_B XXX G#DNA_family_or_group_B
alpha G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
suggests NE xxx NE
that NE xxx NE
this NE xxx NE
factor NE xxx NE
plays NE xxx NE
an NE xx NE
important NE xxx NE
role NE xxx NE
in NE xx NE
the NE xxx NE
coordinate NE xxx NE
induction NE xxx NE
of NE xx NE
multiple NE xxx NE
cytokine G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
, NE , NE
starting NE xxx NE
at NE xx NE
the NE xxx NE
earliest NE xxx NE
stages NE xxx NE
of NE xx NE
T G#other_name_B X G#other_name_B
cell G#other_name_M xxx G#other_name_M
activation G#other_name_E xxx G#other_name_E
. NE . NE

Regulation NE Xxxx NE
and NE xxx NE
specificity NE xxx NE
of NE xx NE
MNDA G#other_name_B XXXX G#other_name_B
expression G#other_name_E xxx G#other_name_E
in NE xx NE
monocytes G#cell_type xxx G#cell_type
, NE , NE
macrophages G#cell_type xxx G#cell_type
, NE , NE
and NE xxx NE
leukemia/B G#cell_line_B xxx/X G#cell_line_B
lymphoma G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
. NE . NE

The NE Xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
human G#protein_molecule_B xxx G#protein_molecule_B
myeloid G#protein_molecule_M xxx G#protein_molecule_M
cell G#protein_molecule_M xxx G#protein_molecule_M
nuclear G#protein_molecule_M xxx G#protein_molecule_M
differentiation G#protein_molecule_M xxx G#protein_molecule_M
antigen G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
MNDA G#protein_molecule XXXX G#protein_molecule
) NE ) NE
was NE xxx NE
observed NE xxx NE
specifically NE xxx NE
in NE xx NE
cells NE xxx NE
of NE xx NE
the NE xxx NE
granulocyte-macrophage G#other_name_B xxx-xxx G#other_name_B
lineage G#other_name_E xxx G#other_name_E
in NE xx NE
our NE xxx NE
earlier NE xxx NE
reports NE xxx NE
. NE . NE

The NE Xxx NE
specificity NE xxx NE
of NE xx NE
MNDA G#other_name_B XXXX G#other_name_B
expression G#other_name_E xxx G#other_name_E
for NE xxx NE
cells NE xxx NE
in NE xx NE
the NE xxx NE
granulocyte-macrophage G#other_name_B xxx-xxx G#other_name_B
lineage G#other_name_E xxx G#other_name_E
was NE xxx NE
reexamined NE xxx NE
in NE xx NE
cell G#cell_line_B xxx G#cell_line_B
lines G#cell_line_E xxx G#cell_line_E
established NE xxx NE
from NE xxx NE
patients G#multi_cell xxx G#multi_cell
with NE xxx NE
Philadelphia G#other_name_B Xxxx G#other_name_B
chromosome-positive G#other_name_M xxx-xxx G#other_name_M
chronic G#other_name_M xxx G#other_name_M
myeloid G#other_name_M xxx G#other_name_M
leukemia G#other_name_E xxx G#other_name_E
. NE . NE

Cell NE Xxxx NE
lines NE xxx NE
that NE xxx NE
expressed NE xxx NE
MNDA G#protein_molecule XXXX G#protein_molecule
exhibited NE xxx NE
myeloid G#other_name_B xxx G#other_name_B
cell G#other_name_M xxx G#other_name_M
features G#other_name_E xxx G#other_name_E
and NE xxx NE
granulocyte G#other_name_B xxx G#other_name_B
differentiation G#other_name_M xxx G#other_name_M
or G#other_name_M xx G#other_name_M
monocyte G#other_name_M xxx G#other_name_M
differentiation G#other_name_E xxx G#other_name_E
multipotential NE xxx NE
cells NE xxx NE
did NE xxx NE
not NE xxx NE
express NE xxx NE
MNDA G#protein_molecule XXXX G#protein_molecule
. NE . NE

Cells NE Xxxx NE
originating NE xxx NE
from NE xxx NE
cases NE xxx NE
of NE xx NE
Burkitt's G#other_name_B Xxxx'x G#other_name_B
lymphoma G#other_name_E xxx G#other_name_E
were NE xxx NE
negative NE xxx NE
. NE . NE

By NE Xx NE
contrast NE xxx NE
, NE , NE
three NE xxx NE
lymphoblastoid G#cell_line_B xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
(immortalized NE (xxx NE
in NE xx NE
vitro NE xxx NE
with NE xxx NE
Epstein-Barr G#virus_B Xxxx-Xxxx G#virus_B
virus G#virus_E xxx G#virus_E
) NE ) NE
were NE xxx NE
weakly NE xxx NE
positive NE xxx NE
and NE xxx NE
MNDA G#protein_molecule XXXX G#protein_molecule
was NE xxx NE
up-regulated NE xx-xxx NE
by NE xx NE
interferon-alpha NE xxx-xxx NE
( NE ( NE
IFN-alpha NE XXX-xxx NE
) NE ) NE
treatment NE xxx NE
. NE . NE

As NE Xx NE
we NE xx NE
reported NE xxx NE
previously NE xxx NE
, NE , NE
MNDA G#other_name_B XXXX G#other_name_B
mRNA G#other_name_M xXXX G#other_name_M
level G#other_name_E xxx G#other_name_E
in NE xx NE
adherent NE xxx NE
monocytes G#cell_type xxx G#cell_type
is NE xx NE
elevated NE xxx NE
by NE xx NE
IFN-alpha G#protein_molecule XXX-xxx G#protein_molecule
; NE ; NE
in NE xx NE
this NE xxx NE
study NE xxx NE
, NE , NE
we NE xx NE
further NE xxx NE
assessed NE xxx NE
MNDA G#other_name_B XXXX G#other_name_B
expression G#other_name_E xxx G#other_name_E
in NE xx NE
in NE xx NE
vitro NE xxx NE
monocyte-derived NE xxx-xxx NE
macrophages G#cell_type xxx G#cell_type
. NE . NE

Three NE Xxxx NE
additional NE xxx NE
agents NE xxx NE
( NE ( NE
endotoxin G#other_organic_compound xxx G#other_organic_compound
, NE , NE
phytohemagglutinin G#protein_molecule xxx G#protein_molecule
, NE , NE
and NE xxx NE
phorbol G#other_organic_compound_B xxx G#other_organic_compound_B
ester G#other_organic_compound_E xxx G#other_organic_compound_E
) NE ) NE
and NE xxx NE
other NE xxx NE
conditions NE xxx NE
that NE xxx NE
affect NE xxx NE
function NE xxx NE
, NE , NE
cytokine G#other_name_B xxx G#other_name_B
production G#other_name_E xxx G#other_name_E
, NE , NE
differentiation G#other_name xxx G#other_name
, NE , NE
and/or NE xxx/xx NE
growth NE xxx NE
of NE xx NE
monocytes G#cell_type xxx G#cell_type
were NE xxx NE
examined NE xxx NE
for NE xxx NE
their NE xxx NE
ability NE xxx NE
to NE xx NE
alter NE xxx NE
MNDA G#other_name_B XXXX G#other_name_B
expression G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
results NE xxx NE
varied NE xxx NE
with NE xxx NE
the NE xxx NE
agent NE xxx NE
, NE , NE
cell NE xxx NE
type NE xxx NE
, NE , NE
and NE xxx NE
stage NE xxx NE
of NE xx NE
differentiation G#other_name xxx G#other_name
. NE . NE

Changes NE Xxxx NE
in NE xx NE
MNDA G#other_name_B XXXX G#other_name_B
expression G#other_name_E xxx G#other_name_E
occurred NE xxx NE
slowly NE xxx NE
(hours NE (xxx NE
to NE xx NE
days) NE xxx) NE
, NE , NE
suggesting NE xxx NE
that NE xxx NE
MNDA G#protein_molecule XXXX G#protein_molecule
could NE xxx NE
mediate NE xxx NE
changes NE xxx NE
realized NE xxx NE
over NE xxx NE
a NE x NE
long NE xxx NE
period NE xxx NE
. NE . NE

The NE Xxx NE
results NE xxx NE
also NE xxx NE
reveal NE xxx NE
a NE x NE
discordance NE xxx NE
in NE xx NE
certain NE xxx NE
MNDA G#cell_line_B XXXX G#cell_line_B
positive G#cell_line_M xxx G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
between NE xxx NE
steady-state NE xxx-xxx NE
levels NE xxx NE
or NE xx NE
changes NE xxx NE
in NE xx NE
levels NE xxx NE
of NE xx NE
protein NE xxx NE
and NE xxx NE
mRNA G#RNA_family_or_group xXXX G#RNA_family_or_group
indicating NE xxx NE
that NE xxx NE
the NE xxx NE
regulation NE xxx NE
of NE xx NE
MNDA G#other_name_B XXXX G#other_name_B
expression G#other_name_E xxx G#other_name_E
occurs NE xxx NE
at NE xx NE
more NE xxx NE
than NE xxx NE
one NE xxx NE
point NE xxx NE
. NE . NE

Changes NE Xxxx NE
in NE xx NE
MNDA G#other_name_B XXXX G#other_name_B
expression G#other_name_E xxx G#other_name_E
are NE xxx NE
consistent NE xxx NE
with NE xxx NE
a NE x NE
role NE xxx NE
in NE xx NE
opposing NE xxx NE
macrophage G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
and NE xxx NE
activation NE xxx NE
of NE xx NE
monocytes G#cell_type xxx G#cell_type
/macrophages NE /xxx NE
. NE . NE

DNA-binding NE XXX-xxx NE
studies NE xxx NE
of NE xx NE
the NE xxx NE
Epstein-Barr G#protein_molecule_B Xxxx-Xxxx G#protein_molecule_B
virus G#protein_molecule_M xxx G#protein_molecule_M
nuclear G#protein_molecule_M xxx G#protein_molecule_M
antigen G#protein_molecule_M xxx G#protein_molecule_M
2 G#protein_molecule_E d G#protein_molecule_E
( NE ( NE
EBNA-2 G#protein_molecule XXXX-d G#protein_molecule
) NE ) NE
: NE : NE
evidence NE xxx NE
for NE xxx NE
complex NE xxx NE
formation NE xxx NE
by NE xx NE
latent G#protein_family_or_group_B xxx G#protein_family_or_group_B
membrane G#protein_family_or_group_M xxx G#protein_family_or_group_M
protein G#protein_family_or_group_M xxx G#protein_family_or_group_M
gene G#protein_family_or_group_M xxx G#protein_family_or_group_M
promoter-binding G#protein_family_or_group_M xxx-xxx G#protein_family_or_group_M
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
in NE xx NE
EBNA-2 NE XXXX-d NE
-positive NE -xxx NE
cell NE xxx NE
lines NE xxx NE
. NE . NE

The NE Xxx NE
Epstein-Barr NE Xxxx-Xxxx NE
virus NE xxx NE
( NE ( NE
EBV NE XXX NE
) NE ) NE
nuclear NE xxx NE
antigen NE xxx NE
2 NE d NE
( NE ( NE
EBNA-2 NE XXXX-d NE
) NE ) NE
protein NE xxx NE
is NE xx NE
essential NE xxx NE
for NE xxx NE
the NE xxx NE
immortalization NE xxx NE
of NE xx NE
human NE xxx NE
primary NE xxx NE
B NE X NE
cells NE xxx NE
by NE xx NE
EBV NE XXX NE
. NE . NE

EBNA-2 G#protein_molecule XXXX-d G#protein_molecule
trans-activates NE xxx-xxx NE
cellular G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
gene G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
and G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
viral G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
gene G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
like NE xxx NE
CD23 G#DNA_domain_or_region XXdd G#DNA_domain_or_region
, NE , NE
c-fgr G#DNA_domain_or_region x-xxx G#DNA_domain_or_region
, NE , NE
latent G#protein_molecule_B xxx G#protein_molecule_B
membrane G#protein_molecule_M xxx G#protein_molecule_M
protein G#protein_molecule_M xxx G#protein_molecule_M
1 G#protein_molecule_E d G#protein_molecule_E
( NE ( NE
LMP1 G#protein_molecule XXXd G#protein_molecule
) NE ) NE
and NE xxx NE
terminal G#protein_molecule_B xxx G#protein_molecule_B
protein G#protein_molecule_M xxx G#protein_molecule_M
1 G#protein_molecule_E d G#protein_molecule_E
( NE ( NE
TP1 G#protein_molecule XXd G#protein_molecule
) NE ) NE
. NE . NE

Trans-activation NE Xxxx-xxx NE
of NE xx NE
the NE xxx NE
TP1 G#DNA_domain_or_region_B XXd G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
of NE xx NE
the NE xxx NE
BamHI G#DNA_domain_or_region_B XxxXX G#DNA_domain_or_region_B
C G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
has NE xxx NE
already NE xxx NE
been NE xxx NE
investigated NE xxx NE
in NE xx NE
detail NE xxx NE
and NE xxx NE
appears NE xxx NE
to NE xx NE
be NE xx NE
mediated NE xxx NE
via NE xxx NE
protein-protein G#other_name_B xxx-xxx G#other_name_B
interactions G#other_name_E xxx G#other_name_E
and NE xxx NE
not NE xxx NE
by NE xx NE
direct NE xxx NE
binding NE xxx NE
of NE xx NE
EBNA-2 G#protein_molecule_B XXXX-d G#protein_molecule_B
type G#protein_molecule_M xxx G#protein_molecule_M
A G#protein_molecule_E X G#protein_molecule_E
(of NE (xx NE
EBV G#virus_B XXX G#virus_B
type G#virus_M xxx G#virus_M
1 G#virus_E d G#virus_E
) NE ) NE
to NE xx NE
the NE xxx NE
DNA NE XXX NE
. NE . NE

EBNA-2 G#protein_molecule XXXX-d G#protein_molecule
is NE xx NE
able NE xxx NE
to NE xx NE
trans-activate NE xxx-xxx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
LMP G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
several NE xxx NE
cell NE xxx NE
lines NE xxx NE
. NE . NE

Various NE Xxxx NE
reports NE xxx NE
have NE xxx NE
delineated NE xxx NE
the NE xxx NE
cis-acting G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
elements G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
the NE xxx NE
LMP G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
through NE xxx NE
which NE xxx NE
EBNA-2 G#protein_molecule XXXX-d G#protein_molecule
mediates NE xxx NE
trans-activation G#other_name xxx-xxx G#other_name
. NE . NE

To NE Xx NE
determine NE xxx NE
whether NE xxx NE
EBNA-2 G#protein_molecule XXXX-d G#protein_molecule
also NE xxx NE
trans-activates NE xxx-xxx NE
the NE xxx NE
LMP G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
by NE xx NE
protein-protein G#other_name_B xxx-xxx G#other_name_B
interactions G#other_name_E xxx G#other_name_E
, NE , NE
we NE xx NE
performed NE xxx NE
a NE x NE
series NE xxx NE
of NE xx NE
gel G#other_name_B xxx G#other_name_B
retardation G#other_name_M xxx G#other_name_M
assays G#other_name_E xxx G#other_name_E
and NE xxx NE
competition NE xxx NE
experiments NE xxx NE
with NE xxx NE
LMP G#DNA_molecule_B XXX G#DNA_molecule_B
promoter G#DNA_molecule_M xxx G#DNA_molecule_M
fragments G#DNA_molecule_E xxx G#DNA_molecule_E
of NE xx NE
different NE xxx NE
sizes NE xxx NE
. NE . NE

We NE Xx NE
determined NE xxx NE
that NE xxx NE
the NE xxx NE
protein-binding G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
on NE xx NE
the NE xxx NE
LMP G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
was NE xxx NE
within NE xxx NE
a NE x NE
42 G#DNA_domain_or_region_B dd G#DNA_domain_or_region_B
bp G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
fragment G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
encompassing NE xxx NE
nucleotides G#DNA_substructure_B xxx G#DNA_substructure_B
-135 G#DNA_substructure_M -ddd G#DNA_substructure_M
to G#DNA_substructure_M xx G#DNA_substructure_M
-176 G#DNA_substructure_E -ddd G#DNA_substructure_E
relative NE xxx NE
to NE xx NE
the NE xxx NE
LMP G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
transcriptional G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
start G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

None NE Xxxx NE
of NE xx NE
the NE xxx NE
DNA NE XXX NE
fragments NE xxx NE
investigated NE xxx NE
indicated NE xxx NE
interaction NE xxx NE
of NE xx NE
EBNA-2 G#protein_molecule XXXX-d G#protein_molecule
with NE xxx NE
the NE xxx NE
DNA NE XXX NE
via NE xxx NE
protein-protein G#other_name_B xxx-xxx G#other_name_B
interactions G#other_name_E xxx G#other_name_E
. NE . NE

No NE Xx NE
significant NE xxx NE
differences NE xxx NE
between NE xxx NE
EBNA-2 G#protein_molecule XXXX-d G#protein_molecule
-positive NE -xxx NE
and NE xxx NE
EBNA-2 G#protein_molecule XXXX-d G#protein_molecule
-negative NE -xxx NE
nuclear G#cell_component_B xxx G#cell_component_B
extracts G#cell_component_E xxx G#cell_component_E
could NE xxx NE
be NE xx NE
seen NE xxx NE
in NE xx NE
the NE xxx NE
gel G#other_name_B xxx G#other_name_B
retardation G#other_name_M xxx G#other_name_M
assay G#other_name_E xxx G#other_name_E
under NE xxx NE
conditions NE xxx NE
that NE xxx NE
clearly NE xxx NE
showed NE xxx NE
binding NE xxx NE
of NE xx NE
EBNA-2A G#protein_molecule XXXX-dX G#protein_molecule
to NE xx NE
the NE xxx NE
TP1 G#DNA_domain_or_region_B XXd G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

However NE Xxxx NE
, NE , NE
analysis NE xxx NE
of NE xx NE
sucrose G#other_name_B xxx G#other_name_B
gradient G#other_name_M xxx G#other_name_M
fractions G#other_name_E xxx G#other_name_E
in NE xx NE
the NE xxx NE
gel G#other_name_B xxx G#other_name_B
retardation G#other_name_M xxx G#other_name_M
assay G#other_name_E xxx G#other_name_E
provided NE xxx NE
evidence NE xxx NE
that NE xxx NE
the NE xxx NE
LMP NE XXX NE
promoter NE xxx NE
-binding NE -xxx NE
proteins NE xxx NE
form NE xxx NE
a NE x NE
complex NE xxx NE
of NE xx NE
higher NE xxx NE
M(r) NE X(x) NE
in NE xx NE
EBNA-2 NE XXXX-d NE
-positive NE -xxx NE
cell NE xxx NE
extracts NE xxx NE
. NE . NE

These NE Xxxx NE
complexes NE xxx NE
were NE xxx NE
destroyed NE xxx NE
by NE xx NE
detergent NE xxx NE
. NE . NE

We NE Xx NE
deduce NE xxx NE
from NE xxx NE
these NE xxx NE
results NE xxx NE
that NE xxx NE
EBNA-2 NE XXXX-d NE
-positive NE -xxx NE
cells NE xxx NE
might NE xxx NE
indeed NE xxx NE
contain NE xxx NE
specific NE xxx NE
complexes NE xxx NE
bound NE xxx NE
to NE xx NE
the NE xxx NE
LMP NE XXX NE
promoter NE xxx NE
which NE xxx NE
are NE xxx NE
, NE , NE
however NE xxx NE
, NE , NE
too NE xxx NE
labile NE xxx NE
to NE xx NE
be NE xx NE
detected NE xxx NE
in NE xx NE
a NE x NE
standard NE xxx NE
gel NE xxx NE
retardation NE xxx NE
assay NE xxx NE
. NE . NE

Simultaneous NE Xxxx NE
activation NE xxx NE
of NE xx NE
Ig G#protein_family_or_group Xx G#protein_family_or_group
and NE xxx NE
Oct-2 G#other_name_B Xxx-d G#other_name_B
synthesis G#other_name_E xxx G#other_name_E
and NE xxx NE
reduction NE xxx NE
of NE xx NE
surface NE xxx NE
MHC G#other_name_B XXX G#other_name_B
class G#other_name_M xxx G#other_name_M
II G#other_name_M XX G#other_name_M
expression G#other_name_E xxx G#other_name_E
by NE xx NE
IL-6 G#protein_molecule XX-d G#protein_molecule
. NE . NE

Terminal NE Xxxx NE
differentiation NE xxx NE
of NE xx NE
B G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
to NE xx NE
plasma G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
in NE xx NE
vivo NE xxx NE
is NE xx NE
characterized NE xxx NE
by NE xx NE
secretion NE xxx NE
of NE xx NE
Ig G#protein_family_or_group Xx G#protein_family_or_group
and NE xxx NE
extinction NE xxx NE
of NE xx NE
MHC G#other_name_B XXX G#other_name_B
class G#other_name_M xxx G#other_name_M
II G#other_name_M XX G#other_name_M
expression G#other_name_E xxx G#other_name_E
on NE xx NE
the NE xxx NE
cell NE xxx NE
surface NE xxx NE
. NE . NE

We NE Xx NE
show NE xxx NE
that NE xxx NE
IL-6 G#protein_molecule XX-d G#protein_molecule
signaling NE xxx NE
leads NE xxx NE
to NE xx NE
marked NE xxx NE
increases NE xxx NE
in NE xx NE
the NE xxx NE
synthesis NE xxx NE
and NE xxx NE
secretion NE xxx NE
of NE xx NE
Ig G#protein_family_or_group Xx G#protein_family_or_group
in NE xx NE
clonal G#cell_line_B xxx G#cell_line_B
human G#cell_line_M xxx G#cell_line_M
B G#cell_line_M X G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
and NE xxx NE
newly NE xxx NE
isolated G#cell_type_B xxx G#cell_type_B
polyclonal G#cell_type_M xxx G#cell_type_M
B G#cell_type_M X G#cell_type_M
lymphocytes G#cell_type_E xxx G#cell_type_E
in NE xx NE
vitro NE xxx NE
. NE . NE

The NE Xxx NE
IL-6-induced G#cell_line_B XX-d-xxx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
resemble NE xxx NE
plasma G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
in NE xx NE
ultrastructure NE xxx NE
and NE xxx NE
in NE xx NE
reduced NE xxx NE
expression NE xxx NE
of NE xx NE
surface G#protein_family_or_group_B xxx G#protein_family_or_group_B
MHC G#protein_family_or_group_M XXX G#protein_family_or_group_M
class G#protein_family_or_group_M xxx G#protein_family_or_group_M
II G#protein_family_or_group_E XX G#protein_family_or_group_E
. NE . NE

Enhanced NE Xxxx NE
Ig G#protein_family_or_group Xx G#protein_family_or_group
synthesis NE xxx NE
is NE xx NE
a NE x NE
result NE xxx NE
of NE xx NE
coordinated NE xxx NE
transcriptional NE xxx NE
activation NE xxx NE
of NE xx NE
Ig G#DNA_family_or_group_B Xx G#DNA_family_or_group_B
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
without NE xxx NE
promoter NE xxx NE
or NE xx NE
isotype NE xxx NE
specificity NE xxx NE
, NE , NE
and NE xxx NE
differential NE xxx NE
accumulation NE xxx NE
of NE xx NE
the NE xxx NE
mRNA G#RNA_family_or_group xXXX G#RNA_family_or_group
encoding NE xxx NE
the NE xxx NE
secreted NE xxx NE
form NE xxx NE
of NE xx NE
Ig G#protein_subunit_B Xx G#protein_subunit_B
heavy G#protein_subunit_M xxx G#protein_subunit_M
chain G#protein_subunit_E xxx G#protein_subunit_E
. NE . NE

It NE Xx NE
is NE xx NE
saturable NE xxx NE
and NE xxx NE
subject NE xxx NE
to NE xx NE
negative NE xxx NE
control NE xxx NE
when NE xxx NE
IL-6 G#other_name_B XX-d G#other_name_B
stimulation G#other_name_E xxx G#other_name_E
is NE xx NE
prolonged NE xxx NE
. NE . NE

Coordinate NE Xxxx NE
with NE xxx NE
temporal NE xxx NE
changes NE xxx NE
in NE xx NE
Ig G#other_name_B Xx G#other_name_B
synthesis G#other_name_E xxx G#other_name_E
, NE , NE
the NE xxx NE
DNA-binding G#other_name_B XXX-xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
and NE xxx NE
the NE xxx NE
synthesis NE xxx NE
of NE xx NE
the NE xxx NE
B G#protein_family_or_group_B X G#protein_family_or_group_B
cell-enriched G#protein_family_or_group_M xxx-xxx G#protein_family_or_group_M
transcription G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
Oct-2 G#protein_molecule Xxx-d G#protein_molecule
are NE xxx NE
regulated NE xxx NE
. NE . NE

Thus NE Xxxx NE
, NE , NE
differentiation G#other_name xxx G#other_name
of NE xx NE
B G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
with NE xxx NE
IL-6 G#protein_molecule XX-d G#protein_molecule
in NE xx NE
vitro NE xxx NE
recapitulates NE xxx NE
the NE xxx NE
hallmarks NE xxx NE
of NE xx NE
terminal NE xxx NE
B G#other_name_B X G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
in NE xx NE
vivo NE xxx NE
; NE ; NE
Oct-2 G#protein_molecule Xxx-d G#protein_molecule
may NE xxx NE
have NE xxx NE
a NE x NE
role NE xxx NE
in NE xx NE
this NE xxx NE
process NE xxx NE
. NE . NE

T-cell G#DNA_domain_or_region_B X-xxx G#DNA_domain_or_region_B
functional G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
regions G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
the NE xxx NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
IL-3 G#DNA_domain_or_region_M XX-d G#DNA_domain_or_region_M
proximal G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

The NE Xxx NE
human NE xxx NE
interleukin-3 NE xxx-d NE
( NE ( NE
IL-3 NE XX-d NE
) NE ) NE
gene NE xxx NE
is NE xx NE
expressed NE xxx NE
almost NE xxx NE
exclusively NE xxx NE
in NE xx NE
activated NE xxx NE
T NE X NE
cells NE xxx NE
. NE . NE

Its NE Xxx NE
expression NE xxx NE
is NE xx NE
regulated NE xxx NE
at NE xx NE
both NE xxx NE
the NE xxx NE
transcriptional NE xxx NE
and NE xxx NE
post-transcriptional NE xxx-xxx NE
level NE xxx NE
. NE . NE

We NE Xx NE
have NE xxx NE
previously NE xxx NE
shown NE xxx NE
that NE xxx NE
treatment NE xxx NE
of NE xx NE
Jurkat G#cell_line_B Xxxx G#cell_line_B
T G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
with NE xxx NE
phytohemaglutinin G#protein_molecule xxx G#protein_molecule
( NE ( NE
PHA G#protein_molecule XXX G#protein_molecule
) NE ) NE
and NE xxx NE
the NE xxx NE
phorbol G#other_organic_compound_B xxx G#other_organic_compound_B
ester G#other_organic_compound_E xxx G#other_organic_compound_E
, NE , NE
PMA G#other_organic_compound XXX G#other_organic_compound
, NE , NE
activated NE xxx NE
transcription NE xxx NE
initiation NE xxx NE
from NE xxx NE
the NE xxx NE
IL-3 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

To NE Xx NE
define NE xxx NE
the NE xxx NE
regions NE xxx NE
of NE xx NE
the NE xxx NE
gene NE xxx NE
required NE xxx NE
for NE xxx NE
transcription NE xxx NE
activation NE xxx NE
, NE , NE
we NE xx NE
generated NE xxx NE
a NE x NE
series NE xxx NE
of NE xx NE
reporter NE xxx NE
constructs NE xxx NE
containing NE xxx NE
different NE xxx NE
regions NE xxx NE
of NE xx NE
the NE xxx NE
IL-3 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
5' G#DNA_domain_or_region_M d' G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
3' G#DNA_domain_or_region_M d' G#DNA_domain_or_region_M
flanking G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sequences G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Both NE Xxxx NE
positive G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
regulatory G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
element G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
and G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
negative G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
regulatory G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
element G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
were NE xxx NE
identified NE xxx NE
in NE xx NE
the NE xxx NE
proximal G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
5' G#DNA_domain_or_region_M d' G#DNA_domain_or_region_M
flanking G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
the NE xxx NE
IL-3 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

The NE Xxx NE
promoter G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
between NE xxx NE
-173 G#DNA_domain_or_region_B -ddd G#DNA_domain_or_region_B
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
-60 G#DNA_domain_or_region_E -dd G#DNA_domain_or_region_E
contained NE xxx NE
the NE xxx NE
strongest NE xxx NE
activating G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
elements G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

The NE Xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
AP-1 G#protein_molecule XX-d G#protein_molecule
could NE xxx NE
bind NE xxx NE
to NE xx NE
this NE xxx NE
positive NE xxx NE
activator NE xxx NE
region NE xxx NE
of NE xx NE
the NE xxx NE
promoter NE xxx NE
. NE . NE

We NE Xx NE
also NE xxx NE
examined NE xxx NE
the NE xxx NE
function NE xxx NE
of NE xx NE
the NE xxx NE
IL-3 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
CK-1/CK-2 G#DNA_domain_or_region_M XX-d/XX-d G#DNA_domain_or_region_M
elements G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
that NE xxx NE
are NE xxx NE
present NE xxx NE
in NE xx NE
many NE xxx NE
cytokine G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
and NE xxx NE
found NE xxx NE
that NE xxx NE
they NE xxx NE
acted NE xxx NE
as NE xx NE
a NE x NE
repressor NE xxx NE
of NE xx NE
basal G#other_name_B xxx G#other_name_B
level G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
when NE xxx NE
cloned NE xxx NE
upstream NE xxx NE
of NE xx NE
a NE x NE
heterologous G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
but NE xxx NE
were NE xxx NE
also NE xxx NE
inducible NE xxx NE
by NE xx NE
PMA G#other_organic_compound XXX G#other_organic_compound
/PHA NE /XXX NE
. NE . NE

Expression NE Xxxx NE
of NE xx NE
the NE xxx NE
Runt NE Xxxx NE
domain NE xxx NE
-encoding NE -xxx NE
PEBP2 NE XXXXd NE
alpha NE xxx NE
genes NE xxx NE
in NE xx NE
T NE X NE
cells NE xxx NE
during NE xxx NE
thymic NE xxx NE
development NE xxx NE
. NE . NE

The NE Xxx NE
PEBP2 G#DNA_domain_or_region_B XXXXd G#DNA_domain_or_region_B
alpha G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
A G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
PEBP2 G#DNA_domain_or_region_M XXXXd G#DNA_domain_or_region_M
alpha G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
B G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
encode NE xxx NE
the NE xxx NE
DNA-binding G#protein_subunit_B XXX-xxx G#protein_subunit_B
subunit G#protein_subunit_E xxx G#protein_subunit_E
of NE xx NE
a NE x NE
murine G#protein_family_or_group_B xxx G#protein_family_or_group_B
transcription G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
PEBP2 G#protein_molecule XXXXd G#protein_molecule
, NE , NE
which NE xxx NE
is NE xx NE
implicated NE xxx NE
as NE xx NE
a NE x NE
T-cell-specific G#protein_family_or_group_B X-xxx-xxx G#protein_family_or_group_B
transcriptional G#protein_family_or_group_M xxx G#protein_family_or_group_M
regulator G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

These NE Xxxx NE
two NE xxx NE
related NE xxx NE
genes NE xxx NE
share NE xxx NE
the NE xxx NE
evolutionarily NE xxx NE
conserved NE xxx NE
region NE xxx NE
encoding NE xxx NE
the NE xxx NE
Runt G#protein_domain_or_region_B Xxxx G#protein_domain_or_region_B
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
. NE . NE

PEBP2 G#protein_molecule_B XXXXd G#protein_molecule_B
alpha G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_E X G#protein_molecule_E
is NE xx NE
the NE xxx NE
murine G#protein_family_or_group_B xxx G#protein_family_or_group_B
counterpart G#protein_family_or_group_E xxx G#protein_family_or_group_E
of NE xx NE
human G#protein_molecule_B xxx G#protein_molecule_B
AML1 G#protein_molecule_E XXXd G#protein_molecule_E
, NE , NE
which NE xxx NE
is NE xx NE
located NE xxx NE
at NE xx NE
the NE xxx NE
breakpoints NE xxx NE
of NE xx NE
the NE xxx NE
8;21 G#DNA_domain_or_region_B d;dd G#DNA_domain_or_region_B
chromosome G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
translocation G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
3;21 G#DNA_domain_or_region_M d;dd G#DNA_domain_or_region_M
chromosome G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
translocation G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
associated NE xxx NE
with NE xxx NE
acute G#other_name_B xxx G#other_name_B
myeloid G#other_name_M xxx G#other_name_M
leukemia G#other_name_E xxx G#other_name_E
. NE . NE

Northern G#other_name_B Xxxx G#other_name_B
(RNA) G#other_name_M (XXX) G#other_name_M
blots G#other_name_E xxx G#other_name_E
of NE xx NE
various NE xxx NE
adult G#tissue_B xxx G#tissue_B
mouse G#tissue_M xxx G#tissue_M
tissues G#tissue_E xxx G#tissue_E
revealed NE xxx NE
that NE xxx NE
the NE xxx NE
levels NE xxx NE
of NE xx NE
expression NE xxx NE
of NE xx NE
both NE xxx NE
genes NE xxx NE
were NE xxx NE
most NE xxx NE
prominent NE xxx NE
in NE xx NE
the NE xxx NE
thymus G#body_part xxx G#body_part
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
transcripts NE xxx NE
of NE xx NE
PEBP2 G#protein_molecule_B XXXXd G#protein_molecule_B
alpha G#protein_molecule_M xxx G#protein_molecule_M
A G#protein_molecule_E X G#protein_molecule_E
and NE xxx NE
mouse NE xxx NE
AML1 NE XXXd NE
/ NE / NE
PEBP2 NE XXXXd NE
alpha NE xxx NE
B NE X NE
were NE xxx NE
detected NE xxx NE
in NE xx NE
T NE X NE
lymphocytes NE xxx NE
in NE xx NE
the NE xxx NE
thymuses NE xxx NE
from NE xxx NE
day NE xxx NE
16 NE dd NE
embryos NE xxx NE
and NE xxx NE
newborns NE xxx NE
, NE , NE
as NE xx NE
well NE xxx NE
as NE xx NE
4-week-old NE d-xxx-xxx NE
adult NE xxx NE
mice NE xxx NE
, NE , NE
by NE xx NE
in NE xx NE
situ NE xxx NE
hybridization NE xxx NE
. NE . NE

The NE Xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
genes NE xxx NE
persisted NE xxx NE
in NE xx NE
peripheral G#body_part_B xxx G#body_part_B
lymph G#body_part_M xxx G#body_part_M
nodes G#body_part_E xxx G#body_part_E
of NE xx NE
adult G#multi_cell_B xxx G#multi_cell_B
mice G#multi_cell_E xxx G#multi_cell_E
. NE . NE

The NE Xxx NE
transcripts NE xxx NE
were NE xxx NE
detected NE xxx NE
in NE xx NE
all NE xxx NE
the NE xxx NE
CD4- G#cell_type_B XXd- G#cell_type_B
CD8- G#cell_type_M XXd- G#cell_type_M
cell G#cell_type_M xxx G#cell_type_M
population G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
CD4+ G#cell_type_M XXd+ G#cell_type_M
CD8+ G#cell_type_M XXd+ G#cell_type_M
cell G#cell_type_M xxx G#cell_type_M
population G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
CD4+ G#cell_type_M XXd+ G#cell_type_M
CD8- G#cell_type_M XXd- G#cell_type_M
cell G#cell_type_M xxx G#cell_type_M
population G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
CD4- G#cell_type_M XXd- G#cell_type_M
CD8+ G#cell_type_M XXd+ G#cell_type_M
cell G#cell_type_M xxx G#cell_type_M
population G#cell_type_E xxx G#cell_type_E

The NE Xxx NE
results NE xxx NE
indicated NE xxx NE
that NE xxx NE
both NE xxx NE
genes NE xxx NE
are NE xxx NE
expressed NE xxx NE
in NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
throughout NE xxx NE
their NE xxx NE
development NE xxx NE
, NE , NE
supporting NE xxx NE
the NE xxx NE
notion NE xxx NE
that NE xxx NE
PEBP2 G#protein_molecule XXXXd G#protein_molecule
is NE xx NE
a NE x NE
T-cell-specific G#protein_family_or_group_B X-xxx-xxx G#protein_family_or_group_B
transcription G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Transcripts NE Xxxx NE
of NE xx NE
mouse NE xxx NE
AML1 NE XXXd NE
/ NE / NE
PEBP2 NE XXXXd NE
alpha NE xxx NE
B NE X NE
were NE xxx NE
also NE xxx NE
detected NE xxx NE
in NE xx NE
day NE xxx NE
12 NE dd NE
fetal NE xxx NE
hematopoietic NE xxx NE
liver NE xxx NE
and NE xxx NE
in NE xx NE
the NE xxx NE
bone NE xxx NE
marrow NE xxx NE
cells NE xxx NE
of NE xx NE
newborn NE xxx NE
mice NE xxx NE
. NE . NE

The NE Xxx NE
implication NE xxx NE
of NE xx NE
mouse NE xxx NE
AML1 NE XXXd NE
/ NE / NE
PEBP2 NE XXXXd NE
alpha NE xxx NE
B NE X NE
expression NE xxx NE
in NE xx NE
hematopoietic NE xxx NE
cells NE xxx NE
other NE xxx NE
than NE xxx NE
those NE xxx NE
of NE xx NE
T-cell NE X-xxx NE
lineage NE xxx NE
is NE xx NE
discussed NE xxx NE
in NE xx NE
relation NE xxx NE
to NE xx NE
myeloid NE xxx NE
leukemogenesis NE xxx NE
. NE . NE

Effects NE Xxxx NE
of NE xx NE
glucocorticoids G#lipid xxx G#lipid
on NE xx NE
transcription G#other_name_B xxx G#other_name_B
factor G#other_name_M xxx G#other_name_M
activation G#other_name_E xxx G#other_name_E
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
peripheral G#cell_type_M xxx G#cell_type_M
blood G#cell_type_M xxx G#cell_type_M
mononuclear G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Glucocorticoids G#lipid Xxxx G#lipid
have NE xxx NE
an NE xx NE
inhibitory NE xxx NE
effect NE xxx NE
on NE xx NE
inflammatory G#other_name_B xxx G#other_name_B
response G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
immune G#other_name_M xxx G#other_name_M
response G#other_name_E xxx G#other_name_E
transcription NE xxx NE
factor NE xxx NE
binding NE xxx NE
to NE xx NE
DNA NE XXX NE
. NE . NE

The NE Xxx NE
interaction NE xxx NE
of NE xx NE
the NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
activator G#protein_molecule_B xxx G#protein_molecule_B
protein-1 G#protein_molecule_E xxx-d G#protein_molecule_E
( NE ( NE
AP-1 G#protein_molecule XX-d G#protein_molecule
) NE ) NE
, NE , NE
nuclear G#protein_molecule_B xxx G#protein_molecule_B
factor G#protein_molecule_M xxx G#protein_molecule_M
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_E X G#protein_molecule_E
( NE ( NE
NF G#protein_molecule_B XX G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_E X G#protein_molecule_E
) NE ) NE
, NE , NE
and NE xxx NE
cAMP-responsive G#protein_molecule_B xXXX-xxx G#protein_molecule_B
element G#protein_molecule_M xxx G#protein_molecule_M
binding G#protein_molecule_M xxx G#protein_molecule_M
protein G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
CREB G#protein_molecule XXXX G#protein_molecule
) NE ) NE
with NE xxx NE
DNA NE XXX NE
and NE xxx NE
glucocorticoid G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
GR G#protein_family_or_group XX G#protein_family_or_group
) NE ) NE
was NE xxx NE
analyzed NE xxx NE
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
peripheral G#cell_type_M xxx G#cell_type_M
blood G#cell_type_M xxx G#cell_type_M
mononuclear G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
by NE xx NE
gel G#other_name_B xxx G#other_name_B
mobility G#other_name_M xxx G#other_name_M
shift G#other_name_M xxx G#other_name_M
assays G#other_name_E xxx G#other_name_E
. NE . NE

TNF-alpha, G#other_name_B XXX-xxx, G#other_name_B
IL-1 G#other_name_M XX-d G#other_name_M
beta G#other_name_M xxx G#other_name_M
treatment G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
phorbol G#other_name_M xxx G#other_name_M
myristate G#other_name_M xxx G#other_name_M
acetate G#other_name_M xxx G#other_name_M
(PMA) G#other_name_M (XXX) G#other_name_M
treatment G#other_name_E xxx G#other_name_E
increased NE xxx NE
AP-1 G#protein_molecule XX-d G#protein_molecule
and NE xxx NE
NF NE XX NE
kappa NE xxx NE
B NE X NE
DNA NE XXX NE
binding NE xxx NE
by NE xx NE
up NE xx NE
to NE xx NE
200% NE ddd% NE
but NE xxx NE
decreased NE xxx NE
CREB G#other_name_B XXXX G#other_name_B
binding G#other_name_E xxx G#other_name_E
(38%) NE (dd%) NE
over NE xxx NE
a NE x NE
60-min NE dd-xxx NE
time NE xxx NE
course NE xxx NE
. NE . NE

Dexamethasone G#lipid Xxxx G#lipid
produced NE xxx NE
a NE x NE
rapid NE xxx NE
and NE xxx NE
sustained NE xxx NE
increase NE xxx NE
in NE xx NE
glucocorticoid G#other_name_B xxx G#other_name_B
response G#other_name_M xxx G#other_name_M
element G#other_name_M xxx G#other_name_M
binding G#other_name_E xxx G#other_name_E
and NE xxx NE
a NE x NE
concomitant NE xxx NE
40-50% NE dd-dd% NE
decrease NE xxx NE
in NE xx NE
AP-1 G#other_name_B XX-d G#other_name_B
DNA G#other_name_M XXX G#other_name_M
binding G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
NF G#other_name_M XX G#other_name_M
kappa G#other_name_M xxx G#other_name_M
B G#other_name_M X G#other_name_M
DNA G#other_name_M XXX G#other_name_M
binding G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
CREB G#other_name_M XXXX G#other_name_M
DNA G#other_name_M XXX G#other_name_M
binding G#other_name_E xxx G#other_name_E
that NE xxx NE
was NE xxx NE
blocked NE xxx NE
by NE xx NE
combined NE xxx NE
dexamethasone G#lipid xxx G#lipid
and NE xxx NE
cytokine G#other_name xxx G#other_name
or NE xx NE
PMA G#other_name_B XXX G#other_name_B
treatment G#other_name_E xxx G#other_name_E
. NE . NE

These NE Xxxx NE
latter NE xxx NE
effects NE xxx NE
were NE xxx NE
due NE xxx NE
to NE xx NE
increases NE xxx NE
in NE xx NE
the NE xxx NE
nuclear G#other_name_B xxx G#other_name_B
localization G#other_name_E xxx G#other_name_E
of NE xx NE
GR G#protein_family_or_group XX G#protein_family_or_group
, NE , NE
not NE xxx NE
to NE xx NE
reduced NE xxx NE
amounts NE xxx NE
of NE xx NE
the NE xxx NE
other NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

This NE Xxxx NE
suggests NE xxx NE
that NE xxx NE
in NE xx NE
these NE xxx NE
cells NE xxx NE
GR G#protein_family_or_group XX G#protein_family_or_group
within NE xxx NE
the NE xxx NE
nucleus G#protein_N/A xxx G#protein_N/A
interacts NE xxx NE
with NE xxx NE
cytokine NE xxx NE
-stimulated NE -xxx NE
transcription NE xxx NE
factors NE xxx NE
by NE xx NE
the NE xxx NE
process NE xxx NE
of NE xx NE
cross NE xxx NE
coupling NE xxx NE
. NE . NE

This NE Xxxx NE
may NE xxx NE
be NE xx NE
an NE xx NE
important NE xxx NE
molecular NE xxx NE
site NE xxx NE
of NE xx NE
steroid G#lipid xxx G#lipid
action NE xxx NE
. NE . NE

Differential G#other_name_B Xxxx G#other_name_B
induction G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
NF-AT G#protein_complex_B XX-XX G#protein_complex_B
complex G#protein_complex_E xxx G#protein_complex_E
during NE xxx NE
restimulation G#other_name xxx G#other_name
and NE xxx NE
the NE xxx NE
induction NE xxx NE
of NE xx NE
T-cell G#other_name_B X-xxx G#other_name_B
anergy G#other_name_E xxx G#other_name_E
. NE . NE

Stimulation NE Xxxx NE
of NE xx NE
human G#cell_line_B xxx G#cell_line_B
CD4+ G#cell_line_M XXd+ G#cell_line_M
T-cell G#cell_line_M X-xxx G#cell_line_M
clones G#cell_line_E xxx G#cell_line_E
through NE xxx NE
the NE xxx NE
T-cell G#protein_family_or_group_B X-xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
TcR G#protein_family_or_group XxX G#protein_family_or_group
) NE ) NE
by NE xx NE
high NE xxx NE
doses NE xxx NE
of NE xx NE
specific NE xxx NE
peptide G#peptide xxx G#peptide
results NE xxx NE
in NE xx NE
the NE xxx NE
induction NE xxx NE
of NE xx NE
a NE x NE
long-lived NE xxx-xxx NE
state NE xxx NE
of NE xx NE
nonresponsiveness G#other_name xxx G#other_name
that NE xxx NE
has NE xxx NE
been NE xxx NE
called NE xxx NE
anergy G#other_name xxx G#other_name
. NE . NE

During NE Xxxx NE
the NE xxx NE
induction NE xxx NE
of NE xx NE
anergy G#other_name xxx G#other_name
, NE , NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
are NE xxx NE
phenotypically NE xxx NE
similar NE xxx NE
to NE xx NE
cells NE xxx NE
responding NE xxx NE
to NE xx NE
an NE xx NE
immunogenic G#other_name_B xxx G#other_name_B
stimulus G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
amount NE xxx NE
of NE xx NE
TcR G#protein_family_or_group XxX G#protein_family_or_group
at NE xx NE
the NE xxx NE
cell NE xxx NE
surface NE xxx NE
is NE xx NE
downmodulated NE xxx NE
, NE , NE
whereas NE xxx NE
the NE xxx NE
CD2 G#protein_molecule_B XXd G#protein_molecule_B
receptor G#protein_molecule_M xxx G#protein_molecule_M
and G#protein_molecule_M xxx G#protein_molecule_M
CD25 G#protein_molecule_M XXdd G#protein_molecule_M
receptor G#protein_molecule_E xxx G#protein_molecule_E

When NE Xxxx NE
restimulated NE xxx NE
, NE , NE
however NE xxx NE
, NE , NE
anergic G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
fail NE xxx NE
to NE xx NE
up-regulate NE xx-xxx NE
transcription NE xxx NE
of NE xx NE
the NE xxx NE
IL-2 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
in NE xx NE
consequence NE xxx NE
do NE xx NE
not NE xxx NE
produce NE xxx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
. NE . NE

In NE Xx NE
this NE xxx NE
study NE xxx NE
, NE , NE
we NE xx NE
have NE xxx NE
compared NE xxx NE
the NE xxx NE
ability NE xxx NE
of NE xx NE
various NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
to NE xx NE
bind NE xxx NE
to NE xx NE
their NE xxx NE
appropriate NE xxx NE
site NE xxx NE
on NE xx NE
DNA NE XXX NE
. NE . NE

Factors NE Xxxx NE
were NE xxx NE
isolated NE xxx NE
from NE xxx NE
the NE xxx NE
nuclei G#cell_component xxx G#cell_component
of NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
that NE xxx NE
were NE xxx NE
in NE xx NE
the NE xxx NE
induction NE xxx NE
phase NE xxx NE
of NE xx NE
anergy G#other_name xxx G#other_name
or NE xx NE
were NE xxx NE
undergoing NE xxx NE
activation NE xxx NE
. NE . NE

The NE Xxx NE
pattern NE xxx NE
of NE xx NE
binding G#other_name_B xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
in NE xx NE
restimulated NE xxx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
is NE xx NE
consistent NE xxx NE
with NE xxx NE
the NE xxx NE
pattern NE xxx NE
that NE xxx NE
has NE xxx NE
previously NE xxx NE
been NE xxx NE
shown NE xxx NE
to NE xx NE
regulate NE xxx NE
T-cell-specific G#other_name_B X-xxx-xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
and NE xxx NE
the NE xxx NE
beta NE xxx NE
chain NE xxx NE
of NE xx NE
the NE xxx NE
TcR G#DNA_family_or_group_B XxX G#DNA_family_or_group_B
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
. NE . NE

The NE Xxx NE
measured NE xxx NE
binding NE xxx NE
to NE xx NE
a NE x NE
TCF-1 G#DNA_domain_or_region_B XXX-d G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
is NE xx NE
the NE xxx NE
same NE xxx NE
in NE xx NE
the NE xxx NE
nuclei G#cell_component xxx G#cell_component
of NE xx NE
resting G#cell_type_B xxx G#cell_type_B
cell G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
activated G#cell_type_M xxx G#cell_type_M
cell G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
anergized G#cell_type_M xxx G#cell_type_M
cell G#cell_type_E xxx G#cell_type_E

The NE Xxx NE
inducible G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
NK-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
, NE , NE
beta G#protein_family_or_group_B xxx G#protein_family_or_group_B
E2 G#protein_family_or_group_E Xd G#protein_family_or_group_E
, NE , NE
CD28RC G#protein_molecule XXddXX G#protein_molecule
, NE , NE
and NE xxx NE
AP-1 G#protein_molecule XX-d G#protein_molecule
are NE xxx NE
not NE xxx NE
expressed NE xxx NE
in NE xx NE
resting G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
and NE xxx NE
are NE xxx NE
twofold NE xxx NE
lower NE xxx NE
in NE xx NE
anergized NE xxx NE
as NE xx NE
compared NE xxx NE
with NE xxx NE
activated NE xxx NE
cells NE xxx NE
. NE . NE

In NE Xx NE
contrast NE xxx NE
, NE , NE
anergic G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
express NE xxx NE
approximately NE xxx NE
eightfold NE xxx NE
lower NE xxx NE
amounts NE xxx NE
of NE xx NE
NF-AT G#protein_family_or_group XX-XX G#protein_family_or_group
, NE , NE
a NE x NE
member NE xxx NE
of NE xx NE
the NE xxx NE
class NE xxx NE
of NE xx NE
inducible G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
that NE xxx NE
regulates NE xxx NE
IL-2 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
transcription NE xxx NE
. NE . NE

(ABSTRACT NE (XXXXXXXX NE
TRUNCATED NE XXXXXXXXX NE
AT NE XX NE
250 NE ddd NE
WORDS) NE XXXXX) NE

The NE Xxx NE
number NE xxx NE
of NE xx NE
glucocorticoid G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
in NE xx NE
peripheral G#cell_type_B xxx G#cell_type_B
human G#cell_type_M xxx G#cell_type_M
lymphocytes G#cell_type_E xxx G#cell_type_E
is NE xx NE
elevated NE xxx NE
by NE xx NE
a NE x NE
zinc G#other_name_B xxx G#other_name_B
containing G#other_name_M xxx G#other_name_M
trace G#other_name_M xxx G#other_name_M
element G#other_name_M xxx G#other_name_M
preparation G#other_name_E xxx G#other_name_E
. NE . NE

A NE X NE
trace G#other_name_B xxx G#other_name_B
element G#other_name_M xxx G#other_name_M
preparation G#other_name_E xxx G#other_name_E
( NE ( NE
Beres G#other_name_B Xxxx G#other_name_B
Drops G#other_name_M Xxxx G#other_name_M
Plus G#other_name_E Xxxx G#other_name_E
, NE , NE
BDP G#other_name XXX G#other_name
) NE ) NE
elevates NE xxx NE
the NE xxx NE
number NE xxx NE
of NE xx NE
glucocorticoid G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
gcR G#protein_family_or_group xxX G#protein_family_or_group
) NE ) NE
in NE xx NE
peripheral G#cell_type_B xxx G#cell_type_B
lymphocytes G#cell_type_E xxx G#cell_type_E
isolated NE xxx NE
both NE xxx NE
from NE xxx NE
healthy G#multi_cell_B xxx G#multi_cell_B
blood G#multi_cell_M xxx G#multi_cell_M
donors G#multi_cell_E xxx G#multi_cell_E
and NE xxx NE
rheumatoid G#multi_cell_B xxx G#multi_cell_B
arthritis G#multi_cell_M xxx G#multi_cell_M
patients G#multi_cell_E xxx G#multi_cell_E
. NE . NE

This NE Xxxx NE
enhancement NE xxx NE
by NE xx NE
BDP G#other_name XXX G#other_name
was NE xxx NE
found NE xxx NE
either NE xxx NE
for NE xxx NE
constitutive NE xxx NE
expression NE xxx NE
of NE xx NE
gcRs G#protein_family_or_group xxXx G#protein_family_or_group
or NE xx NE
in NE xx NE
experiments NE xxx NE
when NE xxx NE
the NE xxx NE
lymphocytes G#cell_type xxx G#cell_type
were NE xxx NE
stimulated NE xxx NE
by NE xx NE
interleukin G#protein_molecule_B xxx G#protein_molecule_B
(IL)-6 G#protein_molecule_E (XX)-d G#protein_molecule_E
. NE . NE

There NE Xxxx NE
was NE xxx NE
no NE xx NE
significant NE xxx NE
effect NE xxx NE
of NE xx NE
BDP G#other_name XXX G#other_name
on NE xx NE
IL-1-induced G#other_name_B XX-d-xxx G#other_name_B
change G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
tumour G#other_name_M xxx G#other_name_M
necrosis G#other_name_M xxx G#other_name_M
factor G#other_name_M xxx G#other_name_M
alpha G#other_name_M xxx G#other_name_M
(TNF G#other_name_M (XXX G#other_name_M
alpha)-induced G#other_name_M xxx)-xxx G#other_name_M
change G#other_name_E xxx G#other_name_E
of NE xx NE
gcRs G#protein_family_or_group xxXx G#protein_family_or_group
. NE . NE

The NE Xxx NE
effect NE xxx NE
of NE xx NE
BDP G#other_name XXX G#other_name
was NE xxx NE
greatly NE xxx NE
dependent NE xxx NE
on NE xx NE
the NE xxx NE
presence NE xxx NE
of NE xx NE
Zn++ G#atom_B Xx++ G#atom_B
ions G#atom_E xxx G#atom_E
in NE xx NE
the NE xxx NE
preparation NE xxx NE
, NE , NE
since NE xxx NE
the NE xxx NE
augmenting NE xxx NE
effect NE xxx NE
was NE xxx NE
abolished NE xxx NE
if NE xx NE
BDP G#other_name XXX G#other_name
did NE xxx NE
not NE xxx NE
contain NE xxx NE
zinc G#atom xxx G#atom
. NE . NE

The NE Xxx NE
DNA NE XXX NE
and NE xxx NE
steroid G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
binding G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
domains G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
of NE xx NE
the NE xxx NE
glucocorticoid G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
are NE xxx NE
not NE xxx NE
altered NE xxx NE
in NE xx NE
mononuclear G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
of NE xx NE
treated G#multi_cell_B xxx G#multi_cell_B
CLL G#multi_cell_M XXX G#multi_cell_M
patients G#multi_cell_E xxx G#multi_cell_E
. NE . NE

The NE Xxx NE
aim NE xxx NE
of NE xx NE
this NE xxx NE
study NE xxx NE
was NE xxx NE
to NE xx NE
investigate NE xxx NE
whether NE xxx NE
mutations NE xxx NE
in NE xx NE
the NE xxx NE
glucocorticoid G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
could NE xxx NE
account NE xxx NE
for NE xxx NE
the NE xxx NE
increasing NE xxx NE
unresponsiveness NE xxx NE
of NE xx NE
patients G#multi_cell xxx G#multi_cell
with NE xxx NE
chronic G#other_name_B xxx G#other_name_B
lymphatic G#other_name_M xxx G#other_name_M
leukemia G#other_name_E xxx G#other_name_E
( NE ( NE
CLL G#other_name XXX G#other_name
) NE ) NE
to NE xx NE
combination G#other_name_B xxx G#other_name_B
chemotherapy G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
receptor NE xxx NE
was NE xxx NE
tested NE xxx NE
immunocytochemically NE xxx NE
, NE , NE
in NE xx NE
steroid G#other_name_B xxx G#other_name_B
binding G#other_name_M xxx G#other_name_M
assays G#other_name_E xxx G#other_name_E
, NE , NE
and NE xxx NE
by NE xx NE
a NE x NE
mutation NE xxx NE
screening NE xxx NE
( NE ( NE
denaturing G#other_name_B xxx G#other_name_B
gradient G#other_name_M xxx G#other_name_M
gel G#other_name_M xxx G#other_name_M
electrophoresis G#other_name_E xxx G#other_name_E
) NE ) NE
of NE xx NE
the NE xxx NE
receptor-cDNA G#protein_complex xxx-xXXX G#protein_complex
. NE . NE

The NE Xxx NE
receptor G#other_name_B xxx G#other_name_B
concentration G#other_name_E xxx G#other_name_E
, NE , NE
as NE xx NE
measured NE xxx NE
by NE xx NE
staining NE xxx NE
and NE xxx NE
steroid G#other_name_B xxx G#other_name_B
binding G#other_name_M xxx G#other_name_M
test G#other_name_E xxx G#other_name_E
, NE , NE
varied NE xxx NE
considerably NE xxx NE
but NE xxx NE
showed NE xxx NE
no NE xx NE
clear NE xxx NE
correlation NE xxx NE
to NE xx NE
clinical NE xxx NE
response NE xxx NE
. NE . NE

Using NE Xxxx NE
a NE x NE
highly NE xxx NE
sensitive NE xxx NE
mutation G#other_name_B xxx G#other_name_B
screening G#other_name_M xxx G#other_name_M
assay G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
DNA-binding G#protein_domain_or_region_B XXX-xxx G#protein_domain_or_region_B
region G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
and G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
the G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
steroid-binding G#protein_domain_or_region_M xxx-xxx G#protein_domain_or_region_M
region G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
patients NE xxx NE
revealed NE xxx NE
any NE xxx NE
mutation NE xxx NE
, NE , NE
suggesting NE xxx NE
that NE xxx NE
the NE xxx NE
glucocorticoid G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
in NE xx NE
the NE xxx NE
CLL G#other_name XXX G#other_name
patients NE xxx NE
tested NE xxx NE
is NE xx NE
not NE xxx NE
altered NE xxx NE
in NE xx NE
these NE xxx NE
domains NE xxx NE
. NE . NE

In NE Xx NE
one NE xxx NE
individual NE xxx NE
who NE xxx NE
had NE xxx NE
not NE xxx NE
been NE xxx NE
treated NE xxx NE
before NE xxx NE
analysis NE xxx NE
a NE x NE
silent G#other_name_B xxx G#other_name_B
mutation G#other_name_E xxx G#other_name_E
was NE xxx NE
found NE xxx NE
in NE xx NE
one NE xxx NE
receptor G#other_name_B xxx G#other_name_B
allele G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
results NE xxx NE
suggest NE xxx NE
that NE xxx NE
mechanisms NE xxx NE
other NE xxx NE
than NE xxx NE
altered NE xxx NE
ligand NE xxx NE
or NE xx NE
DNA NE XXX NE
binding NE xxx NE
of NE xx NE
the NE xxx NE
receptor NE xxx NE
may NE xxx NE
be NE xx NE
responsible NE xxx NE
for NE xxx NE
the NE xxx NE
lack NE xxx NE
of NE xx NE
response NE xxx NE
to NE xx NE
chemotherapy G#other_name xxx G#other_name
. NE . NE

This NE Xxxx NE
conclusion NE xxx NE
is NE xx NE
discussed NE xxx NE
in NE xx NE
relation NE xxx NE
to NE xx NE
the NE xxx NE
mechanism NE xxx NE
of NE xx NE
corticoid G#other_name_B xxx G#other_name_B
resistance G#other_name_E xxx G#other_name_E
in NE xx NE
mouse G#cell_line_B xxx G#cell_line_B
lymphoma G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
and G#cell_line_M xxx G#cell_line_M
human G#cell_line_M xxx G#cell_line_M
lymphoma G#cell_line_M xxx G#cell_line_M
cell G#cell_line_E xxx G#cell_line_E

An NE Xx NE
AP1 G#DNA_domain_or_region_B XXd G#DNA_domain_or_region_B
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
upstream NE xxx NE
of NE xx NE
the NE xxx NE
kappa G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
immunoglobulin G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
intron G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
enhancer G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
binds NE xxx NE
inducible G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
and NE xxx NE
contributes NE xxx NE
to NE xx NE
expression NE xxx NE
. NE . NE

Expression NE Xxxx NE
of NE xx NE
the NE xxx NE
kappa G#DNA_substructure_B xxx G#DNA_substructure_B
immunoglobulin G#DNA_substructure_M xxx G#DNA_substructure_M
light G#DNA_substructure_M xxx G#DNA_substructure_M
chain G#DNA_substructure_M xxx G#DNA_substructure_M
gene G#DNA_substructure_E xxx G#DNA_substructure_E
requires NE xxx NE
developmental- NE xxx- NE
and NE xxx NE
tissue-specific NE xxx-xxx NE
regulation NE xxx NE
by NE xx NE
trans-acting G#protein_family_or_group_B xxx-xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
which NE xxx NE
interact NE xxx NE
with NE xxx NE
two NE xxx NE
distinct NE xxx NE
enhancer G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
elements G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
. NE . NE

A NE X NE
new NE xxx NE
protein-DNA G#other_name_B xxx-XXX G#other_name_B
interaction G#other_name_E xxx G#other_name_E
has NE xxx NE
been NE xxx NE
identified NE xxx NE
upstream NE xxx NE
of NE xx NE
the NE xxx NE
intron G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
enhancer G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
within NE xxx NE
the NE xxx NE
matrix-associated G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
the NE xxx NE
J-C G#DNA_domain_or_region_B X-X G#DNA_domain_or_region_B
intron G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

The NE Xxx NE
binding G#other_name_B xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
is NE xx NE
greatly NE xxx NE
inducible NE xxx NE
in NE xx NE
pre-B G#cell_type_B xxx-X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
by NE xx NE
bacterial G#lipid_B xxx G#lipid_B
lipopolysaccharide G#lipid_E xxx G#lipid_E
and NE xxx NE
interleukin-1 G#protein_molecule xxx-d G#protein_molecule
but NE xxx NE
specific NE xxx NE
complexes NE xxx NE
are NE xxx NE
found NE xxx NE
at NE xx NE
all NE xxx NE
stages NE xxx NE
of NE xx NE
B G#other_name_B X G#other_name_B
cell G#other_name_M xxx G#other_name_M
development G#other_name_E xxx G#other_name_E
tested NE xxx NE
. NE . NE

The NE Xxx NE
footprinted G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
is NE xx NE
homologous NE xxx NE
to NE xx NE
the NE xxx NE
consensus G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
AP1 G#DNA_domain_or_region_M XXd G#DNA_domain_or_region_M
motif G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

The NE Xxx NE
protein NE xxx NE
components NE xxx NE
of NE xx NE
this NE xxx NE
complex NE xxx NE
are NE xxx NE
specifically NE xxx NE
competed NE xxx NE
by NE xx NE
an NE xx NE
AP1 G#DNA_domain_or_region_B XXd G#DNA_domain_or_region_B
consensus G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
motif G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
were NE xxx NE
shown NE xxx NE
by NE xx NE
supershift NE xxx NE
to NE xx NE
include NE xxx NE
c-Jun G#protein_molecule x-Xxx G#protein_molecule
and NE xxx NE
c-Fos G#protein_molecule x-Xxx G#protein_molecule
, NE , NE
suggesting NE xxx NE
that NE xxx NE
this NE xxx NE
binding G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
is NE xx NE
an NE xx NE
AP1 G#DNA_domain_or_region_B XXd G#DNA_domain_or_region_B
motif G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
that NE xxx NE
the NE xxx NE
Jun G#protein_family_or_group_B Xxx G#protein_family_or_group_B
family G#protein_family_or_group_M xxx G#protein_family_or_group_M
and G#protein_family_or_group_M xxx G#protein_family_or_group_M
Fos G#protein_family_or_group_M Xxx G#protein_family_or_group_M
family G#protein_family_or_group_E xxx G#protein_family_or_group_E
families NE xxx NE
of NE xx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
play NE xxx NE
a NE x NE
role NE xxx NE
in NE xx NE
the NE xxx NE
regulation NE xxx NE
of NE xx NE
the NE xxx NE
kappa G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
light G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
chain G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Mutation NE Xxxx NE
of NE xx NE
the NE xxx NE
AP1 G#DNA_domain_or_region_B XXd G#DNA_domain_or_region_B
motif G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
the NE xxx NE
context NE xxx NE
of NE xx NE
the NE xxx NE
intron G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
enhancer G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
was NE xxx NE
shown NE xxx NE
to NE xx NE
decrease NE xxx NE
enhancer-mediated G#other_name_B xxx-xxx G#other_name_B
activation G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
promoter NE xxx NE
in NE xx NE
both NE xxx NE
pre-B G#cell_type_B xxx-X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
induced NE xxx NE
with NE xxx NE
LPS NE XXX NE
and NE xxx NE
constitutive NE xxx NE
expression NE xxx NE
in NE xx NE
mature G#cell_type_B xxx G#cell_type_B
B G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Distinct NE Xxxx NE
DNase-I G#DNA_domain_or_region_B XXxxx-X G#DNA_domain_or_region_B
hypersensitive G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
are NE xxx NE
associated NE xxx NE
with NE xxx NE
TAL-1 G#other_name_B XXX-d G#other_name_B
transcription G#other_name_E xxx G#other_name_E
in NE xx NE
erythroid G#cell_line_B xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_M xxx G#cell_line_M
and G#cell_line_M xxx G#cell_line_M
T-cell G#cell_line_M X-xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E

The NE Xxx NE
tal-1 G#DNA_domain_or_region_B xxx-d G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
frequently NE xxx NE
activated NE xxx NE
in NE xx NE
human G#other_name_B xxx G#other_name_B
T-cell G#other_name_M X-xxx G#other_name_M
acute G#other_name_M xxx G#other_name_M
lymphoblastic G#other_name_M xxx G#other_name_M
leukemia G#other_name_E xxx G#other_name_E
( NE ( NE
T-ALL G#other_name X-XXX G#other_name
) NE ) NE
, NE , NE
is NE xx NE
expressed NE xxx NE
in NE xx NE
the NE xxx NE
erythroid G#cell_type_B xxx G#cell_type_B
cell G#cell_type_M xxx G#cell_type_M
lineage G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
megakaryocytic G#cell_type_M xxx G#cell_type_M
cell G#cell_type_M xxx G#cell_type_M
lineage G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
mast G#cell_type_M xxx G#cell_type_M
cell G#cell_type_M xxx G#cell_type_M
lineage G#cell_type_E xxx G#cell_type_E
during NE xxx NE
normal G#other_name_B xxx G#other_name_B
hematopoiesis G#other_name_E xxx G#other_name_E
. NE . NE

To NE Xx NE
gain NE xxx NE
further NE xxx NE
insight NE xxx NE
into NE xxx NE
the NE xxx NE
molecular NE xxx NE
mechanisms NE xxx NE
that NE xxx NE
control NE xxx NE
tal-1 G#other_name_B xxx-d G#other_name_B
expression G#other_name_E xxx G#other_name_E
, NE , NE
we NE xx NE
investigated NE xxx NE
tal-1 G#DNA_substructure_B xxx-d G#DNA_substructure_B
chromatin G#DNA_substructure_M xxx G#DNA_substructure_M
structure G#DNA_substructure_E xxx G#DNA_substructure_E
in NE xx NE
erythroid/megakaryocytic G#cell_line_B xxx/xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
and NE xxx NE
in NE xx NE
T-cell G#cell_line_B X-xxx G#cell_line_B
lines G#cell_line_E xxx G#cell_line_E
either NE xxx NE
with NE xxx NE
or NE xx NE
without NE xxx NE
tal-1 G#DNA_domain_or_region_B xxx-d G#DNA_domain_or_region_B
rearrangements G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Tal-1 NE Xxx-d NE
transcription NE xxx NE
was NE xxx NE
shown NE xxx NE
to NE xx NE
be NE xx NE
monoallelic NE xxx NE
in NE xx NE
Jurkat G#cell_line Xxxx G#cell_line
, NE , NE
a NE x NE
T-cell NE X-xxx NE
line NE xxx NE
that NE xxx NE
expresses NE xxx NE
tal-1 G#DNA_domain_or_region xxx-d G#DNA_domain_or_region
in NE xx NE
the NE xxx NE
absence NE xxx NE
of NE xx NE
apparent NE xxx NE
genomic NE xxx NE
alteration NE xxx NE
of NE xx NE
the NE xxx NE
locus NE xxx NE
. NE . NE

Methylation NE Xxxx NE
studies NE xxx NE
indicated NE xxx NE
that NE xxx NE
the NE xxx NE
tal-15' NE xxx-dd' NE
GC-rich NE XX-xxx NE
region NE xxx NE
behaves NE xxx NE
like NE xxx NE
a NE x NE
CpG NE XxX NE
island NE xxx NE
, NE , NE
hypomethylated NE xxx NE
in NE xx NE
normal NE xxx NE
cells NE xxx NE
, NE , NE
and NE xxx NE
methylated NE xxx NE
de NE xx NE
novo NE xxx NE
on NE xx NE
transcriptionally NE xxx NE
inactive NE xxx NE
alleles NE xxx NE
in NE xx NE
established NE xxx NE
cell NE xxx NE
lines NE xxx NE
. NE . NE

Five NE Xxxx NE
major NE xxx NE
DNase-I G#DNA_domain_or_region_B XXxxx-X G#DNA_domain_or_region_B
hypersensitive G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
HS G#DNA_domain_or_region XX G#DNA_domain_or_region
) NE ) NE
were NE xxx NE
mapped NE xxx NE
in NE xx NE
the NE xxx NE
tal-1 G#DNA_domain_or_region xxx-d G#DNA_domain_or_region
locus NE xxx NE
. NE . NE

HS G#DNA_domain_or_region_B XX G#DNA_domain_or_region_B
I G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
HS G#DNA_domain_or_region_M XX G#DNA_domain_or_region_M
IV G#DNA_domain_or_region_M XX G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
HS G#DNA_domain_or_region_M XX G#DNA_domain_or_region_M
V G#DNA_domain_or_region_E X G#DNA_domain_or_region_E
were NE xxx NE
exclusively NE xxx NE
observed NE xxx NE
in NE xx NE
the NE xxx NE
erythroid/megakaryocytic G#cell_line_B xxx/xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
that NE xxx NE
express NE xxx NE
tal-1 G#DNA_domain_or_region xxx-d G#DNA_domain_or_region
from NE xxx NE
the NE xxx NE
promoters NE xxx NE
promoter G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
1a G#DNA_domain_or_region_M dx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
1b G#DNA_domain_or_region_E dx G#DNA_domain_or_region_E

HS G#DNA_domain_or_region_B XX G#DNA_domain_or_region_B
II G#DNA_domain_or_region_E XX G#DNA_domain_or_region_E
was NE xxx NE
weak NE xxx NE
in NE xx NE
hematopoietic G#cell_line_B xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
, NE , NE
absent NE xxx NE
in NE xx NE
Hela G#cell_line Xxxx G#cell_line
, NE , NE
and NE xxx NE
greatly NE xxx NE
enhanced NE xxx NE
in NE xx NE
Jurkat G#cell_line Xxxx G#cell_line
, NE , NE
suggesting NE xxx NE
that NE xxx NE
this NE xxx NE
region NE xxx NE
might NE xxx NE
be NE xx NE
implicated NE xxx NE
in NE xx NE
the NE xxx NE
cis-activation NE xxx-xxx NE
of NE xx NE
tal-1 G#DNA_domain_or_region_B xxx-d G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
1b G#DNA_domain_or_region_E dx G#DNA_domain_or_region_E
in NE xx NE
this NE xxx NE
cell NE xxx NE
line NE xxx NE
. NE . NE

HS G#DNA_domain_or_region_B XX G#DNA_domain_or_region_B
III G#DNA_domain_or_region_E XXX G#DNA_domain_or_region_E
was NE xxx NE
weak NE xxx NE
in NE xx NE
HEL G#cell_line XXX G#cell_line
and NE xxx NE
Jurkat G#cell_line Xxxx G#cell_line
, NE , NE
and NE xxx NE
greatly NE xxx NE
enhanced NE xxx NE
in NE xx NE
DU528 G#cell_line XXddd G#cell_line
, NE , NE
a NE x NE
T-cell G#cell_line_B X-xxx G#cell_line_B
line G#cell_line_E xxx G#cell_line_E
that NE xxx NE
bears NE xxx NE
a G#DNA_domain_or_region_B x G#DNA_domain_or_region_B
t G#DNA_domain_or_region_M x G#DNA_domain_or_region_M
(1;14) G#DNA_domain_or_region_E (d;dd) G#DNA_domain_or_region_E
and NE xxx NE
initiates NE xxx NE
tal-1 G#other_name_B xxx-d G#other_name_B
transcription G#other_name_E xxx G#other_name_E
within NE xxx NE
exon G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
4 G#DNA_domain_or_region_E d G#DNA_domain_or_region_E
. NE . NE

These NE Xxxx NE
results NE xxx NE
suggest NE xxx NE
that NE xxx NE
distinct NE xxx NE
regulatory G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
elements G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
are NE xxx NE
associated NE xxx NE
with NE xxx NE
the NE xxx NE
use NE xxx NE
of NE xx NE
the NE xxx NE
different NE xxx NE
tal-1 G#DNA_domain_or_region_B xxx-d G#DNA_domain_or_region_B
promoters G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Erythropoietin NE Xxxx NE
-dependent NE -xxx NE
induction NE xxx NE
of NE xx NE
hemoglobin NE xxx NE
synthesis NE xxx NE
in NE xx NE
a NE x NE
cytokine NE xxx NE
-dependent NE -xxx NE
cell NE xxx NE
line NE xxx NE
M-TAT NE X-XXX NE
. NE . NE

M-TAT G#cell_line X-XXX G#cell_line
is NE xx NE
a NE x NE
cytokine G#cell_line xxx G#cell_line
-dependent NE -xxx NE
cell NE xxx NE
line NE xxx NE
with NE xxx NE
the NE xxx NE
potential NE xxx NE
to NE xx NE
differentiate NE xxx NE
along NE xxx NE
the NE xxx NE
erythroid G#cell_type_B xxx G#cell_type_B
lineage G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
megakaryocytic G#cell_type_M xxx G#cell_type_M
lineage G#cell_type_E xxx G#cell_type_E

We NE Xx NE
cultured NE xxx NE
M-TAT G#cell_line_B X-XXX G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
long NE xxx NE
term NE xxx NE
(> NE (> NE
1 NE d NE
year) NE xxx) NE
in NE xx NE
the NE xxx NE
continuous NE xxx NE
presence NE xxx NE
of NE xx NE
erythropoietin G#protein_molecule xxx G#protein_molecule
( NE ( NE
EPO G#protein_molecule XXX G#protein_molecule
) NE ) NE
, NE , NE
granulocyte-macrophage G#protein_molecule_B xxx-xxx G#protein_molecule_B
colony-stimulating G#protein_molecule_M xxx-xxx G#protein_molecule_M
factor G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
GM-CSF G#protein_molecule XX-XXX G#protein_molecule
) NE ) NE
, NE , NE
or NE xx NE
stem G#protein_molecule_B xxx G#protein_molecule_B
cell G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
SCF G#protein_molecule XXX G#protein_molecule
) NE ) NE
. NE . NE

These NE Xxxx NE
long NE xxx NE
term NE xxx NE
cultures NE xxx NE
are NE xxx NE
referred NE xxx NE
to NE xx NE
as NE xx NE
M-TAT/EPO G#cell_line_B X-XXX/XXX G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
and G#cell_line_M xxx G#cell_line_M
M-TAT/GM-CSF G#cell_line_M X-XXX/XX-XXX G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
and G#cell_line_M xxx G#cell_line_M
M-TAT/SCF G#cell_line_M X-XXX/XXX G#cell_line_M
cell G#cell_line_E xxx G#cell_line_E

Hemoglobin G#other_name_B Xxxx G#other_name_B
concentration G#other_name_E xxx G#other_name_E
and NE xxx NE
gamma-globin G#protein_family_or_group xxx-xxx G#protein_family_or_group
and NE xxx NE
erythroid G#other_name_B xxx G#other_name_B
delta-aminolevulinate G#other_name_M xxx-xxx G#other_name_M
synthase G#other_name_M xxx G#other_name_M
mRNA G#other_name_M xXXX G#other_name_M
levels G#other_name_E xxx G#other_name_E
were NE xxx NE
significantly NE xxx NE
higher NE xxx NE
in NE xx NE
M-TAT/EPO G#cell_line_B X-XXX/XXX G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
than NE xxx NE
in NE xx NE
M-TAT/GM-CSF G#cell_line_B X-XXX/XX-XXX G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

When NE Xxxx NE
the NE xxx NE
supplemented NE xxx NE
cytokine G#protein_family_or_group xxx G#protein_family_or_group
was NE xxx NE
switched NE xxx NE
from NE xxx NE
GM-CSF G#protein_molecule XX-XXX G#protein_molecule
to NE xx NE
EPO G#protein_molecule XXX G#protein_molecule
, NE , NE
hemoglobin G#other_name_B xxx G#other_name_B
synthesis G#other_name_E xxx G#other_name_E
in NE xx NE
M-TAT/GM-CSF G#cell_line_B X-XXX/XX-XXX G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
increased NE xxx NE
rapidly NE xxx NE
(within NE (xxx NE
5 NE d NE
h) NE x) NE
, NE , NE
and NE xxx NE
the NE xxx NE
level NE xxx NE
of NE xx NE
GATA-1 G#RNA_molecule_B XXXX-d G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
increased NE xxx NE
. NE . NE

In NE Xx NE
contrast NE xxx NE
, NE , NE
the NE xxx NE
addition NE xxx NE
of NE xx NE
GM-CSF G#protein_molecule XX-XXX G#protein_molecule
to NE xx NE
the NE xxx NE
M-TAT/EPO G#cell_line_B X-XXX/XXX G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
culture G#cell_line_E xxx G#cell_line_E
decreased NE xxx NE
the NE xxx NE
amount NE xxx NE
of NE xx NE
hemoglobin NE xxx NE
, NE , NE
even NE xxx NE
in NE xx NE
the NE xxx NE
presence NE xxx NE
of NE xx NE
EPO G#protein_molecule XXX G#protein_molecule
, NE , NE
indicating NE xxx NE
that NE xxx NE
the NE xxx NE
EPO G#protein_molecule XXX G#protein_molecule
signal NE xxx NE
for NE xxx NE
erythroid G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
is NE xx NE
suppressed NE xxx NE
by NE xx NE
GM-CSF G#protein_molecule XX-XXX G#protein_molecule
. NE . NE

Thus NE Xxxx NE
, NE , NE
erythroid NE xxx NE
development NE xxx NE
of NE xx NE
M-TAT G#cell_line_B X-XXX G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
is NE xx NE
promoted NE xxx NE
by NE xx NE
EPO G#protein_molecule XXX G#protein_molecule
and NE xxx NE
suppressed NE xxx NE
by NE xx NE
GM-CSF G#protein_molecule XX-XXX G#protein_molecule
. NE . NE

These NE Xxxx NE
results NE xxx NE
support NE xxx NE
the NE xxx NE
hypothesis NE xxx NE
that NE xxx NE
EPO G#protein_molecule XXX G#protein_molecule
actively NE xxx NE
influences NE xxx NE
the NE xxx NE
programming NE xxx NE
of NE xx NE
gene NE xxx NE
expression NE xxx NE
required NE xxx NE
for NE xxx NE
erythroid G#other_name_B xxx G#other_name_B
progenitor G#other_name_M xxx G#other_name_M
cell G#other_name_M xxx G#other_name_M
differentiation G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
role NE xxx NE
of NE xx NE
cellular G#protein_molecule_B xxx G#protein_molecule_B
transcription G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_M xxx G#protein_molecule_M
E2F G#protein_molecule_E XdX G#protein_molecule_E
in NE xx NE
the NE xxx NE
regulation NE xxx NE
of NE xx NE
cdc2 G#other_name_B xxxd G#other_name_B
mRNA G#other_name_M xXXX G#other_name_M
expression G#other_name_E xxx G#other_name_E
and NE xxx NE
cell G#other_name_B xxx G#other_name_B
cycle G#other_name_M xxx G#other_name_M
control G#other_name_E xxx G#other_name_E
of NE xx NE
human NE xxx NE
hematopoietic G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

cdc2 G#RNA_molecule_B xxxd G#RNA_molecule_B
mRNA G#RNA_molecule_M xXXX G#RNA_molecule_M
transcripts G#RNA_molecule_E xxx G#RNA_molecule_E
were NE xxx NE
detected NE xxx NE
in NE xx NE
immature G#cell_type_B xxx G#cell_type_B
bone G#cell_type_M xxx G#cell_type_M
marrow G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
and NE xxx NE
became NE xxx NE
undetectable NE xxx NE
along NE xxx NE
with NE xxx NE
differentiation NE xxx NE
. NE . NE

Peripheral G#cell_type_B Xxxx G#cell_type_B
blood G#cell_type_M xxx G#cell_type_M
resting G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
did NE xxx NE
not NE xxx NE
express NE xxx NE
cdc2 G#RNA_molecule_B xxxd G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
, NE , NE
but NE xxx NE
it NE xx NE
was NE xxx NE
induced NE xxx NE
in NE xx NE
T-lymphocytes G#cell_type X-xxx G#cell_type
when NE xxx NE
the NE xxx NE
cells NE xxx NE
reentered NE xxx NE
the NE xxx NE
cell G#other_name_B xxx G#other_name_B
cycle G#other_name_E xxx G#other_name_E
in NE xx NE
response NE xxx NE
to NE xx NE
specific NE xxx NE
mitogens G#other_organic_compound xxx G#other_organic_compound
. NE . NE

In NE Xx NE
contrast NE xxx NE
, NE , NE
cdc2 G#RNA_molecule_B xxxd G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
could NE xxx NE
not NE xxx NE
be NE xx NE
induced NE xxx NE
in NE xx NE
granulocytes G#cell_type xxx G#cell_type
and NE xxx NE
monocytes G#cell_type xxx G#cell_type
even NE xxx NE
after NE xxx NE
the NE xxx NE
culture NE xxx NE
with NE xxx NE
the NE xxx NE
appropriate NE xxx NE
stimulants NE xxx NE
. NE . NE

In NE Xx NE
order NE xxx NE
to NE xx NE
investigate NE xxx NE
the NE xxx NE
mechanism NE xxx NE
of NE xx NE
the NE xxx NE
regulation NE xxx NE
of NE xx NE
cdc2 G#other_name_B xxxd G#other_name_B
mRNA G#other_name_M xXXX G#other_name_M
expression G#other_name_E xxx G#other_name_E
in NE xx NE
hematopoietic G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
, NE , NE
we NE xx NE
isolated NE xxx NE
the NE xxx NE
5'-flanking G#DNA_domain_or_region_B d'-xxx G#DNA_domain_or_region_B
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
the NE xxx NE
cdc2 G#DNA_domain_or_region_B xxxd G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
found NE xxx NE
the NE xxx NE
putative NE xxx NE
E2F NE XdX NE
binding G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
at NE xx NE
the NE xxx NE
position NE xxx NE
of NE xx NE
nucleotides G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
-124 G#DNA_domain_or_region_M -ddd G#DNA_domain_or_region_M
to G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
-117 G#DNA_domain_or_region_E -ddd G#DNA_domain_or_region_E
. NE . NE

The NE Xxx NE
binding NE xxx NE
of NE xx NE
E2F G#protein_molecule XdX G#protein_molecule
at NE xx NE
this NE xxx NE
region NE xxx NE
was NE xxx NE
detected NE xxx NE
by NE xx NE
a NE x NE
gel-retardation G#other_name_B xxx-xxx G#other_name_B
assay G#other_name_E xxx G#other_name_E
and NE xxx NE
DNaseI G#other_name_B XXxxxX G#other_name_B
footprinting G#other_name_E xxx G#other_name_E
in NE xx NE
phytohemagglutinin NE xxx NE
-stimulated NE -xxx NE
T-lymphocytes NE X-xxx NE
, NE , NE
which NE xxx NE
was NE xxx NE
coincident NE xxx NE
with NE xxx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
cdc2 NE xxxd NE
mRNA NE xXXX NE
. NE . NE

E2F G#other_name_B XdX G#other_name_B
binding G#other_name_E xxx G#other_name_E
was NE xxx NE
not NE xxx NE
observed NE xxx NE
in NE xx NE
both NE xxx NE
granulocytes G#cell_type xxx G#cell_type
and NE xxx NE
monocytes G#cell_type xxx G#cell_type
. NE . NE

Transient G#other_name_B Xxxx G#other_name_B
chloramphenicol G#other_name_M xxx G#other_name_M
acetyltransferase G#other_name_M xxx G#other_name_M
assay G#other_name_E xxx G#other_name_E
revealed NE xxx NE
that NE xxx NE
the NE xxx NE
region NE xxx NE
containing NE xxx NE
E2F G#DNA_domain_or_region_B XdX G#DNA_domain_or_region_B
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
had NE xxx NE
a NE x NE
strong NE xxx NE
promoter G#other_name_B xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
, NE , NE
and NE xxx NE
introduction NE xxx NE
of NE xx NE
the NE xxx NE
mutation G#other_name xxx G#other_name
at NE xx NE
the NE xxx NE
E2F G#DNA_domain_or_region_B XdX G#DNA_domain_or_region_B
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
resulted NE xxx NE
in NE xx NE
a NE x NE
significant NE xxx NE
loss NE xxx NE
of NE xx NE
the NE xxx NE
activity NE xxx NE
. NE . NE

E2F-1 G#RNA_molecule_B XdX-d G#RNA_molecule_B
mRNA G#RNA_molecule_M xXXX G#RNA_molecule_M
and G#RNA_molecule_M xxx G#RNA_molecule_M
DP-1 G#RNA_molecule_M XX-d G#RNA_molecule_M
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
were NE xxx NE
not NE xxx NE
detectable NE xxx NE
in NE xx NE
granulocytes G#cell_type xxx G#cell_type
, NE , NE
monocytes G#cell_type xxx G#cell_type
and NE xxx NE
resting G#cell_type_B xxx G#cell_type_B
T-lymphocytes G#cell_type_E X-xxx G#cell_type_E
but NE xxx NE
were NE xxx NE
induced NE xxx NE
after NE xxx NE
the NE xxx NE
mitogenic NE xxx NE
stimulation NE xxx NE
of NE xx NE
T-lymphocytes G#cell_type X-xxx G#cell_type
. NE . NE

The NE Xxx NE
induction NE xxx NE
of NE xx NE
E2F G#protein_molecule XdX G#protein_molecule
activity NE xxx NE
preceded NE xxx NE
the NE xxx NE
appearance NE xxx NE
of NE xx NE
cdc2 G#RNA_molecule_B xxxd G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
, NE , NE
which NE xxx NE
is NE xx NE
consistent NE xxx NE
with NE xxx NE
the NE xxx NE
role NE xxx NE
of NE xx NE
E2F G#protein_molecule XdX G#protein_molecule
in NE xx NE
the NE xxx NE
regulation NE xxx NE
of NE xx NE
cdc2 G#cell_type_B xxxd G#cell_type_B
mRNA G#cell_type_M xXXX G#cell_type_M
expression G#cell_type_E xxx G#cell_type_E
. NE . NE

These NE Xxxx NE
results NE xxx NE
suggest NE xxx NE
that NE xxx NE
cdc2 G#other_name_B xxxd G#other_name_B
mRNA G#other_name_M xXXX G#other_name_M
expression G#other_name_E xxx G#other_name_E
is NE xx NE
related NE xxx NE
to NE xx NE
the NE xxx NE
cell NE xxx NE
cycling NE xxx NE
of NE xx NE
normal G#cell_type_B xxx G#cell_type_B
human G#cell_type_M xxx G#cell_type_M
hematopoietic G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
and NE xxx NE
that NE xxx NE
E2F G#protein_molecule XdX G#protein_molecule
plays NE xxx NE
some NE xxx NE
roles NE xxx NE
in NE xx NE
the NE xxx NE
regulation NE xxx NE
of NE xx NE
its NE xxx NE
expression NE xxx NE
. NE . NE

Association NE Xxxx NE
of NE xx NE
alterations NE xxx NE
in NE xx NE
NF-kappa NE XX-xxx NE
B NE X NE
moieties NE xxx NE
with NE xxx NE
HIV NE XXX NE
type NE xxx NE
1 NE d NE
proviral NE xxx NE
latency NE xxx NE
in NE xx NE
certain NE xxx NE
monocytic NE xxx NE
cells NE xxx NE
. NE . NE

Human G#other_name_B Xxxx G#other_name_B
immunodeficiency G#other_name_M xxx G#other_name_M
virus G#other_name_M xxx G#other_name_M
type G#other_name_M xxx G#other_name_M
1 G#other_name_M d G#other_name_M
( G#other_name_E ( G#other_name_E
HIV-1 NE XXX-d NE
) NE ) NE
replication NE xxx NE
is NE xx NE
controlled NE xxx NE
by NE xx NE
a NE x NE
complex NE xxx NE
array NE xxx NE
of NE xx NE
virally G#protein_family_or_group_B xxx G#protein_family_or_group_B
encoded G#protein_family_or_group_M xxx G#protein_family_or_group_M
protein G#protein_family_or_group_M xxx G#protein_family_or_group_M
and G#protein_family_or_group_M xxx G#protein_family_or_group_M
cellular G#protein_family_or_group_M xxx G#protein_family_or_group_M
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E

A NE X NE
wide NE xxx NE
spectrum NE xxx NE
of NE xx NE
levels NE xxx NE
of NE xx NE
HIV-1 G#other_name_B XXX-d G#other_name_B
expression G#other_name_E xxx G#other_name_E
have NE xxx NE
been NE xxx NE
demonstrated NE xxx NE
in NE xx NE
various NE xxx NE
cells NE xxx NE
, NE , NE
both NE xxx NE
in NE xx NE
cell G#other_name_B xxx G#other_name_B
culture G#other_name_E xxx G#other_name_E
and NE xxx NE
in G#other_name_B xx G#other_name_B
vivo G#other_name_E xxx G#other_name_E
. NE . NE

Molecular NE Xxxx NE
mechanisms NE xxx NE
leading NE xxx NE
to NE xx NE
restricted NE xxx NE
HIV-1 G#other_name_B XXX-d G#other_name_B
replication G#other_name_E xxx G#other_name_E
may NE xxx NE
differ NE xxx NE
between NE xxx NE
certain NE xxx NE
cell NE xxx NE
types NE xxx NE
. NE . NE

It NE Xx NE
is NE xx NE
now NE xxx NE
demonstrated NE xxx NE
that NE xxx NE
HIV-1 G#other_name_B XXX-d G#other_name_B
proviral G#other_name_M xxx G#other_name_M
latency G#other_name_E xxx G#other_name_E
in NE xx NE
the NE xxx NE
monocytic G#cell_line_B xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_M xxx G#cell_line_M
U1 G#cell_line_E Xd G#cell_line_E
, NE , NE
in NE xx NE
which NE xxx NE
only NE xxx NE
extremely NE xxx NE
low NE xxx NE
levels NE xxx NE
of NE xx NE
HIV-1 G#other_name_B XXX-d G#other_name_B
expression G#other_name_E xxx G#other_name_E
are NE xxx NE
detected NE xxx NE
in NE xx NE
the NE xxx NE
baseline NE xxx NE
unstimulated NE xxx NE
state NE xxx NE
, NE , NE
is NE xx NE
associated NE xxx NE
with NE xxx NE
alterations NE xxx NE
in NE xx NE
nuclear NE xxx NE
factor-kappa NE xxx-xxx NE
B NE X NE
( NE ( NE
NF-kappa NE XX-xxx NE
B NE X NE
) NE ) NE
moieties NE xxx NE
demonstrated NE xxx NE
in NE xx NE
these NE xxx NE
cells NE xxx NE
by NE xx NE
electrophoretic NE xxx NE
mobility NE xxx NE
shift NE xxx NE
assays NE xxx NE
( NE ( NE
EMSAs NE XXXXx NE
) NE ) NE
and NE xxx NE
in NE xx NE
situ NE xxx NE
UV NE XX NE
cross-linking NE xxx-xxx NE
studies NE xxx NE
. NE . NE

A NE X NE
predominance NE xxx NE
of NE xx NE
p50 G#protein_family_or_group xdd G#protein_family_or_group
NF-kappa NE XX-xxx NE
B NE X NE
moieties NE xxx NE
and NE xxx NE
possibly NE xxx NE
p50 G#protein_complex_B xdd G#protein_complex_B
homodimers G#protein_complex_E xxx G#protein_complex_E
or NE xx NE
closely NE xxx NE
related NE xxx NE
species NE xxx NE
, NE , NE
rather NE xxx NE
than NE xxx NE
the NE xxx NE
p50-p56 G#protein_complex_B xdd-xdd G#protein_complex_B
heterodimer G#protein_complex_E xxx G#protein_complex_E
of NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
that NE xxx NE
is NE xx NE
the NE xxx NE
predominant NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
species NE xxx NE
in NE xx NE
most NE xxx NE
T G#cell_type_B X G#cell_type_B
lymphocytic G#cell_type_M xxx G#cell_type_M
cell G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
monocytic G#cell_type_M xxx G#cell_type_M
cell G#cell_type_E xxx G#cell_type_E
nuclei NE xxx NE
of NE xx NE
U1 G#cell_line_B Xd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

This NE Xxxx NE
pattern NE xxx NE
of NE xx NE
NF-kappa NE XX-xxx NE
B-related NE X-xxx NE
moieties NE xxx NE
differs NE xxx NE
from NE xxx NE
the NE xxx NE
latently NE xxx NE
infected NE xxx NE
T NE X NE
lymphocytic NE xxx NE
cell NE xxx NE
line NE xxx NE
ACH-2 NE XXX-d NE
, NE , NE
and NE xxx NE
from NE xxx NE
the NE xxx NE
U937 NE Xddd NE
monocytic NE xxx NE
line NE xxx NE
, NE , NE
the NE xxx NE
parental NE xxx NE
cell NE xxx NE
line NE xxx NE
of NE xx NE
the NE xxx NE
U1 NE Xd NE
cellular NE xxx NE
clone NE xxx NE
. NE . NE

As NE Xx NE
such NE xxx NE
, NE , NE
these NE xxx NE
data NE xxx NE
suggest NE xxx NE
that NE xxx NE
different NE xxx NE
proximal G#other_name_B xxx G#other_name_B
mechanisms G#other_name_E xxx G#other_name_E
may NE xxx NE
lead NE xxx NE
to NE xx NE
restricted NE xxx NE
HIV-1 G#other_name_B XXX-d G#other_name_B
replication G#other_name_E xxx G#other_name_E
in NE xx NE
various NE xxx NE
cell NE xxx NE
types NE xxx NE
. NE . NE

[Regulation NE [Xxxx NE
of NE xx NE
transcription G#other_name xxx G#other_name
of NE xx NE
the NE xxx NE
interleukin-2 G#DNA_domain_or_region_B xxx-d G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
B-lymphocytes G#cell_type X-xxx G#cell_type
] NE ] NE

Since NE Xxxx NE
most NE xxx NE
B G#cell_line_B X G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
clones G#cell_line_E xxx G#cell_line_E
immortalized NE xxx NE
with NE xxx NE
EBV G#virus_B XXX G#virus_B
virus G#virus_E xxx G#virus_E
can NE xxx NE
be NE xx NE
induced NE xxx NE
to NE xx NE
produce NE xxx NE
interleukin-2 G#protein_molecule xxx-d G#protein_molecule
, NE , NE
a NE x NE
typical NE xxx NE
T G#protein_molecule_B X G#protein_molecule_B
cell G#protein_molecule_M xxx G#protein_molecule_M
cytokine G#protein_molecule_E xxx G#protein_molecule_E
, NE , NE
we NE xx NE
studied NE xxx NE
the NE xxx NE
role NE xxx NE
of NE xx NE
different NE xxx NE
elements NE xxx NE
of NE xx NE
the NE xxx NE
IL-2 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
such NE xxx NE
clones NE xxx NE
by NE xx NE
transfection NE xxx NE
. NE . NE

It NE Xx NE
was NE xxx NE
found NE xxx NE
, NE , NE
in NE xx NE
particular NE xxx NE
, NE , NE
that NE xxx NE
the NE xxx NE
element NE xxx NE
TCEd G#DNA_domain_or_region XXXx G#DNA_domain_or_region
, NE , NE
which NE xxx NE
binds NE xxx NE
the NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
NF-kB G#protein_molecule XX-xX G#protein_molecule
, NE , NE
is NE xx NE
very NE xxx NE
active NE xxx NE
in NE xx NE
all NE xxx NE
three NE xxx NE
B G#cell_line_B X G#cell_line_B
clones G#cell_line_E xxx G#cell_line_E
tested NE xxx NE
. NE . NE

This NE Xxxx NE
element NE xxx NE
has NE xxx NE
no NE xx NE
activity NE xxx NE
in NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
of NE xx NE
the NE xxx NE
Jurkat G#cell_line_B Xxxx G#cell_line_B
line G#cell_line_E xxx G#cell_line_E
. NE . NE

The NE Xxx NE
NFATd G#DNA_domain_or_region_B XXXXx G#DNA_domain_or_region_B
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
which NE xxx NE
binds NE xxx NE
the NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
NFAT-1 G#protein_molecule XXXX-d G#protein_molecule
and NE xxx NE
is NE xx NE
very NE xxx NE
active NE xxx NE
in NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
, NE , NE
is NE xx NE
only NE xxx NE
weakly NE xxx NE
active NE xxx NE
in NE xx NE
one NE xxx NE
B G#cell_line_B X G#cell_line_B
clone G#cell_line_E xxx G#cell_line_E
and NE xxx NE
not NE xxx NE
at NE xx NE
all NE xxx NE
in NE xx NE
another NE xxx NE
. NE . NE

Different NE Xxxx NE
elements NE xxx NE
thus NE xxx NE
contribute NE xxx NE
to NE xx NE
IL-2 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
activity NE xxx NE
in NE xx NE
different NE xxx NE
cells NE xxx NE
. NE . NE

Regulation NE Xxxx NE
of NE xx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
and NE xxx NE
p105 G#protein_molecule xddd G#protein_molecule
in NE xx NE
monocytes G#cell_type xxx G#cell_type
and NE xxx NE
macrophages G#cell_type xxx G#cell_type
persistently NE xxx NE
infected NE xxx NE
with NE xxx NE
human G#virus_B xxx G#virus_B
immunodeficiency G#virus_M xxx G#virus_M
virus G#virus_E xxx G#virus_E
. NE . NE

The NE Xxx NE
mechanisms NE xxx NE
regulating NE xxx NE
human G#virus_B xxx G#virus_B
immunodeficiency G#virus_M xxx G#virus_M
virus G#virus_E xxx G#virus_E
( NE ( NE
HIV G#virus XXX G#virus
) NE ) NE
persistence NE xxx NE
in NE xx NE
human NE xxx NE
monocytes G#cell_type xxx G#cell_type
/macrophages NE /xxx NE
are NE xxx NE
partially NE xxx NE
understood NE xxx NE
. NE . NE

Persistent NE Xxxx NE
HIV G#other_name_B XXX G#other_name_B
infection G#other_name_E xxx G#other_name_E
of NE xx NE
U937 G#cell_line_B Xddd G#cell_line_B
monocytic G#cell_line_M xxx G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
results NE xxx NE
in NE xx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
activation G#other_name_E xxx G#other_name_E
. NE . NE

Whether NE Xxxx NE
virus-induced NE xxx-xxx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
activation G#other_name_E xxx G#other_name_E
is NE xx NE
a NE x NE
mechanism NE xxx NE
that NE xxx NE
favors NE xxx NE
continuous NE xxx NE
viral NE xxx NE
replication NE xxx NE
in NE xx NE
macrophages G#cell_type xxx G#cell_type
remains NE xxx NE
unknown NE xxx NE
. NE . NE

To NE Xx NE
further NE xxx NE
delineate NE xxx NE
the NE xxx NE
molecular NE xxx NE
mechanisms NE xxx NE
involved NE xxx NE
in NE xx NE
the NE xxx NE
activation NE xxx NE
of NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
in NE xx NE
HIV G#virus XXX G#virus
-infected NE -xxx NE
monocytes G#cell_type xxx G#cell_type
and NE xxx NE
macrophages G#cell_type xxx G#cell_type
, NE , NE
we NE xx NE
have NE xxx NE
focused NE xxx NE
on NE xx NE
the NE xxx NE
regulation NE xxx NE
of NE xx NE
the NE xxx NE
I NE X NE
kappa NE xxx NE
B NE X NE
molecules NE xxx NE
. NE . NE

First NE Xxxx NE
, NE , NE
we NE xx NE
show NE xxx NE
that NE xxx NE
persistent NE xxx NE
HIV G#virus XXX G#virus
infection NE xxx NE
results NE xxx NE
in NE xx NE
the NE xxx NE
activation NE xxx NE
of NE xx NE
NF-kappa NE XX-xxx NE
B NE X NE
not NE xxx NE
only NE xxx NE
in NE xx NE
monocytic NE xxx NE
cells NE xxx NE
but NE xxx NE
also NE xxx NE
in NE xx NE
macrophages G#cell_type xxx G#cell_type
. NE . NE

In NE Xx NE
HIV G#virus XXX G#virus
-infected NE -xxx NE
cells NE xxx NE
, NE , NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
protein NE xxx NE
levels NE xxx NE
are NE xxx NE
decreased NE xxx NE
secondary NE xxx NE
to NE xx NE
enhanced NE xxx NE
protein NE xxx NE
degradation NE xxx NE
. NE . NE

This NE Xxxx NE
parallels NE xxx NE
the NE xxx NE
increased NE xxx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
synthesis NE xxx NE
secondary NE xxx NE
to NE xx NE
increased NE xxx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
gene NE xxx NE
transcription NE xxx NE
, NE , NE
i.e. NE x.x. NE
, NE , NE
increased NE xxx NE
RNA NE XXX NE
and NE xxx NE
transcriptional NE xxx NE
activity NE xxx NE
of NE xx NE
its NE xxx NE
promoter-enhancer NE xxx-xxx NE
. NE . NE

Another NE Xxxx NE
protein NE xxx NE
with NE xxx NE
I NE X NE
kappa NE xxx NE
B NE X NE
function NE xxx NE
, NE , NE
p105 G#protein_molecule xddd G#protein_molecule
, NE , NE
is NE xx NE
also NE xxx NE
modified NE xxx NE
in NE xx NE
HIV G#virus XXX G#virus
-infected NE -xxx NE
cells NE xxx NE
: NE : NE
p105 G#protein_molecule xddd G#protein_molecule
and NE xxx NE
p50 G#protein_molecule xdd G#protein_molecule
steady-state G#other_name_B xxx-xxx G#other_name_B
protein G#other_name_M xxx G#other_name_M
levels G#other_name_E xxx G#other_name_E
are NE xxx NE
increased NE xxx NE
as NE xx NE
a NE x NE
result NE xxx NE
of NE xx NE
increased NE xxx NE
synthesis NE xxx NE
and NE xxx NE
proteolytic NE xxx NE
processing NE xxx NE
of NE xx NE
p105 G#protein_molecule xddd G#protein_molecule
. NE . NE

Transcriptional NE Xxxx NE
activity NE xxx NE
of NE xx NE
p105 G#protein_molecule xddd G#protein_molecule
is NE xx NE
also NE xxx NE
increased NE xxx NE
in NE xx NE
infected G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
and NE xxx NE
is NE xx NE
also NE xxx NE
mediated NE xxx NE
by NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
through NE xxx NE
a NE x NE
specific NE xxx NE
kappa G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
B G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
motif G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

These NE Xxxx NE
results NE xxx NE
demonstrate NE xxx NE
the NE xxx NE
existence NE xxx NE
of NE xx NE
a NE x NE
triple NE xxx NE
autoregulatory G#DNA_N/A_B xxx G#DNA_N/A_B
loop G#DNA_N/A_E xxx G#DNA_N/A_E
in NE xx NE
monocytes G#cell_type xxx G#cell_type
and NE xxx NE
macrophages G#cell_type xxx G#cell_type
involving NE xxx NE
HIV G#virus XXX G#virus
, NE , NE
p105 G#protein_molecule xddd G#protein_molecule
and NE xxx NE
p50 G#protein_molecule xdd G#protein_molecule
, NE , NE
and NE xxx NE
MAD3 G#protein_molecule XXXd G#protein_molecule
, NE , NE
with NE xxx NE
the NE xxx NE
end NE xxx NE
result NE xxx NE
of NE xx NE
persistent NE xxx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
activation G#other_name_E xxx G#other_name_E
and NE xxx NE
viral G#other_name_B xxx G#other_name_B
persistence G#other_name_E xxx G#other_name_E
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
persistent NE xxx NE
HIV G#virus XXX G#virus
infection NE xxx NE
of NE xx NE
monocytes G#cell_type xxx G#cell_type
and NE xxx NE
macrophages G#cell_type xxx G#cell_type
provides NE xxx NE
a NE x NE
useful NE xxx NE
model NE xxx NE
with NE xxx NE
which NE xxx NE
to NE xx NE
study NE xxx NE
concomitant NE xxx NE
modifications NE xxx NE
of NE xx NE
different NE xxx NE
I G#protein_family_or_group_B X G#protein_family_or_group_B
kappa G#protein_family_or_group_M xxx G#protein_family_or_group_M
B G#protein_family_or_group_M X G#protein_family_or_group_M
molecules G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Glucocorticoid NE Xxxx NE
-induced NE -xxx NE
apoptosis NE xxx NE
of NE xx NE
human NE xxx NE
leukemic NE xxx NE
cells NE xxx NE
is NE xx NE
caused NE xxx NE
by NE xx NE
the NE xxx NE
repressive NE xxx NE
function NE xxx NE
of NE xx NE
the NE xxx NE
glucocorticoid NE xxx NE
receptor NE xxx NE
. NE . NE

Induction NE Xxxx NE
of NE xx NE
apoptosis G#other_name xxx G#other_name
in NE xx NE
lymphocytes G#cell_type xxx G#cell_type
, NE , NE
which NE xxx NE
may NE xxx NE
account NE xxx NE
for NE xxx NE
the NE xxx NE
therapeutic NE xxx NE
effects NE xxx NE
of NE xx NE
glucocorticoids G#lipid xxx G#lipid
in NE xx NE
various NE xxx NE
diseases NE xxx NE
including NE xxx NE
leukemia G#other_name xxx G#other_name
, NE , NE
depends NE xxx NE
on NE xx NE
the NE xxx NE
glucocorticoid G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

However NE Xxxx NE
, NE , NE
the NE xxx NE
events NE xxx NE
leading NE xxx NE
from NE xxx NE
the NE xxx NE
activated NE xxx NE
receptor NE xxx NE
to NE xx NE
cell G#other_name_B xxx G#other_name_B
lysis G#other_name_E xxx G#other_name_E
are NE xxx NE
not NE xxx NE
understood NE xxx NE
. NE . NE

A NE X NE
prevailing NE xxx NE
hypothesis NE xxx NE
postulates NE xxx NE
induction NE xxx NE
of NE xx NE
so-called NE xx-xxx NE
' NE ' NE
lysis G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
' NE ' NE
by NE xx NE
the NE xxx NE
activated G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

In NE Xx NE
this NE xxx NE
study NE xxx NE
, NE , NE
we NE xx NE
show NE xxx NE
that NE xxx NE
an NE xx NE
activation-deficient G#protein_molecule_B xxx-xxx G#protein_molecule_B
glucocorticoid G#protein_molecule_M xxx G#protein_molecule_M
receptor G#protein_molecule_M xxx G#protein_molecule_M
mutant G#protein_molecule_E xxx G#protein_molecule_E
is NE xx NE
as NE xx NE
effective NE xxx NE
as NE xx NE
the NE xxx NE
wild-type G#protein_family_or_group_B xxx-xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
in NE xx NE
repression NE xxx NE
of NE xx NE
AP-1 G#other_name_B XX-d G#other_name_B
activity G#other_name_E xxx G#other_name_E
, NE , NE
inhibition NE xxx NE
of NE xx NE
interleukin-2 G#other_name_B xxx-d G#other_name_B
production G#other_name_E xxx G#other_name_E
, NE , NE
inhibition NE xxx NE
of NE xx NE
c-myc G#other_name_B x-xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
and NE xxx NE
induction NE xxx NE
of NE xx NE
apoptosis G#other_name xxx G#other_name
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
we NE xx NE
show NE xxx NE
that NE xxx NE
retinoic NE xxx NE
acid NE xxx NE
can NE xxx NE
also NE xxx NE
induce NE xxx NE
apoptosis G#other_name xxx G#other_name
in NE xx NE
these NE xxx NE
cells NE xxx NE
through NE xxx NE
the NE xxx NE
retinoic G#protein_family_or_group_B xxx G#protein_family_or_group_B
acid G#protein_family_or_group_M xxx G#protein_family_or_group_M
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
whose NE xxx NE
repressive NE xxx NE
functions NE xxx NE
but NE xxx NE
not NE xxx NE
target NE xxx NE
site NE xxx NE
specificity NE xxx NE
, NE , NE
are NE xxx NE
similar NE xxx NE
to NE xx NE
those NE xxx NE
of NE xx NE
the NE xxx NE
glucocorticoid G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Therefore NE Xxxx NE
, NE , NE
the NE xxx NE
primary NE xxx NE
effect NE xxx NE
of NE xx NE
the NE xxx NE
receptor NE xxx NE
in NE xx NE
glucocorticoid NE xxx NE
-mediated NE -xxx NE
apoptosis NE xxx NE
correlates NE xxx NE
with NE xxx NE
transcriptional NE xxx NE
repression NE xxx NE
rather NE xxx NE
than NE xxx NE
activation NE xxx NE
and NE xxx NE
could NE xxx NE
be NE xx NE
mediated NE xxx NE
by NE xx NE
interference NE xxx NE
with NE xxx NE
other NE xxx NE
transcription NE xxx NE
factors NE xxx NE
required NE xxx NE
for NE xxx NE
cell NE xxx NE
survival NE xxx NE
. NE . NE

HIV G#other_name_B XXX G#other_name_B
type G#other_name_M xxx G#other_name_M
1 G#other_name_M d G#other_name_M
protease G#other_name_M xxx G#other_name_M
activation G#other_name_E xxx G#other_name_E
of NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
within NE xxx NE
T G#cell_type_B X G#cell_type_B
lymphoid G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
is NE xx NE
a NE x NE
nuclear G#protein_family_or_group_B xxx G#protein_family_or_group_B
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
of NE xx NE
the NE xxx NE
rel G#protein_family_or_group_B xxx G#protein_family_or_group_B
oncogene G#protein_family_or_group_M xxx G#protein_family_or_group_M
family G#protein_family_or_group_E xxx G#protein_family_or_group_E
capable NE xxx NE
of NE xx NE
enhancing NE xxx NE
transcription NE xxx NE
of NE xx NE
several G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
cellular G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
, NE , NE
including NE xxx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
and NE xxx NE
the NE xxx NE
IL-2 G#protein_molecule_B XX-d G#protein_molecule_B
receptor G#protein_molecule_E xxx G#protein_molecule_E
, NE , NE
and NE xxx NE
viral G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
transcribed NE xxx NE
from NE xxx NE
the NE xxx NE
HIV-1 G#DNA_domain_or_region_B XXX-d G#DNA_domain_or_region_B
LTR G#DNA_domain_or_region_E XXX G#DNA_domain_or_region_E
. NE . NE

It NE Xx NE
has NE xxx NE
been NE xxx NE
reported NE xxx NE
that NE xxx NE
HIV-1 G#protein_molecule_B XXX-d G#protein_molecule_B
protease G#protein_molecule_E xxx G#protein_molecule_E
may NE xxx NE
cleave NE xxx NE
the NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
precursor NE xxx NE
to NE xx NE
its NE xxx NE
active NE xxx NE
form NE xxx NE
in NE xx NE
vitro NE xxx NE
. NE . NE

In NE Xx NE
this NE xxx NE
study NE xxx NE
the NE xxx NE
effects NE xxx NE
of NE xx NE
HIV G#virus XXX G#virus
protease NE xxx NE
on NE xx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
precursor G#other_name_M xxx G#other_name_M
activation G#other_name_E xxx G#other_name_E
were NE xxx NE
examined NE xxx NE
in NE xx NE
Jurkat NE Xxxx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
by NE xx NE
introducing NE xxx NE
a NE x NE
protease G#DNA_molecule_B xxx G#DNA_molecule_B
expression G#DNA_molecule_M xxx G#DNA_molecule_M
vector G#DNA_molecule_E xxx G#DNA_molecule_E
into NE xxx NE
the NE xxx NE
cells NE xxx NE
. NE . NE

Increased NE Xxxx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
activity G#other_name_E xxx G#other_name_E
was NE xxx NE
observed NE xxx NE
and NE xxx NE
this NE xxx NE
increased NE xxx NE
activity NE xxx NE
was NE xxx NE
blocked NE xxx NE
by NE xx NE
a NE x NE
specific NE xxx NE
inhibitor NE xxx NE
of NE xx NE
the NE xxx NE
viral G#protein_molecule_B xxx G#protein_molecule_B
protease G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

Viral NE Xxxx NE
transcription NE xxx NE
, NE , NE
as NE xx NE
measured NE xxx NE
using NE xxx NE
LTR NE XXX NE
-CAT NE -XXX NE
assays NE xxx NE
, NE , NE
was NE xxx NE
only NE xxx NE
slightly NE xxx NE
enhanced NE xxx NE
in NE xx NE
the NE xxx NE
HIV-protease NE XXX-xxx NE
expressing NE xxx NE
cells NE xxx NE
, NE , NE
while NE xxx NE
secretion NE xxx NE
of NE xx NE
IL-2 NE XX-d NE
and NE xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
IL-2 NE XX-d NE
receptor NE xxx NE
were NE xxx NE
not NE xxx NE
affected NE xxx NE
. NE . NE

The NE Xxx NE
limited NE xxx NE
activation NE xxx NE
of NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
by NE xx NE
HIV G#protein_molecule_B XXX G#protein_molecule_B
protease G#protein_molecule_E xxx G#protein_molecule_E
appears NE xxx NE
unlikely NE xxx NE
to NE xx NE
have NE xxx NE
a NE x NE
significant NE xxx NE
effect NE xxx NE
on NE xx NE
virus G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
or NE xx NE
T G#other_name_B X G#other_name_B
cell G#other_name_M xxx G#other_name_M
function G#other_name_E xxx G#other_name_E
. NE . NE

Inhibition NE Xxxx NE
of NE xx NE
human G#virus_B xxx G#virus_B
immunodeficiency G#virus_M xxx G#virus_M
virus G#virus_M xxx G#virus_M
type G#virus_M xxx G#virus_M
1 G#virus_E d G#virus_E
replication NE xxx NE
by NE xx NE
a NE x NE
Tat-activated, G#DNA_domain_or_region_B Xxx-xxx, G#DNA_domain_or_region_B
transduced G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
interferon G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
: NE : NE
targeted NE xxx NE
expression NE xxx NE
to NE xx NE
human NE xxx NE
immunodeficiency NE xxx NE
virus NE xxx NE
type NE xxx NE
1 NE d NE
-infected NE -xxx NE
cells NE xxx NE
. NE . NE

We NE Xx NE
have NE xxx NE
examined NE xxx NE
the NE xxx NE
feasibility NE xxx NE
of NE xx NE
using NE xxx NE
interferon NE xxx NE
( NE ( NE
IFN NE XXX NE
) NE ) NE
gene NE xxx NE
transfer NE xxx NE
as NE xx NE
a NE x NE
novel NE xxx NE
approach NE xxx NE
to NE xx NE
anti- NE xxx- NE
human NE xxx NE
immunodeficiency NE xxx NE
virus NE xxx NE
type NE xxx NE
1 NE d NE
(HIV-1) NE (XXX-d) NE
therapy NE xxx NE
in NE xx NE
this NE xxx NE
study NE xxx NE
. NE . NE

To NE Xx NE
limit NE xxx NE
expression NE xxx NE
of NE xx NE
a NE x NE
transduced NE xxx NE
HIV-1 G#DNA_domain_or_region_B XXX-d G#DNA_domain_or_region_B
long G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
terminal G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
repeat G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
(LTR)-IFNA2 G#DNA_domain_or_region_E (XXX)-XXXXd G#DNA_domain_or_region_E
(the NE (xxx NE
new NE xxx NE
approved NE xxx NE
nomenclature NE xxx NE
for NE xxx NE
IFN G#DNA_family_or_group_B XXX G#DNA_family_or_group_B
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
is NE xx NE
used NE xxx NE
throughout NE xxx NE
this NE xxx NE
article) NE xxx) NE
hybrid G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
gene G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
to NE xx NE
the NE xxx NE
HIV-1-infected G#cell_line_B XXX-d-xxx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
HIV-1 G#DNA_domain_or_region_B XXX-d G#DNA_domain_or_region_B
LTR G#DNA_domain_or_region_E XXX G#DNA_domain_or_region_E
was NE xxx NE
modified NE xxx NE
. NE . NE

Deletion NE Xxxx NE
of NE xx NE
the NE xxx NE
NF-kappa G#DNA_family_or_group_B XX-xxx G#DNA_family_or_group_B
B G#DNA_family_or_group_M X G#DNA_family_or_group_M
elements G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
of NE xx NE
the NE xxx NE
HIV-1 G#DNA_domain_or_region_B XXX-d G#DNA_domain_or_region_B
LTR G#DNA_domain_or_region_E XXX G#DNA_domain_or_region_E
significantly NE xxx NE
inhibited NE xxx NE
Tat NE Xxx NE
-mediated NE -xxx NE
transactivation NE xxx NE
in NE xx NE
T-cell NE X-xxx NE
lines NE xxx NE
, NE , NE
as NE xx NE
well NE xxx NE
as NE xx NE
in NE xx NE
a NE x NE
monocyte NE xxx NE
line NE xxx NE
, NE , NE
U937 NE Xddd NE
. NE . NE

Replacement NE Xxxx NE
of NE xx NE
the NE xxx NE
NF-kappa G#DNA_domain_or_region_B XX-xxx G#DNA_domain_or_region_B
B G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
elements G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
the NE xxx NE
HIV-1 G#DNA_domain_or_region_B XXX-d G#DNA_domain_or_region_B
LTR G#DNA_domain_or_region_E XXX G#DNA_domain_or_region_E
by NE xx NE
a NE x NE
DNA G#DNA_molecule_B XXX G#DNA_molecule_B
fragment G#DNA_molecule_E xxx G#DNA_molecule_E
derived NE xxx NE
from NE xxx NE
the NE xxx NE
5'-flanking G#DNA_domain_or_region_B d'-xxx G#DNA_domain_or_region_B
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
IFN-stimulated G#DNA_domain_or_region_B XXX-xxx G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
15 G#DNA_domain_or_region_E dd G#DNA_domain_or_region_E
( NE ( NE
ISG15 G#DNA_domain_or_region XXXdd G#DNA_domain_or_region
) NE ) NE
, NE , NE
containing NE xxx NE
the NE xxx NE
IFN-stimulated G#DNA_domain_or_region_B XXX-xxx G#DNA_domain_or_region_B
response G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
partially NE xxx NE
restored NE xxx NE
Tat NE Xxx NE
-mediated NE -xxx NE
activation NE xxx NE
of NE xx NE
LTR NE XXX NE
in NE xx NE
T NE X NE
cells NE xxx NE
as NE xx NE
well NE xxx NE
as NE xx NE
in NE xx NE
monocytes NE xxx NE
. NE . NE

Insertion NE Xxxx NE
of NE xx NE
this NE xxx NE
chimeric G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
promoter G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
( NE ( NE
ISG15 G#DNA_domain_or_region_B XXXdd G#DNA_domain_or_region_B
LTR G#DNA_domain_or_region_E XXX G#DNA_domain_or_region_E
) NE ) NE
upstream NE xxx NE
of NE xx NE
the NE xxx NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
IFNA2 G#DNA_domain_or_region_M XXXXd G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
directed NE xxx NE
high NE xxx NE
levels NE xxx NE
of NE xx NE
IFN G#other_name_B XXX G#other_name_B
synthesis G#other_name_E xxx G#other_name_E
in NE xx NE
Tat-expressing G#cell_line_B Xxx-xxx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
while NE xxx NE
this NE xxx NE
promoter NE xxx NE
was NE xxx NE
not NE xxx NE
responsive NE xxx NE
to NE xx NE
tumor NE xxx NE
necrosis NE xxx NE
factor NE xxx NE
alpha NE xxx NE
-mediated NE -xxx NE
activation NE xxx NE
. NE . NE

ISG15-LTR-IFN G#DNA_domain_or_region_B XXXdd-XXX-XXX G#DNA_domain_or_region_B
hybrid G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
inserted NE xxx NE
into NE xxx NE
the NE xxx NE
retrovirus G#DNA_molecule_B xxx G#DNA_molecule_B
vector G#DNA_molecule_E xxx G#DNA_molecule_E
was NE xxx NE
transduced NE xxx NE
into NE xxx NE
Jurkat G#cell_line Xxxx G#cell_line
and NE xxx NE
U937 G#cell_line_B Xddd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

Selected NE Xxxx NE
transfected G#cell_line_B xxx G#cell_line_B
clones G#cell_line_E xxx G#cell_line_E
produced NE xxx NE
low NE xxx NE
levels NE xxx NE
of NE xx NE
IFN G#protein_molecule_B XXX G#protein_molecule_B
A G#protein_molecule_E X G#protein_molecule_E
( NE ( NE
IFNA G#protein_molecule XXXX G#protein_molecule
) NE ) NE
constitutively NE xxx NE
, NE , NE
and NE xxx NE
their NE xxx NE
abilities NE xxx NE
to NE xx NE
express NE xxx NE
interleukin-2 G#protein_molecule xxx-d G#protein_molecule
and NE xxx NE
interleukin-2 G#protein_molecule_B xxx-d G#protein_molecule_B
receptor G#protein_molecule_E xxx G#protein_molecule_E
upon NE xxx NE
stimulation NE xxx NE
with NE xxx NE
phytohemagglutinin G#protein_molecule xxx G#protein_molecule
and NE xxx NE
phorbol G#other_organic_compound_B xxx G#other_organic_compound_B
myristate G#other_organic_compound_M xxx G#other_organic_compound_M
acetate G#other_organic_compound_E xxx G#other_organic_compound_E
were NE xxx NE
retained NE xxx NE
. NE . NE

Enhancement NE Xxxx NE
of NE xx NE
IFNA G#other_name_B XXXX G#other_name_B
synthesis G#other_name_E xxx G#other_name_E
observed NE xxx NE
upon NE xxx NE
HIV-1 G#other_name_B XXX-d G#other_name_B
infection G#other_name_E xxx G#other_name_E
resulted NE xxx NE
in NE xx NE
significant NE xxx NE
inhibition NE xxx NE
of NE xx NE
HIV-1 G#other_name_B XXX-d G#other_name_B
replication G#other_name_E xxx G#other_name_E
for NE xxx NE
a NE x NE
period NE xxx NE
of NE xx NE
at NE xx NE
least NE xxx NE
30 NE dd NE
days NE xxx NE
. NE . NE

Virus NE Xxxx NE
isolated NE xxx NE
from NE xxx NE
IFNA NE XXXX NE
-producing NE -xxx NE
cells NE xxx NE
was NE xxx NE
able NE xxx NE
to NE xx NE
replicate NE xxx NE
in NE xx NE
the NE xxx NE
U937 NE Xddd NE
cells NE xxx NE
but NE xxx NE
did NE xxx NE
not NE xxx NE
replicate NE xxx NE
efficiently NE xxx NE
in NE xx NE
U937 NE Xddd NE
cells NE xxx NE
transduced NE xxx NE
with NE xxx NE
the NE xxx NE
IFNA NE XXXX NE
gene NE xxx NE
. NE . NE

These NE Xxxx NE
results NE xxx NE
suggest NE xxx NE
that NE xxx NE
targeting NE xxx NE
IFN G#other_name_B XXX G#other_name_B
synthesis G#other_name_E xxx G#other_name_E
to NE xx NE
HIV-1 NE XXX-d NE
-infected NE -xxx NE
cells NE xxx NE
is NE xx NE
an NE xx NE
attainable NE xxx NE
goal NE xxx NE
and NE xxx NE
that NE xxx NE
autocrine NE xxx NE
IFN NE XXX NE
synthesis NE xxx NE
results NE xxx NE
in NE xx NE
a NE x NE
long-lasting NE xxx-xxx NE
and NE xxx NE
permanent NE xxx NE
suppression NE xxx NE
of NE xx NE
HIV-1 NE XXX-d NE
replication NE xxx NE
. NE . NE

Chromosomal G#other_name_B Xxxx G#other_name_B
localization G#other_name_E xxx G#other_name_E
of NE xx NE
two NE xxx NE
KOX G#DNA_family_or_group_B XXX G#DNA_family_or_group_B
zinc G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
finger G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
on NE xx NE
chromosome G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
bands G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
7q21-q22 G#DNA_domain_or_region dxdd-xdd G#DNA_domain_or_region
. NE . NE

Human G#DNA_family_or_group_B Xxxx G#DNA_family_or_group_B
cDNAs G#DNA_family_or_group_E xXXXx G#DNA_family_or_group_E
encoding NE xxx NE
Kruppel-type G#protein_domain_or_region_B Xxxx-xxx G#protein_domain_or_region_B
zinc G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
finger G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
domains G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
, NE , NE
designated NE xxx NE
KOX G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
1-32 G#DNA_domain_or_region_E d-dd G#DNA_domain_or_region_E
, NE , NE
have NE xxx NE
been NE xxx NE
cloned NE xxx NE
from NE xxx NE
human NE xxx NE
T NE X NE
lymphocyte NE xxx NE
cell NE xxx NE
line NE xxx NE
libraries NE xxx NE
. NE . NE

We NE Xx NE
report NE xxx NE
here NE xxx NE
the NE xxx NE
regional NE xxx NE
localizations NE xxx NE
by NE xx NE
in G#other_name_B xx G#other_name_B
situ G#other_name_M xxx G#other_name_M
hybridization G#other_name_E xxx G#other_name_E
of NE xx NE
KOX G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
18 G#DNA_domain_or_region_E dd G#DNA_domain_or_region_E
and NE xxx NE
KOX G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
25 G#DNA_domain_or_region_E dd G#DNA_domain_or_region_E
on NE xx NE
chromosome G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
bands G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
7q21q22 G#DNA_domain_or_region_E dxddxdd G#DNA_domain_or_region_E
. NE . NE

Pulse-field G#other_name_B Xxxx-xxx G#other_name_B
gel G#other_name_M xxx G#other_name_M
electrophoresis G#other_name_M xxx G#other_name_M
(PFGE) G#other_name_M (XXXX) G#other_name_M
analysis G#other_name_E xxx G#other_name_E
showed NE xxx NE
that NE xxx NE
these NE xxx NE
genes NE xxx NE
are NE xxx NE
physically NE xxx NE
located NE xxx NE
within NE xxx NE
a NE x NE
DNA G#DNA_molecule_B XXX G#DNA_molecule_B
fragment G#DNA_molecule_E xxx G#DNA_molecule_E
of NE xx NE
250 G#DNA_domain_or_region_B ddd G#DNA_domain_or_region_B
kb G#DNA_domain_or_region_E xx G#DNA_domain_or_region_E
. NE . NE

The NE Xxx NE
genes NE xxx NE
KOX G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
4 G#DNA_domain_or_region_E d G#DNA_domain_or_region_E
and NE xxx NE
KOX G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
9 G#DNA_domain_or_region_E d G#DNA_domain_or_region_E
, NE , NE
mapped NE xxx NE
on NE xx NE
chromosome G#DNA_molecule_B xxx G#DNA_molecule_B
8q24 G#DNA_molecule_E dxdd G#DNA_molecule_E
, NE , NE
were NE xxx NE
found NE xxx NE
to NE xx NE
be NE xx NE
located NE xxx NE
within NE xxx NE
a NE x NE
DNA G#DNA_molecule_B XXX G#DNA_molecule_B
fragment G#DNA_molecule_E xxx G#DNA_molecule_E
of NE xx NE
450 G#polynucleotide_B ddd G#polynucleotide_B
kb G#polynucleotide_E xx G#polynucleotide_E
. NE . NE

From NE Xxxx NE
the NE xxx NE
present NE xxx NE
and NE xxx NE
previous NE xxx NE
data NE xxx NE
, NE , NE
eighteen NE xxx NE
different NE xxx NE
KOX G#DNA_family_or_group_B XXX G#DNA_family_or_group_B
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
have NE xxx NE
been NE xxx NE
located NE xxx NE
at NE xx NE
least NE xxx NE
two NE xxx NE
by NE xx NE
two NE xxx NE
within NE xxx NE
nine NE xxx NE
DNA G#DNA_molecule_B XXX G#DNA_molecule_B
fragments G#DNA_molecule_E xxx G#DNA_molecule_E
of NE xx NE
200 NE ddd NE
to NE xx NE
580 NE ddd NE
kb NE xx NE
. NE . NE

Influence NE Xxxx NE
of NE xx NE
age NE xxx NE
on NE xx NE
the NE xxx NE
production NE xxx NE
of NE xx NE
Fos G#protein_molecule Xxx G#protein_molecule
and NE xxx NE
Jun G#protein_molecule Xxx G#protein_molecule
by NE xx NE
influenza G#cell_type_B xxx G#cell_type_B
virus-exposed G#cell_type_M xxx-xxx G#cell_type_M
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

This NE Xxxx NE
study NE xxx NE
investigated NE xxx NE
age-related NE xxx-xxx NE
T G#other_name_B X G#other_name_B
cell G#other_name_M xxx G#other_name_M
responses G#other_name_E xxx G#other_name_E
after NE xxx NE
in NE xx NE
vitro NE xxx NE
exposure NE xxx NE
to NE xx NE
influenza G#virus_B xxx G#virus_B
A G#virus_M X G#virus_M
virus G#virus_E xxx G#virus_E
. NE . NE

Mononuclear G#cell_type_B Xxxx G#cell_type_B
leukocytes G#cell_type_E xxx G#cell_type_E
from NE xxx NE
young NE xxx NE
or NE xx NE
elderly NE xxx NE
persons NE xxx NE
were NE xxx NE
sham-exposed NE xxx-xxx NE
or NE xx NE
exposed NE xxx NE
to NE xx NE
influenza G#virus_B xxx G#virus_B
virus G#virus_E xxx G#virus_E
for NE xxx NE
1 NE d NE
, NE , NE
24 NE dd NE
, NE , NE
and NE xxx NE
72 NE dd NE
h NE x NE
. NE . NE

Immunofluorescent G#other_name_B Xxxx G#other_name_B
staining G#other_name_E xxx G#other_name_E
and NE xxx NE
flow G#other_name_B xxx G#other_name_B
cytometric G#other_name_M xxx G#other_name_M
analysis G#other_name_E xxx G#other_name_E
were NE xxx NE
then NE xxx NE
used NE xxx NE
to NE xx NE
detect NE xxx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
producing NE xxx NE
the NE xxx NE
transcriptional G#protein_family_or_group_B xxx G#protein_family_or_group_B
regulating G#protein_family_or_group_M xxx G#protein_family_or_group_M
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
Fos G#protein_molecule Xxx G#protein_molecule
and NE xxx NE
Jun G#protein_molecule Xxx G#protein_molecule
. NE . NE

Fewer NE Xxxx NE
virus-exposed NE xxx-xxx NE
cells NE xxx NE
from NE xxx NE
elderly NE xxx NE
donors NE xxx NE
stained NE xxx NE
for NE xxx NE
Fos G#protein_molecule Xxx G#protein_molecule
and NE xxx NE
Jun G#protein_molecule Xxx G#protein_molecule
at NE xx NE
each NE xxx NE
data NE xxx NE
point NE xxx NE
compared NE xxx NE
with NE xxx NE
cells NE xxx NE
from NE xxx NE
young NE xxx NE
donors G#multi_cell xxx G#multi_cell
. NE . NE

Flow NE Xxxx NE
cytometric NE xxx NE
analysis NE xxx NE
also NE xxx NE
showed NE xxx NE
that NE xxx NE
at NE xx NE
72 NE dd NE
h NE x NE
of NE xx NE
virus G#virus xxx G#virus
exposure NE xxx NE
fewer NE xxx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
from NE xxx NE
the NE xxx NE
elderly NE xxx NE
produced NE xxx NE
interferon-gamma G#protein_molecule xxx-xxx G#protein_molecule
( NE ( NE
IFN-gamma G#protein_molecule XXX-xxx G#protein_molecule
) NE ) NE
, NE , NE
suggesting NE xxx NE
a NE x NE
link NE xxx NE
between NE xxx NE
the NE xxx NE
magnitude NE xxx NE
of NE xx NE
the NE xxx NE
Fos G#protein_molecule Xxx G#protein_molecule
and NE xxx NE
Jun G#protein_molecule Xxx G#protein_molecule
and NE xxx NE
IFN-gamma G#protein_molecule XXX-xxx G#protein_molecule
responses NE xxx NE
. NE . NE

Thus NE Xxxx NE
, NE , NE
failure NE xxx NE
of NE xx NE
virus-exposed G#cell_type_B xxx-xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
to NE xx NE
produce NE xxx NE
Fos G#protein_molecule Xxx G#protein_molecule
and NE xxx NE
Jun G#protein_molecule Xxx G#protein_molecule
could NE xxx NE
contribute NE xxx NE
to NE xx NE
the NE xxx NE
increase NE xxx NE
in NE xx NE
illness NE xxx NE
due NE xxx NE
to NE xx NE
influenza G#virus_B xxx G#virus_B
virus G#virus_E xxx G#virus_E
in NE xx NE
the NE xxx NE
elderly G#multi_cell xxx G#multi_cell
. NE . NE

The NE Xxx NE
regulation NE xxx NE
of NE xx NE
HIV G#virus XXX G#virus
by NE xx NE
retinoic G#other_organic_compound_B xxx G#other_organic_compound_B
acid G#other_organic_compound_E xxx G#other_organic_compound_E
correlates NE xxx NE
with NE xxx NE
cellular NE xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
retinoic G#protein_family_or_group_B xxx G#protein_family_or_group_B
acid G#protein_family_or_group_M xxx G#protein_family_or_group_M
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

OBJECTIVES NE XXXXXXXXXX NE
: NE : NE
To NE Xx NE
analyze NE xxx NE
the NE xxx NE
effect NE xxx NE
of NE xx NE
retinoic G#other_organic_compound_B xxx G#other_organic_compound_B
acids G#other_organic_compound_E xxx G#other_organic_compound_E
( NE ( NE
RA G#other_organic_compound XX G#other_organic_compound
) NE ) NE
on NE xx NE
HIV-1 G#other_name_B XXX-d G#other_name_B
expression G#other_name_E xxx G#other_name_E
and NE xxx NE
correlate NE xxx NE
this NE xxx NE
effect NE xxx NE
with NE xxx NE
expression NE xxx NE
levels NE xxx NE
of NE xx NE
RA G#protein_family_or_group_B XX G#protein_family_or_group_B
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
RARs G#protein_family_or_group XXXx G#protein_family_or_group
) NE ) NE
in NE xx NE
T-lymphoid G#cell_line_B X-xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_M xxx G#cell_line_M
and G#cell_line_M xxx G#cell_line_M
monocytoid G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E

DESIGN NE XXXXXX NE
AND NE XXX NE
METHODS NE XXXXXXX NE
: NE : NE
The NE Xxx NE
effect NE xxx NE
of NE xx NE
all-trans G#other_organic_compound_B xxx-xxx G#other_organic_compound_B
RA G#other_organic_compound_M XX G#other_organic_compound_M
and G#other_organic_compound_M xxx G#other_organic_compound_M
9-cis G#other_organic_compound_M d-xxx G#other_organic_compound_M
RA G#other_organic_compound_E XX G#other_organic_compound_E
on NE xx NE
HIV-1 G#other_name_B XXX-d G#other_name_B
production G#other_name_E xxx G#other_name_E
in NE xx NE
T-lymphoid G#cell_line X-xxx G#cell_line
( NE ( NE
H9, G#cell_line_B Xd, G#cell_line_B
CEM G#cell_line_E XXX G#cell_line_E
) NE ) NE
and NE xxx NE
monocytoid G#cell_line_B xxx G#cell_line_B
(U937,THP-1) G#cell_line_M (Xddd,XXX-d) G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
was NE xxx NE
measured NE xxx NE
during NE xxx NE
acute G#other_name_B xxx G#other_name_B
infection G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
chronic G#other_name_M xxx G#other_name_M
infection G#other_name_E xxx G#other_name_E

The NE Xxx NE
expression NE xxx NE
levels NE xxx NE
of NE xx NE
human G#protein_molecule_B xxx G#protein_molecule_B
RAR G#protein_molecule_M XXX G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
hRAR G#protein_molecule_B xXXX G#protein_molecule_B
alpha, G#protein_molecule_M xxx, G#protein_molecule_M
receptor G#protein_molecule_E xxx G#protein_molecule_E
for NE xxx NE
all-trans G#other_organic_compound_B xxx-xxx G#other_organic_compound_B
RA G#other_organic_compound_E XX G#other_organic_compound_E
) NE ) NE
and NE xxx NE
the NE xxx NE
human G#protein_molecule_B xxx G#protein_molecule_B
retinoid-X G#protein_molecule_M xxx-X G#protein_molecule_M
receptor G#protein_molecule_M xxx G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
hRXR G#protein_molecule_B xXXX G#protein_molecule_B
alpha G#protein_molecule_M xxx G#protein_molecule_M
receptor G#protein_molecule_E xxx G#protein_molecule_E
for NE xxx NE
9-cis G#other_organic_compound_B d-xxx G#other_organic_compound_B
RA G#other_organic_compound_E XX G#other_organic_compound_E
) NE ) NE
were NE xxx NE
determined NE xxx NE
by NE xx NE
Northern NE Xxxx NE
blot NE xxx NE
analysis NE xxx NE
. NE . NE

RESULTS NE XXXXXXX NE
: NE : NE
Both NE Xxxx NE
all-trans G#other_organic_compound_B xxx-xxx G#other_organic_compound_B
RA G#other_organic_compound_M XX G#other_organic_compound_M
and G#other_organic_compound_M xxx G#other_organic_compound_M
9-cis G#other_organic_compound_M d-xxx G#other_organic_compound_M
RA G#other_organic_compound_E XX G#other_organic_compound_E
inhibited NE xxx NE
virus G#other_name_B xxx G#other_name_B
replication G#other_name_E xxx G#other_name_E
in NE xx NE
HIV-1 G#cell_line_B XXX-d G#cell_line_B
IIIB-infected G#cell_line_M XXXX-xxx G#cell_line_M
monocytoid G#cell_line_M xxx G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
in NE xx NE
the NE xxx NE
presence NE xxx NE
and NE xxx NE
absence NE xxx NE
of NE xx NE
the NE xxx NE
co-stimulatory NE xx-xxx NE
agent NE xxx NE
phorbol G#other_organic_compound_B xxx G#other_organic_compound_B
myristate G#other_organic_compound_M xxx G#other_organic_compound_M
acetate G#other_organic_compound_E xxx G#other_organic_compound_E
( NE ( NE
PMA G#other_organic_compound XXX G#other_organic_compound
) NE ) NE
. NE . NE

The NE Xxx NE
retinoids NE xxx NE
had NE xxx NE
weak NE xxx NE
or NE xx NE
no NE xx NE
stimulatory NE xxx NE
effects NE xxx NE
on NE xx NE
HIV G#other_name_B XXX G#other_name_B
production G#other_name_E xxx G#other_name_E
by NE xx NE
T-cell G#cell_line_B X-xxx G#cell_line_B
lines G#cell_line_E xxx G#cell_line_E
. NE . NE

HIV G#other_name_B XXX G#other_name_B
production G#other_name_E xxx G#other_name_E
by NE xx NE
PMA NE XXX NE
-stimulated NE -xxx NE
T-cell NE X-xxx NE
lines NE xxx NE
was NE xxx NE
inhibited NE xxx NE
by NE xx NE
these NE xxx NE
retinoids NE xxx NE
. NE . NE

The NE Xxx NE
9-cis G#other_organic_compound_B d-xxx G#other_organic_compound_B
RA G#other_organic_compound_E XX G#other_organic_compound_E
was NE xxx NE
generally NE xxx NE
more NE xxx NE
effective NE xxx NE
than NE xxx NE
all-trans G#other_organic_compound_B xxx-xxx G#other_organic_compound_B
RA G#other_organic_compound_E XX G#other_organic_compound_E
in NE xx NE
inhibiting NE xxx NE
HIV G#other_name_B XXX G#other_name_B
production G#other_name_E xxx G#other_name_E
and NE xxx NE
in NE xx NE
combination NE xxx NE
generally NE xxx NE
more NE xxx NE
effective NE xxx NE
than NE xxx NE
the NE xxx NE
single NE xxx NE
agents NE xxx NE
alone NE xxx NE
. NE . NE

Human G#protein_molecule_B Xxxx G#protein_molecule_B
RAR G#protein_molecule_M XXX G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
was NE xxx NE
expressed NE xxx NE
in NE xx NE
H9 G#cell_line Xd G#cell_line
, NE , NE
U937 G#cell_line Xddd G#cell_line
and NE xxx NE
THP-1 G#cell_line_B XXX-d G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
but NE xxx NE
almost NE xxx NE
undetectable NE xxx NE
in NE xx NE
CEM G#cell_line_B XXX G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

Human G#protein_molecule_B Xxxx G#protein_molecule_B
RXR G#protein_molecule_M XXX G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
was NE xxx NE
significantly NE xxx NE
expressed NE xxx NE
in NE xx NE
U937 G#cell_line_B Xddd G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
and G#cell_line_M xxx G#cell_line_M
THP-1 G#cell_line_M XXX-d G#cell_line_M
cell G#cell_line_E xxx G#cell_line_E
H9 NE Xd NE
cells NE xxx NE
and NE xxx NE
not NE xxx NE
detectable NE xxx NE
in NE xx NE
CEM G#cell_line_B XXX G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

After NE Xxxx NE
stimulation NE xxx NE
by NE xx NE
PMA G#other_organic_compound XXX G#other_organic_compound
, NE , NE
RXR G#other_name_B XXX G#other_name_B
alpha G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
increased NE xxx NE
in NE xx NE
H9 G#cell_line Xd G#cell_line
and NE xxx NE
U937 G#cell_line_B Xddd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
but NE xxx NE
not NE xxx NE
in NE xx NE
CEM G#cell_line_B XXX G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

Human NE Xxxx NE
RAR NE XXX NE
alpha NE xxx NE
expression NE xxx NE
was NE xxx NE
unchanged NE xxx NE
in NE xx NE
H9 G#cell_line Xd G#cell_line
and NE xxx NE
CEM G#cell_line_B XXX G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
and NE xxx NE
elevated NE xxx NE
in NE xx NE
U937 G#cell_line_B Xddd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
after NE xxx NE
PMA G#other_organic_compound XXX G#other_organic_compound
stimulation NE xxx NE
. NE . NE

CONCLUSION NE XXXXXXXXXX NE
: NE : NE
The NE Xxx NE
effect NE xxx NE
of NE xx NE
RA G#other_organic_compound XX G#other_organic_compound
on NE xx NE
HIV-1 G#virus XXX-d G#virus
expression NE xxx NE
was NE xxx NE
cell-type-dependent NE xxx-xxx-xxx NE
and NE xxx NE
partially NE xxx NE
correlated NE xxx NE
with NE xxx NE
cellular G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
of NE xx NE
RARs G#protein_family_or_group XXXx G#protein_family_or_group
. NE . NE

Endogenous NE Xxxx NE
or NE xx NE
exogenously NE xxx NE
administered NE xxx NE
RA G#other_organic_compound XX G#other_organic_compound
may NE xxx NE
have NE xxx NE
a NE x NE
significant NE xxx NE
role NE xxx NE
in NE xx NE
HIV G#other_name_B XXX G#other_name_B
regulation G#other_name_E xxx G#other_name_E
. NE . NE

Functions NE Xxxx NE
of NE xx NE
glutathione G#peptide xxx G#peptide
and NE xxx NE
glutathione G#peptide_B xxx G#peptide_B
disulfide G#peptide_E xxx G#peptide_E
in NE xx NE
immunology G#other_name xxx G#other_name
and NE xxx NE
immunopathology G#other_name xxx G#other_name
. NE . NE

Even NE Xxxx NE
a NE x NE
moderate NE xxx NE
increase NE xxx NE
in NE xx NE
the NE xxx NE
cellular G#other_name_B xxx G#other_name_B
cysteine G#other_name_M xxx G#other_name_M
supply G#other_name_E xxx G#other_name_E
elevates NE xxx NE
the NE xxx NE
intracellular NE xxx NE
glutathione G#peptide xxx G#peptide
( NE ( NE
GSH G#peptide XXX G#peptide
) NE ) NE
and NE xxx NE
glutathione G#peptide_B xxx G#peptide_B
disulfide G#peptide_E xxx G#peptide_E
( NE ( NE
GSSG G#peptide XXXX G#peptide
) NE ) NE
levels NE xxx NE
and NE xxx NE
potentiates G#other_name_B xxx G#other_name_B
immunological G#other_name_M xxx G#other_name_M
functions G#other_name_E xxx G#other_name_E
of NE xx NE
lymphocytes G#cell_type xxx G#cell_type
in NE xx NE
vitro NE xxx NE
. NE . NE

At NE Xx NE
low NE xxx NE
GSSG G#other_name_B XXXX G#other_name_B
levels G#other_name_E xxx G#other_name_E
, NE , NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
cannot NE xxx NE
optimally NE xxx NE
activate NE xxx NE
the NE xxx NE
immunologically NE xxx NE
important NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
NF G#protein_molecule_B XX G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_E X G#protein_molecule_E
, NE , NE
whereas NE xxx NE
high NE xxx NE
GSSG G#other_name_B XXXX G#other_name_B
levels G#other_name_E xxx G#other_name_E
inhibit NE xxx NE
the NE xxx NE
DNA G#other_name_B XXX G#other_name_B
binding G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
of NE xx NE
NF G#protein_molecule_B XX G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_E X G#protein_molecule_E
. NE . NE

The NE Xxx NE
effects NE xxx NE
of NE xx NE
GSSG G#peptide XXXX G#peptide
are NE xxx NE
antagonized NE xxx NE
by NE xx NE
reduced NE xxx NE
thioredoxin G#protein_molecule xxx G#protein_molecule
( NE ( NE
TRX G#protein_molecule XXX G#protein_molecule
) NE ) NE
. NE . NE

As NE Xx NE
the NE xxx NE
protein NE xxx NE
tyrosine NE xxx NE
kinase NE xxx NE
activities NE xxx NE
p56lck NE xddxxx NE
and NE xxx NE
p59fyn NE xddxxx NE
are NE xxx NE
activated NE xxx NE
in NE xx NE
intact NE xxx NE
cells NE xxx NE
by NE xx NE
hydrogen NE xxx NE
peroxide NE xxx NE
, NE , NE
they NE xxx NE
are NE xxx NE
likely NE xxx NE
targets NE xxx NE
for NE xxx NE
GSSG NE XXXX NE
action NE xxx NE
. NE . NE

These NE Xxxx NE
redox-regulated G#protein_family_or_group_B xxx-xxx G#protein_family_or_group_B
enzymes G#protein_family_or_group_E xxx G#protein_family_or_group_E
trigger NE xxx NE
signal NE xxx NE
cascades NE xxx NE
for NE xxx NE
NF G#other_name_B XX G#other_name_B
kappa G#other_name_M xxx G#other_name_M
B G#other_name_M X G#other_name_M
activation G#other_name_E xxx G#other_name_E
and NE xxx NE
transduce NE xxx NE
signals NE xxx NE
from NE xxx NE
the NE xxx NE
T G#protein_family_or_group_B X G#protein_family_or_group_B
cell G#protein_family_or_group_M xxx G#protein_family_or_group_M
antigen G#protein_family_or_group_M xxx G#protein_family_or_group_M
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
from NE xxx NE
CD4 G#protein_molecule XXd G#protein_molecule
and NE xxx NE
CD8 G#protein_molecule_B XXd G#protein_molecule_B
molecules G#protein_molecule_E xxx G#protein_molecule_E
, NE , NE
and NE xxx NE
from NE xxx NE
the NE xxx NE
IL-2 G#protein_subunit_B XX-d G#protein_subunit_B
receptor G#protein_subunit_M xxx G#protein_subunit_M
beta-chain G#protein_subunit_E xxx-xxx G#protein_subunit_E
. NE . NE

The NE Xxx NE
effector NE xxx NE
phase NE xxx NE
of NE xx NE
cytotoxic G#other_name_B xxx G#other_name_B
T G#other_name_M X G#other_name_M
cell G#other_name_M xxx G#other_name_M
responses G#other_name_E xxx G#other_name_E
and NE xxx NE
IL-2 NE XX-d NE
-dependent NE -xxx NE
functions NE xxx NE
are NE xxx NE
inhibited NE xxx NE
even NE xxx NE
by NE xx NE
a NE x NE
partial NE xxx NE
depletion NE xxx NE
of NE xx NE
the NE xxx NE
intracellular NE xxx NE
GSH NE XXX NE
pool NE xxx NE
. NE . NE

As NE Xx NE
signal NE xxx NE
transduction NE xxx NE
is NE xx NE
facilitated NE xxx NE
by NE xx NE
prooxidant G#other_name_B xxx G#other_name_B
conditions G#other_name_E xxx G#other_name_E
, NE , NE
we NE xx NE
propose NE xxx NE
that NE xxx NE
the NE xxx NE
well-known NE xxx-xxx NE
immunological NE xxx NE
consequences NE xxx NE
of NE xx NE
GSH G#other_name_B XXX G#other_name_B
depletion G#other_name_E xxx G#other_name_E
ultimately NE xxx NE
may NE xxx NE
be NE xx NE
results NE xxx NE
of NE xx NE
the NE xxx NE
accompanying NE xxx NE
GSSG G#other_name_B XXXX G#other_name_B
deficiency G#other_name_E xxx G#other_name_E
. NE . NE

decreased G#other_name_B xxx G#other_name_B
plasma G#other_name_M xxx G#other_name_M
cyst(e)ine G#other_name_M xxx(x)xxx G#other_name_M
level G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
intracellular G#other_name_M xxx G#other_name_M
GSH G#other_name_M XXX G#other_name_M
level G#other_name_E xxx G#other_name_E
HIV NE XXX NE
-infected G#multi_cell_B -xxx G#multi_cell_B
patients G#multi_cell_E xxx G#multi_cell_E
and NE xxx NE
SIV-infected G#multi_cell_B XXX-xxx G#multi_cell_B
rhesus G#multi_cell_M xxx G#multi_cell_M
macaques G#multi_cell_E xxx G#multi_cell_E
have NE xxx NE
, NE , NE
on NE xx NE
the NE xxx NE
average NE xxx NE
, NE , NE
significantly NE xxx NE
decreased NE xxx NE
plasma NE xxx NE
cyst(e)ine NE xxx(x)xxx NE
and NE xxx NE
intracellular NE xxx NE
GSH NE XXX NE
levels NE xxx NE
, NE , NE
we NE xx NE
also NE xxx NE
hypothesize NE xxx NE
that NE xxx NE
AIDS G#other_name XXXX G#other_name
may NE xxx NE
be NE xx NE
the NE xxx NE
consequence NE xxx NE
of NE xx NE
a NE x NE
GSSG G#other_name_B XXXX G#other_name_B
deficiency G#other_name_E xxx G#other_name_E
as NE xx NE
well NE xxx NE
. NE . NE

T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
from NE xxx NE
renal G#multi_cell_B xxx G#multi_cell_B
cell G#multi_cell_M xxx G#multi_cell_M
carcinoma G#multi_cell_M xxx G#multi_cell_M
patients G#multi_cell_E xxx G#multi_cell_E
exhibit NE xxx NE
an NE xx NE
abnormal NE xxx NE
pattern NE xxx NE
of NE xx NE
kappa G#other_name_B xxx G#other_name_B
B-specific G#other_name_M X-xxx G#other_name_M
DNA-binding G#other_name_M XXX-xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
: NE : NE
a NE x NE
preliminary NE xxx NE
report NE xxx NE
. NE . NE

Recent NE Xxxx NE
data NE xxx NE
suggest NE xxx NE
that NE xxx NE
the NE xxx NE
poor NE xxx NE
induction NE xxx NE
of NE xx NE
a NE x NE
T-cell G#other_name_B X-xxx G#other_name_B
response G#other_name_E xxx G#other_name_E
to NE xx NE
human G#other_name_B xxx G#other_name_B
renal G#other_name_M xxx G#other_name_M
cell G#other_name_M xxx G#other_name_M
carcinoma G#other_name_E xxx G#other_name_E
( NE ( NE
RCC G#other_name XXX G#other_name
) NE ) NE
may NE xxx NE
be NE xx NE
related NE xxx NE
to NE xx NE
alterations NE xxx NE
in NE xx NE
signal G#other_name_B xxx G#other_name_B
transduction G#other_name_M xxx G#other_name_M
pathways G#other_name_E xxx G#other_name_E
. NE . NE

We NE Xx NE
report NE xxx NE
that NE xxx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
from NE xxx NE
RCC G#multi_cell_B XXX G#multi_cell_B
patients G#multi_cell_E xxx G#multi_cell_E
have NE xxx NE
two NE xxx NE
alterations NE xxx NE
in NE xx NE
kappa NE xxx NE
B NE X NE
motif NE xxx NE
-specific NE -xxx NE
DNA-binding NE XXX-xxx NE
activity NE xxx NE
. NE . NE

The NE Xxx NE
first NE xxx NE
alteration NE xxx NE
involves NE xxx NE
the NE xxx NE
constitutive NE xxx NE
expression NE xxx NE
of NE xx NE
substantial NE xxx NE
kappa G#other_name_B xxx G#other_name_B
B-binding G#other_name_M X-xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
in NE xx NE
nuclear G#cell_component_B xxx G#cell_component_B
extracts G#cell_component_E xxx G#cell_component_E
, NE , NE
which NE xxx NE
was NE xxx NE
observed NE xxx NE
in NE xx NE
the NE xxx NE
electrophoretic G#other_name_B xxx G#other_name_B
mobility G#other_name_M xxx G#other_name_M
shift G#other_name_M xxx G#other_name_M
assay G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
magnitude NE xxx NE
of NE xx NE
kappa G#other_name_B xxx G#other_name_B
B G#other_name_M X G#other_name_M
activity G#other_name_E xxx G#other_name_E
in NE xx NE
unstimulated G#cell_type_B xxx G#cell_type_B
patient G#cell_type_M xxx G#cell_type_M
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
was NE xxx NE
similar NE xxx NE
to NE xx NE
that NE xxx NE
observed NE xxx NE
in NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
from NE xxx NE
normal G#multi_cell_B xxx G#multi_cell_B
individuals G#multi_cell_E xxx G#multi_cell_E
that NE xxx NE
had NE xxx NE
been NE xxx NE
activated NE xxx NE
in NE xx NE
vitro NE xxx NE
. NE . NE

On NE Xx NE
the NE xxx NE
basis NE xxx NE
of NE xx NE
Western G#other_name_B Xxxx G#other_name_B
blotting G#other_name_M xxx G#other_name_M
experiments G#other_name_E xxx G#other_name_E
using NE xxx NE
antibodies NE xxx NE
to NE xx NE
kappa NE xxx NE
B/Rel NE X/Xxx NE
family NE xxx NE
proteins NE xxx NE
, NE , NE
the NE xxx NE
kappa NE xxx NE
B-binding NE X-xxx NE
activity NE xxx NE
constitutively NE xxx NE
expressed NE xxx NE
in NE xx NE
T NE X NE
cells NE xxx NE
from NE xxx NE
RCC NE XXX NE
patients NE xxx NE
is NE xx NE
composed NE xxx NE
mostly NE xxx NE
of NE xx NE
the NE xxx NE
NF-kappa NE XX-xxx NE
B1 NE Xd NE
( NE ( NE
p50 NE xdd NE
) NE ) NE
subunit NE xxx NE
. NE . NE

The NE Xxx NE
second NE xxx NE
abnormality NE xxx NE
in NE xx NE
kappa G#other_name_B xxx G#other_name_B
B-binding G#other_name_M X-xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
in NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
from NE xxx NE
these NE xxx NE
patients G#multi_cell xxx G#multi_cell
is NE xx NE
that NE xxx NE
RelA G#protein_molecule XxxX G#protein_molecule
, NE , NE
a NE x NE
member NE xxx NE
of NE xx NE
the NE xxx NE
Rel G#protein_family_or_group_B Xxx G#protein_family_or_group_B
homology G#protein_family_or_group_M xxx G#protein_family_or_group_M
family G#protein_family_or_group_E xxx G#protein_family_or_group_E
which NE xxx NE
is NE xx NE
part NE xxx NE
of NE xx NE
the NE xxx NE
normal NE xxx NE
NF-kappa G#protein_complex_B XX-xxx G#protein_complex_B
B G#protein_complex_M X G#protein_complex_M
complex G#protein_complex_E xxx G#protein_complex_E
, NE , NE
was NE xxx NE
not NE xxx NE
induced NE xxx NE
in NE xx NE
the NE xxx NE
nucleus NE xxx NE
following NE xxx NE
activation NE xxx NE
. NE . NE

Western NE Xxxx NE
blotting NE xxx NE
analysis NE xxx NE
did NE xxx NE
not NE xxx NE
detect NE xxx NE
any NE xxx NE
RelA G#protein_molecule XxxX G#protein_molecule
in NE xx NE
nuclear G#cell_component_B xxx G#cell_component_B
extracts G#cell_component_E xxx G#cell_component_E
either NE xxx NE
before NE xxx NE
or NE xx NE
after NE xxx NE
stimulation NE xxx NE
of NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

The NE Xxx NE
altered NE xxx NE
kappa G#other_name_B xxx G#other_name_B
B-binding G#other_name_M X-xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
in NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
from NE xxx NE
RCC G#multi_cell_B XXX G#multi_cell_B
patients G#multi_cell_E xxx G#multi_cell_E
may NE xxx NE
impair NE xxx NE
their NE xxx NE
capacity NE xxx NE
to NE xx NE
respond NE xxx NE
normally NE xxx NE
to NE xx NE
various NE xxx NE
stimuli NE xxx NE
. NE . NE

Hemoglobin G#other_name_B Xxxx G#other_name_B
switching G#other_name_E xxx G#other_name_E
in NE xx NE
humans NE xxx NE
is NE xx NE
accompanied NE xxx NE
by NE xx NE
changes NE xxx NE
in NE xx NE
the NE xxx NE
ratio NE xxx NE
of NE xx NE
the NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
GATA-1 G#protein_molecule XXXX-d G#protein_molecule
and NE xxx NE
SP1 G#protein_molecule XXd G#protein_molecule
. NE . NE

BACKGROUND NE XXXXXXXXXX NE
: NE : NE
Understanding NE Xxxx NE
the NE xxx NE
mechanism NE xxx NE
of NE xx NE
developmental NE xxx NE
regulation NE xxx NE
of NE xx NE
hemoglobin G#other_name_B xxx G#other_name_B
switching G#other_name_E xxx G#other_name_E
has NE xxx NE
scientific NE xxx NE
as NE xx NE
well NE xxx NE
as NE xx NE
clinical NE xxx NE
relevance NE xxx NE
because NE xxx NE
of NE xx NE
the NE xxx NE
influence NE xxx NE
of NE xx NE
fetal NE xxx NE
hemoglobin NE xxx NE
( NE ( NE
HbF NE XxX NE
) NE ) NE
production NE xxx NE
in NE xx NE
adulthood NE xxx NE
on NE xx NE
the NE xxx NE
clinical NE xxx NE
manifestation NE xxx NE
of NE xx NE
thalassemia NE xxx NE
and NE xxx NE
sickle NE xxx NE
cell NE xxx NE
anemia NE xxx NE
. NE . NE

We NE Xx NE
have NE xxx NE
previously NE xxx NE
found NE xxx NE
that NE xxx NE
the NE xxx NE
normal NE xxx NE
developmental NE xxx NE
patterns NE xxx NE
of NE xx NE
globin G#other_name_B xxx G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
are NE xxx NE
recapitulated NE xxx NE
in NE xx NE
an NE xx NE
experimental NE xxx NE
system NE xxx NE
of NE xx NE
primary G#cell_line_B xxx G#cell_line_B
cultures G#cell_line_E xxx G#cell_line_E
that NE xxx NE
support NE xxx NE
differentiation NE xxx NE
of NE xx NE
erythroid G#cell_type_B xxx G#cell_type_B
progenitors G#cell_type_E xxx G#cell_type_E
. NE . NE

We NE Xx NE
further NE xxx NE
found NE xxx NE
that NE xxx NE
high NE xxx NE
activities NE xxx NE
of NE xx NE
the NE xxx NE
transcriptional G#protein_family_or_group_B xxx G#protein_family_or_group_B
activators G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
GATA-1 G#protein_molecule XXXX-d G#protein_molecule
and NE xxx NE
SP1 G#protein_molecule XXd G#protein_molecule
, NE , NE
are NE xxx NE
associated NE xxx NE
with NE xxx NE
normal G#other_name_B xxx G#other_name_B
adult G#other_name_M xxx G#other_name_M
erythroid G#other_name_M xxx G#other_name_M
differentiation G#other_name_E xxx G#other_name_E
. NE . NE

MATERIALS NE XXXXXXXXX NE
AND NE XXX NE
METHODS NE XXXXXXX NE
: NE : NE
In NE Xx NE
the NE xxx NE
present NE xxx NE
work NE xxx NE
, NE , NE
we NE xx NE
have NE xxx NE
studied NE xxx NE
, NE , NE
the NE xxx NE
activities NE xxx NE
of NE xx NE
GATA-1 G#protein_molecule XXXX-d G#protein_molecule
and NE xxx NE
SP1 G#protein_molecule XXd G#protein_molecule
during NE xxx NE
differentiation G#other_name xxx G#other_name
of NE xx NE
cultured NE xxx NE
erythroid G#cell_type_B xxx G#cell_type_B
progenitors G#cell_type_E xxx G#cell_type_E
derived NE xxx NE
from NE xxx NE
cord G#tissue_B xxx G#tissue_B
blood G#tissue_E xxx G#tissue_E
and NE xxx NE
from NE xxx NE
fetal G#body_part_B xxx G#body_part_B
livers G#body_part_E xxx G#body_part_E
, NE , NE
as NE xx NE
well NE xxx NE
as NE xx NE
from NE xxx NE
beta NE xxx NE
zero- NE xxx- NE
thalassemia NE xxx NE
patients NE xxx NE
. NE . NE

RESULTS NE XXXXXXX NE
: NE : NE
The NE Xxx NE
results NE xxx NE
showed NE xxx NE
high NE xxx NE
GATA-1 G#other_name_B XXXX-d G#other_name_B
binding G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
and NE xxx NE
very NE xxx NE
low NE xxx NE
SP1 G#other_name_B XXd G#other_name_B
activity G#other_name_E xxx G#other_name_E
in NE xx NE
the NE xxx NE
fetal G#cell_line_B xxx G#cell_line_B
liver G#cell_line_M xxx G#cell_line_M
cultures G#cell_line_E xxx G#cell_line_E
. NE . NE

This NE Xxxx NE
pattern NE xxx NE
was NE xxx NE
in NE xx NE
contrast NE xxx NE
to NE xx NE
cultures NE xxx NE
derived NE xxx NE
from NE xxx NE
normal G#tissue_B xxx G#tissue_B
adult G#tissue_M xxx G#tissue_M
peripheral G#tissue_M xxx G#tissue_M
blood G#tissue_E xxx G#tissue_E
, NE , NE
in NE xx NE
which NE xxx NE
both NE xxx NE
GATA-1 G#protein_molecule XXXX-d G#protein_molecule
and NE xxx NE
SP1 G#protein_molecule XXd G#protein_molecule
activities NE xxx NE
were NE xxx NE
high NE xxx NE
. NE . NE

Cord NE Xxxx NE
blood NE xxx NE
cultures NE xxx NE
showed NE xxx NE
an NE xx NE
additive NE xxx NE
combination NE xxx NE
of NE xx NE
"adult" NE "xxx" NE
and NE xxx NE
"fetal" NE "xxx" NE
patterns NE xxx NE
. NE . NE

The NE Xxx NE
progenitors NE xxx NE
derived NE xxx NE
from NE xxx NE
a NE x NE
beta NE xxx NE
zero- NE xxx- NE
thalassemia NE xxx NE
patient NE xxx NE
with NE xxx NE
high NE xxx NE
HbF NE XxX NE
production NE xxx NE
showed NE xxx NE
"fetal" NE "xxx" NE
pattern NE xxx NE
. NE . NE

On NE Xx NE
the NE xxx NE
other NE xxx NE
hand NE xxx NE
, NE , NE
in NE xx NE
cultures NE xxx NE
of NE xx NE
2 NE d NE
beta NE xxx NE
zero- NE xxx- NE
thalassemia NE xxx NE
patients NE xxx NE
without NE xxx NE
high NE xxx NE
HbF NE XxX NE
, NE , NE
"adult" NE "xxx" NE
pattern NE xxx NE
was NE xxx NE
observed NE xxx NE
. NE . NE

CONCLUSIONS NE XXXXXXXXXXX NE
: NE : NE
In NE Xx NE
the NE xxx NE
present NE xxx NE
work NE xxx NE
, NE , NE
we NE xx NE
show NE xxx NE
that NE xxx NE
human G#cell_type_B xxx G#cell_type_B
fetal G#cell_type_M xxx G#cell_type_M
erythroid G#cell_type_M xxx G#cell_type_M
progenitor G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
human G#cell_type_M xxx G#cell_type_M
adult G#cell_type_M xxx G#cell_type_M
erythroid G#cell_type_M xxx G#cell_type_M
progenitor G#cell_type_E xxx G#cell_type_E
are NE xxx NE
distinct NE xxx NE
in NE xx NE
their NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
and NE xxx NE
that NE xxx NE
the NE xxx NE
commitment NE xxx NE
to NE xx NE
fetal NE xxx NE
or NE xx NE
adult NE xxx NE
program NE xxx NE
occurs NE xxx NE
at NE xx NE
a NE x NE
very NE xxx NE
early NE xxx NE
differentiation NE xxx NE
stage NE xxx NE
. NE . NE

Our NE Xxx NE
studies NE xxx NE
also NE xxx NE
demonstrate NE xxx NE
that NE xxx NE
under NE xxx NE
anemic G#other_name_B xxx G#other_name_B
stress G#other_name_E xxx G#other_name_E
, NE , NE
recruitment NE xxx NE
of NE xx NE
fetal G#cell_type_B xxx G#cell_type_B
progenitors G#cell_type_E xxx G#cell_type_E
may NE xxx NE
occur NE xxx NE
in NE xx NE
adulthood G#other_name xxx G#other_name
. NE . NE

Transcription-independent G#other_name_B Xxxx-xxx G#other_name_B
turnover G#other_name_E xxx G#other_name_E
of NE xx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
during NE xxx NE
monocyte G#other_name_B xxx G#other_name_B
adherence G#other_name_E xxx G#other_name_E
: NE : NE
implications NE xxx NE
for NE xxx NE
a NE x NE
translational NE xxx NE
component NE xxx NE
regulating NE xxx NE
I NE X NE
kappa NE xxx NE
B NE X NE
alpha NE xxx NE
/MAD-3 NE /XXX-d NE
mRNA NE xXXX NE
levels NE xxx NE
. NE . NE

We NE Xx NE
identified NE xxx NE
I NE X NE
kappa NE xxx NE
B NE X NE
alpha NE xxx NE
/MAD-3 NE /XXX-d NE
as NE xx NE
an NE xx NE
immediate-early NE xxx-xxx NE
gene NE xxx NE
in NE xx NE
human NE xxx NE
monocytes NE xxx NE
that NE xxx NE
is NE xx NE
expressed NE xxx NE
in NE xx NE
response NE xxx NE
to NE xx NE
a NE x NE
variety NE xxx NE
of NE xx NE
signals NE xxx NE
, NE , NE
including NE xxx NE
adhesion NE xxx NE
, NE , NE
lipopolysaccharide NE xxx NE
, NE , NE
and NE xxx NE
phorbol NE xxx NE
myristate NE xxx NE
acetate NE xxx NE
. NE . NE

Within NE Xxxx NE
5 NE d NE
min NE xxx NE
of NE xx NE
monocyte G#other_name_B xxx G#other_name_B
adhesion G#other_name_E xxx G#other_name_E
, NE , NE
the NE xxx NE
level NE xxx NE
of NE xx NE
the NE xxx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
alpha G#protein_molecule_M xxx G#protein_molecule_M
protein G#protein_molecule_E xxx G#protein_molecule_E
is NE xx NE
markedly NE xxx NE
diminished NE xxx NE
but NE xxx NE
is NE xx NE
rapidly NE xxx NE
replaced NE xxx NE
in NE xx NE
a NE x NE
cycloheximide-sensitive G#other_name_B xxx-xxx G#other_name_B
manner G#other_name_E xxx G#other_name_E
within NE xxx NE
20 NE dd NE
min NE xxx NE
. NE . NE

Accompanying NE Xxxx NE
the NE xxx NE
rapid NE xxx NE
turnover NE xxx NE
of NE xx NE
the NE xxx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
alpha G#protein_molecule_M xxx G#protein_molecule_M
protein G#protein_molecule_E xxx G#protein_molecule_E
is NE xx NE
simultaneous NE xxx NE
translocation NE xxx NE
of NE xx NE
NF-kappa G#protein_family_or_group_B XX-xxx G#protein_family_or_group_B
B-related G#protein_family_or_group_M X-xxx G#protein_family_or_group_M
transcription G#protein_family_or_group_M xxx G#protein_family_or_group_M
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
to NE xx NE
nuclei NE xxx NE
of NE xx NE
adhered NE xxx NE
monocytes NE xxx NE
. NE . NE

The NE Xxx NE
demonstration NE xxx NE
that NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
can NE xxx NE
regulate NE xxx NE
I NE X NE
kappa NE xxx NE
B NE X NE
alpha NE xxx NE
/MAD-3 NE /XXX-d NE
gene NE xxx NE
transcription NE xxx NE
in NE xx NE
other NE xxx NE
cell NE xxx NE
types NE xxx NE
suggested NE xxx NE
that NE xxx NE
the NE xxx NE
rapid NE xxx NE
increase NE xxx NE
in NE xx NE
steady-state NE xxx-xxx NE
I NE X NE
kappa NE xxx NE
B NE X NE
alpha NE xxx NE
/MAD-3 NE /XXX-d NE
mRNA NE xXXX NE
levels NE xxx NE
we NE xx NE
observed NE xxx NE
within NE xxx NE
30 NE dd NE
min NE xxx NE
of NE xx NE
monocyte NE xxx NE
adherence NE xxx NE
would NE xxx NE
result NE xxx NE
from NE xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
-dependent NE -xxx NE
transcriptional NE xxx NE
stimulation NE xxx NE
of NE xx NE
the NE xxx NE
I NE X NE
kappa NE xxx NE
B NE X NE
alpha NE xxx NE
/MAD-3 NE /XXX-d NE
gene NE xxx NE
. NE . NE

Nuclear NE Xxxx NE
run-on NE xxx-xx NE
analyses NE xxx NE
indicated NE xxx NE
that NE xxx NE
, NE , NE
instead NE xxx NE
, NE , NE
while NE xxx NE
several NE xxx NE
immediate-early G#DNA_family_or_group_B xxx-xxx G#DNA_family_or_group_B
cytokine G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
, NE , NE
such NE xxx NE
as NE xx NE
the NE xxx NE
interleukin NE xxx NE
1 NE d NE
beta NE xxx NE
( NE ( NE
IL-1 NE XX-d NE
beta NE xxx NE
) NE ) NE
gene NE xxx NE
, NE , NE
were NE xxx NE
transcriptionally NE xxx NE
activated NE xxx NE
during NE xxx NE
monocyte NE xxx NE
adhesion NE xxx NE
, NE , NE
the NE xxx NE
rate NE xxx NE
of NE xx NE
I NE X NE
kappa NE xxx NE
B NE X NE
alpha NE xxx NE
/MAD-3 NE /XXX-d NE
gene NE xxx NE
transcription NE xxx NE
remained NE xxx NE
constant NE xxx NE
. NE . NE

The NE Xxx NE
adherence-dependent NE xxx-xxx NE
increase NE xxx NE
in NE xx NE
I NE X NE
kappa NE xxx NE
B NE X NE
alpha NE xxx NE
/MAD-3 NE /XXX-d NE
mRNA NE xXXX NE
levels NE xxx NE
was NE xxx NE
also NE xxx NE
not NE xxx NE
a NE x NE
consequence NE xxx NE
of NE xx NE
mRNA NE xXXX NE
stabilization NE xxx NE
events NE xxx NE
. NE . NE

Interestingly NE Xxxx NE
, NE , NE
while NE xxx NE
increases NE xxx NE
in NE xx NE
both NE xxx NE
IL-1 G#other_name_B XX-d G#other_name_B
beta G#other_name_M xxx G#other_name_M
mRNA G#other_name_M xXXX G#other_name_M
level G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
I G#other_name_M X G#other_name_M
kappa G#other_name_M xxx G#other_name_M
B G#other_name_M X G#other_name_M
alpha/MAD-3 G#other_name_M xxx/XXX-d G#other_name_M
mRNA G#other_name_M xXXX G#other_name_M
level G#other_name_E xxx G#other_name_E
IL-1 G#RNA_molecule_B XX-d G#RNA_molecule_B
beta G#RNA_molecule_E xxx G#RNA_molecule_E
were NE xxx NE
detected NE xxx NE
in NE xx NE
nuclei G#cell_component xxx G#cell_component
of NE xx NE
adherent G#cell_type_B xxx G#cell_type_B
monocytes G#cell_type_E xxx G#cell_type_E
, NE , NE
cytoplasmic G#other_name_B xxx G#other_name_B
levels G#other_name_E xxx G#other_name_E
of NE xx NE
IL-1 NE XX-d NE
beta NE xxx NE
mRNA G#RNA_molecule xXXX G#RNA_molecule
increased NE xxx NE
during NE xxx NE
adherence NE xxx NE
whereas NE xxx NE
those NE xxx NE
of NE xx NE
I NE X NE
kappa NE xxx NE
B NE X NE
alpha NE xxx NE
/MAD-3 NE /XXX-d NE
mRNA NE xXXX NE
did NE xxx NE
not NE xxx NE
. NE . NE

Taken NE Xxxx NE
together NE xxx NE
, NE , NE
our NE xxx NE
data NE xxx NE
suggest NE xxx NE
that NE xxx NE
two NE xxx NE
interactive NE xxx NE
mechanisms NE xxx NE
regulate NE xxx NE
monocytic NE xxx NE
I NE X NE
kappa NE xxx NE
B NE X NE
alpha NE xxx NE
/MAD-3 NE /XXX-d NE
mRNA NE xXXX NE
levels NE xxx NE
. NE . NE

We NE Xx NE
propose NE xxx NE
that NE xxx NE
adherent G#cell_type_B xxx G#cell_type_B
monocytes G#cell_type_E xxx G#cell_type_E
regulate NE xxx NE
nuclear NE xxx NE
processing NE xxx NE
(or NE (xx NE
decay) NE xxx) NE
of NE xx NE
I NE X NE
kappa NE xxx NE
B NE X NE
alpha NE xxx NE
/MAD-3 NE /XXX-d NE
mRNA NE xXXX NE
, NE , NE
thereby NE xxx NE
increasing NE xxx NE
mRNA NE xXXX NE
levels NE xxx NE
without NE xxx NE
stimulating NE xxx NE
I NE X NE
kappa NE xxx NE
B NE X NE
alpha NE xxx NE
/MAD-3 NE /XXX-d NE
gene NE xxx NE
transcription NE xxx NE
. NE . NE

Moreover NE Xxxx NE
, NE , NE
since NE xxx NE
inhibition NE xxx NE
of NE xx NE
protein NE xxx NE
synthesis NE xxx NE
leads NE xxx NE
to NE xx NE
accumulation NE xxx NE
of NE xx NE
I NE X NE
kappa NE xxx NE
B NE X NE
alpha NE xxx NE
/MAD-3 NE /XXX-d NE
mRNA NE xXXX NE
without NE xxx NE
stimulating NE xxx NE
I NE X NE
kappa NE xxx NE
B NE X NE
alpha NE xxx NE
/MAD-3 NE /XXX-d NE
gene NE xxx NE
transcription NE xxx NE
, NE , NE
we NE xx NE
suggest NE xxx NE
that NE xxx NE
low NE xxx NE
cytoplasmic NE xxx NE
levels NE xxx NE
of NE xx NE
I NE X NE
kappa NE xxx NE
B NE X NE
alpha NE xxx NE
/MAD-3 NE /XXX-d NE
mRNA NE xXXX NE
are NE xxx NE
maintained NE xxx NE
by NE xx NE
a NE x NE
translation-dependent NE xxx-xxx NE
degradation NE xxx NE
mechanism NE xxx NE
. NE . NE

Distinct NE Xxxx NE
roles NE xxx NE
of NE xx NE
the NE xxx NE
molecular NE xxx NE
chaperone G#protein_molecule_B xxx G#protein_molecule_B
hsp90 G#protein_molecule_E xxxdd G#protein_molecule_E
in NE xx NE
modulating NE xxx NE
dioxin NE xxx NE
receptor NE xxx NE
function NE xxx NE
via NE xxx NE
the NE xxx NE
basic NE xxx NE
helix-loop-helix G#protein_substructure xxx-xxx-xxx G#protein_substructure
and NE xxx NE
PAS G#protein_domain_or_region_B XXX G#protein_domain_or_region_B
domains G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
. NE . NE

The NE Xxx NE
intracellular G#protein_molecule_B xxx G#protein_molecule_B
dioxin G#protein_molecule_M xxx G#protein_molecule_M
receptor G#protein_molecule_E xxx G#protein_molecule_E
mediates NE xxx NE
signal NE xxx NE
transduction NE xxx NE
by NE xx NE
dioxin G#inorganic xxx G#inorganic
and NE xxx NE
functions NE xxx NE
as NE xx NE
a NE x NE
ligand-activated G#protein_family_or_group_B xxx-xxx G#protein_family_or_group_B
transcription G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

It NE Xx NE
contains NE xxx NE
a NE x NE
basic NE xxx NE
helix-loop-helix NE xxx-xxx-xxx NE
( NE ( NE
bHLH NE xXXX NE
) NE ) NE
motif NE xxx NE
contiguous NE xxx NE
with NE xxx NE
a NE x NE
Per-Arnt-Sim NE Xxx-Xxxx-Xxx NE
(PAS) NE (XXX) NE
homology NE xxx NE
region NE xxx NE
. NE . NE

In NE Xx NE
extracts NE xxx NE
from NE xxx NE
nonstimulated NE xxx NE
cells NE xxx NE
the NE xxx NE
receptor NE xxx NE
is NE xx NE
recovered NE xxx NE
in NE xx NE
an NE xx NE
inducible NE xxx NE
cytoplasmic NE xxx NE
form NE xxx NE
associated NE xxx NE
with NE xxx NE
the NE xxx NE
90-kDa G#protein_molecule_B dd-xXx G#protein_molecule_B
heat G#protein_molecule_M xxx G#protein_molecule_M
shock G#protein_molecule_M xxx G#protein_molecule_M
protein G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
hsp90 G#protein_molecule xxxdd G#protein_molecule
) NE ) NE
, NE , NE
a NE x NE
molecular G#protein_family_or_group_B xxx G#protein_family_or_group_B
chaperone G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

We NE Xx NE
have NE xxx NE
reconstituted NE xxx NE
ligand-dependent NE xxx-xxx NE
activation NE xxx NE
of NE xx NE
the NE xxx NE
receptor NE xxx NE
to NE xx NE
a NE x NE
DNA-binding G#protein_family_or_group_B XXX-xxx G#protein_family_or_group_B
form G#protein_family_or_group_E xxx G#protein_family_or_group_E
by NE xx NE
using NE xxx NE
the NE xxx NE
dioxin G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
and NE xxx NE
its NE xxx NE
bHLH-PAS G#protein_molecule_B xXXX-XXX G#protein_molecule_B
partner G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_E xxx G#protein_molecule_E
Arnt G#protein_molecule Xxxx G#protein_molecule
expressed NE xxx NE
by NE xx NE
in NE xx NE
vitro NE xxx NE
translation NE xxx NE
in NE xx NE
reticulocyte NE xxx NE
lysate NE xxx NE
. NE . NE

Deletion NE Xxxx NE
of NE xx NE
the NE xxx NE
PAS G#protein_domain_or_region_B XXX G#protein_domain_or_region_B
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
of NE xx NE
the NE xxx NE
receptor NE xxx NE
resulted NE xxx NE
in NE xx NE
constitutive NE xxx NE
dimerization NE xxx NE
with NE xxx NE
Arnt G#protein_molecule Xxxx G#protein_molecule
. NE . NE

In NE Xx NE
contrast NE xxx NE
, NE , NE
this NE xxx NE
receptor NE xxx NE
mutant NE xxx NE
showed NE xxx NE
low NE xxx NE
levels NE xxx NE
of NE xx NE
xenobiotic NE xxx NE
response NE xxx NE
element-binding G#other_name_B xxx-xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
, NE , NE
indicating NE xxx NE
that NE xxx NE
the NE xxx NE
PAS G#protein_domain_or_region_B XXX G#protein_domain_or_region_B
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
may NE xxx NE
be NE xx NE
important NE xxx NE
for NE xxx NE
DNA-binding G#other_name_B XXX-xxx G#other_name_B
affinity G#other_name_E xxx G#other_name_E
and/or NE xxx/xx NE
specificity NE xxx NE
of NE xx NE
the NE xxx NE
receptor NE xxx NE
. NE . NE

It NE Xx NE
was NE xxx NE
not NE xxx NE
possible NE xxx NE
to NE xx NE
reconstitute NE xxx NE
dioxin G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
function NE xxx NE
with NE xxx NE
proteins NE xxx NE
expressed NE xxx NE
in NE xx NE
wheat G#cell_component_B xxx G#cell_component_B
germ G#cell_component_M xxx G#cell_component_M
lysate G#cell_component_E xxx G#cell_component_E
. NE . NE

In NE Xx NE
line NE xxx NE
with NE xxx NE
these NE xxx NE
observations NE xxx NE
, NE , NE
reticulocyte G#cell_component_B xxx G#cell_component_B
lysate G#cell_component_E xxx G#cell_component_E
but NE xxx NE
not NE xxx NE
wheat G#cell_component_B xxx G#cell_component_B
germ G#cell_component_M xxx G#cell_component_M
lysate G#cell_component_E xxx G#cell_component_E
promoted NE xxx NE
the NE xxx NE
association NE xxx NE
of NE xx NE
de NE xx NE
novo NE xxx NE
synthesized NE xxx NE
dioxin G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
with NE xxx NE
hsp90 G#protein_molecule xxxdd G#protein_molecule
. NE . NE

At NE Xx NE
least NE xxx NE
two NE xxx NE
distinct NE xxx NE
domains NE xxx NE
of NE xx NE
the NE xxx NE
receptor NE xxx NE
mediated NE xxx NE
interaction NE xxx NE
with NE xxx NE
hsp90 G#protein_molecule xxxdd G#protein_molecule
: NE : NE
the NE xxx NE
ligand-binding G#protein_domain_or_region_B xxx-xxx G#protein_domain_or_region_B
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
located NE xxx NE
within NE xxx NE
the NE xxx NE
PAS G#protein_domain_or_region_B XXX G#protein_domain_or_region_B
region G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
and NE xxx NE
, NE , NE
surprisingly NE xxx NE
, NE , NE
the NE xxx NE
bHLH G#protein_domain_or_region_B xXXX G#protein_domain_or_region_B
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
. NE . NE

Whereas NE Xxxx NE
ligand-binding G#other_name_B xxx-xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
correlated NE xxx NE
with NE xxx NE
association NE xxx NE
with NE xxx NE
hsp90 G#protein_molecule xxxdd G#protein_molecule
, NE , NE
bHLH- NE xXXX- NE
hsp90 NE xxxdd NE
interaction NE xxx NE
appeared NE xxx NE
to NE xx NE
be NE xx NE
important NE xxx NE
for NE xxx NE
DNA-binding NE XXX-xxx NE
activity NE xxx NE
but NE xxx NE
not NE xxx NE
for NE xxx NE
dimerization NE xxx NE
of NE xx NE
the NE xxx NE
receptor NE xxx NE
. NE . NE

Several NE Xxxx NE
distinct NE xxx NE
roles NE xxx NE
for NE xxx NE
hsp90 G#protein_molecule xxxdd G#protein_molecule
in NE xx NE
modulating NE xxx NE
dioxin G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
function NE xxx NE
are NE xxx NE
therefore NE xxx NE
likely NE xxx NE
: NE : NE
correct NE xxx NE
folding NE xxx NE
of NE xx NE
the NE xxx NE
ligand-binding NE xxx-xxx NE
domain NE xxx NE
, NE , NE
interference NE xxx NE
with NE xxx NE
Arnt G#protein_molecule Xxxx G#protein_molecule
heterodimerization NE xxx NE
, NE , NE
and NE xxx NE
folding NE xxx NE
of NE xx NE
a NE x NE
DNA-binding NE XXX-xxx NE
conformation NE xxx NE
of NE xx NE
the NE xxx NE
bHLH G#protein_domain_or_region_B xXXX G#protein_domain_or_region_B
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
. NE . NE

Thus NE Xxxx NE
, NE , NE
the NE xxx NE
dioxin G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
system NE xxx NE
provides NE xxx NE
a NE x NE
complex NE xxx NE
and NE xxx NE
interesting NE xxx NE
model NE xxx NE
of NE xx NE
the NE xxx NE
regulation NE xxx NE
of NE xx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
by NE xx NE
hsp90 G#protein_molecule xxxdd G#protein_molecule
. NE . NE

Induction NE Xxxx NE
of NE xx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
lymphocytes G#cell_type_E xxx G#cell_type_E
by NE xx NE
aspirin NE xxx NE
-like NE -xxx NE
drugs NE xxx NE
. NE . NE

Aspirin-like G#other_organic_compound_B Xxxx-xxx G#other_organic_compound_B
drugs G#other_organic_compound_E xxx G#other_organic_compound_E
( NE ( NE
ALD G#other_organic_compound XXX G#other_organic_compound
) NE ) NE
induce NE xxx NE
calcium G#other_name_B xxx G#other_name_B
mobilization G#other_name_E xxx G#other_name_E
, NE , NE
an NE xx NE
essential NE xxx NE
component NE xxx NE
of NE xx NE
T G#other_name_B X G#other_name_B
cell G#other_name_M xxx G#other_name_M
activation G#other_name_E xxx G#other_name_E
, NE , NE
but NE xxx NE
do NE xx NE
not NE xxx NE
induce NE xxx NE
the NE xxx NE
biosynthesis NE xxx NE
of NE xx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
. NE . NE

To NE Xx NE
understand NE xxx NE
the NE xxx NE
extent NE xxx NE
to NE xx NE
which NE xxx NE
ALD G#other_organic_compound XXX G#other_organic_compound
may NE xxx NE
mimic NE xxx NE
mitogenic G#other_name_B xxx G#other_name_B
stimulation G#other_name_E xxx G#other_name_E
, NE , NE
we NE xx NE
studied NE xxx NE
cytoplasmic G#other_name_B xxx G#other_name_B
signaling G#other_name_M xxx G#other_name_M
step G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
nuclear G#other_name_M xxx G#other_name_M
signaling G#other_name_M xxx G#other_name_M
step G#other_name_E xxx G#other_name_E
ALD NE XXX NE
-treated G#cell_line_B -xxx G#cell_line_B
T G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

We NE Xx NE
found NE xxx NE
that NE xxx NE
ALD G#other_organic_compound XXX G#other_organic_compound
induce NE xxx NE
a NE x NE
transient NE xxx NE
activation NE xxx NE
of NE xx NE
protein G#protein_family_or_group_B xxx G#protein_family_or_group_B
kinase G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
PKC G#protein_molecule XXX G#protein_molecule
) NE ) NE
but NE xxx NE
have NE xxx NE
no NE xx NE
effect NE xxx NE
(in NE (xx NE
comparison NE xxx NE
to NE xx NE
anti-CD3 NE xxx-XXd NE
antibodies NE xxx NE
) NE ) NE
on NE xx NE
protein NE xxx NE
tyrosine NE xxx NE
phosphorylation NE xxx NE
nor NE xxx NE
on NE xx NE
PCL NE XXX NE
gamma NE xxx NE
1 NE d NE
tyrosine NE xxx NE
phosphorylation NE xxx NE
. NE . NE

ALD G#other_organic_compound XXX G#other_organic_compound
-induced NE -xxx NE
calcium G#other_name_B xxx G#other_name_B
mobilization G#other_name_E xxx G#other_name_E
and NE xxx NE
PKC G#other_name_B XXX G#other_name_B
activation G#other_name_E xxx G#other_name_E
are NE xxx NE
independent NE xxx NE
of NE xx NE
tyrosine G#other_name_B xxx G#other_name_B
protein G#other_name_M xxx G#other_name_M
kinase G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
as NE xx NE
shown NE xxx NE
by NE xx NE
the NE xxx NE
lack NE xxx NE
of NE xx NE
effect NE xxx NE
of NE xx NE
herbimycin G#other_organic_compound xxx G#other_organic_compound
, NE , NE
a NE x NE
tyrosine NE xxx NE
-protein NE -xxx NE
kinase NE xxx NE
-specific NE -xxx NE
inhibitor NE xxx NE
. NE . NE

Although NE Xxxx NE
we NE xx NE
detected NE xxx NE
no NE xx NE
IL-2 G#RNA_molecule_B XX-d G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
in NE xx NE
ALD NE XXX NE
-treated NE -xxx NE
cells NE xxx NE
, NE , NE
the NE xxx NE
nuclei NE xxx NE
of NE xx NE
these NE xxx NE
cells NE xxx NE
contain NE xxx NE
proteins NE xxx NE
capable NE xxx NE
of NE xx NE
binding NE xxx NE
to NE xx NE
three NE xxx NE
regulatory NE xxx NE
sequences NE xxx NE
in NE xx NE
the NE xxx NE
IL-2 NE XX-d NE
promoter NE xxx NE
region NE xxx NE
: NE : NE
NFAT NE XXXX NE
, NE , NE
NF NE XX NE
kappa NE xxx NE
B NE X NE
, NE , NE
and NE xxx NE
AP-1 NE XX-d NE
. NE . NE

These NE Xxxx NE
binding NE xxx NE
activities NE xxx NE
are NE xxx NE
expressed NE xxx NE
only NE xxx NE
in NE xx NE
activated G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

The NE Xxx NE
expression NE xxx NE
of NE xx NE
AP-1 G#protein_molecule XX-d G#protein_molecule
depended NE xxx NE
on NE xx NE
calcium G#other_name_B xxx G#other_name_B
mobilization G#other_name_E xxx G#other_name_E
and NE xxx NE
PKC G#other_name_B XXX G#other_name_B
activation G#other_name_E xxx G#other_name_E
. NE . NE

These NE Xxxx NE
data NE xxx NE
suggest NE xxx NE
that NE xxx NE
ALD G#other_organic_compound XXX G#other_organic_compound
cause NE xxx NE
transient NE xxx NE
but NE xxx NE
significant NE xxx NE
changes NE xxx NE
in NE xx NE
T G#other_name_B X G#other_name_B
cell G#other_name_M xxx G#other_name_M
transmembrane G#other_name_M xxx G#other_name_M
signaling G#other_name_E xxx G#other_name_E
, NE , NE
although NE xxx NE
some NE xxx NE
events NE xxx NE
induced NE xxx NE
by NE xx NE
stimulation NE xxx NE
with NE xxx NE
anti-CD3 NE xxx-XXd NE
antibodies NE xxx NE
are NE xxx NE
not NE xxx NE
induced NE xxx NE
by NE xx NE
ALD NE XXX NE
. NE . NE

The NE Xxx NE
signal NE xxx NE
is NE xx NE
transmitted NE xxx NE
to NE xx NE
the NE xxx NE
nucleus G#cell_component xxx G#cell_component
and NE xxx NE
induces NE xxx NE
DNA-binding G#other_name_B XXX-xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
by NE xx NE
several NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

However NE Xxxx NE
, NE , NE
the NE xxx NE
ALD G#other_organic_compound XXX G#other_organic_compound
stimulus NE xxx NE
is NE xx NE
not NE xxx NE
capable NE xxx NE
of NE xx NE
causing NE xxx NE
complete NE xxx NE
T G#other_name_B X G#other_name_B
cell G#other_name_M xxx G#other_name_M
activation G#other_name_E xxx G#other_name_E
. NE . NE

Protein G#protein_molecule_B Xxxx G#protein_molecule_B
kinase G#protein_molecule_M xxx G#protein_molecule_M
C G#protein_molecule_E X G#protein_molecule_E
is NE xx NE
not NE xxx NE
a NE x NE
downstream NE xxx NE
effector NE xxx NE
of NE xx NE
p21ras G#DNA_domain_or_region xddxxx G#DNA_domain_or_region
in NE xx NE
activated G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

The NE Xxx NE
aim NE xxx NE
of NE xx NE
this NE xxx NE
present NE xxx NE
study NE xxx NE
was NE xxx NE
to NE xx NE
investigate NE xxx NE
the NE xxx NE
role NE xxx NE
of NE xx NE
protein G#protein_molecule_B xxx G#protein_molecule_B
kinase G#protein_molecule_M xxx G#protein_molecule_M
C G#protein_molecule_E X G#protein_molecule_E
( NE ( NE
PKC G#protein_molecule XXX G#protein_molecule
) NE ) NE
, NE , NE
downstream NE xxx NE
of NE xx NE
p21ras G#DNA_domain_or_region xddxxx G#DNA_domain_or_region
, NE , NE
in NE xx NE
activating NE xxx NE
interleukin-2 G#other_name_B xxx-d G#other_name_B
(IL-2) G#other_name_M (XX-d) G#other_name_M
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
. NE . NE

It NE Xx NE
has NE xxx NE
been NE xxx NE
reported NE xxx NE
that NE xxx NE
PKC G#protein_molecule XXX G#protein_molecule
is NE xx NE
an NE xx NE
effector G#protein_family_or_group xxx G#protein_family_or_group
of NE xx NE
p21ras G#DNA_domain_or_region xddxxx G#DNA_domain_or_region
in NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Data NE Xxxx NE
is NE xx NE
presented NE xxx NE
, NE , NE
using NE xxx NE
the NE xxx NE
potent NE xxx NE
and NE xxx NE
selective NE xxx NE
PKC G#other_organic_compound_B XXX G#other_organic_compound_B
inhibitor G#other_organic_compound_E xxx G#other_organic_compound_E
Ro G#other_organic_compound_B Xx G#other_organic_compound_B
31-8425 G#other_organic_compound_E dd-dddd G#other_organic_compound_E
and NE xxx NE
transient NE xxx NE
expression NE xxx NE
of NE xx NE
a NE x NE
constitutively NE xxx NE
active NE xxx NE
ras NE xxx NE
mutant NE xxx NE
, NE , NE
which NE xxx NE
clearly NE xxx NE
shows NE xxx NE
that NE xxx NE
PKC G#protein_molecule XXX G#protein_molecule
is NE xx NE
not NE xxx NE
downstream NE xxx NE
of NE xx NE
p21ras G#DNA_domain_or_region xddxxx G#DNA_domain_or_region
in NE xx NE
the NE xxx NE
induction NE xxx NE
of NE xx NE
NF-AT G#protein_molecule XX-XX G#protein_molecule
and NE xxx NE
AP-1 G#other_name_B XX-d G#other_name_B
transcriptional G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
and NE xxx NE
in NE xx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
in NE xx NE
human G#cell_line_B xxx G#cell_line_B
Jurkat G#cell_line_M Xxxx G#cell_line_M
T G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

Reporter G#other_name_B Xxxx G#other_name_B
gene G#other_name_M xxx G#other_name_M
experiments G#other_name_E xxx G#other_name_E
demonstrated NE xxx NE
that NE xxx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
transcriptional G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
is NE xx NE
not NE xxx NE
affected NE xxx NE
by NE xx NE
expression NE xxx NE
of NE xx NE
activated NE xxx NE
p21ras G#DNA_domain_or_region xddxxx G#DNA_domain_or_region
. NE . NE

The NE Xxx NE
signaling NE xxx NE
pathways NE xxx NE
involving NE xxx NE
PKC G#other_name_B XXX G#other_name_B
activation G#other_name_E xxx G#other_name_E
, NE , NE
calcium G#other_name_B xxx G#other_name_B
mobilization G#other_name_E xxx G#other_name_E
and NE xxx NE
ras G#other_name_B xxx G#other_name_B
activation G#other_name_E xxx G#other_name_E
combine NE xxx NE
to NE xx NE
provide NE xxx NE
the NE xxx NE
necessary NE xxx NE
components NE xxx NE
for NE xxx NE
production NE xxx NE
of NE xx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
during NE xxx NE
T G#other_name_B X G#other_name_B
cell G#other_name_M xxx G#other_name_M
activation G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
C-terminus G#protein_domain_or_region X-xxx G#protein_domain_or_region
of NE xx NE
the NE xxx NE
B G#protein_domain_or_region_B X G#protein_domain_or_region_B
cell G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
activator G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
Oct-2 G#protein_molecule Xxx-d G#protein_molecule
functions NE xxx NE
as NE xx NE
an NE xx NE
activation G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
in NE xx NE
yeast G#mono_cell xxx G#mono_cell
. NE . NE

Oct-1 G#protein_molecule Xxx-d G#protein_molecule
and NE xxx NE
Oct-2 G#protein_molecule Xxx-d G#protein_molecule
are NE xxx NE
human NE xxx NE
transcriptional G#protein_family_or_group_B xxx G#protein_family_or_group_B
activators G#protein_family_or_group_E xxx G#protein_family_or_group_E
that NE xxx NE
bind NE xxx NE
to NE xx NE
the NE xxx NE
same NE xxx NE
DNA NE XXX NE
element NE xxx NE
but NE xxx NE
activate NE xxx NE
distinct NE xxx NE
sets NE xxx NE
of NE xx NE
genes NE xxx NE
. NE . NE

We NE Xx NE
expressed NE xxx NE
these NE xxx NE
factors NE xxx NE
in NE xx NE
S. G#mono_cell_B X. G#mono_cell_B
cerevisiae G#mono_cell_E xxx G#mono_cell_E
and NE xxx NE
observed NE xxx NE
greater NE xxx NE
than NE xxx NE
5-fold NE d-xxx NE
stimulation NE xxx NE
of NE xx NE
a NE x NE
lacZ G#DNA_molecule_B xxxX G#DNA_molecule_B
reporter G#DNA_molecule_M xxx G#DNA_molecule_M
gene G#DNA_molecule_E xxx G#DNA_molecule_E
only NE xxx NE
with NE xxx NE
Oct-2 G#protein_molecule Xxx-d G#protein_molecule
. NE . NE

Transfer NE Xxxx NE
of NE xx NE
the NE xxx NE
Oct-2 G#protein_domain_or_region_B Xxx-d G#protein_domain_or_region_B
C-terminal G#protein_domain_or_region_M X-xxx G#protein_domain_or_region_M
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
onto NE xxx NE
either NE xxx NE
Oct-1 G#protein_molecule Xxx-d G#protein_molecule
( NE ( NE
Oct1.2 G#protein_molecule Xxxd.d G#protein_molecule
) NE ) NE
or NE xx NE
a NE x NE
nonactivating G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
DNA-binding G#protein_domain_or_region_M XXX-xxx G#protein_domain_or_region_M
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
from NE xxx NE
GAL4 G#protein_molecule XXXd G#protein_molecule
created NE xxx NE
activators NE xxx NE
capable NE xxx NE
of NE xx NE
greater NE xxx NE
than NE xxx NE
15 NE dd NE
and NE xxx NE
10-fold NE dd-xxx NE
stimulation NE xxx NE
of NE xx NE
activity NE xxx NE
, NE , NE
respectively NE xxx NE
. NE . NE

Thus NE Xxxx NE
, NE , NE
the NE xxx NE
C-terminus G#protein_domain_or_region X-xxx G#protein_domain_or_region
of NE xx NE
Oct-2 G#protein_molecule Xxx-d G#protein_molecule
is NE xx NE
sufficient NE xxx NE
to NE xx NE
confer NE xxx NE
activation NE xxx NE
potential NE xxx NE
to NE xx NE
nonactive NE xxx NE
DNA-binding G#DNA_family_or_group_B XXX-xxx G#DNA_family_or_group_B
fragments G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
in NE xx NE
yeast G#mono_cell xxx G#mono_cell
. NE . NE

Glucocorticoid-induced G#other_name_B Xxxx-xxx G#other_name_B
apoptosis G#other_name_E xxx G#other_name_E
of NE xx NE
lymphoid G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

The NE Xxx NE
induction NE xxx NE
of NE xx NE
cell G#other_name_B xxx G#other_name_B
death G#other_name_E xxx G#other_name_E
in NE xx NE
lymphoid G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
by NE xx NE
glucocorticoids G#lipid xxx G#lipid
is NE xx NE
one NE xxx NE
of NE xx NE
the NE xxx NE
earliest NE xxx NE
and NE xxx NE
most NE xxx NE
thoroughly NE xxx NE
studied NE xxx NE
models NE xxx NE
of NE xx NE
apoptosis G#other_name xxx G#other_name
. NE . NE

Although NE Xxxx NE
the NE xxx NE
exact NE xxx NE
mechanism NE xxx NE
by NE xx NE
which NE xxx NE
apoptosis G#other_name xxx G#other_name
occurs NE xxx NE
in NE xx NE
lymphocytes G#cell_type xxx G#cell_type
is NE xx NE
unknown NE xxx NE
many NE xxx NE
biochemical NE xxx NE
and NE xxx NE
molecular NE xxx NE
changes NE xxx NE
have NE xxx NE
been NE xxx NE
shown NE xxx NE
to NE xx NE
occur NE xxx NE
in NE xx NE
these NE xxx NE
cells NE xxx NE
in NE xx NE
response NE xxx NE
to NE xx NE
glucocorticoids G#lipid xxx G#lipid
. NE . NE

The NE Xxx NE
role NE xxx NE
of NE xx NE
chromatin G#other_name_B xxx G#other_name_B
degradation G#other_name_E xxx G#other_name_E
and NE xxx NE
endonucleases G#protein_family_or_group xxx G#protein_family_or_group
in NE xx NE
the NE xxx NE
apoptotic G#other_name_B xxx G#other_name_B
process G#other_name_E xxx G#other_name_E
has NE xxx NE
been NE xxx NE
closely NE xxx NE
studied NE xxx NE
, NE , NE
as NE xx NE
well NE xxx NE
as NE xx NE
the NE xxx NE
involvement NE xxx NE
of NE xx NE
several NE xxx NE
oncogenes G#DNA_family_or_group xxx G#DNA_family_or_group
in NE xx NE
glucocorticoid NE xxx NE
-induced NE -xxx NE
cell NE xxx NE
lysis NE xxx NE
. NE . NE

In NE Xx NE
addition NE xxx NE
, NE , NE
the NE xxx NE
clinical NE xxx NE
importance NE xxx NE
of NE xx NE
glucocorticoid NE xxx NE
-induced NE -xxx NE
apoptosis NE xxx NE
in NE xx NE
the NE xxx NE
treatment NE xxx NE
of NE xx NE
lymphoid NE xxx NE
neoplasms NE xxx NE
has NE xxx NE
recently NE xxx NE
received NE xxx NE
increased NE xxx NE
attention NE xxx NE
. NE . NE

Interleukin-2 G#protein_molecule Xxxx-d G#protein_molecule
induces NE xxx NE
tyrosine G#other_name_B xxx G#other_name_B
phosphorylation G#other_name_E xxx G#other_name_E
and NE xxx NE
nuclear G#other_name_B xxx G#other_name_B
translocation G#other_name_E xxx G#other_name_E
of NE xx NE
stat3 G#protein_molecule xxxd G#protein_molecule
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
lymphocytes G#cell_type_E xxx G#cell_type_E
. NE . NE

An NE Xx NE
early NE xxx NE
biochemical NE xxx NE
event NE xxx NE
associated NE xxx NE
with NE xxx NE
T G#other_name_B X G#other_name_B
cell G#other_name_M xxx G#other_name_M
activation G#other_name_E xxx G#other_name_E
through NE xxx NE
the NE xxx NE
interleukin-2 G#protein_family_or_group_B xxx-d G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
IL-2R G#protein_family_or_group XX-dX G#protein_family_or_group
) NE ) NE
is NE xx NE
tyrosine G#other_name_B xxx G#other_name_B
phosphorylation G#other_name_E xxx G#other_name_E
of NE xx NE
several NE xxx NE
intracellular G#other_organic_compound_B xxx G#other_organic_compound_B
substrates G#other_organic_compound_E xxx G#other_organic_compound_E
. NE . NE

The NE Xxx NE
exact NE xxx NE
mechanism NE xxx NE
by NE xx NE
which NE xxx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
regulates NE xxx NE
transcription NE xxx NE
of NE xx NE
different NE xxx NE
genes NE xxx NE
is NE xx NE
presently NE xxx NE
unknown NE xxx NE
. NE . NE

Here NE Xxxx NE
, NE , NE
we NE xx NE
report NE xxx NE
that NE xxx NE
stimulation NE xxx NE
through NE xxx NE
the NE xxx NE
IL-2R G#protein_family_or_group XX-dX G#protein_family_or_group
induced NE xxx NE
tyrosine G#amino_acid_monomer xxx G#amino_acid_monomer
phosphorylation NE xxx NE
and NE xxx NE
subsequent NE xxx NE
nuclear G#other_name_B xxx G#other_name_B
translocation G#other_name_E xxx G#other_name_E
of NE xx NE
stat3 G#protein_molecule xxxd G#protein_molecule
, NE , NE
a NE x NE
newly NE xxx NE
identified NE xxx NE
member NE xxx NE
of NE xx NE
the NE xxx NE
signal G#protein_family_or_group_B xxx G#protein_family_or_group_B
transducers G#protein_family_or_group_M xxx G#protein_family_or_group_M
and G#protein_family_or_group_M xxx G#protein_family_or_group_M
activators G#protein_family_or_group_M xxx G#protein_family_or_group_M
of G#protein_family_or_group_M xx G#protein_family_or_group_M
transcription G#protein_family_or_group_M xxx G#protein_family_or_group_M
(STAT) G#protein_family_or_group_M (XXXX) G#protein_family_or_group_M
family G#protein_family_or_group_E xxx G#protein_family_or_group_E
of NE xx NE
proteins NE xxx NE
. NE . NE

In NE Xx NE
contrast NE xxx NE
, NE , NE
stat1 NE xxxd NE
proteins NE xxx NE
were NE xxx NE
not NE xxx NE
tyrosine G#other_name_B xxx G#other_name_B
phosphorylated G#other_name_E xxx G#other_name_E
after NE xxx NE
IL-2 G#other_name_B XX-d G#other_name_B
ligation G#other_name_E xxx G#other_name_E
, NE , NE
whereas NE xxx NE
tyrosine G#protein_family_or_group xxx G#protein_family_or_group
-phosphorylated NE -xxx NE
stat1 NE xxxd NE
proteins NE xxx NE
( NE ( NE
91 G#protein_family_or_group_B dd G#protein_family_or_group_B
kDa G#protein_family_or_group_M xXx G#protein_family_or_group_M
protein G#protein_family_or_group_M xxx G#protein_family_or_group_M
and G#protein_family_or_group_M xxx G#protein_family_or_group_M
84 G#protein_family_or_group_M dd G#protein_family_or_group_M
kDa G#protein_family_or_group_M xXx G#protein_family_or_group_M
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
nucleus NE xxx NE
following NE xxx NE
interferon-gamma G#other_name_B xxx-xxx G#other_name_B
treatment G#other_name_E xxx G#other_name_E
of NE xx NE
HeLa G#cell_line_B XxXx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

Apart NE Xxxx NE
from NE xxx NE
stat3 G#protein_molecule xxxd G#protein_molecule
, NE , NE
another NE xxx NE
cytoplasmic G#protein_family_or_group_B xxx G#protein_family_or_group_B
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
was NE xxx NE
tyrosine G#other_name_B xxx G#other_name_B
phosphorylated G#other_name_E xxx G#other_name_E
and NE xxx NE
subsequently NE xxx NE
translocated NE xxx NE
to NE xx NE
the NE xxx NE
nucleus G#cell_component xxx G#cell_component
in NE xx NE
response NE xxx NE
to NE xx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
. NE . NE

This NE Xxxx NE
protein NE xxx NE
had NE xxx NE
an NE xx NE
apparent NE xxx NE
molecular NE xxx NE
mass NE xxx NE
of NE xx NE
84 G#protein_N/A_B dd G#protein_N/A_B
kDa G#protein_N/A_E xXx G#protein_N/A_E
and NE xxx NE
was NE xxx NE
not NE xxx NE
recognized NE xxx NE
by NE xx NE
stat3 G#protein_molecule xxxd G#protein_molecule
or NE xx NE
stat1 G#protein_family_or_group_B xxxd G#protein_family_or_group_B
mAb G#protein_family_or_group_E xXx G#protein_family_or_group_E
or NE xx NE
antisera G#other_organic_compound xxx G#other_organic_compound
. NE . NE

Since NE Xxxx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
induced NE xxx NE
nuclear G#other_name_B xxx G#other_name_B
translocation G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
84 G#protein_molecule_B dd G#protein_molecule_B
kDa G#protein_molecule_M xXx G#protein_molecule_M
protein G#protein_molecule_E xxx G#protein_molecule_E
and NE xxx NE
stat3 G#protein_molecule xxxd G#protein_molecule
followed NE xxx NE
identical NE xxx NE
kinetics NE xxx NE
, NE , NE
p84 G#protein_molecule xdd G#protein_molecule
is NE xx NE
a NE x NE
candidate NE xxx NE
for NE xxx NE
a NE x NE
new NE xxx NE
, NE , NE
yet NE xxx NE
undefined NE xxx NE
, NE , NE
member NE xxx NE
of NE xx NE
the NE xxx NE
STAT NE XXXX NE
family NE xxx NE
. NE . NE

Taken NE Xxxx NE
together NE xxx NE
, NE , NE
we NE xx NE
report NE xxx NE
that NE xxx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
induces NE xxx NE
tyrosine G#other_name_B xxx G#other_name_B
phosphorylation G#other_name_E xxx G#other_name_E
and NE xxx NE
subsequent NE xxx NE
nuclear G#other_name_B xxx G#other_name_B
translocation G#other_name_E xxx G#other_name_E
of NE xx NE
stat3 G#protein_molecule xxxd G#protein_molecule
and NE xxx NE
an NE xx NE
as NE xx NE
yet NE xxx NE
undefined NE xxx NE
84-kDa G#protein_molecule_B dd-xXx G#protein_molecule_B
protein G#protein_molecule_E xxx G#protein_molecule_E
in NE xx NE
antigen-specific G#cell_line_B xxx-xxx G#cell_line_B
human G#cell_line_M xxx G#cell_line_M
T G#cell_line_M X G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
. NE . NE

Human G#other_name_B Xxxx G#other_name_B
T-cell G#other_name_M X-xxx G#other_name_M
leukemia G#other_name_M xxx G#other_name_M
virus G#other_name_M xxx G#other_name_M
type G#other_name_M xxx G#other_name_M
I G#other_name_M X G#other_name_M
Tax G#other_name_M Xxx G#other_name_M
activation G#other_name_E xxx G#other_name_E
of NE xx NE
NF-kappa NE XX-xxx NE
B NE X NE
/Rel NE /Xxx NE
involves NE xxx NE
phosphorylation NE xxx NE
and NE xxx NE
degradation NE xxx NE
of NE xx NE
I NE X NE
kappa NE xxx NE
B NE X NE
alpha NE xxx NE
and NE xxx NE
RelA NE XxxX NE
( NE ( NE
p65 NE xdd NE
)-mediated NE )-xxx NE
induction NE xxx NE
of NE xx NE
the NE xxx NE
c-rel NE x-xxx NE
gene NE xxx NE
. NE . NE

The NE Xxx NE
tax NE xxx NE
gene NE xxx NE
product NE xxx NE
of NE xx NE
human G#virus_B xxx G#virus_B
T-cell G#virus_M X-xxx G#virus_M
leukemia G#virus_M xxx G#virus_M
virus G#virus_M xxx G#virus_M
type G#virus_M xxx G#virus_M
I G#virus_E X G#virus_E
( NE ( NE
HTLV-I G#virus XXXX-X G#virus
) NE ) NE
is NE xx NE
a NE x NE
potent NE xxx NE
transcriptional G#protein_family_or_group_B xxx G#protein_family_or_group_B
activator G#protein_family_or_group_E xxx G#protein_family_or_group_E
that NE xxx NE
both NE xxx NE
stimulates NE xxx NE
viral NE xxx NE
gene NE xxx NE
expression NE xxx NE
and NE xxx NE
activates NE xxx NE
an NE xx NE
array NE xxx NE
of NE xx NE
cellular G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
involved NE xxx NE
in NE xx NE
T-cell G#other_name_B X-xxx G#other_name_B
growth G#other_name_E xxx G#other_name_E
. NE . NE

Tax NE Xxx NE
acts NE xxx NE
indirectly NE xxx NE
by NE xx NE
inducing NE xxx NE
or NE xx NE
modifying NE xxx NE
the NE xxx NE
action NE xxx NE
of NE xx NE
various NE xxx NE
host NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
including NE xxx NE
members NE xxx NE
of NE xx NE
the NE xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
/Rel NE /Xxx NE
family NE xxx NE
of NE xx NE
enhancer-binding NE xxx-xxx NE
proteins NE xxx NE
. NE . NE

In NE Xx NE
resting G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
, NE , NE
many NE xxx NE
of NE xx NE
these NE xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
/Rel NE /Xxx NE
factors NE xxx NE
are NE xxx NE
sequestered NE xxx NE
in NE xx NE
the NE xxx NE
cytoplasm NE xxx NE
by NE xx NE
various NE xxx NE
ankyrin-rich NE xxx-xxx NE
inhibitory NE xxx NE
proteins NE xxx NE
, NE , NE
including NE xxx NE
I NE X NE
kappa NE xxx NE
B NE X NE
alpha NE xxx NE
. NE . NE

HTLV-I G#other_name_B XXXX-X G#other_name_B
Tax G#other_name_M Xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
leads NE xxx NE
to NE xx NE
the NE xxx NE
constitutive G#other_name_B xxx G#other_name_B
nuclear G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
of NE xx NE
biologically NE xxx NE
active NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
and NE xxx NE
c-Rel NE x-Xxx NE
complexes NE xxx NE
; NE ; NE
however NE xxx NE
, NE , NE
the NE xxx NE
biochemical NE xxx NE
mechanism NE xxx NE
(s) NE (x) NE
underlying NE xxx NE
this NE xxx NE
response NE xxx NE
remains NE xxx NE
poorly NE xxx NE
understood NE xxx NE
. NE . NE

In NE Xx NE
this NE xxx NE
study NE xxx NE
, NE , NE
we NE xx NE
demonstrate NE xxx NE
that NE xxx NE
Tax NE Xxx NE
-stimulated NE -xxx NE
nuclear NE xxx NE
expression NE xxx NE
of NE xx NE
NF-kappa NE XX-xxx NE
B NE X NE
in NE xx NE
both NE xxx NE
HTLV-I NE XXXX-X NE
-infected NE -xxx NE
and NE xxx NE
Tax NE Xxx NE
-transfected NE -xxx NE
human NE xxx NE
T NE X NE
cells NE xxx NE
is NE xx NE
associated NE xxx NE
with NE xxx NE
the NE xxx NE
phosphorylation NE xxx NE
and NE xxx NE
rapid NE xxx NE
proteolytic NE xxx NE
degradation NE xxx NE
of NE xx NE
I NE X NE
kappa NE xxx NE
B NE X NE
alpha NE xxx NE
. NE . NE

In NE Xx NE
contrast NE xxx NE
to NE xx NE
prior NE xxx NE
in NE xx NE
vitro NE xxx NE
studies NE xxx NE
, NE , NE
at NE xx NE
least NE xxx NE
a NE x NE
fraction NE xxx NE
of NE xx NE
the NE xxx NE
phosphorylated NE xxx NE
form NE xxx NE
of NE xx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
remains NE xxx NE
physically NE xxx NE
associated NE xxx NE
with NE xxx NE
the NE xxx NE
NF-kappa G#protein_complex_B XX-xxx G#protein_complex_B
B G#protein_complex_M X G#protein_complex_M
complex G#protein_complex_E xxx G#protein_complex_E
in NE xx NE
vivo NE xxx NE
but NE xxx NE
is NE xx NE
subject NE xxx NE
to NE xx NE
rapid NE xxx NE
degradation NE xxx NE
, NE , NE
thereby NE xxx NE
promoting NE xxx NE
the NE xxx NE
nuclear G#other_name_B xxx G#other_name_B
translocation G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
active NE xxx NE
NF-kappa G#protein_complex_B XX-xxx G#protein_complex_B
B G#protein_complex_M X G#protein_complex_M
complex G#protein_complex_E xxx G#protein_complex_E
. NE . NE

We NE Xx NE
further NE xxx NE
demonstrate NE xxx NE
that NE xxx NE
Tax G#other_name_B Xxx G#other_name_B
induction G#other_name_E xxx G#other_name_E
of NE xx NE
nuclear G#other_name_B xxx G#other_name_B
c-Rel G#other_name_M x-Xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
is NE xx NE
activated NE xxx NE
by NE xx NE
the NE xxx NE
RelA G#protein_subunit XxxX G#protein_subunit
( NE ( NE
p65 G#protein_subunit xdd G#protein_subunit
) NE ) NE
subunit NE xxx NE
of NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
, NE , NE
which NE xxx NE
activates NE xxx NE
transcription NE xxx NE
of NE xx NE
the NE xxx NE
c-rel G#DNA_domain_or_region_B x-xxx G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
through NE xxx NE
an NE xx NE
intrinsic NE xxx NE
kappa G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
B G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
enhancer G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

In NE Xx NE
normal NE xxx NE
cells NE xxx NE
, NE , NE
the NE xxx NE
subsequent NE xxx NE
accumulation NE xxx NE
of NE xx NE
nuclear G#protein_molecule_B xxx G#protein_molecule_B
c-Rel G#protein_molecule_E x-Xxx G#protein_molecule_E
acts NE xxx NE
to NE xx NE
inhibit NE xxx NE
its NE xxx NE
own NE xxx NE
continued NE xxx NE
production NE xxx NE
, NE , NE
indicating NE xxx NE
the NE xxx NE
presence NE xxx NE
of NE xx NE
an NE xx NE
autoregulatory G#other_name_B xxx G#other_name_B
loop G#other_name_E xxx G#other_name_E
. NE . NE

(ABSTRACT NE (XXXXXXXX NE
TRUNCATED NE XXXXXXXXX NE
AT NE XX NE
250 NE ddd NE
WORDS) NE XXXXX) NE

Activation NE Xxxx NE
of NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
in NE xx NE
vivo NE xxx NE
is NE xx NE
regulated NE xxx NE
by NE xx NE
multiple NE xxx NE
phosphorylations NE xxx NE
. NE . NE

The NE Xxx NE
activation NE xxx NE
of NE xx NE
nuclear G#protein_molecule_B xxx G#protein_molecule_B
factor G#protein_molecule_M xxx G#protein_molecule_M
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_E X G#protein_molecule_E
( NE ( NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
) NE ) NE
in NE xx NE
intact NE xxx NE
cells NE xxx NE
is NE xx NE
mechanistically NE xxx NE
not NE xxx NE
well NE xxx NE
understood NE xxx NE
. NE . NE

Therefore NE Xxxx NE
we NE xx NE
investigated NE xxx NE
the NE xxx NE
modifications NE xxx NE
imposed NE xxx NE
on NE xx NE
NF-kappa NE XX-xxx NE
B NE X NE
/I NE /X NE
kappa NE xxx NE
B NE X NE
components NE xxx NE
following NE xxx NE
stimulation NE xxx NE
and NE xxx NE
show NE xxx NE
that NE xxx NE
the NE xxx NE
final NE xxx NE
step NE xxx NE
of NE xx NE
NF-kappa NE XX-xxx NE
B NE X NE
induction NE xxx NE
in NE xx NE
vivo NE xxx NE
involves NE xxx NE
phosphorylation NE xxx NE
of NE xx NE
several NE xxx NE
members NE xxx NE
of NE xx NE
the NE xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
/I NE /X NE
kappa NE xxx NE
B NE X NE
protein NE xxx NE
families NE xxx NE
. NE . NE

In NE Xx NE
HeLa G#cell_line_B XxXx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
as NE xx NE
well NE xxx NE
as NE xx NE
in NE xx NE
B G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
, NE , NE
TNF-alpha NE XXX-xxx NE
rapidly NE xxx NE
induced NE xxx NE
nuclear G#other_name_B xxx G#other_name_B
translocation G#other_name_E xxx G#other_name_E
primarily NE xxx NE
of NE xx NE
p50-p65 G#protein_complex xdd-xdd G#protein_complex
, NE , NE
but NE xxx NE
not NE xxx NE
of NE xx NE
c-rel G#protein_molecule x-xxx G#protein_molecule
. NE . NE

Both NE Xxxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
precursors NE xxx NE
and NE xxx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
became NE xxx NE
strongly NE xxx NE
phosphorylated NE xxx NE
with NE xxx NE
the NE xxx NE
same NE xxx NE
kinetics NE xxx NE
. NE . NE

In NE Xx NE
addition NE xxx NE
to NE xx NE
the NE xxx NE
inducible NE xxx NE
phosphorylation NE xxx NE
after NE xxx NE
stimulation NE xxx NE
, NE , NE
B G#cell_type_B X G#cell_type_B
lymphocytes G#cell_type_E xxx G#cell_type_E
containing NE xxx NE
constitutive NE xxx NE
nuclear NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
revealed NE xxx NE
constitutively NE xxx NE
phosphorylated NE xxx NE
p65 G#protein_subunit xdd G#protein_subunit
and NE xxx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

Phosphorylation NE Xxxx NE
was NE xxx NE
accompanied NE xxx NE
by NE xx NE
induced NE xxx NE
processing NE xxx NE
of NE xx NE
the NE xxx NE
precursors NE xxx NE
p100 G#protein_molecule xddd G#protein_molecule
and NE xxx NE
p105 G#protein_molecule xddd G#protein_molecule
and NE xxx NE
by NE xx NE
degradation NE xxx NE
of NE xx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

As NE Xx NE
an NE xx NE
in NE xx NE
vitro NE xxx NE
model NE xxx NE
we NE xx NE
show NE xxx NE
that NE xxx NE
phosphorylation NE xxx NE
of NE xx NE
p105 G#protein_molecule xddd G#protein_molecule
impedes NE xxx NE
its NE xxx NE
ability NE xxx NE
to NE xx NE
interact NE xxx NE
with NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
, NE , NE
as NE xx NE
has NE xxx NE
been NE xxx NE
shown NE xxx NE
before NE xxx NE
for NE xxx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

Surprisingly NE Xxxx NE
, NE , NE
even NE xxx NE
p65 G#protein_subunit xdd G#protein_subunit
, NE , NE
but NE xxx NE
not NE xxx NE
c-rel G#protein_molecule x-xxx G#protein_molecule
, NE , NE
was NE xxx NE
phosphorylated NE xxx NE
after NE xxx NE
induction NE xxx NE
in NE xx NE
vivo NE xxx NE
, NE , NE
suggesting NE xxx NE
that NE xxx NE
TNF-alpha G#protein_molecule XXX-xxx G#protein_molecule
selectively NE xxx NE
activates NE xxx NE
only NE xxx NE
specific NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
heteromers NE xxx NE
and NE xxx NE
that NE xxx NE
modifications NE xxx NE
regulate NE xxx NE
not NE xxx NE
only NE xxx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
molecules G#protein_molecule_E xxx G#protein_molecule_E
but NE xxx NE
also NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
molecules NE xxx NE
. NE . NE

In NE Xx NE
fact NE xxx NE
, NE , NE
cellular G#other_name_B xxx G#other_name_B
NF-kappa G#other_name_M XX-xxx G#other_name_M
B G#other_name_M X G#other_name_M
activity G#other_name_E xxx G#other_name_E
was NE xxx NE
phosphorylation-dependent NE xxx-xxx NE
and NE xxx NE
the NE xxx NE
DNA G#other_name_B XXX G#other_name_B
binding G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
of NE xx NE
p65 NE xdd NE
-containing NE -xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
was NE xxx NE
enhanced NE xxx NE
by NE xx NE
phosphorylation NE xxx NE
in NE xx NE
vitro NE xxx NE
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
we NE xx NE
found NE xxx NE
that NE xxx NE
the NE xxx NE
induction NE xxx NE
by NE xx NE
hydrogen G#inorganic_B xxx G#inorganic_B
peroxide G#inorganic_E xxx G#inorganic_E
of NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
translocation NE xxx NE
to NE xx NE
the NE xxx NE
nucleus G#cell_component xxx G#cell_component
, NE , NE
which NE xxx NE
is NE xx NE
assumed NE xxx NE
to NE xx NE
be NE xx NE
triggered NE xxx NE
by NE xx NE
reactive G#inorganic_B xxx G#inorganic_B
oxygen G#inorganic_M xxx G#inorganic_M
intermediates G#inorganic_E xxx G#inorganic_E
, NE , NE
also NE xxx NE
coincided NE xxx NE
with NE xxx NE
incorporation NE xxx NE
of NE xx NE
phosphate G#other_organic_compound xxx G#other_organic_compound
into NE xxx NE
the NE xxx NE
same NE xxx NE
subunits NE xxx NE
that NE xxx NE
were NE xxx NE
modified NE xxx NE
after NE xxx NE
stimulation NE xxx NE
by NE xx NE
TNF-alpha G#protein_molecule XXX-xxx G#protein_molecule
. NE . NE

Thus NE Xxxx NE
, NE , NE
phosphorylation G#other_name xxx G#other_name
appears NE xxx NE
to NE xx NE
be NE xx NE
a NE x NE
general NE xxx NE
mechanism NE xxx NE
for NE xxx NE
activation NE xxx NE
of NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
in NE xx NE
vivo NE xxx NE
. NE . NE

Treatment NE Xxxx NE
of NE xx NE
HL60 G#cell_line_B XXdd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
with NE xxx NE
various NE xxx NE
combinations NE xxx NE
of NE xx NE
retinoids G#other_organic_compound xxx G#other_organic_compound
and NE xxx NE
1 G#lipid_B d G#lipid_B
alpha,25 G#lipid_M xxx,dd G#lipid_M
dihydroxyvitamin G#lipid_M xxx G#lipid_M
D3 G#lipid_E Xd G#lipid_E
results NE xxx NE
in NE xx NE
differentiation NE xxx NE
towards NE xxx NE
neutrophils G#cell_type xxx G#cell_type
or NE xx NE
monocytes G#cell_type xxx G#cell_type
or NE xx NE
a NE x NE
failure NE xxx NE
to NE xx NE
differentiate NE xxx NE
and NE xxx NE
apoptosis G#other_name xxx G#other_name
. NE . NE

It NE Xx NE
is NE xx NE
well NE xxx NE
documented NE xxx NE
that NE xxx NE
treatment NE xxx NE
of NE xx NE
serum-grown G#cell_line_B xxx-xxx G#cell_line_B
HL60 G#cell_line_M XXdd G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
with NE xxx NE
10(-7) NE dd(-d) NE
M NE X NE
all-trans G#other_organic_compound_B xxx-xxx G#other_organic_compound_B
retinoic G#other_organic_compound_M xxx G#other_organic_compound_M
acid G#other_organic_compound_E xxx G#other_organic_compound_E
( NE ( NE
all-trans G#other_organic_compound_B xxx-xxx G#other_organic_compound_B
RA G#other_organic_compound_E XX G#other_organic_compound_E
) NE ) NE
induces NE xxx NE
neutrophil G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
, NE , NE
whereas NE xxx NE
treatment NE xxx NE
with NE xxx NE
10(-7) NE dd(-d) NE
M NE X NE
1 G#lipid_B d G#lipid_B
alpha,25 G#lipid_M xxx,dd G#lipid_M
dihydroxyvitamin G#lipid_M xxx G#lipid_M
D3 G#lipid_E Xd G#lipid_E
( NE ( NE
D3 G#lipid Xd G#lipid
) NE ) NE
induces NE xxx NE
differentiation NE xxx NE
towards NE xxx NE
monocytes G#cell_type xxx G#cell_type
. NE . NE

In NE Xx NE
recent NE xxx NE
investigations NE xxx NE
, NE , NE
using NE xxx NE
serum-free G#cell_line_B xxx-xxx G#cell_line_B
grown G#cell_line_M xxx G#cell_line_M
HL60 G#cell_line_M XXdd G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
we NE xx NE
observed NE xxx NE
that NE xxx NE
all-trans G#other_organic_compound_B xxx-xxx G#other_organic_compound_B
RA G#other_organic_compound_E XX G#other_organic_compound_E
, NE , NE
at NE xx NE
10(-7) NE dd(-d) NE
M NE X NE
, NE , NE
did NE xxx NE
not NE xxx NE
induce NE xxx NE
neutrophil G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
and NE xxx NE
that NE xxx NE
all-trans G#other_organic_compound_B xxx-xxx G#other_organic_compound_B
RA G#other_organic_compound_E XX G#other_organic_compound_E
, NE , NE
at NE xx NE
10(-8) NE dd(-d) NE
M NE X NE
, NE , NE
reduced NE xxx NE
the NE xxx NE
D3 G#lipid Xd G#lipid
concentration NE xxx NE
required NE xxx NE
for NE xxx NE
monocyte G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
to NE xx NE
5 NE d NE
x NE x NE
10(-9) NE dd(-d) NE
M NE X NE
. NE . NE

In NE Xx NE
this NE xxx NE
study NE xxx NE
, NE , NE
co-operative NE xx-xxx NE
interactions NE xxx NE
between NE xxx NE
all-trans G#other_organic_compound_B xxx-xxx G#other_organic_compound_B
RA G#other_organic_compound_M XX G#other_organic_compound_M
and G#other_organic_compound_M xxx G#other_organic_compound_M
9-cis G#other_organic_compound_M d-xxx G#other_organic_compound_M
RA G#other_organic_compound_E XX G#other_organic_compound_E
D3 NE Xd NE
which NE xxx NE
promote NE xxx NE
neutrophil NE xxx NE
and NE xxx NE
monocyte G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
of NE xx NE
HL60 G#cell_line_B XXdd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
have NE xxx NE
been NE xxx NE
analysed NE xxx NE
in NE xx NE
detail NE xxx NE
. NE . NE

Treatment NE Xxxx NE
of NE xx NE
serum-free G#cell_line_B xxx-xxx G#cell_line_B
grown G#cell_line_M xxx G#cell_line_M
HL60 G#cell_line_M XXdd G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
with NE xxx NE
5 NE d NE
x NE x NE
10(-7) NE dd(-d) NE
M NE X NE
all-trans G#other_organic_compound_B xxx-xxx G#other_organic_compound_B
RA G#other_organic_compound_E XX G#other_organic_compound_E
or NE xx NE
9-cis G#other_organic_compound_B d-xxx G#other_organic_compound_B
RA G#other_organic_compound_E XX G#other_organic_compound_E
resulted NE xxx NE
in NE xx NE
sub-optimal NE xxx-xxx NE
neutrophil G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
(up NE (xx NE
to NE xx NE
25% NE dd% NE
mature NE xxx NE
cells) NE xxx) NE
. NE . NE

As NE Xx NE
shown NE xxx NE
for NE xxx NE
all-trans G#other_organic_compound_B xxx-xxx G#other_organic_compound_B
RA G#other_organic_compound_E XX G#other_organic_compound_E
, NE , NE
9-cis G#other_organic_compound_B d-xxx G#other_organic_compound_B
RA G#other_organic_compound_E XX G#other_organic_compound_E
cooperated NE xxx NE
with NE xxx NE
D3 G#lipid Xd G#lipid
to NE xx NE
promote NE xxx NE
monocyte G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
. NE . NE

Culture NE Xxxx NE
of NE xx NE
HL60 G#cell_line_B XXdd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
in NE xx NE
5 NE d NE
x NE x NE
10(-7) NE dd(-d) NE
M NE X NE
9-cis G#other_organic_compound_B d-xxx G#other_organic_compound_B
RA G#other_organic_compound_E XX G#other_organic_compound_E
together NE xxx NE
with NE xxx NE
a NE x NE
wide NE xxx NE
range NE xxx NE
of NE xx NE
concentrations NE xxx NE
of NE xx NE
D3 G#lipid Xd G#lipid
resulted NE xxx NE
in NE xx NE
promotion NE xxx NE
of NE xx NE
neutrophil G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
at NE xx NE
10(-15)-10(-12) NE dd(-dd)-dd(-dd) NE
D3 G#lipid Xd G#lipid
, NE , NE
a NE x NE
failure NE xxx NE
to NE xx NE
differentiate NE xxx NE
and NE xxx NE
apoptosis G#other_name xxx G#other_name
at NE xx NE
10(-11)-10(-10) NE dd(-dd)-dd(-dd) NE
M NE X NE
D3 G#lipid Xd G#lipid
, NE , NE
followed NE xxx NE
by NE xx NE
co-operativity NE xx-xxx NE
between NE xxx NE
9-cis G#other_organic_compound_B d-xxx G#other_organic_compound_B
RA G#other_organic_compound_E XX G#other_organic_compound_E
and NE xxx NE
5 NE d NE
x NE x NE
10(-9) NE dd(-d) NE
M NE X NE
D3 G#lipid Xd G#lipid
in NE xx NE
inducing NE xxx NE
monocyte G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
in NE xx NE
the NE xxx NE
absence NE xxx NE
of NE xx NE
neutrophil G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
. NE . NE

Similar NE Xxxx NE
results NE xxx NE
were NE xxx NE
obtained NE xxx NE
when NE xxx NE
HL60 G#cell_line_B XXdd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
were NE xxx NE
treated NE xxx NE
with NE xxx NE
5 NE d NE
x NE x NE
10(-7) NE dd(-d) NE
all-trans G#other_organic_compound_B xxx-xxx G#other_organic_compound_B
RA G#other_organic_compound_E XX G#other_organic_compound_E
together NE xxx NE
with NE xxx NE
a NE x NE
wide NE xxx NE
range NE xxx NE
of NE xx NE
concentrations NE xxx NE
of NE xx NE
D3 G#lipid Xd G#lipid
. NE . NE

Cross NE Xxxx NE
titration NE xxx NE
analyses NE xxx NE
of NE xx NE
the NE xxx NE
effects NE xxx NE
of NE xx NE
9-cis G#other_organic_compound_B d-xxx G#other_organic_compound_B
RA G#other_organic_compound_E XX G#other_organic_compound_E
and NE xxx NE
D3 G#lipid Xd G#lipid
on NE xx NE
HL60 G#other_name_B XXdd G#other_name_B
cell G#other_name_M xxx G#other_name_M
differentiation G#other_name_E xxx G#other_name_E
were NE xxx NE
undertaken NE xxx NE
to NE xx NE
determine NE xxx NE
the NE xxx NE
boundaries NE xxx NE
of NE xx NE
the NE xxx NE
concentrations NE xxx NE
of NE xx NE
each NE xxx NE
agent NE xxx NE
, NE , NE
alone NE xxx NE
and NE xxx NE
in NE xx NE
combination NE xxx NE
, NE , NE
that NE xxx NE
give NE xxx NE
rise NE xxx NE
to NE xx NE
optimal NE xxx NE
neutrophil G#other_name_B xxx G#other_name_B
differentiation G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
monocyte G#other_name_M xxx G#other_name_M
differentiation G#other_name_E xxx G#other_name_E
of NE xx NE
HL60 G#cell_line_B XXdd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

The NE Xxx NE
observed NE xxx NE
cooperativities NE xxx NE
between NE xxx NE
either NE xxx NE
9-cis G#other_organic_compound_B d-xxx G#other_organic_compound_B
RA G#other_organic_compound_E XX G#other_organic_compound_E
or NE xx NE
all-trans G#other_organic_compound_B xxx-xxx G#other_organic_compound_B
RA G#other_organic_compound_E XX G#other_organic_compound_E
and NE xxx NE
D3 G#lipid Xd G#lipid
have NE xxx NE
important NE xxx NE
implications NE xxx NE
for NE xxx NE
the NE xxx NE
use NE xxx NE
of NE xx NE
combinations NE xxx NE
of NE xx NE
these NE xxx NE
agents NE xxx NE
in NE xx NE
differentiation G#other_name_B xxx G#other_name_B
therapy G#other_name_E xxx G#other_name_E
. NE . NE

Isolation NE Xxxx NE
of NE xx NE
differentially NE xxx NE
expressed NE xxx NE
sequence NE xxx NE
tags NE xxx NE
from NE xxx NE
steroid-responsive G#cell_type_B xxx-xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
using NE xxx NE
mRNA G#other_name_B xXXX G#other_name_B
differential G#other_name_M xxx G#other_name_M
display G#other_name_E xxx G#other_name_E
. NE . NE

Transcriptional NE Xxxx NE
control NE xxx NE
of NE xx NE
steroid-regulated G#DNA_family_or_group_B xxx-xxx G#DNA_family_or_group_B
gene G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
networks G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
by NE xx NE
nuclear G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_M xxx G#protein_family_or_group_M
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
results NE xxx NE
in NE xx NE
the NE xxx NE
coordinate NE xxx NE
expression NE xxx NE
of NE xx NE
a NE x NE
limited NE xxx NE
number NE xxx NE
of NE xx NE
target G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
. NE . NE

Although NE Xxxx NE
much NE xxx NE
is NE xx NE
known NE xxx NE
about NE xxx NE
the NE xxx NE
structure NE xxx NE
and NE xxx NE
function NE xxx NE
of NE xx NE
steroid NE xxx NE
receptors NE xxx NE
, NE , NE
relatively NE xxx NE
few NE xxx NE
cell-specific NE xxx-xxx NE
steroid-regulated NE xxx-xxx NE
genes NE xxx NE
have NE xxx NE
been NE xxx NE
isolated NE xxx NE
and NE xxx NE
characterized NE xxx NE
. NE . NE

In NE Xx NE
this NE xxx NE
paper NE xxx NE
we NE xx NE
describe NE xxx NE
results NE xxx NE
using NE xxx NE
mRNA G#other_name_B xXXX G#other_name_B
differential G#other_name_M xxx G#other_name_M
display G#other_name_M xxx G#other_name_M
reverse G#other_name_M xxx G#other_name_M
transcriptase G#other_name_M xxx G#other_name_M
PCR G#other_name_E XXX G#other_name_E
( NE ( NE
DDPCR G#other_name XXXXX G#other_name
) NE ) NE
to NE xx NE
identify NE xxx NE
and NE xxx NE
isolate NE xxx NE
short NE xxx NE
cDNA NE xXXX NE
sequence NE xxx NE
tags NE xxx NE
from NE xxx NE
thymocyte G#cell_type xxx G#cell_type
and NE xxx NE
prostate G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
under NE xxx NE
various NE xxx NE
hormone G#other_name_B xxx G#other_name_B
conditions G#other_name_E xxx G#other_name_E
. NE . NE

Using NE Xxxx NE
this NE xxx NE
technique NE xxx NE
we NE xx NE
have NE xxx NE
isolated NE xxx NE
several NE xxx NE
differentially G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
expressed G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sequence G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
tags G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
DESTs G#DNA_domain_or_region XXXXx G#DNA_domain_or_region
) NE ) NE
from NE xxx NE
the NE xxx NE
mouse G#cell_line_B xxx G#cell_line_B
thymocyte G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
WEHI G#cell_line_B XXXX G#cell_line_B
7.2 G#cell_line_E d.d G#cell_line_E
. NE . NE

Two NE Xxx NE
of NE xx NE
these NE xxx NE
DESTs G#DNA_domain_or_region XXXXx G#DNA_domain_or_region
, NE , NE
GIG10 G#DNA_domain_or_region XXXdd G#DNA_domain_or_region
and NE xxx NE
GIG18 G#DNA_domain_or_region XXXdd G#DNA_domain_or_region
, NE , NE
are NE xxx NE
rapidly NE xxx NE
induced NE xxx NE
by NE xx NE
dexamethasone NE xxx NE
within NE xxx NE
2 NE d NE
h NE x NE
of NE xx NE
treatment NE xxx NE
. NE . NE

GIG10 G#DNA_domain_or_region XXXdd G#DNA_domain_or_region
is NE xx NE
a NE x NE
novel NE xxx NE
sequence NE xxx NE
and NE xxx NE
GIG18 G#DNA_domain_or_region XXXdd G#DNA_domain_or_region
is NE xx NE
the NE xxx NE
mouse NE xxx NE
homologue NE xxx NE
of NE xx NE
a NE x NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
expressed G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sequence G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
tag G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
isolated NE xxx NE
from NE xxx NE
activated G#cell_type_B xxx G#cell_type_B
B G#cell_type_M X G#cell_type_M
lymphocytes G#cell_type_E xxx G#cell_type_E
. NE . NE

We NE Xx NE
also NE xxx NE
used NE xxx NE
DDPCR G#other_name XXXXX G#other_name
to NE xx NE
isolate NE xxx NE
DESTs G#DNA_domain_or_region XXXXx G#DNA_domain_or_region
from NE xxx NE
androgen-modulated G#tissue_B xxx-xxx G#tissue_B
rat G#tissue_M xxx G#tissue_M
ventral G#tissue_M xxx G#tissue_M
prostate G#tissue_M xxx G#tissue_M
tissue G#tissue_E xxx G#tissue_E
, NE , NE
one NE xxx NE
of NE xx NE
which NE xxx NE
we NE xx NE
characterized NE xxx NE
and NE xxx NE
found NE xxx NE
to NE xx NE
correspond NE xxx NE
to NE xx NE
the NE xxx NE
3' G#RNA_domain_or_region_B d' G#RNA_domain_or_region_B
end G#RNA_domain_or_region_E xxx G#RNA_domain_or_region_E
of NE xx NE
prostatic G#RNA_molecule_B xxx G#RNA_molecule_B
spermine G#RNA_molecule_M xxx G#RNA_molecule_M
binding G#RNA_molecule_M xxx G#RNA_molecule_M
protein G#RNA_molecule_M xxx G#RNA_molecule_M
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
, NE , NE
a NE x NE
known NE xxx NE
androgen-regulated G#DNA_family_or_group_B xxx-xxx G#DNA_family_or_group_B
gene G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
. NE . NE

Modifications NE Xxxx NE
of NE xx NE
the NE xxx NE
original NE xxx NE
DDPCR G#other_name_B XXXXX G#other_name_B
protocol G#other_name_E xxx G#other_name_E
, NE , NE
which NE xxx NE
we NE xx NE
found NE xxx NE
can NE xxx NE
potentially NE xxx NE
decrease NE xxx NE
the NE xxx NE
frequency NE xxx NE
of NE xx NE
isolating NE xxx NE
false-positive NE xxx-xxx NE
DESTs G#DNA_domain_or_region XXXXx G#DNA_domain_or_region
, NE , NE
are NE xxx NE
described NE xxx NE
and NE xxx NE
the NE xxx NE
merits NE xxx NE
of NE xx NE
DDPCR G#other_name XXXXX G#other_name
, NE , NE
relative NE xxx NE
to NE xx NE
other NE xxx NE
differential NE xxx NE
cDNA NE xXXX NE
cloning NE xxx NE
strategies NE xxx NE
, NE , NE
are NE xxx NE
discussed NE xxx NE
. NE . NE

Activation NE Xxxx NE
of NE xx NE
human G#cell_type_B xxx G#cell_type_B
thymocytes G#cell_type_E xxx G#cell_type_E
after NE xxx NE
infection NE xxx NE
by NE xx NE
EBV G#virus XXX G#virus
. NE . NE

The NE Xxx NE
discovery NE xxx NE
of NE xx NE
EBV G#virus XXX G#virus
in NE xx NE
certain NE xxx NE
T NE X NE
cell NE xxx NE
malignancies NE xxx NE
and NE xxx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
EBV NE XXX NE
receptor NE xxx NE
, NE , NE
CR2/CD21 NE XXd/XXdd NE
, NE , NE
on NE xx NE
a NE x NE
population NE xxx NE
of NE xx NE
immature NE xxx NE
thymocytes NE xxx NE
, NE , NE
T NE X NE
lymphoblastoid NE xxx NE
cell NE xxx NE
lines NE xxx NE
, NE , NE
and NE xxx NE
childhood NE xxx NE
acute NE xxx NE
T NE X NE
lymphoblastic NE xxx NE
leukemia NE xxx NE
cells NE xxx NE
suggested NE xxx NE
that NE xxx NE
EBV NE XXX NE
-receptor NE -xxx NE
interactions NE xxx NE
on NE xx NE
T NE X NE
cells NE xxx NE
may NE xxx NE
be NE xx NE
of NE xx NE
importance NE xxx NE
. NE . NE

We NE Xx NE
have NE xxx NE
shown NE xxx NE
that NE xxx NE
, NE , NE
within NE xxx NE
the NE xxx NE
thymus G#body_part xxx G#body_part
, NE , NE
a NE x NE
population NE xxx NE
of NE xx NE
large, G#cell_type_B xxx, G#cell_type_B
immature G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
expresses NE xxx NE
CD21 G#protein_molecule XXdd G#protein_molecule
. NE . NE

EBV G#virus XXX G#virus
altered NE xxx NE
the NE xxx NE
activation NE xxx NE
responses NE xxx NE
of NE xx NE
immature G#cell_type_B xxx G#cell_type_B
thymocytes G#cell_type_E xxx G#cell_type_E
in NE xx NE
vitro NE xxx NE
. NE . NE

Triggering NE Xxxx NE
through NE xxx NE
CD2 G#protein_molecule XXd G#protein_molecule
is NE xx NE
mitogenic NE xxx NE
for NE xxx NE
mature NE xxx NE
, NE , NE
but NE xxx NE
not NE xxx NE
immature NE xxx NE
, NE , NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

However NE Xxxx NE
, NE , NE
during NE xxx NE
infection NE xxx NE
by NE xx NE
EBV G#virus XXX G#virus
, NE , NE
ligation NE xxx NE
of NE xx NE
CD2 G#protein_molecule XXd G#protein_molecule
caused NE xxx NE
thymocytes G#cell_type xxx G#cell_type
to NE xx NE
proliferate NE xxx NE
in NE xx NE
the NE xxx NE
absence NE xxx NE
of NE xx NE
exogenous G#protein_family_or_group_B xxx G#protein_family_or_group_B
cytokines G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

This NE Xxxx NE
function NE xxx NE
was NE xxx NE
a NE x NE
result NE xxx NE
of NE xx NE
the NE xxx NE
interaction NE xxx NE
of NE xx NE
EBV G#virus XXX G#virus
with NE xxx NE
its NE xxx NE
receptor NE xxx NE
, NE , NE
CD21 G#protein_molecule XXdd G#protein_molecule
, NE , NE
but NE xxx NE
was NE xxx NE
caused NE xxx NE
by NE xx NE
infection NE xxx NE
rather NE xxx NE
than NE xxx NE
surface NE xxx NE
signaling NE xxx NE
, NE , NE
because NE xxx NE
neither NE xxx NE
specific G#protein_family_or_group_B xxx G#protein_family_or_group_B
mAb G#protein_family_or_group_E xXx G#protein_family_or_group_E
nor NE xxx NE
the NE xxx NE
P3HR-1 G#virus_B XdXX-d G#virus_B
strain G#virus_E xxx G#virus_E
of NE xx NE
virus G#virus xxx G#virus
mimicked NE xxx NE
the NE xxx NE
effect NE xxx NE
of NE xx NE
B95-8 NE Xdd-d NE
. NE . NE

Immature NE Xxxx NE
thymocytes G#cell_type xxx G#cell_type
were NE xxx NE
infected NE xxx NE
by NE xx NE
EBV G#virus XXX G#virus
, NE , NE
as NE xx NE
determined NE xxx NE
by NE xx NE
the NE xxx NE
internalization NE xxx NE
of NE xx NE
the NE xxx NE
viral G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
genome G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
and NE xxx NE
its NE xxx NE
transcriptional G#other_name_B xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
. NE . NE

Consistent NE Xxxx NE
with NE xxx NE
the NE xxx NE
activity NE xxx NE
of NE xx NE
B95-8 G#protein_molecule Xdd-d G#protein_molecule
, NE , NE
EBNA-2 G#RNA_family_or_group_B XXXX-d G#RNA_family_or_group_B
transcripts G#RNA_family_or_group_E xxx G#RNA_family_or_group_E
were NE xxx NE
identified NE xxx NE
within NE xxx NE
infected G#cell_line_B xxx G#cell_line_B
thymocyte G#cell_line_M xxx G#cell_line_M
populations G#cell_line_E xxx G#cell_line_E
. NE . NE

In NE Xx NE
addition NE xxx NE
, NE , NE
components NE xxx NE
of NE xx NE
the NE xxx NE
viral NE xxx NE
replicative NE xxx NE
pathway NE xxx NE
were NE xxx NE
expressed NE xxx NE
during NE xxx NE
infection NE xxx NE
of NE xx NE
thymocytes G#cell_type xxx G#cell_type
. NE . NE

These NE Xxxx NE
components NE xxx NE
included NE xxx NE
transcription NE xxx NE
of NE xx NE
BZLF-1 G#DNA_domain_or_region XXXX-d G#DNA_domain_or_region
, NE , NE
an NE xx NE
early G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
gene G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
that NE xxx NE
characterizes NE xxx NE
EBV NE XXX NE
-infected NE -xxx NE
B NE X NE
cells NE xxx NE
after NE xxx NE
disruption NE xxx NE
of NE xx NE
latency NE xxx NE
. NE . NE

A NE X NE
second NE xxx NE
transcript NE xxx NE
was NE xxx NE
identified NE xxx NE
as NE xx NE
encoding NE xxx NE
the NE xxx NE
recently NE xxx NE
characterized NE xxx NE
RAZ G#protein_molecule XXX G#protein_molecule
, NE , NE
which NE xxx NE
also NE xxx NE
is NE xx NE
associated NE xxx NE
with NE xxx NE
replicative NE xxx NE
infection NE xxx NE
. NE . NE

The NE Xxx NE
consequences NE xxx NE
of NE xx NE
EBV G#other_name_B XXX G#other_name_B
infection G#other_name_E xxx G#other_name_E
of NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
at NE xx NE
an NE xx NE
early NE xxx NE
stage NE xxx NE
of NE xx NE
differentiation NE xxx NE
may NE xxx NE
lead NE xxx NE
to NE xx NE
failure NE xxx NE
of NE xx NE
normal NE xxx NE
T G#other_name_B X G#other_name_B
cell G#other_name_M xxx G#other_name_M
repertoire G#other_name_M xxx G#other_name_M
development G#other_name_E xxx G#other_name_E
, NE , NE
autoimmunity G#other_name xxx G#other_name
, NE , NE
or NE xx NE
malignancy G#other_name xxx G#other_name
. NE . NE

Effects NE Xxxx NE
of NE xx NE
intranasal G#lipid_B xxx G#lipid_B
glucocorticoids G#lipid_E xxx G#lipid_E
on NE xx NE
endogenous G#other_name_B xxx G#other_name_B
glucocorticoid G#other_name_M xxx G#other_name_M
peripheral G#other_name_M xxx G#other_name_M
function G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
endogenous G#other_name_M xxx G#other_name_M
glucocorticoid G#other_name_M xxx G#other_name_M
central G#other_name_M xxx G#other_name_M
function G#other_name_E xxx G#other_name_E

Glucocorticoids G#lipid Xxxx G#lipid
are NE xxx NE
among NE xxx NE
the NE xxx NE
most NE xxx NE
potent NE xxx NE
antiinflammatory G#other_name_B xxx G#other_name_B
agents G#other_name_E xxx G#other_name_E
that NE xxx NE
can NE xxx NE
be NE xx NE
used NE xxx NE
in NE xx NE
the NE xxx NE
treatment NE xxx NE
of NE xx NE
rhinitis G#other_name xxx G#other_name
. NE . NE

Their NE Xxxx NE
mechanisms NE xxx NE
of NE xx NE
action NE xxx NE
are NE xxx NE
multiple NE xxx NE
and NE xxx NE
complex NE xxx NE
and NE xxx NE
a NE x NE
number NE xxx NE
of NE xx NE
reports NE xxx NE
describe NE xxx NE
significant NE xxx NE
systemic NE xxx NE
effects NE xxx NE
of NE xx NE
locally G#lipid_B xxx G#lipid_B
administered G#lipid_M xxx G#lipid_M
glucocorticoids G#lipid_E xxx G#lipid_E
. NE . NE

In NE Xx NE
order NE xxx NE
to NE xx NE
evaluate NE xxx NE
the NE xxx NE
short-term NE xxx-xxx NE
systemic NE xxx NE
effects NE xxx NE
of NE xx NE
intranasally G#lipid_B xxx G#lipid_B
administered G#lipid_M xxx G#lipid_M
glucocorticoids G#lipid_E xxx G#lipid_E
, NE , NE
14 NE dd NE
normal G#multi_cell_B xxx G#multi_cell_B
healthy G#multi_cell_M xxx G#multi_cell_M
subjects G#multi_cell_E xxx G#multi_cell_E
were NE xxx NE
treated NE xxx NE
with NE xxx NE
two NE xxx NE
doses NE xxx NE
of NE xx NE
either NE xxx NE
budesonide G#other_organic_compound xxx G#other_organic_compound
( NE ( NE
BUD G#other_organic_compound XXX G#other_organic_compound
) NE ) NE
or NE xx NE
fluticasone G#other_organic_compound_B xxx G#other_organic_compound_B
propionate G#other_organic_compound_E xxx G#other_organic_compound_E
( NE ( NE
FP G#other_organic_compound XX G#other_organic_compound
) NE ) NE
for NE xxx NE
2 NE d NE
weeks NE xxx NE
. NE . NE

Before NE Xxxx NE
treatment NE xxx NE
, NE , NE
at NE xx NE
regular NE xxx NE
intervals NE xxx NE
during NE xxx NE
the NE xxx NE
treatment NE xxx NE
, NE , NE
1 NE d NE
week NE xxx NE
and NE xxx NE
finally NE xxx NE
6 NE d NE
weeks NE xxx NE
after NE xxx NE
termination NE xxx NE
of NE xx NE
treatment NE xxx NE
, NE , NE
the NE xxx NE
effects NE xxx NE
on NE xx NE
glucocorticoid G#other_name_B xxx G#other_name_B
receptor G#other_name_M xxx G#other_name_M
(GR) G#other_name_M (XX) G#other_name_M
mRNA G#other_name_M xXXX G#other_name_M
expression G#other_name_M xxx G#other_name_M
level G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
methallothionein G#other_name_M xxx G#other_name_M
(MTIIa) G#other_name_M (XXXXx) G#other_name_M
mRNA G#other_name_M xXXX G#other_name_M
expression G#other_name_M xxx G#other_name_M
level G#other_name_E xxx G#other_name_E
were NE xxx NE
examined NE xxx NE
in NE xx NE
peripheral G#cell_type_B xxx G#cell_type_B
lymphocytes G#cell_type_E xxx G#cell_type_E
using NE xxx NE
a NE x NE
solution G#other_name_B xxx G#other_name_B
hybridization G#other_name_M xxx G#other_name_M
assay G#other_name_E xxx G#other_name_E
. NE . NE

serum G#other_name_B xxx G#other_name_B
cortisol G#other_name_M xxx G#other_name_M
level G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
serum G#other_name_M xxx G#other_name_M
osteocalcin G#other_name_M xxx G#other_name_M
level G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
urinary G#other_name_M xxx G#other_name_M
cortisol G#other_name_M xxx G#other_name_M
level G#other_name_E xxx G#other_name_E

An NE Xx NE
insulin G#other_name_B xxx G#other_name_B
tolerance G#other_name_M xxx G#other_name_M
test G#other_name_E xxx G#other_name_E
( NE ( NE
ITT G#other_name XXX G#other_name
) NE ) NE
was NE xxx NE
performed NE xxx NE
at NE xx NE
the NE xxx NE
end NE xxx NE
of NE xx NE
the NE xxx NE
second NE xxx NE
week NE xxx NE
of NE xx NE
treatment NE xxx NE
and NE xxx NE
at NE xx NE
the NE xxx NE
end NE xxx NE
of NE xx NE
the NE xxx NE
6-week NE d-xxx NE
washout NE xxx NE
period NE xxx NE
with NE xxx NE
no NE xx NE
statistically NE xxx NE
significant NE xxx NE
change NE xxx NE
in NE xx NE
cortisol G#lipid xxx G#lipid
response NE xxx NE
. NE . NE

In NE Xx NE
peripheral G#cell_type_B xxx G#cell_type_B
lymphocytes G#cell_type_E xxx G#cell_type_E
, NE , NE
GR G#other_name_B XX G#other_name_B
mRNA G#other_name_M xXXX G#other_name_M
levels G#other_name_E xxx G#other_name_E
were NE xxx NE
significantly NE xxx NE
down-regulated NE xxx-xxx NE
. NE . NE

MTIIa G#other_name_B XXXXx G#other_name_B
mRNA G#other_name_M xXXX G#other_name_M
levels G#other_name_E xxx G#other_name_E
increased NE xxx NE
significantly NE xxx NE
. NE . NE

Serum NE Xxxx NE
osteocalcin G#protein_molecule xxx G#protein_molecule
decreased NE xxx NE
significantly NE xxx NE
during NE xxx NE
treatment NE xxx NE
with NE xxx NE
both NE xxx NE
BUD G#other_organic_compound XXX G#other_organic_compound
and NE xxx NE
FP G#other_organic_compound XX G#other_organic_compound
. NE . NE

Serum NE Xxxx NE
cortisol G#lipid xxx G#lipid
decreased NE xxx NE
after NE xxx NE
1 NE d NE
week NE xxx NE
of NE xx NE
treatment NE xxx NE
whereas NE xxx NE
urinary G#lipid_B xxx G#lipid_B
cortisol G#lipid_E xxx G#lipid_E
was NE xxx NE
not NE xxx NE
affected NE xxx NE
until NE xxx NE
the NE xxx NE
second NE xxx NE
week NE xxx NE
of NE xx NE
treatment NE xxx NE
. NE . NE

In NE Xx NE
conclusion NE xxx NE
, NE , NE
intranasal G#lipid_B xxx G#lipid_B
glucocorticoids G#lipid_E xxx G#lipid_E
at NE xx NE
clinically NE xxx NE
recommended NE xxx NE
doses NE xxx NE
have NE xxx NE
not NE xxx NE
only NE xxx NE
significant NE xxx NE
systemic NE xxx NE
effects NE xxx NE
on NE xx NE
adrenal G#other_name_B xxx G#other_name_B
function G#other_name_E xxx G#other_name_E
, NE , NE
but NE xxx NE
also NE xxx NE
have NE xxx NE
an NE xx NE
effect NE xxx NE
on NE xx NE
specific G#other_name_B xxx G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
in NE xx NE
peripheral G#cell_type_B xxx G#cell_type_B
lymphocytes G#cell_type_E xxx G#cell_type_E
. NE . NE

These NE Xxxx NE
effects NE xxx NE
are NE xxx NE
receptor-dependent NE xxx-xxx NE
, NE , NE
reversible NE xxx NE
, NE , NE
and NE xxx NE
according NE xxx NE
to NE xx NE
serum NE xxx NE
and NE xxx NE
urinary NE xxx NE
cortisol G#other_name_B xxx G#other_name_B
levels G#other_name_E xxx G#other_name_E
and NE xxx NE
ITT G#other_name XXX G#other_name
, NE , NE
leave NE xxx NE
the NE xxx NE
hypothalamic-pituitary-adrenal G#other_name_B xxx-xxx-xxx G#other_name_B
function G#other_name_E xxx G#other_name_E
intact NE xxx NE
. NE . NE

Finally NE Xxxx NE
, NE , NE
these NE xxx NE
short-term G#other_name_B xxx-xxx G#other_name_B
systemic G#other_name_M xxx G#other_name_M
effects G#other_name_E xxx G#other_name_E
were NE xxx NE
not NE xxx NE
associated NE xxx NE
with NE xxx NE
any NE xxx NE
of NE xx NE
the NE xxx NE
noticeable NE xxx NE
side-effects G#other_name xxx-xxx G#other_name
usually NE xxx NE
observed NE xxx NE
during NE xxx NE
long-term G#other_name_B xxx-xxx G#other_name_B
treatment G#other_name_E xxx G#other_name_E
with NE xxx NE
glucocorticoids G#lipid xxx G#lipid
. NE . NE

Biphasic NE Xxxx NE
control NE xxx NE
of NE xx NE
nuclear G#other_name_B xxx G#other_name_B
factor-kappa G#other_name_M xxx-xxx G#other_name_M
B G#other_name_M X G#other_name_M
activation G#other_name_E xxx G#other_name_E
by NE xx NE
the NE xxx NE
T G#protein_complex_B X G#protein_complex_B
cell G#protein_complex_M xxx G#protein_complex_M
receptor G#protein_complex_M xxx G#protein_complex_M
complex G#protein_complex_E xxx G#protein_complex_E
: NE : NE
role NE xxx NE
of NE xx NE
tumor G#protein_molecule_B xxx G#protein_molecule_B
necrosis G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_M xxx G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

The NE Xxx NE
regulation NE xxx NE
of NE xx NE
nuclear G#other_name_B xxx G#other_name_B
factor G#other_name_M xxx G#other_name_M
(NF)-kappa G#other_name_M (XX)-xxx G#other_name_M
B G#other_name_M X G#other_name_M
activation G#other_name_E xxx G#other_name_E
by NE xx NE
the NE xxx NE
T G#protein_complex_B X G#protein_complex_B
cell G#protein_complex_M xxx G#protein_complex_M
receptor G#protein_complex_M xxx G#protein_complex_M
(TcR)/CD3 G#protein_complex_M (XxX)/XXd G#protein_complex_M
complex G#protein_complex_E xxx G#protein_complex_E
in NE xx NE
primary NE xxx NE
human NE xxx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
has NE xxx NE
been NE xxx NE
studied NE xxx NE
at NE xx NE
various NE xxx NE
times NE xxx NE
after NE xxx NE
activation NE xxx NE
. NE . NE

Only NE Xxxx NE
p50 G#protein_molecule_B xdd G#protein_molecule_B
NF-kappa G#protein_molecule_M XX-xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
protein G#protein_molecule_E xxx G#protein_molecule_E
bound NE xxx NE
the NE xxx NE
kappa G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
B G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
interleukin-2 NE xxx-d NE
receptor NE xxx NE
( NE ( NE
IL-2R NE XX-dX NE
) NE ) NE
alpha NE xxx NE
chain NE xxx NE
promoter NE xxx NE
on NE xx NE
resting NE xxx NE
T NE X NE
cells NE xxx NE
. NE . NE

However NE Xxxx NE
, NE , NE
immediately NE xxx NE
after NE xxx NE
TcR/CD3 G#protein_complex XxX/XXd G#protein_complex
cross-linking NE xxx-xxx NE
(after NE (xxx NE
approximately NE xxx NE
1 NE d NE
h NE x NE
; NE ; NE
immediate) NE xxx) NE
binding NE xxx NE
of NE xx NE
p50.p65 G#protein_complex_B xdd.xdd G#protein_complex_B
heterodimers G#protein_complex_E xxx G#protein_complex_E
was NE xxx NE
observed NE xxx NE
. NE . NE

p50.c-rel G#protein_complex_B xdd.x-xxx G#protein_complex_B
heterodimers G#protein_complex_E xxx G#protein_complex_E
were NE xxx NE
also NE xxx NE
detected NE xxx NE
bound NE xxx NE
to NE xx NE
this NE xxx NE
sequence NE xxx NE
at NE xx NE
early NE xxx NE
time NE xxx NE
points NE xxx NE
(7-16 NE (d-dd NE
h NE x NE
; NE ; NE
early) NE xxx) NE
, NE , NE
and NE xxx NE
both NE xxx NE
remained NE xxx NE
active NE xxx NE
at NE xx NE
later NE xxx NE
time NE xxx NE
points NE xxx NE
(40 NE (dd NE
h NE x NE
; NE ; NE
late) NE xxx) NE
after NE xxx NE
activation NE xxx NE
. NE . NE

This NE Xxxx NE
regulation NE xxx NE
takes NE xxx NE
place NE xxx NE
mainly NE xxx NE
at NE xx NE
the NE xxx NE
level NE xxx NE
of NE xx NE
nuclear G#other_name_B xxx G#other_name_B
translocation G#other_name_E xxx G#other_name_E
of NE xx NE
p65 G#protein_subunit xdd G#protein_subunit
and NE xxx NE
c-rel G#protein_subunit x-xxx G#protein_subunit
, NE , NE
at NE xx NE
immediate NE xxx NE
and NE xxx NE
early NE xxx NE
time NE xxx NE
points NE xxx NE
. NE . NE

Activation NE Xxxx NE
also NE xxx NE
induced NE xxx NE
c-rel G#other_name_B x-xxx G#other_name_B
mRNA G#other_name_M xXXX G#other_name_M
synthesis G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
p105/p50 G#other_name_M xddd/xdd G#other_name_M
mRNA G#other_name_M xXXX G#other_name_M
synthesis G#other_name_E xxx G#other_name_E
p65 NE xdd NE
mRNA G#RNA_molecule xXXX G#RNA_molecule
whose NE xxx NE
expression NE xxx NE
was NE xxx NE
constitutive NE xxx NE
. NE . NE

Interestingly NE Xxxx NE
, NE , NE
all NE xxx NE
those NE xxx NE
early NE xxx NE
and NE xxx NE
late NE xxx NE
events NE xxx NE
, NE , NE
but NE xxx NE
not NE xxx NE
the NE xxx NE
immediate NE xxx NE
ones NE xxx NE
, NE , NE
were NE xxx NE
inhibited NE xxx NE
by NE xx NE
a NE x NE
neutralizing NE xxx NE
anti- NE xxx- NE
tumor NE xxx NE
necrosis NE xxx NE
factor NE xxx NE
alpha NE xxx NE
(TNF-alpha) NE (XXX-xxx) NE
monoclonal NE xxx NE
antibody NE xxx NE
. NE . NE

Similarly NE Xxxx NE
, NE , NE
cycloheximide NE xxx NE
prevented NE xxx NE
the NE xxx NE
p65 G#protein_subunit xdd G#protein_subunit
and NE xxx NE
c-rel G#protein_subunit x-xxx G#protein_subunit
translocation G#other_name xxx G#other_name
and NE xxx NE
consequent NE xxx NE
formation NE xxx NE
of NE xx NE
active NE xxx NE
binding NE xxx NE
heterodimers NE xxx NE
, NE , NE
at NE xx NE
early NE xxx NE
and NE xxx NE
late NE xxx NE
times NE xxx NE
. NE . NE

Cyclosporin G#other_organic_compound_B Xxxx G#other_organic_compound_B
A G#other_organic_compound_E X G#other_organic_compound_E
impaired NE xxx NE
not NE xxx NE
only NE xxx NE
early NE xxx NE
and NE xxx NE
late NE xxx NE
, NE , NE
but NE xxx NE
also NE xxx NE
immediate NE xxx NE
events NE xxx NE
; NE ; NE
however NE xxx NE
, NE , NE
addition NE xxx NE
of NE xx NE
TNF-alpha G#protein_molecule XXX-xxx G#protein_molecule
prevented NE xxx NE
all NE xxx NE
inhibition NE xxx NE
. NE . NE

These NE Xxxx NE
results NE xxx NE
indicate NE xxx NE
that NE xxx NE
the NE xxx NE
regulation NE xxx NE
of NE xx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
activation G#other_name_E xxx G#other_name_E
during NE xxx NE
T G#other_name_B X G#other_name_B
cell G#other_name_M xxx G#other_name_M
activation G#other_name_E xxx G#other_name_E
by NE xx NE
TcR/CD3 G#protein_complex XxX/XXd G#protein_complex
signals NE xxx NE
is NE xx NE
biphasic NE xxx NE
: NE : NE
TcR/CD3 G#protein_complex XxX/XXd G#protein_complex
triggers NE xxx NE
its NE xxx NE
immediate NE xxx NE
translocation NE xxx NE
, NE , NE
which NE xxx NE
is NE xx NE
transient NE xxx NE
if NE xx NE
no NE xx NE
TNF-alpha G#protein_molecule XXX-xxx G#protein_molecule
is NE xx NE
present NE xxx NE
. NE . NE

TNF-alpha G#protein_molecule XXX-xxx G#protein_molecule
, NE , NE
therefore NE xxx NE
, NE , NE
emerges NE xxx NE
as NE xx NE
the NE xxx NE
main NE xxx NE
factor NE xxx NE
responsible NE xxx NE
for NE xxx NE
a NE x NE
second NE xxx NE
phase NE xxx NE
of NE xx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
regulation G#other_name_E xxx G#other_name_E
, NE , NE
controlling NE xxx NE
both NE xxx NE
translocation NE xxx NE
of NE xx NE
p65 G#protein_subunit xdd G#protein_subunit
and NE xxx NE
c-rel G#protein_subunit x-xxx G#protein_subunit
, NE , NE
and NE xxx NE
new NE xxx NE
mRNA G#RNA_family_or_group xXXX G#RNA_family_or_group
synthesis NE xxx NE
for NE xxx NE
c-rel G#protein_subunit x-xxx G#protein_subunit
and NE xxx NE
p105/p50 G#protein_complex xddd/xdd G#protein_complex
. NE . NE

The NE Xxx NE
transcription G#protein_molecule_B xxx G#protein_molecule_B
factor G#protein_molecule_M xxx G#protein_molecule_M
Sp1 G#protein_molecule_E Xxd G#protein_molecule_E
is NE xx NE
required NE xxx NE
for NE xxx NE
induction NE xxx NE
of NE xx NE
the NE xxx NE
murine G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
GM-CSF G#DNA_domain_or_region_M XX-XXX G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

The NE Xxx NE
cis-acting G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
GM-kappa G#DNA_domain_or_region_B XX-xxx G#DNA_domain_or_region_B
B/GC-box G#DNA_domain_or_region_E X/XX-xxx G#DNA_domain_or_region_E
( NE ( NE
positions NE xxx NE
-95 NE -dd NE
and NE xxx NE
-73 NE -dd NE
) NE ) NE
, NE , NE
within NE xxx NE
the NE xxx NE
murine NE xxx NE
GM-CSF NE XX-XXX NE
gene NE xxx NE
promoter NE xxx NE
is NE xx NE
required NE xxx NE
for NE xxx NE
maximal NE xxx NE
induction NE xxx NE
by NE xx NE
stimulation NE xxx NE
with NE xxx NE
phorbol-12-myristate NE xxx-dd-xxx NE
acetate NE xxx NE
( NE ( NE
PMA NE XXX NE
) NE ) NE
and NE xxx NE
calcium NE xxx NE
ionophore NE xxx NE
( NE ( NE
A23187 NE Xddddd NE
) NE ) NE
in NE xx NE
T NE X NE
cells NE xxx NE
. NE . NE

GM-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
defines NE xxx NE
a NE x NE
binding NE xxx NE
site NE xxx NE
for NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
, NE , NE
and NE xxx NE
GC-box G#DNA_domain_or_region XX-xxx G#DNA_domain_or_region
defines NE xxx NE
a NE x NE
binding NE xxx NE
site NE xxx NE
for NE xxx NE
three NE xxx NE
( NE ( NE
A1 G#protein_molecule Xd G#protein_molecule
, NE , NE
A2 G#protein_molecule Xd G#protein_molecule
, NE , NE
B G#protein_molecule X G#protein_molecule
) NE ) NE
constitutive G#protein_family_or_group_B xxx G#protein_family_or_group_B
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

We NE Xx NE
report NE xxx NE
here NE xxx NE
that NE xxx NE
three NE xxx NE
copies NE xxx NE
of NE xx NE
the NE xxx NE
GC-box G#DNA_domain_or_region XX-xxx G#DNA_domain_or_region
can NE xxx NE
functionally NE xxx NE
compensate NE xxx NE
for NE xxx NE
the NE xxx NE
GM-kappa NE XX-xxx NE
B NE X NE
/ NE / NE
GC-box NE XX-xxx NE
region NE xxx NE
, NE , NE
suggesting NE xxx NE
that NE xxx NE
the NE xxx NE
GC-motif NE XX-xxx NE
can NE xxx NE
function NE xxx NE
independently NE xxx NE
of NE xx NE
the NE xxx NE
GM-kappa NE XX-xxx NE
B NE X NE
motif NE xxx NE
. NE . NE

The NE Xxx NE
major NE xxx NE
GC-box G#other_name_B XX-xxx G#other_name_B
binding G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
A1 G#protein_molecule Xd G#protein_molecule
was NE xxx NE
purified NE xxx NE
and NE xxx NE
identified NE xxx NE
as NE xx NE
the NE xxx NE
transcription G#protein_molecule_B xxx G#protein_molecule_B
factor G#protein_molecule_M xxx G#protein_molecule_M
Sp1 G#protein_molecule_E Xxd G#protein_molecule_E
. NE . NE

We NE Xx NE
show NE xxx NE
that NE xxx NE
depletion NE xxx NE
of NE xx NE
Sp1 G#protein_molecule Xxd G#protein_molecule
( NE ( NE
A1 G#protein_molecule Xd G#protein_molecule
) NE ) NE
from NE xxx NE
nuclear NE xxx NE
extracts NE xxx NE
specifically NE xxx NE
decreases NE xxx NE
in G#other_name_B xx G#other_name_B
vitro G#other_name_M xxx G#other_name_M
transcription G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
on NE xx NE
GM-CSF G#other_name_B XX-XXX G#other_name_B
templates G#other_name_E xxx G#other_name_E
. NE . NE

Since NE Xxxx NE
the NE xxx NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
GM-CSF G#DNA_domain_or_region_M XX-XXX G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
has NE xxx NE
a NE x NE
base NE xxx NE
difference NE xxx NE
within NE xxx NE
the NE xxx NE
GC-box G#DNA_domain_or_region XX-xxx G#DNA_domain_or_region
, NE , NE
we NE xx NE
speculate NE xxx NE
that NE xxx NE
this NE xxx NE
may NE xxx NE
explain NE xxx NE
why NE xxx NE
the NE xxx NE
human NE xxx NE
promoter NE xxx NE
is NE xx NE
weak NE xxx NE
and NE xxx NE
that NE xxx NE
an NE xx NE
upstream G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
enhancer G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
is NE xx NE
required NE xxx NE
for NE xxx NE
the NE xxx NE
induction NE xxx NE
of NE xx NE
the NE xxx NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
GM-CSF G#DNA_domain_or_region_M XX-XXX G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

A NE X NE
factor NE xxx NE
that NE xxx NE
regulates NE xxx NE
the NE xxx NE
class G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
II G#DNA_family_or_group_M XX G#DNA_family_or_group_M
major G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
histocompatibility G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
complex G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
gene G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
DPA G#DNA_domain_or_region XXX G#DNA_domain_or_region
is NE xx NE
a NE x NE
member NE xxx NE
of NE xx NE
a NE x NE
subfamily NE xxx NE
of NE xx NE
zinc G#protein_family_or_group_B xxx G#protein_family_or_group_B
finger G#protein_family_or_group_M xxx G#protein_family_or_group_M
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
that NE xxx NE
includes NE xxx NE
a NE x NE
Drosophila G#protein_family_or_group_B Xxxx G#protein_family_or_group_B
developmental G#protein_family_or_group_M xxx G#protein_family_or_group_M
control G#protein_family_or_group_M xxx G#protein_family_or_group_M
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

A NE X NE
novel NE xxx NE
DNA G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
sequence G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
termed NE xxx NE
the NE xxx NE
J G#DNA_domain_or_region_B X G#DNA_domain_or_region_B
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
involved NE xxx NE
in NE xx NE
the NE xxx NE
regulated NE xxx NE
expression NE xxx NE
of NE xx NE
class G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
II G#DNA_family_or_group_M XX G#DNA_family_or_group_M
major G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
histocompatibility G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
complex G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
was NE xxx NE
recently NE xxx NE
described NE xxx NE
. NE . NE

To NE Xx NE
study NE xxx NE
this NE xxx NE
element NE xxx NE
and NE xxx NE
its NE xxx NE
role NE xxx NE
in NE xx NE
class G#other_name_B xxx G#other_name_B
II G#other_name_M XX G#other_name_M
gene G#other_name_M xxx G#other_name_M
regulation G#other_name_E xxx G#other_name_E
further NE xxx NE
, NE , NE
a NE x NE
cDNA G#DNA_family_or_group_B xXXX G#DNA_family_or_group_B
library G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
was NE xxx NE
screened NE xxx NE
with NE xxx NE
oligonucleotide G#polynucleotide_B xxx G#polynucleotide_B
probes G#polynucleotide_E xxx G#polynucleotide_E
containing NE xxx NE
both NE xxx NE
the NE xxx NE
S G#DNA_domain_or_region_B X G#DNA_domain_or_region_B
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
the NE xxx NE
nearby NE xxx NE
J G#DNA_domain_or_region_B X G#DNA_domain_or_region_B
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
the NE xxx NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
DPA G#DNA_domain_or_region_M XXX G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Several NE Xxxx NE
DNA G#DNA_molecule_B XXX G#DNA_molecule_B
clones G#DNA_molecule_E xxx G#DNA_molecule_E
were NE xxx NE
obtained NE xxx NE
by NE xx NE
this NE xxx NE
procedure NE xxx NE
, NE , NE
one NE xxx NE
of NE xx NE
which NE xxx NE
, NE , NE
clone G#DNA_molecule_B xxx G#DNA_molecule_B
18 G#DNA_molecule_E dd G#DNA_molecule_E
, NE , NE
is NE xx NE
reported NE xxx NE
and NE xxx NE
characterized NE xxx NE
here NE xxx NE
. NE . NE

It NE Xx NE
encodes NE xxx NE
a NE x NE
protein NE xxx NE
predicted NE xxx NE
to NE xx NE
contain NE xxx NE
688 G#peptide_B ddd G#peptide_B
amino G#peptide_M xxx G#peptide_M
acid G#peptide_M xxx G#peptide_M
residues G#peptide_E xxx G#peptide_E
, NE , NE
including NE xxx NE
11 NE dd NE
zinc G#protein_substructure_B xxx G#protein_substructure_B
finger G#protein_substructure_M xxx G#protein_substructure_M
motifs G#protein_substructure_E xxx G#protein_substructure_E
of NE xx NE
the NE xxx NE
C2H2 G#protein_substructure_B XdXd G#protein_substructure_B
type G#protein_substructure_E xxx G#protein_substructure_E
in NE xx NE
the NE xxx NE
C-terminal G#protein_domain_or_region_B X-xxx G#protein_domain_or_region_B
region G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
, NE , NE
that NE xxx NE
are NE xxx NE
Kruppel-like NE Xxxx-xxx NE
in NE xx NE
the NE xxx NE
conservation NE xxx NE
of NE xx NE
the NE xxx NE
H/C G#protein_domain_or_region_B X/X G#protein_domain_or_region_B
link G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
sequence G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
connecting NE xxx NE
them NE xxx NE
. NE . NE

The NE Xxx NE
160 G#protein_domain_or_region_B ddd G#protein_domain_or_region_B
N-terminal G#protein_domain_or_region_M X-xxx G#protein_domain_or_region_M
amino G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
acids G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
in NE xx NE
the NE xxx NE
nonfinger G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
region G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
of NE xx NE
clone G#protein_molecule_B xxx G#protein_molecule_B
18 G#protein_molecule_E dd G#protein_molecule_E
are NE xxx NE
highly NE xxx NE
homologous NE xxx NE
with NE xxx NE
similar NE xxx NE
regions NE xxx NE
of NE xx NE
several NE xxx NE
other NE xxx NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
sequence G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
mouse G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sequence G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
Drosophila G#DNA_domain_or_region_M Xxxx G#DNA_domain_or_region_M
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
zinc NE xxx NE
finger NE xxx NE
proteins NE xxx NE
termed NE xxx NE
TAB G#protein_family_or_group XXX G#protein_family_or_group
( NE ( NE
tramtrack G#protein_family_or_group_B xxx G#protein_family_or_group_B
[ttk]-associated G#protein_family_or_group_M [xxx]-xxx G#protein_family_or_group_M
box G#protein_family_or_group_E xxx G#protein_family_or_group_E
) NE ) NE
here NE xxx NE
. NE . NE

One NE Xxx NE
of NE xx NE
the NE xxx NE
Drosophila G#DNA_domain_or_region_B Xxxx G#DNA_domain_or_region_B
sequences G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
ttk G#DNA_domain_or_region xxx G#DNA_domain_or_region
, NE , NE
is NE xx NE
a NE x NE
developmental G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
control G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
gene G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
, NE , NE
while NE xxx NE
a NE x NE
second NE xxx NE
does NE xxx NE
not NE xxx NE
contain NE xxx NE
a NE x NE
zinc G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
finger G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
region G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
but NE xxx NE
encodes NE xxx NE
a NE x NE
structure NE xxx NE
important NE xxx NE
in NE xx NE
oocyte G#other_name_B xxx G#other_name_B
development G#other_name_E xxx G#other_name_E
. NE . NE

An NE Xx NE
acidic G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
activation G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
is NE xx NE
located NE xxx NE
between NE xxx NE
the NE xxx NE
N-terminal G#protein_domain_or_region_B X-xxx G#protein_domain_or_region_B
conserved G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
region G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
of NE xx NE
clone G#protein_molecule_B xxx G#protein_molecule_B
18 G#protein_molecule_E dd G#protein_molecule_E
and NE xxx NE
its NE xxx NE
zinc G#protein_substructure_B xxx G#protein_substructure_B
fingers G#protein_substructure_E xxx G#protein_substructure_E
. NE . NE

This NE Xxxx NE
protein NE xxx NE
appears NE xxx NE
to NE xx NE
require NE xxx NE
both NE xxx NE
the NE xxx NE
S G#DNA_domain_or_region_B X G#DNA_domain_or_region_B
element G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
J G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
10 NE dd NE
bp NE xx NE
for NE xxx NE
optimal NE xxx NE
binding NE xxx NE
. NE . NE

Antisense NE Xxxx NE
cDNA NE xXXX NE
to NE xx NE
clone G#protein_molecule_B xxx G#protein_molecule_B
18 G#protein_molecule_E dd G#protein_molecule_E
inhibited NE xxx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
a NE x NE
reporter NE xxx NE
construct NE xxx NE
containing NE xxx NE
the NE xxx NE
DPA G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
indicating NE xxx NE
its NE xxx NE
functional NE xxx NE
importance NE xxx NE
in NE xx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
this NE xxx NE
class G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
II G#DNA_family_or_group_M XX G#DNA_family_or_group_M
gene G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
. NE . NE

Separation NE Xxxx NE
of NE xx NE
oxidant-initiated NE xxx-xxx NE
and NE xxx NE
redox-regulated NE xxx-xxx NE
steps NE xxx NE
in NE xx NE
the NE xxx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
signal G#other_name_M xxx G#other_name_M
transduction G#other_name_M xxx G#other_name_M
pathway G#other_name_E xxx G#other_name_E
. NE . NE

Studies NE Xxxx NE
presented NE xxx NE
here NE xxx NE
show NE xxx NE
that NE xxx NE
overall NE xxx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
signal G#other_name_M xxx G#other_name_M
transduction G#other_name_E xxx G#other_name_E
begins NE xxx NE
with NE xxx NE
a NE x NE
parallel NE xxx NE
series NE xxx NE
of NE xx NE
stimuli-specific G#other_name_B xxx-xxx G#other_name_B
pathways G#other_name_E xxx G#other_name_E
through NE xxx NE
which NE xxx NE
cytokines G#protein_family_or_group xxx G#protein_family_or_group
( NE ( NE
tumor G#protein_molecule_B xxx G#protein_molecule_B
necrosis G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_M xxx G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
) NE ) NE
, NE , NE
oxidants G#other_name xxx G#other_name
( NE ( NE
hydrogen G#other_organic_compound_B xxx G#other_organic_compound_B
peroxide G#other_organic_compound_E xxx G#other_organic_compound_E
and NE xxx NE
mitomycin G#other_organic_compound_B xxx G#other_organic_compound_B
C G#other_organic_compound_E X G#other_organic_compound_E
) NE ) NE
, NE , NE
and NE xxx NE
phorbol G#other_organic_compound_B xxx G#other_organic_compound_B
ester G#other_organic_compound_E xxx G#other_organic_compound_E
( NE ( NE
phorbol G#other_organic_compound_B xxx G#other_organic_compound_B
12-myristate G#other_organic_compound_M dd-xxx G#other_organic_compound_M
13-acetate G#other_organic_compound_E dd-xxx G#other_organic_compound_E
) NE ) NE
individually NE xxx NE
initiate NE xxx NE
signaling NE xxx NE
. NE . NE

These NE Xxxx NE
initial NE xxx NE
pathways NE xxx NE
culminate NE xxx NE
in NE xx NE
a NE x NE
common NE xxx NE
pathway NE xxx NE
through NE xxx NE
which NE xxx NE
all NE xxx NE
of NE xx NE
the NE xxx NE
stimulating NE xxx NE
agents NE xxx NE
ultimately NE xxx NE
signal NE xxx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
activation G#other_name_E xxx G#other_name_E
. NE . NE

We NE Xx NE
distinguish NE xxx NE
the NE xxx NE
stimuli-specific NE xxx-xxx NE
pathways NE xxx NE
by NE xx NE
showing NE xxx NE
that NE xxx NE
the NE xxx NE
oxidative NE xxx NE
stimuli NE xxx NE
trigger NE xxx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
activation G#other_name_E xxx G#other_name_E
in NE xx NE
only NE xxx NE
one NE xxx NE
of NE xx NE
two NE xxx NE
human G#cell_line_B xxx G#cell_line_B
T-cell G#cell_line_M X-xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
( NE ( NE
Wurzburg G#cell_line Xxxx G#cell_line
but NE xxx NE
not NE xxx NE
Jurkat G#cell_line Xxxx G#cell_line
) NE ) NE
, NE , NE
whereas NE xxx NE
tumor G#protein_molecule_B xxx G#protein_molecule_B
necrosis G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_M xxx G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
and NE xxx NE
phorbol G#other_organic_compound_B xxx G#other_organic_compound_B
12-myristate G#other_organic_compound_M dd-xxx G#other_organic_compound_M
13-acetate G#other_organic_compound_E dd-xxx G#other_organic_compound_E
readily NE xxx NE
stimulate NE xxx NE
in NE xx NE
both NE xxx NE
lines NE xxx NE
. NE . NE

We NE Xx NE
propose NE xxx NE
the NE xxx NE
common NE xxx NE
pathway NE xxx NE
as NE xx NE
the NE xxx NE
simplest NE xxx NE
way NE xxx NE
of NE xx NE
accounting NE xxx NE
for NE xxx NE
the NE xxx NE
common NE xxx NE
requirements NE xxx NE
and NE xxx NE
properties NE xxx NE
of NE xx NE
the NE xxx NE
signaling NE xxx NE
pathway NE xxx NE
. NE . NE

We NE Xx NE
include NE xxx NE
a NE x NE
redox-regulatory G#other_name_B xxx-xxx G#other_name_B
mechanism G#other_name_E xxx G#other_name_E
(s) NE (x) NE
in NE xx NE
this NE xxx NE
common NE xxx NE
pathway NE xxx NE
to NE xx NE
account NE xxx NE
for NE xxx NE
the NE xxx NE
previously NE xxx NE
demonstrated NE xxx NE
redox G#other_name_B xxx G#other_name_B
regulation G#other_name_E xxx G#other_name_E
of NE xx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
activation G#other_name_E xxx G#other_name_E
in NE xx NE
Jurkat G#cell_line_B Xxxx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
(in NE (xx NE
which NE xxx NE
oxidants NE xxx NE
don't NE xxx'x NE
activate NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
) NE ) NE
; NE ; NE
we NE xx NE
put NE xxx NE
tyrosine G#other_name_B xxx G#other_name_B
phosphorylation G#other_name_E xxx G#other_name_E
in NE xx NE
the NE xxx NE
common NE xxx NE
pathway NE xxx NE
by NE xx NE
showing NE xxx NE
that NE xxx NE
kinase G#other_name_B xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
(inhibitable NE (xxx NE
by NE xx NE
herbimycin G#other_organic_compound_B xxx G#other_organic_compound_B
A G#other_organic_compound_E X G#other_organic_compound_E
and NE xxx NE
tyrphostin G#other_organic_compound_B xxx G#other_organic_compound_B
47 G#other_organic_compound_E dd G#other_organic_compound_E
) NE ) NE
is NE xx NE
required NE xxx NE
for NE xxx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
activation G#other_name_E xxx G#other_name_E
by NE xx NE
all NE xxx NE
stimuli NE xxx NE
tested NE xxx NE
in NE xx NE
both NE xxx NE
cell NE xxx NE
lines NE xxx NE
. NE . NE

Since NE Xxxx NE
internal NE xxx NE
sites NE xxx NE
of NE xx NE
oxidant NE xxx NE
production NE xxx NE
have NE xxx NE
been NE xxx NE
shown NE xxx NE
to NE xx NE
play NE xxx NE
a NE x NE
key NE xxx NE
role NE xxx NE
in NE xx NE
the NE xxx NE
cytokine NE xxx NE
-stimulated NE -xxx NE
activation NE xxx NE
of NE xx NE
NF-kappa NE XX-xxx NE
B NE X NE
, NE , NE
and NE xxx NE
since NE xxx NE
tyrosine NE xxx NE
kinase NE xxx NE
and NE xxx NE
phosphatase NE xxx NE
activities NE xxx NE
are NE xxx NE
known NE xxx NE
to NE xx NE
be NE xx NE
altered NE xxx NE
by NE xx NE
oxidants NE xxx NE
, NE , NE
these NE xxx NE
findings NE xxx NE
suggest NE xxx NE
that NE xxx NE
intracellular NE xxx NE
redox NE xxx NE
status NE xxx NE
controls NE xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
activation NE xxx NE
by NE xx NE
regulating NE xxx NE
tyrosine NE xxx NE
phosphorylation NE xxx NE
event(s) NE xxx(x) NE
within NE xxx NE
the NE xxx NE
common NE xxx NE
step NE xxx NE
of NE xx NE
the NE xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
signal NE xxx NE
transduction NE xxx NE
pathway NE xxx NE
. NE . NE

Deleted NE Xxxx NE
chromosome G#DNA_molecule_B xxx G#DNA_molecule_B
20 G#DNA_molecule_E dd G#DNA_molecule_E
from NE xxx NE
a NE x NE
patient G#multi_cell xxx G#multi_cell
with NE xxx NE
Alagille G#other_name_B Xxxx G#other_name_B
syndrome G#other_name_E xxx G#other_name_E
isolated NE xxx NE
in NE xx NE
a NE x NE
cell NE xxx NE
hybrid NE xxx NE
through NE xxx NE
leucine G#other_name_B xxx G#other_name_B
transport G#other_name_M xxx G#other_name_M
selection G#other_name_E xxx G#other_name_E
: NE : NE
study NE xxx NE
of NE xx NE
three NE xxx NE
candidate NE xxx NE
genes NE xxx NE
. NE . NE

Alagille G#other_name_B Xxxx G#other_name_B
syndrome G#other_name_E xxx G#other_name_E
( NE ( NE
AGS G#other_name XXX G#other_name
) NE ) NE
is NE xx NE
a NE x NE
well-defined NE xxx-xxx NE
genetic NE xxx NE
entity NE xxx NE
assigned NE xxx NE
to NE xx NE
the NE xxx NE
short G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
arm G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
Chromosome G#DNA_molecule_B Xxxx G#DNA_molecule_B
(Chr) G#DNA_molecule_M (Xxx) G#DNA_molecule_M
20 G#DNA_molecule_E dd G#DNA_molecule_E
by NE xx NE
a NE x NE
series NE xxx NE
of NE xx NE
observations NE xxx NE
of NE xx NE
AGS G#other_name XXX G#other_name
patients NE xxx NE
associated NE xxx NE
with NE xxx NE
microdeletions G#other_name xxx G#other_name
in NE xx NE
this NE xxx NE
region NE xxx NE
. NE . NE

By NE Xx NE
fusing NE xxx NE
lymphoblastoid G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
of NE xx NE
an NE xx NE
AGS G#multi_cell_B XXX G#multi_cell_B
patient G#multi_cell_E xxx G#multi_cell_E
that NE xxx NE
exhibited NE xxx NE
a NE x NE
microdeletion NE xxx NE
in NE xx NE
the NE xxx NE
short G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
arm G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
of G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
Chr G#DNA_domain_or_region_M Xxx G#DNA_domain_or_region_M
20 G#DNA_domain_or_region_E dd G#DNA_domain_or_region_E
encompassing NE xxx NE
bands NE xxx NE
p11.23 G#DNA_domain_or_region_B xdd.dd G#DNA_domain_or_region_B
to G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
p12.3 G#DNA_domain_or_region_E xdd.d G#DNA_domain_or_region_E
with NE xxx NE
rodent G#cell_line_B xxx G#cell_line_B
thermosensitive G#cell_line_M xxx G#cell_line_M
mutant G#cell_line_M xxx G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
( NE ( NE
CHOtsH1-1 G#cell_line XXXxxXd-d G#cell_line
) NE ) NE
deficient NE xxx NE
in-leucyl-tRNA G#protein_molecule_B xx-xxx-xXXX G#protein_molecule_B
synthetase G#protein_molecule_E xxx G#protein_molecule_E
, NE , NE
we NE xx NE
isolated NE xxx NE
a NE x NE
somatic G#cell_line_B xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
hybrid G#cell_line_E xxx G#cell_line_E
segregating NE xxx NE
the NE xxx NE
deleted NE xxx NE
human NE xxx NE
Chr G#DNA_molecule_B Xxx G#DNA_molecule_B
20 G#DNA_molecule_E dd G#DNA_molecule_E
. NE . NE

This NE Xxxx NE
hybrid NE xxx NE
clone NE xxx NE
, NE , NE
designated NE xxx NE
NR2 G#cell_line XXd G#cell_line
, NE , NE
was NE xxx NE
characterized NE xxx NE
by NE xx NE
several NE xxx NE
methods NE xxx NE
, NE , NE
including NE xxx NE
PCR G#other_name XXX G#other_name
, NE , NE
with NE xxx NE
eight NE xxx NE
pairs NE xxx NE
of NE xx NE
oligonucleotides G#polynucleotide xxx G#polynucleotide
mapped NE xxx NE
to NE xx NE
Chr G#DNA_molecule_B Xxx G#DNA_molecule_B
20 G#DNA_molecule_E dd G#DNA_molecule_E
: NE : NE
D20S5 G#DNA_domain_or_region XddXd G#DNA_domain_or_region
, NE , NE
D20S41 G#DNA_domain_or_region XddXdd G#DNA_domain_or_region
, NE , NE
D20S42 G#DNA_domain_or_region XddXdd G#DNA_domain_or_region
, NE , NE
D20S56 G#DNA_domain_or_region XddXdd G#DNA_domain_or_region
, NE , NE
D20S57 G#DNA_domain_or_region XddXdd G#DNA_domain_or_region
, NE , NE
D20S58 G#DNA_domain_or_region XddXdd G#DNA_domain_or_region
, NE , NE
adenosine G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
deaminase G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
ADA G#protein_molecule XXX G#protein_molecule
) NE ) NE
, NE , NE
and NE xxx NE
Prion G#DNA_domain_or_region_B Xxxx G#DNA_domain_or_region_B
protein G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
PRIP G#protein_molecule XXXX G#protein_molecule
) NE ) NE
; NE ; NE
Restriction NE Xxxx NE
Fragment NE Xxxx NE
Length NE Xxxx NE
Polymorphism NE Xxxx NE
( NE ( NE
RFLP NE XXXX NE
) NE ) NE
analyses NE xxx NE
with NE xxx NE
four NE xxx NE
genomic NE xxx NE
anonymous NE xxx NE
probes NE xxx NE
( NE ( NE
D20S5 NE XddXd NE
, NE , NE
cD3H12 NE xXdXdd NE
, NE , NE
D20S17 NE XddXdd NE
, NE , NE
D20S18 NE XddXdd NE
) NE ) NE
; NE ; NE
and NE xxx NE
fluorescent NE xxx NE
in NE xx NE
situ NE xxx NE
hybridization NE xxx NE
( NE ( NE
FISH NE XXXX NE
) NE ) NE
with NE xxx NE
total NE xxx NE
human NE xxx NE
DNA NE XXX NE
and NE xxx NE
D20Z1 NE XddXd NE
, NE , NE
a NE x NE
sequence NE xxx NE
specific NE xxx NE
to NE xx NE
the NE xxx NE
human NE xxx NE
Chr NE Xxx NE
20 NE dd NE
centromere NE xxx NE
, NE , NE
as NE xx NE
probes NE xxx NE
. NE . NE

The NE Xxx NE
NR2 G#cell_line_B XXd G#cell_line_B
hybrid G#cell_line_E xxx G#cell_line_E
allowed NE xxx NE
us NE xx NE
to NE xx NE
exclude NE xxx NE
three NE xxx NE
candidate G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
for NE xxx NE
AGS G#other_name XXX G#other_name
: NE : NE
hepatic G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
nuclear G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
factor G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
3 G#DNA_domain_or_region_M d G#DNA_domain_or_region_M
beta G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
HNF3 G#DNA_domain_or_region_B XXXd G#DNA_domain_or_region_B
beta G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
) NE ) NE
, NE , NE
paired G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
box G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
1 G#DNA_domain_or_region_E d G#DNA_domain_or_region_E
( NE ( NE
PAX1 G#DNA_domain_or_region XXXd G#DNA_domain_or_region
) NE ) NE
, NE , NE
and NE xxx NE
cystatin G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
C G#DNA_domain_or_region_E X G#DNA_domain_or_region_E
( NE ( NE
CST3 G#DNA_domain_or_region XXXd G#DNA_domain_or_region
) NE ) NE
as NE xx NE
shown NE xxx NE
by NE xx NE
their NE xxx NE
localization NE xxx NE
outside NE xxx NE
of NE xx NE
the NE xxx NE
deletion NE xxx NE
. NE . NE

The NE Xxx NE
NR2 G#cell_line_B XXd G#cell_line_B
hybrid G#cell_line_E xxx G#cell_line_E
is NE xx NE
a NE x NE
powerful NE xxx NE
tool NE xxx NE
for NE xxx NE
the NE xxx NE
mapping NE xxx NE
of NE xx NE
new NE xxx NE
probes NE xxx NE
of NE xx NE
this NE xxx NE
region NE xxx NE
, NE , NE
as NE xx NE
well NE xxx NE
as NE xx NE
for NE xxx NE
obtaining NE xxx NE
new NE xxx NE
informative NE xxx NE
probes NE xxx NE
specific NE xxx NE
for NE xxx NE
the NE xxx NE
deletion NE xxx NE
by NE xx NE
subtractive G#other_name_B xxx G#other_name_B
cloning G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
region NE xxx NE
. NE . NE

Such NE Xxxx NE
markers NE xxx NE
will NE xxx NE
be NE xx NE
useful NE xxx NE
for NE xxx NE
linkage NE xxx NE
analysis NE xxx NE
and NE xxx NE
screening NE xxx NE
of NE xx NE
cDNA NE xXXX NE
libraries NE xxx NE
. NE . NE

positive G#other_name_B xxx G#other_name_B
regulation G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
negative G#other_name_M xxx G#other_name_M
regulation G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
composite G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
octamer G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
motif G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
the NE xxx NE
interleukin G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
2 G#DNA_domain_or_region_M d G#DNA_domain_or_region_M
enhancer G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
by NE xx NE
AP-1 G#protein_molecule XX-d G#protein_molecule
, NE , NE
Oct-2 G#protein_molecule Xxx-d G#protein_molecule
, NE , NE
and NE xxx NE
retinoic G#protein_molecule_B xxx G#protein_molecule_B
acid G#protein_molecule_M xxx G#protein_molecule_M
receptor G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

The NE Xxx NE
differentiating NE xxx NE
agent NE xxx NE
retinoic G#other_organic_compound_B xxx G#other_organic_compound_B
acid G#other_organic_compound_E xxx G#other_organic_compound_E
( NE ( NE
RA G#other_organic_compound XX G#other_organic_compound
) NE ) NE
has NE xxx NE
been NE xxx NE
previously NE xxx NE
reported NE xxx NE
to NE xx NE
interfere NE xxx NE
with NE xxx NE
12-O-tetradecanoyl-phorbol-13-acetate NE dd-X-xxx-xxx-dd-xxx NE
( NE ( NE
TPA NE XXX NE
) NE ) NE
/ NE / NE
Ca(2+) NE Xx(d+) NE
-induced NE -xxx NE
signals NE xxx NE
for NE xxx NE
the NE xxx NE
regulation NE xxx NE
of NE xx NE
the NE xxx NE
-96 NE -dd NE
to NE xx NE
-66-bp NE -dd-xx NE
octamer NE xxx NE
motif NE xxx NE
found NE xxx NE
in NE xx NE
the NE xxx NE
enhancer NE xxx NE
for NE xxx NE
the NE xxx NE
interleukin NE xxx NE
(IL)-2 NE (XX)-d NE
gene NE xxx NE
, NE , NE
which NE xxx NE
encodes NE xxx NE
a NE x NE
major NE xxx NE
T NE X NE
lymphocyte NE xxx NE
growth NE xxx NE
factor NE xxx NE
. NE . NE

The NE Xxx NE
IL-2 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
octamer G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
motif G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
is NE xx NE
a NE x NE
composite NE xxx NE
cis-element G#DNA_family_or_group xxx-xxx G#DNA_family_or_group
which NE xxx NE
binds NE xxx NE
Oct-1 G#protein_molecule Xxx-d G#protein_molecule
and NE xxx NE
Oct-2 G#protein_molecule Xxx-d G#protein_molecule
as NE xx NE
well NE xxx NE
as NE xx NE
a NE x NE
TPA NE XXX NE
/ NE / NE
Ca(2+) NE Xx(d+) NE
-inducible NE -xxx NE
nuclear NE xxx NE
factor NE xxx NE
, NE , NE
previously NE xxx NE
termed NE xxx NE
octamer-associated NE xxx-xxx NE
protein NE xxx NE
( NE ( NE
OAP40 NE XXXdd NE
) NE ) NE
. NE . NE

We NE Xx NE
show NE xxx NE
here NE xxx NE
that NE xxx NE
Oct-2 G#protein_molecule Xxx-d G#protein_molecule
, NE , NE
despite NE xxx NE
the NE xxx NE
presence NE xxx NE
of NE xx NE
an NE xx NE
active NE xxx NE
transcriptional NE xxx NE
activation NE xxx NE
domain NE xxx NE
, NE , NE
requires NE xxx NE
TPA/Ca(2+)-induced NE XXX/Xx(d+)-xxx NE
signals NE xxx NE
to NE xx NE
strongly NE xxx NE
transactivate NE xxx NE
the NE xxx NE
IL-2 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
octamer G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
motif G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
Jurkat NE Xxxx NE
T NE X NE
cells NE xxx NE
. NE . NE

This NE Xxxx NE
Oct-2 NE Xxx-d NE
-dependent NE -xxx NE
transactivation NE xxx NE
is NE xx NE
inhibited NE xxx NE
by NE xx NE
RA NE XX NE
. NE . NE

The NE Xxx NE
presence NE xxx NE
of NE xx NE
an NE xx NE
intact G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
COOH-terminal G#protein_domain_or_region_M XXXX-xxx G#protein_domain_or_region_M
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
of NE xx NE
Oct-2 G#protein_molecule Xxx-d G#protein_molecule
contributes NE xxx NE
to NE xx NE
both NE xxx NE
TPA NE XXX NE
/ NE / NE
Ca(2+) NE Xx(d+) NE
-induced NE -xxx NE
transactivation NE xxx NE
and NE xxx NE
the NE xxx NE
RA NE XX NE
-mediated NE -xxx NE
repression NE xxx NE
. NE . NE

We NE Xx NE
also NE xxx NE
show NE xxx NE
that NE xxx NE
both NE xxx NE
Fos G#protein_family_or_group Xxx G#protein_family_or_group
and NE xxx NE
Jun G#protein_family_or_group Xxx G#protein_family_or_group
components NE xxx NE
of NE xx NE
the NE xxx NE
AP-1 G#protein_molecule XX-d G#protein_molecule
factors NE xxx NE
participate NE xxx NE
in NE xx NE
the NE xxx NE
OAP40 G#protein_complex_B XXXdd G#protein_complex_B
complex G#protein_complex_E xxx G#protein_complex_E
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
transfected NE xxx NE
c-jun G#DNA_molecule_B x-xxx G#DNA_molecule_B
expression G#DNA_molecule_M xxx G#DNA_molecule_M
vector G#DNA_molecule_M xxx G#DNA_molecule_M
or G#DNA_molecule_M xx G#DNA_molecule_M
jun-B G#DNA_molecule_M xxx-X G#DNA_molecule_M
expression G#DNA_molecule_M xxx G#DNA_molecule_M
vector G#DNA_molecule_M xxx G#DNA_molecule_M
or G#DNA_molecule_M xx G#DNA_molecule_M
jun-D G#DNA_molecule_M xxx-X G#DNA_molecule_M
expression G#DNA_molecule_M xxx G#DNA_molecule_M
vector G#DNA_molecule_M xxx G#DNA_molecule_M
or G#DNA_molecule_M xx G#DNA_molecule_M
c-fos G#DNA_molecule_M x-xxx G#DNA_molecule_M
expression G#DNA_molecule_M xxx G#DNA_molecule_M
vector G#DNA_molecule_M xxx G#DNA_molecule_M
or G#DNA_molecule_M xx G#DNA_molecule_M
Fos-B G#DNA_molecule_M Xxx-X G#DNA_molecule_M
expression G#DNA_molecule_M xxx G#DNA_molecule_M
vector G#DNA_molecule_E xxx G#DNA_molecule_E
TPA NE XXX NE
and NE xxx NE
Ca2+ G#atom Xxd+ G#atom
and NE xxx NE
cooperate NE xxx NE
with NE xxx NE
Oct-2 G#protein_molecule Xxx-d G#protein_molecule
for NE xxx NE
the NE xxx NE
transactivation NE xxx NE
of NE xx NE
the NE xxx NE
combined NE xxx NE
OAP/octamer G#DNA_domain_or_region_B XXX/xxx G#DNA_domain_or_region_B
cis-element G#DNA_domain_or_region_E xxx-xxx G#DNA_domain_or_region_E
. NE . NE

Mutations NE Xxxx NE
of NE xx NE
the NE xxx NE
genuine G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
octamer-binding G#DNA_domain_or_region_M xxx-xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
abrogate NE xxx NE
both NE xxx NE
the NE xxx NE
binding NE xxx NE
of NE xx NE
Oct-1 G#protein_molecule Xxx-d G#protein_molecule
and NE xxx NE
Oct-2 G#protein_molecule Xxx-d G#protein_molecule
and NE xxx NE
the NE xxx NE
TPA NE XXX NE
/ NE / NE
Ca(2+) NE Xx(d+) NE
-induced NE -xxx NE
transactivation NE xxx NE
of NE xx NE
the NE xxx NE
OAP NE XXX NE
/octamer NE /xxx NE
motif NE xxx NE
. NE . NE

OAP G#protein_family_or_group XXX G#protein_family_or_group
confers NE xxx NE
to NE xx NE
Oct-2 G#protein_molecule Xxx-d G#protein_molecule
responsivity NE xxx NE
to NE xx NE
both NE xxx NE
TPA G#other_organic_compound XXX G#other_organic_compound
/Ca2+ NE /Xxd+ NE
and NE xxx NE
RA NE XX NE
, NE , NE
since NE xxx NE
specific NE xxx NE
mutations NE xxx NE
of NE xx NE
the NE xxx NE
AP-1 NE XX-d NE
/ NE / NE
OAP NE XXX NE
-binding NE -xxx NE
site NE xxx NE
significantly NE xxx NE
reduce NE xxx NE
the NE xxx NE
transactivation NE xxx NE
by NE xx NE
Oct-2 NE Xxx-d NE
in NE xx NE
response NE xxx NE
to NE xx NE
TPA NE XXX NE
and NE xxx NE
Ca2+ G#atom Xxd+ G#atom
and NE xxx NE
abolish NE xxx NE
the NE xxx NE
inhibition NE xxx NE
by NE xx NE
RA G#other_organic_compound XX G#other_organic_compound
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
retinoic G#protein_molecule_B xxx G#protein_molecule_B
acid G#protein_molecule_M xxx G#protein_molecule_M
receptor G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
RAR G#protein_molecule XXX G#protein_molecule
) NE ) NE
alpha NE xxx NE
is NE xx NE
able NE xxx NE
to NE xx NE
inhibit NE xxx NE
in NE xx NE
vitro NE xxx NE
the NE xxx NE
formation NE xxx NE
of NE xx NE
the NE xxx NE
complex NE xxx NE
between NE xxx NE
the NE xxx NE
nuclear NE xxx NE
AP-1 G#protein_molecule XX-d G#protein_molecule
/OAP NE /XXX NE
and NE xxx NE
its NE xxx NE
specific NE xxx NE
binding NE xxx NE
site NE xxx NE
, NE , NE
resulting NE xxx NE
in NE xx NE
the NE xxx NE
interference NE xxx NE
with NE xxx NE
Oct-2 NE Xxx-d NE
-dependent NE -xxx NE
cis-regulatory NE xxx-xxx NE
function NE xxx NE
of NE xx NE
this NE xxx NE
AP-1 NE XX-d NE
element NE xxx NE
. NE . NE

Therefore NE Xxxx NE
, NE , NE
we NE xx NE
propose NE xxx NE
that NE xxx NE
the NE xxx NE
TPA G#other_organic_compound XXX G#other_organic_compound
/ NE / NE
calcium G#atom xxx G#atom
-activated NE -xxx NE
AP-1 G#protein_molecule XX-d G#protein_molecule
/OAP NE /XXX NE
element NE xxx NE
is NE xx NE
the NE xxx NE
main NE xxx NE
target NE xxx NE
of NE xx NE
positive NE xxx NE
or NE xx NE
negative NE xxx NE
regulatory NE xxx NE
signals NE xxx NE
influencing NE xxx NE
the NE xxx NE
IL-2 NE XX-d NE
octamer NE xxx NE
motif NE xxx NE
, NE , NE
through NE xxx NE
synergism NE xxx NE
with NE xxx NE
Oct-2 NE Xxx-d NE
and NE xxx NE
antagonism NE xxx NE
by NE xx NE
RAR NE XXX NE
. NE . NE

Missense G#other_name_B Xxxx G#other_name_B
mutation G#other_name_E xxx G#other_name_E
in NE xx NE
exon G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
7 G#DNA_domain_or_region_E d G#DNA_domain_or_region_E
of NE xx NE
the NE xxx NE
common G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
gamma G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
chain G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
causes NE xxx NE
a NE x NE
moderate NE xxx NE
form NE xxx NE
of NE xx NE
X-linked G#other_name_B X-xxx G#other_name_B
combined G#other_name_M xxx G#other_name_M
immunodeficiency G#other_name_E xxx G#other_name_E
. NE . NE

Clinical NE Xxxx NE
and NE xxx NE
immunologic NE xxx NE
features NE xxx NE
of NE xx NE
a NE x NE
recently NE xxx NE
recognized NE xxx NE
X-linked G#other_name_B X-xxx G#other_name_B
combined G#other_name_M xxx G#other_name_M
immunodeficiency G#other_name_M xxx G#other_name_M
disease G#other_name_E xxx G#other_name_E
( NE ( NE
XCID G#other_name XXXX G#other_name
) NE ) NE
suggested NE xxx NE
that NE xxx NE
XCID G#other_name XXXX G#other_name
and NE xxx NE
X-linked G#other_name_B X-xxx G#other_name_B
severe G#other_name_M xxx G#other_name_M
combined G#other_name_M xxx G#other_name_M
immunodeficiency G#other_name_E xxx G#other_name_E
( NE ( NE
XSCID G#other_name XXXXX G#other_name
) NE ) NE
might NE xxx NE
arise NE xxx NE
from NE xxx NE
different NE xxx NE
genetic G#other_name_B xxx G#other_name_B
defects G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
recent NE xxx NE
discovery NE xxx NE
of NE xx NE
mutations NE xxx NE
in NE xx NE
the NE xxx NE
common G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
gamma G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
chain G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
(gamma G#DNA_domain_or_region_M (xxx G#DNA_domain_or_region_M
c) G#DNA_domain_or_region_M x) G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
a NE x NE
constituent NE xxx NE
of NE xx NE
several NE xxx NE
cytokine G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
in NE xx NE
XSCID G#other_name XXXXX G#other_name
provided NE xxx NE
an NE xx NE
opportunity NE xxx NE
to NE xx NE
test NE xxx NE
directly NE xxx NE
whether NE xxx NE
a NE x NE
previously NE xxx NE
unrecognized NE xxx NE
mutation NE xxx NE
in NE xx NE
this NE xxx NE
same NE xxx NE
gene NE xxx NE
was NE xxx NE
responsible NE xxx NE
for NE xxx NE
XCID G#other_name XXXX G#other_name
. NE . NE

The NE Xxx NE
status NE xxx NE
of NE xx NE
X G#other_name_B X G#other_name_B
chromosome G#other_name_M xxx G#other_name_M
inactivation G#other_name_E xxx G#other_name_E
in NE xx NE
blood NE xxx NE
leukocytes NE xxx NE
from NE xxx NE
obligate NE xxx NE
carriers NE xxx NE
of NE xx NE
XCID G#other_name XXXX G#other_name
was NE xxx NE
determined NE xxx NE
from NE xxx NE
the NE xxx NE
polymorphic NE xxx NE
, NE , NE
short G#DNA_substructure_B xxx G#DNA_substructure_B
tandem G#DNA_substructure_M xxx G#DNA_substructure_M
repeats G#DNA_substructure_E xxx G#DNA_substructure_E
( NE ( NE
CAG G#polynucleotide XXX G#polynucleotide
) NE ) NE
, NE , NE
in NE xx NE
the NE xxx NE
androgen G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
receptor G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
which NE xxx NE
also NE xxx NE
contains NE xxx NE
a NE x NE
methylation-sensitive G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
HpaII G#DNA_domain_or_region_M XxxXX G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

As NE Xx NE
in NE xx NE
XSCID NE XXXXX NE
, NE , NE
X-chromosome NE X-xxx NE
inactivation NE xxx NE
in NE xx NE
obligate NE xxx NE
carriers NE xxx NE
of NE xx NE
XCID G#other_name XXXX G#other_name
was NE xxx NE
nonrandom NE xxx NE
in NE xx NE
T G#cell_type_B X G#cell_type_B
lymphocyte G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
B G#cell_type_M X G#cell_type_M
lymphocyte G#cell_type_E xxx G#cell_type_E

In NE Xx NE
addition NE xxx NE
, NE , NE
X G#DNA_molecule_B X G#DNA_molecule_B
chromosome G#DNA_molecule_E xxx G#DNA_molecule_E
inactivation NE xxx NE
in NE xx NE
PMNs G#other_name XXXx G#other_name
was NE xxx NE
variable NE xxx NE
. NE . NE

Findings NE Xxxx NE
from NE xxx NE
this NE xxx NE
analysis NE xxx NE
prompted NE xxx NE
sequencing NE xxx NE
of NE xx NE
the NE xxx NE
gamma G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
c G#DNA_domain_or_region_M x G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
this NE xxx NE
pedigree NE xxx NE
. NE . NE

A NE X NE
missense NE xxx NE
mutation NE xxx NE
in NE xx NE
the NE xxx NE
region NE xxx NE
coding NE xxx NE
for NE xxx NE
the NE xxx NE
cytoplasmic G#other_name_B xxx G#other_name_B
portion G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
gamma G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
c G#DNA_domain_or_region_M x G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
was NE xxx NE
found NE xxx NE
in NE xx NE
three NE xxx NE
affected NE xxx NE
males NE xxx NE
but NE xxx NE
not NE xxx NE
in NE xx NE
a NE x NE
normal NE xxx NE
brother NE xxx NE
. NE . NE

Therefore NE Xxxx NE
, NE , NE
this NE xxx NE
point G#other_name_B xxx G#other_name_B
mutation G#other_name_E xxx G#other_name_E
in NE xx NE
the NE xxx NE
gamma G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
c G#DNA_domain_or_region_M x G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
leads NE xxx NE
to NE xx NE
a NE x NE
less NE xxx NE
severe NE xxx NE
degree NE xxx NE
of NE xx NE
deficiency NE xxx NE
in NE xx NE
cellular NE xxx NE
and NE xxx NE
humoral NE xxx NE
immunity NE xxx NE
than NE xxx NE
that NE xxx NE
seen NE xxx NE
in NE xx NE
XSCID NE XXXXX NE
. NE . NE

Posttranscriptional G#other_name_B Xxxx G#other_name_B
regulation G#other_name_E xxx G#other_name_E
of NE xx NE
macrophage G#other_name_B xxx G#other_name_B
tissue G#other_name_M xxx G#other_name_M
factor G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
by NE xx NE
antioxidants G#other_organic_compound xxx G#other_organic_compound
. NE . NE

Tissue NE Xxxx NE
factor NE xxx NE
( NE ( NE
TF NE XX NE
) NE ) NE
expression NE xxx NE
by NE xx NE
cells NE xxx NE
of NE xx NE
monocyte/macrophage NE xxx/xxx NE
lineage NE xxx NE
represents NE xxx NE
an NE xx NE
important NE xxx NE
mechanism NE xxx NE
underlying NE xxx NE
the NE xxx NE
initiation NE xxx NE
of NE xx NE
fibrin NE xxx NE
deposition NE xxx NE
at NE xx NE
sites NE xxx NE
of NE xx NE
extravascular NE xxx NE
inflammation NE xxx NE
. NE . NE

Recent NE Xxxx NE
evidence NE xxx NE
suggests NE xxx NE
a NE x NE
role NE xxx NE
for NE xxx NE
oxidant NE xxx NE
stress NE xxx NE
in NE xx NE
the NE xxx NE
signalling NE xxx NE
pathway NE xxx NE
of NE xx NE
various NE xxx NE
cell NE xxx NE
types NE xxx NE
by NE xx NE
virtue NE xxx NE
of NE xx NE
its NE xxx NE
ability NE xxx NE
to NE xx NE
induce NE xxx NE
DNA G#other_name_B XXX G#other_name_B
binding G#other_name_E xxx G#other_name_E
of NE xx NE
various NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
including NE xxx NE
nuclear G#protein_molecule_B xxx G#protein_molecule_B
factor G#protein_molecule_M xxx G#protein_molecule_M
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_E X G#protein_molecule_E
and NE xxx NE
AP-1 G#protein_molecule XX-d G#protein_molecule
. NE . NE

The NE Xxx NE
effect NE xxx NE
of NE xx NE
antioxidant NE xxx NE
treatment NE xxx NE
on NE xx NE
lipopolysaccharide NE xxx NE
( NE ( NE
LPS NE XXX NE
)-induced NE )-xxx NE
TF NE XX NE
expression NE xxx NE
was NE xxx NE
examined NE xxx NE
in NE xx NE
murine NE xxx NE
peritoneal NE xxx NE
macrophages NE xxx NE
and NE xxx NE
human NE xxx NE
monocytes NE xxx NE
. NE . NE

Both NE Xxxx NE
pyrrolidine G#other_organic_compound_B xxx G#other_organic_compound_B
dithiocarbamate G#other_organic_compound_E xxx G#other_organic_compound_E
, NE , NE
an NE xx NE
oxidant G#other_organic_compound_B xxx G#other_organic_compound_B
scavenger G#other_organic_compound_E xxx G#other_organic_compound_E
, NE , NE
and NE xxx NE
N-acetyl-cysteine G#amino_acid_monomer X-xxx-xxx G#amino_acid_monomer
, NE , NE
a NE x NE
precursor NE xxx NE
of NE xx NE
the NE xxx NE
endogenous G#other_organic_compound_B xxx G#other_organic_compound_B
antioxidant G#other_organic_compound_E xxx G#other_organic_compound_E
glutathione G#peptide xxx G#peptide
, NE , NE
inhibited NE xxx NE
stimulation NE xxx NE
of NE xx NE
macrophage NE xxx NE
procoagulant NE xxx NE
activity NE xxx NE
by NE xx NE
LPS G#lipid XXX G#lipid
. NE . NE

Northern G#other_name_B Xxxx G#other_name_B
blot G#other_name_M xxx G#other_name_M
analysis G#other_name_E xxx G#other_name_E
showed NE xxx NE
that NE xxx NE
neither NE xxx NE
of NE xx NE
these NE xxx NE
agents NE xxx NE
reduced NE xxx NE
LPS NE XXX NE
-stimulated NE -xxx NE
TF NE XX NE
mRNA NE xXXX NE
accumulation NE xxx NE
, NE , NE
thereby NE xxx NE
suggesting NE xxx NE
a NE x NE
posttranscriptional NE xxx NE
mechanism NE xxx NE
for NE xxx NE
the NE xxx NE
effect NE xxx NE
. NE . NE

Immunofluorescence NE Xxxx NE
studies NE xxx NE
of NE xx NE
human NE xxx NE
monocytes NE xxx NE
using NE xxx NE
polyclonal NE xxx NE
anti- NE xxx- NE
TF NE XX NE
antibody NE xxx NE
showed NE xxx NE
that NE xxx NE
N-acetyl-cysteine NE X-xxx-xxx NE
treatment NE xxx NE
prevented NE xxx NE
the NE xxx NE
characteristic NE xxx NE
plasmalemmal NE xxx NE
localization NE xxx NE
of NE xx NE
TF NE XX NE
antigen NE xxx NE
that NE xxx NE
occurs NE xxx NE
in NE xx NE
response NE xxx NE
to NE xx NE
LPS NE XXX NE
. NE . NE

Western NE Xxxx NE
blot NE xxx NE
analysis NE xxx NE
showed NE xxx NE
that NE xxx NE
N-acetyl-cysteine G#amino_acid_monomer X-xxx-xxx G#amino_acid_monomer
reduced NE xxx NE
the NE xxx NE
accumulation NE xxx NE
of NE xx NE
the NE xxx NE
47-kD G#protein_molecule_B dd-xX G#protein_molecule_B
mature G#protein_molecule_M xxx G#protein_molecule_M
glycoprotein G#protein_molecule_E xxx G#protein_molecule_E
in NE xx NE
LPS NE XXX NE
-treated NE -xxx NE
cells NE xxx NE
, NE , NE
a NE x NE
finding NE xxx NE
consistent NE xxx NE
with NE xxx NE
the NE xxx NE
results NE xxx NE
of NE xx NE
the NE xxx NE
immunofluorescence NE xxx NE
studies NE xxx NE
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
these NE xxx NE
conditions NE xxx NE
did NE xxx NE
not NE xxx NE
result NE xxx NE
in NE xx NE
an NE xx NE
accumulation NE xxx NE
of NE xx NE
the NE xxx NE
less NE xxx NE
mature NE xxx NE
forms NE xxx NE
of NE xx NE
TF G#protein_family_or_group XX G#protein_family_or_group
. NE . NE

When NE Xxxx NE
considered NE xxx NE
together NE xxx NE
, NE , NE
these NE xxx NE
data NE xxx NE
suggest NE xxx NE
that NE xxx NE
antioxidants G#other_organic_compound xxx G#other_organic_compound
exert NE xxx NE
their NE xxx NE
effects NE xxx NE
by NE xx NE
impairing NE xxx NE
translation NE xxx NE
and/or NE xxx/xx NE
by NE xx NE
causing NE xxx NE
degradation NE xxx NE
of NE xx NE
newly NE xxx NE
translated G#protein_family_or_group_B xxx G#protein_family_or_group_B
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

The NE Xxx NE
effect NE xxx NE
of NE xx NE
antioxidants G#other_organic_compound xxx G#other_organic_compound
on NE xx NE
tumor G#protein_family_or_group_B xxx G#protein_family_or_group_B
necrosis G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
appeared NE xxx NE
to NE xx NE
be NE xx NE
species NE xxx NE
specific NE xxx NE
, NE , NE
with NE xxx NE
no NE xx NE
effect NE xxx NE
on NE xx NE
LPS G#lipid XXX G#lipid
-induced NE -xxx NE
tumor NE xxx NE
necrosis NE xxx NE
factor NE xxx NE
in NE xx NE
murine NE xxx NE
cells NE xxx NE
, NE , NE
but NE xxx NE
with NE xxx NE
inhibition NE xxx NE
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
monocytes G#cell_type_E xxx G#cell_type_E
. NE . NE

The NE Xxx NE
posttranscriptional G#other_name_B xxx G#other_name_B
effect G#other_name_E xxx G#other_name_E
of NE xx NE
antioxidants G#other_organic_compound xxx G#other_organic_compound
on NE xx NE
TF G#other_name_B XX G#other_name_B
expression G#other_name_M xxx G#other_name_M
data G#other_name_E xxx G#other_name_E
suggests NE xxx NE
a NE x NE
novel NE xxx NE
mechanism NE xxx NE
whereby NE xxx NE
these NE xxx NE
agents NE xxx NE
might NE xxx NE
modulate NE xxx NE
monocyte NE xxx NE
/macrophage NE /xxx NE
activation NE xxx NE
. NE . NE

Characterization NE Xxxx NE
of NE xx NE
the NE xxx NE
CD48 G#DNA_domain_or_region_B XXdd G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
demonstrates NE xxx NE
a NE x NE
positive NE xxx NE
element NE xxx NE
that NE xxx NE
is NE xx NE
specific NE xxx NE
to NE xx NE
Epstein-Barr NE Xxxx-Xxxx NE
virus NE xxx NE
-immortalized NE -xxx NE
B-cell NE X-xxx NE
lines NE xxx NE
and NE xxx NE
contains NE xxx NE
an NE xx NE
essential NE xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
site NE xxx NE
. NE . NE

Epstein-Barr G#virus_B Xxxx-Xxxx G#virus_B
virus G#virus_E xxx G#virus_E
( NE ( NE
EBV G#virus XXX G#virus
) NE ) NE
infection NE xxx NE
of NE xx NE
mature NE xxx NE
, NE , NE
resting G#cell_type_B xxx G#cell_type_B
B G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
drives NE xxx NE
them NE xxx NE
to NE xx NE
become NE xxx NE
lymphoblasts NE xxx NE
expressing NE xxx NE
high NE xxx NE
levels NE xxx NE
of NE xx NE
cell NE xxx NE
surface NE xxx NE
molecules NE xxx NE
, NE , NE
such NE xxx NE
as NE xx NE
CD48 G#protein_molecule XXdd G#protein_molecule
, NE , NE
characteristically NE xxx NE
expressed NE xxx NE
on NE xx NE
normal G#cell_type_B xxx G#cell_type_B
activated G#cell_type_M xxx G#cell_type_M
B G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Here NE Xxxx NE
, NE , NE
we NE xx NE
report NE xxx NE
on NE xx NE
the NE xxx NE
identification NE xxx NE
of NE xx NE
an NE xx NE
enhancer G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
the NE xxx NE
CD48 G#DNA_domain_or_region_B XXdd G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
which NE xxx NE
reproducibly NE xxx NE
confers NE xxx NE
strong NE xxx NE
transcriptional G#other_name_B xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
only NE xxx NE
in NE xx NE
EBV NE XXX NE
-positive NE -xxx NE
B-lymphoblastoid NE X-xxx NE
cell NE xxx NE
lines NE xxx NE
. NE . NE

The NE Xxx NE
element NE xxx NE
is NE xx NE
not NE xxx NE
activated NE xxx NE
upon NE xxx NE
infection NE xxx NE
of NE xx NE
established NE xxx NE
EBV NE XXX NE
-negative NE -xxx NE
B-cell NE X-xxx NE
lines NE xxx NE
, NE , NE
indicating NE xxx NE
that NE xxx NE
EBV NE XXX NE
fails NE xxx NE
to NE xx NE
drive NE xxx NE
these NE xxx NE
cells NE xxx NE
to NE xx NE
a NE x NE
fully NE xxx NE
lymphoblastoid NE xxx NE
phenotype NE xxx NE
. NE . NE

An NE Xx NE
NF-kappa G#DNA_substructure_B XX-xxx G#DNA_substructure_B
B G#DNA_substructure_M X G#DNA_substructure_M
binding G#DNA_substructure_M xxx G#DNA_substructure_M
site G#DNA_substructure_E xxx G#DNA_substructure_E
is NE xx NE
an NE xx NE
essential NE xxx NE
component NE xxx NE
of NE xx NE
the NE xxx NE
element NE xxx NE
but NE xxx NE
alone NE xxx NE
is NE xx NE
not NE xxx NE
sufficient NE xxx NE
to NE xx NE
account NE xxx NE
for NE xxx NE
the NE xxx NE
activity NE xxx NE
or NE xx NE
the NE xxx NE
specificity NE xxx NE
of NE xx NE
the NE xxx NE
element NE xxx NE
. NE . NE

We NE Xx NE
have NE xxx NE
detected NE xxx NE
a NE x NE
specific NE xxx NE
nuclear G#protein_complex_B xxx G#protein_complex_B
protein G#protein_complex_M xxx G#protein_complex_M
complex G#protein_complex_E xxx G#protein_complex_E
that NE xxx NE
binds NE xxx NE
to NE xx NE
the NE xxx NE
element NE xxx NE
and NE xxx NE
show NE xxx NE
that NE xxx NE
NF-kappa G#protein_subunit_B XX-xxx G#protein_subunit_B
B1 G#protein_subunit_E Xd G#protein_subunit_E
( NE ( NE
p50 G#protein_subunit xdd G#protein_subunit
) NE ) NE
is NE xx NE
a NE x NE
part NE xxx NE
of NE xx NE
this NE xxx NE
complex NE xxx NE
. NE . NE

The NE Xxx NE
EBV NE XXX NE
-encoded NE -xxx NE
latent NE xxx NE
membrane NE xxx NE
protein NE xxx NE
1 NE d NE
is NE xx NE
capable NE xxx NE
of NE xx NE
transactivating NE xxx NE
the NE xxx NE
isolated NE xxx NE
CD48 NE XXdd NE
NF-kappa NE XX-xxx NE
B NE X NE
site NE xxx NE
but NE xxx NE
not NE xxx NE
the NE xxx NE
intact NE xxx NE
element NE xxx NE
, NE , NE
suggesting NE xxx NE
that NE xxx NE
the NE xxx NE
latent NE xxx NE
membrane NE xxx NE
protein NE xxx NE
1 NE d NE
-driven NE -xxx NE
activation NE xxx NE
of NE xx NE
NF-kappa NE XX-xxx NE
B/Rel NE X/Xxx NE
must NE xxx NE
interact NE xxx NE
with NE xxx NE
other NE xxx NE
regulatory NE xxx NE
pathways NE xxx NE
to NE xx NE
control NE xxx NE
expression NE xxx NE
of NE xx NE
cellular NE xxx NE
genes NE xxx NE
as NE xx NE
EBV NE XXX NE
drives NE xxx NE
resting NE xxx NE
B NE X NE
cells NE xxx NE
into NE xxx NE
the NE xxx NE
cell NE xxx NE
cycle NE xxx NE
. NE . NE

Thapsigargin G#other_organic_compound Xxxx G#other_organic_compound
induces NE xxx NE
IL-2 G#protein_subunit_B XX-d G#protein_subunit_B
receptor G#protein_subunit_M xxx G#protein_subunit_M
alpha-chain G#protein_subunit_E xxx-xxx G#protein_subunit_E
in NE xx NE
human NE xxx NE
peripheral NE xxx NE
and NE xxx NE
Jurkat NE Xxxx NE
T NE X NE
cells NE xxx NE
via NE xxx NE
a NE x NE
protein NE xxx NE
kinase NE xxx NE
C NE X NE
-independent NE -xxx NE
mechanism NE xxx NE
. NE . NE

Thapsigargin G#other_organic_compound Xxxx G#other_organic_compound
( NE ( NE
TG G#other_organic_compound XX G#other_organic_compound
) NE ) NE
, NE , NE
an NE xx NE
inhibitor NE xxx NE
of NE xx NE
Ca(2+)-ATPase G#protein_complex Xx(d+)-XXXxxx G#protein_complex
, NE , NE
depletes NE xxx NE
intracellular NE xxx NE
Ca2+ G#other_name_B Xxd+ G#other_name_B
stores G#other_name_E xxx G#other_name_E
and NE xxx NE
induces NE xxx NE
a NE x NE
sustained NE xxx NE
Ca2+ G#atom Xxd+ G#atom
influx NE xxx NE
without NE xxx NE
altering NE xxx NE
phosphatidyl G#other_name_B xxx G#other_name_B
inositol G#other_name_M xxx G#other_name_M
levels G#other_name_E xxx G#other_name_E
. NE . NE

TG G#other_organic_compound XX G#other_organic_compound
plus NE xxx NE
phorbol G#other_organic_compound_B xxx G#other_organic_compound_B
myristate G#other_organic_compound_M xxx G#other_organic_compound_M
acetate G#other_organic_compound_E xxx G#other_organic_compound_E
( NE ( NE
PMA G#other_organic_compound XXX G#other_organic_compound
) NE ) NE
but NE xxx NE
not NE xxx NE
TG G#other_organic_compound XX G#other_organic_compound
alone NE xxx NE
induced NE xxx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
in NE xx NE
Jurkat G#cell_line_B Xxxx G#cell_line_B
T G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
suggesting NE xxx NE
that NE xxx NE
TG G#other_organic_compound XX G#other_organic_compound
had NE xxx NE
no NE xx NE
effect NE xxx NE
on NE xx NE
protein G#protein_molecule_B xxx G#protein_molecule_B
kinase G#protein_molecule_M xxx G#protein_molecule_M
C G#protein_molecule_E X G#protein_molecule_E
( NE ( NE
PKC G#protein_molecule XXX G#protein_molecule
) NE ) NE
. NE . NE

However NE Xxxx NE
, NE , NE
TG G#other_organic_compound XX G#other_organic_compound
induced NE xxx NE
increases NE xxx NE
in NE xx NE
IL-2R G#protein_molecule_B XX-dX G#protein_molecule_B
alpha G#protein_molecule_M xxx G#protein_molecule_M
protein G#protein_molecule_E xxx G#protein_molecule_E
as NE xx NE
well NE xxx NE
as NE xx NE
IL-2R G#RNA_molecule_B XX-dX G#RNA_molecule_B
alpha G#RNA_molecule_M xxx G#RNA_molecule_M
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
in NE xx NE
Jurkat G#cell_line_B Xxxx G#cell_line_B
T G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
in NE xx NE
a NE x NE
dose-dependent NE xxx-xxx NE
manner NE xxx NE
. NE . NE

A NE X NE
similar NE xxx NE
increase NE xxx NE
in NE xx NE
IL-2R G#protein_molecule_B XX-dX G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
by NE xx NE
TG G#other_organic_compound XX G#other_organic_compound
was NE xxx NE
also NE xxx NE
observed NE xxx NE
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
peripheral G#cell_type_M xxx G#cell_type_M
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Further NE Xxxx NE
, NE , NE
like NE xxx NE
PMA G#other_organic_compound XXX G#other_organic_compound
, NE , NE
TG G#other_organic_compound XX G#other_organic_compound
markedly NE xxx NE
induced NE xxx NE
NF G#protein_molecule_B XX G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_E X G#protein_molecule_E
in NE xx NE
Jurkat G#cell_line_B Xxxx G#cell_line_B
T G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

However NE Xxxx NE
, NE , NE
TG G#other_organic_compound XX G#other_organic_compound
and NE xxx NE
PMA G#other_organic_compound XXX G#other_organic_compound
exhibited NE xxx NE
a NE x NE
synergistic NE xxx NE
action NE xxx NE
on NE xx NE
IL-2R G#protein_subunit_B XX-dX G#protein_subunit_B
alpha G#protein_subunit_E xxx G#protein_subunit_E
expression NE xxx NE
, NE , NE
suggesting NE xxx NE
that NE xxx NE
TG G#other_organic_compound XX G#other_organic_compound
and NE xxx NE
PMA G#other_organic_compound XXX G#other_organic_compound
induce NE xxx NE
IL-2R G#protein_subunit_B XX-dX G#protein_subunit_B
alpha G#protein_subunit_E xxx G#protein_subunit_E
through NE xxx NE
distinct NE xxx NE
pathways NE xxx NE
. NE . NE

PMA-induced G#protein_molecule_B XXX-xxx G#protein_molecule_B
IL-2R G#protein_molecule_M XX-dX G#protein_molecule_M
alpha G#protein_molecule_M xxx G#protein_molecule_M
but G#protein_molecule_M xxx G#protein_molecule_M
not G#protein_molecule_M xxx G#protein_molecule_M
TG-induced G#protein_molecule_M XX-xxx G#protein_molecule_M
IL-2R G#protein_molecule_M XX-dX G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
TG-induced G#protein_molecule_B XX-xxx G#protein_molecule_B
IL-2R G#protein_molecule_M XX-dX G#protein_molecule_M
alpha G#protein_molecule_M xxx G#protein_molecule_M
but G#protein_molecule_M xxx G#protein_molecule_M
not G#protein_molecule_M xxx G#protein_molecule_M
PMA-induced G#protein_molecule_M XXX-xxx G#protein_molecule_M
IL-2R G#protein_molecule_M XX-dX G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
is NE xx NE
inhibited NE xxx NE
by NE xx NE
the NE xxx NE
PKC G#other_organic_compound_B XXX G#other_organic_compound_B
inhibitor G#other_organic_compound_M xxx G#other_organic_compound_M
H7 G#other_organic_compound_E Xd G#other_organic_compound_E
, NE , NE
whereas NE xxx NE
TG NE XX NE
-but NE -xxx NE
not NE xxx NE
PMA NE XXX NE
-induced NE -xxx NE
IL-2R NE XX-dX NE
alpha NE xxx NE
was NE xxx NE
inhibited NE xxx NE
by NE xx NE
cholera G#other_organic_compound_B xxx G#other_organic_compound_B
toxin G#other_organic_compound_E xxx G#other_organic_compound_E
, NE , NE
forskolin G#other_organic_compound xxx G#other_organic_compound
and NE xxx NE
1,9-dideoxy G#other_organic_compound_B d,d-xxx G#other_organic_compound_B
forskolin G#other_organic_compound_E xxx G#other_organic_compound_E
. NE . NE

In NE Xx NE
toto NE xxx NE
, NE , NE
these NE xxx NE
results NE xxx NE
suggest NE xxx NE
that NE xxx NE
TG G#other_organic_compound XX G#other_organic_compound
induces NE xxx NE
IL-2R G#protein_subunit_B XX-dX G#protein_subunit_B
alpha G#protein_subunit_E xxx G#protein_subunit_E
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
through NE xxx NE
a NE x NE
PKC NE XXX NE
-independent NE -xxx NE
pathway NE xxx NE
. NE . NE

Physiological NE Xxxx NE
concentration NE xxx NE
of NE xx NE
estradiol G#lipid xxx G#lipid
inhibits NE xxx NE
polymorphonuclear G#other_name_B xxx G#other_name_B
leukocyte G#other_name_M xxx G#other_name_M
chemotaxis G#other_name_E xxx G#other_name_E
via NE xxx NE
a NE x NE
receptor NE xxx NE
mediated NE xxx NE
system NE xxx NE
. NE . NE

Estrogen G#lipid Xxxx G#lipid
exhibits NE xxx NE
a NE x NE
variety NE xxx NE
of NE xx NE
actions NE xxx NE
, NE , NE
including NE xxx NE
immuno-modulatory G#other_name_B xxx-xxx G#other_name_B
effects G#other_name_E xxx G#other_name_E
, NE , NE
in NE xx NE
vivo NE xxx NE
and NE xxx NE
in NE xx NE
vitro NE xxx NE
. NE . NE

The NE Xxx NE
mechanism NE xxx NE
by NE xx NE
which NE xxx NE
estrogen NE xxx NE
exerts NE xxx NE
its NE xxx NE
anti-inflammatory G#other_name_B xxx-xxx G#other_name_B
effect G#other_name_E xxx G#other_name_E
is NE xx NE
not NE xxx NE
yet NE xxx NE
understood NE xxx NE
. NE . NE

We NE Xx NE
investigated NE xxx NE
the NE xxx NE
possible NE xxx NE
mechanisms NE xxx NE
of NE xx NE
estradiol G#lipid xxx G#lipid
acting NE xxx NE
via NE xxx NE
the NE xxx NE
polymorphonuclear G#cell_type_B xxx G#cell_type_B
leukocytes G#cell_type_E xxx G#cell_type_E
( NE ( NE
PMNs G#cell_type XXXx G#cell_type
) NE ) NE
, NE , NE
which NE xxx NE
are NE xxx NE
important NE xxx NE
in NE xx NE
the NE xxx NE
immune G#other_name_B xxx G#other_name_B
response G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
agent NE xxx NE
, NE , NE
17 NE dd NE
beta- NE xxx- NE
estradiol NE xxx NE
, NE , NE
but NE xxx NE
not NE xxx NE
17 NE dd NE
alpha- NE xxx- NE
estradiol NE xxx NE
, NE , NE
significantly NE xxx NE
reduced NE xxx NE
PMNs NE XXXx NE
chemotaxis NE xxx NE
to NE xx NE
FMLP NE XXXX NE
in NE xx NE
a NE x NE
dose-dependent NE xxx-xxx NE
manner NE xxx NE
(control NE (xxx NE
vs NE xx NE
estrogen NE xxx NE
10(-10)-(-6) NE dd(-dd)-(-d) NE
M NE X NE
, NE , NE
P NE X NE
< NE < NE
0.05) NE d.dd) NE
. NE . NE

Physiological NE Xxxx NE
concentrations NE xxx NE
of NE xx NE
estradiol G#lipid xxx G#lipid
significantly NE xxx NE
reduced NE xxx NE
the NE xxx NE
chemotaxis NE xxx NE
of NE xx NE
PMNs G#cell_type XXXx G#cell_type
(10(-10) NE (dd(-dd) NE
mol) NE xxx) NE
. NE . NE

Pre-incubation NE Xxx-xxx NE
with NE xxx NE
clomiphene G#other_organic_compound xxx G#other_organic_compound
or NE xx NE
tamoxifen G#other_organic_compound xxx G#other_organic_compound
which NE xxx NE
are NE xxx NE
estrogen NE xxx NE
receptor NE xxx NE
antagonists NE xxx NE
, NE , NE
eliminated NE xxx NE
the NE xxx NE
inhibitory NE xxx NE
effect NE xxx NE
of NE xx NE
17 NE dd NE
beta- NE xxx- NE
estradiol NE xxx NE
on NE xx NE
the NE xxx NE
chemotaxis NE xxx NE
of NE xx NE
PMNs NE XXXx NE
, NE , NE
restoring NE xxx NE
it NE xx NE
to NE xx NE
the NE xxx NE
control NE xxx NE
level NE xxx NE
. NE . NE

These NE Xxxx NE
observations NE xxx NE
suggest NE xxx NE
that NE xxx NE
17 NE dd NE
beta- NE xxx- NE
estradiol NE xxx NE
suppressed NE xxx NE
the NE xxx NE
chemotaxis NE xxx NE
of NE xx NE
PMNs NE XXXx NE
by NE xx NE
a NE x NE
receptor-dependent NE xxx-xxx NE
mechanism NE xxx NE
. NE . NE

In NE Xx NE
addition NE xxx NE
, NE , NE
the NE xxx NE
level NE xxx NE
of NE xx NE
estradiol G#lipid xxx G#lipid
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
plasma G#cell_type_E xxx G#cell_type_E
, NE , NE
which NE xxx NE
PMNs G#cell_type XXXx G#cell_type
were NE xxx NE
drawn NE xxx NE
, NE , NE
showed NE xxx NE
a NE x NE
close NE xxx NE
, NE , NE
inverse NE xxx NE
correlation NE xxx NE
with NE xxx NE
the NE xxx NE
PMNs G#cell_type XXXx G#cell_type
chemotaxis G#other_name xxx G#other_name
to NE xx NE
FMLP G#lipid XXXX G#lipid
(r NE (x NE
= NE = NE
-0.821 NE -d.ddd NE
p NE x NE
< NE < NE
0.001) NE d.ddd) NE
. NE . NE

Estrogen G#lipid Xxxx G#lipid
may NE xxx NE
modify NE xxx NE
the NE xxx NE
activity NE xxx NE
of NE xx NE
neutrophils G#cell_type xxx G#cell_type
during NE xxx NE
the NE xxx NE
normal NE xxx NE
menstrual NE xxx NE
cycle NE xxx NE
, NE , NE
not NE xxx NE
only NE xxx NE
during NE xxx NE
pregnancy NE xxx NE
, NE , NE
and NE xxx NE
influence NE xxx NE
inflammation NE xxx NE
. NE . NE

Identification NE Xxxx NE
of NE xx NE
the NE xxx NE
TCL1 G#DNA_domain_or_region_B XXXd G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
involved NE xxx NE
in NE xx NE
T-cell NE X-xxx NE
malignancies NE xxx NE
. NE . NE

The NE Xxx NE
TCL1 G#DNA_domain_or_region_B XXXd G#DNA_domain_or_region_B
locus G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
on NE xx NE
chromosome G#DNA_molecule_B xxx G#DNA_molecule_B
14q32.1 G#DNA_molecule_E ddxdd.d G#DNA_molecule_E
is NE xx NE
frequently NE xxx NE
involved NE xxx NE
in NE xx NE
chromosomal G#other_name_B xxx G#other_name_B
translocations G#other_name_E xxx G#other_name_E
and NE xxx NE
inversions NE xxx NE
with NE xxx NE
one NE xxx NE
of NE xx NE
the NE xxx NE
T-cell G#DNA_domain_or_region_B X-xxx G#DNA_domain_or_region_B
receptor G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
loci G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
human G#other_name_B xxx G#other_name_B
T-cell G#other_name_M X-xxx G#other_name_M
leukemias G#other_name_E xxx G#other_name_E
and NE xxx NE
lymphomas G#other_name xxx G#other_name
. NE . NE

The NE Xxx NE
chromosome G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
14 G#DNA_domain_or_region_M dd G#DNA_domain_or_region_M
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
translocated NE xxx NE
or NE xx NE
rearranged NE xxx NE
involves NE xxx NE
approximately NE xxx NE
350 G#polynucleotide_B ddd G#polynucleotide_B
kb G#polynucleotide_E xx G#polynucleotide_E
of NE xx NE
DNA NE XXX NE
at NE xx NE
chromosome G#DNA_substructure_B xxx G#DNA_substructure_B
band G#DNA_substructure_M xxx G#DNA_substructure_M
14q32.1 G#DNA_substructure_E ddxdd.d G#DNA_substructure_E
. NE . NE

Within NE Xxxx NE
this NE xxx NE
region NE xxx NE
we NE xx NE
have NE xxx NE
identified NE xxx NE
a NE x NE
gene NE xxx NE
coding NE xxx NE
for NE xxx NE
a NE x NE
1.3-kb G#RNA_molecule_B d.d-xx G#RNA_molecule_B
transcript G#RNA_molecule_E xxx G#RNA_molecule_E
, NE , NE
expressed NE xxx NE
only NE xxx NE
in NE xx NE
restricted NE xxx NE
subsets NE xxx NE
of NE xx NE
cells NE xxx NE
within NE xxx NE
the NE xxx NE
lymphoid G#cell_type_B xxx G#cell_type_B
lineage G#cell_type_E xxx G#cell_type_E
and NE xxx NE
expressed NE xxx NE
at NE xx NE
high NE xxx NE
levels NE xxx NE
in NE xx NE
leukemic G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
carrying NE xxx NE
a NE x NE
t(14;14)(q11;q32) G#DNA_N/A_B x(dd;dd)(xdd;xdd) G#DNA_N/A_B
chromosome G#DNA_N/A_M xxx G#DNA_N/A_M
translocation G#DNA_N/A_E xxx G#DNA_N/A_E
or NE xx NE
a NE x NE
inv(14)(q11;q32) G#DNA_N/A_B xxx(dd)(xdd;xdd) G#DNA_N/A_B
chromosome G#DNA_N/A_M xxx G#DNA_N/A_M
inversion G#DNA_N/A_E xxx G#DNA_N/A_E
. NE . NE

The NE Xxx NE
cognate G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
cDNA G#DNA_domain_or_region_M xXXX G#DNA_domain_or_region_M
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
reveals NE xxx NE
an NE xx NE
open G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
reading G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
frame G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
342 G#polynucleotide_B ddd G#polynucleotide_B
nt G#polynucleotide_E xx G#polynucleotide_E
encoding NE xxx NE
a NE x NE
protein G#protein_molecule_B xxx G#protein_molecule_B
of G#protein_molecule_M xx G#protein_molecule_M
14 G#protein_molecule_M dd G#protein_molecule_M
kDa G#protein_molecule_E xXx G#protein_molecule_E
. NE . NE

The NE Xxx NE
TCL1 G#DNA_domain_or_region_B XXXd G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
sequence NE xxx NE
, NE , NE
which NE xxx NE
, NE , NE
to NE xx NE
our NE xxx NE
knowledge NE xxx NE
, NE , NE
shows NE xxx NE
no NE xx NE
sequence NE xxx NE
homology NE xxx NE
with NE xxx NE
other NE xxx NE
human G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
, NE , NE
is NE xx NE
preferentially NE xxx NE
expressed NE xxx NE
early NE xxx NE
in NE xx NE
T-lymphocyte G#cell_type_B X-xxx G#cell_type_B
and G#cell_type_M xxx G#cell_type_M
B-lymphocyte G#cell_type_E X-xxx G#cell_type_E

Identification NE Xxxx NE
of NE xx NE
a NE x NE
region NE xxx NE
which NE xxx NE
directs NE xxx NE
the NE xxx NE
monocytic G#other_name_B xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
colony-stimulating NE xxx-xxx NE
factor NE xxx NE
1 NE d NE
( NE ( NE
macrophage NE xxx NE
colony-stimulating NE xxx-xxx NE
factor NE xxx NE
) NE ) NE
receptor NE xxx NE
promoter NE xxx NE
and NE xxx NE
binds NE xxx NE
PEBP2/CBF NE XXXXd/XXX NE
( NE ( NE
AML1 NE XXXd NE
) NE ) NE
. NE . NE

The NE Xxx NE
receptor NE xxx NE
for NE xxx NE
the NE xxx NE
macrophage G#protein_molecule_B xxx G#protein_molecule_B
colony-stimulating G#protein_molecule_M xxx-xxx G#protein_molecule_M
factor G#protein_molecule_E xxx G#protein_molecule_E
(or NE (xx NE
colony-stimulating G#protein_molecule_B xxx-xxx G#protein_molecule_B
factor G#protein_molecule_M xxx G#protein_molecule_M
1 G#protein_molecule_E d G#protein_molecule_E
[ NE [ NE
CSF-1 G#protein_molecule XXX-d G#protein_molecule
]) NE ]) NE
is NE xx NE
expressed NE xxx NE
from NE xxx NE
different NE xxx NE
promoters NE xxx NE
in NE xx NE
monocytic G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
and NE xxx NE
placental G#cell_type_B xxx G#cell_type_B
trophoblasts G#cell_type_E xxx G#cell_type_E
. NE . NE

We NE Xx NE
have NE xxx NE
demonstrated NE xxx NE
that NE xxx NE
the NE xxx NE
monocyte-specific G#other_name_B xxx-xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
CSF-1 G#protein_molecule_B XXX-d G#protein_molecule_B
receptor G#protein_molecule_E xxx G#protein_molecule_E
is NE xx NE
regulated NE xxx NE
at NE xx NE
the NE xxx NE
level NE xxx NE
of NE xx NE
transcription NE xxx NE
by NE xx NE
a NE x NE
tissue-specific G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
whose NE xxx NE
activity NE xxx NE
is NE xx NE
stimulated NE xxx NE
by NE xx NE
the NE xxx NE
monocyte/B-cell-specific G#protein_family_or_group_B xxx/X-xxx-xxx G#protein_family_or_group_B
transcription G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
PU.1 G#protein_molecule XX.d G#protein_molecule
(D.-E.Zhang NE (X.-X.Xxxx NE
, NE , NE
C.J.Hetherington NE X.X.Xxxx NE
, NE , NE
H.-M.Chen NE X.-X.Xxxx NE
, NE , NE
and NE xxx NE
D.G.Tenen NE X.X.Xxxx NE
, NE , NE
Mol.Cell NE Xxx.Xxxx NE
. NE . NE
Biol.14:373-381 NE Xxxx.dd:ddd-ddd NE
, NE , NE
1994) NE dddd) NE
. NE . NE

Here NE Xxxx NE
we NE xx NE
report NE xxx NE
that NE xxx NE
the NE xxx NE
tissue NE xxx NE
specificity NE xxx NE
of NE xx NE
this NE xxx NE
promoter G#DNA_domain_or_region xxx G#DNA_domain_or_region
is NE xx NE
also NE xxx NE
mediated NE xxx NE
by NE xx NE
sequences NE xxx NE
in NE xx NE
a NE x NE
region G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
II G#DNA_domain_or_region_E XX G#DNA_domain_or_region_E
(bp NE (xx NE
-88 NE -dd NE
to NE xx NE
- NE - NE
59) NE dd) NE
, NE , NE
which NE xxx NE
lies NE xxx NE
10 G#DNA_domain_or_region_B dd G#DNA_domain_or_region_B
bp G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
upstream G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
from NE xxx NE
the NE xxx NE
PU.1 NE XX.d NE
-binding NE -xxx NE
site NE xxx NE
. NE . NE

When NE Xxxx NE
analyzed NE xxx NE
by NE xx NE
DNase G#other_name_B XXxxx G#other_name_B
footprinting G#other_name_E xxx G#other_name_E
, NE , NE
region G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
II G#DNA_domain_or_region_E XX G#DNA_domain_or_region_E
was NE xxx NE
protected NE xxx NE
preferentially NE xxx NE
in NE xx NE
monocytic G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Electrophoretic G#other_name_B Xxxx G#other_name_B
mobility G#other_name_M xxx G#other_name_M
shift G#other_name_M xxx G#other_name_M
assays G#other_name_E xxx G#other_name_E
confirmed NE xxx NE
that NE xxx NE
region G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
II G#DNA_domain_or_region_E XX G#DNA_domain_or_region_E
interacts NE xxx NE
specifically NE xxx NE
with NE xxx NE
nuclear G#protein_family_or_group_B xxx G#protein_family_or_group_B
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
from NE xxx NE
monocytic G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Two NE Xxx NE
gel NE xxx NE
shift NE xxx NE
complexes NE xxx NE
( NE ( NE
Mono NE Xxxx NE
A NE X NE
and NE xxx NE
Mono NE Xxxx NE
B NE X NE
) NE ) NE
were NE xxx NE
formed NE xxx NE
with NE xxx NE
separate NE xxx NE
sequence NE xxx NE
elements NE xxx NE
within NE xxx NE
this NE xxx NE
region NE xxx NE
. NE . NE

Competition NE Xxxx NE
and NE xxx NE
supershift NE xxx NE
experiments NE xxx NE
indicate NE xxx NE
that NE xxx NE
Mono NE Xxxx NE
B NE X NE
contains NE xxx NE
a NE x NE
member NE xxx NE
of NE xx NE
the NE xxx NE
polyomavirus NE xxx NE
enhancer-binding NE xxx-xxx NE
protein NE xxx NE
2/core-binding NE d/xxx-xxx NE
factor NE xxx NE
( NE ( NE
PEBP2/CBF NE XXXXd/XXX NE
) NE ) NE
family NE xxx NE
, NE , NE
which NE xxx NE
includes NE xxx NE
the NE xxx NE
AML1 NE XXXd NE
gene NE xxx NE
product NE xxx NE
, NE , NE
while NE xxx NE
Mono NE Xxxx NE
A NE X NE
is NE xx NE
a NE x NE
distinct NE xxx NE
complex NE xxx NE
preferentially NE xxx NE
expressed NE xxx NE
in NE xx NE
monocytic NE xxx NE
cells NE xxx NE
. NE . NE

Promoter G#DNA_molecule_B Xxxx G#DNA_molecule_B
constructs G#DNA_molecule_E xxx G#DNA_molecule_E
with NE xxx NE
mutations NE xxx NE
in NE xx NE
these NE xxx NE
sequence NE xxx NE
elements NE xxx NE
were NE xxx NE
no NE xx NE
longer NE xxx NE
expressed NE xxx NE
specifically NE xxx NE
in NE xx NE
monocytes G#cell_type xxx G#cell_type
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
multimerized G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
region G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
II G#DNA_domain_or_region_M XX G#DNA_domain_or_region_M
sequence G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
elements G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
enhanced NE xxx NE
the NE xxx NE
activity NE xxx NE
of NE xx NE
a NE x NE
heterologous G#DNA_substructure_B xxx G#DNA_substructure_B
thymidine G#DNA_substructure_M xxx G#DNA_substructure_M
kinase G#DNA_substructure_M xxx G#DNA_substructure_M
promoter G#DNA_substructure_E xxx G#DNA_substructure_E
in NE xx NE
monocytic G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
but NE xxx NE
not NE xxx NE
other NE xxx NE
cell NE xxx NE
types NE xxx NE
tested NE xxx NE
. NE . NE

These NE Xxxx NE
results NE xxx NE
indicate NE xxx NE
that NE xxx NE
the NE xxx NE
monocyte/B-cell-specific G#protein_family_or_group_B xxx/X-xxx-xxx G#protein_family_or_group_B
transcription G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
PU.1 NE XX.d NE
and NE xxx NE
the NE xxx NE
Mono G#protein_complex_B Xxxx G#protein_complex_B
A G#protein_complex_M X G#protein_complex_M
protein G#protein_complex_M xxx G#protein_complex_M
complex G#protein_complex_M xxx G#protein_complex_M
and G#protein_complex_M xxx G#protein_complex_M
Mono G#protein_complex_M Xxxx G#protein_complex_M
B G#protein_complex_M X G#protein_complex_M
protein G#protein_complex_M xxx G#protein_complex_M
complex G#protein_complex_E xxx G#protein_complex_E
protein NE xxx NE
complexes NE xxx NE
act NE xxx NE
in NE xx NE
concert NE xxx NE
to NE xx NE
regulate NE xxx NE
monocyte-specific G#other_name_B xxx-xxx G#other_name_B
transcription G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
CSF-1 G#protein_molecule_B XXX-d G#protein_molecule_B
receptor G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

Pyrrolidine G#other_organic_compound_B Xxxx G#other_organic_compound_B
dithiocarbamate G#other_organic_compound_E xxx G#other_organic_compound_E
, NE , NE
a NE x NE
potent NE xxx NE
inhibitor NE xxx NE
of NE xx NE
nuclear G#protein_molecule_B xxx G#protein_molecule_B
factor G#protein_molecule_M xxx G#protein_molecule_M
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_E X G#protein_molecule_E
( NE ( NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
) NE ) NE
activation NE xxx NE
, NE , NE
prevents NE xxx NE
apoptosis NE xxx NE
in NE xx NE
human NE xxx NE
promyelocytic G#cell_line_B xxx G#cell_line_B
leukemia G#cell_line_M xxx G#cell_line_M
HL-60 G#cell_line_M XX-dd G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
and NE xxx NE
thymocytes G#cell_type xxx G#cell_type
. NE . NE

We NE Xx NE
examined NE xxx NE
the NE xxx NE
effect NE xxx NE
of NE xx NE
pyrrolidine G#other_organic_compound_B xxx G#other_organic_compound_B
dithiocarbamate G#other_organic_compound_E xxx G#other_organic_compound_E
( NE ( NE
PDTC G#other_organic_compound XXXX G#other_organic_compound
) NE ) NE
, NE , NE
which NE xxx NE
potently NE xxx NE
blocks NE xxx NE
the NE xxx NE
activation NE xxx NE
of NE xx NE
nuclear G#protein_molecule_B xxx G#protein_molecule_B
factor G#protein_molecule_M xxx G#protein_molecule_M
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_E X G#protein_molecule_E
( NE ( NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
) NE ) NE
, NE , NE
on NE xx NE
the NE xxx NE
induction NE xxx NE
of NE xx NE
apoptosis NE xxx NE
by NE xx NE
a NE x NE
variety NE xxx NE
of NE xx NE
agents NE xxx NE
. NE . NE

Treatment NE Xxxx NE
of NE xx NE
a NE x NE
human G#cell_line_B xxx G#cell_line_B
promyelocytic G#cell_line_M xxx G#cell_line_M
leukemia G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
, NE , NE
HL-60 G#cell_line XX-dd G#cell_line
, NE , NE
with NE xxx NE
10 NE dd NE
micrograms/mL NE xxx/xX NE
etoposide G#other_organic_compound xxx G#other_organic_compound
or NE xx NE
2 NE d NE
microM NE xxxX NE
1-beta-D-arabinofuranosylcytosine G#other_organic_compound d-xxx-X-xxx G#other_organic_compound
induced NE xxx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
activation G#other_name_E xxx G#other_name_E
within NE xxx NE
1 NE d NE
hr NE xx NE
and NE xxx NE
subsequently NE xxx NE
caused NE xxx NE
apoptosis NE xxx NE
within NE xxx NE
3-4 NE d-d NE
hr NE xx NE
. NE . NE

The NE Xxx NE
simultaneous NE xxx NE
addition NE xxx NE
of NE xx NE
50-500 NE dd-ddd NE
microM NE xxxX NE
PDTC G#other_organic_compound XXXX G#other_organic_compound
with NE xxx NE
these NE xxx NE
agents NE xxx NE
blocked NE xxx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
activation G#other_name_E xxx G#other_name_E
and NE xxx NE
completely NE xxx NE
abrogated NE xxx NE
both NE xxx NE
morphologically NE xxx NE
apoptotic NE xxx NE
changes NE xxx NE
and NE xxx NE
internucleosomal G#other_name_B xxx G#other_name_B
DNA G#other_name_M XXX G#other_name_M
fragmentation G#other_name_E xxx G#other_name_E
for NE xxx NE
up NE xx NE
to NE xx NE
6 NE d NE
hr NE xx NE
. NE . NE

However NE Xxxx NE
, NE , NE
PDTC G#other_organic_compound XXXX G#other_organic_compound
failed NE xxx NE
to NE xx NE
inhibit NE xxx NE
the NE xxx NE
endonuclease G#other_name_B xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
contained NE xxx NE
in NE xx NE
the NE xxx NE
whole NE xxx NE
cell NE xxx NE
lysates NE xxx NE
. NE . NE

The NE Xxx NE
inhibitory NE xxx NE
effect NE xxx NE
of NE xx NE
PDTC G#other_organic_compound XXXX G#other_organic_compound
was NE xxx NE
also NE xxx NE
observed NE xxx NE
in NE xx NE
etoposide G#other_organic_compound xxx G#other_organic_compound
-and NE -xxx NE
dexamethasone-induced NE xxx-xxx NE
apoptosis NE xxx NE
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
thymocytes G#cell_type_E xxx G#cell_type_E
at NE xx NE
a NE x NE
concentration NE xxx NE
of NE xx NE
1-10 NE d-dd NE
microM NE xxxX NE
. NE . NE

Since NE Xxxx NE
PDTC G#other_organic_compound XXXX G#other_organic_compound
has NE xxx NE
both NE xxx NE
antioxidant G#other_organic_compound xxx G#other_organic_compound
and NE xxx NE
metal-ion NE xxx-xxx NE
chelating NE xxx NE
activities NE xxx NE
, NE , NE
we NE xx NE
tested NE xxx NE
the NE xxx NE
effects NE xxx NE
of NE xx NE
N-acetyl-L-cysteine NE X-xxx-X-xxx NE
( NE ( NE
NAC NE XXX NE
) NE ) NE
( NE ( NE
antioxidant NE xxx NE
) NE ) NE
or NE xx NE
o-phenanthroline NE x-xxx NE
( NE ( NE
OP NE XX NE
) NE ) NE
( NE ( NE
metal-ion NE xxx-xxx NE
chelator NE xxx NE
) NE ) NE
on NE xx NE
the NE xxx NE
induction NE xxx NE
of NE xx NE
apoptosis NE xxx NE
. NE . NE

Pretreatment NE Xxxx NE
of NE xx NE
HL-60 NE XX-dd NE
cells NE xxx NE
or NE xx NE
thymocytes G#cell_type xxx G#cell_type
with NE xxx NE
100-500 NE ddd-ddd NE
microM NE xxxX NE
OP G#other_organic_compound XX G#other_organic_compound
for NE xxx NE
2 NE d NE
hr NE xx NE
, NE , NE
but NE xxx NE
not NE xxx NE
10-60 NE dd-dd NE
mM NE xX NE
NAC G#amino_acid_monomer XXX G#amino_acid_monomer
, NE , NE
suppressed NE xxx NE
subsequent NE xxx NE
occurrence NE xxx NE
of NE xx NE
apoptosis G#other_name xxx G#other_name
induced NE xxx NE
by NE xx NE
etoposide G#other_organic_compound xxx G#other_organic_compound
. NE . NE

These NE Xxxx NE
results NE xxx NE
suggest NE xxx NE
that NE xxx NE
the NE xxx NE
activation NE xxx NE
of NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
plays NE xxx NE
an NE xx NE
important NE xxx NE
role NE xxx NE
in NE xx NE
the NE xxx NE
apoptotic G#other_name_B xxx G#other_name_B
process G#other_name_E xxx G#other_name_E
of NE xx NE
human G#cell_type_B xxx G#cell_type_B
hematopoietic G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Overexpression NE Xxxx NE
of NE xx NE
protein NE xxx NE
kinase NE xxx NE
C NE X NE
-zeta NE -xxx NE
stimulates NE xxx NE
leukemic NE xxx NE
cell NE xxx NE
differentiation NE xxx NE
. NE . NE

A NE X NE
function NE xxx NE
for NE xxx NE
protein NE xxx NE
kinase NE xxx NE
C NE X NE
-zeta NE -xxx NE
( NE ( NE
PKC NE XXX NE
-zeta NE -xxx NE
) NE ) NE
, NE , NE
a NE x NE
member NE xxx NE
of NE xx NE
the NE xxx NE
phorbol NE xxx NE
ester NE xxx NE
nonresponsive NE xxx NE
atypical NE xxx NE
protein NE xxx NE
kinase NE xxx NE
C NE X NE
subfamily NE xxx NE
, NE , NE
in NE xx NE
modulating NE xxx NE
differentiation NE xxx NE
was NE xxx NE
examined NE xxx NE
in NE xx NE
the NE xxx NE
leukemic NE xxx NE
U937 NE Xddd NE
cell NE xxx NE
. NE . NE

Transfected NE Xxxx NE
U937 G#cell_line_B Xddd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
stably NE xxx NE
overexpressing NE xxx NE
PKC-zeta G#protein_molecule XXX-xxx G#protein_molecule
displayed NE xxx NE
a NE x NE
longer NE xxx NE
doubling NE xxx NE
time NE xxx NE
, NE , NE
lower NE xxx NE
saturation NE xxx NE
density NE xxx NE
at NE xx NE
confluency NE xxx NE
, NE , NE
and NE xxx NE
an NE xx NE
increase NE xxx NE
in NE xx NE
adherence NE xxx NE
to NE xx NE
plastic NE xxx NE
as NE xx NE
compared NE xxx NE
to NE xx NE
control G#cell_line_B xxx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

PKC-zeta G#cell_line_B XXX-xxx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
expressed NE xxx NE
a NE x NE
more NE xxx NE
differentiated NE xxx NE
phenotype NE xxx NE
as NE xx NE
assessed NE xxx NE
by NE xx NE
changes NE xxx NE
in NE xx NE
morphology NE xxx NE
, NE , NE
surface NE xxx NE
antigen NE xxx NE
expression NE xxx NE
, NE , NE
and NE xxx NE
lysosomal NE xxx NE
enzyme NE xxx NE
activities NE xxx NE
and NE xxx NE
were NE xxx NE
distinct NE xxx NE
from NE xxx NE
parental NE xxx NE
U937 NE Xddd NE
cells NE xxx NE
stimulated NE xxx NE
to NE xx NE
differentiate NE xxx NE
by NE xx NE
exposure NE xxx NE
to NE xx NE
phorbol NE xxx NE
esters NE xxx NE
. NE . NE

In NE Xx NE
contrast NE xxx NE
to NE xx NE
parental NE xxx NE
U937 G#cell_line_B Xddd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
PKC-zeta G#cell_line_B XXX-xxx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
constitutively NE xxx NE
expressed NE xxx NE
mRNA G#RNA_family_or_group_B xXXX G#RNA_family_or_group_B
transcripts G#RNA_family_or_group_E xxx G#RNA_family_or_group_E
for NE xxx NE
c-jun G#DNA_domain_or_region x-xxx G#DNA_domain_or_region
and NE xxx NE
a NE x NE
low NE xxx NE
mobility NE xxx NE
AP-1 G#other_name_B XX-d G#other_name_B
binding G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
. NE . NE

Thus NE Xxxx NE
, NE , NE
PKC-zeta G#protein_molecule XXX-xxx G#protein_molecule
overexpression NE xxx NE
stimulates NE xxx NE
a NE x NE
type NE xxx NE
of NE xx NE
phenotypic NE xxx NE
differentiation NE xxx NE
that NE xxx NE
differs NE xxx NE
significantly NE xxx NE
from NE xxx NE
maturation NE xxx NE
occurring NE xxx NE
upon NE xxx NE
activation NE xxx NE
of NE xx NE
other NE xxx NE
PKC G#protein_family_or_group_B XXX G#protein_family_or_group_B
subfamilies G#protein_family_or_group_E xxx G#protein_family_or_group_E
induced NE xxx NE
by NE xx NE
phorbol G#other_name_B xxx G#other_name_B
ester G#other_name_M xxx G#other_name_M
treatment G#other_name_E xxx G#other_name_E
. NE . NE

Increased NE Xxxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
c-jun G#DNA_domain_or_region x-xxx G#DNA_domain_or_region
protooncogene NE xxx NE
and NE xxx NE
an NE xx NE
increase NE xxx NE
in NE xx NE
AP-1 G#other_name_B XX-d G#other_name_B
binding G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
in NE xx NE
PKC-zeta G#cell_line_B XXX-xxx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
provides NE xxx NE
a NE x NE
potential NE xxx NE
mechanism NE xxx NE
for NE xxx NE
explaining NE xxx NE
the NE xxx NE
altered NE xxx NE
differentiation NE xxx NE
status NE xxx NE
of NE xx NE
this NE xxx NE
cell NE xxx NE
. NE . NE

A NE X NE
family NE xxx NE
of NE xx NE
serine G#protein_family_or_group_B xxx G#protein_family_or_group_B
proteases G#protein_family_or_group_E xxx G#protein_family_or_group_E
expressed NE xxx NE
exclusively NE xxx NE
in NE xx NE
myelo- NE xxx- NE
monocytic G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
specifically NE xxx NE
processes NE xxx NE
the NE xxx NE
nuclear G#protein_subunit_B xxx G#protein_subunit_B
factor-kappa G#protein_subunit_M xxx-xxx G#protein_subunit_M
B G#protein_subunit_M X G#protein_subunit_M
subunit G#protein_subunit_M xxx G#protein_subunit_M
p65 G#protein_subunit_E xdd G#protein_subunit_E
in NE xx NE
vitro NE xxx NE
and NE xxx NE
may NE xxx NE
impair NE xxx NE
human NE xxx NE
immunodeficiency G#other_name_B xxx G#other_name_B
virus G#other_name_M xxx G#other_name_M
replication G#other_name_E xxx G#other_name_E
in NE xx NE
these NE xxx NE
cells NE xxx NE
. NE . NE

Two NE Xxx NE
groups NE xxx NE
of NE xx NE
U937 G#cell_line_B Xddd G#cell_line_B
promonocytic G#cell_line_M xxx G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
were NE xxx NE
obtained NE xxx NE
by NE xx NE
limiting NE xxx NE
dilution NE xxx NE
cloning NE xxx NE
which NE xxx NE
differed NE xxx NE
strikingly NE xxx NE
in NE xx NE
their NE xxx NE
ability NE xxx NE
to NE xx NE
support NE xxx NE
human NE xxx NE
immunodeficiency NE xxx NE
virus NE xxx NE
1 NE d NE
( NE ( NE
HIV-1 NE XXX-d NE
) NE ) NE
replication NE xxx NE
. NE . NE

"Plus" G#cell_line_B "Xxxx" G#cell_line_B
clones G#cell_line_E xxx G#cell_line_E
replicated NE xxx NE
the NE xxx NE
virus NE xxx NE
efficiently NE xxx NE
, NE , NE
whereas NE xxx NE
"minus" G#cell_line_B "xxx" G#cell_line_B
clones G#cell_line_E xxx G#cell_line_E
did NE xxx NE
not NE xxx NE
. NE . NE

We NE Xx NE
examined NE xxx NE
these NE xxx NE
clones NE xxx NE
for NE xxx NE
differences NE xxx NE
in NE xx NE
nuclear G#other_name_B xxx G#other_name_B
factor G#other_name_M xxx G#other_name_M
(NF)-kappa G#other_name_M (XX)-xxx G#other_name_M
B G#other_name_M X G#other_name_M
activity G#other_name_E xxx G#other_name_E
which NE xxx NE
might NE xxx NE
account NE xxx NE
for NE xxx NE
the NE xxx NE
observed NE xxx NE
phenomenon NE xxx NE
. NE . NE

Stimulation NE Xxxx NE
of NE xx NE
plus G#cell_line_B xxx G#cell_line_B
clones G#cell_line_E xxx G#cell_line_E
liberated NE xxx NE
the NE xxx NE
classical NE xxx NE
p50-p65 G#protein_complex_B xdd-xdd G#protein_complex_B
complex G#protein_complex_E xxx G#protein_complex_E
from NE xxx NE
cytoplasmic NE xxx NE
pools NE xxx NE
, NE , NE
whereas NE xxx NE
minus G#cell_line_B xxx G#cell_line_B
clones G#cell_line_E xxx G#cell_line_E
produced NE xxx NE
an NE xx NE
apparently NE xxx NE
novel NE xxx NE
, NE , NE
faster-migrating G#protein_complex_B xxx-xxx G#protein_complex_B
complex G#protein_complex_E xxx G#protein_complex_E
, NE , NE
as NE xx NE
judged NE xxx NE
by NE xx NE
electrophoretic G#other_name_B xxx G#other_name_B
mobility G#other_name_M xxx G#other_name_M
shift G#other_name_M xxx G#other_name_M
assays G#other_name_E xxx G#other_name_E
. NE . NE

It NE Xx NE
is NE xx NE
surprising NE xxx NE
that NE xxx NE
the NE xxx NE
faster-migrating G#protein_complex_B xxx-xxx G#protein_complex_B
complex G#protein_complex_E xxx G#protein_complex_E
was NE xxx NE
composed NE xxx NE
also NE xxx NE
of NE xx NE
p50 G#protein_subunit xdd G#protein_subunit
and NE xxx NE
p65 G#protein_subunit xdd G#protein_subunit
. NE . NE

However NE Xxxx NE
, NE , NE
the NE xxx NE
p65 G#protein_subunit_B xdd G#protein_subunit_B
subunit G#protein_subunit_E xxx G#protein_subunit_E
was NE xxx NE
COOH-terminally G#other_name_B XXXX-xxx G#other_name_B
truncated G#other_name_E xxx G#other_name_E
, NE , NE
as NE xx NE
shown NE xxx NE
by NE xx NE
immunoprecipitation G#other_name xxx G#other_name
. NE . NE

The NE Xxx NE
truncation NE xxx NE
resulted NE xxx NE
from NE xxx NE
limited NE xxx NE
proteolysis NE xxx NE
of NE xx NE
p65 G#protein_subunit xdd G#protein_subunit
during NE xxx NE
cellular G#other_name_B xxx G#other_name_B
extraction G#other_name_E xxx G#other_name_E
which NE xxx NE
released NE xxx NE
particular NE xxx NE
lysosomal G#protein_family_or_group_B xxx G#protein_family_or_group_B
serine G#protein_family_or_group_M xxx G#protein_family_or_group_M
proteases G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
such NE xxx NE
as NE xx NE
elastase G#protein_family_or_group xxx G#protein_family_or_group
, NE , NE
cathepsin G#protein_molecule_B xxx G#protein_molecule_B
G G#protein_molecule_E X G#protein_molecule_E
, NE , NE
and NE xxx NE
proteinase G#protein_molecule_B xxx G#protein_molecule_B
3 G#protein_molecule_E d G#protein_molecule_E
. NE . NE

These NE Xxxx NE
specific NE xxx NE
proteases NE xxx NE
are NE xxx NE
coordinately NE xxx NE
expressed NE xxx NE
and NE xxx NE
were NE xxx NE
present NE xxx NE
exclusively NE xxx NE
in NE xx NE
the NE xxx NE
minus G#cell_line_B xxx G#cell_line_B
U937 G#cell_line_M Xddd G#cell_line_M
clones G#cell_line_E xxx G#cell_line_E
, NE , NE
but NE xxx NE
not NE xxx NE
in NE xx NE
the NE xxx NE
plus G#cell_line_B xxx G#cell_line_B
clones G#cell_line_E xxx G#cell_line_E
, NE , NE
as NE xx NE
demonstrated NE xxx NE
in NE xx NE
the NE xxx NE
case NE xxx NE
of NE xx NE
cathepsin G#protein_molecule_B xxx G#protein_molecule_B
G G#protein_molecule_E X G#protein_molecule_E
. NE . NE

In NE Xx NE
addition NE xxx NE
, NE , NE
these NE xxx NE
proteases NE xxx NE
were NE xxx NE
detected NE xxx NE
in NE xx NE
certain NE xxx NE
subclones NE xxx NE
of NE xx NE
THP-1 G#cell_line XXX-d G#cell_line
and NE xxx NE
HL-60 G#cell_line_B XX-dd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
and NE xxx NE
in NE xx NE
primary NE xxx NE
monocytes G#cell_type xxx G#cell_type
, NE , NE
in NE xx NE
each NE xxx NE
case NE xxx NE
correlating NE xxx NE
with NE xxx NE
the NE xxx NE
truncated NE xxx NE
from NE xxx NE
of NE xx NE
p65 G#protein_subunit xdd G#protein_subunit
. NE . NE

We NE Xx NE
demonstrate NE xxx NE
in NE xx NE
vitro NE xxx NE
cleavage NE xxx NE
of NE xx NE
p65 G#protein_subunit xdd G#protein_subunit
by NE xx NE
purified NE xxx NE
elastase G#protein_family_or_group xxx G#protein_family_or_group
and NE xxx NE
cathepsin G#protein_molecule_B xxx G#protein_molecule_B
G G#protein_molecule_E X G#protein_molecule_E
. NE . NE

It NE Xx NE
is NE xx NE
possible NE xxx NE
that NE xxx NE
particular NE xxx NE
serine G#protein_family_or_group_B xxx G#protein_family_or_group_B
proteases G#protein_family_or_group_E xxx G#protein_family_or_group_E
may NE xxx NE
have NE xxx NE
inhibiting NE xxx NE
effects NE xxx NE
on NE xx NE
the NE xxx NE
replication NE xxx NE
of NE xx NE
HIV-1 G#virus XXX-d G#virus
in NE xx NE
myelo- NE xxx- NE
monocytic NE xxx NE
cells NE xxx NE
. NE . NE

The NE Xxx NE
data NE xxx NE
also NE xxx NE
demonstrate NE xxx NE
that NE xxx NE
special NE xxx NE
precautions NE xxx NE
must NE xxx NE
be NE xx NE
taken NE xxx NE
when NE xxx NE
making NE xxx NE
extracts NE xxx NE
from NE xxx NE
myelo- NE xxx- NE
monocytic NE xxx NE
cells NE xxx NE
. NE . NE

A NE X NE
germline G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
TaqI G#DNA_domain_or_region_M XxxX G#DNA_domain_or_region_M
restriction G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
fragment G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
length G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
polymorphism G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
the NE xxx NE
progesterone G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
receptor G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
ovarian G#other_name_B xxx G#other_name_B
carcinoma G#other_name_E xxx G#other_name_E
[see NE [xxx NE
comments] NE xxx] NE

Clinical NE Xxxx NE
outcome NE xxx NE
in NE xx NE
ovarian G#other_name_B xxx G#other_name_B
carcinoma G#other_name_E xxx G#other_name_E
is NE xx NE
predicted NE xxx NE
by NE xx NE
progesterone G#other_name_B xxx G#other_name_B
receptor G#other_name_M xxx G#other_name_M
status G#other_name_E xxx G#other_name_E
, NE , NE
indicating NE xxx NE
an NE xx NE
endocrine NE xxx NE
aspect NE xxx NE
to NE xx NE
this NE xxx NE
disease NE xxx NE
. NE . NE

Peripheral G#DNA_family_or_group_B Xxxx G#DNA_family_or_group_B
leucocyte G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
genomic G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
DNAs G#DNA_family_or_group_E XXXx G#DNA_family_or_group_E
were NE xxx NE
obtained NE xxx NE
from NE xxx NE
41 NE dd NE
patients G#multi_cell xxx G#multi_cell
with NE xxx NE
primary G#other_name_B xxx G#other_name_B
ovarian G#other_name_M xxx G#other_name_M
carcinoma G#other_name_E xxx G#other_name_E
and NE xxx NE
83 NE dd NE
controls G#multi_cell xxx G#multi_cell
from NE xxx NE
Ireland NE Xxxx NE
, NE , NE
as NE xx NE
well NE xxx NE
as NE xx NE
from NE xxx NE
26 NE dd NE
primary NE xxx NE
ovarian G#multi_cell_B xxx G#multi_cell_B
carcinoma G#multi_cell_M xxx G#multi_cell_M
patients G#multi_cell_E xxx G#multi_cell_E
and NE xxx NE
101 NE ddd NE
controls NE xxx NE
in NE xx NE
Germany NE Xxxx NE
. NE . NE

Southern NE Xxxx NE
analysis NE xxx NE
using NE xxx NE
a NE x NE
human NE xxx NE
progesterone NE xxx NE
receptor NE xxx NE
( NE ( NE
hPR NE xXX NE
) NE ) NE
cDNA NE xXXX NE
probe NE xxx NE
identified NE xxx NE
a NE x NE
germline NE xxx NE
TaqI NE XxxX NE
restriction NE xxx NE
fragment NE xxx NE
length NE xxx NE
polymorphism NE xxx NE
( NE ( NE
RFLP NE XXXX NE
) NE ) NE
defined NE xxx NE
by NE xx NE
two NE xxx NE
alleles NE xxx NE
: NE : NE
T1 NE Xd NE
, NE , NE
represented NE xxx NE
by NE xx NE
a NE x NE
2.7 NE d.d NE
kb NE xx NE
fragment NE xxx NE
; NE ; NE
and NE xxx NE
T2 NE Xd NE
, NE , NE
represented NE xxx NE
by NE xx NE
a NE x NE
1.9 NE d.d NE
kb NE xx NE
fragment NE xxx NE
and NE xxx NE
characterised NE xxx NE
by NE xx NE
an NE xx NE
additional NE xxx NE
TaqI NE XxxX NE
restriction NE xxx NE
site NE xxx NE
with NE xxx NE
respect NE xxx NE
to NE xx NE
T1 NE Xd NE
. NE . NE

An NE Xx NE
over-representation NE xxx-xxx NE
of NE xx NE
T2 G#DNA_domain_or_region Xd G#DNA_domain_or_region
in NE xx NE
ovarian G#multi_cell_B xxx G#multi_cell_B
cancer G#multi_cell_M xxx G#multi_cell_M
patients G#multi_cell_E xxx G#multi_cell_E
compared NE xxx NE
with NE xxx NE
controls NE xxx NE
in NE xx NE
the NE xxx NE
pooled NE xxx NE
Irish/German G#multi_cell_B Xxxx/Xxxx G#multi_cell_B
population G#multi_cell_E xxx G#multi_cell_E
(P NE (X NE
< NE < NE
0.025) NE d.ddd) NE
was NE xxx NE
observed NE xxx NE
. NE . NE

A NE X NE
difference NE xxx NE
(P NE (X NE
< NE < NE
0.02) NE d.dd) NE
in NE xx NE
the NE xxx NE
distribution NE xxx NE
of NE xx NE
the NE xxx NE
RFLP G#DNA_domain_or_region XXXX G#DNA_domain_or_region
genotypes NE xxx NE
between NE xxx NE
Irish NE Xxxx NE
and NE xxx NE
German NE Xxxx NE
control NE xxx NE
populations NE xxx NE
was NE xxx NE
also NE xxx NE
observed NE xxx NE
. NE . NE

The NE Xxx NE
allele G#other_name_B xxx G#other_name_B
distributions G#other_name_E xxx G#other_name_E
could NE xxx NE
not NE xxx NE
be NE xx NE
shown NE xxx NE
to NE xx NE
differ NE xxx NE
significantly NE xxx NE
from NE xxx NE
Hardy-Weinberg G#other_name_B Xxxx-Xxxx G#other_name_B
distribution G#other_name_E xxx G#other_name_E
in NE xx NE
any NE xxx NE
subgroup NE xxx NE
. NE . NE

Using NE Xxxx NE
hPR G#DNA_family_or_group_B xXX G#DNA_family_or_group_B
cDNA G#DNA_family_or_group_M xXXX G#DNA_family_or_group_M
region-specific G#DNA_family_or_group_M xxx-xxx G#DNA_family_or_group_M
probes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
, NE , NE
the NE xxx NE
extra NE xxx NE
TaqI NE XxxX NE
restriction NE xxx NE
site NE xxx NE
was NE xxx NE
mapped NE xxx NE
to NE xx NE
intron G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
G G#DNA_domain_or_region_E X G#DNA_domain_or_region_E
of NE xx NE
the NE xxx NE
hPR G#DNA_domain_or_region_B xXX G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

OBF-1 G#protein_molecule XXX-d G#protein_molecule
, NE , NE
a NE x NE
novel G#protein_family_or_group_B xxx G#protein_family_or_group_B
B G#protein_family_or_group_M X G#protein_family_or_group_M
cell-specific G#protein_family_or_group_M xxx-xxx G#protein_family_or_group_M
coactivator G#protein_family_or_group_E xxx G#protein_family_or_group_E
that NE xxx NE
stimulates NE xxx NE
immunoglobulin G#other_name_B xxx G#other_name_B
promoter G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
through NE xxx NE
association NE xxx NE
with NE xxx NE
octamer-binding G#protein_family_or_group_B xxx-xxx G#protein_family_or_group_B
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Recent NE Xxxx NE
biochemical NE xxx NE
and NE xxx NE
genetic NE xxx NE
studies NE xxx NE
indicate NE xxx NE
that NE xxx NE
in NE xx NE
addition NE xxx NE
to NE xx NE
the NE xxx NE
octamer-binding G#protein_family_or_group_B xxx-xxx G#protein_family_or_group_B
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
Oct-1 G#protein_molecule Xxx-d G#protein_molecule
and NE xxx NE
Oct-2 G#protein_molecule Xxx-d G#protein_molecule
, NE , NE
other NE xxx NE
B G#protein_family_or_group_B X G#protein_family_or_group_B
cell G#protein_family_or_group_M xxx G#protein_family_or_group_M
components G#protein_family_or_group_E xxx G#protein_family_or_group_E
are NE xxx NE
required NE xxx NE
for NE xxx NE
lymphoid-restricted, G#other_name_B xxx-xxx, G#other_name_B
octamer G#other_name_M xxx G#other_name_M
site-mediated G#other_name_M xxx-xxx G#other_name_M
immunoglobulin G#other_name_M xxx G#other_name_M
gene G#other_name_M xxx G#other_name_M
promoter G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
. NE . NE

Using NE Xxxx NE
a NE x NE
genetic NE xxx NE
screen NE xxx NE
in NE xx NE
yeast NE xxx NE
, NE , NE
we NE xx NE
have NE xxx NE
isolated NE xxx NE
B G#DNA_family_or_group_B X G#DNA_family_or_group_B
cell-derived G#DNA_family_or_group_M xxx-xxx G#DNA_family_or_group_M
cDNAs G#DNA_family_or_group_E xXXXx G#DNA_family_or_group_E
encoding NE xxx NE
Oct-binding G#protein_molecule_B Xxx-xxx G#protein_molecule_B
factor G#protein_molecule_M xxx G#protein_molecule_M
1 G#protein_molecule_E d G#protein_molecule_E
( NE ( NE
OBF-1 G#protein_molecule XXX-d G#protein_molecule
) NE ) NE
, NE , NE
a NE x NE
novel NE xxx NE
protein NE xxx NE
that NE xxx NE
specifically NE xxx NE
associates NE xxx NE
with NE xxx NE
Oct-1 G#protein_molecule Xxx-d G#protein_molecule
and NE xxx NE
Oct-2 G#protein_molecule Xxx-d G#protein_molecule
. NE . NE

Biochemical NE Xxxx NE
studies NE xxx NE
demonstrate NE xxx NE
that NE xxx NE
OBF-1 G#protein_molecule XXX-d G#protein_molecule
has NE xxx NE
no NE xx NE
intrinsic NE xxx NE
DNA-binding NE XXX-xxx NE
activity NE xxx NE
and NE xxx NE
recognizes NE xxx NE
the NE xxx NE
POU G#protein_domain_or_region_B XXX G#protein_domain_or_region_B
domains G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
of NE xx NE
Oct-1 G#protein_molecule Xxx-d G#protein_molecule
and NE xxx NE
Oct-2 G#protein_molecule Xxx-d G#protein_molecule
, NE , NE
but NE xxx NE
not NE xxx NE
those NE xxx NE
of NE xx NE
Oct-4 G#protein_molecule Xxx-d G#protein_molecule
and NE xxx NE
Oct-6 G#protein_molecule Xxx-d G#protein_molecule
. NE . NE

The NE Xxx NE
OBF-1 G#RNA_molecule_B XXX-d G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
is NE xx NE
expressed NE xxx NE
in NE xx NE
a NE x NE
highly NE xxx NE
cell-specific NE xxx-xxx NE
manner NE xxx NE
, NE , NE
being NE xxx NE
most NE xxx NE
abundant NE xxx NE
in NE xx NE
B G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
and NE xxx NE
essentially NE xxx NE
absent NE xxx NE
in NE xx NE
most NE xxx NE
of NE xx NE
the NE xxx NE
other NE xxx NE
cells NE xxx NE
or NE xx NE
tissues NE xxx NE
tested NE xxx NE
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
expression NE xxx NE
of NE xx NE
OBF-1 G#protein_molecule XXX-d G#protein_molecule
in NE xx NE
HeLa G#cell_line_B XxXx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
selectively NE xxx NE
stimulates NE xxx NE
the NE xxx NE
activity NE xxx NE
of NE xx NE
a NE x NE
natural NE xxx NE
immunoglobulin G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
an NE xx NE
octamer NE xxx NE
site NE xxx NE
-dependent NE -xxx NE
manner NE xxx NE
. NE . NE

Thus NE Xxxx NE
, NE , NE
OBF-1 G#protein_molecule XXX-d G#protein_molecule
has NE xxx NE
all NE xxx NE
the NE xxx NE
properties NE xxx NE
expected NE xxx NE
for NE xxx NE
a NE x NE
B G#protein_family_or_group_B X G#protein_family_or_group_B
cell-specific G#protein_family_or_group_M xxx-xxx G#protein_family_or_group_M
transcriptional G#protein_family_or_group_M xxx G#protein_family_or_group_M
coactivator G#protein_family_or_group_M xxx G#protein_family_or_group_M
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Modulation NE Xxxx NE
of NE xx NE
transcription G#other_name_B xxx G#other_name_B
factor G#other_name_M xxx G#other_name_M
NF G#other_name_M XX G#other_name_M
kappa G#other_name_M xxx G#other_name_M
B G#other_name_M X G#other_name_M
activity G#other_name_E xxx G#other_name_E
by NE xx NE
intracellular G#other_name_B xxx G#other_name_B
glutathione G#other_name_M xxx G#other_name_M
levels G#other_name_E xxx G#other_name_E
and NE xxx NE
by NE xx NE
variations NE xxx NE
of NE xx NE
the NE xxx NE
extracellular G#other_name_B xxx G#other_name_B
cysteine G#other_name_M xxx G#other_name_M
supply G#other_name_E xxx G#other_name_E
. NE . NE

HIV NE XXX NE
-infected NE -xxx NE
individuals NE xxx NE
and NE xxx NE
SIV NE XXX NE
-infected NE -xxx NE
rhesus NE xxx NE
macaques NE xxx NE
have NE xxx NE
, NE , NE
on NE xx NE
the NE xxx NE
average NE xxx NE
, NE , NE
decreased NE xxx NE
plasma NE xxx NE
cysteine NE xxx NE
and NE xxx NE
cystine NE xxx NE
concentrations NE xxx NE
and NE xxx NE
decreased NE xxx NE
intracellular NE xxx NE
glutathione NE xxx NE
levels NE xxx NE
. NE . NE

We NE Xx NE
now NE xxx NE
show NE xxx NE
that NE xxx NE
a NE x NE
depletion NE xxx NE
of NE xx NE
intracellular G#peptide_B xxx G#peptide_B
glutathione G#peptide_E xxx G#peptide_E
in NE xx NE
a NE x NE
human G#cell_line_B xxx G#cell_line_B
T G#cell_line_M X G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
( NE ( NE
Molt-4 G#cell_line Xxxx-d G#cell_line
) NE ) NE
inhibits NE xxx NE
the NE xxx NE
activation NE xxx NE
and NE xxx NE
nuclear G#other_name_B xxx G#other_name_B
translocation G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
transcription G#protein_molecule_B xxx G#protein_molecule_B
factor G#protein_molecule_M xxx G#protein_molecule_M
NF G#protein_molecule_M XX G#protein_molecule_M
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_E X G#protein_molecule_E
, NE , NE
whereas NE xxx NE
incubation NE xxx NE
with NE xxx NE
increasing NE xxx NE
extracellular NE xxx NE
concentrations NE xxx NE
of NE xx NE
cysteine G#amino_acid_monomer xxx G#amino_acid_monomer
inhibits NE xxx NE
the NE xxx NE
DNA-binding NE XXX-xxx NE
and NE xxx NE
transactivating NE xxx NE
activity NE xxx NE
of NE xx NE
NF G#protein_molecule_B XX G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_E X G#protein_molecule_E
. NE . NE

Because NE Xxxx NE
inhibition NE xxx NE
of NE xx NE
DNA-binding G#other_name_B XXX-xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
is NE xx NE
associated NE xxx NE
with NE xxx NE
increasing NE xxx NE
intracellular NE xxx NE
glutathione G#other_name_B xxx G#other_name_B
disulfide G#other_name_M xxx G#other_name_M
levels G#other_name_E xxx G#other_name_E
and NE xxx NE
GSSG G#protein_substructure XXXX G#protein_substructure
can NE xxx NE
be NE xx NE
shown NE xxx NE
to NE xx NE
inhibit NE xxx NE
the NE xxx NE
DNA-binding G#other_name_B XXX-xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
directly NE xxx NE
in NE xx NE
cell-free G#other_name_B xxx-xxx G#other_name_B
systems G#other_name_E xxx G#other_name_E
, NE , NE
our NE xxx NE
studies NE xxx NE
suggest NE xxx NE
that NE xxx NE
GSSG G#protein_substructure XXXX G#protein_substructure
is NE xx NE
a NE x NE
physiologically NE xxx NE
relevant NE xxx NE
inhibitor NE xxx NE
in NE xx NE
intact G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
also NE xxx NE
. NE . NE

NF G#protein_molecule_B XX G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_E X G#protein_molecule_E
controls NE xxx NE
many NE xxx NE
immunologically G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
important G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
, NE , NE
so NE xx NE
our NE xxx NE
studies NE xxx NE
suggest NE xxx NE
that NE xxx NE
the NE xxx NE
immune NE xxx NE
system NE xxx NE
may NE xxx NE
be NE xx NE
sensitive NE xxx NE
not NE xxx NE
only NE xxx NE
against NE xxx NE
a NE x NE
cysteine G#other_name_B xxx G#other_name_B
and G#other_name_M xxx G#other_name_M
glutathione G#other_name_M xxx G#other_name_M
deficiency G#other_name_E xxx G#other_name_E
but NE xxx NE
also NE xxx NE
against NE xxx NE
an NE xx NE
excess NE xxx NE
of NE xx NE
cysteine G#amino_acid_monomer xxx G#amino_acid_monomer
. NE . NE

Two NE Xxx NE
distinct NE xxx NE
signalling NE xxx NE
pathways NE xxx NE
are NE xxx NE
involved NE xxx NE
in NE xx NE
the NE xxx NE
control NE xxx NE
of NE xx NE
the NE xxx NE
biphasic G#other_name_B xxx G#other_name_B
junB G#other_name_M xxxX G#other_name_M
transcription G#other_name_E xxx G#other_name_E
induced NE xxx NE
by NE xx NE
interleukin-6 G#protein_molecule xxx-d G#protein_molecule
in NE xx NE
the NE xxx NE
B G#cell_line_B X G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
hybridoma G#cell_line_M xxx G#cell_line_M
7TD1 G#cell_line_E dXXd G#cell_line_E
. NE . NE

We NE Xx NE
have NE xxx NE
measured NE xxx NE
the NE xxx NE
level NE xxx NE
of NE xx NE
junB G#RNA_molecule_B xxxX G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
in NE xx NE
the NE xxx NE
B G#cell_line_B X G#cell_line_B
hybridoma G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_M xxx G#cell_line_M
7TD1 G#cell_line_E dXXd G#cell_line_E
, NE , NE
under NE xxx NE
interleukin-6 G#protein_molecule xxx-d G#protein_molecule
( NE ( NE
IL-6 G#protein_molecule XX-d G#protein_molecule
) NE ) NE
stimulation NE xxx NE
. NE . NE

IL-6 G#protein_molecule XX-d G#protein_molecule
increases NE xxx NE
junB G#RNA_molecule_B xxxX G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
in NE xx NE
a NE x NE
biphasic NE xxx NE
fashion NE xxx NE
. NE . NE

The NE Xxx NE
first NE xxx NE
early-induced NE xxx-xxx NE
peak NE xxx NE
was NE xxx NE
transient NE xxx NE
and NE xxx NE
likely NE xxx NE
corresponds NE xxx NE
to NE xx NE
the NE xxx NE
well NE xxx NE
documented NE xxx NE
typical NE xxx NE
junB G#RNA_molecule_B xxxX G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
, NE , NE
stimulated NE xxx NE
in NE xx NE
response NE xxx NE
to NE xx NE
numerous NE xxx NE
growth G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
including NE xxx NE
IL-6 G#protein_molecule XX-d G#protein_molecule
. NE . NE

At NE Xx NE
variance NE xxx NE
, NE , NE
the NE xxx NE
second NE xxx NE
peak NE xxx NE
which NE xxx NE
has NE xxx NE
never NE xxx NE
been NE xxx NE
reported NE xxx NE
previously NE xxx NE
, NE , NE
lasted NE xxx NE
several NE xxx NE
hours NE xxx NE
. NE . NE

As NE Xx NE
a NE x NE
consequence NE xxx NE
of NE xx NE
its NE xxx NE
effect NE xxx NE
on NE xx NE
junB G#RNA_molecule_B xxxX G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
, NE , NE
IL-6 G#protein_molecule XX-d G#protein_molecule
stimulated NE xxx NE
, NE , NE
in NE xx NE
a NE x NE
biphasic NE xxx NE
fashion NE xxx NE
, NE , NE
the NE xxx NE
nuclear NE xxx NE
accumulation NE xxx NE
of NE xx NE
the NE xxx NE
JunB G#protein_molecule_B XxxX G#protein_molecule_B
protein G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

In NE Xx NE
this NE xxx NE
study NE xxx NE
, NE , NE
we NE xx NE
demonstrated NE xxx NE
that NE xxx NE
IL-6 G#protein_molecule XX-d G#protein_molecule
regulation NE xxx NE
occurred NE xxx NE
exclusively NE xxx NE
at NE xx NE
the NE xxx NE
transcriptional G#other_name_B xxx G#other_name_B
level G#other_name_E xxx G#other_name_E
and NE xxx NE
that NE xxx NE
the NE xxx NE
bimodal NE xxx NE
increase NE xxx NE
of NE xx NE
junB G#RNA_molecule_B xxxX G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
and NE xxx NE
JunB G#protein_molecule_B XxxX G#protein_molecule_B
protein G#protein_molecule_E xxx G#protein_molecule_E
can NE xxx NE
be NE xx NE
accounted NE xxx NE
for NE xxx NE
by NE xx NE
a NE x NE
biphasic NE xxx NE
stimulation NE xxx NE
of NE xx NE
junB G#other_name_B xxxX G#other_name_B
transcription G#other_name_E xxx G#other_name_E
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
our NE xxx NE
data NE xxx NE
point NE xxx NE
to NE xx NE
two NE xxx NE
major NE xxx NE
differences NE xxx NE
between NE xxx NE
the NE xxx NE
mechanism NE xxx NE
of NE xx NE
control NE xxx NE
of NE xx NE
the NE xxx NE
early NE xxx NE
and NE xxx NE
the NE xxx NE
late NE xxx NE
IL-6 NE XX-d NE
-induced NE -xxx NE
junB NE xxxX NE
transcription NE xxx NE
waves NE xxx NE
. NE . NE

First NE Xxxx NE
, NE , NE
cycloheximide G#other_organic_compound xxx G#other_organic_compound
strongly NE xxx NE
potentiated NE xxx NE
the NE xxx NE
transcription NE xxx NE
of NE xx NE
the NE xxx NE
second NE xxx NE
wave NE xxx NE
, NE , NE
whereas NE xxx NE
it NE xx NE
failed NE xxx NE
to NE xx NE
affect NE xxx NE
the NE xxx NE
early-induced NE xxx-xxx NE
burst NE xxx NE
. NE . NE

Second NE Xxxx NE
, NE , NE
tyrphostin G#other_organic_compound xxx G#other_organic_compound
, NE , NE
a NE x NE
tyrosine G#other_organic_compound_B xxx G#other_organic_compound_B
kinase G#other_organic_compound_M xxx G#other_organic_compound_M
inhibitor G#other_organic_compound_E xxx G#other_organic_compound_E
, NE , NE
impaired NE xxx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
first NE xxx NE
but NE xxx NE
not NE xxx NE
the NE xxx NE
second NE xxx NE
junB G#other_name_B xxxX G#other_name_B
mRNA G#other_name_M xXXX G#other_name_M
peak G#other_name_E xxx G#other_name_E
. NE . NE

Conversely NE Xxxx NE
, NE , NE
genistein G#other_organic_compound xxx G#other_organic_compound
, NE , NE
another NE xxx NE
tyrosine G#other_organic_compound_B xxx G#other_organic_compound_B
kinase G#other_organic_compound_M xxx G#other_organic_compound_M
inhibitor G#other_organic_compound_E xxx G#other_organic_compound_E
, NE , NE
totally NE xxx NE
abolished NE xxx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
second NE xxx NE
peak NE xxx NE
of NE xx NE
junB G#RNA_molecule_B xxxX G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
whereas NE xxx NE
it NE xx NE
did NE xxx NE
not NE xxx NE
affect NE xxx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
first NE xxx NE
peak NE xxx NE
. NE . NE

Altogether NE Xxxx NE
these NE xxx NE
data NE xxx NE
indicate NE xxx NE
that NE xxx NE
, NE , NE
in NE xx NE
7TD1 G#cell_line_B dXXd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
IL-6 G#protein_molecule XX-d G#protein_molecule
controls NE xxx NE
junB G#other_name_B xxxX G#other_name_B
transcription G#other_name_E xxx G#other_name_E
in NE xx NE
a NE x NE
biphasic NE xxx NE
fashion NE xxx NE
by NE xx NE
means NE xxx NE
of NE xx NE
two NE xxx NE
separate NE xxx NE
transduction G#other_name_B xxx G#other_name_B
pathways G#other_name_E xxx G#other_name_E
. NE . NE

A NE X NE
newly NE xxx NE
established NE xxx NE
megakaryoblastic/erythroid G#cell_line_B xxx/xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
that NE xxx NE
differentiates NE xxx NE
to NE xx NE
red G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
in NE xx NE
the NE xxx NE
presence NE xxx NE
of NE xx NE
erythropoietin G#protein_molecule xxx G#protein_molecule
and NE xxx NE
produces NE xxx NE
platelet-like G#cell_type_B xxx-xxx G#cell_type_B
particles G#cell_type_E xxx G#cell_type_E
. NE . NE

In NE Xx NE
August NE Xxxx NE
, NE , NE
1992 NE dddd NE
, NE , NE
we NE xx NE
established NE xxx NE
a NE x NE
leukemic G#cell_line_B xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
( NE ( NE
NS-Meg G#cell_line XX-Xxx G#cell_line
) NE ) NE
from NE xxx NE
a NE x NE
patient NE xxx NE
in NE xx NE
megakaryoblastic G#other_name_B xxx G#other_name_B
transformation G#other_name_E xxx G#other_name_E
of NE xx NE
Philadelphia G#other_name_B Xxxx G#other_name_B
chromosome-positive G#other_name_M xxx-xxx G#other_name_M
chronic G#other_name_M xxx G#other_name_M
myeloid G#other_name_M xxx G#other_name_M
leukemia G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
NS-Meg G#cell_line_B XX-Xxx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
were NE xxx NE
positive NE xxx NE
for NE xxx NE
alpha-naphthyl G#protein_molecule_B xxx-xxx G#protein_molecule_B
acetate G#protein_molecule_M xxx G#protein_molecule_M
esterase G#protein_molecule_E xxx G#protein_molecule_E
and NE xxx NE
periodic G#other_name_B xxx G#other_name_B
acid-Schiff G#other_name_M xxx-Xxxx G#other_name_M
(PAS) G#other_name_M (XXX) G#other_name_M
staining G#other_name_E xxx G#other_name_E
and NE xxx NE
for NE xxx NE
surface NE xxx NE
CD4 G#protein_molecule XXd G#protein_molecule
, NE , NE
CD7 G#protein_molecule XXd G#protein_molecule
, NE , NE
CD13 G#protein_molecule XXdd G#protein_molecule
, NE , NE
CD34 G#protein_molecule XXdd G#protein_molecule
, NE , NE
CD41a G#protein_molecule XXddx G#protein_molecule
, NE , NE
and NE xxx NE
glycophorin G#protein_molecule_B xxx G#protein_molecule_B
A G#protein_molecule_M X G#protein_molecule_M
antigens G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

Ultrastructurally NE Xxxx NE
, NE , NE
the NE xxx NE
cells NE xxx NE
had NE xxx NE
alpha-granules G#cell_component xxx-xxx G#cell_component
, NE , NE
demarcation G#cell_component_B xxx G#cell_component_B
membranes G#cell_component_E xxx G#cell_component_E
, NE , NE
and NE xxx NE
platelet G#other_name_B xxx G#other_name_B
peroxidase G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
NS-Meg G#cell_line_B XX-Xxx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
spontaneously NE xxx NE
produced NE xxx NE
platelet-like G#cell_type_B xxx-xxx G#cell_type_B
particles G#cell_type_E xxx G#cell_type_E
which NE xxx NE
contained NE xxx NE
alpha-granules G#cell_component xxx-xxx G#cell_component
, NE , NE
mitochondria G#cell_component xxx G#cell_component
and NE xxx NE
dense NE xxx NE
bodies NE xxx NE
, NE , NE
strongly NE xxx NE
suggesting NE xxx NE
platelet NE xxx NE
production NE xxx NE
. NE . NE

Erythropoietin G#protein_molecule Xxxx G#protein_molecule
( NE ( NE
Epo G#protein_molecule Xxx G#protein_molecule
) NE ) NE
, NE , NE
granulocyte/macrophage G#protein_family_or_group_B xxx/xxx G#protein_family_or_group_B
colony G#protein_family_or_group_M xxx G#protein_family_or_group_M
stimulating G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
GM-CSF G#protein_molecule XX-XXX G#protein_molecule
) NE ) NE
, NE , NE
and NE xxx NE
interleukin G#protein_molecule_B xxx G#protein_molecule_B
3 G#protein_molecule_E d G#protein_molecule_E
( NE ( NE
IL-3 G#protein_molecule XX-d G#protein_molecule
) NE ) NE
promoted NE xxx NE
the NE xxx NE
growth NE xxx NE
of NE xx NE
NS-Meg G#cell_line_B XX-Xxx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

Phorbol-12-myristate-13-acetate G#other_organic_compound Xxxx-dd-xxx-dd-xxx G#other_organic_compound
increased NE xxx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
both NE xxx NE
CD41a G#protein_molecule XXddx G#protein_molecule
and NE xxx NE
CD61 NE XXdd NE
antigens NE xxx NE
. NE . NE

Ten-day NE Xxx-xxx NE
exposure NE xxx NE
to NE xx NE
Epo G#protein_molecule Xxx G#protein_molecule
induced NE xxx NE
mature G#cell_type_B xxx G#cell_type_B
erythroblasts G#cell_type_E xxx G#cell_type_E
and NE xxx NE
red G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

These NE Xxxx NE
benzidine-positive G#cell_line_B xxx-xxx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
were NE xxx NE
positive NE xxx NE
for NE xxx NE
hemoglobin G#other_name_B xxx G#other_name_B
F G#other_name_M X G#other_name_M
staining G#other_name_E xxx G#other_name_E
. NE . NE

Untreated NE Xxxx NE
NS-Meg G#cell_line_B XX-Xxx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
expressed NE xxx NE
mRNA G#RNA_family_or_group xXXX G#RNA_family_or_group
for NE xxx NE
the NE xxx NE
Epo G#protein_molecule_B Xxx G#protein_molecule_B
receptor G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
EpoR G#protein_molecule XxxX G#protein_molecule
) NE ) NE
, NE , NE
for NE xxx NE
GATA-1 G#protein_molecule XXXX-d G#protein_molecule
, NE , NE
and NE xxx NE
for NE xxx NE
alpha G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
1 G#DNA_domain_or_region_M d G#DNA_domain_or_region_M
globin G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
alpha G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
2 G#DNA_domain_or_region_M d G#DNA_domain_or_region_M
globin G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gamma G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
globin G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E

These NE Xxxx NE
results NE xxx NE
indicate NE xxx NE
that NE xxx NE
NS-Meg G#cell_line_B XX-Xxx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
undergo NE xxx NE
terminal NE xxx NE
differentiation NE xxx NE
of NE xx NE
both NE xxx NE
megakaryocytic G#cell_type_B xxx G#cell_type_B
lineage G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
erythroid G#cell_type_M xxx G#cell_type_M
lineage G#cell_type_E xxx G#cell_type_E

This NE Xxxx NE
cell G#cell_line_B xxx G#cell_line_B
line G#cell_line_E xxx G#cell_line_E
should NE xxx NE
be NE xx NE
a NE x NE
very NE xxx NE
useful NE xxx NE
tool NE xxx NE
for NE xxx NE
the NE xxx NE
investigation NE xxx NE
of NE xx NE
both NE xxx NE
megakaryocytic G#other_name_B xxx G#other_name_B
maturation G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
erythroid G#other_name_M xxx G#other_name_M
maturation G#other_name_E xxx G#other_name_E

Differential NE Xxxx NE
regulation NE xxx NE
of NE xx NE
proto-oncogenes G#DNA_family_or_group xxx-xxx G#DNA_family_or_group
c-jun G#DNA_domain_or_region x-xxx G#DNA_domain_or_region
and NE xxx NE
c-fos G#DNA_domain_or_region x-xxx G#DNA_domain_or_region
in NE xx NE
T G#cell_type_B X G#cell_type_B
lymphocytes G#cell_type_E xxx G#cell_type_E
activated NE xxx NE
through NE xxx NE
CD28 G#protein_molecule XXdd G#protein_molecule
. NE . NE

The NE Xxx NE
T G#protein_family_or_group_B X G#protein_family_or_group_B
cell G#protein_family_or_group_M xxx G#protein_family_or_group_M
surface G#protein_family_or_group_M xxx G#protein_family_or_group_M
molecule G#protein_family_or_group_E xxx G#protein_family_or_group_E
CD28 G#protein_molecule XXdd G#protein_molecule
binds NE xxx NE
to NE xx NE
ligands NE xxx NE
on NE xx NE
accessory G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
and NE xxx NE
APCs G#cell_type XXXx G#cell_type
, NE , NE
playing NE xxx NE
an NE xx NE
important NE xxx NE
costimulatory NE xxx NE
role NE xxx NE
in NE xx NE
the NE xxx NE
response NE xxx NE
of NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
to NE xx NE
Ags G#protein_family_or_group Xxx G#protein_family_or_group
. NE . NE

Our NE Xxx NE
knowledge NE xxx NE
of NE xx NE
the NE xxx NE
intracellular G#other_name_B xxx G#other_name_B
signaling G#other_name_M xxx G#other_name_M
pathways G#other_name_E xxx G#other_name_E
coupled NE xxx NE
to NE xx NE
this NE xxx NE
receptor NE xxx NE
is NE xx NE
incomplete NE xxx NE
. NE . NE

In NE Xx NE
addition NE xxx NE
to NE xx NE
activation NE xxx NE
of NE xx NE
phospholipase G#protein_molecule_B xxx G#protein_molecule_B
C G#protein_molecule_M X G#protein_molecule_M
gamma G#protein_molecule_M xxx G#protein_molecule_M
1 G#protein_molecule_E d G#protein_molecule_E
, NE , NE
ligation NE xxx NE
of NE xx NE
this NE xxx NE
receptor NE xxx NE
also NE xxx NE
seems NE xxx NE
to NE xx NE
activate NE xxx NE
a NE x NE
calcium NE xxx NE
-independent NE -xxx NE
, NE , NE
CD28 NE XXdd NE
-specific NE -xxx NE
pathway NE xxx NE
. NE . NE

In NE Xx NE
this NE xxx NE
paper NE xxx NE
, NE , NE
we NE xx NE
report NE xxx NE
that NE xxx NE
cross-linking NE xxx-xxx NE
of NE xx NE
CD28 G#protein_molecule XXdd G#protein_molecule
(but NE (xxx NE
not NE xxx NE
CD2 G#protein_molecule XXd G#protein_molecule
, NE , NE
CD5 G#protein_molecule XXd G#protein_molecule
, NE , NE
LFA-1 G#protein_molecule XXX-d G#protein_molecule
, NE , NE
or NE xx NE
CD7 G#protein_molecule XXd G#protein_molecule
) NE ) NE
leads NE xxx NE
to NE xx NE
an NE xx NE
elevation NE xxx NE
of NE xx NE
c-jun G#RNA_molecule_B x-xxx G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
, NE , NE
with NE xxx NE
only NE xxx NE
minimal NE xxx NE
activation NE xxx NE
of NE xx NE
c-fos G#other_name_B x-xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
. NE . NE

CD28 NE XXdd NE
-dependent NE -xxx NE
induction NE xxx NE
of NE xx NE
c-jun NE x-xxx NE
expression NE xxx NE
requires NE xxx NE
protein NE xxx NE
tyrosine NE xxx NE
kinase NE xxx NE
activity NE xxx NE
, NE , NE
but NE xxx NE
does NE xxx NE
not NE xxx NE
depend NE xxx NE
on NE xx NE
activation NE xxx NE
of NE xx NE
a NE x NE
phorbol NE xxx NE
ester NE xxx NE
-responsive NE -xxx NE
protein NE xxx NE
kinase NE xxx NE
C NE X NE
or NE xx NE
elevation NE xxx NE
of NE xx NE
cytosolic NE xxx NE
calcium NE xxx NE
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
CD28 NE XXdd NE
-dependent NE -xxx NE
elevation NE xxx NE
of NE xx NE
c-jun NE x-xxx NE
mRNA NE xXXX NE
does NE xxx NE
not NE xxx NE
appear NE xxx NE
to NE xx NE
be NE xx NE
mediated NE xxx NE
at NE xx NE
the NE xxx NE
level NE xxx NE
of NE xx NE
mRNA NE xXXX NE
stability NE xxx NE
. NE . NE

A NE X NE
mechanism NE xxx NE
is NE xx NE
suggested NE xxx NE
whereby NE xxx NE
expression NE xxx NE
of NE xx NE
c-jun G#DNA_domain_or_region x-xxx G#DNA_domain_or_region
and NE xxx NE
junB G#DNA_domain_or_region xxxX G#DNA_domain_or_region
, NE , NE
in NE xx NE
the NE xxx NE
absence NE xxx NE
of NE xx NE
members NE xxx NE
of NE xx NE
the NE xxx NE
fos G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
family G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
, NE , NE
can NE xxx NE
prevent NE xxx NE
inappropriate NE xxx NE
activation NE xxx NE
of NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
caused NE xxx NE
by NE xx NE
ligation NE xxx NE
of NE xx NE
CD28 G#protein_molecule XXdd G#protein_molecule
in NE xx NE
the NE xxx NE
absence NE xxx NE
of NE xx NE
a NE x NE
specific NE xxx NE
antigenic G#other_name_B xxx G#other_name_B
stimulus G#other_name_E xxx G#other_name_E
. NE . NE

Enhanced NE Xxxx NE
responsiveness NE xxx NE
to NE xx NE
nuclear G#protein_molecule_B xxx G#protein_molecule_B
factor G#protein_molecule_M xxx G#protein_molecule_M
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_E X G#protein_molecule_E
contributes NE xxx NE
to NE xx NE
the NE xxx NE
unique NE xxx NE
phenotype NE xxx NE
of NE xx NE
simian G#virus_B xxx G#virus_B
immunodeficiency G#virus_M xxx G#virus_M
virus G#virus_M xxx G#virus_M
variant G#virus_E xxx G#virus_E
SIVsmmPBj14 G#virus XXXxxxXXxdd G#virus
. NE . NE

Infection NE Xxxx NE
with NE xxx NE
a NE x NE
variant NE xxx NE
of NE xx NE
simian G#virus_B xxx G#virus_B
immunodeficiency G#virus_M xxx G#virus_M
virus G#virus_E xxx G#virus_E
, NE , NE
SIVsmmPBj14 G#virus XXXxxxXXxdd G#virus
, NE , NE
leads NE xxx NE
to NE xx NE
severe NE xxx NE
acute NE xxx NE
disease NE xxx NE
in NE xx NE
macaques G#multi_cell xxx G#multi_cell
. NE . NE

This NE Xxxx NE
study NE xxx NE
was NE xxx NE
designed NE xxx NE
to NE xx NE
investigate NE xxx NE
the NE xxx NE
functional NE xxx NE
significance NE xxx NE
of NE xx NE
previously NE xxx NE
described NE xxx NE
mutations NE xxx NE
in NE xx NE
the NE xxx NE
viral G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
long G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
terminal G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
repeat G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
LTR G#DNA_domain_or_region XXX G#DNA_domain_or_region
) NE ) NE
and NE xxx NE
to NE xx NE
elucidate NE xxx NE
their NE xxx NE
contribution NE xxx NE
to NE xx NE
the NE xxx NE
unique NE xxx NE
phenotype NE xxx NE
of NE xx NE
SIVsmmPBj14 G#virus XXXxxxXXxdd G#virus
. NE . NE

LTR NE XXX NE
-directed NE -xxx NE
transcription NE xxx NE
was NE xxx NE
measured NE xxx NE
by NE xx NE
using NE xxx NE
luciferase NE xxx NE
reporter NE xxx NE
constructs NE xxx NE
that NE xxx NE
were NE xxx NE
transiently NE xxx NE
transfected NE xxx NE
into NE xxx NE
cultured NE xxx NE
cells NE xxx NE
. NE . NE

In NE Xx NE
a NE x NE
wide NE xxx NE
range NE xxx NE
of NE xx NE
cell NE xxx NE
types NE xxx NE
, NE , NE
the NE xxx NE
basal NE xxx NE
transcriptional NE xxx NE
activity NE xxx NE
of NE xx NE
the NE xxx NE
LTR G#DNA_domain_or_region XXX G#DNA_domain_or_region
from NE xxx NE
SIVsmmPBj14 G#virus XXXxxxXXxdd G#virus
was NE xxx NE
found NE xxx NE
to NE xx NE
be NE xx NE
2- NE d- NE
to NE xx NE
4.5-fold NE d.d-xxx NE
higher NE xxx NE
than NE xxx NE
that NE xxx NE
of NE xx NE
an NE xx NE
LTR G#DNA_domain_or_region XXX G#DNA_domain_or_region
from NE xxx NE
a NE x NE
non-acutely NE xxx-xxx NE
pathogenic NE xxx NE
strain NE xxx NE
. NE . NE

These NE Xxxx NE
LTRs G#DNA_domain_or_region XXXx G#DNA_domain_or_region
differ NE xxx NE
by NE xx NE
five G#other_name_B xxx G#other_name_B
point G#other_name_M xxx G#other_name_M
mutations G#other_name_E xxx G#other_name_E
and NE xxx NE
a NE x NE
22-bp G#DNA_domain_or_region_B dd-xx G#DNA_domain_or_region_B
duplication G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
SIVsmmPBj14 G#virus XXXxxxXXxdd G#virus
, NE , NE
which NE xxx NE
includes NE xxx NE
a NE x NE
nuclear NE xxx NE
factor NE xxx NE
kappa NE xxx NE
B NE X NE
( NE ( NE
NF NE XX NE
kappa NE xxx NE
B NE X NE
) NE ) NE
site NE xxx NE
. NE . NE

Transcriptional NE Xxxx NE
differences NE xxx NE
between NE xxx NE
these NE xxx NE
LTRs G#DNA_domain_or_region XXXx G#DNA_domain_or_region
were NE xxx NE
further NE xxx NE
enhanced NE xxx NE
by NE xx NE
two- NE xxx- NE
to NE xx NE
threefold NE xxx NE
upon NE xxx NE
treatment NE xxx NE
of NE xx NE
cells NE xxx NE
with NE xxx NE
phorbol G#other_organic_compound_B xxx G#other_organic_compound_B
ester G#other_organic_compound_E xxx G#other_organic_compound_E
or NE xx NE
tumor G#protein_molecule_B xxx G#protein_molecule_B
necrosis G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_M xxx G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
or NE xx NE
by NE xx NE
cotransfection NE xxx NE
with NE xxx NE
plasmids G#DNA_molecule xxx G#DNA_molecule
expressing NE xxx NE
NF G#protein_molecule_B XX G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_E X G#protein_molecule_E
subunits NE xxx NE
. NE . NE

Mutagenesis NE Xxxx NE
studies NE xxx NE
, NE , NE
and NE xxx NE
the NE xxx NE
use NE xxx NE
of NE xx NE
a NE x NE
reporter NE xxx NE
construct NE xxx NE
containing NE xxx NE
an NE xx NE
enhancerless NE xxx NE
promoter NE xxx NE
, NE , NE
indicate NE xxx NE
that NE xxx NE
these NE xxx NE
transcriptional NE xxx NE
effects NE xxx NE
are NE xxx NE
due NE xxx NE
principally NE xxx NE
to NE xx NE
the NE xxx NE
22-bp G#DNA_domain_or_region_B dd-xx G#DNA_domain_or_region_B
sequence G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
duplication G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
the NE xxx NE
NF G#DNA_domain_or_region_B XX G#DNA_domain_or_region_B
kappa G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
B G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
contained NE xxx NE
within NE xxx NE
it NE xx NE
. NE . NE

Finally NE Xxxx NE
, NE , NE
infectious NE xxx NE
virus NE xxx NE
stocks NE xxx NE
that NE xxx NE
were NE xxx NE
isogenic NE xxx NE
except NE xxx NE
for NE xxx NE
the NE xxx NE
LTR G#DNA_domain_or_region XXX G#DNA_domain_or_region
were NE xxx NE
generated NE xxx NE
. NE . NE

The NE Xxx NE
LTR G#DNA_domain_or_region XXX G#DNA_domain_or_region
from NE xxx NE
SIVsmmPBj14 G#virus XXXxxxXXxdd G#virus
was NE xxx NE
found NE xxx NE
to NE xx NE
confer NE xxx NE
an NE xx NE
increase NE xxx NE
in NE xx NE
the NE xxx NE
kinetics NE xxx NE
of NE xx NE
virus G#other_name_B xxx G#other_name_B
replication G#other_name_E xxx G#other_name_E
in NE xx NE
cultured G#cell_line_B xxx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

Inclusion NE Xxxx NE
of NE xx NE
this NE xxx NE
LTR G#DNA_domain_or_region XXX G#DNA_domain_or_region
in NE xx NE
recombinant G#virus_B xxx G#virus_B
SIVs G#virus_E XXXx G#virus_E
also NE xxx NE
resulted NE xxx NE
in NE xx NE
a NE x NE
two- NE xxx- NE
to NE xx NE
threefold NE xxx NE
rise NE xxx NE
in NE xx NE
the NE xxx NE
extent NE xxx NE
of NE xx NE
cellular G#other_name_B xxx G#other_name_B
proliferation G#other_name_E xxx G#other_name_E
that NE xxx NE
was NE xxx NE
induced NE xxx NE
in NE xx NE
quiescent G#cell_line_B xxx G#cell_line_B
simian G#cell_line_M xxx G#cell_line_M
peripheral G#cell_line_M xxx G#cell_line_M
blood G#cell_line_M xxx G#cell_line_M
mononuclear G#cell_line_M xxx G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

These NE Xxxx NE
studies NE xxx NE
are NE xxx NE
consistent NE xxx NE
with NE xxx NE
the NE xxx NE
hypothesis NE xxx NE
that NE xxx NE
LTR G#other_name_B XXX G#other_name_B
mutations G#other_name_E xxx G#other_name_E
assist NE xxx NE
SIVsmmPBj14 G#virus XXXxxxXXxdd G#virus
in NE xx NE
responding NE xxx NE
efficiently NE xxx NE
to NE xx NE
cellular NE xxx NE
stimulation NE xxx NE
and NE xxx NE
allow NE xxx NE
it NE xx NE
to NE xx NE
replicate NE xxx NE
to NE xx NE
high NE xxx NE
titers NE xxx NE
during NE xxx NE
the NE xxx NE
acute G#other_name_B xxx G#other_name_B
phase G#other_name_M xxx G#other_name_M
of G#other_name_M xx G#other_name_M
viral G#other_name_M xxx G#other_name_M
infection G#other_name_E xxx G#other_name_E
. NE . NE

Constitutive NE Xxxx NE
nuclear G#protein_molecule_B xxx G#protein_molecule_B
NF-kappa G#protein_molecule_M XX-xxx G#protein_molecule_M
B G#protein_molecule_E X G#protein_molecule_E
in NE xx NE
cells NE xxx NE
of NE xx NE
the NE xxx NE
monocyte NE xxx NE
lineage NE xxx NE
. NE . NE

In NE Xx NE
monocytes G#cell_type xxx G#cell_type
, NE , NE
the NE xxx NE
nuclear G#protein_molecule_B xxx G#protein_molecule_B
factor G#protein_molecule_M xxx G#protein_molecule_M
NF-kappa G#protein_molecule_M XX-xxx G#protein_molecule_M
B G#protein_molecule_E X G#protein_molecule_E
has NE xxx NE
been NE xxx NE
invoked NE xxx NE
as NE xx NE
an NE xx NE
important NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
in NE xx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
cytokine G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
, NE , NE
of NE xx NE
cell-surface G#protein_family_or_group_B xxx-xxx G#protein_family_or_group_B
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
and NE xxx NE
in NE xx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
human G#virus_B xxx G#virus_B
immunodeficiency G#virus_M xxx G#virus_M
virus G#virus_E xxx G#virus_E
. NE . NE

In NE Xx NE
such NE xxx NE
cells NE xxx NE
, NE , NE
DNA G#other_name_B XXX G#other_name_B
binding G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
of NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
can NE xxx NE
be NE xx NE
detected NE xxx NE
without NE xxx NE
intentional NE xxx NE
stimulation NE xxx NE
. NE . NE

In NE Xx NE
our NE xxx NE
studies NE xxx NE
, NE , NE
cells NE xxx NE
of NE xx NE
the NE xxx NE
human G#cell_line_B xxx G#cell_line_B
monocytic G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
Mono G#cell_line_B Xxxx G#cell_line_B
Mac G#cell_line_M Xxx G#cell_line_M
6 G#cell_line_E d G#cell_line_E
, NE , NE
cultured NE xxx NE
in NE xx NE
medium NE xxx NE
containing NE xxx NE
fetal-calf G#tissue_B xxx-xxx G#tissue_B
serum G#tissue_E xxx G#tissue_E
and NE xxx NE
low NE xxx NE
levels NE xxx NE
of NE xx NE
lipopolysaccharide G#lipid xxx G#lipid
( NE ( NE
LPS G#lipid XXX G#lipid
) NE ) NE
, NE , NE
also NE xxx NE
exhibit NE xxx NE
such NE xxx NE
'constitutive' NE 'xxx' NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
, NE , NE
as NE xx NE
demonstrated NE xxx NE
by NE xx NE
mobility-shift NE xxx-xxx NE
analysis NE xxx NE
of NE xx NE
nuclear G#cell_component_B xxx G#cell_component_B
extracts G#cell_component_E xxx G#cell_component_E
. NE . NE

This NE Xxxx NE
nuclear G#protein_molecule_B xxx G#protein_molecule_B
NF-kappa G#protein_molecule_M XX-xxx G#protein_molecule_M
B G#protein_molecule_E X G#protein_molecule_E
was NE xxx NE
still NE xxx NE
present NE xxx NE
when NE xxx NE
contaminant NE xxx NE
LPS G#lipid XXX G#lipid
was NE xxx NE
removed NE xxx NE
by NE xx NE
ultrafiltration G#other_name xxx G#other_name
and NE xxx NE
when NE xxx NE
serum G#tissue xxx G#tissue
was NE xxx NE
omitted NE xxx NE
. NE . NE

Protein-DNA NE Xxxx-XXX NE
complexes NE xxx NE
of NE xx NE
constitutive NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
are NE xxx NE
similar NE xxx NE
in NE xx NE
mobility NE xxx NE
to NE xx NE
the NE xxx NE
LPS NE XXX NE
-induced NE -xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
and NE xxx NE
both NE xxx NE
are NE xxx NE
recognized NE xxx NE
by NE xx NE
an NE xx NE
antibody NE xxx NE
specific NE xxx NE
to NE xx NE
the NE xxx NE
p50 NE xdd NE
subunit NE xxx NE
of NE xx NE
NF-kappa NE XX-xxx NE
B NE X NE
. NE . NE

By NE Xx NE
contrast NE xxx NE
, NE , NE
treatment NE xxx NE
of NE xx NE
cells NE xxx NE
with NE xxx NE
pyrrolidine G#other_organic_compound_B xxx G#other_organic_compound_B
dithiocarbamate G#other_organic_compound_E xxx G#other_organic_compound_E
( NE ( NE
PDTC G#other_organic_compound XXXX G#other_organic_compound
) NE ) NE
will NE xxx NE
only NE xxx NE
block NE xxx NE
LPS NE XXX NE
-induced NE -xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
, NE , NE
but NE xxx NE
not NE xxx NE
the NE xxx NE
constitutive NE xxx NE
binding NE xxx NE
protein NE xxx NE
. NE . NE

Using NE Xxxx NE
LPS-free G#other_name_B XXX-xxx G#other_name_B
condition G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
serum-free G#other_name_M xxx-xxx G#other_name_M
condition G#other_name_E xxx G#other_name_E
can NE xxx NE
be NE xx NE
detected NE xxx NE
in NE xx NE
different NE xxx NE
cell G#cell_line_B xxx G#cell_line_B
lines G#cell_line_E xxx G#cell_line_E
of NE xx NE
the NE xxx NE
monocytic G#cell_type_B xxx G#cell_type_B
lineage G#cell_type_E xxx G#cell_type_E
( NE ( NE
HL60 G#cell_line XXdd G#cell_line
, NE , NE
U937 G#cell_line Xddd G#cell_line
, NE , NE
THP-1 G#cell_line XXX-d G#cell_line
, NE , NE
Mono G#cell_line_B Xxxx G#cell_line_B
Mac G#cell_line_M Xxx G#cell_line_M
1 G#cell_line_E d G#cell_line_E
and NE xxx NE
Mono G#cell_line_B Xxxx G#cell_line_B
Mac G#cell_line_M Xxx G#cell_line_M
6 G#cell_line_E d G#cell_line_E
) NE ) NE
, NE , NE
but NE xxx NE
not NE xxx NE
in NE xx NE
Molt G#cell_line_B Xxxx G#cell_line_B
4 G#cell_line_M d G#cell_line_M
T G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
or NE xx NE
K562 G#cell_line_B Xddd G#cell_line_B
stem G#cell_line_M xxx G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

When NE Xxxx NE
ordered NE xxx NE
according NE xxx NE
to NE xx NE
stage NE xxx NE
of NE xx NE
maturation NE xxx NE
, NE , NE
the NE xxx NE
amount NE xxx NE
of NE xx NE
constitutive NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
was NE xxx NE
not NE xxx NE
increased NE xxx NE
in NE xx NE
more NE xxx NE
mature G#cell_line_B xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
when NE xxx NE
inducing NE xxx NE
differentiation NE xxx NE
in NE xx NE
Mono G#cell_line_B Xxxx G#cell_line_B
Mac G#cell_line_M Xxx G#cell_line_M
6 G#cell_line_M d G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
with NE xxx NE
vitamin G#lipid_B xxx G#lipid_B
D3 G#lipid_E Xd G#lipid_E
, NE , NE
no NE xx NE
change NE xxx NE
in NE xx NE
constitutive NE xxx NE
or NE xx NE
inducible NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
can NE xxx NE
be NE xx NE
detected NE xxx NE
. NE . NE

Analysis NE Xxxx NE
of NE xx NE
primary NE xxx NE
cells NE xxx NE
revealed NE xxx NE
substantial NE xxx NE
constitutive NE xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
-binding NE -xxx NE
activity NE xxx NE
in NE xx NE
blood NE xxx NE
monocytes NE xxx NE
, NE , NE
pleural NE xxx NE
macrophages NE xxx NE
and NE xxx NE
alveolar NE xxx NE
macrophages NE xxx NE
. NE . NE

The NE Xxx NE
constitutive NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
appears NE xxx NE
to NE xx NE
be NE xx NE
functionally NE xxx NE
active NE xxx NE
, NE , NE
since NE xxx NE
a NE x NE
low NE xxx NE
level NE xxx NE
of NE xx NE
tumour G#RNA_molecule_B xxx G#RNA_molecule_B
necrosis G#RNA_molecule_M xxx G#RNA_molecule_M
factor G#RNA_molecule_M xxx G#RNA_molecule_M
(TNF) G#RNA_molecule_M (XXX) G#RNA_molecule_M
transcript G#RNA_molecule_E xxx G#RNA_molecule_E
is NE xx NE
detectable NE xxx NE
in NE xx NE
monocytes G#cell_type xxx G#cell_type
, NE , NE
and NE xxx NE
this NE xxx NE
level NE xxx NE
can NE xxx NE
be NE xx NE
increased NE xxx NE
by NE xx NE
blocking NE xxx NE
transcript NE xxx NE
degradation NE xxx NE
using NE xxx NE
cycloheximide G#other_organic_compound xxx G#other_organic_compound
. NE . NE

The NE Xxx NE
level NE xxx NE
of NE xx NE
constitutive NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
in NE xx NE
these NE xxx NE
cells NE xxx NE
is NE xx NE
variable NE xxx NE
and NE xxx NE
is NE xx NE
frequently NE xxx NE
found NE xxx NE
to NE xx NE
be NE xx NE
lower NE xxx NE
in NE xx NE
the NE xxx NE
more NE xxx NE
mature G#cell_type_B xxx G#cell_type_B
macrophages G#cell_type_E xxx G#cell_type_E
. NE . NE

Constitutive NE Xxxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
was NE xxx NE
not NE xxx NE
maintained NE xxx NE
by NE xx NE
autocrine NE xxx NE
action NE xxx NE
of NE xx NE
cytokines G#protein_family_or_group xxx G#protein_family_or_group
TNF G#protein_family_or_group XXX G#protein_family_or_group
, NE , NE
interleukin G#protein_molecule_B xxx G#protein_molecule_B
6 G#protein_molecule_E d G#protein_molecule_E
, NE , NE
interleukin G#protein_molecule xxx G#protein_molecule
10 NE dd NE
, NE , NE
granulocyte-macrophage G#protein_molecule_B xxx-xxx G#protein_molecule_B
colony-stimulating G#protein_molecule_M xxx-xxx G#protein_molecule_M
factor G#protein_molecule_E xxx G#protein_molecule_E
or NE xx NE
macrophage G#protein_molecule_B xxx G#protein_molecule_B
colony-stimulating G#protein_molecule_M xxx-xxx G#protein_molecule_M
factor G#protein_molecule_E xxx G#protein_molecule_E
, NE , NE
since NE xxx NE
neutralizing NE xxx NE
antibodies NE xxx NE
did NE xxx NE
not NE xxx NE
reduce NE xxx NE
constitutive NE xxx NE
DNA-binding G#other_name_B XXX-xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
blockade NE xxx NE
of NE xx NE
prostaglandin NE xxx NE
or NE xx NE
leukotriene NE xxx NE
biosynthesis NE xxx NE
did NE xxx NE
not NE xxx NE
affect NE xxx NE
constitutive NE xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
. NE . NE

(ABSTRACT NE (XXXXXXXX NE
TRUNCATED NE XXXXXXXXX NE
AT NE XX NE
400 NE ddd NE
WORDS) NE XXXXX) NE

Steel G#protein_molecule_B Xxxx G#protein_molecule_B
factor G#protein_molecule_E xxx G#protein_molecule_E
affects NE xxx NE
SCL G#other_name_B XXX G#other_name_B
expression G#other_name_E xxx G#other_name_E
during NE xxx NE
normal NE xxx NE
erythroid G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
. NE . NE

Steel G#protein_molecule_B Xxxx G#protein_molecule_B
factor G#protein_molecule_E xxx G#protein_molecule_E
is NE xx NE
one NE xxx NE
of NE xx NE
the NE xxx NE
growth G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
that NE xxx NE
controls NE xxx NE
the NE xxx NE
proliferation G#other_name xxx G#other_name
and NE xxx NE
differentiation G#other_name xxx G#other_name
of NE xx NE
hematopoietic G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
and NE xxx NE
SCL G#protein_molecule XXX G#protein_molecule
, NE , NE
also NE xxx NE
known NE xxx NE
as NE xx NE
Tcl-5 G#protein_molecule Xxx-d G#protein_molecule
or NE xx NE
Tal-1 G#protein_molecule Xxx-d G#protein_molecule
, NE , NE
is NE xx NE
a NE x NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
involved NE xxx NE
in NE xx NE
erythropoiesis NE xxx NE
. NE . NE

In NE Xx NE
this NE xxx NE
report NE xxx NE
, NE , NE
we NE xx NE
studied NE xxx NE
the NE xxx NE
role NE xxx NE
of NE xx NE
SCL NE XXX NE
in NE xx NE
the NE xxx NE
proliferation G#other_name xxx G#other_name
of NE xx NE
human G#cell_type_B xxx G#cell_type_B
peripheral G#cell_type_M xxx G#cell_type_M
blood G#cell_type_M xxx G#cell_type_M
burst-forming G#cell_type_M xxx-xxx G#cell_type_M
unit-erythroid G#cell_type_E xxx-xxx G#cell_type_E
( NE ( NE
BFU-E G#cell_type XXX-X G#cell_type
) NE ) NE
and NE xxx NE
the NE xxx NE
effects NE xxx NE
of NE xx NE
Steel G#protein_molecule_B Xxxx G#protein_molecule_B
factor G#protein_molecule_E xxx G#protein_molecule_E
on NE xx NE
SCL G#other_name_B XXX G#other_name_B
expression G#other_name_E xxx G#other_name_E
in NE xx NE
proliferating G#cell_type_B xxx G#cell_type_B
erythroid G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

BFU-E NE XXX-X NE
-derived NE -xxx NE
colonies NE xxx NE
increase NE xxx NE
progressively NE xxx NE
in NE xx NE
size NE xxx NE
, NE , NE
as NE xx NE
determined NE xxx NE
by NE xx NE
cell NE xxx NE
number NE xxx NE
, NE , NE
from NE xxx NE
day NE xxx NE
7 NE d NE
to NE xx NE
day NE xxx NE
14 NE dd NE
of NE xx NE
culture NE xxx NE
, NE , NE
with NE xxx NE
the NE xxx NE
greatest NE xxx NE
increase NE xxx NE
in NE xx NE
colony NE xxx NE
size NE xxx NE
(10-fold NE (dd-xxx NE
expansion) NE xxx) NE
occurring NE xxx NE
between NE xxx NE
day NE xxx NE
7 NE d NE
and NE xxx NE
day NE xxx NE
10 NE dd NE
. NE . NE

SCL G#other_name_B XXX G#other_name_B
protein G#other_name_M xxx G#other_name_M
levels G#other_name_E xxx G#other_name_E
in NE xx NE
BFU-E NE XXX-X NE
-derived NE -xxx NE
cells NE xxx NE
were NE xxx NE
highest NE xxx NE
in NE xx NE
day NE xxx NE
7 NE d NE
cells NE xxx NE
and NE xxx NE
decreased NE xxx NE
progressively NE xxx NE
from NE xxx NE
day NE xxx NE
7 NE d NE
to NE xx NE
day NE xxx NE
14 NE dd NE
of NE xx NE
culture NE xxx NE
, NE , NE
suggesting NE xxx NE
an NE xx NE
association NE xxx NE
of NE xx NE
SCL NE XXX NE
with NE xxx NE
erythroid NE xxx NE
proliferation NE xxx NE
. NE . NE

In NE Xx NE
contrast NE xxx NE
, NE , NE
SCL G#other_name_B XXX G#other_name_B
mRNA G#other_name_M xXXX G#other_name_M
levels G#other_name_E xxx G#other_name_E
did NE xxx NE
not NE xxx NE
decrease NE xxx NE
significantly NE xxx NE
between NE xxx NE
day NE xxx NE
7 NE d NE
and NE xxx NE
day NE xxx NE
14 NE dd NE
cells NE xxx NE
, NE , NE
suggesting NE xxx NE
that NE xxx NE
posttranscriptional NE xxx NE
mechanisms NE xxx NE
are NE xxx NE
largely NE xxx NE
responsible NE xxx NE
for NE xxx NE
the NE xxx NE
decrease NE xxx NE
in NE xx NE
SCL G#protein_molecule_B XXX G#protein_molecule_B
protein G#protein_molecule_E xxx G#protein_molecule_E
observed NE xxx NE
. NE . NE

The NE Xxx NE
role NE xxx NE
of NE xx NE
SCL G#protein_molecule XXX G#protein_molecule
in NE xx NE
Steel NE Xxxx NE
factor NE xxx NE
-induced NE -xxx NE
erythroid NE xxx NE
proliferation NE xxx NE
was NE xxx NE
then NE xxx NE
examined NE xxx NE
. NE . NE

In NE Xx NE
BFU-E NE XXX-X NE
-derived NE -xxx NE
colonies NE xxx NE
cultured NE xxx NE
with NE xxx NE
Steel NE Xxxx NE
factor NE xxx NE
, NE , NE
colony NE xxx NE
size NE xxx NE
was NE xxx NE
significantly NE xxx NE
increased NE xxx NE
compared NE xxx NE
to NE xx NE
control NE xxx NE
. NE . NE

In NE Xx NE
day NE xxx NE
7 NE d NE
and NE xxx NE
day NE xxx NE
10 NE dd NE
erythroid G#cell_type_B xxx G#cell_type_B
precursors G#cell_type_E xxx G#cell_type_E
cultured NE xxx NE
with NE xxx NE
Steel G#protein_molecule_B Xxxx G#protein_molecule_B
factor G#protein_molecule_E xxx G#protein_molecule_E
, NE , NE
SCL G#protein_molecule_B XXX G#protein_molecule_B
protein G#protein_molecule_E xxx G#protein_molecule_E
was NE xxx NE
increased NE xxx NE
significantly NE xxx NE
compared NE xxx NE
to NE xx NE
control NE xxx NE
. NE . NE

The NE Xxx NE
increase NE xxx NE
in NE xx NE
SCL G#other_name_B XXX G#other_name_B
protein G#other_name_M xxx G#other_name_M
levels G#other_name_E xxx G#other_name_E
in NE xx NE
early NE xxx NE
erythroid G#cell_type_B xxx G#cell_type_B
precursors G#cell_type_E xxx G#cell_type_E
stimulated NE xxx NE
with NE xxx NE
Steel G#protein_molecule_B Xxxx G#protein_molecule_B
factor G#protein_molecule_E xxx G#protein_molecule_E
suggests NE xxx NE
one NE xxx NE
mechanism NE xxx NE
through NE xxx NE
which NE xxx NE
Steel G#protein_molecule_B Xxxx G#protein_molecule_B
factor G#protein_molecule_E xxx G#protein_molecule_E
may NE xxx NE
enhance NE xxx NE
normal NE xxx NE
erythroid G#other_name_B xxx G#other_name_B
proliferation G#other_name_E xxx G#other_name_E
. NE . NE

SCL G#other_name_B XXX G#other_name_B
mRNA G#other_name_M xXXX G#other_name_M
levels G#other_name_E xxx G#other_name_E
assessed NE xxx NE
by NE xx NE
Northern NE Xxxx NE
blot NE xxx NE
in NE xx NE
day NE xxx NE
7 NE d NE
cells NE xxx NE
did NE xxx NE
not NE xxx NE
increase NE xxx NE
significantly NE xxx NE
in NE xx NE
response NE xxx NE
to NE xx NE
Steel G#protein_molecule_B Xxxx G#protein_molecule_B
factor G#protein_molecule_E xxx G#protein_molecule_E
stimulation NE xxx NE
, NE , NE
suggesting NE xxx NE
that NE xxx NE
posttranscriptional G#other_name_B xxx G#other_name_B
mechanisms G#other_name_E xxx G#other_name_E
may NE xxx NE
also NE xxx NE
be NE xx NE
important NE xxx NE
in NE xx NE
the NE xxx NE
increase NE xxx NE
in NE xx NE
SCL G#protein_molecule_B XXX G#protein_molecule_B
protein G#protein_molecule_E xxx G#protein_molecule_E
observed NE xxx NE
in NE xx NE
response NE xxx NE
to NE xx NE
Steel G#protein_molecule Xxxx G#protein_molecule
. NE . NE

C/EBP G#other_name_B X/XXX G#other_name_B
beta G#other_name_M xxx G#other_name_M
regulation G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
tumor G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
necrosis G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
factor G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
alpha G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Activated G#cell_type_B Xxxx G#cell_type_B
macrophages G#cell_type_E xxx G#cell_type_E
contribute NE xxx NE
to NE xx NE
chronic G#other_name_B xxx G#other_name_B
inflammation G#other_name_E xxx G#other_name_E
by NE xx NE
the NE xxx NE
secretion NE xxx NE
of NE xx NE
cytokines G#protein_family_or_group xxx G#protein_family_or_group
and NE xxx NE
proteinases G#protein_family_or_group xxx G#protein_family_or_group
. NE . NE

Tumor G#protein_molecule_B Xxxx G#protein_molecule_B
necrosis G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_M xxx G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
TNF G#protein_molecule_B XXX G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
) NE ) NE
is NE xx NE
particularly NE xxx NE
important NE xxx NE
in NE xx NE
this NE xxx NE
process NE xxx NE
because NE xxx NE
of NE xx NE
its NE xxx NE
ability NE xxx NE
to NE xx NE
regulate NE xxx NE
other NE xxx NE
inflammatory G#other_name_B xxx G#other_name_B
mediators G#other_name_E xxx G#other_name_E
in NE xx NE
an NE xx NE
autocrine G#other_name_B xxx G#other_name_B
fashion G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
paracrine G#other_name_M xxx G#other_name_M
fashion G#other_name_E xxx G#other_name_E

The NE Xxx NE
mechanism(s) NE xxx(x) NE
responsible NE xxx NE
for NE xxx NE
the NE xxx NE
cell G#other_name_B xxx G#other_name_B
type-specific G#other_name_M xxx-xxx G#other_name_M
regulation G#other_name_E xxx G#other_name_E
of NE xx NE
TNF G#protein_molecule_B XXX G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
is NE xx NE
not NE xxx NE
known NE xxx NE
. NE . NE

We NE Xx NE
present NE xxx NE
data NE xxx NE
to NE xx NE
show NE xxx NE
that NE xxx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
TNF G#protein_molecule_B XXX G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
is NE xx NE
regulated NE xxx NE
by NE xx NE
the NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
C/EBP G#protein_molecule_B X/XXX G#protein_molecule_B
beta G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
NF-IL6 G#protein_molecule XX-XXd G#protein_molecule
) NE ) NE
. NE . NE

C/EBP G#protein_molecule_B X/XXX G#protein_molecule_B
beta G#protein_molecule_E xxx G#protein_molecule_E
activated NE xxx NE
the NE xxx NE
TNF G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
alpha G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
cotransfection G#other_name_B xxx G#other_name_B
assays G#other_name_E xxx G#other_name_E
and NE xxx NE
bound NE xxx NE
to NE xx NE
it NE xx NE
at NE xx NE
a NE x NE
site NE xxx NE
which NE xxx NE
failed NE xxx NE
to NE xx NE
bind NE xxx NE
the NE xxx NE
closely NE xxx NE
related NE xxx NE
protein NE xxx NE
C/EBP G#protein_molecule_B X/XXX G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

Finally NE Xxxx NE
, NE , NE
a NE x NE
dominant-negative NE xxx-xxx NE
version NE xxx NE
of NE xx NE
C/EBP G#protein_molecule_B X/XXX G#protein_molecule_B
beta G#protein_molecule_E xxx G#protein_molecule_E
blocked NE xxx NE
TNF G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
alpha G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
activation NE xxx NE
in NE xx NE
myeloid G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Our NE Xxx NE
results NE xxx NE
implicate NE xxx NE
C/EBP G#protein_molecule_B X/XXX G#protein_molecule_B
beta G#protein_molecule_E xxx G#protein_molecule_E
as NE xx NE
an NE xx NE
important NE xxx NE
regulator NE xxx NE
of NE xx NE
TNF G#protein_molecule_B XXX G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
by NE xx NE
myelomonocytic G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Calcium/calmodulin-dependent G#protein_molecule_B Xxxx/xxx-xxx G#protein_molecule_B
protein G#protein_molecule_M xxx G#protein_molecule_M
kinase G#protein_molecule_M xxx G#protein_molecule_M
II G#protein_molecule_E XX G#protein_molecule_E
downregulates NE xxx NE
both NE xxx NE
calcineurin-mediated G#other_name_B xxx-xxx G#other_name_B
pathway G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
protein G#other_name_M xxx G#other_name_M
kinase G#other_name_M xxx G#other_name_M
C-mediated G#other_name_M X-xxx G#other_name_M
pathway G#other_name_E xxx G#other_name_E
for NE xxx NE
cytokine G#other_name_B xxx G#other_name_B
gene G#other_name_M xxx G#other_name_M
transcription G#other_name_E xxx G#other_name_E
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Engagement NE Xxxx NE
of NE xx NE
the NE xxx NE
T G#protein_family_or_group_B X G#protein_family_or_group_B
cell G#protein_family_or_group_M xxx G#protein_family_or_group_M
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
for NE xxx NE
antigen G#other_name xxx G#other_name
activates NE xxx NE
phospholipase G#protein_molecule_B xxx G#protein_molecule_B
C G#protein_molecule_E X G#protein_molecule_E
resulting NE xxx NE
in NE xx NE
an NE xx NE
increase NE xxx NE
in NE xx NE
intracellular G#other_name_B xxx G#other_name_B
free G#other_name_M xxx G#other_name_M
calcium G#other_name_M xxx G#other_name_M
concentration G#other_name_E xxx G#other_name_E
( NE ( NE
[ NE [ NE
Ca2+ NE Xxd+ NE
]i NE ]x NE
) NE ) NE
and NE xxx NE
activation NE xxx NE
of NE xx NE
protein NE xxx NE
kinase NE xxx NE
C NE X NE
( NE ( NE
PKC NE XXX NE
) NE ) NE
. NE . NE

Increased NE Xxxx NE
[ NE [ NE
Ca2+ NE Xxd+ NE
]i NE ]x NE
activates NE xxx NE
Ca2+ NE Xxd+ NE
/calmodulin-dependent NE /xxx-xxx NE
kinases NE xxx NE
including NE xxx NE
the NE xxx NE
multifunctional NE xxx NE
Ca2+ NE Xxd+ NE
/calmodulin-dependent NE /xxx-xxx NE
protein NE xxx NE
kinase NE xxx NE
II NE XX NE
( NE ( NE
CaM-K NE XxX-X NE
II NE XX NE
) NE ) NE
, NE , NE
as NE xx NE
well NE xxx NE
as NE xx NE
calcineurin NE xxx NE
, NE , NE
a NE x NE
type NE xxx NE
2B NE dX NE
protein NE xxx NE
phosphatase NE xxx NE
. NE . NE

Recent NE Xxxx NE
studies NE xxx NE
have NE xxx NE
identified NE xxx NE
calcineurin G#protein_molecule xxx G#protein_molecule
as NE xx NE
a NE x NE
key NE xxx NE
enzyme NE xxx NE
for NE xxx NE
interleukin G#other_name_B xxx G#other_name_B
(IL)-2 G#other_name_M (XX)-d G#other_name_M
promoter G#other_name_M xxx G#other_name_M
activation G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
IL-4 G#other_name_M XX-d G#other_name_M
promoter G#other_name_M xxx G#other_name_M
activation G#other_name_E xxx G#other_name_E

However NE Xxxx NE
, NE , NE
the NE xxx NE
role NE xxx NE
of NE xx NE
CaM-K G#protein_molecule_B XxX-X G#protein_molecule_B
II G#protein_molecule_E XX G#protein_molecule_E
remains NE xxx NE
unknown NE xxx NE
. NE . NE

We NE Xx NE
have NE xxx NE
used NE xxx NE
mutants NE xxx NE
of NE xx NE
these NE xxx NE
kinases G#protein_family_or_group xxx G#protein_family_or_group
and NE xxx NE
phosphatases G#protein_family_or_group xxx G#protein_family_or_group
( NE ( NE
gamma G#protein_molecule_B xxx G#protein_molecule_B
B*CaM-K G#protein_molecule_E X*XxX-X G#protein_molecule_E
and NE xxx NE
delta G#protein_molecule_B xxx G#protein_molecule_B
CaM-AI G#protein_molecule_E XxX-XX G#protein_molecule_E
, NE , NE
respectively) NE xxx) NE
to NE xx NE
explore NE xxx NE
their NE xxx NE
relative NE xxx NE
role NE xxx NE
in NE xx NE
cytokine G#other_name_B xxx G#other_name_B
gene G#other_name_M xxx G#other_name_M
transcription G#other_name_E xxx G#other_name_E
and NE xxx NE
their NE xxx NE
interactions NE xxx NE
with NE xxx NE
PKC NE XXX NE
-dependent NE -xxx NE
signaling NE xxx NE
systems NE xxx NE
. NE . NE

gamma G#protein_molecule_B xxx G#protein_molecule_B
B*CaM-K G#protein_molecule_E X*XxX-X G#protein_molecule_E
and NE xxx NE
delta G#protein_molecule_B xxx G#protein_molecule_B
CaM-AI G#protein_molecule_E XxX-XX G#protein_molecule_E
, NE , NE
known NE xxx NE
to NE xx NE
exhibit NE xxx NE
constitutive NE xxx NE
Ca(2+)-independent G#other_name_B Xx(d+)-xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
, NE , NE
were NE xxx NE
cotransfected NE xxx NE
(alone NE (xxx NE
or NE xx NE
in NE xx NE
combination) NE xxx) NE
in NE xx NE
Jurkat G#cell_line_B Xxxx G#cell_line_B
T G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
with NE xxx NE
a NE x NE
plasmid NE xxx NE
containing NE xxx NE
the NE xxx NE
intact NE xxx NE
IL-2 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
driving NE xxx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
chloramphenicol G#DNA_molecule_B xxx G#DNA_molecule_B
acetyltransferase G#DNA_molecule_M xxx G#DNA_molecule_M
reporter G#DNA_molecule_M xxx G#DNA_molecule_M
gene G#DNA_molecule_E xxx G#DNA_molecule_E
. NE . NE

Cotransfection NE Xxxx NE
of NE xx NE
gamma G#protein_molecule_B xxx G#protein_molecule_B
B*CaM-K G#protein_molecule_E X*XxX-X G#protein_molecule_E
with NE xxx NE
the NE xxx NE
IL-2 G#DNA_molecule_B XX-d G#DNA_molecule_B
promoter G#DNA_molecule_M xxx G#DNA_molecule_M
construct G#DNA_molecule_E xxx G#DNA_molecule_E
downregulated NE xxx NE
its NE xxx NE
transcription NE xxx NE
in NE xx NE
response NE xxx NE
to NE xx NE
stimulation NE xxx NE
with NE xxx NE
ionomycin G#other_organic_compound xxx G#other_organic_compound
and NE xxx NE
phorbol G#other_organic_compound_B xxx G#other_organic_compound_B
myristate G#other_organic_compound_M xxx G#other_organic_compound_M
acetate G#other_organic_compound_E xxx G#other_organic_compound_E
( NE ( NE
PMA G#other_organic_compound XXX G#other_organic_compound
) NE ) NE
. NE . NE

The NE Xxx NE
inhibitory NE xxx NE
effect NE xxx NE
of NE xx NE
CaM-K G#protein_molecule_B XxX-X G#protein_molecule_B
II G#protein_molecule_E XX G#protein_molecule_E
on NE xx NE
IL-2 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
was NE xxx NE
associated NE xxx NE
with NE xxx NE
decreased NE xxx NE
transcription NE xxx NE
of NE xx NE
its NE xxx NE
AP-1 G#other_name_B XX-d G#other_name_B
transactivating G#other_name_M xxx G#other_name_M
pathway G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
NF-AT G#other_name_M XX-XX G#other_name_M
transactivating G#other_name_M xxx G#other_name_M
pathway G#other_name_E xxx G#other_name_E

Under NE Xxxx NE
the NE xxx NE
same NE xxx NE
conditions NE xxx NE
, NE , NE
delta G#protein_molecule_B xxx G#protein_molecule_B
CaM-AI G#protein_molecule_E XxX-XX G#protein_molecule_E
superinduced NE xxx NE
IL-2 G#other_name_B XX-d G#other_name_B
promoter G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
(approximately NE (xxx NE
twofold NE xxx NE
increase) NE xxx) NE
. NE . NE

When NE Xxxx NE
both NE xxx NE
mutants NE xxx NE
were NE xxx NE
used NE xxx NE
in NE xx NE
combination NE xxx NE
, NE , NE
gamma G#protein_molecule_B xxx G#protein_molecule_B
B*CaM-K G#protein_molecule_E X*XxX-X G#protein_molecule_E
inhibited NE xxx NE
the NE xxx NE
induction NE xxx NE
of NE xx NE
the NE xxx NE
IL-2 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
by NE xx NE
delta G#protein_molecule_B xxx G#protein_molecule_B
CaM-AI G#protein_molecule_E XxX-XX G#protein_molecule_E
. NE . NE

Similar NE Xxxx NE
results NE xxx NE
were NE xxx NE
obtained NE xxx NE
when NE xxx NE
a NE x NE
construct NE xxx NE
containing NE xxx NE
the NE xxx NE
IL-4 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
also NE xxx NE
was NE xxx NE
used NE xxx NE
. NE . NE

gamma G#protein_molecule_B xxx G#protein_molecule_B
B*CaM-K G#protein_molecule_E X*XxX-X G#protein_molecule_E
also NE xxx NE
downregulated NE xxx NE
the NE xxx NE
activation NE xxx NE
of NE xx NE
AP-1 G#protein_molecule XX-d G#protein_molecule
in NE xx NE
response NE xxx NE
to NE xx NE
transfection NE xxx NE
with NE xxx NE
a NE x NE
constitutively NE xxx NE
active NE xxx NE
mutant NE xxx NE
of NE xx NE
PKC G#protein_molecule XXX G#protein_molecule
or NE xx NE
stimulation NE xxx NE
with NE xxx NE
PMA G#other_organic_compound XXX G#other_organic_compound
. NE . NE

These NE Xxxx NE
results NE xxx NE
suggest NE xxx NE
that NE xxx NE
CaM-K G#protein_molecule_B XxX-X G#protein_molecule_B
II G#protein_molecule_E XX G#protein_molecule_E
may NE xxx NE
exert NE xxx NE
negative NE xxx NE
influences NE xxx NE
on NE xx NE
cytokine G#other_name_B xxx G#other_name_B
gene G#other_name_M xxx G#other_name_M
transcription G#other_name_E xxx G#other_name_E
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
, NE , NE
and NE xxx NE
provide NE xxx NE
preliminary NE xxx NE
evidence NE xxx NE
for NE xxx NE
negative G#other_name_B xxx G#other_name_B
cross-talk G#other_name_E xxx-xxx G#other_name_E
with NE xxx NE
the NE xxx NE
calcineurin- G#other_name_B xxx- G#other_name_B
dependent G#other_name_M xxx G#other_name_M
signaling G#other_name_M xxx G#other_name_M
system G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
PKC- G#other_name_M XXX- G#other_name_M
dependent G#other_name_M xxx G#other_name_M
signaling G#other_name_M xxx G#other_name_M
system G#other_name_E xxx G#other_name_E

Induction NE Xxxx NE
of NE xx NE
ICAM-1 G#protein_molecule XXXX-d G#protein_molecule
and NE xxx NE
LFA-3 G#protein_molecule XXX-d G#protein_molecule
by NE xx NE
Tax1 G#protein_molecule Xxxd G#protein_molecule
of NE xx NE
human NE xxx NE
T-cell G#virus_B X-xxx G#virus_B
leukemia G#virus_M xxx G#virus_M
virus G#virus_M xxx G#virus_M
type G#virus_M xxx G#virus_M
1 G#virus_E d G#virus_E
and NE xxx NE
mechanism NE xxx NE
of NE xx NE
down-regulation NE xxx-xxx NE
of NE xx NE
ICAM-1 G#protein_molecule XXXX-d G#protein_molecule
or NE xx NE
LFA-1 G#protein_molecule XXX-d G#protein_molecule
in NE xx NE
adult-T-cell-leukemia G#cell_line_B xxx-X-xxx-xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
. NE . NE

The NE Xxx NE
present NE xxx NE
study NE xxx NE
was NE xxx NE
undertaken NE xxx NE
to NE xx NE
determine NE xxx NE
the NE xxx NE
role NE xxx NE
of NE xx NE
HTLV-I G#protein_molecule_B XXXX-X G#protein_molecule_B
TaxI G#protein_molecule_E XxxX G#protein_molecule_E
in NE xx NE
the NE xxx NE
up-regulation NE xx-xxx NE
of NE xx NE
ICAM-I G#protein_molecule XXXX-X G#protein_molecule
and NE xxx NE
LFA-3 G#protein_molecule XXX-d G#protein_molecule
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
transformed NE xxx NE
with NE xxx NE
HTLV-I G#virus XXXX-X G#virus
and NE xxx NE
the NE xxx NE
mechanism NE xxx NE
of NE xx NE
down-regulation NE xxx-xxx NE
of NE xx NE
ICAM-I G#protein_molecule XXXX-X G#protein_molecule
and NE xxx NE
LFA-I G#protein_molecule XXX-X G#protein_molecule
in NE xx NE
ATL-derived G#cell_line_B XXX-xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
. NE . NE

Induction NE Xxxx NE
of NE xx NE
TaxI G#protein_molecule XxxX G#protein_molecule
in NE xx NE
a NE x NE
human G#cell_line_B xxx G#cell_line_B
T-cell G#cell_line_M X-xxx G#cell_line_M
line G#cell_line_M xxx G#cell_line_M
Jurkat G#cell_line_E Xxxx G#cell_line_E
carrying NE xxx NE
the NE xxx NE
TaxI G#DNA_domain_or_region_B XxxX G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
under NE xxx NE
the NE xxx NE
metallothionein G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
led NE xxx NE
to NE xx NE
increases NE xxx NE
in NE xx NE
mRNA G#RNA_family_or_group xXXX G#RNA_family_or_group
and NE xxx NE
surface NE xxx NE
expression NE xxx NE
of NE xx NE
ICAM-I G#protein_molecule XXXX-X G#protein_molecule
. NE . NE

The NE Xxx NE
response NE xxx NE
of NE xx NE
LFA-3 G#protein_molecule XXX-d G#protein_molecule
to NE xx NE
TaxI G#other_name_B XxxX G#other_name_B
induction G#other_name_E xxx G#other_name_E
was NE xxx NE
, NE , NE
on NE xx NE
the NE xxx NE
other NE xxx NE
hand NE xxx NE
, NE , NE
relatively NE xxx NE
slow NE xxx NE
and NE xxx NE
weak NE xxx NE
, NE , NE
and NE xxx NE
might NE xxx NE
be NE xx NE
indirect NE xxx NE
. NE . NE

Transactivation NE Xxxx NE
of NE xx NE
the NE xxx NE
ICAM-I G#DNA_domain_or_region_B XXXX-X G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
by NE xx NE
TaxI G#protein_molecule XxxX G#protein_molecule
was NE xxx NE
further NE xxx NE
shown NE xxx NE
by NE xx NE
co-transfection NE xx-xxx NE
of NE xx NE
a NE x NE
CAT G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
reporter G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
construct G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
with NE xxx NE
the NE xxx NE
ICAM-I G#DNA_domain_or_region_B XXXX-X G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
and NE xxx NE
a NE x NE
plasmid G#DNA_molecule xxx G#DNA_molecule
expressing NE xxx NE
TaxI G#protein_molecule XxxX G#protein_molecule
. NE . NE

The NE Xxx NE
mechanism NE xxx NE
of NE xx NE
down-regulation NE xxx-xxx NE
of NE xx NE
ICAM-I G#protein_molecule XXXX-X G#protein_molecule
or NE xx NE
LFA-I G#protein_molecule XXX-X G#protein_molecule
in NE xx NE
4 G#cell_line_B d G#cell_line_B
ATL G#cell_line_M XXX G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
was NE xxx NE
next NE xxx NE
examined NE xxx NE
. NE . NE

ICAM-I G#RNA_molecule_B XXXX-X G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
was NE xxx NE
quite NE xxx NE
low NE xxx NE
in NE xx NE
MT-I G#cell_line XX-X G#cell_line
, NE , NE
but NE xxx NE
no NE xx NE
genomic NE xxx NE
changes NE xxx NE
were NE xxx NE
found NE xxx NE
. NE . NE

The NE Xxx NE
CAT G#DNA_molecule_B XXX G#DNA_molecule_B
reporter G#DNA_molecule_E xxx G#DNA_molecule_E
with NE xxx NE
the NE xxx NE
ICAM-I G#DNA_domain_or_region_B XXXX-X G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
was NE xxx NE
inactive NE xxx NE
in NE xx NE
MT-I G#cell_line XX-X G#cell_line
. NE . NE

Finally NE Xxxx NE
, NE , NE
combined NE xxx NE
treatment NE xxx NE
of NE xx NE
MT-I G#cell_line XX-X G#cell_line
with NE xxx NE
5-azacytidine G#other_organic_compound d-xxx G#other_organic_compound
and NE xxx NE
IFN-gamma G#other_name_B XXX-xxx G#other_name_B
induced G#other_name_M xxx G#other_name_M
re-expression G#other_name_E xx-xxx G#other_name_E
of NE xx NE
ICAM-I G#protein_molecule XXXX-X G#protein_molecule
. NE . NE

Collectively NE Xxxx NE
, NE , NE
(a) NE (x) NE
transcriptional G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
(s) NE (x) NE
necessary NE xxx NE
for NE xxx NE
expression NE xxx NE
of NE xx NE
ICAM-I G#DNA_domain_or_region_B XXXX-X G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
may NE xxx NE
be NE xx NE
repressed NE xxx NE
in NE xx NE
MT-I G#cell_line XX-X G#cell_line
through NE xxx NE
DNA G#other_name_B XXX G#other_name_B
methylation G#other_name_E xxx G#other_name_E
. NE . NE

Three NE Xxxx NE
other NE xxx NE
ATL G#cell_line_B XXX G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
( NE ( NE
TL-OmI G#cell_line XX-XxX G#cell_line
, NE , NE
H582 G#cell_line Xddd G#cell_line
, NE , NE
HuT102 G#cell_line XxXddd G#cell_line
) NE ) NE
were NE xxx NE
found NE xxx NE
to NE xx NE
have NE xxx NE
little NE xxx NE
mRNA G#RNA_family_or_group xXXX G#RNA_family_or_group
for NE xxx NE
the NE xxx NE
LFA-I G#protein_subunit_B XXX-X G#protein_subunit_B
beta G#protein_subunit_M xxx G#protein_subunit_M
chain G#protein_subunit_E xxx G#protein_subunit_E
( NE ( NE
CD18 G#protein_subunit XXdd G#protein_subunit
) NE ) NE
. NE . NE

H582 G#cell_line Xddd G#cell_line
and NE xxx NE
HuT102 G#cell_line XxXddd G#cell_line
were NE xxx NE
also NE xxx NE
negative NE xxx NE
for NE xxx NE
the NE xxx NE
LFA-I G#RNA_molecule_B XXX-X G#RNA_molecule_B
alpha G#RNA_molecule_M xxx G#RNA_molecule_M
chain G#RNA_molecule_M xxx G#RNA_molecule_M
(CDIIa) G#RNA_molecule_M (XXXXx) G#RNA_molecule_M
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
. NE . NE

No NE Xx NE
genomic NE xxx NE
changes NE xxx NE
were NE xxx NE
found NE xxx NE
, NE , NE
and NE xxx NE
a NE x NE
CAT G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
reporter G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
with NE xxx NE
the NE xxx NE
CD18 G#DNA_domain_or_region_B XXdd G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
was NE xxx NE
inactive NE xxx NE
in NE xx NE
the NE xxx NE
3 NE d NE
of NE xx NE
them NE xxx NE
, NE , NE
again NE xxx NE
suggesting NE xxx NE
lack NE xxx NE
of NE xx NE
(a) NE (x) NE
transcriptional G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
(s) NE (x) NE
necessary NE xxx NE
for NE xxx NE
CD18 G#other_name_B XXdd G#other_name_B
expression G#other_name_E xxx G#other_name_E
. NE . NE

Infection NE Xxxx NE
with NE xxx NE
Theileria G#mono_cell_B Xxxx G#mono_cell_B
annulata G#mono_cell_E xxx G#mono_cell_E
induces NE xxx NE
expression NE xxx NE
of NE xx NE
matrix G#protein_molecule_B xxx G#protein_molecule_B
metalloproteinase G#protein_molecule_M xxx G#protein_molecule_M
9 G#protein_molecule_E d G#protein_molecule_E
and NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
AP-1 G#protein_molecule XX-d G#protein_molecule
in NE xx NE
bovine G#cell_type_B xxx G#cell_type_B
leucocytes G#cell_type_E xxx G#cell_type_E
. NE . NE

Theileria G#mono_cell_B Xxxx G#mono_cell_B
annulata G#mono_cell_E xxx G#mono_cell_E
infects NE xxx NE
bovine G#cell_type_B xxx G#cell_type_B
leucocytes G#cell_type_E xxx G#cell_type_E
and NE xxx NE
results NE xxx NE
in NE xx NE
their NE xxx NE
reversible NE xxx NE
transformation NE xxx NE
such NE xxx NE
that NE xxx NE
they NE xxx NE
become NE xxx NE
immortalised NE xxx NE
and NE xxx NE
metastatic NE xxx NE
. NE . NE

The NE Xxx NE
present NE xxx NE
study NE xxx NE
describes NE xxx NE
parasite-induced G#other_name_B xxx-xxx G#other_name_B
changes G#other_name_E xxx G#other_name_E
in NE xx NE
host G#other_name_B xxx G#other_name_B
cell G#other_name_M xxx G#other_name_M
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
which NE xxx NE
have NE xxx NE
a NE x NE
direct NE xxx NE
bearing NE xxx NE
on NE xx NE
this NE xxx NE
transformation NE xxx NE
process NE xxx NE
. NE . NE

T NE X NE
. NE . NE
annulata NE xxx NE
-infected NE -xxx NE
leucocytes NE xxx NE
produce NE xxx NE
a NE x NE
number NE xxx NE
of NE xx NE
novel NE xxx NE
metalloproteinase NE xxx NE
activities NE xxx NE
. NE . NE

One NE Xxx NE
of NE xx NE
these NE xxx NE
, NE , NE
previously NE xxx NE
called NE xxx NE
B1 G#protein_molecule Xd G#protein_molecule
, NE , NE
is NE xx NE
a NE x NE
97-kDa G#protein_molecule_B dd-xXx G#protein_molecule_B
protein G#protein_molecule_E xxx G#protein_molecule_E
which NE xxx NE
is NE xx NE
secreted NE xxx NE
in NE xx NE
large NE xxx NE
amounts NE xxx NE
and NE xxx NE
has NE xxx NE
been NE xxx NE
purified NE xxx NE
from NE xxx NE
protein-free, G#other_name_B xxx-xxx, G#other_name_B
conditioned G#other_name_M xxx G#other_name_M
medium G#other_name_E xxx G#other_name_E
. NE . NE

An NE Xx NE
antiserum NE xxx NE
to NE xx NE
this NE xxx NE
enzyme NE xxx NE
was NE xxx NE
used NE xxx NE
to NE xx NE
isolate NE xxx NE
a NE x NE
cDNA G#DNA_family_or_group_B xXXX G#DNA_family_or_group_B
clone G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
. NE . NE

The NE Xxx NE
predicted NE xxx NE
protein NE xxx NE
sequence NE xxx NE
of NE xx NE
B1 G#protein_molecule Xd G#protein_molecule
is NE xx NE
81% NE dd% NE
identical NE xxx NE
to NE xx NE
human NE xxx NE
matrix G#protein_molecule_B xxx G#protein_molecule_B
metalloproteinase G#protein_molecule_M xxx G#protein_molecule_M
9 G#protein_molecule_E d G#protein_molecule_E
( NE ( NE
MMP9 G#protein_molecule XXXd G#protein_molecule
) NE ) NE
, NE , NE
demonstrating NE xxx NE
that NE xxx NE
it NE xx NE
is NE xx NE
the NE xxx NE
bovine NE xxx NE
homologue NE xxx NE
of NE xx NE
this NE xxx NE
enzyme NE xxx NE
. NE . NE

RNAase G#other_name_B XXXxxx G#other_name_B
protection G#other_name_M xxx G#other_name_M
assays G#other_name_E xxx G#other_name_E
demonstrated NE xxx NE
that NE xxx NE
the NE xxx NE
MMP9 G#protein_molecule XXXd G#protein_molecule
activity NE xxx NE
, NE , NE
unique NE xxx NE
to NE xx NE
infected G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
, NE , NE
is NE xx NE
due NE xxx NE
to NE xx NE
increased NE xxx NE
MMP9 G#other_name_B XXXd G#other_name_B
mRNA G#other_name_M xXXX G#other_name_M
levels G#other_name_E xxx G#other_name_E
. NE . NE

We NE Xx NE
also NE xxx NE
assayed NE xxx NE
the NE xxx NE
levels NE xxx NE
of NE xx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
AP-1 G#protein_molecule XX-d G#protein_molecule
and NE xxx NE
demonstrated NE xxx NE
that NE xxx NE
it NE xx NE
was NE xxx NE
constitutively NE xxx NE
present NE xxx NE
in NE xx NE
increased NE xxx NE
amounts NE xxx NE
in NE xx NE
Theileria-infected G#cell_type_B Xxxx-xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

In NE Xx NE
addition NE xxx NE
we NE xx NE
assayed NE xxx NE
the NE xxx NE
level NE xxx NE
of NE xx NE
mRNA G#RNA_family_or_group xXXX G#RNA_family_or_group
encoding NE xxx NE
c-Fos G#protein_molecule x-Xxx G#protein_molecule
, NE , NE
a NE x NE
common NE xxx NE
component NE xxx NE
of NE xx NE
AP-1 G#protein_molecule XX-d G#protein_molecule
and NE xxx NE
observed NE xxx NE
that NE xxx NE
it NE xx NE
was NE xxx NE
indeed NE xxx NE
up-regulated NE xx-xxx NE
in NE xx NE
infected G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Since NE Xxxx NE
AP-1 G#protein_molecule XX-d G#protein_molecule
is NE xx NE
implicated NE xxx NE
in NE xx NE
the NE xxx NE
control NE xxx NE
of NE xx NE
the NE xxx NE
cell NE xxx NE
cycle NE xxx NE
, NE , NE
and NE xxx NE
MMP9 G#protein_molecule XXXd G#protein_molecule
can NE xxx NE
confer NE xxx NE
metastatic NE xxx NE
properties NE xxx NE
, NE , NE
these NE xxx NE
results NE xxx NE
are NE xxx NE
of NE xx NE
considerable NE xxx NE
significance NE xxx NE
with NE xxx NE
respect NE xxx NE
to NE xx NE
the NE xxx NE
transformed NE xxx NE
phenotype NE xxx NE
induced NE xxx NE
by NE xx NE
Theileria G#other_name_B Xxxx G#other_name_B
infection G#other_name_E xxx G#other_name_E
. NE . NE

B-cell G#other_name_B X-xxx G#other_name_B
proliferation G#other_name_E xxx G#other_name_E
and NE xxx NE
induction NE xxx NE
of NE xx NE
early NE xxx NE
G1-regulating G#protein_family_or_group_B Xd-xxx G#protein_family_or_group_B
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
by NE xx NE
Epstein-Barr G#virus_B Xxxx-Xxxx G#virus_B
virus G#virus_M xxx G#virus_M
mutants G#virus_E xxx G#virus_E
conditional NE xxx NE
for NE xxx NE
EBNA2 G#protein_molecule XXXXd G#protein_molecule
. NE . NE

Infection NE Xxxx NE
of NE xx NE
primary G#cell_type_B xxx G#cell_type_B
B-lymphocytes G#cell_type_E X-xxx G#cell_type_E
by NE xx NE
Epstein-Barr G#virus_B Xxxx-Xxxx G#virus_B
virus G#virus_E xxx G#virus_E
( NE ( NE
EBV G#virus XXX G#virus
) NE ) NE
leads NE xxx NE
to NE xx NE
growth NE xxx NE
transformation NE xxx NE
of NE xx NE
these NE xxx NE
B-cells G#cell_type X-xxx G#cell_type
in NE xx NE
vitro NE xxx NE
. NE . NE

EBV G#virus XXX G#virus
nuclear NE xxx NE
antigen NE xxx NE
2 NE d NE
( NE ( NE
EBNA2 G#protein_molecule XXXXd G#protein_molecule
) NE ) NE
, NE , NE
one NE xxx NE
of NE xx NE
the NE xxx NE
first NE xxx NE
genes NE xxx NE
expressed NE xxx NE
after NE xxx NE
EBV G#virus XXX G#virus
infection NE xxx NE
of NE xx NE
B-cells G#cell_type X-xxx G#cell_type
, NE , NE
is NE xx NE
a NE x NE
transcriptional NE xxx NE
activator NE xxx NE
of NE xx NE
viral G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
and G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
cellular G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
and NE xxx NE
is NE xx NE
essential NE xxx NE
for NE xxx NE
the NE xxx NE
transforming NE xxx NE
potential NE xxx NE
of NE xx NE
the NE xxx NE
virus G#virus xxx G#virus
. NE . NE

We NE Xx NE
generated NE xxx NE
conditional NE xxx NE
EBV G#virus_B XXX G#virus_B
mutants G#virus_E xxx G#virus_E
by NE xx NE
expressing NE xxx NE
EBNA2 G#protein_molecule XXXXd G#protein_molecule
as NE xx NE
chimeric G#protein_family_or_group_B xxx G#protein_family_or_group_B
fusion G#protein_family_or_group_M xxx G#protein_family_or_group_M
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
with NE xxx NE
the NE xxx NE
hormone NE xxx NE
binding NE xxx NE
domain NE xxx NE
of NE xx NE
the NE xxx NE
estrogen G#protein_molecule_B xxx G#protein_molecule_B
receptor G#protein_molecule_E xxx G#protein_molecule_E
on NE xx NE
the NE xxx NE
genetic NE xxx NE
background NE xxx NE
of NE xx NE
the NE xxx NE
virus NE xxx NE
. NE . NE

Growth NE Xxxx NE
transformation NE xxx NE
of NE xx NE
primary G#cell_type_B xxx G#cell_type_B
normal G#cell_type_M xxx G#cell_type_M
B-cells G#cell_type_E X-xxx G#cell_type_E
by NE xx NE
mutant G#virus_B xxx G#virus_B
virus G#virus_E xxx G#virus_E
resulted NE xxx NE
in NE xx NE
estrogen NE xxx NE
-dependent NE -xxx NE
lymphoblastoid NE xxx NE
cell NE xxx NE
lines NE xxx NE
expressing NE xxx NE
the NE xxx NE
chimeric NE xxx NE
EBNA2 NE XXXXd NE
protein NE xxx NE
. NE . NE

In NE Xx NE
the NE xxx NE
absence NE xxx NE
of NE xx NE
estrogen G#lipid xxx G#lipid
about NE xxx NE
half NE xxx NE
of NE xx NE
the NE xxx NE
cells NE xxx NE
enter NE xxx NE
a NE x NE
quiescent G#other_name_B xxx G#other_name_B
non-proliferative G#other_name_M xxx-xxx G#other_name_M
state G#other_name_E xxx G#other_name_E
whereas NE xxx NE
the NE xxx NE
others NE xxx NE
die NE xxx NE
by NE xx NE
apoptosis G#other_name xxx G#other_name
. NE . NE

EBNA2 G#protein_molecule XXXXd G#protein_molecule
is NE xx NE
thus NE xxx NE
required NE xxx NE
not NE xxx NE
only NE xxx NE
for NE xxx NE
initiation NE xxx NE
but NE xxx NE
also NE xxx NE
for NE xxx NE
maintenance NE xxx NE
of NE xx NE
transformation NE xxx NE
. NE . NE

Growth NE Xxxx NE
arrest NE xxx NE
occurred NE xxx NE
at NE xx NE
G1 G#other_name_B Xd G#other_name_B
stage G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
G2 G#other_name_M Xd G#other_name_M
stage G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
cell G#other_name_B xxx G#other_name_B
cycle G#other_name_E xxx G#other_name_E
, NE , NE
indicating NE xxx NE
that NE xxx NE
functional NE xxx NE
EBNA2 G#protein_molecule XXXXd G#protein_molecule
is NE xx NE
required NE xxx NE
at NE xx NE
different NE xxx NE
restriction NE xxx NE
points NE xxx NE
of NE xx NE
the NE xxx NE
cell G#other_name_B xxx G#other_name_B
cycle G#other_name_E xxx G#other_name_E
. NE . NE

Growth G#other_name_B Xxxx G#other_name_B
arrest G#other_name_E xxx G#other_name_E
is NE xx NE
reversible NE xxx NE
for NE xxx NE
G1/G0 G#cell_type_B Xd/Xd G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
as NE xx NE
indicated NE xxx NE
by NE xx NE
the NE xxx NE
sequential NE xxx NE
accumulation NE xxx NE
and NE xxx NE
modification NE xxx NE
of NE xx NE
cell G#protein_family_or_group_B xxx G#protein_family_or_group_B
cycle G#protein_family_or_group_M xxx G#protein_family_or_group_M
regulating G#protein_family_or_group_M xxx G#protein_family_or_group_M
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

EBV G#virus XXX G#virus
induces NE xxx NE
the NE xxx NE
same NE xxx NE
cell G#other_name_B xxx G#other_name_B
cycle G#other_name_E xxx G#other_name_E
regulating NE xxx NE
proteins NE xxx NE
as NE xx NE
polyclonal NE xxx NE
stimuli NE xxx NE
in NE xx NE
primary NE xxx NE
B-cells G#cell_type X-xxx G#cell_type
. NE . NE

These NE Xxxx NE
data NE xxx NE
suggest NE xxx NE
that NE xxx NE
EBV G#virus XXX G#virus
is NE xx NE
using NE xxx NE
a NE x NE
common NE xxx NE
pathway NE xxx NE
for NE xxx NE
B-cell G#other_name_B X-xxx G#other_name_B
activation G#other_name_E xxx G#other_name_E
bypassing NE xxx NE
the NE xxx NE
requirement NE xxx NE
for NE xxx NE
antigen NE xxx NE
, NE , NE
T-cell G#other_name_B X-xxx G#other_name_B
signals G#other_name_E xxx G#other_name_E
and NE xxx NE
growth G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

IL-1 G#protein_molecule_B XX-d G#protein_molecule_B
receptor G#protein_molecule_E xxx G#protein_molecule_E
and NE xxx NE
TCR G#other_name_B XXX G#other_name_B
signals G#other_name_E xxx G#other_name_E
synergize NE xxx NE
to NE xx NE
activate NE xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
-mediated NE -xxx NE
gene NE xxx NE
transcription NE xxx NE
. NE . NE

Previous NE Xxxx NE
studies NE xxx NE
have NE xxx NE
demonstrated NE xxx NE
that NE xxx NE
IL-1 G#other_name_B XX-d G#other_name_B
receptor G#other_name_M xxx G#other_name_M
( G#other_name_E ( G#other_name_E
IL-1R NE XX-dX NE
)- NE )- NE
and NE xxx NE
TCR G#other_name XXX G#other_name
-initiated NE -xxx NE
signals NE xxx NE
can NE xxx NE
interact NE xxx NE
synergistically NE xxx NE
to NE xx NE
increase NE xxx NE
the NE xxx NE
rate NE xxx NE
of NE xx NE
transcription NE xxx NE
of NE xx NE
several NE xxx NE
lymphokine G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
gene G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
and G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
lymphokine G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
receptor G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
gene G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
during NE xxx NE
the NE xxx NE
competence G#other_name_B xxx G#other_name_B
phase G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
activation G#other_name_B xxx G#other_name_B
program G#other_name_E xxx G#other_name_E
in NE xx NE
T G#cell_type_B X G#cell_type_B
helper G#cell_type_M xxx G#cell_type_M
lymphocytes G#cell_type_E xxx G#cell_type_E
. NE . NE

In NE Xx NE
this NE xxx NE
report NE xxx NE
we NE xx NE
describe NE xxx NE
how NE xxx NE
signals NE xxx NE
initiated NE xxx NE
through NE xxx NE
the NE xxx NE
type G#protein_molecule_B xxx G#protein_molecule_B
I G#protein_molecule_M X G#protein_molecule_M
IL-1R G#protein_molecule_E XX-dX G#protein_molecule_E
interact NE xxx NE
with NE xxx NE
signals NE xxx NE
from NE xxx NE
the NE xxx NE
antigen NE xxx NE
receptor NE xxx NE
to NE xx NE
synergistically NE xxx NE
augment NE xxx NE
the NE xxx NE
transactivating NE xxx NE
properties NE xxx NE
of NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
. NE . NE

The NE Xxx NE
synergistic NE xxx NE
antigen G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
initiated NE xxx NE
signals NE xxx NE
are NE xxx NE
mediated NE xxx NE
through NE xxx NE
protein G#protein_molecule_B xxx G#protein_molecule_B
kinase G#protein_molecule_M xxx G#protein_molecule_M
C G#protein_molecule_E X G#protein_molecule_E
because NE xxx NE
they NE xxx NE
can NE xxx NE
be NE xx NE
mimicked NE xxx NE
by NE xx NE
the NE xxx NE
phorbol G#other_organic_compound_B xxx G#other_organic_compound_B
ester, G#other_organic_compound_M xxx, G#other_organic_compound_M
12-O-tetradecanoylphorbol-13-acetate G#other_organic_compound_E dd-X-xxx-dd-xxx G#other_organic_compound_E
, NE , NE
but NE xxx NE
not NE xxx NE
with NE xxx NE
calcium NE xxx NE
ionophores NE xxx NE
; NE ; NE
and NE xxx NE
are NE xxx NE
staurosporine G#other_name_B xxx G#other_name_B
sensitive G#other_name_E xxx G#other_name_E
but NE xxx NE
cyclosporine G#other_name_B xxx G#other_name_B
resistant G#other_name_E xxx G#other_name_E
. NE . NE

Gel NE Xxx NE
shift NE xxx NE
analyses NE xxx NE
demonstrate NE xxx NE
that NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
nuclear NE xxx NE
translocation NE xxx NE
is NE xx NE
stimulated NE xxx NE
primarily NE xxx NE
by NE xx NE
IL-1 G#protein_molecule XX-d G#protein_molecule
rather NE xxx NE
than NE xxx NE
by NE xx NE
antigen G#other_name_B xxx G#other_name_B
receptor G#other_name_M xxx G#other_name_M
signals G#other_name_E xxx G#other_name_E
. NE . NE

Western NE Xxxx NE
blot NE xxx NE
and NE xxx NE
phosphorylation NE xxx NE
analyses NE xxx NE
demonstrate NE xxx NE
that NE xxx NE
the NE xxx NE
synergistic NE xxx NE
effect NE xxx NE
on NE xx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
functional G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
is NE xx NE
independent NE xxx NE
of NE xx NE
I NE X NE
kappa NE xxx NE
B NE X NE
alpha NE xxx NE
( NE ( NE
MAD3 NE XXXd NE
)- NE )- NE
NF-kappa NE XX-xxx NE
B NE X NE
dissociation NE xxx NE
in NE xx NE
the NE xxx NE
cytosol NE xxx NE
and NE xxx NE
is NE xx NE
not NE xxx NE
associated NE xxx NE
with NE xxx NE
I NE X NE
kappa NE xxx NE
B NE X NE
nuclear NE xxx NE
translocation NE xxx NE
. NE . NE

The NE Xxx NE
IL-1 NE XX-d NE
-induced NE -xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
DNA NE XXX NE
nuclear NE xxx NE
localization NE xxx NE
is NE xx NE
transient NE xxx NE
and NE xxx NE
can NE xxx NE
be NE xx NE
prolonged NE xxx NE
either NE xxx NE
by NE xx NE
an NE xx NE
antigen NE xxx NE
receptor-initiated NE xxx-xxx NE
signal NE xxx NE
or NE xx NE
by NE xx NE
inhibiting NE xxx NE
protein NE xxx NE
synthesis NE xxx NE
. NE . NE

These NE Xxxx NE
results NE xxx NE
suggest NE xxx NE
that NE xxx NE
IL-1 G#protein_molecule XX-d G#protein_molecule
induces NE xxx NE
both NE xxx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
nuclear G#other_name_M xxx G#other_name_M
translocation G#other_name_E xxx G#other_name_E
and NE xxx NE
the NE xxx NE
synthesis NE xxx NE
of NE xx NE
a NE x NE
protein(s) NE xxx(x) NE
responsible NE xxx NE
for NE xxx NE
terminating NE xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
-DNA NE -XXX NE
interaction NE xxx NE
in NE xx NE
the NE xxx NE
nucleus NE xxx NE
. NE . NE

Antigen NE Xxxx NE
receptor NE xxx NE
signals NE xxx NE
prolong NE xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
-DNA NE -XXX NE
interaction NE xxx NE
, NE , NE
probably NE xxx NE
by NE xx NE
functionally NE xxx NE
antagonizing NE xxx NE
the NE xxx NE
IL-1 NE XX-d NE
-induced NE -xxx NE
synthesis NE xxx NE
of NE xx NE
a NE x NE
protein(s) NE xxx(x) NE
responsible NE xxx NE
for NE xxx NE
the NE xxx NE
transient NE xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
-DNA NE -XXX NE
interaction NE xxx NE
and NE xxx NE
consequently NE xxx NE
synergistically NE xxx NE
enhance NE xxx NE
IL-1 NE XX-d NE
-induced NE -xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
-dependent NE -xxx NE
gene NE xxx NE
transcription NE xxx NE
. NE . NE

Identification NE Xxxx NE
of NE xx NE
the NE xxx NE
promoter G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
chicken G#virus_B xxx G#virus_B
anemia G#virus_M xxx G#virus_M
virus G#virus_E xxx G#virus_E
( NE ( NE
CAV G#virus XXX G#virus
) NE ) NE
containing NE xxx NE
a NE x NE
novel NE xxx NE
enhancer-like G#DNA_family_or_group_B xxx-xxx G#DNA_family_or_group_B
element G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
. NE . NE

The NE Xxx NE
single NE xxx NE
promoter G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
the NE xxx NE
cloned NE xxx NE
genome NE xxx NE
[Noteborn NE [Xxxx NE
et NE xx NE
al. NE xx. NE
, NE , NE
J NE X NE
. NE . NE
Virol NE Xxxx NE
. NE . NE
65 NE dd NE
(1991) NE (dddd) NE
3131-3139] NE dddd-dddd] NE
of NE xx NE
chicken G#virus_B xxx G#virus_B
anemia G#virus_M xxx G#virus_M
virus G#virus_E xxx G#virus_E
( NE ( NE
CAV G#virus XXX G#virus
) NE ) NE
in NE xx NE
chicken G#cell_type_B xxx G#cell_type_B
T-cells G#cell_type_E X-xxx G#cell_type_E
was NE xxx NE
analysed NE xxx NE
via NE xxx NE
CAT G#other_name_B XXX G#other_name_B
assays G#other_name_E xxx G#other_name_E
. NE . NE

A NE X NE
unique NE xxx NE
region NE xxx NE
containing NE xxx NE
four NE xxx NE
or NE xx NE
five NE xxx NE
near-perfect NE xxx-xxx NE
direct G#DNA_substructure_B xxx G#DNA_substructure_B
repeats G#DNA_substructure_E xxx G#DNA_substructure_E
( NE ( NE
DR G#DNA_substructure XX G#DNA_substructure
) NE ) NE
of NE xx NE
21 G#polynucleotide_B dd G#polynucleotide_B
bp G#polynucleotide_E xx G#polynucleotide_E
with NE xxx NE
one NE xxx NE
12-bp G#DNA_domain_or_region_B dd-xx G#DNA_domain_or_region_B
insert G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
was NE xxx NE
proven NE xxx NE
to NE xx NE
be NE xx NE
the NE xxx NE
main NE xxx NE
transcription-activation G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
with NE xxx NE
enhancer-like G#other_name_B xxx-xxx G#other_name_B
characteristics G#other_name_E xxx G#other_name_E
. NE . NE

PCR NE XXX NE
studies NE xxx NE
revealed NE xxx NE
that NE xxx NE
CAV G#virus XXX G#virus
isolates NE xxx NE
from NE xxx NE
across NE xxx NE
the NE xxx NE
world NE xxx NE
all NE xxx NE
contained NE xxx NE
this NE xxx NE
promoter G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Electrophoretic G#other_name_B Xxxx G#other_name_B
mobility-shift G#other_name_M xxx-xxx G#other_name_M
assays G#other_name_E xxx G#other_name_E
( NE ( NE
EMSA G#other_name XXXX G#other_name
) NE ) NE
showed NE xxx NE
that NE xxx NE
individual G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
DR G#DNA_domain_or_region_M XX G#DNA_domain_or_region_M
units G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
as NE xx NE
well NE xxx NE
as NE xx NE
the NE xxx NE
12-bp G#DNA_domain_or_region_B dd-xx G#DNA_domain_or_region_B
insert G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
can NE xxx NE
bind NE xxx NE
to NE xx NE
nuclear G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
of NE xx NE
chicken G#cell_type_B xxx G#cell_type_B
T-cells G#cell_type_E X-xxx G#cell_type_E
. NE . NE

Competition G#other_name_B Xxxx G#other_name_B
assays G#other_name_E xxx G#other_name_E
revealed NE xxx NE
that NE xxx NE
the NE xxx NE
DR G#DNA_domain_or_region_B XX G#DNA_domain_or_region_B
units G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
bound NE xxx NE
to NE xx NE
factors NE xxx NE
other NE xxx NE
than NE xxx NE
the NE xxx NE
12-bp G#DNA_domain_or_region_B dd-xx G#DNA_domain_or_region_B
insert G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

A NE X NE
synthetic NE xxx NE
oligodeoxyribonucleotide G#polynucleotide xxx G#polynucleotide
containing NE xxx NE
an NE xx NE
SP1-box G#DNA_domain_or_region XXd-xxx G#DNA_domain_or_region
( NE ( NE
5'-GGGCGG G#polynucleotide d'-XXXXXX G#polynucleotide
) NE ) NE
could NE xxx NE
compete NE xxx NE
with NE xxx NE
factors NE xxx NE
binding NE xxx NE
to NE xx NE
the NE xxx NE
12-bp G#DNA_domain_or_region_B dd-xx G#DNA_domain_or_region_B
insert G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Purified NE Xxxx NE
human G#protein_molecule_B xxx G#protein_molecule_B
SP1 G#protein_molecule_E XXd G#protein_molecule_E
was NE xxx NE
shown NE xxx NE
to NE xx NE
have NE xxx NE
very NE xxx NE
strong NE xxx NE
affinity NE xxx NE
for NE xxx NE
the NE xxx NE
12-bp G#DNA_domain_or_region_B dd-xx G#DNA_domain_or_region_B
insert G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Functional NE Xxxx NE
Myc-Max G#protein_complex_B Xxx-Xxx G#protein_complex_B
heterodimer G#protein_complex_E xxx G#protein_complex_E
is NE xx NE
required NE xxx NE
for NE xxx NE
activation-induced NE xxx-xxx NE
apoptosis G#other_name xxx G#other_name
in NE xx NE
T G#cell_line_B X G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
hybridomas G#cell_line_E xxx G#cell_line_E
. NE . NE

T G#cell_line_B X G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
hybridomas G#cell_line_E xxx G#cell_line_E
respond NE xxx NE
to NE xx NE
activation G#other_name_B xxx G#other_name_B
signals G#other_name_E xxx G#other_name_E
by NE xx NE
undergoing NE xxx NE
apoptotic G#other_name_B xxx G#other_name_B
cell G#other_name_M xxx G#other_name_M
death G#other_name_E xxx G#other_name_E
, NE , NE
and NE xxx NE
this NE xxx NE
is NE xx NE
likely NE xxx NE
to NE xx NE
represent NE xxx NE
comparable NE xxx NE
events NE xxx NE
related NE xxx NE
to NE xx NE
tolerance NE xxx NE
induction NE xxx NE
in NE xx NE
immature G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
cell G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
mature G#cell_type_M xxx G#cell_type_M
T G#cell_type_M X G#cell_type_M
cell G#cell_type_E xxx G#cell_type_E

Previous NE Xxxx NE
studies NE xxx NE
using NE xxx NE
antisense G#polynucleotide_B xxx G#polynucleotide_B
oligonucleotides G#polynucleotide_E xxx G#polynucleotide_E
implicated NE xxx NE
the NE xxx NE
c-Myc G#protein_molecule_B x-Xxx G#protein_molecule_B
protein G#protein_molecule_E xxx G#protein_molecule_E
in NE xx NE
the NE xxx NE
phenomenon NE xxx NE
of NE xx NE
activation-induced NE xxx-xxx NE
apoptosis G#other_name xxx G#other_name
. NE . NE

This NE Xxxx NE
role NE xxx NE
for NE xxx NE
c-Myc G#protein_molecule x-Xxx G#protein_molecule
in NE xx NE
apoptosis G#other_name xxx G#other_name
is NE xx NE
now NE xxx NE
confirmed NE xxx NE
in NE xx NE
studies NE xxx NE
using NE xxx NE
a NE x NE
dominant NE xxx NE
negative NE xxx NE
form NE xxx NE
of NE xx NE
its NE xxx NE
heterodimeric NE xxx NE
binding NE xxx NE
partner NE xxx NE
, NE , NE
Max G#protein_molecule Xxx G#protein_molecule
, NE , NE
which NE xxx NE
we NE xx NE
show NE xxx NE
here NE xxx NE
inhibits NE xxx NE
activation-induced NE xxx-xxx NE
apoptosis G#other_name xxx G#other_name
. NE . NE

Further NE Xxxx NE
, NE , NE
coexpression NE xxx NE
of NE xx NE
a NE x NE
reciprocally G#protein_molecule_B xxx G#protein_molecule_B
mutant G#protein_molecule_M xxx G#protein_molecule_M
Myc G#protein_molecule_M Xxx G#protein_molecule_M
protein G#protein_molecule_E xxx G#protein_molecule_E
capable NE xxx NE
of NE xx NE
forming NE xxx NE
functional NE xxx NE
heterodimers G#protein_complex xxx G#protein_complex
with NE xxx NE
the NE xxx NE
mutant NE xxx NE
Max G#protein_molecule Xxx G#protein_molecule
can NE xxx NE
compensate NE xxx NE
for NE xxx NE
the NE xxx NE
dominant G#other_name_B xxx G#other_name_B
negative G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
and NE xxx NE
restore NE xxx NE
activation-induced NE xxx-xxx NE
apoptosis G#other_name xxx G#other_name
. NE . NE

These NE Xxxx NE
results NE xxx NE
imply NE xxx NE
that NE xxx NE
Myc G#protein_molecule Xxx G#protein_molecule
promotes NE xxx NE
activation-induced NE xxx-xxx NE
apoptosis G#other_name xxx G#other_name
by NE xx NE
obligatory G#other_name_B xxx G#other_name_B
heterodimerization G#other_name_E xxx G#other_name_E
with NE xxx NE
Max G#protein_molecule Xxx G#protein_molecule
, NE , NE
and NE xxx NE
therefore NE xxx NE
, NE , NE
by NE xx NE
regulating NE xxx NE
gene G#other_name_B xxx G#other_name_B
transcription G#other_name_E xxx G#other_name_E
. NE . NE

Epstein-Barr G#protein_molecule_B Xxxx-Xxxx G#protein_molecule_B
virus G#protein_molecule_M xxx G#protein_molecule_M
SM G#protein_molecule_M XX G#protein_molecule_M
protein G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

The NE Xxx NE
protein NE xxx NE
products NE xxx NE
of NE xx NE
the NE xxx NE
Epstein-Barr NE Xxxx-Xxxx NE
virus NE xxx NE
( NE ( NE
EBV NE XXX NE
) NE ) NE
BMLF1 NE XXXXd NE
open NE xxx NE
reading NE xxx NE
frame NE xxx NE
have NE xxx NE
been NE xxx NE
characterized NE xxx NE
in NE xx NE
the NE xxx NE
early NE xxx NE
productive NE xxx NE
cycle NE xxx NE
in NE xx NE
B95-8 NE Xdd-d NE
and NE xxx NE
Akata NE Xxxx NE
cells NE xxx NE
. NE . NE

The NE Xxx NE
SM G#protein_molecule_B XX G#protein_molecule_B
protein G#protein_molecule_E xxx G#protein_molecule_E
derived NE xxx NE
from NE xxx NE
the NE xxx NE
spliced NE xxx NE
RNA NE XXX NE
joining NE xxx NE
BSLF2 G#protein_molecule XXXXd G#protein_molecule
to NE xx NE
BMLF1 G#protein_molecule XXXXd G#protein_molecule
is NE xx NE
much NE xxx NE
the NE xxx NE
most NE xxx NE
abundant NE xxx NE
protein NE xxx NE
. NE . NE

SM G#protein_molecule XX G#protein_molecule
is NE xx NE
a NE x NE
phosphoprotein G#protein_family_or_group xxx G#protein_family_or_group
in NE xx NE
EBV G#virus XXX G#virus
-infected NE -xxx NE
cells NE xxx NE
and NE xxx NE
can NE xxx NE
be NE xx NE
phosphorylated NE xxx NE
in NE xx NE
vitro NE xxx NE
with NE xxx NE
casein NE xxx NE
kinase NE xxx NE
II NE XX NE
( NE ( NE
CKII NE XXXX NE
) NE ) NE
. NE . NE

Computer NE Xxxx NE
analysis NE xxx NE
of NE xx NE
the NE xxx NE
SM G#protein_N/A_B XX G#protein_N/A_B
protein G#protein_N/A_M xxx G#protein_N/A_M
sequence G#protein_N/A_E xxx G#protein_N/A_E
showed NE xxx NE
a NE x NE
C G#protein_domain_or_region_B X G#protein_domain_or_region_B
terminal G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
section G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
of NE xx NE
SM G#protein_molecule XX G#protein_molecule
to NE xx NE
be NE xx NE
related NE xxx NE
to NE xx NE
genome G#protein_family_or_group_B xxx G#protein_family_or_group_B
positional G#protein_family_or_group_M xxx G#protein_family_or_group_M
homologues G#protein_family_or_group_E xxx G#protein_family_or_group_E
of NE xx NE
four NE xxx NE
other NE xxx NE
herpesviruses NE xxx NE
and NE xxx NE
revealed NE xxx NE
consensus NE xxx NE
CKII NE XXXX NE
sites NE xxx NE
near NE xxx NE
the NE xxx NE
N NE X NE
termini NE xxx NE
of NE xx NE
the NE xxx NE
EBV NE XXX NE
SM NE XX NE
protein NE xxx NE
, NE , NE
the NE xxx NE
herpes NE xxx NE
simplex NE xxx NE
virus NE xxx NE
( NE ( NE
HSV NE XXX NE
) NE ) NE
ICP27 NE XXXdd NE
protein NE xxx NE
and NE xxx NE
the NE xxx NE
herpesvirus NE xxx NE
saimiri NE xxx NE
( NE ( NE
HVS NE XXX NE
) NE ) NE
open NE xxx NE
reading NE xxx NE
frame NE xxx NE
57 NE dd NE
protein NE xxx NE
. NE . NE

Site-directed NE Xxxx-xxx NE
mutagenesis NE xxx NE
of NE xx NE
the NE xxx NE
consensus G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
CKII G#DNA_domain_or_region_M XXXX G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
EBV G#virus XXX G#virus
SM NE XX NE
greatly NE xxx NE
reduced NE xxx NE
the NE xxx NE
in NE xx NE
vitro NE xxx NE
phosphorylation NE xxx NE
of NE xx NE
SM G#protein_molecule XX G#protein_molecule
by NE xx NE
CKII G#protein_molecule XXXX G#protein_molecule
. NE . NE

The NE Xxx NE
mechanism NE xxx NE
of NE xx NE
transactivation NE xxx NE
by NE xx NE
BMLF1 G#protein_family_or_group_B XXXXd G#protein_family_or_group_B
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
has NE xxx NE
been NE xxx NE
controversial NE xxx NE
but NE xxx NE
SM G#protein_molecule XX G#protein_molecule
was NE xxx NE
shown NE xxx NE
to NE xx NE
transactivate NE xxx NE
gene NE xxx NE
expression NE xxx NE
from NE xxx NE
a NE x NE
CAT G#DNA_molecule_B XXX G#DNA_molecule_B
reporter G#DNA_molecule_M xxx G#DNA_molecule_M
construct G#DNA_molecule_E xxx G#DNA_molecule_E
by NE xx NE
increasing NE xxx NE
the NE xxx NE
amount NE xxx NE
of NE xx NE
cytoplasmic G#RNA_molecule_B xxx G#RNA_molecule_B
CAT G#RNA_molecule_M XXX G#RNA_molecule_M
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
. NE . NE

Mutagenesis NE Xxxx NE
of NE xx NE
the NE xxx NE
CKII G#protein_molecule XXXX G#protein_molecule
site NE xxx NE
in NE xx NE
SM G#protein_molecule XX G#protein_molecule
made NE xxx NE
no NE xx NE
difference NE xxx NE
to NE xx NE
the NE xxx NE
transactivation NE xxx NE
in NE xx NE
this NE xxx NE
transient G#other_name_B xxx G#other_name_B
transfection G#other_name_M xxx G#other_name_M
assay G#other_name_E xxx G#other_name_E
. NE . NE

Inducible NE Xxxx NE
binding NE xxx NE
to NE xx NE
the NE xxx NE
c-fos NE x-xxx NE
serum NE xxx NE
response NE xxx NE
element NE xxx NE
during NE xxx NE
T G#other_name_B X G#other_name_B
cell G#other_name_M xxx G#other_name_M
activation G#other_name_E xxx G#other_name_E
is NE xx NE
regulated NE xxx NE
by NE xx NE
a NE x NE
phosphotyrosine-containing G#protein_family_or_group_B xxx-xxx G#protein_family_or_group_B
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

The NE Xxx NE
proto-oncogene G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
c-fos G#DNA_domain_or_region_E x-xxx G#DNA_domain_or_region_E
is NE xx NE
an NE xx NE
immediate-early G#DNA_family_or_group_B xxx-xxx G#DNA_family_or_group_B
gene G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
, NE , NE
and NE xxx NE
one NE xxx NE
of NE xx NE
the NE xxx NE
first NE xxx NE
genes NE xxx NE
transcribed NE xxx NE
after NE xxx NE
stimulation NE xxx NE
of NE xx NE
most NE xxx NE
cells NE xxx NE
with NE xxx NE
a NE x NE
variety NE xxx NE
of NE xx NE
ligands NE xxx NE
. NE . NE

Fos NE Xxx NE
expression NE xxx NE
may NE xxx NE
be NE xx NE
a NE x NE
pivotal NE xxx NE
event NE xxx NE
in NE xx NE
converting NE xxx NE
ligand-receptor G#other_name_B xxx-xxx G#other_name_B
interactions G#other_name_E xxx G#other_name_E
at NE xx NE
the NE xxx NE
membrane G#cell_component xxx G#cell_component
into NE xxx NE
functional NE xxx NE
modulation NE xxx NE
of NE xx NE
cell G#other_name_B xxx G#other_name_B
phenotype G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
serum G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
response G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
SRE G#DNA_domain_or_region XXX G#DNA_domain_or_region
) NE ) NE
in NE xx NE
the NE xxx NE
c-fos G#DNA_domain_or_region_B x-xxx G#DNA_domain_or_region_B
regulatory G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
participates NE xxx NE
in NE xx NE
induction NE xxx NE
of NE xx NE
transcription NE xxx NE
by NE xx NE
various NE xxx NE
growth G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
and NE xxx NE
by NE xx NE
phorbol G#other_organic_compound_B xxx G#other_organic_compound_B
esters G#other_organic_compound_E xxx G#other_organic_compound_E
and NE xxx NE
subsequent NE xxx NE
squelching NE xxx NE
of NE xx NE
transcription NE xxx NE
. NE . NE

We NE Xx NE
show NE xxx NE
that NE xxx NE
an NE xx NE
inducible NE xxx NE
protein G#protein_complex_B xxx G#protein_complex_B
complex G#protein_complex_E xxx G#protein_complex_E
( NE ( NE
Band G#protein_molecule_B Xxxx G#protein_molecule_B
A G#protein_molecule_E X G#protein_molecule_E
) NE ) NE
binds NE xxx NE
to NE xx NE
SRE G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
DNA G#DNA_domain_or_region_E XXX G#DNA_domain_or_region_E
within NE xxx NE
10 NE dd NE
min NE xxx NE
after NE xxx NE
mitogenic G#other_name_B xxx G#other_name_B
stimulation G#other_name_E xxx G#other_name_E
of NE xx NE
human G#cell_line_B xxx G#cell_line_B
PBL-T G#cell_line_E XXX-X G#cell_line_E
, NE , NE
and NE xxx NE
becomes NE xxx NE
nondetectable NE xxx NE
by NE xx NE
60 NE dd NE
min NE xxx NE
. NE . NE

Band G#protein_molecule_B Xxxx G#protein_molecule_B
A G#protein_molecule_E X G#protein_molecule_E
contains NE xxx NE
the NE xxx NE
serum G#protein_family_or_group_B xxx G#protein_family_or_group_B
response G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
plus NE xxx NE
additional NE xxx NE
factor(s) NE xxx(x) NE
. NE . NE

A NE X NE
protein NE xxx NE
that NE xxx NE
is NE xx NE
phosphorylated NE xxx NE
on NE xx NE
a NE x NE
tyrosine G#amino_acid_monomer_B xxx G#amino_acid_monomer_B
residue G#amino_acid_monomer_E xxx G#amino_acid_monomer_E
in NE xx NE
resting G#cell_line_B xxx G#cell_line_B
PBL-T G#cell_line_E XXX-X G#cell_line_E
suppresses NE xxx NE
binding NE xxx NE
of NE xx NE
a NE x NE
component NE xxx NE
of NE xx NE
Band G#protein_molecule_B Xxxx G#protein_molecule_B
A G#protein_molecule_E X G#protein_molecule_E
to NE xx NE
the NE xxx NE
SRE G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
motif G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Upon NE Xxxx NE
stimulation NE xxx NE
of NE xx NE
the NE xxx NE
cells NE xxx NE
, NE , NE
this NE xxx NE
protein NE xxx NE
no NE xx NE
longer NE xxx NE
prevents NE xxx NE
binding NE xxx NE
of NE xx NE
DNA NE XXX NE
by NE xx NE
Band G#protein_molecule_B Xxxx G#protein_molecule_B
A G#protein_molecule_E X G#protein_molecule_E
, NE , NE
and NE xxx NE
suppression NE xxx NE
of NE xx NE
binding NE xxx NE
is NE xx NE
restored NE xxx NE
within NE xxx NE
30 NE dd NE
min NE xxx NE
. NE . NE

The NE Xxx NE
phosphorylated G#amino_acid_monomer_B xxx G#amino_acid_monomer_B
tyrosine G#amino_acid_monomer_M xxx G#amino_acid_monomer_M
residue G#amino_acid_monomer_E xxx G#amino_acid_monomer_E
itself NE xxx NE
is NE xx NE
important NE xxx NE
for NE xxx NE
the NE xxx NE
protein-protein G#other_name_B xxx-xxx G#other_name_B
interaction G#other_name_E xxx G#other_name_E
. NE . NE

In NE Xx NE
vivo NE xxx NE
modification NE xxx NE
of NE xx NE
major G#other_name_B xxx G#other_name_B
histocompatibility G#other_name_M xxx G#other_name_M
complex G#other_name_M xxx G#other_name_M
class G#other_name_M xxx G#other_name_M
II G#other_name_M XX G#other_name_M
DRA G#other_name_M XXX G#other_name_M
promoter G#other_name_M xxx G#other_name_M
occupancy G#other_name_E xxx G#other_name_E
mediated NE xxx NE
by NE xx NE
the NE xxx NE
AIR-1 G#protein_molecule_B XXX-d G#protein_molecule_B
trans-activator G#protein_molecule_E xxx-xxx G#protein_molecule_E
. NE . NE

RJ G#cell_line_B XX G#cell_line_B
2.2.5 G#cell_line_E d.d.d G#cell_line_E
is NE xx NE
a NE x NE
human G#cell_line_B xxx G#cell_line_B
B G#cell_line_M X G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
mutant G#cell_line_E xxx G#cell_line_E
derived NE xxx NE
from NE xxx NE
the NE xxx NE
Burkitt G#cell_line_B Xxxx G#cell_line_B
lymphoma G#cell_line_M xxx G#cell_line_M
Raji G#cell_line_M Xxxx G#cell_line_M
cell G#cell_line_E xxx G#cell_line_E
which NE xxx NE
is NE xx NE
defective NE xxx NE
in NE xx NE
the NE xxx NE
AIR-1 G#atom_B XXX-d G#atom_B
locus G#atom_M xxx G#atom_M
function G#atom_E xxx G#atom_E
. NE . NE

This NE Xxxx NE
locus NE xxx NE
encodes NE xxx NE
a NE x NE
transcriptional NE xxx NE
trans-activator NE xxx-xxx NE
required NE xxx NE
for NE xxx NE
the NE xxx NE
constitutive G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
of NE xx NE
major G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
histocompatibility G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
complex G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
(MHC) G#DNA_family_or_group_M (XXX) G#DNA_family_or_group_M
class G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
II G#DNA_family_or_group_M XX G#DNA_family_or_group_M
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
. NE . NE

Here NE Xxxx NE
we NE xx NE
show NE xxx NE
, NE , NE
by NE xx NE
in G#other_name_B xx G#other_name_B
vivo G#other_name_M xxx G#other_name_M
DNase G#other_name_M XXxxx G#other_name_M
I G#other_name_M X G#other_name_M
footprinting G#other_name_E xxx G#other_name_E
, NE , NE
that NE xxx NE
the NE xxx NE
AIR-1 G#DNA_domain_or_region_B XXX-d G#DNA_domain_or_region_B
locus G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
defect G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
correlates NE xxx NE
with NE xxx NE
changes NE xxx NE
in NE xx NE
the NE xxx NE
DRA G#other_name_B XXX G#other_name_B
promoter G#other_name_M xxx G#other_name_M
occupancy G#other_name_E xxx G#other_name_E
. NE . NE

Interestingly NE Xxxx NE
, NE , NE
reexpression NE xxx NE
of NE xx NE
human G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
MHC G#DNA_family_or_group_M XXX G#DNA_family_or_group_M
class G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
II G#DNA_family_or_group_M XX G#DNA_family_or_group_M
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
in NE xx NE
RJ G#cell_line_B XX G#cell_line_B
2.2.5 G#cell_line_M d.d.d G#cell_line_M
x G#cell_line_M x G#cell_line_M
mouse G#cell_line_M xxx G#cell_line_M
spleen G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
hybrids G#cell_line_E xxx G#cell_line_E
is NE xx NE
associated NE xxx NE
with NE xxx NE
partial NE xxx NE
reversion NE xxx NE
of NE xx NE
DRA G#other_name_B XXX G#other_name_B
promoter G#other_name_M xxx G#other_name_M
occupancy G#other_name_E xxx G#other_name_E
to NE xx NE
the NE xxx NE
Raji G#other_name_B Xxxx G#other_name_B
pattern G#other_name_E xxx G#other_name_E
. NE . NE

DRA G#other_name_B XXX G#other_name_B
promoter G#other_name_M xxx G#other_name_M
occupancy G#other_name_E xxx G#other_name_E
in NE xx NE
other NE xxx NE
class G#cell_line_B xxx G#cell_line_B
II-negative G#cell_line_M XX-xxx G#cell_line_M
B G#cell_line_M X G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
, NE , NE
derived NE xxx NE
from NE xxx NE
patients G#multi_cell xxx G#multi_cell
with NE xxx NE
bare G#other_name_B xxx G#other_name_B
lymphocyte G#other_name_M xxx G#other_name_M
syndrome G#other_name_E xxx G#other_name_E
, NE , NE
is NE xx NE
drastically NE xxx NE
different NE xxx NE
from NE xxx NE
the NE xxx NE
one NE xxx NE
observed NE xxx NE
in NE xx NE
RJ G#cell_line_B XX G#cell_line_B
2.2.5 G#cell_line_E d.d.d G#cell_line_E
and NE xxx NE
Raji G#cell_line_B Xxxx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

Moreover NE Xxxx NE
, NE , NE
the NE xxx NE
use NE xxx NE
of NE xx NE
the NE xxx NE
DNase G#protein_molecule_B XXxxx G#protein_molecule_B
I G#protein_molecule_E X G#protein_molecule_E
as NE xx NE
an NE xx NE
in G#other_name_B xx G#other_name_B
vivo G#other_name_M xxx G#other_name_M
footprinting G#other_name_E xxx G#other_name_E
agent NE xxx NE
reveals NE xxx NE
that NE xxx NE
the NE xxx NE
patients NE xxx NE
' NE ' NE
cell NE xxx NE
lines NE xxx NE
do NE xx NE
not NE xxx NE
display NE xxx NE
a NE x NE
completely NE xxx NE
" NE " NE
bare NE xxx NE
promoter NE xxx NE
" NE " NE
as NE xx NE
previously NE xxx NE
reported NE xxx NE
using NE xxx NE
dimethyl NE xxx NE
sulfate NE xxx NE
as NE xx NE
the NE xxx NE
footprinting NE xxx NE
agent NE xxx NE
. NE . NE

Thus NE Xxxx NE
, NE , NE
the NE xxx NE
use NE xxx NE
of NE xx NE
DNase G#protein_molecule_B XXxxx G#protein_molecule_B
I G#protein_molecule_E X G#protein_molecule_E
allowed NE xxx NE
us NE xx NE
, NE , NE
for NE xxx NE
the NE xxx NE
first NE xxx NE
time NE xxx NE
, NE , NE
to NE xx NE
correlate NE xxx NE
the NE xxx NE
AIR-1 G#DNA_domain_or_region_B XXX-d G#DNA_domain_or_region_B
locus G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
defect G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
with NE xxx NE
class G#other_name_B xxx G#other_name_B
II G#other_name_M XX G#other_name_M
promoter G#other_name_M xxx G#other_name_M
occupancy G#other_name_M xxx G#other_name_M
alterations G#other_name_E xxx G#other_name_E
and NE xxx NE
distinguish NE xxx NE
these NE xxx NE
alterations NE xxx NE
from NE xxx NE
the NE xxx NE
ones NE xxx NE
observed NE xxx NE
in NE xx NE
phenotypically NE xxx NE
similar NE xxx NE
but NE xxx NE
genetically NE xxx NE
distinct NE xxx NE
MHC G#cell_line_B XXX G#cell_line_B
class G#cell_line_M xxx G#cell_line_M
II-negative G#cell_line_M XX-xxx G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

Regulation NE Xxxx NE
of NE xx NE
cell-type-specific G#other_name_B xxx-xxx-xxx G#other_name_B
interleukin-2 G#other_name_M xxx-d G#other_name_M
receptor G#other_name_M xxx G#other_name_M
alpha-chain G#other_name_M xxx-xxx G#other_name_M
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
: NE : NE
potential NE xxx NE
role NE xxx NE
of NE xx NE
physical NE xxx NE
interactions NE xxx NE
between NE xxx NE
Elf-1 G#protein_molecule Xxx-d G#protein_molecule
, NE , NE
HMG-I(Y) G#protein_molecule XXX-X(X) G#protein_molecule
, NE , NE
and NE xxx NE
NF-kappa G#protein_family_or_group_B XX-xxx G#protein_family_or_group_B
B G#protein_family_or_group_M X G#protein_family_or_group_M
family G#protein_family_or_group_M xxx G#protein_family_or_group_M
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

The NE Xxx NE
interleukin NE xxx NE
2 NE d NE
receptor NE xxx NE
alpha-chain NE xxx-xxx NE
( NE ( NE
IL-2R NE XX-dX NE
alpha NE xxx NE
) NE ) NE
gene NE xxx NE
is NE xx NE
rapidly NE xxx NE
and NE xxx NE
potently NE xxx NE
induced NE xxx NE
in NE xx NE
T NE X NE
cells NE xxx NE
in NE xx NE
response NE xxx NE
to NE xx NE
mitogenic NE xxx NE
stimuli NE xxx NE
. NE . NE

Previously NE Xxxx NE
, NE , NE
an NE xx NE
inducible G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
enhancer G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
between NE xxx NE
nucleotides G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
-299 G#DNA_domain_or_region_M -ddd G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
-228 G#DNA_domain_or_region_E -ddd G#DNA_domain_or_region_E
that NE xxx NE
contains NE xxx NE
NF-kappa G#DNA_domain_or_region_B XX-xxx G#DNA_domain_or_region_B
B G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
motif G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
CArG G#DNA_domain_or_region_M XXxX G#DNA_domain_or_region_M
motif G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E

We NE Xx NE
now NE xxx NE
report NE xxx NE
the NE xxx NE
characterization NE xxx NE
of NE xx NE
a NE x NE
second NE xxx NE
essential G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
positive G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
regulatory G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
element G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
located NE xxx NE
between NE xxx NE
nucleotides G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
-137 G#DNA_domain_or_region_M -ddd G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
-64 G#DNA_domain_or_region_E -dd G#DNA_domain_or_region_E
that NE xxx NE
binds NE xxx NE
Elf-1 G#protein_molecule Xxx-d G#protein_molecule
and NE xxx NE
HMG-I(Y) G#protein_molecule XXX-X(X) G#protein_molecule
. NE . NE

This NE Xxxx NE
element NE xxx NE
had NE xxx NE
maximal NE xxx NE
activity NE xxx NE
in NE xx NE
lymphoid G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
, NE , NE
paralleling NE xxx NE
the NE xxx NE
cell NE xxx NE
type NE xxx NE
specificity NE xxx NE
of NE xx NE
Elf-1 G#other_name_B Xxx-d G#other_name_B
expression G#other_name_E xxx G#other_name_E
. NE . NE

Transcription NE Xxxx NE
from NE xxx NE
the NE xxx NE
IL-2R G#DNA_domain_or_region_B XX-dX G#DNA_domain_or_region_B
alpha G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
was NE xxx NE
inhibited NE xxx NE
when NE xxx NE
either NE xxx NE
the NE xxx NE
Elf-1 G#DNA_domain_or_region_B Xxx-d G#DNA_domain_or_region_B
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
or G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
HMG-I(Y) G#DNA_domain_or_region_M XXX-X(X) G#DNA_domain_or_region_M
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E

Coexpression NE Xxxx NE
of NE xx NE
both NE xxx NE
proteins NE xxx NE
activated NE xxx NE
transcription NE xxx NE
of NE xx NE
the NE xxx NE
-137 G#DNA_domain_or_region_B -ddd G#DNA_domain_or_region_B
to G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
-64 G#DNA_domain_or_region_M -dd G#DNA_domain_or_region_M
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
COS-7 G#cell_line_B XXX-d G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

Elf-1 G#protein_molecule Xxx-d G#protein_molecule
physically NE xxx NE
associated NE xxx NE
with NE xxx NE
HMG-I G#protein_molecule XXX-X G#protein_molecule
and NE xxx NE
with NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
p50 NE xdd NE
and NE xxx NE
c-Rel G#protein_subunit x-Xxx G#protein_subunit
in NE xx NE
vitro NE xxx NE
, NE , NE
suggesting NE xxx NE
that NE xxx NE
protein-protein G#other_name_B xxx-xxx G#other_name_B
interactions G#other_name_E xxx G#other_name_E
might NE xxx NE
functionally NE xxx NE
coordinate NE xxx NE
the NE xxx NE
actions NE xxx NE
of NE xx NE
the NE xxx NE
upstream G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
positive G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
regulatory G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
element G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
and G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
downstream G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
positive G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
regulatory G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
element G#DNA_family_or_group_E xxx G#DNA_family_or_group_E

This NE Xxxx NE
is NE xx NE
the NE xxx NE
first NE xxx NE
report NE xxx NE
of NE xx NE
a NE x NE
physical NE xxx NE
interaction NE xxx NE
between NE xxx NE
an NE xx NE
Ets NE Xxx NE
family NE xxx NE
member NE xxx NE
and NE xxx NE
NF-kappa G#protein_family_or_group_B XX-xxx G#protein_family_or_group_B
B G#protein_family_or_group_M X G#protein_family_or_group_M
family G#protein_family_or_group_M xxx G#protein_family_or_group_M
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

These NE Xxxx NE
findings NE xxx NE
provide NE xxx NE
significant NE xxx NE
new NE xxx NE
insights NE xxx NE
into NE xxx NE
the NE xxx NE
protein-protein NE xxx-xxx NE
and NE xxx NE
protein-DNA G#other_name_B xxx-XXX G#other_name_B
interactions G#other_name_E xxx G#other_name_E
that NE xxx NE
regulate NE xxx NE
cell-type-specific NE xxx-xxx-xxx NE
and NE xxx NE
inducible G#other_name_B xxx G#other_name_B
IL-2R G#other_name_M XX-dX G#other_name_M
alpha G#other_name_M xxx G#other_name_M
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
and NE xxx NE
also NE xxx NE
have NE xxx NE
implications NE xxx NE
for NE xxx NE
other NE xxx NE
genes NE xxx NE
regulated NE xxx NE
by NE xx NE
Elf-1 G#protein_molecule Xxx-d G#protein_molecule
and NE xxx NE
NF-kappa G#protein_family_or_group_B XX-xxx G#protein_family_or_group_B
B G#protein_family_or_group_M X G#protein_family_or_group_M
family G#protein_family_or_group_M xxx G#protein_family_or_group_M
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Isolation NE Xxxx NE
of NE xx NE
cDNA G#DNA_family_or_group_B xXXX G#DNA_family_or_group_B
clones G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
for NE xxx NE
42 NE dd NE
different NE xxx NE
Kruppel-related G#protein_family_or_group_B Xxxx-xxx G#protein_family_or_group_B
zinc G#protein_family_or_group_M xxx G#protein_family_or_group_M
finger G#protein_family_or_group_M xxx G#protein_family_or_group_M
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
expressed NE xxx NE
in NE xx NE
the NE xxx NE
human G#cell_line_B xxx G#cell_line_B
monoblast G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_M xxx G#cell_line_M
U-937 G#cell_line_E X-ddd G#cell_line_E
. NE . NE

To NE Xx NE
study NE xxx NE
the NE xxx NE
complexity NE xxx NE
and NE xxx NE
structural NE xxx NE
characteristics NE xxx NE
of NE xx NE
zinc G#protein_family_or_group_B xxx G#protein_family_or_group_B
finger G#protein_family_or_group_M xxx G#protein_family_or_group_M
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
expressed NE xxx NE
during NE xxx NE
human G#other_name_B xxx G#other_name_B
hematopoiesis G#other_name_E xxx G#other_name_E
and NE xxx NE
to NE xx NE
isolate NE xxx NE
novel NE xxx NE
regulators NE xxx NE
of NE xx NE
blood G#other_name_B xxx G#other_name_B
cell G#other_name_M xxx G#other_name_M
development G#other_name_E xxx G#other_name_E
, NE , NE
a NE x NE
degenerate NE xxx NE
oligonucleotide NE xxx NE
probe NE xxx NE
specific NE xxx NE
for NE xxx NE
a NE x NE
consensus G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
zinc G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
finger G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
peptide G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
was NE xxx NE
used NE xxx NE
to NE xx NE
isolate NE xxx NE
63 NE dd NE
cDNA G#DNA_family_or_group_B xXXX G#DNA_family_or_group_B
clones G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
for NE xxx NE
Kruppel-related G#DNA_family_or_group_B Xxxx-xxx G#DNA_family_or_group_B
zinc G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
finger G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
from NE xxx NE
the NE xxx NE
human G#cell_line_B xxx G#cell_line_B
monoblast G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_M xxx G#cell_line_M
U-937 G#cell_line_E X-ddd G#cell_line_E
. NE . NE

By NE Xx NE
extensive NE xxx NE
nucleotide NE xxx NE
sequence NE xxx NE
and NE xxx NE
Northern NE Xxxx NE
blot NE xxx NE
analysis NE xxx NE
, NE , NE
these NE xxx NE
cDNA NE xXXX NE
clones NE xxx NE
were NE xxx NE
found NE xxx NE
to NE xx NE
originate NE xxx NE
from NE xxx NE
approximately NE xxx NE
42 NE dd NE
different NE xxx NE
genes NE xxx NE
( NE ( NE
HZF NE XXX NE
1-42 NE d-dd NE
) NE ) NE
of NE xx NE
which NE xxx NE
only NE xxx NE
8 NE d NE
have NE xxx NE
previously NE xxx NE
been NE xxx NE
described NE xxx NE
. NE . NE

Northern G#other_name_B Xxxx G#other_name_B
blot G#other_name_M xxx G#other_name_M
analysis G#other_name_E xxx G#other_name_E
showed NE xxx NE
that NE xxx NE
a NE x NE
majority NE xxx NE
of NE xx NE
these NE xxx NE
genes NE xxx NE
were NE xxx NE
expressed NE xxx NE
at NE xx NE
comparable NE xxx NE
levels NE xxx NE
in NE xx NE
U-937 G#cell_line X-ddd G#cell_line
and NE xxx NE
HeLa G#cell_line_B XxXx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
. NE . NE

The NE Xxx NE
large NE xxx NE
number NE xxx NE
of NE xx NE
individual NE xxx NE
genes NE xxx NE
represented NE xxx NE
among NE xxx NE
the NE xxx NE
63 NE dd NE
clones NE xxx NE
and NE xxx NE
their NE xxx NE
apparent NE xxx NE
non-cell-type-specific G#other_name_B xxx-xxx-xxx-xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
suggest NE xxx NE
that NE xxx NE
the NE xxx NE
majority NE xxx NE
of NE xx NE
the NE xxx NE
Kruppel-related G#DNA_family_or_group_B Xxxx-xxx G#DNA_family_or_group_B
zinc G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
finger G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
are NE xxx NE
likely NE xxx NE
to NE xx NE
be NE xx NE
expressed NE xxx NE
in NE xx NE
most NE xxx NE
human G#tissue_B xxx G#tissue_B
tissues G#tissue_E xxx G#tissue_E
. NE . NE

In NE Xx NE
contrast NE xxx NE
, NE , NE
some NE xxx NE
of NE xx NE
the NE xxx NE
genes NE xxx NE
displayed NE xxx NE
a NE x NE
restricted NE xxx NE
expression NE xxx NE
pattern NE xxx NE
, NE , NE
indicating NE xxx NE
that NE xxx NE
they NE xxx NE
represent NE xxx NE
potential NE xxx NE
regulators NE xxx NE
of NE xx NE
monocyte G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
or NE xx NE
proliferation G#other_name xxx G#other_name
. NE . NE

Detailed NE Xxxx NE
structural NE xxx NE
analysis NE xxx NE
of NE xx NE
the NE xxx NE
first NE xxx NE
12 NE dd NE
cDNAs G#DNA_family_or_group xXXXx G#DNA_family_or_group
( NE ( NE
HZF G#DNA_family_or_group_B XXX G#DNA_family_or_group_B
1-10 G#DNA_family_or_group_E d-dd G#DNA_family_or_group_E
) NE ) NE
and NE xxx NE
a NE x NE
partial NE xxx NE
characterization NE xxx NE
of NE xx NE
HZF G#DNA_family_or_group_B XXX G#DNA_family_or_group_B
11-42 G#DNA_family_or_group_E dd-dd G#DNA_family_or_group_E
revealed NE xxx NE
that NE xxx NE
a NE x NE
common NE xxx NE
feature NE xxx NE
of NE xx NE
human G#protein_family_or_group_B xxx G#protein_family_or_group_B
Kruppel-related G#protein_family_or_group_M Xxxx-xxx G#protein_family_or_group_M
zinc G#protein_family_or_group_M xxx G#protein_family_or_group_M
finger G#protein_family_or_group_M xxx G#protein_family_or_group_M
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
is NE xx NE
the NE xxx NE
presence NE xxx NE
of NE xx NE
tandem NE xxx NE
arrays NE xxx NE
of NE xx NE
zinc G#protein_substructure_B xxx G#protein_substructure_B
fingers G#protein_substructure_E xxx G#protein_substructure_E
ranging NE xxx NE
in NE xx NE
number NE xxx NE
from NE xxx NE
3 NE d NE
to NE xx NE
over NE xxx NE
20 NE dd NE
that NE xxx NE
are NE xxx NE
preferentially NE xxx NE
located NE xxx NE
in NE xx NE
the NE xxx NE
carboxy-terminal G#protein_domain_or_region_B xxx-xxx G#protein_domain_or_region_B
regions G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
of NE xx NE
the NE xxx NE
proteins NE xxx NE
. NE . NE

In NE Xx NE
addition NE xxx NE
, NE , NE
several NE xxx NE
novel NE xxx NE
KRAB-containing G#DNA_family_or_group_B XXXX-xxx G#DNA_family_or_group_B
zinc G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
finger G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
and NE xxx NE
a NE x NE
novel NE xxx NE
conserved G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
sequence G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
were NE xxx NE
identified NE xxx NE
. NE . NE

CAG G#DNA_N/A_B XXX G#DNA_N/A_B
repeat G#DNA_N/A_M xxx G#DNA_N/A_M
length G#DNA_N/A_M xxx G#DNA_N/A_M
variation G#DNA_N/A_E xxx G#DNA_N/A_E
in NE xx NE
sperm G#cell_type xxx G#cell_type
from NE xxx NE
a NE x NE
patient G#multi_cell xxx G#multi_cell
with NE xxx NE
Kennedy's G#other_name_B Xxxx'x G#other_name_B
disease G#other_name_E xxx G#other_name_E
. NE . NE

Using NE Xxxx NE
a NE x NE
modified NE xxx NE
sperm G#other_name_B xxx G#other_name_B
typing G#other_name_M xxx G#other_name_M
protocol G#other_name_E xxx G#other_name_E
, NE , NE
the NE xxx NE
mutation NE xxx NE
frequency NE xxx NE
of NE xx NE
the NE xxx NE
CAG G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
repeat G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
at NE xx NE
the NE xxx NE
androgen G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
receptor G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
locus G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
has NE xxx NE
been NE xxx NE
measured NE xxx NE
using NE xxx NE
a NE x NE
rare NE xxx NE
semen NE xxx NE
sample NE xxx NE
from NE xxx NE
an NE xx NE
individual NE xxx NE
with NE xxx NE
spinal G#other_name_B xxx G#other_name_B
and G#other_name_M xxx G#other_name_M
bulbar G#other_name_M xxx G#other_name_M
muscular G#other_name_M xxx G#other_name_M
atrophy G#other_name_E xxx G#other_name_E
( NE ( NE
SBMA G#other_name XXXX G#other_name
) NE ) NE
. NE . NE

Among NE Xxxx NE
258 NE ddd NE
X G#cell_type_B X G#cell_type_B
chromosome-containing G#cell_type_M xxx-xxx G#cell_type_M
sperm G#cell_type_E xxx G#cell_type_E
, NE , NE
19% NE dd% NE
had NE xxx NE
a NE x NE
repeat NE xxx NE
number NE xxx NE
equal NE xxx NE
to NE xx NE
the NE xxx NE
donor's G#DNA_family_or_group_B xxx'x G#DNA_family_or_group_B
somatic G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
DNA G#DNA_family_or_group_E XXX G#DNA_family_or_group_E
(47 NE (dd NE
repeats) NE xxx) NE
, NE , NE
66% NE dd% NE
were NE xxx NE
expansions G#other_name xxx G#other_name
and NE xxx NE
15% NE dd% NE
were NE xxx NE
contractions G#other_name xxx G#other_name
. NE . NE

The NE Xxx NE
average NE xxx NE
expansion NE xxx NE
was NE xxx NE
2.7 NE d.d NE
repeats NE xxx NE
. NE . NE

More NE Xxxx NE
than NE xxx NE
half NE xxx NE
of NE xx NE
the NE xxx NE
expansions G#other_name xxx G#other_name
involved NE xxx NE
one NE xxx NE
or NE xx NE
two NE xxx NE
repeats NE xxx NE
; NE ; NE
the NE xxx NE
largest NE xxx NE
was NE xxx NE
11 NE dd NE
repeats NE xxx NE
. NE . NE

68% NE dd% NE
of NE xx NE
the NE xxx NE
contractions G#other_name xxx G#other_name
were NE xxx NE
also NE xxx NE
one NE xxx NE
or NE xx NE
two NE xxx NE
repeats NE xxx NE
but NE xxx NE
six NE xxx NE
(16%) NE (dd%) NE
were NE xxx NE
very NE xxx NE
large NE xxx NE
(12-25 NE (dd-dd NE
repeats) NE xxx) NE
. NE . NE

One NE Xxx NE
contraction NE xxx NE
generated NE xxx NE
an NE xx NE
allele NE xxx NE
in NE xx NE
an NE xx NE
intermediate NE xxx NE
size NE xxx NE
range NE xxx NE
(33-39 NE (dd-dd NE
repeats) NE xxx) NE
. NE . NE

Such NE Xxxx NE
alleles G#other_name xxx G#other_name
have NE xxx NE
not NE xxx NE
been NE xxx NE
observed NE xxx NE
among NE xxx NE
more NE xxx NE
than NE xxx NE
900 NE ddd NE
normal NE xxx NE
and NE xxx NE
SBMA G#DNA_molecule_B XXXX G#DNA_molecule_B
X-chromosomes G#DNA_molecule_E X-xxx G#DNA_molecule_E
that NE xxx NE
have NE xxx NE
been NE xxx NE
examined NE xxx NE
. NE . NE

Comparison NE Xxxx NE
of NE xx NE
the NE xxx NE
SBMA G#other_name XXXX G#other_name
sperm G#cell_type xxx G#cell_type
typing NE xxx NE
results NE xxx NE
with NE xxx NE
mutation G#other_name_B xxx G#other_name_B
frequency G#other_name_M xxx G#other_name_M
data G#other_name_E xxx G#other_name_E
on NE xx NE
normal NE xxx NE
alleles G#other_name xxx G#other_name
supports NE xxx NE
the NE xxx NE
hypothesis NE xxx NE
that NE xxx NE
trinucleotide G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
repeat G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
expansions G#other_name xxx G#other_name
may NE xxx NE
have NE xxx NE
a NE x NE
different NE xxx NE
molecular NE xxx NE
origin NE xxx NE
than NE xxx NE
contractions G#other_name xxx G#other_name
. NE . NE

Aspirin-like G#other_organic_compound_B Xxxx-xxx G#other_organic_compound_B
drugs G#other_organic_compound_E xxx G#other_organic_compound_E
can NE xxx NE
protect NE xxx NE
human G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
lymphocytes G#cell_type_E xxx G#cell_type_E
against NE xxx NE
benzoquinone G#other_name_B xxx G#other_name_B
cytotoxicity G#other_name_E xxx G#other_name_E
: NE : NE
evidence NE xxx NE
for NE xxx NE
a NE x NE
NAD(P)H:quinone NE XXX(X)X:xxx NE
reductase NE xxx NE
-dependent NE -xxx NE
mechanism NE xxx NE
. NE . NE

Benzene G#other_organic_compound Xxxx G#other_organic_compound
toxicity NE xxx NE
towards NE xxx NE
lymphocytes G#cell_type xxx G#cell_type
is NE xx NE
thought NE xxx NE
to NE xx NE
be NE xx NE
mediated NE xxx NE
by NE xx NE
metabolites NE xxx NE
of NE xx NE
benzene G#other_organic_compound xxx G#other_organic_compound
including NE xxx NE
benzoquinone G#other_organic_compound xxx G#other_organic_compound
( NE ( NE
BQ G#other_organic_compound XX G#other_organic_compound
) NE ) NE
. NE . NE

NAD(P)H:quinone G#protein_molecule_B XXX(X)X:xxx G#protein_molecule_B
reductase G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
QR G#protein_molecule XX G#protein_molecule
) NE ) NE
is NE xx NE
known NE xxx NE
to NE xx NE
protect NE xxx NE
against NE xxx NE
BQ G#other_name_B XX G#other_name_B
toxicity G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
QR G#DNA_domain_or_region_B XX G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
is NE xx NE
regulated NE xxx NE
by NE xx NE
the NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
AP-1 G#protein_molecule XX-d G#protein_molecule
. NE . NE

We NE Xx NE
had NE xxx NE
previously NE xxx NE
found NE xxx NE
that NE xxx NE
aspirin-like G#other_organic_compound_B xxx-xxx G#other_organic_compound_B
drugs G#other_organic_compound_E xxx G#other_organic_compound_E
( NE ( NE
ALD G#other_organic_compound XXX G#other_organic_compound
) NE ) NE
induce NE xxx NE
AP-1 G#protein_molecule XX-d G#protein_molecule
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
lymphocytes G#cell_type_E xxx G#cell_type_E
. NE . NE

It NE Xx NE
was NE xxx NE
therefore NE xxx NE
hypothesized NE xxx NE
that NE xxx NE
ALD G#other_organic_compound XXX G#other_organic_compound
would NE xxx NE
protect NE xxx NE
lymphocytes G#cell_type xxx G#cell_type
against NE xxx NE
BQ G#other_name_B XX G#other_name_B
toxicity G#other_name_E xxx G#other_name_E
by NE xx NE
inducing NE xxx NE
QR G#protein_molecule XX G#protein_molecule
. NE . NE

Molt-4 G#cell_line_B Xxxx-d G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
( NE ( NE
M4 G#cell_line Xd G#cell_line
) NE ) NE
, NE , NE
a NE x NE
human G#cell_line_B xxx G#cell_line_B
T G#cell_line_M X G#cell_line_M
lymphocyte G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
, NE , NE
were NE xxx NE
incubated NE xxx NE
with NE xxx NE
different NE xxx NE
concentrations NE xxx NE
of NE xx NE
two NE xxx NE
ALD G#other_organic_compound XXX G#other_organic_compound
, NE , NE
flurbiprofen G#other_organic_compound xxx G#other_organic_compound
and NE xxx NE
sodium G#other_organic_compound_B xxx G#other_organic_compound_B
diclofenac G#other_organic_compound_E xxx G#other_organic_compound_E
, NE , NE
and NE xxx NE
then NE xxx NE
exposed NE xxx NE
to NE xx NE
BQ G#other_organic_compound XX G#other_organic_compound
. NE . NE

Toxicity NE Xxxx NE
was NE xxx NE
measured NE xxx NE
by NE xx NE
viability NE xxx NE
( NE ( NE
trypan G#other_name_B xxx G#other_name_B
blue G#other_name_M xxx G#other_name_M
exclusion G#other_name_E xxx G#other_name_E
) NE ) NE
. NE . NE

Both NE Xxxx NE
drugs NE xxx NE
protected NE xxx NE
the NE xxx NE
cells NE xxx NE
against NE xxx NE
BQ G#other_name_B XX G#other_name_B
cytotoxicity G#other_name_E xxx G#other_name_E
in NE xx NE
a NE x NE
dose-dependent G#other_name_B xxx-xxx G#other_name_B
manner G#other_name_E xxx G#other_name_E
, NE , NE
e.g. NE x.x. NE
, NE , NE
sodium G#other_organic_compound_B xxx G#other_organic_compound_B
diclofenac G#other_organic_compound_E xxx G#other_organic_compound_E
at NE xx NE
15 NE dd NE
microM NE xxxX NE
reduced NE xxx NE
the NE xxx NE
fraction NE xxx NE
of NE xx NE
BQ G#other_organic_compound XX G#other_organic_compound
-treated NE -xxx NE
dead NE xxx NE
cells NE xxx NE
by NE xx NE
70% NE dd% NE
. NE . NE

ALDs G#other_organic_compound XXXx G#other_organic_compound
induced NE xxx NE
QR G#other_name_B XX G#other_name_B
activity G#other_name_E xxx G#other_name_E
in NE xx NE
the NE xxx NE
M4 NE Xd NE
cells NE xxx NE
in NE xx NE
the NE xxx NE
same NE xxx NE
range NE xxx NE
of NE xx NE
concentrations NE xxx NE
that NE xxx NE
protected NE xxx NE
the NE xxx NE
cells NE xxx NE
against NE xxx NE
BQ G#other_organic_compound XX G#other_organic_compound
toxicity NE xxx NE
. NE . NE

The NE Xxx NE
protective NE xxx NE
effect NE xxx NE
of NE xx NE
ALD G#other_organic_compound XXX G#other_organic_compound
was NE xxx NE
significantly NE xxx NE
reduced NE xxx NE
by NE xx NE
dicoumarol G#other_organic_compound xxx G#other_organic_compound
, NE , NE
a NE x NE
QR NE XX NE
-specific NE -xxx NE
inhibitor NE xxx NE
. NE . NE

Since NE Xxxx NE
human G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
and NE xxx NE
T G#cell_type_B X G#cell_type_B
cell G#cell_type_M xxx G#cell_type_M
lines G#cell_type_E xxx G#cell_type_E
do NE xx NE
not NE xxx NE
metabolize NE xxx NE
arachidonic NE xxx NE
acid NE xxx NE
, NE , NE
our NE xxx NE
data NE xxx NE
suggest NE xxx NE
that NE xxx NE
ALD G#other_organic_compound XXX G#other_organic_compound
can NE xxx NE
protect NE xxx NE
human G#cell_type_B xxx G#cell_type_B
T G#cell_type_M X G#cell_type_M
lymphocytes G#cell_type_E xxx G#cell_type_E
against NE xxx NE
a NE x NE
metabolite NE xxx NE
of NE xx NE
benzene G#other_artificial_source xxx G#other_artificial_source
by NE xx NE
induction NE xxx NE
of NE xx NE
QR G#other_name_B XX G#other_name_B
activity G#other_name_E xxx G#other_name_E
. NE . NE

Correlation NE Xxxx NE
of NE xx NE
differentiation-inducing G#other_name_B xxx-xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
of NE xx NE
retinoids G#other_organic_compound xxx G#other_organic_compound
on NE xx NE
human G#cell_line_B xxx G#cell_line_B
leukemia G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
HL-60 G#cell_line XX-dd G#cell_line
and NE xxx NE
NB4 G#cell_line XXd G#cell_line
. NE . NE

Retinoids G#other_organic_compound Xxxx G#other_organic_compound
, NE , NE
including NE xxx NE
all-trans-retinoic G#other_organic_compound_B xxx-xxx-xxx G#other_organic_compound_B
acid G#other_organic_compound_E xxx G#other_organic_compound_E
, NE , NE
its NE xxx NE
isomers NE xxx NE
, NE , NE
and NE xxx NE
fifty NE xxx NE
synthetic NE xxx NE
retinoids G#other_organic_compound xxx G#other_organic_compound
(retinobenzoic NE (xxx NE
acids) NE xxx) NE
, NE , NE
were NE xxx NE
tested NE xxx NE
for NE xxx NE
differentiation-inducing G#other_name_B xxx-xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
on NE xx NE
human G#cell_line_B xxx G#cell_line_B
leukemia G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
HL-60 G#cell_line XX-dd G#cell_line
and NE xxx NE
NB4 G#cell_line XXd G#cell_line
. NE . NE

A NE X NE
good NE xxx NE
linear NE xxx NE
correlation NE xxx NE
, NE , NE
with NE xxx NE
an NE xx NE
r NE x NE
value NE xxx NE
of NE xx NE
0.91 NE d.dd NE
, NE , NE
between NE xxx NE
the NE xxx NE
ED50 G#other_name_B XXdd G#other_name_B
values G#other_name_E xxx G#other_name_E
for NE xxx NE
the NE xxx NE
differentiation-inducing G#other_name_B xxx-xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
towards NE xxx NE
HL-60 G#cell_line_B XX-dd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
and NE xxx NE
that NE xxx NE
towards NE xxx NE
NB4 G#cell_line_B XXd G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
was NE xxx NE
found NE xxx NE
. NE . NE

Platelet-activating G#protein_family_or_group_B Xxxx-xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
PAF G#protein_family_or_group XXX G#protein_family_or_group
) NE ) NE
positively NE xxx NE
auto-regulates NE xxx-xxx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
human G#protein_molecule_B xxx G#protein_molecule_B
PAF G#protein_molecule_M XXX G#protein_molecule_M
receptor G#protein_molecule_M xxx G#protein_molecule_M
transcript G#protein_molecule_M xxx G#protein_molecule_M
1 G#protein_molecule_E d G#protein_molecule_E
( NE ( NE
leukocyte-type G#other_name xxx-xxx G#other_name
) NE ) NE
through NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
. NE . NE

The NE Xxx NE
human NE xxx NE
platelet-activating NE xxx-xxx NE
factor NE xxx NE
receptor NE xxx NE
( NE ( NE
PAFR NE XXXX NE
) NE ) NE
gene NE xxx NE
is NE xx NE
transcribed NE xxx NE
by NE xx NE
two NE xxx NE
distinct NE xxx NE
promoters NE xxx NE
( NE ( NE
promoter NE xxx NE
1 NE d NE
and NE xxx NE
promoter NE xxx NE
2 NE d NE
) NE ) NE
to NE xx NE
generate NE xxx NE
two NE xxx NE
transcripts NE xxx NE
(designated NE (xxx NE
as NE xx NE
PAFR NE XXXX NE
transcript NE xxx NE
1 NE d NE
and NE xxx NE
PAFR NE XXXX NE
transcript NE xxx NE
2 NE d NE
) NE ) NE
, NE , NE
though NE xxx NE
their NE xxx NE
open NE xxx NE
reading NE xxx NE
frames NE xxx NE
are NE xxx NE
identical NE xxx NE
. NE . NE

By NE Xx NE
primer NE xxx NE
extension NE xxx NE
analysis NE xxx NE
to NE xx NE
discriminate NE xxx NE
two NE xxx NE
transcripts NE xxx NE
, NE , NE
we NE xx NE
found NE xxx NE
that NE xxx NE
the NE xxx NE
levels NE xxx NE
of NE xx NE
PAFR G#RNA_family_or_group_B XXXX G#RNA_family_or_group_B
transcript G#RNA_family_or_group_M xxx G#RNA_family_or_group_M
1 G#RNA_family_or_group_E d G#RNA_family_or_group_E
( NE ( NE
leukocyte-type G#other_name xxx-xxx G#other_name
) NE ) NE
, NE , NE
but NE xxx NE
not NE xxx NE
PAFR G#RNA_domain_or_region_B XXXX G#RNA_domain_or_region_B
transcript G#RNA_domain_or_region_M xxx G#RNA_domain_or_region_M
2 G#RNA_domain_or_region_E d G#RNA_domain_or_region_E
( NE ( NE
tissue-type G#other_name xxx-xxx G#other_name
) NE ) NE
, NE , NE
are NE xxx NE
upregulated NE xxx NE
by NE xx NE
PAF G#protein_molecule XXX G#protein_molecule
as NE xx NE
well NE xxx NE
as NE xx NE
by NE xx NE
12-O-tetradecanoylphorbol-13-acetate G#other_organic_compound dd-X-xxx-dd-xxx G#other_organic_compound
( NE ( NE
TPA G#other_organic_compound XXX G#other_organic_compound
) NE ) NE
in NE xx NE
the NE xxx NE
human G#cell_line_B xxx G#cell_line_B
stomach G#cell_line_M xxx G#cell_line_M
cancer G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
( NE ( NE
JR-St G#cell_line_B XX-Xx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
) NE ) NE
which NE xxx NE
expresses NE xxx NE
both NE xxx NE
functional NE xxx NE
PAFR G#RNA_molecule_B XXXX G#RNA_molecule_B
transcript G#RNA_molecule_M xxx G#RNA_molecule_M
1 G#RNA_molecule_E d G#RNA_molecule_E
and NE xxx NE
PAFR G#RNA_molecule_B XXXX G#RNA_molecule_B
transcript G#RNA_molecule_M xxx G#RNA_molecule_M
2 G#RNA_molecule_E d G#RNA_molecule_E
endogenously NE xxx NE
. NE . NE

Functional NE Xxxx NE
analysis NE xxx NE
of NE xx NE
the NE xxx NE
promoter G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
1 G#DNA_domain_or_region_E d G#DNA_domain_or_region_E
with NE xxx NE
a NE x NE
transient NE xxx NE
expression NE xxx NE
assay NE xxx NE
using NE xxx NE
chloramphenicol G#DNA_molecule_B xxx G#DNA_molecule_B
acetyltransferase G#DNA_molecule_M xxx G#DNA_molecule_M
(CAT) G#DNA_molecule_M (XXX) G#DNA_molecule_M
gene G#DNA_molecule_E xxx G#DNA_molecule_E
as NE xx NE
a NE x NE
reporter NE xxx NE
showed NE xxx NE
that NE xxx NE
both NE xxx NE
PAF G#protein_molecule XXX G#protein_molecule
and NE xxx NE
TPA G#other_organic_compound XXX G#other_organic_compound
activated NE xxx NE
the NE xxx NE
promoter G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
1 G#DNA_domain_or_region_E d G#DNA_domain_or_region_E
but NE xxx NE
not NE xxx NE
the NE xxx NE
deleted G#DNA_substructure_B xxx G#DNA_substructure_B
promoter G#DNA_substructure_E xxx G#DNA_substructure_E
lacking NE xxx NE
the NE xxx NE
three NE xxx NE
consensus G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
for NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
located NE xxx NE
from NE xxx NE
-571 NE -ddd NE
bp NE xx NE
to NE xx NE
-459 NE -ddd NE
bp NE xx NE
. NE . NE

These NE Xxxx NE
findings NE xxx NE
suggest NE xxx NE
a NE x NE
molecular G#other_name_B xxx G#other_name_B
mechanism G#other_name_E xxx G#other_name_E
of NE xx NE
positive NE xxx NE
regulation NE xxx NE
of NE xx NE
PAFR G#other_name_B XXXX G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
by NE xx NE
PAF G#protein_molecule XXX G#protein_molecule
through NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
, NE , NE
possibly NE xxx NE
by NE xx NE
a NE x NE
phosphorylation NE xxx NE
reaction NE xxx NE
involving NE xxx NE
protein G#protein_molecule_B xxx G#protein_molecule_B
kinase G#protein_molecule_M xxx G#protein_molecule_M
C G#protein_molecule_E X G#protein_molecule_E
by NE xx NE
PAF G#protein_molecule XXX G#protein_molecule
. NE . NE

One NE Xxx NE
gene NE xxx NE
, NE , NE
two NE xxx NE
transcripts G#RNA_family_or_group xxx G#RNA_family_or_group
: NE : NE
isolation NE xxx NE
of NE xx NE
an NE xx NE
alternative G#other_name_B xxx G#other_name_B
transcript G#other_name_M xxx G#other_name_M
encoding G#other_name_E xxx G#other_name_E
for NE xxx NE
the NE xxx NE
autoantigen G#protein_molecule_B xxx G#protein_molecule_B
La/SS-B G#protein_molecule_E Xx/XX-X G#protein_molecule_E
from NE xxx NE
a NE x NE
cDNA G#DNA_family_or_group_B xXXX G#DNA_family_or_group_B
library G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
of NE xx NE
a NE x NE
patient G#multi_cell xxx G#multi_cell
with NE xxx NE
primary G#other_name_B xxx G#other_name_B
Sjogrens' G#other_name_M Xxxx' G#other_name_M
syndrome G#other_name_E xxx G#other_name_E
. NE . NE

A NE X NE
cDNA G#DNA_family_or_group_B xXXX G#DNA_family_or_group_B
library G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
was NE xxx NE
prepared NE xxx NE
from NE xxx NE
peripheral NE xxx NE
blood NE xxx NE
lymphocytes G#cell_type xxx G#cell_type
of NE xx NE
an NE xx NE
autoimmune NE xxx NE
patient G#multi_cell xxx G#multi_cell
with NE xxx NE
primary G#other_name_B xxx G#other_name_B
Sjogrens' G#other_name_M Xxxx' G#other_name_M
syndrome G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
cDNA G#DNA_family_or_group_B xXXX G#DNA_family_or_group_B
library G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
was NE xxx NE
screened NE xxx NE
with NE xxx NE
the NE xxx NE
patients G#multi_cell xxx G#multi_cell
own NE xxx NE
autoimmune NE xxx NE
serum NE xxx NE
being NE xxx NE
monospecific NE xxx NE
for NE xxx NE
the NE xxx NE
nuclear G#protein_molecule_B xxx G#protein_molecule_B
autoantigen G#protein_molecule_M xxx G#protein_molecule_M
La/SS-B G#protein_molecule_E Xx/XX-X G#protein_molecule_E
. NE . NE

Thereby NE Xxxx NE
an NE xx NE
alternative NE xxx NE
type NE xxx NE
of NE xx NE
La G#RNA_molecule_B Xx G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
was NE xxx NE
identified NE xxx NE
that NE xxx NE
differed NE xxx NE
from NE xxx NE
the NE xxx NE
known NE xxx NE
La G#RNA_molecule_B Xx G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
due NE xxx NE
to NE xx NE
an NE xx NE
exchange NE xxx NE
of NE xx NE
the NE xxx NE
exon G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
1 G#DNA_domain_or_region_E d G#DNA_domain_or_region_E
. NE . NE

Sequencing NE Xxxx NE
of NE xx NE
the NE xxx NE
genomic NE xxx NE
region NE xxx NE
between NE xxx NE
the NE xxx NE
exons NE xxx NE
exon G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
1 G#DNA_domain_or_region_M d G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
exon G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
2 G#DNA_domain_or_region_E d G#DNA_domain_or_region_E
showed NE xxx NE
that NE xxx NE
the NE xxx NE
alternative G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
5'-end G#DNA_domain_or_region_E d'-xxx G#DNA_domain_or_region_E
is NE xx NE
a NE x NE
part NE xxx NE
of NE xx NE
the NE xxx NE
intron G#DNA_family_or_group xxx G#DNA_family_or_group
. NE . NE

In NE Xx NE
addition NE xxx NE
, NE , NE
the NE xxx NE
presence NE xxx NE
of NE xx NE
an NE xx NE
alternative G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
which NE xxx NE
exists NE xxx NE
within NE xxx NE
the NE xxx NE
intron G#DNA_domain_or_region xxx G#DNA_domain_or_region
downstream NE xxx NE
of NE xx NE
the NE xxx NE
exon G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
1 G#DNA_domain_or_region_E d G#DNA_domain_or_region_E
, NE , NE
became NE xxx NE
evident NE xxx NE
. NE . NE

In NE Xx NE
consequence NE xxx NE
, NE , NE
the NE xxx NE
alternative G#RNA_molecule_B xxx G#RNA_molecule_B
La G#RNA_molecule_M Xx G#RNA_molecule_M
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
is NE xx NE
the NE xxx NE
result NE xxx NE
of NE xx NE
a NE x NE
promoter NE xxx NE
switching NE xxx NE
combined NE xxx NE
with NE xxx NE
an NE xx NE
alternative G#other_name_B xxx G#other_name_B
splicing G#other_name_M xxx G#other_name_M
mechanism G#other_name_E xxx G#other_name_E
. NE . NE

In NE Xx NE
the NE xxx NE
intron NE xxx NE
, NE , NE
further NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
binding NE xxx NE
sites NE xxx NE
, NE , NE
including NE xxx NE
a NE x NE
NF-kappa G#DNA_domain_or_region_B XX-xxx G#DNA_domain_or_region_B
B G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
were NE xxx NE
identified NE xxx NE
leading NE xxx NE
to NE xx NE
the NE xxx NE
suggestion NE xxx NE
that NE xxx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
the NE xxx NE
gene NE xxx NE
encoding NE xxx NE
for NE xxx NE
the NE xxx NE
nuclear G#protein_molecule_B xxx G#protein_molecule_B
autoantigen G#protein_molecule_M xxx G#protein_molecule_M
La/SS-B G#protein_molecule_E Xx/XX-X G#protein_molecule_E
alters NE xxx NE
in NE xx NE
dependence NE xxx NE
on NE xx NE
disease NE xxx NE
conditions NE xxx NE
. NE . NE

Cross-linking NE Xxxx-xxx NE
CD40 G#protein_molecule XXdd G#protein_molecule
on NE xx NE
B G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
rapidly NE xxx NE
activates NE xxx NE
nuclear G#protein_molecule_B xxx G#protein_molecule_B
factor-kappa G#protein_molecule_M xxx-xxx G#protein_molecule_M
B G#protein_molecule_E X G#protein_molecule_E
. NE . NE

The NE Xxx NE
B G#protein_molecule_B X G#protein_molecule_B
cell-associated G#protein_molecule_M xxx-xxx G#protein_molecule_M
surface G#protein_molecule_M xxx G#protein_molecule_M
molecule G#protein_molecule_M xxx G#protein_molecule_M
CD40 G#protein_molecule_E XXdd G#protein_molecule_E
functions NE xxx NE
to NE xx NE
regulate NE xxx NE
B NE X NE
cell NE xxx NE
responses NE xxx NE
. NE . NE

Cross-linking NE Xxxx-xxx NE
CD40 G#protein_molecule XXdd G#protein_molecule
on NE xx NE
B G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
can NE xxx NE
lead NE xxx NE
to NE xx NE
homotypic NE xxx NE
cell NE xxx NE
adhesion NE xxx NE
, NE , NE
IL-6 G#other_name_B XX-d G#other_name_B
production G#other_name_E xxx G#other_name_E
, NE , NE
and NE xxx NE
, NE , NE
in NE xx NE
combination NE xxx NE
with NE xxx NE
cytokines G#protein_family_or_group xxx G#protein_family_or_group
, NE , NE
to NE xx NE
Ig G#other_name_B Xx G#other_name_B
isotype G#other_name_M xxx G#other_name_M
switching G#other_name_E xxx G#other_name_E
. NE . NE

Tyrosine G#other_name_B Xxxx G#other_name_B
kinase G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
is NE xx NE
increased NE xxx NE
shortly NE xxx NE
after NE xxx NE
engagement NE xxx NE
of NE xx NE
this NE xxx NE
receptor NE xxx NE
. NE . NE

Little NE Xxxx NE
is NE xx NE
known NE xxx NE
about NE xxx NE
how NE xxx NE
the NE xxx NE
very NE xxx NE
early NE xxx NE
events NE xxx NE
induced NE xxx NE
by NE xx NE
CD40 G#other_name_B XXdd G#other_name_B
cross-linking G#other_name_E xxx-xxx G#other_name_E
link NE xxx NE
to NE xx NE
cellular NE xxx NE
responses NE xxx NE
. NE . NE

In NE Xx NE
this NE xxx NE
study NE xxx NE
, NE , NE
we NE xx NE
demonstrate NE xxx NE
that NE xxx NE
nuclear G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_M xxx G#protein_family_or_group_M
(NF)-kappa G#protein_family_or_group_M (XX)-xxx G#protein_family_or_group_M
B G#protein_family_or_group_E X G#protein_family_or_group_E
and NE xxx NE
NF-kappa G#protein_family_or_group_B XX-xxx G#protein_family_or_group_B
B-like G#protein_family_or_group_M X-xxx G#protein_family_or_group_M
transcription G#protein_family_or_group_M xxx G#protein_family_or_group_M
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
are NE xxx NE
activated NE xxx NE
after NE xxx NE
cross-linking NE xxx-xxx NE
CD40 G#protein_molecule XXdd G#protein_molecule
on NE xx NE
resting NE xxx NE
human G#cell_type_B xxx G#cell_type_B
tonsillar G#cell_type_M xxx G#cell_type_M
B G#cell_type_M X G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
and NE xxx NE
on NE xx NE
B G#cell_line_B X G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
. NE . NE

The NE Xxx NE
activation NE xxx NE
is NE xx NE
rapid NE xxx NE
and NE xxx NE
is NE xx NE
mediated NE xxx NE
through NE xxx NE
a NE x NE
tyrosine G#other_name_B xxx G#other_name_B
kinase-dependent G#other_name_M xxx-xxx G#other_name_M
pathway G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
complexes NE xxx NE
detected NE xxx NE
in NE xx NE
electrophoretic G#other_name_B xxx G#other_name_B
mobility G#other_name_M xxx G#other_name_M
shift G#other_name_M xxx G#other_name_M
assays G#other_name_E xxx G#other_name_E
contain NE xxx NE
p50 G#protein_subunit xdd G#protein_subunit
, NE , NE
p65 G#protein_subunit xdd G#protein_subunit
( NE ( NE
RelA G#protein_molecule XxxX G#protein_molecule
) NE ) NE
, NE , NE
c-Rel G#protein_subunit x-Xxx G#protein_subunit
, NE , NE
and NE xxx NE
most NE xxx NE
likely NE xxx NE
other NE xxx NE
components NE xxx NE
. NE . NE

By NE Xx NE
using NE xxx NE
transient G#other_name_B xxx G#other_name_B
transfection G#other_name_M xxx G#other_name_M
assays G#other_name_E xxx G#other_name_E
, NE , NE
we NE xx NE
found NE xxx NE
that NE xxx NE
cross-linking NE xxx-xxx NE
CD40 G#protein_molecule XXdd G#protein_molecule
supports NE xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
-dependent NE -xxx NE
gene NE xxx NE
expression NE xxx NE
. NE . NE

Our NE Xxx NE
results NE xxx NE
define NE xxx NE
the NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
system NE xxx NE
as NE xx NE
an NE xx NE
intermediate NE xxx NE
event NE xxx NE
in NE xx NE
CD40 G#protein_molecule XXdd G#protein_molecule
signaling NE xxx NE
and NE xxx NE
suggest NE xxx NE
that NE xxx NE
the NE xxx NE
CD40 G#other_name_B XXdd G#other_name_B
pathway G#other_name_E xxx G#other_name_E
can NE xxx NE
influence NE xxx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
B G#DNA_family_or_group_B X G#DNA_family_or_group_B
cell-associated G#DNA_family_or_group_M xxx-xxx G#DNA_family_or_group_M
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
with NE xxx NE
NF-kappa G#DNA_family_or_group_B XX-xxx G#DNA_family_or_group_B
B G#DNA_family_or_group_M X G#DNA_family_or_group_M
consensus G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
sites G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
. NE . NE

Protease G#other_organic_compound_B Xxxx G#other_organic_compound_B
inhibitors G#other_organic_compound_E xxx G#other_organic_compound_E
block NE xxx NE
lipopolysaccharide G#other_name_B xxx G#other_name_B
induction G#other_name_E xxx G#other_name_E
of NE xx NE
tissue NE xxx NE
factor NE xxx NE
gene G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
monocytic G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
by NE xx NE
preventing NE xxx NE
activation NE xxx NE
of NE xx NE
c-Rel NE x-Xxx NE
/ NE / NE
p65 NE xdd NE
heterodimers NE xxx NE
. NE . NE

Tissue G#protein_family_or_group_B Xxxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
TF G#protein_family_or_group XX G#protein_family_or_group
) NE ) NE
is NE xx NE
expressed NE xxx NE
rapidly NE xxx NE
by NE xx NE
human G#cell_type_B xxx G#cell_type_B
monocytes G#cell_type_E xxx G#cell_type_E
exposed NE xxx NE
to NE xx NE
bacterial G#protein_family_or_group_B xxx G#protein_family_or_group_B
endotoxin G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
lipopolysaccharide G#lipid xxx G#lipid
, NE , NE
or NE xx NE
LPS G#lipid XXX G#lipid
) NE ) NE
. NE . NE

Transcriptional NE Xxxx NE
regulation NE xxx NE
is NE xx NE
mediated NE xxx NE
by NE xx NE
binding NE xxx NE
of NE xx NE
c-Rel NE x-Xxx NE
/p65 NE /xdd NE
heterodimers NE xxx NE
to NE xx NE
a NE x NE
kappa NE xxx NE
B-like NE X-xxx NE
site NE xxx NE
in NE xx NE
the NE xxx NE
TF NE XX NE
promoter NE xxx NE
. NE . NE

Nuclear NE Xxxx NE
translocation NE xxx NE
of NE xx NE
cytosolic NE xxx NE
c-Rel NE x-Xxx NE
/ NE / NE
p65 NE xdd NE
heterodimers NE xxx NE
and NE xxx NE
other NE xxx NE
members NE xxx NE
of NE xx NE
the NE xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
/Rel NE /Xxx NE
family NE xxx NE
requires NE xxx NE
dissociation NE xxx NE
and NE xxx NE
proteolytic NE xxx NE
degradation NE xxx NE
of NE xx NE
the NE xxx NE
inhibitor NE xxx NE
protein NE xxx NE
, NE , NE
I NE X NE
kappa NE xxx NE
B NE X NE
alpha NE xxx NE
. NE . NE

The NE Xxx NE
protease NE xxx NE
inhibitors NE xxx NE
N G#other_organic_compound_B X G#other_organic_compound_B
alpha-tosylphenylalanyl G#other_organic_compound_M xxx-xxx G#other_organic_compound_M
chloromethyl G#other_organic_compound_M xxx G#other_organic_compound_M
ketone G#other_organic_compound_E xxx G#other_organic_compound_E
( NE ( NE
TPCK G#other_organic_compound XXXX G#other_organic_compound
) NE ) NE
and NE xxx NE
N G#other_organic_compound_B X G#other_organic_compound_B
alpha-tosyl-L-lysine G#other_organic_compound_M xxx-xxx-X-xxx G#other_organic_compound_M
chloromethyl G#other_organic_compound_M xxx G#other_organic_compound_M
ketone G#other_organic_compound_E xxx G#other_organic_compound_E
( NE ( NE
TLCK G#other_organic_compound XXXX G#other_organic_compound
) NE ) NE
block NE xxx NE
activation NE xxx NE
of NE xx NE
NF-kappa NE XX-xxx NE
B NE X NE
/Rel NE /Xxx NE
proteins NE xxx NE
by NE xx NE
preventing NE xxx NE
degradation NE xxx NE
of NE xx NE
I NE X NE
kappa NE xxx NE
B NE X NE
alpha NE xxx NE
. NE . NE

To NE Xx NE
determine NE xxx NE
if NE xx NE
TPCK G#other_organic_compound XXXX G#other_organic_compound
and NE xxx NE
TLCK G#other_organic_compound XXXX G#other_organic_compound
inhibited NE xxx NE
LPS G#other_name_B XXX G#other_name_B
induction G#other_name_E xxx G#other_name_E
of NE xx NE
TF G#other_name_B XX G#other_name_B
expression G#other_name_E xxx G#other_name_E
, NE , NE
freshly NE xxx NE
isolated NE xxx NE
human G#cell_type_B xxx G#cell_type_B
monocytes G#cell_type_E xxx G#cell_type_E
and NE xxx NE
monocytic G#cell_line_B xxx G#cell_line_B
THP-1 G#cell_line_M XXX-d G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
were NE xxx NE
pretreated NE xxx NE
with NE xxx NE
these NE xxx NE
inhibitors NE xxx NE
for NE xxx NE
30 NE dd NE
min NE xxx NE
before NE xxx NE
LPS G#other_name_B XXX G#other_name_B
stimulation G#other_name_E xxx G#other_name_E
. NE . NE

Both NE Xxxx NE
TPCK G#other_organic_compound XXXX G#other_organic_compound
and NE xxx NE
TLCK G#other_name_B XXXX G#other_name_B
inhibited G#other_name_M xxx G#other_name_M
LPS G#other_name_M XXX G#other_name_M
induction G#other_name_E xxx G#other_name_E
of NE xx NE
TF G#protein_molecule_B XX G#protein_molecule_B
protein G#protein_molecule_E xxx G#protein_molecule_E
, NE , NE
TF G#RNA_molecule_B XX G#RNA_molecule_B
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
and NE xxx NE
TF G#other_name_B XX G#other_name_B
promoter G#other_name_M xxx G#other_name_M
activity G#other_name_E xxx G#other_name_E
in NE xx NE
a NE x NE
dose-dependent G#other_name_B xxx-xxx G#other_name_B
manner G#other_name_E xxx G#other_name_E
. NE . NE

These NE Xxxx NE
inhibitors NE xxx NE
specifically NE xxx NE
prevented NE xxx NE
degradation NE xxx NE
of NE xx NE
I G#protein_molecule_B X G#protein_molecule_B
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_M X G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
and NE xxx NE
nuclear G#other_name_B xxx G#other_name_B
translocation G#other_name_E xxx G#other_name_E
of NE xx NE
c-Rel NE x-Xxx NE
/p65 NE /xdd NE
heterodimers NE xxx NE
. NE . NE

In NE Xx NE
contrast NE xxx NE
, NE , NE
TPCK G#other_organic_compound XXXX G#other_organic_compound
and NE xxx NE
TLCK G#other_organic_compound XXXX G#other_organic_compound
did NE xxx NE
not NE xxx NE
block NE xxx NE
induction NE xxx NE
of NE xx NE
an NE xx NE
immediate-early G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
encoding NE xxx NE
the NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
Egr-1 G#protein_molecule Xxx-d G#protein_molecule
. NE . NE

Taken NE Xxxx NE
together NE xxx NE
, NE , NE
these NE xxx NE
data NE xxx NE
indicated NE xxx NE
that NE xxx NE
inhibiting NE xxx NE
nuclear NE xxx NE
translocation NE xxx NE
of NE xx NE
c-Rel NE x-Xxx NE
/p65 NE /xdd NE
heterodimers NE xxx NE
prevented NE xxx NE
LPS NE XXX NE
induction NE xxx NE
of NE xx NE
TF NE XX NE
gene NE xxx NE
transcription NE xxx NE
in NE xx NE
monocytic NE xxx NE
cells NE xxx NE
. NE . NE

1,25-Dihydroxyvitamin G#protein_family_or_group_B d,dd-Xxxx G#protein_family_or_group_B
D3 G#protein_family_or_group_M Xd G#protein_family_or_group_M
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
in NE xx NE
peripheral G#cell_type_B xxx G#cell_type_B
blood G#cell_type_M xxx G#cell_type_M
mononuclear G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
from NE xxx NE
patients G#multi_cell xxx G#multi_cell
with NE xxx NE
primary G#other_name_B xxx G#other_name_B
hyperparathyroidism G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
secondary G#other_name_M xxx G#other_name_M
hyperparathyroidism G#other_name_E xxx G#other_name_E

A NE X NE
decreased NE xxx NE
number NE xxx NE
of NE xx NE
calcitriol NE xxx NE
( NE ( NE
1,25(OH)2D3 NE d,dd(XX)dXd NE
) NE ) NE
receptors NE xxx NE
has NE xxx NE
been NE xxx NE
observed NE xxx NE
in NE xx NE
parathyroid NE xxx NE
glands NE xxx NE
of NE xx NE
uremic NE xxx NE
animals NE xxx NE
. NE . NE

In NE Xx NE
humans G#multi_cell xxx G#multi_cell
, NE , NE
studies NE xxx NE
carried NE xxx NE
out NE xxx NE
in NE xx NE
surgically NE xxx NE
removed NE xxx NE
parathyroid G#body_part_B xxx G#body_part_B
glands G#body_part_E xxx G#body_part_E
have NE xxx NE
shown NE xxx NE
that NE xxx NE
calcitriol G#lipid xxx G#lipid
binding NE xxx NE
is NE xx NE
higher NE xxx NE
in NE xx NE
primary NE xxx NE
than NE xxx NE
in NE xx NE
secondary NE xxx NE
hyperparathyroidism NE xxx NE
. NE . NE

Since NE Xxxx NE
specific NE xxx NE
receptors NE xxx NE
for NE xxx NE
calcitriol G#lipid xxx G#lipid
have NE xxx NE
been NE xxx NE
described NE xxx NE
in NE xx NE
peripheral G#cell_type_B xxx G#cell_type_B
blood G#cell_type_M xxx G#cell_type_M
mononuclear G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
( NE ( NE
PBMC G#cell_type XXXX G#cell_type
) NE ) NE
, NE , NE
we NE xx NE
have NE xxx NE
investigated NE xxx NE
the NE xxx NE
specific NE xxx NE
uptake NE xxx NE
of NE xx NE
3H-labelled NE dX-xxx NE
1,25(OH)2D3 G#lipid d,dd(XX)dXd G#lipid
in NE xx NE
PBMC G#cell_type XXXX G#cell_type
of NE xx NE
12 NE dd NE
women G#multi_cell xxx G#multi_cell
with NE xxx NE
primary G#other_name_B xxx G#other_name_B
hyperparathyroidism G#other_name_E xxx G#other_name_E
( NE ( NE
PHP G#other_name XXX G#other_name
) NE ) NE
, NE , NE
8 NE d NE
women G#multi_cell xxx G#multi_cell
with NE xxx NE
hyperparathyroidism G#other_name_B xxx G#other_name_B
secondary G#other_name_M xxx G#other_name_M
to G#other_name_M xx G#other_name_M
chronic G#other_name_M xxx G#other_name_M
renal G#other_name_M xxx G#other_name_M
failure G#other_name_E xxx G#other_name_E
( NE ( NE
SH G#other_name XX G#other_name
) NE ) NE
, NE , NE
9 NE d NE
women G#multi_cell xxx G#multi_cell
with NE xxx NE
renal G#other_name_B xxx G#other_name_B
transplant G#other_name_E xxx G#other_name_E
( NE ( NE
RT G#other_name XX G#other_name
) NE ) NE
, NE , NE
and NE xxx NE
23 NE dd NE
healthy NE xxx NE
women G#multi_cell xxx G#multi_cell
. NE . NE

The NE Xxx NE
median G#other_name_B xxx G#other_name_B
dissociation G#other_name_M xxx G#other_name_M
constant G#other_name_E xxx G#other_name_E
( NE ( NE
Kd G#other_name Xx G#other_name
) NE ) NE
was NE xxx NE
similar NE xxx NE
in NE xx NE
all NE xxx NE
three NE xxx NE
groups NE xxx NE
of NE xx NE
patients G#multi_cell xxx G#multi_cell
and NE xxx NE
in NE xx NE
healthy NE xxx NE
women G#multi_cell xxx G#multi_cell
(mean NE (xxx NE
+/- NE +/- NE
S.D NE X.X NE
. NE . NE
(range) NE (xxx) NE
: NE : NE
PHP G#other_name XXX G#other_name
, NE , NE
1.2 NE d.d NE
+/- NE +/- NE
1.0 NE d.d NE
(0.2-4) NE (d.d-d) NE
x NE x NE
10(-10) NE dd(-dd) NE
M NE X NE
; NE ; NE
SH G#other_name XX G#other_name
, NE , NE
0.6 NE d.d NE
+/- NE +/- NE
0.4 NE d.d NE
(0.2-1.2) NE (d.d-d.d) NE
x NE x NE
10(-10) NE dd(-dd) NE
M NE X NE
; NE ; NE
RT G#other_name XX G#other_name
, NE , NE
1.1 NE d.d NE
+/- NE +/- NE
0.5 NE d.d NE
(0.4-1.9) NE (d.d-d.d) NE
x NE x NE
10(-10) NE dd(-dd) NE
M NE X NE
; NE ; NE
controls G#multi_cell xxx G#multi_cell
, NE , NE
1.0 NE d.d NE
+/- NE +/- NE
0.6 NE d.d NE
(0.3-2.6) NE (d.d-d.d) NE
x NE x NE
10(-10) NE dd(-dd) NE
M) NE X) NE
. NE . NE
However NE Xxxx NE
, NE , NE
the NE xxx NE
maximal G#other_name_B xxx G#other_name_B
binding G#other_name_M xxx G#other_name_M
capacity G#other_name_E xxx G#other_name_E
( NE ( NE
Nmax G#other_name Xxxx G#other_name
) NE ) NE
was NE xxx NE
significantly NE xxx NE
enhanced NE xxx NE
in NE xx NE
PHP G#other_name XXX G#other_name
(3.9 NE (d.d NE
+/- NE +/- NE
1.9 NE d.d NE
(1.3-7.6) NE (d.d-d.d) NE
fmol/10(7) NE xxx/dd(d) NE
cells NE xxx NE
vs NE xx NE
. NE . NE
2.3 NE d.d NE
+/- NE +/- NE
0.9 NE d.d NE
(1.1-4.4) NE (d.d-d.d) NE
fmol/10(7) NE xxx/dd(d) NE
cells NE xxx NE
in NE xx NE
controls G#multi_cell xxx G#multi_cell
; NE ; NE
P NE X NE
= NE = NE
0.0006) NE d.dddd) NE
and NE xxx NE
decreased NE xxx NE
in NE xx NE
SH G#other_name XX G#other_name
(0.8 NE (d.d NE
+/- NE +/- NE
0.5 NE d.d NE
(0.2-1.6) NE (d.d-d.d) NE
fmol/10(7) NE xxx/dd(d) NE
cells NE xxx NE
vs NE xx NE
. NE . NE
2.3 NE d.d NE
+/- NE +/- NE
0.9 NE d.d NE
(1.1-4.4) NE (d.d-d.d) NE
fmol/10(7) NE xxx/dd(d) NE
cells NE xxx NE
in NE xx NE
controls G#multi_cell xxx G#multi_cell
; NE ; NE
P NE X NE
= NE = NE
0.0001) NE d.dddd) NE
, NE , NE
whereas NE xxx NE
no NE xx NE
changes NE xxx NE
were NE xxx NE
seen NE xxx NE
in NE xx NE
RT G#other_name XX G#other_name
(2.3 NE (d.d NE
+/- NE +/- NE
0.7 NE d.d NE
(1.2-3.3) NE (d.d-d.d) NE
fmol/10(7) NE xxx/dd(d) NE
cells NE xxx NE
vs NE xx NE
. NE . NE
2.3 NE d.d NE
+/- NE +/- NE
0.9 NE d.d NE
(1.1-4.4) NE (d.d-d.d) NE
fmol/10(7) NE xxx/dd(d) NE
cells NE xxx NE
in NE xx NE
controls G#multi_cell xxx G#multi_cell
) NE ) NE
. NE . NE

In NE Xx NE
three NE xxx NE
patients G#multi_cell xxx G#multi_cell
with NE xxx NE
PHP G#other_name XXX G#other_name
who NE xxx NE
were NE xxx NE
subjected NE xxx NE
to NE xx NE
parathyroidectomy NE xxx NE
, NE , NE
the NE xxx NE
calcitriol G#other_name_B xxx G#other_name_B
number G#other_name_E xxx G#other_name_E
came NE xxx NE
down NE xxx NE
to NE xx NE
normal NE xxx NE
. NE . NE

Changes NE Xxxx NE
of NE xx NE
calcitriol G#protein_molecule_B xxx G#protein_molecule_B
receptors G#protein_molecule_E xxx G#protein_molecule_E
in NE xx NE
primary NE xxx NE
and NE xxx NE
secondary G#other_name_B xxx G#other_name_B
hyperparathyroidism G#other_name_E xxx G#other_name_E
could NE xxx NE
magnify NE xxx NE
the NE xxx NE
consequences NE xxx NE
of NE xx NE
disturbances NE xxx NE
in NE xx NE
serum G#other_name_B xxx G#other_name_B
concentration G#other_name_E xxx G#other_name_E
of NE xx NE
calcitriol G#lipid xxx G#lipid
itself NE xxx NE
and NE xxx NE
might NE xxx NE
play NE xxx NE
an NE xx NE
important NE xxx NE
role NE xxx NE
in NE xx NE
the NE xxx NE
development NE xxx NE
of NE xx NE
secondary G#other_name_B xxx G#other_name_B
hyperparathyroidism G#other_name_E xxx G#other_name_E
in NE xx NE
uremia G#other_name xxx G#other_name
. NE . NE

The NE Xxx NE
severe NE xxx NE
phenotype NE xxx NE
of NE xx NE
females G#multi_cell xxx G#multi_cell
with NE xxx NE
tiny G#DNA_molecule_B xxx G#DNA_molecule_B
ring G#DNA_molecule_M xxx G#DNA_molecule_M
X G#DNA_molecule_M X G#DNA_molecule_M
chromosomes G#DNA_molecule_E xxx G#DNA_molecule_E
is NE xx NE
associated NE xxx NE
with NE xxx NE
inability NE xxx NE
of NE xx NE
these NE xxx NE
chromosomes G#DNA_family_or_group xxx G#DNA_family_or_group
to NE xx NE
undergo NE xxx NE
X G#other_name_B X G#other_name_B
inactivation G#other_name_E xxx G#other_name_E
. NE . NE

Mental G#other_name_B Xxxx G#other_name_B
retardation G#other_name_E xxx G#other_name_E
and NE xxx NE
a NE x NE
constellation NE xxx NE
of NE xx NE
congenital G#other_name_B xxx G#other_name_B
malformations G#other_name_E xxx G#other_name_E
not NE xxx NE
usually NE xxx NE
associated NE xxx NE
with NE xxx NE
Turner G#other_name_B Xxxx G#other_name_B
syndrome G#other_name_E xxx G#other_name_E
are NE xxx NE
seen NE xxx NE
in NE xx NE
some NE xxx NE
females G#multi_cell xxx G#multi_cell
with NE xxx NE
a NE x NE
mosaic G#DNA_N/A_B xxx G#DNA_N/A_B
45,X/46,X,r(X) G#DNA_N/A_M dd,X/dd,X,x(X) G#DNA_N/A_M
karyotype G#DNA_N/A_E xxx G#DNA_N/A_E
. NE . NE

Studies NE Xxxx NE
of NE xx NE
these NE xxx NE
females G#multi_cell xxx G#multi_cell
show NE xxx NE
that NE xxx NE
the NE xxx NE
XIST G#DNA_domain_or_region_B XXXX G#DNA_domain_or_region_B
locus G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
on NE xx NE
their NE xxx NE
tiny G#DNA_molecule_B xxx G#DNA_molecule_B
ring G#DNA_molecule_M xxx G#DNA_molecule_M
X G#DNA_molecule_M X G#DNA_molecule_M
chromosomes G#DNA_molecule_E xxx G#DNA_molecule_E
is NE xx NE
either NE xxx NE
not NE xxx NE
present NE xxx NE
or NE xx NE
not NE xxx NE
expressed NE xxx NE
. NE . NE

As NE Xx NE
XIST G#other_name_B XXXX G#other_name_B
transcription G#other_name_E xxx G#other_name_E
is NE xx NE
well NE xxx NE
correlated NE xxx NE
with NE xxx NE
inactivation NE xxx NE
of NE xx NE
the NE xxx NE
X G#DNA_molecule_B X G#DNA_molecule_B
chromosome G#DNA_molecule_E xxx G#DNA_molecule_E
in NE xx NE
female G#cell_type_B xxx G#cell_type_B
somatic G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
and NE xxx NE
spermatogonia G#cell_type xxx G#cell_type
, NE , NE
nonexpression G#other_name xxx G#other_name
of NE xx NE
the NE xxx NE
locus NE xxx NE
even NE xxx NE
when NE xxx NE
it NE xx NE
is NE xx NE
present NE xxx NE
suggests NE xxx NE
that NE xxx NE
these NE xxx NE
chromosomes G#DNA_family_or_group xxx G#DNA_family_or_group
are NE xxx NE
transcriptionally G#other_name_B xxx G#other_name_B
active G#other_name_E xxx G#other_name_E
. NE . NE

We NE Xx NE
examined NE xxx NE
the NE xxx NE
transcriptional G#other_name_B xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
of NE xx NE
ring NE xxx NE
X G#DNA_molecule_B X G#DNA_molecule_B
chromosomes G#DNA_molecule_E xxx G#DNA_molecule_E
lacking NE xxx NE
XIST G#other_name_B XXXX G#other_name_B
expression G#other_name_E xxx G#other_name_E
(XISTE-) NE (XXXXX-) NE
, NE , NE
from NE xxx NE
three NE xxx NE
females G#multi_cell xxx G#multi_cell
with NE xxx NE
severe NE xxx NE
phenotypes NE xxx NE
. NE . NE

The NE Xxx NE
two NE xxx NE
tiny NE xxx NE
ring NE xxx NE
X G#DNA_molecule_B X G#DNA_molecule_B
chromosomes G#DNA_molecule_E xxx G#DNA_molecule_E
studied NE xxx NE
with NE xxx NE
an NE xx NE
antibody G#protein_family_or_group xxx G#protein_family_or_group
specific NE xxx NE
for NE xxx NE
the NE xxx NE
acetylated NE xxx NE
isoforms NE xxx NE
of NE xx NE
histone G#protein_molecule_B xxx G#protein_molecule_B
H4 G#protein_molecule_E Xd G#protein_molecule_E
marking NE xxx NE
transcribed G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
chromatin G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
domains G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
were NE xxx NE
labeled NE xxx NE
at NE xx NE
a NE x NE
level NE xxx NE
consistent NE xxx NE
with NE xxx NE
their NE xxx NE
being NE xxx NE
active NE xxx NE
. NE . NE

We NE Xx NE
also NE xxx NE
examined NE xxx NE
tow NE xxx NE
of NE xx NE
the NE xxx NE
XISTE- G#DNA_molecule_B XXXXX- G#DNA_molecule_B
ring G#DNA_molecule_M xxx G#DNA_molecule_M
chromosomes G#DNA_molecule_E xxx G#DNA_molecule_E
to NE xx NE
determine NE xxx NE
whether NE xxx NE
genes G#DNA_family_or_group xxx G#DNA_family_or_group
that NE xxx NE
are NE xxx NE
normally NE xxx NE
silent NE xxx NE
on NE xx NE
an NE xx NE
inactive G#DNA_molecule_B xxx G#DNA_molecule_B
X G#DNA_molecule_E X G#DNA_molecule_E
are NE xxx NE
expressed NE xxx NE
from NE xxx NE
these NE xxx NE
chromosomes G#DNA_family_or_group xxx G#DNA_family_or_group
. NE . NE

Analyses NE Xxxx NE
of NE xx NE
hybrid G#cell_line_B xxx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
show NE xxx NE
that NE xxx NE
TIMP G#DNA_domain_or_region XXXX G#DNA_domain_or_region
, NE , NE
ZXDA G#DNA_domain_or_region XXXX G#DNA_domain_or_region
, NE , NE
and NE xxx NE
ZXDB G#DNA_domain_or_region_B XXXX G#DNA_domain_or_region_B
loci G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
on NE xx NE
the NE xxx NE
proximal G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
short G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
arm G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
and NE xxx NE
AR G#DNA_domain_or_region XX G#DNA_domain_or_region
and NE xxx NE
PHKA1 G#DNA_domain_or_region_B XXXXd G#DNA_domain_or_region_B
loci G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
on NE xx NE
the NE xxx NE
long NE xxx NE
arm NE xxx NE
, NE , NE
are NE xxx NE
well NE xxx NE
expressed NE xxx NE
from NE xxx NE
the NE xxx NE
tiny G#DNA_molecule_B xxx G#DNA_molecule_B
ring G#DNA_molecule_M xxx G#DNA_molecule_M
X G#DNA_molecule_M X G#DNA_molecule_M
chromosome G#DNA_molecule_E xxx G#DNA_molecule_E
lacking NE xxx NE
XIST G#DNA_family_or_group_B XXXX G#DNA_family_or_group_B
DNA G#DNA_family_or_group_E XXX G#DNA_family_or_group_E
. NE . NE

Studies NE Xxxx NE
of NE xx NE
the NE xxx NE
ring G#DNA_molecule_B xxx G#DNA_molecule_B
chromosome G#DNA_molecule_E xxx G#DNA_molecule_E
that NE xxx NE
has NE xxx NE
XIST G#DNA_family_or_group_B XXXX G#DNA_family_or_group_B
DNA G#DNA_family_or_group_E XXX G#DNA_family_or_group_E
but NE xxx NE
does NE xxx NE
not NE xxx NE
transcribe NE xxx NE
it NE xx NE
show NE xxx NE
that NE xxx NE
its NE xxx NE
AR G#other_name_B XX G#other_name_B
allele G#other_name_E xxx G#other_name_E
is NE xx NE
transcribed NE xxx NE
along NE xxx NE
with NE xxx NE
the NE xxx NE
one NE xxx NE
on NE xx NE
the NE xxx NE
normal NE xxx NE
X G#other_name_B X G#other_name_B
allele G#other_name_E xxx G#other_name_E
. NE . NE

(ABSTRACT NE (XXXXXXXX NE
TRUNCATED NE XXXXXXXXX NE
AT NE XX NE
250 NE ddd NE
WORDS) NE XXXXX) NE

Inhibition NE Xxxx NE
of NE xx NE
activation NE xxx NE
of NE xx NE
transcription G#protein_molecule_B xxx G#protein_molecule_B
factor G#protein_molecule_M xxx G#protein_molecule_M
AP-1 G#protein_molecule_E XX-d G#protein_molecule_E
by NE xx NE
CD28 G#protein_molecule XXdd G#protein_molecule
signalling NE xxx NE
in NE xx NE
human G#cell_type_B xxx G#cell_type_B
T-cells G#cell_type_E X-xxx G#cell_type_E
. NE . NE

Co-stimulation NE Xx-xxx NE
of NE xx NE
T-lymphocytes G#cell_type X-xxx G#cell_type
by NE xx NE
T-cell G#protein_family_or_group_B X-xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
TcR G#protein_family_or_group XxX G#protein_family_or_group
) NE ) NE
occupancy NE xxx NE
and NE xxx NE
activation NE xxx NE
of NE xx NE
the NE xxx NE
CD28 G#protein_molecule_B XXdd G#protein_molecule_B
surface G#protein_molecule_M xxx G#protein_molecule_M
molecule G#protein_molecule_E xxx G#protein_molecule_E
results NE xxx NE
in NE xx NE
enhanced NE xxx NE
proliferation G#other_name xxx G#other_name
and NE xxx NE
interleukin NE xxx NE
2 NE d NE
( NE ( NE
IL-2 NE XX-d NE
) NE ) NE
production NE xxx NE
. NE . NE

The NE Xxx NE
increase NE xxx NE
in NE xx NE
IL-2 G#protein_molecule XX-d G#protein_molecule
gene NE xxx NE
expression NE xxx NE
triggered NE xxx NE
by NE xx NE
CD28 G#protein_molecule XXdd G#protein_molecule
involves NE xxx NE
a NE x NE
kappa G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
B-like G#DNA_domain_or_region_M X-xxx G#DNA_domain_or_region_M
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
the NE xxx NE
5'-regulatory G#DNA_domain_or_region_B d'-xxx G#DNA_domain_or_region_B
region G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
the NE xxx NE
IL-2 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
called NE xxx NE
CD28 NE XXdd NE
-responsive NE -xxx NE
element NE xxx NE
. NE . NE

Stimulation NE Xxxx NE
of NE xx NE
T-cells G#cell_type X-xxx G#cell_type
by NE xx NE
agonistic NE xxx NE
anti- NE xxx- NE
CD28 NE XXdd NE
antibodies NE xxx NE
in NE xx NE
conjunction NE xxx NE
with NE xxx NE
phorbol NE xxx NE
12-myristate NE dd-xxx NE
13-acetate NE dd-xxx NE
( NE ( NE
PMA NE XXX NE
)- NE )- NE
or NE xx NE
TcR NE XxX NE
-derived NE -xxx NE
signals NE xxx NE
induces NE xxx NE
the NE xxx NE
enhanced NE xxx NE
activation NE xxx NE
of NE xx NE
the NE xxx NE
transcription NE xxx NE
factor NE xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
. NE . NE

Here NE Xxxx NE
we NE xx NE
report NE xxx NE
that NE xxx NE
CD28 G#protein_molecule XXdd G#protein_molecule
engagement NE xxx NE
, NE , NE
however NE xxx NE
, NE , NE
exerts NE xxx NE
opposite NE xxx NE
effects NE xxx NE
on NE xx NE
the NE xxx NE
transcription G#protein_molecule_B xxx G#protein_molecule_B
factor G#protein_molecule_M xxx G#protein_molecule_M
AP-1 G#protein_molecule_E XX-d G#protein_molecule_E
. NE . NE

Whereas NE Xxxx NE
anti- NE xxx- NE
CD28 NE XXdd NE
together NE xxx NE
with NE xxx NE
PMA NE XXX NE
increased NE xxx NE
the NE xxx NE
DNA NE XXX NE
binding NE xxx NE
and NE xxx NE
trans-activation NE xxx-xxx NE
activity NE xxx NE
of NE xx NE
NF-kappa NE XX-xxx NE
B NE X NE
, NE , NE
PMA NE XXX NE
-induced NE -xxx NE
activation NE xxx NE
of NE xx NE
AP-1 NE XX-d NE
was NE xxx NE
significantly NE xxx NE
suppressed NE xxx NE
. NE . NE

The NE Xxx NE
inhibitory NE xxx NE
effect NE xxx NE
exerted NE xxx NE
by NE xx NE
anti- NE xxx- NE
CD28 NE XXdd NE
was NE xxx NE
observed NE xxx NE
at NE xx NE
the NE xxx NE
level NE xxx NE
of NE xx NE
DNA NE XXX NE
binding NE xxx NE
as NE xx NE
well NE xxx NE
as NE xx NE
in NE xx NE
functional NE xxx NE
reporter-gene NE xxx-xxx NE
assays NE xxx NE
. NE . NE

These NE Xxxx NE
results NE xxx NE
suggest NE xxx NE
that NE xxx NE
the NE xxx NE
two NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
are NE xxx NE
independently NE xxx NE
regulated NE xxx NE
and NE xxx NE
may NE xxx NE
perform NE xxx NE
different NE xxx NE
functions NE xxx NE
during NE xxx NE
T-cell G#other_name_B X-xxx G#other_name_B
activation G#other_name_E xxx G#other_name_E
. NE . NE

HIV-1 G#protein_molecule_B XXX-d G#protein_molecule_B
Nef G#protein_molecule_E Xxx G#protein_molecule_E
leads NE xxx NE
to NE xx NE
inhibition NE xxx NE
or NE xx NE
activation NE xxx NE
of NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
depending NE xxx NE
on NE xx NE
its NE xxx NE
intracellular G#other_name_B xxx G#other_name_B
localization G#other_name_E xxx G#other_name_E
. NE . NE

Nef G#protein_molecule Xxx G#protein_molecule
of NE xx NE
primate NE xxx NE
lentiviruses NE xxx NE
is NE xx NE
required NE xxx NE
for NE xxx NE
viremia NE xxx NE
and NE xxx NE
progression NE xxx NE
to NE xx NE
AIDS NE XXXX NE
in NE xx NE
monkeys NE xxx NE
. NE . NE

Negative NE Xxxx NE
, NE , NE
positive NE xxx NE
, NE , NE
and NE xxx NE
no NE xx NE
effects NE xxx NE
of NE xx NE
Nef G#protein_molecule Xxx G#protein_molecule
have NE xxx NE
also NE xxx NE
been NE xxx NE
reported NE xxx NE
on NE xx NE
viral G#other_name_B xxx G#other_name_B
replication G#other_name_E xxx G#other_name_E
in NE xx NE
cells NE xxx NE
. NE . NE

To NE Xx NE
reconcile NE xxx NE
these NE xxx NE
observations NE xxx NE
, NE , NE
we NE xx NE
expressed NE xxx NE
a NE x NE
hybrid NE xxx NE
CD8- NE XXd- NE
Nef NE Xxx NE
protein NE xxx NE
in NE xx NE
Jurkat NE Xxxx NE
cells NE xxx NE
. NE . NE

Two NE Xxx NE
opposite NE xxx NE
phenotypes G#other_name xxx G#other_name
were NE xxx NE
found NE xxx NE
, NE , NE
which NE xxx NE
depended NE xxx NE
on NE xx NE
the NE xxx NE
intracellular G#other_name_B xxx G#other_name_B
localization G#other_name_E xxx G#other_name_E
of NE xx NE
Nef G#protein_molecule Xxx G#protein_molecule
. NE . NE

Expressed NE Xxxx NE
in NE xx NE
the NE xxx NE
cytoplasm G#cell_component xxx G#cell_component
or NE xx NE
on NE xx NE
the NE xxx NE
cell G#cell_component_B xxx G#cell_component_B
surface G#cell_component_E xxx G#cell_component_E
, NE , NE
the NE xxx NE
chimera G#protein_family_or_group xxx G#protein_family_or_group
inhibited NE xxx NE
or NE xx NE
activated NE xxx NE
early NE xxx NE
signaling NE xxx NE
events NE xxx NE
from NE xxx NE
the NE xxx NE
T G#protein_family_or_group_B X G#protein_family_or_group_B
cell G#protein_family_or_group_M xxx G#protein_family_or_group_M
antigen G#protein_family_or_group_M xxx G#protein_family_or_group_M
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Activated NE Xxxx NE
Jurkat G#cell_line_B Xxxx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
died NE xxx NE
by NE xx NE
apoptosis G#other_name xxx G#other_name
, NE , NE
and NE xxx NE
only NE xxx NE
cells NE xxx NE
with NE xxx NE
mutated NE xxx NE
nef G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
expressing NE xxx NE
truncated NE xxx NE
Nefs G#protein_molecule Xxxx G#protein_molecule
survived NE xxx NE
, NE , NE
which NE xxx NE
rendered NE xxx NE
Nef G#protein_molecule Xxx G#protein_molecule
nonfunctional NE xxx NE
. NE . NE

These NE Xxxx NE
mutations NE xxx NE
paralleled NE xxx NE
those NE xxx NE
in NE xx NE
other NE xxx NE
viral NE xxx NE
strains NE xxx NE
passaged NE xxx NE
in NE xx NE
vitro NE xxx NE
. NE . NE

Not NE Xxx NE
only NE xxx NE
do NE xx NE
these NE xxx NE
positional NE xxx NE
effects NE xxx NE
of NE xx NE
Nef G#protein_molecule Xxx G#protein_molecule
reconcile NE xxx NE
diverse NE xxx NE
phenotypes NE xxx NE
of NE xx NE
Nef G#protein_molecule Xxx G#protein_molecule
and NE xxx NE
suggest NE xxx NE
a NE x NE
role NE xxx NE
for NE xxx NE
its NE xxx NE
N-terminal G#other_name_B X-xxx G#other_name_B
myristylation G#other_name_E xxx G#other_name_E
, NE , NE
but NE xxx NE
they NE xxx NE
also NE xxx NE
explain NE xxx NE
effects NE xxx NE
of NE xx NE
Nef G#protein_molecule Xxx G#protein_molecule
in NE xx NE
HIV G#other_name_B XXX G#other_name_B
infection G#other_name_E xxx G#other_name_E
and NE xxx NE
progression NE xxx NE
to NE xx NE
AIDS G#other_name XXXX G#other_name
. NE . NE

An NE Xx NE
intricate NE xxx NE
arrangement NE xxx NE
of NE xx NE
binding NE xxx NE
sites NE xxx NE
for NE xxx NE
the NE xxx NE
Ets G#protein_family_or_group_B Xxx G#protein_family_or_group_B
family G#protein_family_or_group_E xxx G#protein_family_or_group_E
of NE xx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
regulates NE xxx NE
activity NE xxx NE
of NE xx NE
the NE xxx NE
alpha G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
4 G#DNA_domain_or_region_M d G#DNA_domain_or_region_M
integrin G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

alpha G#protein_family_or_group_B xxx G#protein_family_or_group_B
4 G#protein_family_or_group_M d G#protein_family_or_group_M
integrins G#protein_family_or_group_E xxx G#protein_family_or_group_E
mediate NE xxx NE
cell-cell G#other_name_B xxx-xxx G#other_name_B
interaction G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
cell-extracellular G#other_name_M xxx-xxx G#other_name_M
matrix G#other_name_M xxx G#other_name_M
interaction G#other_name_E xxx G#other_name_E
differentiation NE xxx NE
of NE xx NE
skeletal G#tissue_B xxx G#tissue_B
muscle G#tissue_E xxx G#tissue_E
. NE . NE

Here NE Xxxx NE
we NE xx NE
examine NE xxx NE
molecular NE xxx NE
mechanisms NE xxx NE
controlling NE xxx NE
the NE xxx NE
pattern NE xxx NE
of NE xx NE
alpha G#other_name_B xxx G#other_name_B
4 G#other_name_M d G#other_name_M
expression G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
activity NE xxx NE
of NE xx NE
constructs NE xxx NE
containing NE xxx NE
5' G#DNA_family_or_group_B d' G#DNA_family_or_group_B
deletion G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
mutants G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
of NE xx NE
the NE xxx NE
alpha G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
4 G#DNA_domain_or_region_M d G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
was NE xxx NE
compared NE xxx NE
in NE xx NE
transfection G#other_name_B xxx G#other_name_B
assays G#other_name_E xxx G#other_name_E
into NE xxx NE
cell G#cell_line_B xxx G#cell_line_B
lines G#cell_line_E xxx G#cell_line_E
that NE xxx NE
express NE xxx NE
alpha G#protein_molecule_B xxx G#protein_molecule_B
4 G#protein_molecule_E d G#protein_molecule_E
and NE xxx NE
cell G#cell_line_B xxx G#cell_line_B
lines G#cell_line_E xxx G#cell_line_E
that NE xxx NE
do NE xx NE
not NE xxx NE
. NE . NE

The NE Xxx NE
sequence NE xxx NE
between NE xxx NE
position NE xxx NE
-42 G#DNA_domain_or_region_B -dd G#DNA_domain_or_region_B
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
-76 G#DNA_domain_or_region_M -dd G#DNA_domain_or_region_M
base G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
pairs G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
(bp) NE (xx) NE
was NE xxx NE
required NE xxx NE
for NE xxx NE
efficient NE xxx NE
transcription NE xxx NE
in NE xx NE
cells NE xxx NE
that NE xxx NE
express NE xxx NE
alpha G#protein_molecule_B xxx G#protein_molecule_B
4 G#protein_molecule_E d G#protein_molecule_E
, NE , NE
but NE xxx NE
it NE xx NE
showed NE xxx NE
no NE xx NE
activity NE xxx NE
in NE xx NE
HeLa G#cell_line_B XxXx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
, NE , NE
which NE xxx NE
do NE xx NE
not NE xxx NE
express NE xxx NE
alpha G#protein_molecule_B xxx G#protein_molecule_B
4 G#protein_molecule_E d G#protein_molecule_E
. NE . NE

Three NE Xxxx NE
binding G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
for NE xxx NE
the NE xxx NE
Ets G#protein_family_or_group_B Xxx G#protein_family_or_group_B
family G#protein_family_or_group_E xxx G#protein_family_or_group_E
of NE xx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
are NE xxx NE
found NE xxx NE
in NE xx NE
this NE xxx NE
region NE xxx NE
: NE : NE
two NE xxx NE
adjacent NE xxx NE
sites NE xxx NE
at NE xx NE
positions NE xxx NE
-50 G#DNA_domain_or_region_B -dd G#DNA_domain_or_region_B
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
-54 G#DNA_domain_or_region_M -dd G#DNA_domain_or_region_M
bp G#DNA_domain_or_region_E xx G#DNA_domain_or_region_E
and NE xxx NE
a NE x NE
more NE xxx NE
5' G#DNA_domain_or_region_B d' G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
at NE xx NE
position NE xxx NE
-67 G#DNA_domain_or_region_B -dd G#DNA_domain_or_region_B
bp G#DNA_domain_or_region_E xx G#DNA_domain_or_region_E
. NE . NE

Using NE Xxxx NE
a NE x NE
series NE xxx NE
of NE xx NE
constructs NE xxx NE
containing NE xxx NE
deletions G#other_name xxx G#other_name
and NE xxx NE
mutations G#other_name xxx G#other_name
in NE xx NE
this NE xxx NE
region NE xxx NE
, NE , NE
we NE xx NE
found NE xxx NE
that NE xxx NE
the NE xxx NE
3'-most G#DNA_domain_or_region_B d'-xxx G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
alone NE xxx NE
was NE xxx NE
sufficient NE xxx NE
for NE xxx NE
binding NE xxx NE
GA-binding G#protein_molecule_B XX-xxx G#protein_molecule_B
protein G#protein_molecule_M xxx G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
GABP NE XXXX NE
alpha NE xxx NE
) NE ) NE
/ NE / NE
GABP NE XXXX NE
beta NE xxx NE
and NE xxx NE
for NE xxx NE
a NE x NE
low NE xxx NE
level NE xxx NE
of NE xx NE
transcriptional NE xxx NE
activation NE xxx NE
. NE . NE

When NE Xxxx NE
all NE xxx NE
three NE xxx NE
sites NE xxx NE
were NE xxx NE
present NE xxx NE
, NE , NE
a NE x NE
second NE xxx NE
complex NE xxx NE
"a" NE "x" NE
was NE xxx NE
detected NE xxx NE
, NE , NE
which NE xxx NE
contains NE xxx NE
an NE xx NE
unknown NE xxx NE
member NE xxx NE
of NE xx NE
the NE xxx NE
Ets G#protein_family_or_group_B Xxx G#protein_family_or_group_B
family G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Formation NE Xxxx NE
of NE xx NE
complex NE xxx NE
a NE x NE
was NE xxx NE
cell-type NE xxx-xxx NE
specific NE xxx NE
and NE xxx NE
correlated NE xxx NE
with NE xxx NE
a NE x NE
high NE xxx NE
level NE xxx NE
of NE xx NE
transcription NE xxx NE
. NE . NE

Deletion NE Xxxx NE
of NE xx NE
the NE xxx NE
5'-most G#DNA_domain_or_region_B d'-xxx G#DNA_domain_or_region_B
Ets G#DNA_domain_or_region_M Xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
had NE xxx NE
no NE xx NE
effect NE xxx NE
on NE xx NE
binding NE xxx NE
to NE xx NE
GABP G#protein_complex_B XXXX G#protein_complex_B
alpha/GABP G#protein_complex_M xxx/XXXX G#protein_complex_M
beta G#protein_complex_E xxx G#protein_complex_E
, NE , NE
but NE xxx NE
it NE xx NE
eliminated NE xxx NE
a NE x NE
. NE . NE

Concomitant NE Xxxx NE
with NE xxx NE
this NE xxx NE
loss NE xxx NE
of NE xx NE
a NE x NE
, NE , NE
a NE x NE
new G#protein_complex_B xxx G#protein_complex_B
Ets-1-containing G#protein_complex_M Xxx-d-xxx G#protein_complex_M
complex G#protein_complex_E xxx G#protein_complex_E
" NE " NE
c G#protein_complex x G#protein_complex
" NE " NE
appeared NE xxx NE
. NE . NE

Complex NE Xxxx NE
c NE x NE
substituted NE xxx NE
efficiently NE xxx NE
for NE xxx NE
complex NE xxx NE
a NE x NE
in NE xx NE
transcriptional G#other_name_B xxx G#other_name_B
activation G#other_name_E xxx G#other_name_E
. NE . NE

We NE Xx NE
conclude NE xxx NE
that NE xxx NE
although NE xxx NE
neither NE xxx NE
of NE xx NE
the NE xxx NE
two NE xxx NE
5'-most G#DNA_domain_or_region_B d'-xxx G#DNA_domain_or_region_B
Ets G#DNA_domain_or_region_M Xxx G#DNA_domain_or_region_M
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
alone NE xxx NE
binds NE xxx NE
nuclear G#protein_family_or_group_B xxx G#protein_family_or_group_B
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
they NE xxx NE
appear NE xxx NE
to NE xx NE
act NE xxx NE
as NE xx NE
modulators NE xxx NE
which NE xxx NE
control NE xxx NE
the NE xxx NE
pattern NE xxx NE
of NE xx NE
Ets G#protein_family_or_group_B Xxx G#protein_family_or_group_B
proteins G#protein_family_or_group_E xxx G#protein_family_or_group_E
that NE xxx NE
bind NE xxx NE
the NE xxx NE
alpha G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
4 G#DNA_domain_or_region_M d G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

This NE Xxxx NE
arrangement NE xxx NE
of NE xx NE
Ets G#DNA_domain_or_region_B Xxx G#DNA_domain_or_region_B
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
coupled NE xxx NE
with NE xxx NE
the NE xxx NE
tissue- NE xxx- NE
and NE xxx NE
developmental-specific NE xxx-xxx NE
expression NE xxx NE
of NE xx NE
Ets G#protein_family_or_group_B Xxx G#protein_family_or_group_B
members G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
likely NE xxx NE
play NE xxx NE
a NE x NE
key NE xxx NE
role NE xxx NE
in NE xx NE
defining NE xxx NE
the NE xxx NE
pattern NE xxx NE
of NE xx NE
alpha G#protein_molecule_B xxx G#protein_molecule_B
4 G#protein_molecule_M d G#protein_molecule_M
integrin G#protein_molecule_E xxx G#protein_molecule_E
. NE . NE

Mechanism NE Xxxx NE
of NE xx NE
antiandrogen G#other_name_B xxx G#other_name_B
action G#other_name_E xxx G#other_name_E
: NE : NE
conformational NE xxx NE
changes NE xxx NE
of NE xx NE
the NE xxx NE
receptor NE xxx NE
. NE . NE

Androgen G#RNA_molecule_B Xxxx G#RNA_molecule_B
receptor G#RNA_molecule_M xxx G#RNA_molecule_M
mRNA G#RNA_molecule_E xXXX G#RNA_molecule_E
was NE xxx NE
translated NE xxx NE
in NE xx NE
vitro NE xxx NE
, NE , NE
and NE xxx NE
androgen-bound G#protein_complex_B xxx-xxx G#protein_complex_B
receptor G#protein_complex_M xxx G#protein_complex_M
complex G#protein_complex_M xxx G#protein_complex_M
and G#protein_complex_M xxx G#protein_complex_M
antiandrogen-bound G#protein_complex_M xxx-xxx G#protein_complex_M
receptor G#protein_complex_M xxx G#protein_complex_M
complex G#protein_complex_E xxx G#protein_complex_E
bound NE xxx NE
receptor NE xxx NE
complexes NE xxx NE
were NE xxx NE
studied NE xxx NE
using NE xxx NE
limited NE xxx NE
proteolytic NE xxx NE
digestion NE xxx NE
by NE xx NE
trypsin G#protein_molecule xxx G#protein_molecule
. NE . NE

Partial NE Xxxx NE
proteolysis NE xxx NE
of NE xx NE
androgen NE xxx NE
-bound NE -xxx NE
receptor NE xxx NE
protein NE xxx NE
resulted NE xxx NE
in NE xx NE
a NE x NE
29-kDa NE dd-xXx NE
proteolysis-resisting NE xxx-xxx NE
fragment NE xxx NE
, NE , NE
whereas NE xxx NE
antiandrogen NE xxx NE
binding NE xxx NE
stabilised NE xxx NE
a NE x NE
35-kDa NE dd-xXx NE
fragment NE xxx NE
. NE . NE

Both NE Xxxx NE
fragments NE xxx NE
contain NE xxx NE
the NE xxx NE
entire NE xxx NE
ligand G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
binding G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
, NE , NE
and NE xxx NE
the NE xxx NE
35-kDa G#protein_molecule_B dd-xXx G#protein_molecule_B
fragment G#protein_molecule_E xxx G#protein_molecule_E
extended NE xxx NE
into NE xxx NE
the NE xxx NE
hinge G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
region G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
of NE xx NE
the NE xxx NE
receptor NE xxx NE
. NE . NE

Several NE Xxxx NE
antiandrogens G#lipid xxx G#lipid
show NE xxx NE
agonistic NE xxx NE
properties NE xxx NE
for NE xxx NE
a NE x NE
mutated G#protein_molecule_B xxx G#protein_molecule_B
androgen G#protein_molecule_M xxx G#protein_molecule_M
receptor G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
LNCaP G#cell_line_B XXXxX G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
variant G#cell_line_E xxx G#cell_line_E
) NE ) NE
; NE ; NE
trypsin G#protein_molecule xxx G#protein_molecule
digestion NE xxx NE
of NE xx NE
antiandrogen NE xxx NE
-bound NE -xxx NE
mutated NE xxx NE
receptor NE xxx NE
also NE xxx NE
resulted NE xxx NE
in NE xx NE
a NE x NE
29-kDa NE dd-xXx NE
fragment NE xxx NE
. NE . NE

Our NE Xxx NE
results NE xxx NE
point NE xxx NE
to NE xx NE
an NE xx NE
important NE xxx NE
difference NE xxx NE
between NE xxx NE
antiandrogens G#lipid xxx G#lipid
and NE xxx NE
antagonists NE xxx NE
of NE xx NE
other NE xxx NE
steroid G#protein_family_or_group_B xxx G#protein_family_or_group_B
hormone G#protein_family_or_group_M xxx G#protein_family_or_group_M
receptors G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Antiandrogens G#lipid Xxxx G#lipid
result NE xxx NE
in NE xx NE
protection NE xxx NE
of NE xx NE
both NE xxx NE
the NE xxx NE
hinge G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
region G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
and NE xxx NE
C-terminus G#protein_domain_or_region X-xxx G#protein_domain_or_region
of NE xx NE
the NE xxx NE
androgen G#protein_family_or_group_B xxx G#protein_family_or_group_B
receptor G#protein_family_or_group_E xxx G#protein_family_or_group_E
agonist NE xxx NE
proteolytic G#other_name_B xxx G#other_name_B
attack G#other_name_E xxx G#other_name_E
, NE , NE
whereas NE xxx NE
other NE xxx NE
studies NE xxx NE
showed NE xxx NE
that NE xxx NE
antiestrogens G#other_organic_compound xxx G#other_organic_compound
and NE xxx NE
antiprogestagens NE xxx NE
expose NE xxx NE
the NE xxx NE
C-terminal G#protein_domain_or_region_B X-xxx G#protein_domain_or_region_B
end G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
of NE xx NE
the NE xxx NE
ligand G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
binding G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
of NE xx NE
their NE xxx NE
respective NE xxx NE
receptors NE xxx NE
to NE xx NE
protease G#protein_molecule xxx G#protein_molecule
. NE . NE

Differences NE Xxxx NE
in NE xx NE
conformation NE xxx NE
of NE xx NE
the NE xxx NE
hinge G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
region G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
distinguish NE xxx NE
androgen NE xxx NE
-bound NE -xxx NE
from NE xxx NE
antiandrogen NE xxx NE
-bound NE -xxx NE
receptor NE xxx NE
complexes NE xxx NE
, NE , NE
which NE xxx NE
represents NE xxx NE
an NE xx NE
important NE xxx NE
feature NE xxx NE
of NE xx NE
antiandrogen NE xxx NE
action NE xxx NE
. NE . NE

Activation NE Xxxx NE
of NE xx NE
nuclear G#protein_molecule_B xxx G#protein_molecule_B
factor G#protein_molecule_M xxx G#protein_molecule_M
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_E X G#protein_molecule_E
in NE xx NE
human G#cell_line_B xxx G#cell_line_B
neuroblastoma G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
. NE . NE

The NE Xxx NE
nuclear G#protein_molecule_B xxx G#protein_molecule_B
factor G#protein_molecule_M xxx G#protein_molecule_M
kappa G#protein_molecule_M xxx G#protein_molecule_M
B G#protein_molecule_E X G#protein_molecule_E
( NE ( NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
) NE ) NE
is NE xx NE
a NE x NE
eukaryotic NE xxx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

In NE Xx NE
B G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
and NE xxx NE
macrophages G#cell_type xxx G#cell_type
it NE xx NE
is NE xx NE
constitutively NE xxx NE
present NE xxx NE
in NE xx NE
cell NE xxx NE
nuclei NE xxx NE
, NE , NE
whereas NE xxx NE
in NE xx NE
many NE xxx NE
other NE xxx NE
cell NE xxx NE
types NE xxx NE
, NE , NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
translocates NE xxx NE
from NE xxx NE
cytosol G#cell_component xxx G#cell_component
to NE xx NE
nucleus G#cell_component xxx G#cell_component
as NE xx NE
a NE x NE
result NE xxx NE
of NE xx NE
transduction NE xxx NE
by NE xx NE
tumor G#protein_molecule_B xxx G#protein_molecule_B
necrosis G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_M xxx G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
TNF G#protein_molecule_B XXX G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
) NE ) NE
, NE , NE
phorbol G#other_organic_compound_B xxx G#other_organic_compound_B
ester G#other_organic_compound_E xxx G#other_organic_compound_E
, NE , NE
and NE xxx NE
other NE xxx NE
polyclonal G#other_name_B xxx G#other_name_B
signals G#other_name_E xxx G#other_name_E
. NE . NE

Using NE Xxxx NE
neuroblastoma G#cell_line_B xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
as NE xx NE
models NE xxx NE
, NE , NE
we NE xx NE
have NE xxx NE
shown NE xxx NE
that NE xxx NE
in NE xx NE
neural G#cell_type_B xxx G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
was NE xxx NE
present NE xxx NE
in NE xx NE
the NE xxx NE
cytosol G#cell_component xxx G#cell_component
and NE xxx NE
translocated NE xxx NE
into NE xxx NE
nuclei G#cell_component xxx G#cell_component
as NE xx NE
a NE x NE
result NE xxx NE
of NE xx NE
TNF G#other_name_B XXX G#other_name_B
alpha G#other_name_M xxx G#other_name_M
treatment G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
TNF G#protein_molecule_B XXX G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
-activated NE -xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
was NE xxx NE
transcriptionally NE xxx NE
functional NE xxx NE
. NE . NE

NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
activation NE xxx NE
by NE xx NE
TNF G#protein_molecule_B XXX G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
was NE xxx NE
not NE xxx NE
correlated NE xxx NE
with NE xxx NE
cell G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
or NE xx NE
proliferation G#other_name xxx G#other_name
. NE . NE

However NE Xxxx NE
, NE , NE
reagents NE xxx NE
such NE xxx NE
as NE xx NE
nerve G#protein_family_or_group_B xxx G#protein_family_or_group_B
growth G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
NGF G#protein_family_or_group XXX G#protein_family_or_group
) NE ) NE
and NE xxx NE
the NE xxx NE
phorbol G#other_organic_compound_B xxx G#other_organic_compound_B
ester G#other_organic_compound_E xxx G#other_organic_compound_E
phorbol NE xxx NE
12-myristate NE dd-xxx NE
13-acetate NE dd-xxx NE
( NE ( NE
PMA G#other_organic_compound XXX G#other_organic_compound
) NE ) NE
, NE , NE
which NE xxx NE
induce NE xxx NE
phenotypical NE xxx NE
differentiation G#other_name xxx G#other_name
of NE xx NE
the NE xxx NE
SH-SY5Y G#cell_line_B XX-XXdX G#cell_line_B
neuroblastoma G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
, NE , NE
activated NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
, NE , NE
but NE xxx NE
only NE xxx NE
in NE xx NE
that NE xxx NE
particular NE xxx NE
cell G#cell_line_B xxx G#cell_line_B
line G#cell_line_E xxx G#cell_line_E
. NE . NE

In NE Xx NE
a NE x NE
NGF NE XXX NE
-responsive NE -xxx NE
rat NE xxx NE
pheochromocytoma NE xxx NE
cell NE xxx NE
line NE xxx NE
, NE , NE
PC12 NE XXdd NE
, NE , NE
PMA NE XXX NE
activated NE xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
, NE , NE
whereas NE xxx NE
NGF NE XXX NE
did NE xxx NE
not NE xxx NE
. NE . NE

In NE Xx NE
other NE xxx NE
neuroblastoma G#cell_line_B xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
, NE , NE
such NE xxx NE
as NE xx NE
SK-N-Be(2) G#cell_line XX-X-Xx(d) G#cell_line
, NE , NE
the NE xxx NE
lack NE xxx NE
of NE xx NE
PMA G#other_organic_compound XXX G#other_organic_compound
induction NE xxx NE
of NE xx NE
differentiation G#other_name xxx G#other_name
was NE xxx NE
correlated NE xxx NE
with NE xxx NE
the NE xxx NE
lack NE xxx NE
of NE xx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
activation G#other_name_E xxx G#other_name_E
. NE . NE

We NE Xx NE
found NE xxx NE
, NE , NE
moreover NE xxx NE
, NE , NE
that NE xxx NE
in NE xx NE
SK-N-Be(2) G#cell_line_B XX-X-Xx(d) G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
protein NE xxx NE
kinase NE xxx NE
C NE X NE
( NE ( NE
PKC NE XXX NE
) NE ) NE
enzymatic NE xxx NE
activity NE xxx NE
was NE xxx NE
much NE xxx NE
lower NE xxx NE
compared NE xxx NE
with NE xxx NE
that NE xxx NE
in NE xx NE
a NE x NE
control NE xxx NE
cell NE xxx NE
line NE xxx NE
and NE xxx NE
that NE xxx NE
the NE xxx NE
low NE xxx NE
PKC NE XXX NE
enzymatic NE xxx NE
activity NE xxx NE
was NE xxx NE
due NE xxx NE
to NE xx NE
low NE xxx NE
PKC NE XXX NE
protein NE xxx NE
expression NE xxx NE
. NE . NE

NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
was NE xxx NE
not NE xxx NE
activated NE xxx NE
by NE xx NE
retinoic G#other_organic_compound_B xxx G#other_organic_compound_B
acid G#other_organic_compound_E xxx G#other_organic_compound_E
, NE , NE
which NE xxx NE
induced NE xxx NE
morphological NE xxx NE
differentiation NE xxx NE
of NE xx NE
all NE xxx NE
the NE xxx NE
neuroblastoma G#cell_line_B xxx G#cell_line_B
cell G#cell_line_M xxx G#cell_line_M
lines G#cell_line_E xxx G#cell_line_E
used NE xxx NE
in NE xx NE
the NE xxx NE
present NE xxx NE
study NE xxx NE
. NE . NE

Thus NE Xxxx NE
, NE , NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
activation NE xxx NE
was NE xxx NE
not NE xxx NE
required NE xxx NE
for NE xxx NE
neuroblastoma G#other_name_B xxx G#other_name_B
cell G#other_name_M xxx G#other_name_M
differentiation G#other_name_E xxx G#other_name_E
. NE . NE

Furthermore NE Xxxx NE
, NE , NE
the NE xxx NE
results NE xxx NE
obtained NE xxx NE
with NE xxx NE
TNF G#protein_molecule_B XXX G#protein_molecule_B
alpha G#protein_molecule_E xxx G#protein_molecule_E
proved NE xxx NE
that NE xxx NE
NF-kappa G#other_name_B XX-xxx G#other_name_B
B G#other_name_M X G#other_name_M
activation G#other_name_E xxx G#other_name_E
was NE xxx NE
not NE xxx NE
sufficient NE xxx NE
for NE xxx NE
induction NE xxx NE
of NE xx NE
neuroblastoma G#other_name_B xxx G#other_name_B
differentiation G#other_name_E xxx G#other_name_E
. NE . NE

ERP G#protein_molecule XXX G#protein_molecule
, NE , NE
a NE x NE
new NE xxx NE
member NE xxx NE
of NE xx NE
the NE xxx NE
ets G#protein_family_or_group_B xxx G#protein_family_or_group_B
transcription G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor/oncoprotein G#protein_family_or_group_M xxx/xxx G#protein_family_or_group_M
family G#protein_family_or_group_E xxx G#protein_family_or_group_E
: NE : NE
cloning G#other_name xxx G#other_name
, NE , NE
characterization G#other_name xxx G#other_name
, NE , NE
and NE xxx NE
differential G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
during NE xxx NE
B-lymphocyte G#other_name_B X-xxx G#other_name_B
development G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
ets G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
gene G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
family G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
encodes NE xxx NE
a NE x NE
group NE xxx NE
of NE xx NE
proteins NE xxx NE
which NE xxx NE
function NE xxx NE
as NE xx NE
transcription G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
under NE xxx NE
physiological NE xxx NE
conditions NE xxx NE
and NE xxx NE
, NE , NE
if NE xx NE
aberrantly NE xxx NE
expressed NE xxx NE
, NE , NE
can NE xxx NE
cause NE xxx NE
cellular G#other_name_B xxx G#other_name_B
transformation G#other_name_E xxx G#other_name_E
. NE . NE

We NE Xx NE
have NE xxx NE
recently NE xxx NE
identified NE xxx NE
two NE xxx NE
regulatory NE xxx NE
elements NE xxx NE
in NE xx NE
the NE xxx NE
murine G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
immunoglobulin G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
heavy-chain G#DNA_domain_or_region_M xxx-xxx G#DNA_domain_or_region_M
(IgH) G#DNA_domain_or_region_M (XxX) G#DNA_domain_or_region_M
enhancer G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
pi G#DNA_domain_or_region xx G#DNA_domain_or_region
and NE xxx NE
microB G#DNA_domain_or_region xxxX G#DNA_domain_or_region
, NE , NE
which NE xxx NE
exhibit NE xxx NE
striking NE xxx NE
similarity NE xxx NE
to NE xx NE
binding G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
for NE xxx NE
ets-related G#DNA_family_or_group_B xxx-xxx G#DNA_family_or_group_B
proteins G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
. NE . NE

To NE Xx NE
identify NE xxx NE
ets-related G#protein_family_or_group_B xxx-xxx G#protein_family_or_group_B
transcriptional G#protein_family_or_group_M xxx G#protein_family_or_group_M
regulators G#protein_family_or_group_E xxx G#protein_family_or_group_E
expressed NE xxx NE
in NE xx NE
pre-B G#cell_type_B xxx-X G#cell_type_B
lymphocytes G#cell_type_E xxx G#cell_type_E
that NE xxx NE
may NE xxx NE
interact NE xxx NE
with NE xxx NE
either NE xxx NE
the NE xxx NE
pi G#DNA_domain_or_region xx G#DNA_domain_or_region
or NE xx NE
the NE xxx NE
microB G#DNA_domain_or_region_B xxxX G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
we NE xx NE
have NE xxx NE
used NE xxx NE
a NE x NE
PCR G#other_name_B XXX G#other_name_B
approach G#other_name_E xxx G#other_name_E
with NE xxx NE
degenerate G#polynucleotide_B xxx G#polynucleotide_B
oligonucleotides G#polynucleotide_E xxx G#polynucleotide_E
encoding NE xxx NE
conserved NE xxx NE
sequences NE xxx NE
in NE xx NE
all NE xxx NE
members NE xxx NE
of NE xx NE
the NE xxx NE
ets G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
family G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
. NE . NE

We NE Xx NE
have NE xxx NE
cloned NE xxx NE
the NE xxx NE
gene NE xxx NE
for NE xxx NE
a NE x NE
new NE xxx NE
ets-related G#protein_family_or_group_B xxx-xxx G#protein_family_or_group_B
transcription G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
, NE , NE
ERP G#protein_molecule XXX G#protein_molecule
( NE ( NE
ets-related G#protein_molecule_B xxx-xxx G#protein_molecule_B
protein G#protein_molecule_E xxx G#protein_molecule_E
) NE ) NE
, NE , NE
from NE xxx NE
the NE xxx NE
murine G#cell_line_B xxx G#cell_line_B
pre-B G#cell_line_M xxx-X G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
BASC G#cell_line_B XXXX G#cell_line_B
6C2 G#cell_line_E dXd G#cell_line_E
and NE xxx NE
from NE xxx NE
mouse G#tissue_B xxx G#tissue_B
lung G#tissue_M xxx G#tissue_M
tissue G#tissue_E xxx G#tissue_E
. NE . NE

The NE Xxx NE
ERP G#protein_molecule XXX G#protein_molecule
protein NE xxx NE
contains NE xxx NE
a NE x NE
region NE xxx NE
of NE xx NE
high NE xxx NE
homology NE xxx NE
with NE xxx NE
the NE xxx NE
ETS NE XXX NE
DNA-binding NE XXX-xxx NE
domain NE xxx NE
common NE xxx NE
to NE xx NE
all NE xxx NE
members NE xxx NE
of NE xx NE
the NE xxx NE
ets G#protein_family_or_group_B xxx G#protein_family_or_group_B
transcription G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor/oncoprotein G#protein_family_or_group_M xxx/xxx G#protein_family_or_group_M
family G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Three NE Xxxx NE
additional NE xxx NE
smaller NE xxx NE
regions NE xxx NE
show NE xxx NE
homology NE xxx NE
to NE xx NE
the NE xxx NE
ELK-1 NE XXX-d NE
and NE xxx NE
SAP-1 G#protein_molecule XXX-d G#protein_molecule
genes NE xxx NE
, NE , NE
a NE x NE
subgroup NE xxx NE
of NE xx NE
the NE xxx NE
ets G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
gene G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
family G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
that NE xxx NE
interacts NE xxx NE
with NE xxx NE
the NE xxx NE
serum G#protein_family_or_group_B xxx G#protein_family_or_group_B
response G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Full-length NE Xxxx-xxx NE
ERP G#protein_molecule XXX G#protein_molecule
expresses NE xxx NE
only NE xxx NE
negligible NE xxx NE
DNA-binding G#other_name_B XXX-xxx G#other_name_B
activity G#other_name_E xxx G#other_name_E
by NE xx NE
itself NE xxx NE
. NE . NE

Removal NE Xxxx NE
of NE xx NE
the NE xxx NE
carboxy G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
terminus G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
enables NE xxx NE
ERP G#protein_molecule XXX G#protein_molecule
to NE xx NE
interact NE xxx NE
with NE xxx NE
a NE x NE
variety NE xxx NE
of NE xx NE
ets-binding G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
sites G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
including NE xxx NE
the NE xxx NE
E74 G#DNA_domain_or_region_B Xdd G#DNA_domain_or_region_B
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
the NE xxx NE
IgH G#DNA_domain_or_region_B XxX G#DNA_domain_or_region_B
enhancer G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
pi G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
and NE xxx NE
the NE xxx NE
lck G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
ets G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
suggesting NE xxx NE
a NE x NE
carboxy-terminal G#protein_domain_or_region_B xxx-xxx G#protein_domain_or_region_B
negative G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
regulatory G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
. NE . NE

At NE Xx NE
least NE xxx NE
three NE xxx NE
ERP NE XXX NE
-related NE -xxx NE
transcripts NE xxx NE
are NE xxx NE
expressed NE xxx NE
in NE xx NE
a NE x NE
variety NE xxx NE
of NE xx NE
tissues NE xxx NE
. NE . NE

However NE Xxxx NE
, NE , NE
within NE xxx NE
the NE xxx NE
B-cell G#cell_type_B X-xxx G#cell_type_B
lineage G#cell_type_E xxx G#cell_type_E
, NE , NE
ERP G#protein_molecule XXX G#protein_molecule
is NE xx NE
highly NE xxx NE
expressed NE xxx NE
primarily NE xxx NE
at NE xx NE
early NE xxx NE
stages NE xxx NE
of NE xx NE
B-lymphocyte G#other_name_B X-xxx G#other_name_B
development G#other_name_E xxx G#other_name_E
, NE , NE
and NE xxx NE
expression NE xxx NE
declines NE xxx NE
drastically NE xxx NE
upon NE xxx NE
B-cell G#other_name_B X-xxx G#other_name_B
maturation G#other_name_E xxx G#other_name_E
, NE , NE
correlating NE xxx NE
with NE xxx NE
the NE xxx NE
enhancer NE xxx NE
activity NE xxx NE
of NE xx NE
the NE xxx NE
IgH G#DNA_domain_or_region_B XxX G#DNA_domain_or_region_B
pi G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

These NE Xxxx NE
data NE xxx NE
suggest NE xxx NE
that NE xxx NE
ERP G#protein_molecule XXX G#protein_molecule
might NE xxx NE
play NE xxx NE
a NE x NE
role NE xxx NE
in NE xx NE
B-cell G#other_name_B X-xxx G#other_name_B
development G#other_name_E xxx G#other_name_E
and NE xxx NE
in NE xx NE
IgH G#other_name_B XxX G#other_name_B
gene G#other_name_M xxx G#other_name_M
regulation G#other_name_E xxx G#other_name_E
. NE . NE

Gene NE Xxxx NE
for NE xxx NE
a NE x NE
tissue-specific G#protein_family_or_group_B xxx-xxx G#protein_family_or_group_B
transcriptional G#protein_family_or_group_M xxx G#protein_family_or_group_M
activator G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
EBF G#protein_family_or_group XXX G#protein_family_or_group
or NE xx NE
Olf-1 G#protein_family_or_group Xxx-d G#protein_family_or_group
) NE ) NE
, NE , NE
expressed NE xxx NE
in NE xx NE
early G#cell_type_B xxx G#cell_type_B
B G#cell_type_M X G#cell_type_M
lymphocytes G#cell_type_E xxx G#cell_type_E
, NE , NE
adipocytes G#cell_type xxx G#cell_type
, NE , NE
and NE xxx NE
olfactory G#cell_type_B xxx G#cell_type_B
neurons G#cell_type_E xxx G#cell_type_E
, NE , NE
is NE xx NE
located NE xxx NE
on NE xx NE
human G#DNA_molecule_B xxx G#DNA_molecule_B
chromosome G#DNA_molecule_M xxx G#DNA_molecule_M
5 G#DNA_molecule_E d G#DNA_molecule_E
, NE , NE
band G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
q34 G#DNA_domain_or_region_E xdd G#DNA_domain_or_region_E
, NE , NE
and NE xxx NE
proximal G#DNA_molecule_B xxx G#DNA_molecule_B
mouse G#DNA_molecule_M xxx G#DNA_molecule_M
chromosome G#DNA_molecule_M xxx G#DNA_molecule_M
11 G#DNA_molecule_E dd G#DNA_molecule_E
. NE . NE

Murine G#cell_type_B Xxxx G#cell_type_B
B G#cell_type_M X G#cell_type_M
lymphocytes G#cell_type_E xxx G#cell_type_E
, NE , NE
adipocytes G#cell_type xxx G#cell_type
, NE , NE
and NE xxx NE
olfactory G#cell_type_B xxx G#cell_type_B
neurons G#cell_type_E xxx G#cell_type_E
contain NE xxx NE
a NE x NE
DNA-binding G#protein_family_or_group_B XXX-xxx G#protein_family_or_group_B
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
that NE xxx NE
participates NE xxx NE
in NE xx NE
the NE xxx NE
regulation NE xxx NE
of NE xx NE
genes G#DNA_family_or_group xxx G#DNA_family_or_group
encoding NE xxx NE
tissue-specific G#other_name_B xxx-xxx G#other_name_B
components G#other_name_E xxx G#other_name_E
of NE xx NE
signal G#other_name_B xxx G#other_name_B
transduction G#other_name_E xxx G#other_name_E
. NE . NE

Purification NE Xxxx NE
and NE xxx NE
cloning NE xxx NE
of NE xx NE
this NE xxx NE
protein NE xxx NE
, NE , NE
termed NE xxx NE
early NE xxx NE
B-cell G#protein_molecule_B X-xxx G#protein_molecule_B
factor G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
EBF G#protein_family_or_group XXX G#protein_family_or_group
) NE ) NE
, NE , NE
from NE xxx NE
murine G#cell_type_B xxx G#cell_type_B
B G#cell_type_M X G#cell_type_M
lymphocytes G#cell_type_E xxx G#cell_type_E
and NE xxx NE
independent NE xxx NE
cloning NE xxx NE
of NE xx NE
a NE x NE
protein NE xxx NE
, NE , NE
termed NE xxx NE
Olf-1 G#protein_family_or_group Xxx-d G#protein_family_or_group
, NE , NE
from NE xxx NE
olfactory G#cell_type_B xxx G#cell_type_B
neuronal G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
revealed NE xxx NE
virtual NE xxx NE
complete NE xxx NE
amino G#protein_N/A_B xxx G#protein_N/A_B
acid G#protein_N/A_M xxx G#protein_N/A_M
sequence G#protein_N/A_E xxx G#protein_N/A_E
identity NE xxx NE
between NE xxx NE
these NE xxx NE
proteins NE xxx NE
. NE . NE

As NE Xx NE
a NE x NE
first NE xxx NE
step NE xxx NE
towards NE xxx NE
identifying NE xxx NE
a NE x NE
human G#other_name_B xxx G#other_name_B
genetic G#other_name_M xxx G#other_name_M
disorder G#other_name_E xxx G#other_name_E
or NE xx NE
mouse G#other_name_B xxx G#other_name_B
mutation G#other_name_E xxx G#other_name_E
for NE xxx NE
which NE xxx NE
EBF G#protein_family_or_group XXX G#protein_family_or_group
could NE xxx NE
be NE xx NE
a NE x NE
candidate NE xxx NE
gene NE xxx NE
, NE , NE
we NE xx NE
have NE xxx NE
chromosomally NE xxx NE
mapped NE xxx NE
the NE xxx NE
corresponding NE xxx NE
locus NE xxx NE
in NE xx NE
both NE xxx NE
species NE xxx NE
. NE . NE

By NE Xx NE
Southern NE Xxxx NE
hybridization NE xxx NE
analyses NE xxx NE
of NE xx NE
somatic NE xxx NE
cell NE xxx NE
hybrid NE xxx NE
panels NE xxx NE
with NE xxx NE
murine NE xxx NE
cDNA NE xXXX NE
probe NE xxx NE
, NE , NE
fluorescence NE xxx NE
chromosomal NE xxx NE
in NE xx NE
situ NE xxx NE
hybridization NE xxx NE
( NE ( NE
FISH NE XXXX NE
) NE ) NE
of NE xx NE
human NE xxx NE
genomic NE xxx NE
clones NE xxx NE
, NE , NE
and NE xxx NE
analysis NE xxx NE
of NE xx NE
recombinant NE xxx NE
inbred NE xxx NE
mouse NE xxx NE
strains NE xxx NE
, NE , NE
we NE xx NE
have NE xxx NE
found NE xxx NE
single NE xxx NE
sites NE xxx NE
for NE xxx NE
EBF NE XXX NE
homologous NE xxx NE
sequences NE xxx NE
on NE xx NE
human NE xxx NE
Chromosome NE Xxxx NE
(Chr) NE (Xxx) NE
5 NE d NE
, NE , NE
band NE xxx NE
q34 NE xdd NE
, NE , NE
and NE xxx NE
on NE xx NE
proximal NE xxx NE
mouse NE xxx NE
Chr NE Xxx NE
11 NE dd NE
, NE , NE
in NE xx NE
an NE xx NE
evolutionarily NE xxx NE
conserved NE xxx NE
region NE xxx NE
. NE . NE

Calcineurin G#protein_molecule Xxxx G#protein_molecule
activates NE xxx NE
transcription NE xxx NE
from NE xxx NE
the NE xxx NE
GM-CSF G#DNA_domain_or_region_B XX-XXX G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
synergy NE xxx NE
with NE xxx NE
either NE xxx NE
protein G#protein_molecule_B xxx G#protein_molecule_B
kinase G#protein_molecule_M xxx G#protein_molecule_M
C G#protein_molecule_E X G#protein_molecule_E
or NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
/AP-1 NE /XX-d NE
in NE xx NE
T NE X NE
cells NE xxx NE
. NE . NE

Two NE Xxx NE
cis-acting G#DNA_family_or_group_B xxx-xxx G#DNA_family_or_group_B
elements G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
GM-kappa G#DNA_domain_or_region_B XX-xxx G#DNA_domain_or_region_B
B/GC-box G#DNA_domain_or_region_E X/XX-xxx G#DNA_domain_or_region_E
and NE xxx NE
CLE0 G#DNA_domain_or_region XXXd G#DNA_domain_or_region
, NE , NE
of NE xx NE
the NE xxx NE
granulocyte-macrophage NE xxx-xxx NE
colony-stimulating NE xxx-xxx NE
factor NE xxx NE
( NE ( NE
GM-CSF NE XX-XXX NE
) NE ) NE
gene NE xxx NE
are NE xxx NE
required NE xxx NE
for NE xxx NE
maximal NE xxx NE
induction NE xxx NE
in NE xx NE
Jurkat NE Xxxx NE
T NE X NE
cells NE xxx NE
by NE xx NE
costimulation NE xxx NE
with NE xxx NE
phorbol-12-myristate NE xxx-dd-xxx NE
acetate NE xxx NE
( NE ( NE
PMA NE XXX NE
) NE ) NE
and NE xxx NE
Ca2+ NE Xxd+ NE
ionophore NE xxx NE
( NE ( NE
A23187 NE Xddddd NE
) NE ) NE
. NE . NE

The NE Xxx NE
GM-kappa G#DNA_domain_or_region_B XX-xxx G#DNA_domain_or_region_B
B G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
is NE xx NE
recognized NE xxx NE
by NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
, NE , NE
which NE xxx NE
is NE xx NE
mainly NE xxx NE
induced NE xxx NE
by NE xx NE
PMA G#other_organic_compound XXX G#other_organic_compound
. NE . NE

The NE Xxx NE
CLE0 G#DNA_domain_or_region_B XXXd G#DNA_domain_or_region_B
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
interacts NE xxx NE
with NE xxx NE
factors NE xxx NE
, NE , NE
related NE xxx NE
to NE xx NE
a NE x NE
PMA NE XXX NE
-induced NE -xxx NE
AP-1 NE XX-d NE
and NE xxx NE
a NE x NE
PMA NE XXX NE
/ NE / NE
A23187 NE Xddddd NE
-induced NE -xxx NE
NF-AT NE XX-XX NE
. NE . NE

We NE Xx NE
examined NE xxx NE
whether NE xxx NE
signal NE xxx NE
transducing NE xxx NE
components NE xxx NE
in NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
can NE xxx NE
activate NE xxx NE
transcription NE xxx NE
of NE xx NE
the NE xxx NE
GM-CSF G#DNA_domain_or_region_B XX-XXX G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Cotransfection NE Xxxx NE
of NE xx NE
NF-kappa G#DNA_family_or_group_B XX-xxx G#DNA_family_or_group_B
B G#DNA_family_or_group_M X G#DNA_family_or_group_M
(p50/p65)- G#DNA_family_or_group_M (xdd/xdd)- G#DNA_family_or_group_M
expression G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
vector G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
or G#DNA_family_or_group_M xx G#DNA_family_or_group_M
AP-1 G#DNA_family_or_group_M XX-d G#DNA_family_or_group_M
(c-Jun/c-Fos)- G#DNA_family_or_group_M (x-Xxx/x-Xxx)- G#DNA_family_or_group_M
expression G#DNA_family_or_group_M xxx G#DNA_family_or_group_M
vector G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
into NE xxx NE
Jurkat G#cell_line_B Xxxx G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
with NE xxx NE
a NE x NE
luciferase G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
reporter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
containing NE xxx NE
the NE xxx NE
GM-CSF G#DNA_domain_or_region_B XX-XXX G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
did NE xxx NE
not NE xxx NE
stimulate NE xxx NE
transcription G#other_name xxx G#other_name
from NE xxx NE
the NE xxx NE
GM-CSF G#DNA_domain_or_region_B XX-XXX G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

In NE Xx NE
contrast NE xxx NE
, NE , NE
cotransfection NE xxx NE
with NE xxx NE
a NE x NE
combination NE xxx NE
of NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
and NE xxx NE
AP-1 G#protein_molecule XX-d G#protein_molecule
significantly NE xxx NE
augmented NE xxx NE
transcription G#other_name xxx G#other_name
from NE xxx NE
the NE xxx NE
GM-CSF G#DNA_domain_or_region_B XX-XXX G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
containing NE xxx NE
the NE xxx NE
GM-kappa G#DNA_domain_or_region_B XX-xxx G#DNA_domain_or_region_B
B/GC-box G#DNA_domain_or_region_E X/XX-xxx G#DNA_domain_or_region_E
and NE xxx NE
the NE xxx NE
CLE0 G#DNA_domain_or_region XXXd G#DNA_domain_or_region
( NE ( NE
AP-1 NE XX-d NE
/NF-AT NE /XX-XX NE
) NE ) NE
. NE . NE

Expression NE Xxxx NE
of NE xx NE
a NE x NE
constitutively NE xxx NE
active NE xxx NE
calcineurin G#protein_molecule xxx G#protein_molecule
( NE ( NE
CN G#protein_molecule XX G#protein_molecule
) NE ) NE
, NE , NE
a NE x NE
Ca2+ NE Xxd+ NE
/calmodulin-dependent NE /xxx-xxx NE
protein NE xxx NE
phosphatase NE xxx NE
, NE , NE
potentiated NE xxx NE
by NE xx NE
two NE xxx NE
fold NE xxx NE
the NE xxx NE
transcriptional NE xxx NE
activation NE xxx NE
by NE xx NE
NF-kappa NE XX-xxx NE
B NE X NE
/AP-1 NE /XX-d NE
. NE . NE

Both NE Xxxx NE
constitutively NE xxx NE
active NE xxx NE
forms NE xxx NE
of NE xx NE
CN G#protein_molecule XX G#protein_molecule
and NE xxx NE
protein G#protein_molecule_B xxx G#protein_molecule_B
kinase G#protein_molecule_M xxx G#protein_molecule_M
C G#protein_molecule_E X G#protein_molecule_E
( NE ( NE
PKC G#protein_molecule XXX G#protein_molecule
) NE ) NE
synergistically NE xxx NE
activated NE xxx NE
transcription G#other_name xxx G#other_name
from NE xxx NE
the NE xxx NE
GM-CSF G#DNA_domain_or_region_B XX-XXX G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

These NE Xxxx NE
results NE xxx NE
suggest NE xxx NE
that NE xxx NE
cooperation NE xxx NE
among NE xxx NE
NF-kappa G#DNA_domain_or_region_B XX-xxx G#DNA_domain_or_region_B
B-binding G#DNA_domain_or_region_M X-xxx G#DNA_domain_or_region_M
sequence G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
AP-1-binding G#DNA_domain_or_region_M XX-d-xxx G#DNA_domain_or_region_M
sequence G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
NF-AT-binding G#DNA_domain_or_region_M XX-XX-xxx G#DNA_domain_or_region_M
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
is NE xx NE
required NE xxx NE
for NE xxx NE
induction NE xxx NE
of NE xx NE
the NE xxx NE
GM-CSF G#DNA_domain_or_region_B XX-XXX G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
through NE xxx NE
PKC- G#other_name_B XXX- G#other_name_B
signaling G#other_name_M xxx G#other_name_M
pathway G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
Ca2+- G#other_name_M Xxd+- G#other_name_M
signaling G#other_name_M xxx G#other_name_M
pathway G#other_name_E xxx G#other_name_E

Nonpituitary G#other_name_B Xxxx G#other_name_B
human G#other_name_M xxx G#other_name_M
prolactin G#other_name_M xxx G#other_name_M
gene G#other_name_M xxx G#other_name_M
transcription G#other_name_E xxx G#other_name_E
is NE xx NE
independent NE xxx NE
of NE xx NE
Pit-1 G#protein_molecule Xxx-d G#protein_molecule
and NE xxx NE
differentially NE xxx NE
controlled NE xxx NE
in NE xx NE
lymphocytes G#cell_type xxx G#cell_type
and NE xxx NE
in NE xx NE
endometrial G#tissue_B xxx G#tissue_B
stroma G#tissue_E xxx G#tissue_E
. NE . NE

Expression NE Xxxx NE
of NE xx NE
the NE xxx NE
human G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
PRL G#DNA_domain_or_region_M XXX G#DNA_domain_or_region_M
(hPRL) G#DNA_domain_or_region_M (xXXX) G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
extrapituitary NE xxx NE
sites NE xxx NE
such NE xxx NE
as NE xx NE
the NE xxx NE
uterus G#body_part xxx G#body_part
(decidualized NE (xxx NE
endometrial G#tissue_B xxx G#tissue_B
stroma G#tissue_E xxx G#tissue_E
and NE xxx NE
myometrium G#tissue xxx G#tissue
) NE ) NE
and NE xxx NE
cells NE xxx NE
of NE xx NE
the NE xxx NE
hematopoietic G#cell_type_B xxx G#cell_type_B
lineage G#cell_type_E xxx G#cell_type_E
is NE xx NE
directed NE xxx NE
by NE xx NE
an NE xx NE
alternative G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
which NE xxx NE
is NE xx NE
located NE xxx NE
approximately NE xxx NE
6 G#DNA_domain_or_region_B d G#DNA_domain_or_region_B
kilobases G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
(kb) G#DNA_domain_or_region_M (xx) G#DNA_domain_or_region_M
upstream G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
of NE xx NE
the NE xxx NE
pituitary-specific G#DNA_domain_or_region_B xxx-xxx G#DNA_domain_or_region_B
start G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

In NE Xx NE
order NE xxx NE
to NE xx NE
delineate NE xxx NE
the NE xxx NE
tissue-specific G#other_name_B xxx-xxx G#other_name_B
mechanisms G#other_name_E xxx G#other_name_E
governing NE xxx NE
the NE xxx NE
control NE xxx NE
of NE xx NE
nonpituitary G#other_name_B xxx G#other_name_B
PRL G#other_name_M XXX G#other_name_M
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
, NE , NE
we NE xx NE
have NE xxx NE
cloned NE xxx NE
and NE xxx NE
sequenced NE xxx NE
3 G#DNA_domain_or_region_B d G#DNA_domain_or_region_B
kb G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
5'-flanking G#DNA_domain_or_region_M d'-xxx G#DNA_domain_or_region_M
DNA G#DNA_domain_or_region_E XXX G#DNA_domain_or_region_E
of NE xx NE
the NE xxx NE
upstream NE xxx NE
decidual/lymphoid G#DNA_domain_or_region_B xxx/xxx G#DNA_domain_or_region_B
(dPRL) G#DNA_domain_or_region_M (xXXX) G#DNA_domain_or_region_M
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

Based NE Xxxx NE
on NE xx NE
sequence NE xxx NE
homology NE xxx NE
we NE xx NE
identified NE xxx NE
two NE xxx NE
binding G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
motifs G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
for NE xxx NE
Pit-1 G#protein_molecule Xxx-d G#protein_molecule
and NE xxx NE
seven NE xxx NE
half-sites G#DNA_domain_or_region xxx-xxx G#DNA_domain_or_region
for NE xxx NE
glucocorticoid NE xxx NE
receptor/progesterone NE xxx/xxx NE
receptor NE xxx NE
( NE ( NE
PR NE XX NE
) NE ) NE
binding NE xxx NE
. NE . NE

We NE Xx NE
focused NE xxx NE
our NE xxx NE
studies NE xxx NE
on NE xx NE
the NE xxx NE
role NE xxx NE
of NE xx NE
Pit-1 G#protein_molecule Xxx-d G#protein_molecule
and NE xxx NE
of NE xx NE
PR G#protein_family_or_group XX G#protein_family_or_group
as NE xx NE
potential G#other_name_B xxx G#other_name_B
transcriptional G#other_name_M xxx G#other_name_M
regulators G#other_name_E xxx G#other_name_E
, NE , NE
since NE xxx NE
the NE xxx NE
POU G#protein_family_or_group_B XXX G#protein_family_or_group_B
domain G#protein_family_or_group_M xxx G#protein_family_or_group_M
protein G#protein_family_or_group_E xxx G#protein_family_or_group_E
Pit-1 G#protein_molecule Xxx-d G#protein_molecule
is NE xx NE
essential NE xxx NE
in NE xx NE
the NE xxx NE
control NE xxx NE
of NE xx NE
pituitary G#other_name_B xxx G#other_name_B
PRL G#other_name_M XXX G#other_name_M
expression G#other_name_E xxx G#other_name_E
, NE , NE
and NE xxx NE
progesterone NE xxx NE
induces NE xxx NE
decidual NE xxx NE
transformation NE xxx NE
of NE xx NE
the NE xxx NE
endometrial G#tissue_B xxx G#tissue_B
stroma G#tissue_E xxx G#tissue_E
, NE , NE
a NE x NE
differentiation G#other_name xxx G#other_name
process NE xxx NE
during NE xxx NE
which NE xxx NE
the NE xxx NE
decidual NE xxx NE
PRL G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
is NE xx NE
activated NE xxx NE
. NE . NE

We NE Xx NE
demonstrate NE xxx NE
in NE xx NE
a NE x NE
variety NE xxx NE
of NE xx NE
cell NE xxx NE
types NE xxx NE
, NE , NE
including NE xxx NE
lymphocytes G#cell_type xxx G#cell_type
and NE xxx NE
endometrial G#tissue_B xxx G#tissue_B
stroma G#tissue_E xxx G#tissue_E
, NE , NE
that NE xxx NE
Pit-1 G#protein_molecule Xxx-d G#protein_molecule
is NE xx NE
not NE xxx NE
involved NE xxx NE
in NE xx NE
the NE xxx NE
regulation NE xxx NE
of NE xx NE
dPRL G#DNA_molecule_B xXXX G#DNA_molecule_B
promoter/reporter G#DNA_molecule_M xxx/xxx G#DNA_molecule_M
gene G#DNA_molecule_M xxx G#DNA_molecule_M
constructs G#DNA_molecule_E xxx G#DNA_molecule_E
carrying NE xxx NE
3 G#DNA_domain_or_region_B d G#DNA_domain_or_region_B
kb G#DNA_domain_or_region_M xx G#DNA_domain_or_region_M
5'-flanking G#DNA_domain_or_region_M d'-xxx G#DNA_domain_or_region_M
DNA G#DNA_domain_or_region_E XXX G#DNA_domain_or_region_E
. NE . NE

Our NE Xxx NE
experiments NE xxx NE
also NE xxx NE
show NE xxx NE
that NE xxx NE
activated NE xxx NE
PR G#protein_family_or_group XX G#protein_family_or_group
does NE xxx NE
not NE xxx NE
confer NE xxx NE
direct NE xxx NE
transcriptional NE xxx NE
control NE xxx NE
on NE xx NE
the NE xxx NE
dPRL G#DNA_domain_or_region_B xXXX G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

When NE Xxxx NE
we NE xx NE
compared NE xxx NE
the NE xxx NE
activity NE xxx NE
of NE xx NE
the NE xxx NE
transfected NE xxx NE
dPRL G#DNA_domain_or_region_B xXXX G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
PRL-secreting G#cell_type_B XXX-xxx G#cell_type_B
lymphoid G#cell_type_M xxx G#cell_type_M
cell G#cell_type_M xxx G#cell_type_M
and G#cell_type_M xxx G#cell_type_M
PRL-nonsecreting G#cell_type_M XXX-xxx G#cell_type_M
lymphoid G#cell_type_M xxx G#cell_type_M
cell G#cell_type_E xxx G#cell_type_E
of NE xx NE
the NE xxx NE
dPRL G#DNA_domain_or_region_B xXXX G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
did NE xxx NE
not NE xxx NE
contain NE xxx NE
elements NE xxx NE
restricting NE xxx NE
expression NE xxx NE
to NE xx NE
only NE xxx NE
those NE xxx NE
lymphocytes G#cell_type xxx G#cell_type
that NE xxx NE
produce NE xxx NE
PRL NE XXX NE
but NE xxx NE
allowed NE xxx NE
expression NE xxx NE
of NE xx NE
fusion NE xxx NE
reporter NE xxx NE
genes NE xxx NE
irrespective NE xxx NE
of NE xx NE
the NE xxx NE
status NE xxx NE
of NE xx NE
the NE xxx NE
endogenous NE xxx NE
PRL G#DNA_domain_or_region_B XXX G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

This NE Xxxx NE
was NE xxx NE
in NE xx NE
sharp NE xxx NE
contrast NE xxx NE
to NE xx NE
endometrial NE xxx NE
cells NE xxx NE
where NE xxx NE
3 NE d NE
kb NE xx NE
5'-flanking NE d'-xxx NE
DNA NE XXX NE
conferred NE xxx NE
strong NE xxx NE
transcriptional G#other_name_B xxx G#other_name_B
activation G#other_name_E xxx G#other_name_E
on NE xx NE
the NE xxx NE
dPRL G#DNA_domain_or_region_B xXXX G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
in NE xx NE
decidualized NE xxx NE
endometrial G#cell_type_B xxx G#cell_type_B
stromal G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
actively NE xxx NE
secreting NE xxx NE
PRL G#protein_molecule XXX G#protein_molecule
, NE , NE
but NE xxx NE
did NE xxx NE
not NE xxx NE
allow NE xxx NE
transcription NE xxx NE
in NE xx NE
undifferentiated NE xxx NE
non-PRL-secreting G#cell_type_B xxx-XXX-xxx G#cell_type_B
endometrial G#cell_type_M xxx G#cell_type_M
stromal G#cell_type_M xxx G#cell_type_M
cells G#cell_type_E xxx G#cell_type_E
. NE . NE

Activation NE Xxxx NE
of NE xx NE
the NE xxx NE
dPRL G#DNA_domain_or_region_B xXXX G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
construct NE xxx NE
in NE xx NE
these NE xxx NE
undifferentiated NE xxx NE
cells NE xxx NE
could NE xxx NE
however NE xxx NE
be NE xx NE
induced NE xxx NE
by NE xx NE
the NE xxx NE
addition NE xxx NE
of NE xx NE
cAMP G#nucleotide xXXX G#nucleotide
, NE , NE
in NE xx NE
the NE xxx NE
absence NE xxx NE
of NE xx NE
progesterone G#lipid xxx G#lipid
, NE , NE
suggesting NE xxx NE
that NE xxx NE
a NE x NE
signal NE xxx NE
transduced NE xxx NE
through NE xxx NE
the NE xxx NE
cAMP G#other_name_B xXXX G#other_name_B
signaling G#other_name_M xxx G#other_name_M
pathway G#other_name_E xxx G#other_name_E
is NE xx NE
a NE x NE
primary NE xxx NE
inducer NE xxx NE
of NE xx NE
decidual NE xxx NE
PRL G#other_name_B XXX G#other_name_B
gene G#other_name_M xxx G#other_name_M
expression G#other_name_E xxx G#other_name_E
. NE . NE

Signals NE Xxxx NE
and NE xxx NE
nuclear G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
that NE xxx NE
regulate NE xxx NE
the NE xxx NE
expression NE xxx NE
of NE xx NE
interleukin-4 G#DNA_domain_or_region_B xxx-d G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
interleukin-5 G#DNA_domain_or_region_M xxx-d G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
helper NE xxx NE
T NE X NE
cells NE xxx NE
. NE . NE

Mouse G#cell_line_B Xxxx G#cell_line_B
thymoma G#cell_line_M xxx G#cell_line_M
line G#cell_line_M xxx G#cell_line_M
EL-4 G#cell_line_M XX-d G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
produce NE xxx NE
cytokines G#protein_family_or_group xxx G#protein_family_or_group
such NE xxx NE
as NE xx NE
interleukin G#protein_molecule_B xxx G#protein_molecule_B
(IL)-2 G#protein_molecule_E (XX)-d G#protein_molecule_E
, NE , NE
IL-3 G#protein_molecule XX-d G#protein_molecule
, NE , NE
IL-4 G#protein_molecule XX-d G#protein_molecule
, NE , NE
IL-10 G#protein_molecule XX-dd G#protein_molecule
, NE , NE
and NE xxx NE
granulocyte-macrophage G#protein_molecule_B xxx-xxx G#protein_molecule_B
colony-stimulating G#protein_molecule_M xxx-xxx G#protein_molecule_M
factor G#protein_molecule_E xxx G#protein_molecule_E
in NE xx NE
response NE xxx NE
to NE xx NE
phorbol G#other_organic_compound_B xxx G#other_organic_compound_B
12-myristate G#other_organic_compound_M dd-xxx G#other_organic_compound_M
13-acetate G#other_organic_compound_E dd-xxx G#other_organic_compound_E
( NE ( NE
PMA G#other_organic_compound XXX G#other_organic_compound
) NE ) NE
. NE . NE

EL-4 G#cell_line_B XX-d G#cell_line_B
cells G#cell_line_E xxx G#cell_line_E
also NE xxx NE
produce NE xxx NE
low NE xxx NE
levels NE xxx NE
of NE xx NE
IL-5 G#protein_molecule XX-d G#protein_molecule
when NE xxx NE
stimulated NE xxx NE
by NE xx NE
PMA G#other_organic_compound XXX G#other_organic_compound
alone NE xxx NE
; NE ; NE
however NE xxx NE
, NE , NE
cAMP G#nucleotide xXXX G#nucleotide
greatly NE xxx NE
augments NE xxx NE
PMA NE XXX NE
-dependent NE -xxx NE
IL-5 NE XX-d NE
production NE xxx NE
. NE . NE

A NE X NE
transient G#other_name_B xxx G#other_name_B
transfection G#other_name_M xxx G#other_name_M
assay G#other_name_E xxx G#other_name_E
revealed NE xxx NE
that NE xxx NE
two NE xxx NE
signals NE xxx NE
, NE , NE
PMA G#other_organic_compound XXX G#other_organic_compound
and NE xxx NE
cAMP G#nucleotide xXXX G#nucleotide
, NE , NE
are NE xxx NE
required NE xxx NE
for NE xxx NE
optimal NE xxx NE
activation NE xxx NE
of NE xx NE
the NE xxx NE
IL-5 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

In NE Xx NE
contrast NE xxx NE
, NE , NE
cAMP G#nucleotide xXXX G#nucleotide
almost NE xxx NE
completely NE xxx NE
inhibited NE xxx NE
the NE xxx NE
PMA G#other_organic_compound XXX G#other_organic_compound
-dependent NE -xxx NE
activation NE xxx NE
of NE xx NE
the NE xxx NE
endogenous G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
IL-2 G#DNA_domain_or_region_M XX-d G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
as NE xx NE
well NE xxx NE
as NE xx NE
the NE xxx NE
transfected NE xxx NE
IL-2 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

These NE Xxxx NE
results NE xxx NE
indicate NE xxx NE
that NE xxx NE
the NE xxx NE
IL-5 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
is NE xx NE
positively NE xxx NE
regulated NE xxx NE
by NE xx NE
cAMP G#nucleotide xXXX G#nucleotide
in NE xx NE
a NE x NE
manner NE xxx NE
opposite NE xxx NE
to NE xx NE
that NE xxx NE
for NE xxx NE
the NE xxx NE
IL-2 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

One NE Xxx NE
of NE xx NE
the NE xxx NE
nuclear G#protein_family_or_group_B xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
( NE ( NE
NFs G#protein_family_or_group XXx G#protein_family_or_group
) NE ) NE
that NE xxx NE
regulates NE xxx NE
the NE xxx NE
response NE xxx NE
of NE xx NE
the NE xxx NE
IL-5 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
promoter G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
to NE xx NE
cAMP G#nucleotide xXXX G#nucleotide
and NE xxx NE
PMA G#other_organic_compound XXX G#other_organic_compound
has NE xxx NE
properties NE xxx NE
similar NE xxx NE
to NE xx NE
NF G#protein_family_or_group XX G#protein_family_or_group
for NE xxx NE
activated G#cell_type_B xxx G#cell_type_B
t G#cell_type_M x G#cell_type_M
cell G#cell_type_E xxx G#cell_type_E
. NE . NE

NF G#DNA_domain_or_region_B XX G#DNA_domain_or_region_B
kappa G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
B G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
the G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
NF-activated G#DNA_domain_or_region_M XX-xxx G#DNA_domain_or_region_M
T G#DNA_domain_or_region_M X G#DNA_domain_or_region_M
cell G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
binding G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
site G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
P NE X NE
sequence NE xxx NE
of NE xx NE
the NE xxx NE
IL-4 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
defined NE xxx NE
as NE xx NE
a NE x NE
responsive G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
element G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
for NE xxx NE
PMA G#other_organic_compound XXX G#other_organic_compound
and NE xxx NE
calcium G#other_organic_compound_B xxx G#other_organic_compound_B
ionophore G#other_organic_compound_E xxx G#other_organic_compound_E
( NE ( NE
A23187 G#other_organic_compound Xddddd G#other_organic_compound
) NE ) NE
, NE , NE
shares NE xxx NE
sequence NE xxx NE
similarity NE xxx NE
with NE xxx NE
the NE xxx NE
NF NE XX NE
kappa NE xxx NE
B NE X NE
and NE xxx NE
the NE xxx NE
NF-activated NE XX-xxx NE
T NE X NE
cell NE xxx NE
binding NE xxx NE
sites NE xxx NE
. NE . NE

We NE Xx NE
attempted NE xxx NE
to NE xx NE
determine NE xxx NE
whether NE xxx NE
NF(P) G#protein_molecule XX(X) G#protein_molecule
, NE , NE
a NE x NE
nuclear NE xxx NE
factor NE xxx NE
specific NE xxx NE
for NE xxx NE
the NE xxx NE
P G#DNA_domain_or_region_B X G#DNA_domain_or_region_B
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
, NE , NE
is NE xx NE
related NE xxx NE
to NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
and NE xxx NE
nuclear G#protein_molecule_B xxx G#protein_molecule_B
factor G#protein_molecule_M xxx G#protein_molecule_M
for G#protein_molecule_M xxx G#protein_molecule_M
activated G#protein_molecule_M xxx G#protein_molecule_M
T G#protein_molecule_M X G#protein_molecule_M
cell G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
NF-AT G#protein_molecule XX-XX G#protein_molecule
) NE ) NE
. NE . NE

In NE Xx NE
electromobility G#other_name_B xxx G#other_name_B
shift G#other_name_M xxx G#other_name_M
assays G#other_name_E xxx G#other_name_E
both NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
( NE ( NE
P65 G#protein_subunit Xdd G#protein_subunit
or NE xx NE
P65/P50 G#protein_complex_B Xdd/Xdd G#protein_complex_B
heterodimer G#protein_complex_E xxx G#protein_complex_E
) NE ) NE
and NE xxx NE
NF-AT G#protein_molecule XX-XX G#protein_molecule
bound NE xxx NE
to NE xx NE
the NE xxx NE
P G#DNA_domain_or_region_B X G#DNA_domain_or_region_B
sequence G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
. NE . NE

However NE Xxxx NE
, NE , NE
sequence NE xxx NE
specificity NE xxx NE
of NE xx NE
NF-AT G#protein_molecule XX-XX G#protein_molecule
was NE xxx NE
more NE xxx NE
similar NE xxx NE
to NE xx NE
that NE xxx NE
of NE xx NE
NF(P) G#protein_molecule XX(X) G#protein_molecule
, NE , NE
and NE xxx NE
only NE xxx NE
a NE x NE
small NE xxx NE
amount NE xxx NE
of NE xx NE
P65 G#protein_subunit Xdd G#protein_subunit
was NE xxx NE
detected NE xxx NE
in NE xx NE
NF(P) G#protein_molecule XX(X) G#protein_molecule
. NE . NE

These NE Xxxx NE
results NE xxx NE
indicate NE xxx NE
that NE xxx NE
a NE x NE
component NE xxx NE
or NE xx NE
components NE xxx NE
of NE xx NE
NF-AT G#protein_molecule XX-XX G#protein_molecule
have NE xxx NE
the NE xxx NE
potential NE xxx NE
to NE xx NE
reconstitute NE xxx NE
NF(P) G#protein_molecule XX(X) G#protein_molecule
, NE , NE
whereas NE xxx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
alone NE xxx NE
does NE xxx NE
not NE xxx NE
account NE xxx NE
for NE xxx NE
NF(P) G#protein_molecule XX(X) G#protein_molecule
in NE xx NE
Jurkat G#cell_component_B Xxxx G#cell_component_B
crude G#cell_component_M xxx G#cell_component_M
extract G#cell_component_E xxx G#cell_component_E
. NE . NE

Taken NE Xxxx NE
together NE xxx NE
, NE , NE
these NE xxx NE
results NE xxx NE
suggest NE xxx NE
that NE xxx NE
NF-AT-like G#protein_family_or_group_B XX-XX-xxx G#protein_family_or_group_B
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
are NE xxx NE
involved NE xxx NE
in NE xx NE
the NE xxx NE
regulation NE xxx NE
of NE xx NE
IL-4 G#DNA_domain_or_region_B XX-d G#DNA_domain_or_region_B
gene G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
and G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
IL-5 G#DNA_domain_or_region_M XX-d G#DNA_domain_or_region_M
gene G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E

Solution NE Xxxx NE
structure NE xxx NE
of NE xx NE
a NE x NE
POU-specific G#protein_domain_or_region_B XXX-xxx G#protein_domain_or_region_B
homeodomain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
: NE : NE
3D-NMR NE dX-XXX NE
studies NE xxx NE
of NE xx NE
human NE xxx NE
B-cell NE X-xxx NE
transcription NE xxx NE
factor NE xxx NE
Oct-2 NE Xxx-d NE
. NE . NE

The NE Xxx NE
POU G#protein_domain_or_region_B XXX G#protein_domain_or_region_B
DNA-binding G#protein_domain_or_region_M XXX-xxx G#protein_domain_or_region_M
motif G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
defines NE xxx NE
a NE x NE
conserved NE xxx NE
family NE xxx NE
of NE xx NE
eukaryotic G#protein_family_or_group_B xxx G#protein_family_or_group_B
transcription G#protein_family_or_group_M xxx G#protein_family_or_group_M
factors G#protein_family_or_group_E xxx G#protein_family_or_group_E
involved NE xxx NE
in NE xx NE
regulation NE xxx NE
of NE xx NE
gene G#other_name_B xxx G#other_name_B
expression G#other_name_E xxx G#other_name_E
. NE . NE

This NE Xxxx NE
bipartite G#protein_substructure_B xxx G#protein_substructure_B
motif G#protein_substructure_E xxx G#protein_substructure_E
consists NE xxx NE
of NE xx NE
an NE xx NE
N-terminal G#protein_domain_or_region_B X-xxx G#protein_domain_or_region_B
POU-specific G#protein_domain_or_region_M XXX-xxx G#protein_domain_or_region_M
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
( NE ( NE
POUs G#protein_domain_or_region XXXx G#protein_domain_or_region
) NE ) NE
, NE , NE
a NE x NE
flexible G#protein_substructure_B xxx G#protein_substructure_B
linker G#protein_substructure_E xxx G#protein_substructure_E
, NE , NE
and NE xxx NE
a NE x NE
C-terminal G#protein_domain_or_region_B X-xxx G#protein_domain_or_region_B
POU-specific G#protein_domain_or_region_M XXX-xxx G#protein_domain_or_region_M
homeodomain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
( NE ( NE
POUHD G#protein_domain_or_region XXXXX G#protein_domain_or_region
) NE ) NE
. NE . NE

Here NE Xxxx NE
we NE xx NE
describe NE xxx NE
the NE xxx NE
solution NE xxx NE
structure NE xxx NE
of NE xx NE
a NE x NE
POU-specific G#protein_domain_or_region_B XXX-xxx G#protein_domain_or_region_B
homeodomain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
. NE . NE

An NE Xx NE
NMR G#other_name_B XXX G#other_name_B
model G#other_name_E xxx G#other_name_E
is NE xx NE
obtained NE xxx NE
from NE xxx NE
Oct-2 G#protein_molecule Xxx-d G#protein_molecule
, NE , NE
a NE x NE
human G#protein_family_or_group_B xxx G#protein_family_or_group_B
B-cell G#protein_family_or_group_M X-xxx G#protein_family_or_group_M
specific G#protein_family_or_group_M xxx G#protein_family_or_group_M
transcription G#protein_family_or_group_M xxx G#protein_family_or_group_M
factor G#protein_family_or_group_E xxx G#protein_family_or_group_E
which NE xxx NE
participates NE xxx NE
in NE xx NE
the NE xxx NE
regulation NE xxx NE
of NE xx NE
immunoglobulin G#DNA_family_or_group_B xxx G#DNA_family_or_group_B
genes G#DNA_family_or_group_E xxx G#DNA_family_or_group_E
. NE . NE

A NE X NE
fragment NE xxx NE
of NE xx NE
Oct-2 G#protein_molecule Xxx-d G#protein_molecule
containing NE xxx NE
POUHD G#protein_domain_or_region XXXXX G#protein_domain_or_region
and NE xxx NE
an NE xx NE
adjoining NE xxx NE
linker NE xxx NE
was NE xxx NE
expressed NE xxx NE
in NE xx NE
Escherichia G#multi_cell_B Xxxx G#multi_cell_B
coli G#multi_cell_E xxx G#multi_cell_E
and NE xxx NE
characterized NE xxx NE
by NE xx NE
three-dimensional NE xxx-xxx NE
nuclear NE xxx NE
magnetic NE xxx NE
resonance NE xxx NE
( NE ( NE
3D-NMR NE dX-XXX NE
) NE ) NE
spectroscopy NE xxx NE
. NE . NE

Complete NE Xxxx NE
1H G#other_name_B dX G#other_name_B
and G#other_name_M xxx G#other_name_M
15N G#other_name_M ddX G#other_name_M
resonance G#other_name_M xxx G#other_name_M
assignment G#other_name_E xxx G#other_name_E
of NE xx NE
the NE xxx NE
POUHD G#protein_domain_or_region_B XXXXX G#protein_domain_or_region_B
moiety G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
is NE xx NE
presented NE xxx NE
. NE . NE

The NE Xxx NE
POUHD G#other_name_B XXXXX G#other_name_B
solution G#other_name_M xxx G#other_name_M
structure G#other_name_E xxx G#other_name_E
, NE , NE
as NE xx NE
calculated NE xxx NE
by NE xx NE
distance G#other_name_B xxx G#other_name_B
geometry G#other_name_E xxx G#other_name_E
and NE xxx NE
simulated G#other_name_B xxx G#other_name_B
annealing G#other_name_E xxx G#other_name_E
( NE ( NE
DG/SA G#other_name XX/XX G#other_name
) NE ) NE
, NE , NE
is NE xx NE
similar NE xxx NE
to NE xx NE
that NE xxx NE
of NE xx NE
canonical G#protein_domain_or_region_B xxx G#protein_domain_or_region_B
homeodomains G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
. NE . NE

A NE X NE
salient NE xxx NE
difference NE xxx NE
between NE xxx NE
solution G#protein_N/A_B xxx G#protein_N/A_B
structure G#protein_N/A_M xxx G#protein_N/A_M
and G#protein_N/A_M xxx G#protein_N/A_M
crystal G#protein_N/A_M xxx G#protein_N/A_M
structure G#protein_N/A_E xxx G#protein_N/A_E
is NE xx NE
observed NE xxx NE
in NE xx NE
the NE xxx NE
C-terminal G#protein_domain_or_region_B X-xxx G#protein_domain_or_region_B
segment G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
of NE xx NE
alpha-helix G#protein_domain_or_region_B xxx-xxx G#protein_domain_or_region_B
3 G#protein_domain_or_region_E d G#protein_domain_or_region_E
(the NE (xxx NE
HTH G#protein_domain_or_region_B XXX G#protein_domain_or_region_B
recognition G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
helix G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
) NE ) NE
, NE , NE
which NE xxx NE
is NE xx NE
not NE xxx NE
well NE xxx NE
ordered NE xxx NE
in NE xx NE
solution NE xxx NE
. NE . NE

Because NE Xxxx NE
this NE xxx NE
segment NE xxx NE
presumably NE xxx NE
folds NE xxx NE
upon NE xxx NE
specific NE xxx NE
DNA NE XXX NE
binding NE xxx NE
, NE , NE
its NE xxx NE
flexibility NE xxx NE
in NE xx NE
solution NE xxx NE
may NE xxx NE
reduce NE xxx NE
the NE xxx NE
intrinsic G#other_name_B xxx G#other_name_B
DNA G#other_name_M XXX G#other_name_M
affinity G#other_name_E xxx G#other_name_E
of NE xx NE
POUHD G#protein_domain_or_region XXXXX G#protein_domain_or_region
in NE xx NE
the NE xxx NE
absence NE xxx NE
of NE xx NE
POUs G#protein_domain_or_region XXXx G#protein_domain_or_region
. NE . NE

NF-kappa G#other_name_B XX-xxx G#other_name_B
B-dependent G#other_name_M X-xxx G#other_name_M
pathway G#other_name_M xxx G#other_name_M
and G#other_name_M xxx G#other_name_M
NF-kappa G#other_name_M XX-xxx G#other_name_M
B-independent G#other_name_M X-xxx G#other_name_M
pathway G#other_name_E xxx G#other_name_E
of NE xx NE
HIV G#other_name_B XXX G#other_name_B
activation G#other_name_E xxx G#other_name_E
in NE xx NE
a NE x NE
chronically G#cell_line_B xxx G#cell_line_B
infected G#cell_line_M xxx G#cell_line_M
T G#cell_line_M X G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
. NE . NE

J G#cell_line_B X G#cell_line_B
delta G#cell_line_M xxx G#cell_line_M
K G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
were NE xxx NE
isolated NE xxx NE
as NE xx NE
a NE x NE
chronically G#cell_line_B xxx G#cell_line_B
infected G#cell_line_M xxx G#cell_line_M
survivor G#cell_line_M xxx G#cell_line_M
cell G#cell_line_M xxx G#cell_line_M
line G#cell_line_E xxx G#cell_line_E
, NE , NE
following NE xxx NE
infection NE xxx NE
of NE xx NE
Jurkat G#cell_line_B Xxxx G#cell_line_B
CD4+ G#cell_line_M XXd+ G#cell_line_M
T G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
with NE xxx NE
dl-NF G#virus xx-XX G#virus
, NE , NE
a NE x NE
mutated G#virus_B xxx G#virus_B
strain G#virus_M xxx G#virus_M
of G#virus_M xx G#virus_M
human G#virus_M xxx G#virus_M
immunodeficiency G#virus_M xxx G#virus_M
virus G#virus_M xxx G#virus_M
type G#virus_M xxx G#virus_M
1 G#virus_E d G#virus_E
( NE ( NE
HIV-1 G#virus XXX-d G#virus
) NE ) NE
containing NE xxx NE
a NE x NE
deletion NE xxx NE
of NE xx NE
the NE xxx NE
long G#DNA_domain_or_region_B xxx G#DNA_domain_or_region_B
terminal G#DNA_domain_or_region_M xxx G#DNA_domain_or_region_M
repeat G#DNA_domain_or_region_E xxx G#DNA_domain_or_region_E
( NE ( NE
LTR G#DNA_domain_or_region XXX G#DNA_domain_or_region
) NE ) NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
sites NE xxx NE
. NE . NE

J G#cell_line_B X G#cell_line_B
delta G#cell_line_M xxx G#cell_line_M
K G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
exhibited NE xxx NE
very NE xxx NE
low NE xxx NE
levels NE xxx NE
of NE xx NE
constitutive G#other_name_B xxx G#other_name_B
HIV G#other_name_M XXX G#other_name_M
production G#other_name_E xxx G#other_name_E
. NE . NE

HIV-1 G#other_name_B XXX-d G#other_name_B
expression G#other_name_E xxx G#other_name_E
was NE xxx NE
activated NE xxx NE
from NE xxx NE
J G#cell_line_B X G#cell_line_B
delta G#cell_line_M xxx G#cell_line_M
K G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
by NE xx NE
treatment NE xxx NE
with NE xxx NE
phorbol G#other_organic_compound_B xxx G#other_organic_compound_B
myristate G#other_organic_compound_M xxx G#other_organic_compound_M
acetate G#other_organic_compound_E xxx G#other_organic_compound_E
( NE ( NE
PMA G#other_organic_compound XXX G#other_organic_compound
) NE ) NE
, NE , NE
sodium G#other_organic_compound_B xxx G#other_organic_compound_B
butyrate G#other_organic_compound_E xxx G#other_organic_compound_E
( NE ( NE
NaB G#other_organic_compound XxX G#other_organic_compound
) NE ) NE
, NE , NE
or NE xx NE
hexamethylene G#other_organic_compound_B xxx G#other_organic_compound_B
bisacetamide G#other_organic_compound_E xxx G#other_organic_compound_E
( NE ( NE
HMBA G#other_organic_compound XXXX G#other_organic_compound
) NE ) NE
, NE , NE
but NE xxx NE
not NE xxx NE
tumor G#protein_molecule_B xxx G#protein_molecule_B
necrosis G#protein_molecule_M xxx G#protein_molecule_M
factor G#protein_molecule_M xxx G#protein_molecule_M
alpha G#protein_molecule_E xxx G#protein_molecule_E
( NE ( NE
TNF-alpha G#protein_molecule XXX-xxx G#protein_molecule
) NE ) NE
, NE , NE
confirming NE xxx NE
the NE xxx NE
role NE xxx NE
of NE xx NE
NF-kappa G#protein_molecule_B XX-xxx G#protein_molecule_B
B G#protein_molecule_E X G#protein_molecule_E
in NE xx NE
mediating NE xxx NE
TNF-alpha G#protein_molecule XXX-xxx G#protein_molecule
induction NE xxx NE
of NE xx NE
HIV G#other_name_B XXX G#other_name_B
transcription G#other_name_E xxx G#other_name_E
. NE . NE

The NE Xxx NE
strong NE xxx NE
induction NE xxx NE
of NE xx NE
HIV G#other_name_B XXX G#other_name_B
expression G#other_name_E xxx G#other_name_E
by NE xx NE
NaB G#other_organic_compound XxX G#other_organic_compound
or NE xx NE
HMBA G#other_organic_compound XXXX G#other_organic_compound
in NE xx NE
J G#cell_line_B X G#cell_line_B
delta G#cell_line_M xxx G#cell_line_M
K G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
clearly NE xxx NE
demonstrates NE xxx NE
the NE xxx NE
existence NE xxx NE
of NE xx NE
NF-kappa NE XX-xxx NE
B NE X NE
-independent NE -xxx NE
mechanisms NE xxx NE
of NE xx NE
HIV NE XXX NE
activation NE xxx NE
in NE xx NE
chronically NE xxx NE
infected NE xxx NE
cells NE xxx NE
. NE . NE

J G#cell_line_B X G#cell_line_B
delta G#cell_line_M xxx G#cell_line_M
K G#cell_line_M X G#cell_line_M
cells G#cell_line_E xxx G#cell_line_E
may NE xxx NE
provide NE xxx NE
a NE x NE
useful NE xxx NE
model NE xxx NE
for NE xxx NE
characterizing NE xxx NE
NF-kappa NE XX-xxx NE
B NE X NE
-independent NE -xxx NE
transcriptional NE xxx NE
activation NE xxx NE
of NE xx NE
the NE xxx NE
HIV NE XXX NE
LTR NE XXX NE
. NE . NE

JNK G#protein_family_or_group XXX G#protein_family_or_group
is NE xx NE
involved NE xxx NE
in NE xx NE
signal G#other_name_B xxx G#other_name_B
integration G#other_name_E xxx G#other_name_E
during NE xxx NE
costimulation G#other_name xxx G#other_name
of NE xx NE
T G#cell_type_B X G#cell_type_B
lymphocytes G#cell_type_E xxx G#cell_type_E
. NE . NE

T G#other_name_B X G#other_name_B
lymphocyte G#other_name_M xxx G#other_name_M
activation G#other_name_E xxx G#other_name_E
and NE xxx NE
interleukin-2 NE xxx-d NE
( NE ( NE
IL-2 NE XX-d NE
) NE ) NE
production NE xxx NE
require NE xxx NE
at NE xx NE
least NE xxx NE
two NE xxx NE
signals NE xxx NE
, NE , NE
generated NE xxx NE
by NE xx NE
phorbol NE xxx NE
ester NE xxx NE
( NE ( NE
TPA NE XXX NE
) NE ) NE
and NE xxx NE
Ca2+ NE Xxd+ NE
ionophore NE xxx NE
or NE xx NE
costimulation NE xxx NE
of NE xx NE
the NE xxx NE
T NE X NE
cell NE xxx NE
receptor NE xxx NE
( NE ( NE
TCR NE XXX NE
) NE ) NE
and NE xxx NE
the NE xxx NE
CD28 NE XXdd NE
auxiliary NE xxx NE
receptor NE xxx NE
. NE . NE

We NE Xx NE
investigated NE xxx NE
how NE xxx NE
these NE xxx NE
stimuli NE xxx NE
affect NE xxx NE
mitogen G#protein_family_or_group_B xxx G#protein_family_or_group_B
activated G#protein_family_or_group_M xxx G#protein_family_or_group_M
protein G#protein_family_or_group_M xxx G#protein_family_or_group_M
(MAP) G#protein_family_or_group_M (XXX) G#protein_family_or_group_M
kinases G#protein_family_or_group_E xxx G#protein_family_or_group_E
. NE . NE

Full NE Xxxx NE
activation NE xxx NE
of NE xx NE
the NE xxx NE
MAP G#protein_family_or_group_B XXX G#protein_family_or_group_B
kinases G#protein_family_or_group_E xxx G#protein_family_or_group_E
that NE xxx NE
phosphorylate NE xxx NE
the NE xxx NE
Jun G#protein_domain_or_region_B Xxx G#protein_domain_or_region_B
activation G#protein_domain_or_region_M xxx G#protein_domain_or_region_M
domain G#protein_domain_or_region_E xxx G#protein_domain_or_region_E
, NE , NE
JNK1 G#protein_molecule XXXd G#protein_molecule
and NE xxx NE
JNK2 G#protein_molecule XXXd G#protein_molecule
, NE , NE
required NE xxx NE
costimulation NE xxx NE
of NE xx NE
T G#cell_type_B X G#cell_type_B
cells G#cell_type_E xxx G#cell_type_E
with NE xxx NE
either NE xxx NE
TPA G#other_organic_compound XXX G#other_organic_compound
and NE xxx NE
Ca2+ G#other_organic_compound_B Xxd+ G#other_organic_compound_B
ionophore G#other_organic_compound_E xxx G#other_organic_compound_E
or NE xx NE
antibodies NE xxx NE
to NE xx NE
TCR G#protein_family_or_group XXX G#protein_family_or_group
and NE xxx NE
CD28 G#protein_molecule XXdd G#protein_molecule
. NE . NE

Alone NE Xxxx NE
, NE , NE
each NE xxx NE
stimulus NE xxx NE
resulted NE xxx NE
in NE xx NE
little NE xxx NE
or NE xx NE
no NE xx NE
activation NE xxx NE
. NE . NE

Similar NE Xxxx NE
to NE xx NE
its NE xxx NE
effect NE xxx NE
on NE xx NE
IL-2 G#other_name_B XX-d G#other_name_B
induction G#other_name_E xxx G#other_name_E
, NE , NE
cyclosporin G#other_organic_compound_B xxx G#other_organic_compound_B
A G#other_organic_compound_E X G#other_organic_compound_E
( NE ( NE
CsA G#other_organic_compound XxX G#other_organic_compound
) NE ) NE
inhibited NE xxx NE
the NE xxx NE
synergistic NE xxx NE
activation NE xxx NE
of NE xx NE
JNK G#protein_molecule XXX G#protein_molecule
, NE , NE
and NE xxx NE
a NE x NE
competitive NE xxx NE
inhibitor NE xxx NE
of NE xx NE
Jun G#other_name_B Xxx G#other_name_B
phosphorylation G#other_name_E xxx G#other_name_E
by NE xx NE
JNK G#protein_molecule XXX G#protein_molecule
inhibited NE xxx NE
IL-2 G#other_name_B XX-d G#other_name_B
promoter G#other_name_M xxx G#other_name_M
activation G#other_name_E xxx G#other_name_E
. NE . NE

